data_2kil_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kil _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 tp . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.637 0.256 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.43 -51.41 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.168 0.509 . . . . 0.0 109.87 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -69.12 -22.26 63.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.495 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -69.64 -54.13 15.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.6 t -61.71 -35.81 69.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.01 0.433 . . . . 0.0 109.835 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.8 tp -70.98 -43.25 68.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.097 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -51.95 -46.09 64.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -61.28 -48.2 82.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.681 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.588 ' SD ' ' CZ ' ' A' ' 72' ' ' PHE . 10.9 tpt -53.84 -43.04 69.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.726 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.15 -35.25 67.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.403 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.01 -23.36 31.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.239 0.542 . . . . 0.0 110.028 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.17 -34.39 19.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.156 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -84.69 -76.62 0.3 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.8 m -91.66 -19.83 22.25 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.282 0.563 . . . . 0.0 110.786 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.02 173.99 26.48 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.825 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.3 ttt -68.74 -29.76 68.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.796 -1.202 . . . . 0.0 110.518 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -62.06 -41.71 98.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.065 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.52 -37.83 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 -51.82 -45.22 63.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -71.73 -29.27 64.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.144 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -67.46 -50.49 58.91 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.492 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -81.26 -22.93 38.31 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.454 -179.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.3 tt -74.32 -56.0 5.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.145 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -61.55 -22.98 65.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.547 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -81.35 -38.27 26.94 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.526 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 78.7 m-70 . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.792 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.777 0.323 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 41.4 mp0 -72.65 -32.81 66.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.812 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.98 -58.26 5.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.134 0.492 . . . . 0.0 110.66 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -37.67 -44.1 0.68 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.042 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.1 t -73.24 -31.23 64.0 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.156 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.9 mt -71.42 -51.25 34.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.129 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.39 -21.7 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.84 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -80.17 -41.52 25.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.002 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 29' ' ' HIS . 72.5 m-20 -58.62 -57.14 14.28 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.834 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 p -58.63 -39.05 74.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.483 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.56 -39.65 84.72 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.221 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -63.61 -31.85 73.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -74.28 -41.31 61.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.562 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.0 mt -80.98 -6.37 58.67 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.652 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 56.11 47.79 18.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.488 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mmt -126.54 149.05 66.79 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.066 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -63.11 135.77 52.69 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.381 1.387 . . . . 0.0 111.092 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 tt -49.11 -28.3 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.156 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -71.78 -34.5 69.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.055 0.455 . . . . 0.0 111.582 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -76.03 -31.77 59.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.066 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.2 t -71.83 -56.16 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.734 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.63 -44.45 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.396 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -52.33 -50.45 62.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.255 0.55 . . . . 0.0 109.518 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.14 -57.39 12.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.925 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.549 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 8.1 m-30 -45.53 -29.72 1.24 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.391 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.19 -48.07 73.98 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -58.24 -52.34 65.98 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.067 0.46 . . . . 0.0 110.054 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 12' ' ' MET . 63.1 m-85 -56.59 -40.18 74.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.747 0.785 . . . . 0.0 110.616 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.9 tp -59.22 -37.85 78.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.387 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -70.54 -37.9 74.11 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.968 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -58.11 -71.31 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.887 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.07 -41.79 30.2 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.296 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.402 ' C ' ' N ' ' A' ' 79' ' ' SER . 24.2 mt -58.39 -43.37 88.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.368 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -51.75 -17.56 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.161 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.43 ' O ' ' OG1' ' A' ' 82' ' ' THR . 8.0 t -85.73 -40.88 15.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.247 0.546 . . . . 0.0 109.62 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -65.44 -72.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.471 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.536 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -87.84 36.91 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.399 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 6.8 m -49.45 -48.99 47.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.926 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -51.43 -33.67 31.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.18 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.538 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 7.1 t -73.82 -29.24 25.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.499 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.582 ' C ' ' H ' ' A' ' 87' ' ' LYS . 89.3 t -76.22 -44.68 36.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.562 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 54.7 t0 -58.24 3.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.366 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.582 ' H ' ' C ' ' A' ' 85' ' ' VAL . 30.6 mtmt -90.57 -22.45 21.27 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.538 ' CZ ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -104.13 125.83 50.76 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.794 -179.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 56.6 p30 -88.44 -6.07 57.87 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 58.8 m-20 -160.29 164.12 32.84 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.636 0.731 . . . . 0.0 112.535 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -55.1 -44.29 74.77 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.979 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.9 m -57.71 -59.72 4.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.352 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 97.4 p -45.67 -40.14 8.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.367 0.604 . . . . 0.0 110.792 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.44 -41.59 96.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.428 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.89 -40.84 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.384 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.9 ptm -83.25 -3.16 57.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.307 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -116.41 -15.74 6.89 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 119.123 -0.82 . . . . 0.0 113.357 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 97' ' ' GLY . 18.8 mt -25.09 -104.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 118.04 0.92 . . . . 0.0 112.477 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -40.38 -49.0 2.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.068 0.461 . . . . 0.0 111.466 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -45.63 -83.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 3.8 m -73.31 -53.81 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.48 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 3.3 mp -59.27 -49.84 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.939 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.33 -55.13 32.41 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.8 tp -49.18 -48.0 45.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.154 0.502 . . . . 0.0 109.769 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -57.59 -46.46 83.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.042 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.6 t -54.22 -50.15 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -49.07 -43.59 41.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.717 0.294 . . . . 0.0 110.803 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp . . . . . 0 C--N 1.33 -0.278 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.211 179.778 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 C--O 1.231 0.108 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.1 128.54 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.716 0.293 . . . . 0.0 110.959 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -133.58 123.57 25.35 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.652 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.12 158.22 14.64 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -149.95 160.1 43.87 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.568 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 1.4 mm? -106.74 146.02 31.34 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.99 160.4 40.99 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.25 -38.12 2.9 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.596 2.197 . . . . 0.0 113.054 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -79.49 44.83 0.63 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.953 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 44.39 58.29 3.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.413 0.625 . . . . 0.0 110.72 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -135.11 159.94 39.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.107 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 45.0 mt -137.41 117.12 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.3 122.86 32.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.049 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.1 tp -118.8 133.03 56.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.044 0.45 . . . . 0.0 111.205 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -114.79 122.98 48.03 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.481 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 62.1 t80 . . . . . 0 N--CA 1.469 0.486 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.786 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.1 tp . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 121.215 0.531 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 172' ' ' CYS . 74.4 m -42.08 -43.87 3.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.469 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -48.87 -41.98 35.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.961 0.41 . . . . 0.0 110.375 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.6 t -64.29 -43.27 95.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -44.52 -50.1 9.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.59 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.03 -49.56 77.17 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.164 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.01 -48.96 50.89 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.0 -55.1 39.36 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.58 0.229 . . . . 0.0 111.315 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.7 mt -54.14 -54.38 40.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.909 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -51.52 -48.02 63.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.952 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.49 -51.54 57.18 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.8 -59.76 2.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.881 0.372 . . . . 0.0 110.844 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -48.28 -51.68 24.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.873 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -52.03 -47.86 64.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.218 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -49.48 -49.9 43.64 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.64 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.507 ' CZ ' ' OD1' ' A' ' 90' ' ' ASP . 71.5 t80 -85.48 37.17 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.939 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 39.21 57.57 1.99 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.021 0.439 . . . . 0.0 111.199 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.468 HE21 ' H ' ' A' ' 156' ' ' LYS . 51.7 tp60 -131.59 143.43 50.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.468 ' H ' HE21 ' A' ' 155' ' ' GLN . 59.9 mttp -118.85 105.25 11.32 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.8 pt -114.47 175.49 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.596 0.712 . . . . 0.0 111.718 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -138.08 127.67 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.407 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mt -111.31 117.76 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.602 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.1 t -98.28 98.89 10.09 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.602 ' CD2' ' SG ' ' A' ' 164' ' ' CYS . 23.7 t-160 -92.14 69.92 5.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.005 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.52 -57.28 3.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.56 119.53 21.26 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.464 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 1.7 m -143.64 119.06 10.28 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.122 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 38.0 ttp -36.11 -21.69 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.036 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 164' ' ' CYS . 58.3 t-80 -51.19 -22.0 2.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.438 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.3 t -91.43 -41.42 10.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.103 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.438 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 126.5 12.25 3.46 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.86 171.6 6.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.0 0.429 . . . . 0.0 110.817 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 171' ' ' HIS . 42.1 p-10 -53.31 -35.65 60.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.273 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.519 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 5.1 p-80 -174.52 -167.06 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 1.7 m -94.9 142.97 26.85 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.758 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 28.3 ttm -119.49 116.12 25.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.058 0.456 . . . . 0.0 109.954 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mt -118.15 99.53 6.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.491 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.5 mm -85.27 126.24 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.939 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.31 149.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.35 0.595 . . . . 0.0 110.375 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -144.14 142.48 30.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.349 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.35 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 tp . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.773 0.321 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.1 mm -72.31 -41.07 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 1.2 m-30 -75.48 -25.45 57.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.643 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -69.16 -52.77 24.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.821 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.71 -39.13 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.061 0.457 . . . . 0.0 109.855 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.9 tp -67.02 -47.62 70.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.87 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -50.37 -44.5 54.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.958 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.18 -54.37 46.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.383 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.439 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 28.5 ttt -51.05 -41.45 59.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.061 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.15 -36.71 77.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.509 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.7 t -62.04 -23.12 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.264 0.554 . . . . 0.0 110.032 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.04 -34.31 18.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.026 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -85.88 -76.51 0.33 Allowed 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.1 m -90.69 -17.71 26.31 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.314 0.578 . . . . 0.0 110.599 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.87 179.19 30.56 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.741 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.8 ttp -72.95 -30.5 63.91 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.004 -1.098 . . . . 0.0 110.701 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.2 t -60.55 -39.31 87.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.981 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.04 -38.61 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 55.4 t-105 -55.26 -47.47 75.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.204 0.526 . . . . 0.0 110.071 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -74.76 -25.8 59.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.494 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.64 -47.48 26.23 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.978 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.495 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -78.34 -23.34 47.02 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.861 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 6.9 tt -76.35 -43.4 41.1 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.366 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -67.74 -18.89 65.04 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.26 -30.83 18.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.474 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.2 m80 . . . . . 0 N--CA 1.463 0.195 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.637 -179.767 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.782 0.325 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -56.62 -29.56 62.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.874 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.8 OUTLIER -51.18 -56.52 12.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.081 0.467 . . . . 0.0 110.978 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -39.87 -42.17 1.27 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.867 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 m -74.05 -29.78 62.07 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.919 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 47' ' ' LEU . 17.8 mt -73.4 -51.4 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.275 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -59.15 -25.08 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.155 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.43 ' O ' ' OE1' ' A' ' 56' ' ' GLN . 6.7 tt0 -77.2 -40.83 43.74 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.735 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -59.3 -56.97 15.33 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.858 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.26 -39.55 52.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.86 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.01 -38.58 83.09 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.479 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.437 ' NE2' ' N ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -63.03 -31.94 73.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -73.28 -40.6 64.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.672 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.7 mt -83.15 -8.91 59.44 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.615 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 58.1 51.54 8.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.453 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.6 mmt -131.14 149.89 74.99 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.448 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.18 138.48 72.52 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.534 1.489 . . . . 0.0 111.27 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 tt -53.18 -28.75 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.654 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -74.59 -29.65 61.4 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.302 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -78.64 -35.22 45.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.034 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.538 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.0 t -65.06 -59.65 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -48.99 -38.8 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.793 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -45.15 70.25 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.18 -57.44 10.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.898 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.538 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 6.3 m-30 -45.18 -29.15 0.88 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.313 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.67 -51.29 58.48 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.515 ' NE2' ' OE1' ' A' ' 151' ' ' GLN . 39.9 tt0 -58.0 -52.93 63.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.995 0.426 . . . . 0.0 110.32 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.439 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 61.1 m-85 -55.0 -41.3 71.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.722 0.772 . . . . 0.0 110.507 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.5 tp -59.05 -38.68 79.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.411 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -67.48 -40.38 85.29 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.139 -0.625 . . . . 0.0 109.896 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -57.93 -69.37 0.18 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.305 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.11 -42.01 30.83 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.74 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.88 -43.27 81.09 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.376 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -52.94 -27.45 18.97 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.424 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.8 t -74.42 -38.61 63.01 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -65.05 -69.22 0.3 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.802 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -98.49 47.03 0.99 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.036 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 7.2 m -51.49 -44.41 62.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.767 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 92.7 m-20 -56.8 -30.13 63.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.609 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.7 t -79.15 -20.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.767 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.526 ' C ' ' H ' ' A' ' 87' ' ' LYS . 49.0 t -75.88 -40.47 38.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.306 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 83' ' ' ASP . 29.8 p-10 -52.82 -8.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.045 0.45 . . . . 0.0 110.661 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 85' ' ' VAL . 56.9 mttm -73.02 -29.96 63.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.468 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.612 ' CZ ' ' CE2' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -97.56 119.6 36.41 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.021 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 53.4 p30 -88.24 -19.09 27.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.498 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 49.4 p30 -156.44 148.04 22.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.752 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -37.67 -40.65 0.43 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.04 0.447 . . . . 0.0 111.176 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.6 m -63.74 -41.67 98.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.869 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.433 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 38.7 m -61.34 -36.67 80.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.527 0.68 . . . . 0.0 110.375 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 98' ' ' ILE . 7.2 tt -65.53 -63.28 1.13 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.462 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.6 t -48.65 -41.72 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.789 0.328 . . . . 0.0 111.722 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.429 ' C ' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -85.49 -6.03 59.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.448 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -110.28 -14.38 13.28 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.659 -0.523 . . . . 0.0 112.439 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.495 ' O ' ' O ' ' A' ' 97' ' ' GLY . 39.8 mt -29.58 -104.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 117.395 0.597 . . . . 0.0 112.58 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.504 ' HD1' ' H ' ' A' ' 99' ' ' HIS . 9.0 p-80 -39.47 -48.33 1.97 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.06 0.457 . . . . 0.0 111.494 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -44.99 -87.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.506 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.5 m -71.05 -51.66 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.506 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mp -63.63 -47.81 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.651 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.14 -52.6 46.03 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.42 ' CD1' ' HZ3' ' A' ' 108' ' ' LYS . 31.9 tp -49.51 -48.17 48.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.119 0.485 . . . . 0.0 110.31 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -57.43 -45.37 84.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.118 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 82.3 t -52.37 -51.92 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -49.42 -41.66 40.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.803 0.335 . . . . 0.0 110.547 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.42 ' HZ3' ' CD1' ' A' ' 104' ' ' LEU . 24.4 mmtm . . . . . 0 C--N 1.329 -0.312 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.495 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 79.2 m80 . . . . . 0 C--O 1.232 0.132 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.6 mt -124.63 128.75 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.71 0.29 . . . . 0.0 110.707 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.619 ' ND2' ' NH2' ' A' ' 131' ' ' ARG . 4.3 m-80 -132.62 115.1 15.0 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.427 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.84 123.68 5.9 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -116.99 152.27 34.97 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 8.8 mp -99.67 148.0 24.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.06 160.67 42.13 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.35 -40.61 2.19 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.573 2.182 . . . . 0.0 113.062 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -77.77 43.67 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.874 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 46.03 60.86 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.267 0.556 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -138.0 160.83 38.31 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.085 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.1 mt -141.84 117.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.69 121.47 31.1 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.845 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.5 tp -114.54 134.85 54.72 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.908 0.385 . . . . 0.0 110.137 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.619 ' NH2' ' ND2' ' A' ' 119' ' ' ASN . 23.5 ttp-105 -120.79 125.22 47.02 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.108 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 141' ' ' CYS . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 121.067 0.46 . . . . 0.0 110.214 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 85.5 m -39.9 -44.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.624 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.601 ' CE2' ' NE2' ' A' ' 166' ' ' HIS . 94.4 m-85 -53.75 -34.76 60.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.629 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 138' ' ' LEU . 43.8 t -69.79 -46.29 66.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.118 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.27 -46.07 12.41 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.384 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.49 -47.81 80.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.732 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.19 -52.47 40.1 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.1 mt -53.32 -55.73 22.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.746 0.308 . . . . 0.0 110.805 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 20.2 mt -54.82 -54.67 39.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.4 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -50.15 -50.58 48.45 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.093 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.11 -49.99 67.8 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.358 -0.448 . . . . 0.0 111.996 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.03 -59.74 2.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.891 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -53.9 -51.99 61.95 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.477 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.515 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 86.6 mt-30 -51.83 -56.68 12.49 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 120.853 0.359 . . . . 0.0 111.164 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -41.5 -47.52 3.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.921 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.612 ' CE2' ' CZ ' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -86.17 36.46 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.665 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 151' ' ' GLN . 6.5 tt0 42.29 57.77 3.23 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.395 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.544 ' NE2' ' N ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -131.76 153.62 49.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.544 ' N ' ' NE2' ' A' ' 155' ' ' GLN . 56.4 mttp -121.7 116.44 24.54 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 31.4 pt -130.2 173.82 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.369 0.604 . . . . 0.0 111.728 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -140.37 126.85 20.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.927 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mt -110.97 118.42 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.4 t -101.81 110.92 23.01 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.667 0.27 . . . . 0.0 111.016 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.553 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 50.1 p-80 -102.57 73.57 1.31 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.688 0.756 . . . . 0.0 111.494 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -76.56 -18.88 58.43 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.801 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 108.4 13.21 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.587 ' SG ' ' CD2' ' A' ' 166' ' ' HIS . 9.1 t -133.68 118.82 18.59 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.608 0.242 . . . . 0.0 110.868 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 44.4 ttm -35.8 -22.36 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.214 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.601 ' NE2' ' CE2' ' A' ' 140' ' ' PHE . 28.3 m-70 -51.43 -23.28 3.7 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.1 t -89.31 -41.89 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.021 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.458 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 127.88 13.3 2.75 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.83 159.43 19.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.998 0.428 . . . . 0.0 110.831 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -56.7 -27.76 59.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.399 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -168.87 175.88 5.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 9.5 m -91.72 143.81 26.16 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.805 0.335 . . . . 0.0 110.627 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.2 tpp -121.99 120.52 34.64 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.44 104.83 8.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.394 0.616 . . . . 0.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.479 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -91.23 125.36 43.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.4 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.32 152.59 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.999 0.428 . . . . 0.0 110.27 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -143.95 141.99 30.51 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.995 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.463 0.193 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.926 179.306 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.49 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 49.6 mm -57.78 -53.89 38.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 0.0 109.755 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -67.56 -18.75 65.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.568 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -73.39 -56.2 5.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.471 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t -56.99 -36.03 49.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -72.09 -41.75 66.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.752 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -51.82 -44.38 63.5 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -61.53 -50.65 71.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.987 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.476 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 13.5 ttt -52.55 -42.89 64.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 86.8 t -68.89 -35.91 71.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.462 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -61.01 -23.42 29.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.336 0.589 . . . . 0.0 109.799 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.22 -34.43 20.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.174 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -85.06 -75.86 0.34 Allowed 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.7 m -92.03 -20.75 21.0 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.234 0.54 . . . . 0.0 110.741 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.8 172.04 25.52 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.819 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 ttt -66.92 -29.08 68.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.798 -1.201 . . . . 0.0 110.55 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t -62.51 -41.54 98.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.133 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.68 -35.87 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -51.97 -45.82 64.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.223 0.535 . . . . 0.0 109.578 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -72.24 -29.65 64.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.211 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -67.39 -49.24 64.69 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -82.38 -23.46 34.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.793 0.33 . . . . 0.0 110.651 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.6 tt -72.62 -61.8 1.68 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.401 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.2 -22.11 60.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.687 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -81.2 -41.15 22.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.488 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 91.7 m-70 . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.554 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.729 0.299 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.42 ' O ' ' OG ' ' A' ' 49' ' ' SER . 98.4 mt-10 -61.27 -42.57 98.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.83 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -40.82 -58.76 1.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.928 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -37.68 -43.36 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.539 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 91.5 p -72.48 -33.32 66.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.272 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.0 mp -68.38 -54.83 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.028 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -24.61 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.878 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.427 ' O ' ' OE1' ' A' ' 56' ' ' GLN . 5.8 tt0 -75.56 -41.79 53.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.598 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.488 ' OD2' ' CD2' ' A' ' 29' ' ' HIS . 19.5 m-20 -58.62 -56.83 17.11 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.136 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.19 -38.82 63.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.096 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.11 -38.5 79.71 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.179 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.502 ' NE2' ' N ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -63.77 -31.68 72.94 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -73.79 -40.56 63.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.9 mt -85.25 -6.75 59.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.085 0.469 . . . . 0.0 110.004 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.489 ' O ' ' SD ' ' A' ' 60' ' ' MET . 20.7 m120 56.47 61.18 2.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.973 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 52.3 mmm -139.76 149.84 60.79 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.708 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.21 136.86 53.68 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.405 1.403 . . . . 0.0 110.778 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 tt -50.21 -27.66 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.042 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -73.44 -31.38 63.79 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.481 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.7 -34.05 52.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.995 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.469 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 84.8 t -69.5 -57.21 9.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.506 ' CG2' ' SG ' ' A' ' 141' ' ' CYS . 9.3 p -51.99 -42.23 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.308 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -52.75 -50.3 63.75 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.38 -48.22 81.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.757 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.469 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.0 m-30 -52.12 -30.42 26.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.632 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.44 -48.13 71.82 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -56.89 -51.74 67.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.931 0.396 . . . . 0.0 109.98 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 55.4 m-85 -58.68 -42.53 88.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.818 0.818 . . . . 0.0 110.447 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.8 tp -56.8 -39.26 73.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.335 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 38.1 t80 -69.0 -41.31 77.97 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.002 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -55.9 -69.28 0.15 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.199 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.63 -46.89 30.37 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.397 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.8 mt -51.0 -43.69 60.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.724 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -54.7 -25.9 30.27 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.277 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 82' ' ' THR . 32.9 t -74.4 -55.68 5.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.045 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.17 -38.04 63.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.781 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -94.26 25.43 3.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.555 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 55.9 m -52.83 -39.0 62.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 110.002 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -57.91 -31.12 66.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.22 -20.17 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.55 -40.81 89.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -53.22 -19.66 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.387 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -64.72 -29.47 70.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.797 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 7.0 p90 -122.54 115.27 21.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.887 0.375 . . . . 0.0 110.843 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 54.8 p30 -85.69 -3.41 58.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.451 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.601 ' H ' ' HG ' ' A' ' 93' ' ' SER . 61.7 m-20 -160.86 156.96 25.83 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.088 0.471 . . . . 0.0 111.452 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -48.12 -53.05 17.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.812 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.8 m -55.69 -42.41 75.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.655 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.601 ' HG ' ' H ' ' A' ' 90' ' ' ASP . 91.0 p -63.0 -38.27 90.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.447 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.0 tt -64.12 -48.97 74.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.004 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.5 t -58.25 -37.39 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 0.0 110.776 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 120' ' ' GLY . 95.6 mmm -87.24 -4.89 59.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.088 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.7 -16.93 7.75 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.163 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.507 ' O ' ' O ' ' A' ' 97' ' ' GLY . 11.2 mt -27.43 -106.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 117.828 0.814 . . . . 0.0 112.645 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -40.45 -48.35 2.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.118 0.485 . . . . 0.0 111.074 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -44.46 -86.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.2 m -72.86 -52.17 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.494 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.8 mp -63.97 -48.3 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.617 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.02 -54.63 35.96 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.9 tp -48.8 -50.58 33.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.138 0.495 . . . . 0.0 110.101 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -54.26 -46.38 72.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.389 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 64.3 t -53.87 -53.38 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -46.54 -43.51 17.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.804 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp . . . . . 0 C--N 1.329 -0.301 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.516 -179.909 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 76.4 m80 . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 120.484 0.183 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.44 123.96 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.45 99.41 5.82 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.892 0.377 . . . . 0.0 110.927 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.479 ' O ' ' SD ' ' A' ' 96' ' ' MET . . . -102.89 123.41 7.83 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -118.87 162.11 19.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.897 0.379 . . . . 0.0 110.447 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -108.12 143.76 36.45 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.12 160.37 41.39 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.77 -38.06 3.38 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.538 2.159 . . . . 0.0 113.343 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -81.0 46.17 0.88 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.27 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 43.7 59.31 3.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 110.685 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -135.52 157.98 45.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.884 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.0 mt -137.06 117.52 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.33 119.99 27.2 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.755 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.5 tp -114.04 125.89 54.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 110.789 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.677 HH21 ' NE2' ' A' ' 171' ' ' HIS . 9.4 tpt180 -111.18 119.73 39.92 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 t80 . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.127 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 3.4 mm? . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 121.298 0.57 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 15.8 p -42.14 -46.57 4.39 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.794 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.596 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 88.6 m-85 -51.49 -38.5 54.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.086 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.506 ' SG ' ' CG2' ' A' ' 66' ' ' VAL . 68.4 m -65.8 -43.29 89.15 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.162 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.54 -49.86 18.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.947 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -62.64 -51.2 68.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.087 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.53 -46.39 37.41 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.5 mt -59.11 -54.29 48.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.707 0.289 . . . . 0.0 111.428 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 mt -55.26 -56.12 23.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.983 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -50.58 -47.6 57.88 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.841 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.02 -50.84 63.57 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.41 -58.48 2.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.002 0.43 . . . . 0.0 110.613 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.7 -52.01 57.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.701 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -50.48 -48.78 56.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.113 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.4 ' ND1' ' C ' ' A' ' 152' ' ' HIS . 16.8 t-80 -48.66 -48.92 39.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.689 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -89.22 39.12 0.92 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.236 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 37.49 57.53 1.37 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.943 0.401 . . . . 0.0 111.379 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.682 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 42.1 tp60 -129.82 141.0 50.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.682 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 21.4 tptp -112.61 124.62 52.95 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.3 pt -138.1 170.3 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.735 0.779 . . . . 0.0 111.975 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -133.63 127.65 33.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.335 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mt -110.0 120.62 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.653 0.263 . . . . 0.0 110.447 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.6 t -103.69 103.81 13.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.771 0.32 . . . . 0.0 110.894 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.1 p-80 -97.14 74.17 2.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.435 0.636 . . . . 0.0 111.338 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -77.29 -7.5 56.08 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.442 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.505 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 4.7 m -123.94 105.79 9.89 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.594 ' O ' ' N ' ' A' ' 166' ' ' HIS . 20.7 t -137.23 114.34 10.74 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.305 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 38.9 ttm -36.34 -18.24 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' CYS . 51.9 m80 -58.15 -28.08 64.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.499 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.2 t -82.41 -46.13 13.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.799 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.499 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 152.65 15.17 0.07 OUTLIER Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.247 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.19 145.64 32.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.907 0.384 . . . . 0.0 110.532 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.469 ' C ' ' ND1' ' A' ' 171' ' ' HIS . 85.7 m-20 -83.44 19.27 1.59 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.021 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.677 ' NE2' HH21 ' A' ' 131' ' ' ARG . 8.5 p-80 174.65 -163.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 163' ' ' THR . 46.6 t -136.48 150.51 48.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.276 0.56 . . . . 0.0 111.426 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.402 ' H ' ' HB ' ' A' ' 163' ' ' THR . 14.8 ttp -126.89 109.95 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.325 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -108.62 111.95 24.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.319 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.6 mp -93.84 128.64 45.06 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.478 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.4 mp -109.63 150.65 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.477 0.656 . . . . 0.0 110.63 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -136.21 134.67 38.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.773 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.463 0.224 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.632 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.464 ' CD1' ' NE ' ' A' ' 80' ' ' ARG . 2.4 tp . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.682 0.277 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.1 mm -51.14 -47.5 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.53 -23.96 61.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.742 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -69.48 -51.26 37.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.426 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.51 -50.86 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.34 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.7 tp -55.46 -44.19 76.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -52.09 -50.88 60.71 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.825 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -57.6 -52.55 64.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.029 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.438 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.5 OUTLIER -47.72 -37.11 12.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.469 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -73.73 -34.76 41.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.403 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.5 t -61.33 -23.69 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.68 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.76 -34.91 22.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.982 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -84.5 -73.88 0.41 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.3 m -93.87 -21.52 19.2 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.089 0.471 . . . . 0.0 111.076 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.68 -178.82 23.3 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.827 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.0 mtm -74.07 -30.41 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.063 -1.069 . . . . 0.0 110.193 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 m -61.99 -42.82 99.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.85 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.7 -38.42 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -51.84 -45.83 64.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.309 0.576 . . . . 0.0 109.453 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -70.93 -28.84 64.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.116 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -67.9 -49.89 59.4 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.472 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -82.69 -20.23 36.54 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.934 0.397 . . . . 0.0 110.659 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 tt -76.31 -63.32 1.35 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.316 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.73 -21.93 43.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.596 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -80.01 -39.93 28.93 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.702 179.772 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.729 0.299 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -59.44 -30.98 68.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.707 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -49.55 -56.2 10.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.107 0.48 . . . . 0.0 110.576 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -38.79 -43.37 0.92 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.808 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.1 p -74.3 -29.3 61.57 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.157 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 47' ' ' LEU . 15.7 mt -72.89 -52.67 21.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.109 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.8 -24.37 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.627 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -78.03 -39.43 41.98 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.43 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -60.28 -56.85 16.48 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.282 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.66 -41.05 73.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.553 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.1 -38.98 74.16 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.887 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -63.73 -30.79 71.84 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -76.94 -38.56 53.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.583 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.74 -7.09 59.34 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.82 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 47.7 t30 56.36 49.28 15.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.54 0.686 . . . . 0.0 109.302 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.4 mmm -126.94 150.02 70.67 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.133 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.29 137.16 59.27 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 121.513 1.475 . . . . 0.0 110.912 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 tt -50.71 -29.68 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.887 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -69.98 -34.18 73.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.225 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -75.47 -32.91 60.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.104 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.1 t -71.6 -55.89 12.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.109 0.48 . . . . 0.0 110.003 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -51.91 -42.86 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.132 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -53.89 -49.85 67.64 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.03 -52.3 66.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.655 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.69 -30.95 4.2 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.707 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.24 -50.94 41.51 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -55.12 -49.72 71.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.04 0.448 . . . . 0.0 109.899 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -58.84 -42.57 89.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.7 0.762 . . . . 0.0 110.733 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.2 tp -54.99 -38.62 68.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.309 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 34.2 t80 -71.27 -40.33 71.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.01 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -57.07 -71.92 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.785 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.76 -40.38 18.29 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.286 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 79' ' ' SER . 44.4 mt -61.81 -39.2 90.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.177 0.489 . . . . 0.0 111.796 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.446 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -54.38 -11.6 0.55 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.697 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.453 ' O ' ' OG1' ' A' ' 82' ' ' THR . 9.3 t -91.91 -48.54 6.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.934 0.397 . . . . 0.0 110.483 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.464 ' NE ' ' CD1' ' A' ' 4' ' ' ILE . 5.5 mtm105 -68.64 -65.95 0.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.315 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.531 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -81.19 28.78 0.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.19 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 79' ' ' SER . 96.5 m -49.01 -45.49 42.6 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.571 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -52.48 -25.6 10.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.404 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 2.8 t -85.91 -24.57 6.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.828 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.8 t -63.05 -40.43 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.529 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -53.84 -16.19 1.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.448 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.404 ' CG ' ' O ' ' A' ' 84' ' ' VAL . 39.0 mmtm -64.85 -30.87 71.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.488 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 12.9 p90 -119.3 119.32 33.69 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.101 0.477 . . . . 0.0 111.126 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 22.1 t70 -83.87 -5.1 59.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.257 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.492 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 67.8 m-20 -159.59 156.34 27.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.089 0.471 . . . . 0.0 111.485 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -45.39 -46.98 13.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.818 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.9 m -56.9 -58.77 6.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.368 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.7 t -45.27 -40.06 7.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.12 0.485 . . . . 0.0 111.145 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.6 tt -63.81 -48.31 77.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.326 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.2 t -59.32 -40.25 80.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.573 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 9.0 ptm -87.96 -1.52 58.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.6 -18.07 7.21 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.327 -0.707 . . . . 0.0 112.851 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 94' ' ' LEU . 13.5 mt -27.41 -105.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 117.77 0.785 . . . . 0.0 112.493 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -40.56 -48.88 2.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.064 0.459 . . . . 0.0 111.141 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -44.02 -85.84 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.509 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.4 m -73.2 -52.27 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.509 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mp -64.71 -48.75 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.7 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.17 -54.49 36.62 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 tp -48.62 -49.83 35.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.191 0.52 . . . . 0.0 109.854 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -55.04 -47.17 75.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.547 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 71.8 t -51.0 -51.04 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -51.72 -40.63 60.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.692 -179.784 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.3 m80 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.696 0.284 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.0 mm -115.65 124.93 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -131.94 116.63 17.39 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.756 0.312 . . . . 0.0 110.962 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.83 158.86 14.06 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -152.79 154.65 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.3 mp -104.72 150.25 24.9 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.13 160.52 38.87 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.74 -56.62 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.627 2.218 . . . . 0.0 112.797 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.466 ' C ' ' ND2' ' A' ' 126' ' ' ASN . 22.0 m120 -45.67 -64.65 0.68 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.501 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.65 ' N ' HD21 ' A' ' 126' ' ' ASN . 0.0 OUTLIER 155.54 63.5 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.57 0.7 . . . . 0.0 109.181 179.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -142.36 165.83 26.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.694 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.6 mt -138.28 117.95 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.76 121.3 30.01 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.83 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 60.2 tp -115.61 136.42 53.09 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.984 0.421 . . . . 0.0 110.607 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -119.99 124.24 45.45 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.093 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.9 t80 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.778 179.882 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.066 0.46 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 71.2 m -41.78 -46.54 3.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.499 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -49.07 -38.39 24.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.454 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.62 -42.84 86.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 109.949 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.84 -49.79 14.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.613 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -61.33 -50.17 74.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.252 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.98 -46.58 41.25 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.75 -53.26 59.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.597 0.237 . . . . 0.0 111.258 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.8 mt -55.02 -56.49 19.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.979 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -50.76 -47.87 59.43 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.751 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.06 -51.65 57.06 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.59 -59.81 2.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.864 0.364 . . . . 0.0 110.839 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -50.51 -51.23 49.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.994 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -51.13 -47.48 62.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.1 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -49.99 -49.74 49.52 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.641 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.517 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 67.9 t80 -87.68 38.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 38.38 55.95 1.79 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.983 0.421 . . . . 0.0 111.185 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.68 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 42.0 tp60 -129.12 141.03 51.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.68 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 50.5 mtmt -113.74 124.48 52.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.05 170.47 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.635 0.731 . . . . 0.0 111.898 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -134.0 127.38 32.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.494 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.3 mt -110.17 117.44 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.3 t -105.19 119.63 39.54 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.065 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.6 p-80 -96.67 74.82 2.75 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.657 0.741 . . . . 0.0 111.376 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -76.9 -19.92 56.85 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.989 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.472 ' HG1' ' CB ' ' A' ' 173' ' ' MET . 0.4 OUTLIER -124.78 111.07 15.1 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 20.1 p -114.23 -178.91 3.49 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.563 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.492 ' O ' ' SD ' ' A' ' 165' ' ' MET . 1.1 tmt? -93.87 -26.77 16.76 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -54.83 -24.05 21.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.577 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.5 t -87.25 -25.37 24.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.286 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.04 21.73 24.71 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.946 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.4 166.17 12.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.86 0.362 . . . . 0.0 110.651 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 171' ' ' HIS . 50.4 p-10 -52.22 -31.13 30.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.427 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.524 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 5.3 p-80 -173.98 -174.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.3 m -93.06 143.41 26.27 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.155 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.472 ' CB ' ' HG1' ' A' ' 163' ' ' THR . 30.1 ttp -121.92 116.3 24.12 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.184 0.516 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.4 mt -116.05 99.49 7.29 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.203 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 13.3 mm -84.37 123.82 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.137 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.92 144.0 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.28 0.562 . . . . 0.0 110.28 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -132.17 133.69 44.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.986 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.463 0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 -179.853 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 tp . . . . . 0 N--CA 1.465 0.275 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mm -59.18 -47.81 88.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.77 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -64.19 -28.44 69.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.244 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.589 ' ND2' ' NH2' ' A' ' 80' ' ' ARG . 64.2 t30 -67.06 -55.05 15.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.016 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t -66.31 -39.0 83.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.17 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.66 -48.6 74.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.961 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -47.42 -44.87 25.01 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.882 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -62.16 -50.54 71.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.863 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.5 tmt? -52.61 -39.62 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.978 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.26 -34.97 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.426 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.0 t -62.06 -22.67 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.322 0.582 . . . . 0.0 110.05 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.35 -34.88 20.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.217 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -84.57 -77.06 0.28 Allowed 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.3 m -90.72 -19.97 22.95 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.309 0.576 . . . . 0.0 110.696 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.79 173.92 26.76 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.738 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.5 ttt -69.37 -25.81 64.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.866 -1.167 . . . . 0.0 110.494 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.0 t -64.94 -43.59 92.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.149 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -34.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -51.52 -45.77 63.03 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -69.8 -31.63 69.64 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.012 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -64.98 -51.07 63.76 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -82.34 -19.6 38.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.921 0.391 . . . . 0.0 110.732 -179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 tt -76.72 -57.16 4.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.357 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.39 -22.48 66.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.507 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -81.13 -39.4 25.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.508 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 72.8 m80 . . . . . 0 N--CA 1.467 0.388 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.188 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.795 0.331 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -62.88 -30.94 71.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.65 -55.79 2.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.027 0.441 . . . . 0.0 110.49 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -39.01 -42.79 0.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.419 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.2 m -72.29 -33.24 67.28 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.335 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.2 mp -71.04 -53.92 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.586 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.97 -24.86 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.124 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -77.6 -39.87 44.02 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.505 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 79.1 m-20 -59.52 -56.21 24.84 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.968 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 p -57.18 -39.2 65.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.026 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.73 -38.42 85.07 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.29 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -63.27 -32.03 73.34 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -73.87 -40.46 63.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.517 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -83.18 -7.72 59.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.218 0.533 . . . . 0.0 109.748 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.1 t30 56.95 49.57 13.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.549 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.9 mmt -128.43 149.52 71.83 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.151 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.24 137.93 68.89 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.49 1.46 . . . . 0.0 111.124 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tt -51.79 -29.18 10.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.014 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -71.4 -34.18 70.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.161 0.505 . . . . 0.0 111.244 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -75.51 -32.89 60.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.884 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.509 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 71.9 t -70.78 -56.53 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.441 ' CG2' ' SG ' ' A' ' 141' ' ' CYS . 7.2 p -52.56 -44.57 45.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.217 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -51.08 -50.13 59.3 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.92 -47.94 81.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.74 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.509 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 8.3 m-30 -53.77 -30.62 45.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.529 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.71 -49.86 61.77 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -56.9 -50.02 73.81 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -58.61 -42.54 88.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.775 0.797 . . . . 0.0 110.555 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.6 tp -55.73 -38.39 69.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.306 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 37.1 t80 -71.55 -39.61 70.55 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.954 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -56.44 -71.05 0.1 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.762 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.06 -45.13 33.3 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.78 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 mt -52.34 -44.41 65.15 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.181 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.458 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -54.37 -23.71 16.68 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.178 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.427 ' O ' ' OG1' ' A' ' 82' ' ' THR . 22.1 t -76.74 -53.86 7.41 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.988 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.589 ' NH2' ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -75.54 -27.84 58.82 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.764 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -107.14 22.68 15.61 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.684 0.278 . . . . 0.0 110.384 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 6.4 m -50.88 -40.72 57.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -57.56 -35.53 70.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.508 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.3 -21.85 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.674 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.588 ' C ' ' H ' ' A' ' 87' ' ' LYS . 95.4 t -85.52 -46.86 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.695 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -55.68 -2.05 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.686 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.588 ' H ' ' C ' ' A' ' 85' ' ' VAL . 86.0 mttt -78.79 -33.95 45.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.58 130.98 55.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.999 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 52.1 t0 -93.0 11.39 27.64 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 93' ' ' SER . 10.2 p-10 -167.8 163.16 14.08 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 118.987 -1.085 . . . . 0.0 113.485 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -62.13 -61.55 2.4 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.786 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.5 m -45.15 -49.3 12.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.209 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 56.9 m -59.86 -38.16 81.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.296 0.57 . . . . 0.0 110.743 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.19 -55.12 31.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.016 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.7 t -49.73 -42.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 O-C-N 123.142 0.276 . . . . 0.0 111.696 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -83.23 -6.28 59.42 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.736 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -109.24 -13.35 17.7 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.46 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 97' ' ' GLY . 49.4 mt -29.93 -104.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.431 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 2.3 p80 -37.36 -48.32 0.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.431 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 59.6 t0 -45.42 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 3.3 m -70.56 -52.9 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.524 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.8 mp -58.8 -48.47 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.71 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.58 -55.1 31.85 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 tp -50.12 -48.55 53.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 110.167 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.514 ' OE1' ' NZ ' ' A' ' 87' ' ' LYS . 37.7 tp10 -55.94 -45.78 78.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.315 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.3 t -53.5 -51.16 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -50.0 -43.35 50.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.829 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt . . . . . 0 C--N 1.329 -0.289 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.268 179.838 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.6 m80 . . . . . 0 N--CA 1.465 0.277 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.7 mt -131.22 129.82 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.687 0.28 . . . . 0.0 110.654 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -125.98 98.51 5.54 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.87 0.367 . . . . 0.0 110.371 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -103.98 119.49 6.33 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -116.58 153.5 32.13 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 8.8 mp -101.18 147.2 26.53 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.25 160.51 41.1 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.15 -38.43 3.81 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.58 2.187 . . . . 0.0 113.105 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -79.54 45.9 0.71 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.918 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 44.22 61.06 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.366 0.603 . . . . 0.0 110.562 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -139.13 158.38 44.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.095 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.6 mt -138.67 116.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.67 28.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 39.9 tp -117.09 132.39 56.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.137 0.494 . . . . 0.0 110.859 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -118.71 125.26 49.28 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.991 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.495 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 29.6 t80 . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 tp . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 121.183 0.516 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.422 ' SG ' ' NE2' ' A' ' 161' ' ' HIS . 9.4 t -41.9 -42.61 2.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.344 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -49.47 -41.69 41.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.454 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.441 ' SG ' ' CG2' ' A' ' 66' ' ' VAL . 56.7 m -65.25 -41.44 94.31 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -44.44 -49.93 9.57 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.674 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -63.78 -48.8 75.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.51 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.35 -46.63 52.02 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.147 -1.025 . . . . 0.0 110.785 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.3 mt -58.77 -55.92 28.88 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.5 mt -53.29 -55.91 20.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.749 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -50.71 -48.15 58.92 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.667 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.03 55.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.72 -60.36 1.82 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.862 0.363 . . . . 0.0 110.821 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.98 -51.01 45.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.847 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -51.36 -46.95 62.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.064 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -50.54 -50.37 53.47 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.344 -0.543 . . . . 0.0 109.563 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.518 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 66.2 t80 -86.04 37.43 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.851 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 39.2 55.65 2.16 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.992 0.425 . . . . 0.0 111.168 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.685 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 40.7 tp60 -128.88 139.8 51.97 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.685 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 11.7 mptt -112.48 124.1 51.77 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.8 pt -137.32 171.15 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.724 0.773 . . . . 0.0 111.896 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -134.24 127.69 32.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.095 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mt -110.43 115.71 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.0 m -96.16 100.06 11.74 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.929 0.395 . . . . 0.0 110.018 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.544 ' NE2' ' SG ' ' A' ' 164' ' ' CYS . 0.9 OUTLIER -100.69 71.49 1.49 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.019 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -81.2 -56.12 4.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.486 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 90.0 m -82.72 112.41 19.55 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.528 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.589 ' O ' ' N ' ' A' ' 166' ' ' HIS . 6.0 t -139.17 130.63 27.08 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.049 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 76.8 mtp -36.27 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.312 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.1 t60 -53.0 -24.44 9.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 5.9 t -90.15 -43.38 10.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.106 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.464 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 132.46 11.98 1.87 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.74 169.56 6.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.928 0.394 . . . . 0.0 110.847 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.539 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 89.5 m-20 -56.44 -44.24 80.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.582 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 170' ' ' ASP . 62.6 m-70 -157.68 -169.81 2.99 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.8 m -92.33 138.31 31.63 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 tpt -115.73 123.65 48.83 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 110.523 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -128.39 100.61 5.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.651 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.6 mp -89.02 127.54 41.68 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.619 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.9 mp -110.45 150.82 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.438 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -144.66 141.47 29.37 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.925 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 N--CA 1.462 0.156 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.152 179.543 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.3 mm -67.75 -51.97 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.448 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -68.1 -24.55 65.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.204 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -70.16 -49.93 45.55 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.915 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.08 -35.43 75.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.621 -0.431 . . . . 0.0 109.903 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.6 tp -71.1 -40.38 71.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.109 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -53.66 -44.93 70.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.634 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -62.66 -48.13 80.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.966 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.8 tmt? -53.86 -41.38 67.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.819 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.7 t -71.02 -34.94 57.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.446 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.96 -26.22 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.191 0.52 . . . . 0.0 110.249 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.26 -34.51 28.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.112 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -83.74 -73.74 0.4 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.4 m -95.29 -22.4 17.8 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.933 0.397 . . . . 0.0 111.332 -177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.06 170.15 22.32 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 121.891 0.717 . . . . 0.0 112.996 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -27.19 67.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.07 -1.065 . . . . 0.0 109.553 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -63.8 -43.6 95.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.531 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.31 -37.24 31.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -51.02 -44.97 61.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -71.66 -29.01 64.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.068 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -66.73 -50.85 61.45 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.479 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -82.57 -20.64 36.12 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.596 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 29' ' ' HIS . 8.5 tt -76.66 -69.55 0.51 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.241 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -50.82 -21.43 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.162 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -80.93 -39.25 26.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 26' ' ' LEU . 89.1 m-70 . . . . . 0 N--CA 1.469 0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.752 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.922 0.391 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 6.4 mp0 -65.59 -29.23 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.53 -57.34 2.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 110.741 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.64 -40.21 0.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.533 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.9 m -75.22 -31.11 60.77 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.892 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 47' ' ' LEU . 13.7 mt -70.94 -50.73 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -26.15 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.398 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -76.0 -40.79 52.9 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.543 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -59.27 -57.0 14.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.005 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.96 -38.33 59.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.221 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.35 86.62 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.218 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -62.9 -32.02 73.2 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.47 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.69 -45.33 53.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.534 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.0 mt -77.77 -7.26 56.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.656 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 t30 56.94 49.75 13.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.934 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.7 mmt -128.45 149.14 70.82 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.225 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.28 139.21 76.3 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.441 1.428 . . . . 0.0 110.892 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 tt -52.84 -29.86 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.433 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -71.7 -31.48 66.79 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.578 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.6 -31.6 47.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.921 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.483 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.4 t -71.04 -57.1 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.0 p -52.03 -41.37 31.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.201 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -53.98 -50.75 65.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.78 83.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.73 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.9 m-30 -53.81 -31.11 47.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.286 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.63 -50.1 60.8 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -55.69 -50.09 71.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.006 0.432 . . . . 0.0 109.941 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -59.93 -41.84 92.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.826 0.822 . . . . 0.0 110.493 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -58.55 -39.81 81.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.597 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 35.1 t80 -68.28 -41.5 80.93 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.904 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -55.07 -68.81 0.16 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.224 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.16 -47.6 33.32 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.618 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.6 mt -52.06 -42.93 63.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.052 0.426 . . . . 0.0 111.991 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -55.11 -24.17 24.54 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.394 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.423 ' O ' ' OG1' ' A' ' 82' ' ' THR . 22.8 t -76.37 -53.1 8.65 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.082 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -39.98 49.15 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.772 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -92.96 27.01 2.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.41 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 34.8 m -53.71 -37.7 63.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.05 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.442 ' O ' ' NZ ' ' A' ' 87' ' ' LYS . 89.9 m-20 -58.09 -30.81 66.53 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.6 -19.7 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.688 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.35 -43.5 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.353 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.34 -16.62 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.994 0.426 . . . . 0.0 110.35 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 83' ' ' ASP . 42.5 mmtm -67.61 -29.07 68.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.022 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 8.9 p90 -120.56 116.5 25.49 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.175 0.512 . . . . 0.0 110.991 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -84.82 -2.37 57.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.369 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.434 ' OD1' ' OG ' ' A' ' 93' ' ' SER . 50.5 p30 -163.48 159.48 22.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.186 0.517 . . . . 0.0 111.637 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -48.7 -46.05 39.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.305 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.2 m -59.08 -61.35 2.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.904 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.496 ' HG ' ' N ' ' A' ' 94' ' ' LEU . 93.8 p -45.4 -37.78 5.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.151 0.501 . . . . 0.0 111.022 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.496 ' N ' ' HG ' ' A' ' 93' ' ' SER . 4.5 tt -65.03 -46.03 82.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.199 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.1 t -62.6 -39.6 85.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.253 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 12.8 ptm -87.2 -1.85 58.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.82 -16.85 7.74 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.353 -0.693 . . . . 0.0 112.891 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 97' ' ' GLY . 12.2 mt -29.12 -102.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 117.868 0.834 . . . . 0.0 112.454 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.489 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 13.3 p-80 -39.75 -50.15 2.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.035 0.445 . . . . 0.0 111.364 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.489 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 80.2 m-20 -44.54 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.5 m -72.18 -53.19 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.498 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 3.1 mp -61.15 -48.41 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.22 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.0 -53.7 43.42 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.9 tp -50.62 -50.85 53.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.92 0.39 . . . . 0.0 110.456 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -55.85 -45.27 78.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.318 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.67 -50.77 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -50.05 -43.19 50.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.746 0.308 . . . . 0.0 111.055 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.612 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.858 ' NE2' HD22 ' A' ' 119' ' ' ASN . 75.8 t60 . . . . . 0 N--CA 1.461 0.124 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.2 mt -129.82 130.04 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.582 0.229 . . . . 0.0 111.02 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.858 HD22 ' NE2' ' A' ' 117' ' ' HIS . 11.6 m-20 -132.51 119.42 20.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.42 137.53 13.4 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -128.71 159.49 35.47 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -107.14 145.84 32.03 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.28 160.46 41.35 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.62 -41.07 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.638 2.225 . . . . 0.0 113.222 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -77.65 46.59 0.56 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.088 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 17.7 p30 43.29 62.21 1.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.545 0.688 . . . . 0.0 110.837 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -139.25 158.31 44.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.964 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 128' ' ' ILE . 51.0 mt -139.04 119.19 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.85 122.3 33.45 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.269 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.1 tp -117.76 134.81 54.54 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.997 0.427 . . . . 0.0 110.689 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -120.73 125.16 46.93 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.49 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 C--N 1.331 -0.232 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.872 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.5 mm? . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.0 t -42.44 -49.49 5.25 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -47.68 -35.03 8.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.096 0.474 . . . . 0.0 109.895 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.69 -43.55 79.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.936 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.48 -51.19 15.78 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.515 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -59.28 -51.66 69.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.43 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.53 -46.49 37.34 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.9 mt -61.45 -52.1 65.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 111.204 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 45.4 mt -55.53 -56.85 15.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.839 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -50.31 -47.86 55.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.764 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.13 -51.69 57.76 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.5 -54.99 4.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.937 0.398 . . . . 0.0 110.54 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -54.55 -51.42 65.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.631 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -51.09 -46.77 61.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.931 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -50.0 -50.06 48.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.514 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 67.7 t80 -87.81 37.89 0.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.014 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 38.76 55.66 1.95 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.93 0.395 . . . . 0.0 111.081 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.686 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 41.9 tp60 -128.83 141.24 51.36 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.686 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 67.2 mttm -114.85 124.04 50.7 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.8 pt -136.89 173.84 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.714 0.769 . . . . 0.0 111.99 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.443 ' NE2' ' OE1' ' A' ' 177' ' ' GLU . 13.0 pt20 -137.02 129.25 29.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.427 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mt -111.77 120.05 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.297 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -102.2 106.12 16.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.821 0.343 . . . . 0.0 110.754 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.533 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 16.6 p80 -102.08 73.12 1.36 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.385 0.612 . . . . 0.0 111.45 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -77.74 -12.84 60.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.33 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.425 ' HB ' ' H ' ' A' ' 173' ' ' MET . 3.2 m -116.45 104.23 11.23 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.589 ' O ' ' N ' ' A' ' 166' ' ' HIS . 38.0 t -136.63 116.36 13.04 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.576 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.5 ptm -39.94 -15.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.23 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 164' ' ' CYS . 56.0 t-80 -58.53 -30.37 67.04 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.498 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.0 t -81.04 -46.22 15.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.053 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.498 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 153.84 12.68 0.07 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.09 149.19 35.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.65 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -85.1 8.85 16.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.088 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -174.71 -173.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 92.3 m -129.18 148.07 51.09 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.182 0.515 . . . . 0.0 111.569 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.425 ' H ' ' HB ' ' A' ' 163' ' ' THR . 7.8 ttm -126.43 111.86 14.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.111 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.27 110.6 21.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.344 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -92.24 127.54 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.775 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.31 150.57 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.075 0.465 . . . . 0.0 110.095 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.443 ' OE1' ' NE2' ' A' ' 158' ' ' GLN . 28.1 mt-10 -145.71 142.59 29.12 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.734 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 N--CA 1.463 0.218 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.192 179.566 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.524 ' CD1' ' HE ' ' A' ' 80' ' ' ARG . 1.9 tp . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.996 0.427 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.19 -50.87 76.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -64.23 -29.19 70.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.196 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -62.02 -59.3 5.29 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.26 0.553 . . . . 0.0 110.847 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.98 -26.98 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.165 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 tp -72.03 -41.17 67.83 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.085 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.79 -41.06 81.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.256 -0.977 . . . . 0.0 109.541 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -60.3 -57.95 10.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.653 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.601 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 68.0 mtm -48.43 -43.64 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.35 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.8 -36.28 75.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.854 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.53 -22.54 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.275 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.82 -34.41 17.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.13 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -84.75 -78.03 0.26 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.9 m -90.61 -17.54 26.74 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.341 0.591 . . . . 0.0 110.57 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.68 178.86 29.54 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.827 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 ttt -72.49 -30.87 64.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.837 -1.181 . . . . 0.0 110.708 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 t -61.5 -41.87 97.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.119 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.18 -38.12 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -51.73 -45.71 63.73 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.89 -29.05 63.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.339 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -67.27 -50.76 59.21 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.475 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -82.07 -22.38 36.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.85 0.357 . . . . 0.0 110.413 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 7.8 tt -73.91 -66.59 0.69 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.117 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -52.44 -21.78 4.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.527 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -81.38 -38.97 25.73 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.45 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 12.8 m-70 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.319 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.934 0.397 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -59.04 -37.92 78.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.64 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -44.53 -53.54 6.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.148 0.499 . . . . 0.0 110.713 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -41.1 -40.94 1.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.387 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.2 m -73.24 -31.13 63.93 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 47' ' ' LEU . 25.8 mm -68.48 -55.35 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.714 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.11 -22.41 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.983 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -79.65 -43.18 23.29 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.383 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.45 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 33.0 m-20 -58.4 -57.08 14.49 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.675 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.95 -41.16 76.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.409 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.24 -38.69 71.43 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.309 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -64.51 -32.97 74.84 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -73.44 -37.98 65.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.781 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -84.21 -7.5 59.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.105 0.479 . . . . 0.0 109.844 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.27 48.36 17.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.573 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.5 mmm -127.19 149.55 69.88 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.073 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.68 135.56 49.47 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.442 1.428 . . . . 0.0 110.94 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 tt -49.54 -27.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.097 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -73.44 -30.93 63.53 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.086 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -78.05 -31.83 50.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.258 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.416 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 73.5 t -72.03 -56.3 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.63 -43.69 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.32 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -52.38 -51.98 56.07 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.76 -55.71 30.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.278 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.5 m-30 -44.53 -28.03 0.53 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.375 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.12 -47.46 59.09 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -56.46 -53.45 57.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.042 0.448 . . . . 0.0 110.273 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.601 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 78.7 m-85 -57.23 -42.14 80.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.755 0.788 . . . . 0.0 110.854 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.1 tp -55.25 -37.5 67.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.654 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 28.8 t80 -69.77 -40.7 75.92 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -57.05 -72.96 0.07 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.847 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.87 -40.65 19.52 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.396 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.7 mt -60.02 -41.56 92.44 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.345 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.447 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -54.09 -22.79 11.8 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.926 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.438 ' O ' ' OG1' ' A' ' 82' ' ' THR . 8.7 t -80.45 -52.56 7.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.212 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.524 ' HE ' ' CD1' ' A' ' 4' ' ' ILE . 4.4 mtt-85 -65.97 -52.66 47.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.188 0.518 . . . . 0.0 110.884 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -93.95 36.47 1.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.567 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 39.6 m -56.92 -45.3 82.78 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.066 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -50.79 -31.09 15.88 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 t -82.75 -19.59 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.699 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' A' ' 87' ' ' LYS . 68.1 t -72.21 -47.05 55.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.569 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 56.1 t0 -52.66 -7.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.808 0.337 . . . . 0.0 110.759 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.545 ' H ' ' C ' ' A' ' 85' ' ' VAL . 43.1 mmtm -80.23 -28.9 38.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.071 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.62 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -95.77 118.12 31.83 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.474 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -84.85 -13.45 50.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.169 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 15.3 p-10 -164.67 171.42 14.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.256 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -58.07 -46.74 84.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.872 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.8 m -59.84 -44.78 93.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.443 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.7 t -55.63 -39.84 71.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.248 0.547 . . . . 0.0 110.304 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tt -64.71 -45.56 86.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.998 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.57 -38.13 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.421 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 83.7 mtp -83.99 -4.42 58.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.427 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -116.75 -14.97 7.05 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.044 -0.865 . . . . 0.0 113.663 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.509 ' O ' ' O ' ' A' ' 97' ' ' GLY . 13.7 mt -26.72 -106.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 117.954 0.877 . . . . 0.0 112.697 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.482 ' CE1' ' O ' ' A' ' 118' ' ' ILE . 8.7 p-80 -41.4 -46.34 3.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.019 0.438 . . . . 0.0 111.271 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -47.46 -87.34 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.1 m -69.89 -51.38 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.499 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 4.5 mp -63.28 -47.61 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.699 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.33 -54.06 40.05 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.3 tp -49.47 -48.03 48.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.934 0.397 . . . . 0.0 109.947 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -56.9 -45.82 82.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.035 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 76.0 t -54.85 -56.06 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -43.94 -45.43 7.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.125 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp . . . . . 0 C--N 1.33 -0.244 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.84 179.621 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.5 m80 . . . . . 0 N--CA 1.463 0.18 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.482 ' O ' ' CE1' ' A' ' 99' ' ' HIS . 4.0 mp -138.48 133.15 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -138.5 130.01 27.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.712 0.291 . . . . 0.0 111.212 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.58 120.8 4.53 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -117.55 130.34 56.35 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.651 0.262 . . . . 0.0 110.819 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 tp -76.19 150.35 37.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 111.383 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -121.43 160.32 46.5 Favored Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.317 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.45 -36.83 3.61 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.668 2.245 . . . . 0.0 113.309 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -79.96 46.7 0.82 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.144 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.6 m120 43.35 58.39 3.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 0.0 110.443 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -137.11 159.06 43.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.057 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.4 mt -135.4 114.6 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.19 120.09 25.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 61.5 tp -114.92 132.73 56.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.166 0.508 . . . . 0.0 111.298 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.67 ' HE ' ' CE1' ' A' ' 171' ' ' HIS . 64.0 ttt-85 -116.95 120.43 38.4 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.008 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.491 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 72.3 t80 . . . . . 0 N--CA 1.467 0.407 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.948 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 142' ' ' ALA . 9.2 t -44.83 -49.75 10.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.582 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -45.76 -41.29 10.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.113 0.482 . . . . 0.0 110.2 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 22.8 t -62.34 -41.46 98.59 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -45.54 -54.18 7.93 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.561 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -56.58 -50.74 71.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.35 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.8 -47.9 45.79 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.37 -54.81 41.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.2 mt -53.4 -55.22 26.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.745 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -51.61 -47.7 63.54 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.897 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.31 -51.99 54.29 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.26 -60.11 2.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.846 0.355 . . . . 0.0 110.916 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -47.84 -50.66 25.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.966 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -52.45 -47.97 66.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.623 0.249 . . . . 0.0 111.237 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -49.38 -49.96 42.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.667 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.25 37.3 0.72 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.968 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 38.76 57.5 1.83 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.976 0.417 . . . . 0.0 111.196 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.488 HE21 ' H ' ' A' ' 156' ' ' LYS . 52.8 tp60 -131.72 142.98 49.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.488 ' H ' HE21 ' A' ' 155' ' ' GLN . 58.4 tttp -118.17 112.31 19.99 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.078 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 17.8 pt -122.53 173.48 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.513 0.673 . . . . 0.0 111.78 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -137.13 128.74 28.62 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.547 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mt -112.04 120.97 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.649 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.9 t -105.19 112.19 25.21 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.705 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 53.8 p-80 -101.97 76.7 1.63 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.983 0.897 . . . . 0.0 111.822 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 4.9 p30 -75.89 -27.56 57.77 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.716 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.409 ' HG1' ' CB ' ' A' ' 173' ' ' MET . 0.4 OUTLIER -108.56 110.44 21.92 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.386 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 6.4 p -113.08 176.33 5.06 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 168' ' ' GLY . 72.5 mtp -91.52 -28.18 17.75 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -53.72 -22.51 9.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.825 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.4 t -88.63 -26.77 21.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.446 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 98.58 21.92 15.51 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.136 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.31 162.68 24.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.04 0.447 . . . . 0.0 110.681 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -45.97 -34.38 3.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.308 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.67 ' CE1' ' HE ' ' A' ' 131' ' ' ARG . 9.0 p-80 -175.49 -167.78 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.2 m -95.18 139.71 31.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.171 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.409 ' CB ' ' HG1' ' A' ' 163' ' ' THR . 12.8 tpp -120.7 116.7 25.79 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.1 107.15 12.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.472 0.654 . . . . 0.0 111.047 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.482 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -89.95 126.98 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.561 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.8 mp -110.83 151.49 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.189 0.519 . . . . 0.0 110.171 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.56 144.0 28.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.933 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 11.7 mt . . . . . 0 N--CA 1.462 0.164 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.072 179.669 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 tp . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 120.778 0.323 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 mm -64.45 -56.76 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.426 0.631 . . . . 0.0 109.461 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -62.26 -27.7 69.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.658 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -62.35 -60.79 3.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.131 0.491 . . . . 0.0 110.939 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -56.96 -27.16 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.115 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.9 tp -71.8 -50.5 29.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.463 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -49.36 -40.22 34.84 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.562 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -60.48 -49.09 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.695 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.579 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 10.4 tpt -56.87 -42.58 80.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.005 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.79 -34.98 58.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.648 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -62.16 -25.0 36.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.216 0.531 . . . . 0.0 110.018 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.93 -34.58 22.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.134 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -85.75 -74.44 0.41 Allowed 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.7 m -92.27 -21.66 20.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.166 0.508 . . . . 0.0 110.966 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.51 170.96 24.72 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.865 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.0 ttp -66.5 -28.67 68.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.904 -1.148 . . . . 0.0 110.347 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 t -62.49 -42.24 99.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.208 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.63 -36.27 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -51.94 -45.86 64.49 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -70.31 -30.6 67.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.986 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -66.05 -50.77 62.99 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.477 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -82.19 -20.53 37.62 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.844 0.354 . . . . 0.0 110.617 -179.26 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.3 tt -75.47 -57.64 3.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.345 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.05 -23.16 67.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.675 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -80.45 -40.63 25.93 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 67.7 m80 . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.326 179.415 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 85.6 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.784 0.326 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -66.37 -33.13 75.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -48.2 -58.15 4.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.105 0.479 . . . . 0.0 110.634 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -39.01 -41.1 0.74 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.541 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.3 p -74.53 -31.87 62.28 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.971 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 47' ' ' LEU . 17.1 mt -70.26 -53.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.789 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.89 -25.03 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.518 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -76.61 -41.28 46.66 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.633 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -59.02 -56.8 17.54 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.744 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.96 -37.53 55.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.016 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.09 88.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.276 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -62.4 -32.83 73.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -72.04 -44.53 63.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.554 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.3 mt -79.14 -7.37 58.13 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.864 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.01 49.85 13.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.678 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.5 mmt -128.55 149.12 70.91 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.182 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.58 138.73 71.86 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.347 1.365 . . . . 0.0 110.967 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tt -52.38 -29.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.428 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -72.46 -31.53 65.52 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.562 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -78.2 -31.85 49.65 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.944 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 82.2 t -70.5 -57.08 8.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -51.58 -43.22 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.34 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -53.32 -50.33 65.19 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.14 80.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.644 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.9 m-30 -52.16 -29.49 22.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.298 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.26 -50.35 56.83 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -55.17 -50.71 68.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.023 0.44 . . . . 0.0 110.049 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.579 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 59.4 m-85 -59.67 -41.19 90.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.883 0.849 . . . . 0.0 110.74 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.62 -40.46 83.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.451 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.401 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 41.9 t80 -68.7 -39.87 80.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 110.229 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -55.27 -70.44 0.11 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.377 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.92 -37.62 53.4 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.385 -0.436 . . . . 0.0 112.637 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.521 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 16.5 mt -55.23 -51.06 67.81 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.086 0.443 . . . . 0.0 111.716 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.85 -15.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.805 -0.56 . . . . 0.0 111.36 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 77' ' ' LEU . 9.3 t -83.75 -49.08 9.44 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -59.48 2.73 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.083 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.0 p80 -81.85 30.22 0.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.815 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 79' ' ' SER . 91.8 m -49.53 -40.07 36.71 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -55.65 -30.38 60.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.455 ' HB ' ' HD1' ' A' ' 81' ' ' HIS . 5.1 t -85.89 -22.8 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.534 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.492 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 54.1 t -61.66 -40.48 86.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -49.6 -20.34 0.76 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.873 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -70.15 -5.03 24.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.381 0.61 . . . . 0.0 109.865 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.607 ' CG ' ' N ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER -89.05 -150.26 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.508 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.607 ' N ' ' CG ' ' A' ' 88' ' ' PHE . 1.1 p-10 159.63 -30.25 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -170.23 155.1 5.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.365 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -46.08 -57.46 4.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.237 0.541 . . . . 0.0 111.29 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.5 m -50.41 -47.12 56.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.108 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.458 ' OG ' ' OD2' ' A' ' 89' ' ' ASP . 32.6 m -61.42 -37.17 82.52 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.151 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.1 tt -64.3 -45.49 87.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.001 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.52 -36.11 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 121.226 0.536 . . . . 0.0 110.639 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.7 mmm -86.19 -6.79 58.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.53 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -111.42 -13.16 13.52 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.894 -0.392 . . . . 0.0 112.654 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 97' ' ' GLY . 15.8 mt -33.0 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 117.509 0.655 . . . . 0.0 111.963 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -39.8 -50.27 2.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.213 0.53 . . . . 0.0 111.498 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -48.12 -91.25 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.7 m -66.71 -51.21 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.442 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 3.7 mp -61.72 -40.97 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.392 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.16 -57.52 10.45 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.4 tp -49.21 -58.05 5.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.15 0.5 . . . . 0.0 110.491 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -50.6 -45.95 57.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.236 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.7 t -54.59 -51.41 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -46.85 -42.91 18.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.792 0.329 . . . . 0.0 110.607 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.69 -179.903 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.741 0.305 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 31.7 mm -117.25 124.14 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.373 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.568 HD21 ' NH2' ' A' ' 131' ' ' ARG . 52.9 t30 -132.89 120.02 20.95 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.735 0.302 . . . . 0.0 110.857 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.8 119.21 5.17 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -117.78 125.65 50.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 tp -72.21 140.04 48.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.886 0.374 . . . . 0.0 110.825 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.29 161.01 41.18 Favored Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.6 178.63 6.48 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.312 2.008 . . . . 0.0 111.992 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.527 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 95.7 m-20 55.23 36.01 26.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.347 0.594 . . . . 0.0 109.832 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.527 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 47.5 m-20 54.35 56.51 6.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.794 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 125' ' ' ASN . 3.8 mp0 -125.98 156.43 39.85 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.1 mt -139.39 115.32 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.87 122.82 31.27 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.844 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 47.8 tp -117.78 132.7 56.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 111.279 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.568 ' NH2' HD21 ' A' ' 119' ' ' ASN . 41.5 ttp180 -112.87 120.24 40.76 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.602 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.494 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 30.6 t80 . . . . . 0 N--CA 1.465 0.32 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.621 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 CA--C 1.535 0.401 0 CA-C-O 121.011 0.434 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.538 ' HG ' ' H ' ' A' ' 140' ' ' PHE . 26.4 p -43.57 -49.13 7.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.586 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.538 ' H ' ' HG ' ' A' ' 139' ' ' CYS . 80.8 m-85 -45.64 -41.89 10.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.973 0.416 . . . . 0.0 110.409 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 48.5 t -64.09 -42.23 96.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.774 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.55 -52.5 10.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.579 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -59.19 -51.85 68.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.613 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.35 -46.99 35.74 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.3 -54.18 48.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.641 0.258 . . . . 0.0 111.638 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 31.2 mt -54.51 -56.13 21.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.026 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -50.59 -47.26 58.14 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.743 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.64 -51.7 57.33 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.14 -59.95 2.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.684 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.0 -52.29 44.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.76 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -50.41 -47.26 56.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.908 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -49.57 -49.38 46.71 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.712 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -88.24 37.97 0.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.851 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 39.11 55.02 2.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 111.16 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.681 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 41.0 tp60 -127.91 140.11 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.681 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 68.7 mttm -112.39 124.1 51.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.998 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.6 pt -137.41 169.41 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.694 0.759 . . . . 0.0 111.9 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -132.99 127.32 33.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.296 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.9 mt -110.54 117.01 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 6.0 t -98.32 100.58 11.87 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.981 0.419 . . . . 0.0 110.16 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -96.43 71.22 2.71 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.209 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -78.1 -51.9 9.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.246 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.72 123.27 22.96 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.715 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.416 ' CB ' ' CD2' ' A' ' 166' ' ' HIS . 61.1 m -125.97 176.5 6.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.948 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 168' ' ' GLY . 1.0 OUTLIER -93.12 -30.18 15.39 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.007 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.472 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 3.5 p80 -51.18 -21.13 1.83 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.732 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.435 ' N ' ' ND1' ' A' ' 166' ' ' HIS . 3.6 t -90.38 -28.24 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.763 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 101.7 20.05 14.06 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.59 169.56 9.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 110.733 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -52.33 -35.07 49.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.304 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -177.39 -165.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.0 OUTLIER -94.85 140.25 30.18 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.4 tpt -119.17 120.87 38.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 109.909 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mt -122.58 103.62 8.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.982 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.464 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -88.19 127.81 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.355 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mp -111.24 149.84 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.298 0.57 . . . . 0.0 110.775 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.72 134.77 37.52 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.951 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 120.945 0.403 . . . . 0.0 110.686 -179.822 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.419 HD12 HG21 ' A' ' 5' ' ' ILE . 46.5 mm -64.23 -62.1 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.852 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -58.71 -29.51 66.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.702 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -61.73 -60.86 3.03 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.211 0.529 . . . . 0.0 111.48 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.4 -27.39 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.431 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 tp -70.87 -42.4 70.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.351 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.6 -39.64 73.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.497 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -60.97 -52.61 64.28 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.166 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 14.4 tpt -53.18 -41.39 65.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.983 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.06 -34.66 55.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.74 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.13 -22.28 30.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 0.0 110.068 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.17 -34.5 19.01 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.259 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -85.77 -76.94 0.31 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.0 m -89.77 -19.11 25.12 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.385 0.612 . . . . 0.0 110.627 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.02 175.14 29.13 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.7 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.5 ttt -69.91 -26.96 64.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.888 -1.156 . . . . 0.0 110.67 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.6 m -64.34 -42.95 95.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.045 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -35.89 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.0 t-105 -51.21 -46.04 62.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -69.68 -31.74 69.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.083 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -65.24 -51.39 61.21 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -81.21 -20.17 41.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.93 0.395 . . . . 0.0 110.69 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 tt -76.27 -47.75 22.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.381 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -70.57 -24.41 62.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.67 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -80.35 -40.14 27.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.51 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 73.9 m80 . . . . . 0 N--CA 1.465 0.322 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.305 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.681 0.277 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -59.7 -36.63 76.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.727 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -51.12 -56.94 10.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.028 0.442 . . . . 0.0 110.794 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -39.61 -43.34 1.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.659 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 m -72.25 -30.58 65.01 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.082 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 47' ' ' LEU . 13.3 mt -72.36 -54.84 15.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.156 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -55.65 -24.09 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.727 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -77.51 -40.56 42.42 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.477 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.51 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 55.2 m-20 -59.42 -56.2 25.02 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.92 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 p -57.56 -37.68 59.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.917 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.92 88.23 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.2 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -62.79 -32.31 73.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -72.35 -43.63 63.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.6 mt -80.71 -8.13 59.56 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.839 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.96 51.49 8.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.628 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 22.3 mmt -130.8 149.39 73.51 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.392 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.79 139.42 80.17 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.461 1.441 . . . . 0.0 111.096 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.3 tt -54.66 -28.81 19.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.851 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -73.91 -29.99 62.34 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.438 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -79.1 -35.61 42.0 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.745 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.65 -59.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -49.1 -38.89 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.611 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.28 -45.57 72.53 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.82 -55.82 17.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.296 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -44.78 -29.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.976 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.88 -59.38 8.68 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -49.49 -48.24 48.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.922 0.391 . . . . 0.0 110.127 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 52.1 m-85 -60.15 -39.85 87.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.704 0.764 . . . . 0.0 110.687 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.1 tp -59.61 -38.27 80.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.815 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 30.6 t80 -69.54 -39.02 77.73 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.159 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.676 ' ND2' ' HE2' ' A' ' 152' ' ' HIS . 6.0 m120 -55.89 -70.55 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.69 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.81 -47.87 30.62 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.474 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.6 mt -50.64 -44.22 57.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.041 0.421 . . . . 0.0 111.765 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -55.78 -26.01 43.9 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.405 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.42 ' O ' ' OG1' ' A' ' 82' ' ' THR . 26.0 t -74.89 -55.1 6.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.05 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -36.67 66.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.797 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -97.17 25.25 5.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.777 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 31.5 m -52.51 -38.1 58.91 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -58.62 -34.13 70.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.868 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.6 -19.65 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.669 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.476 ' C ' ' H ' ' A' ' 87' ' ' LYS . 38.6 t -71.5 -43.6 71.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.949 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -51.5 -12.7 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.069 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 85' ' ' VAL . 41.9 mmtm -69.09 -29.46 67.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.822 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 18.8 p90 -120.49 122.53 40.84 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.136 0.493 . . . . 0.0 111.328 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -87.29 -0.76 57.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.514 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 153' ' ' PHE . 45.7 t0 -162.31 165.58 26.41 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.583 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -57.04 -42.2 80.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.219 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.0 m -63.24 -59.34 4.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.46 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.1 m -46.81 -37.39 8.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.253 0.549 . . . . 0.0 110.649 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 tt -64.25 -44.36 92.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.431 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.4 t -66.77 -39.37 83.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.405 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 6.9 ptm -86.9 -1.43 57.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -113.43 -16.23 8.36 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.746 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.442 ' C ' ' O ' ' A' ' 97' ' ' GLY . 9.4 mt -34.26 -82.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 117.809 0.804 . . . . 0.0 111.712 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -45.17 -53.5 8.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.146 0.498 . . . . 0.0 110.915 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -46.99 -89.19 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 m -70.04 -49.84 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.29 -39.5 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.586 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.47 -57.62 11.03 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.4 tp -47.68 -54.67 11.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.136 0.493 . . . . 0.0 110.185 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -52.59 -46.52 66.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.775 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.7 t -52.66 -54.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -45.09 -43.46 9.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.749 0.309 . . . . 0.0 110.666 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt . . . . . 0 C--N 1.331 -0.197 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.501 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.448 0.166 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.28 129.74 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -136.66 121.32 18.46 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.939 0.399 . . . . 0.0 111.726 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.35 123.48 5.73 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' A' ' 122' ' ' LEU . 37.9 tt0 -115.73 160.92 19.45 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -107.89 145.57 33.56 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.45 160.48 41.64 Favored Pre-proline 0 N--CA 1.468 0.461 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 126' ' ' ASN . 70.5 Cg_endo -72.8 -44.57 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.578 2.185 . . . . 0.0 113.247 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.641 HD22 ' NE2' ' A' ' 127' ' ' GLN . 47.7 p-10 -74.58 45.46 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.184 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 124' ' ' PRO . 15.3 m120 44.99 60.72 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 0.0 111.102 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.641 ' NE2' HD22 ' A' ' 125' ' ' ASN . 21.8 mt-30 -136.72 158.83 43.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.913 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.6 mt -138.85 118.56 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.16 122.5 33.85 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.389 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.3 tp -115.42 136.24 53.29 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.111 0.481 . . . . 0.0 110.726 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -122.58 123.17 40.58 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.409 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.6 t80 . . . . . 0 N--CA 1.465 0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.257 -179.438 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.9 mm? . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.651 0.262 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 93.6 m -41.41 -54.75 3.0 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 111.58 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -47.96 -30.26 4.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.935 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 138' ' ' LEU . 5.3 t -71.11 -44.59 65.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.772 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.66 -47.28 15.0 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.407 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -64.59 -48.86 73.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.349 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.74 -49.12 35.26 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 31.2 mt -59.16 -53.93 52.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.602 0.239 . . . . 0.0 111.507 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 31.3 mt -54.62 -55.66 27.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.947 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -51.43 -47.78 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.862 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.01 -52.0 54.95 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.08 -59.83 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.926 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.85 -49.9 47.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -52.03 -50.1 62.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.565 0.221 . . . . 0.0 111.323 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.676 ' HE2' ' ND2' ' A' ' 75' ' ' ASN . 43.4 m80 -48.87 -49.35 40.02 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.826 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.526 ' CE2' ' OD1' ' A' ' 90' ' ' ASP . 64.7 t80 -85.43 35.68 0.61 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.949 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 39.22 55.17 2.21 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.056 0.455 . . . . 0.0 110.983 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.504 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 50.5 tp60 -130.5 141.79 50.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.504 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 30.9 mtmm -113.84 123.25 49.36 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.844 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 28.9 pt -133.3 172.45 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.65 0.738 . . . . 0.0 112.347 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -136.58 126.77 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.566 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mt -111.51 120.35 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.685 0.278 . . . . 0.0 110.61 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.6 t -105.38 112.36 25.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.821 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.559 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 18.5 p80 -101.0 74.79 1.63 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.651 0.739 . . . . 0.0 111.503 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -76.21 -29.3 57.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.805 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.04 109.13 20.93 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.432 ' SG ' ' N ' ' A' ' 165' ' ' MET . 13.4 t -111.88 177.0 4.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.84 0.353 . . . . 0.0 110.417 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.432 ' N ' ' SG ' ' A' ' 164' ' ' CYS . 81.1 mtp -91.37 -28.26 17.82 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -53.62 -22.8 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.957 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 169' ' ' ALA . 3.4 t -88.76 -28.15 20.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.466 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.59 20.35 15.22 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.099 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.402 ' H ' HG22 ' A' ' 167' ' ' THR . . . -66.03 163.14 17.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.722 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -49.44 -34.31 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.344 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.497 ' HD1' ' N ' ' A' ' 172' ' ' CYS . 8.0 p80 -172.25 -170.84 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.497 ' N ' ' HD1' ' A' ' 171' ' ' HIS . 3.2 m -93.65 140.4 29.68 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 tpt -122.87 114.67 20.79 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -119.05 105.59 11.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.826 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.466 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -88.17 125.77 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.344 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.17 149.35 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.258 0.552 . . . . 0.0 110.385 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.499 ' OE2' ' N ' ' A' ' 178' ' ' LEU . 9.3 tp10 -136.47 135.47 38.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.993 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.499 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 13.0 mt . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.77 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 tp . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.81 0.338 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.4 mm -60.77 -45.24 98.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -70.99 -26.39 63.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.211 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -67.61 -53.23 29.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.016 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.35 -31.83 55.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.072 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.3 tp -71.86 -42.03 67.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.694 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -54.28 -43.92 71.46 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.566 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -61.02 -51.14 70.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.326 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.615 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 58.2 mtm -54.01 -43.26 69.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.79 -36.43 75.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.666 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.7 -25.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.265 0.555 . . . . 0.0 110.143 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.97 -34.45 22.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.199 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -84.33 -75.56 0.34 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.8 m -92.78 -22.88 19.08 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.199 0.524 . . . . 0.0 110.935 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.8 171.23 22.63 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.806 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 30.3 ttm -66.91 -27.45 67.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.707 -1.246 . . . . 0.0 110.292 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -63.25 -42.85 99.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.221 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.82 -35.56 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -53.42 -44.74 69.03 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.98 -28.13 64.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.09 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -66.27 -51.17 60.1 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -83.47 -18.88 37.06 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.705 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 29' ' ' HIS . 9.0 tt -78.1 -70.66 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -49.58 -22.31 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.995 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 tttp -80.94 -37.27 29.75 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 26' ' ' LEU . 21.8 m80 . . . . . 0 N--CA 1.464 0.25 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.893 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.802 0.335 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -63.58 -30.64 71.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.634 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.43 -57.21 7.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 110.559 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -38.36 -43.81 0.85 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.122 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 m -74.32 -30.13 61.92 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.092 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.7 mt -72.96 -51.76 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.152 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -58.05 -26.0 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.816 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -77.18 -41.36 41.86 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.682 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -58.77 -56.35 23.39 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.725 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.454 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 7.2 p -57.67 -34.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.066 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.44 -35.45 79.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.73 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -60.21 -47.76 84.59 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.21 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.504 HH22 ' CD1' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -69.09 -39.79 78.8 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.663 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.6 mt -70.59 -10.8 60.18 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.091 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.5 t30 56.87 50.12 12.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.28 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.8 mmm -128.74 148.58 69.15 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.32 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.48 138.04 63.16 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.462 1.441 . . . . 0.0 111.028 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 tt -52.09 -29.3 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.291 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -72.35 -34.38 67.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.148 0.499 . . . . 0.0 111.482 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -75.61 -32.46 60.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.068 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.435 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 93.1 t -71.1 -56.31 11.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.01 -44.23 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.348 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -51.7 -50.44 60.49 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.27 -52.11 66.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.529 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.435 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.3 m-30 -46.91 -28.07 1.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.373 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.84 -48.21 42.92 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -55.05 -52.22 63.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.888 0.375 . . . . 0.0 110.635 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.615 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 57.7 m-85 -59.79 -42.17 92.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.695 0.76 . . . . 0.0 110.842 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.9 tp -53.36 -38.15 63.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.621 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 22.6 t80 -70.94 -42.45 69.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.233 0.539 . . . . 0.0 109.746 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -54.34 -72.83 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.653 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.06 -47.6 20.1 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.298 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.4 mt -50.71 -42.0 56.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.99 0.395 . . . . 0.0 112.013 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -54.95 -25.43 29.47 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.362 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.428 ' O ' ' OG1' ' A' ' 82' ' ' THR . 22.4 t -74.03 -55.94 5.52 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.928 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.653 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -71.24 -42.44 68.86 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.05 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -92.92 28.54 2.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.077 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 42.8 m -54.81 -38.45 67.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.015 0.436 . . . . 0.0 109.992 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.64 -34.78 73.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.235 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.23 -20.9 12.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.8 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 87' ' ' LYS . 38.9 t -69.9 -40.93 79.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.139 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -53.03 -14.0 0.53 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.408 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.622 ' HZ1' ' CG ' ' A' ' 105' ' ' GLU . 21.6 mmtp -68.69 -29.6 68.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.034 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 15.8 p90 -119.75 121.27 38.79 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.171 0.51 . . . . 0.0 111.235 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -86.71 2.4 48.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.167 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.426 ' OD1' ' CD2' ' A' ' 153' ' ' PHE . 45.0 t0 -167.2 162.46 15.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.183 0.516 . . . . 0.0 111.522 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.408 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 80.0 t80 -51.49 -49.88 60.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.953 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.6 m -55.11 -58.34 8.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.519 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.5 t -46.73 -40.69 13.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.126 0.488 . . . . 0.0 111.217 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.0 tt -63.56 -43.92 95.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.396 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.6 t -64.3 -39.1 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.396 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 8.9 ptm -87.99 -1.09 57.78 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -114.08 -17.46 7.27 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 119.398 -0.668 . . . . 0.0 112.843 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.503 ' O ' ' O ' ' A' ' 97' ' ' GLY . 13.1 mt -28.12 -104.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 117.735 0.768 . . . . 0.0 112.494 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -39.6 -49.12 2.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.039 0.447 . . . . 0.0 111.341 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -45.08 -86.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.505 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.4 m -72.44 -52.61 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.505 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 3.0 mp -62.23 -47.99 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.38 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.34 -53.08 48.74 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.4 tp -49.32 -50.86 37.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.622 ' CG ' ' HZ1' ' A' ' 87' ' ' LYS . 65.2 mm-40 -55.46 -44.88 76.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.134 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.95 -53.7 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -45.65 -44.56 13.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.666 0.27 . . . . 0.0 110.958 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt . . . . . 0 C--N 1.328 -0.353 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.399 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.4 m80 . . . . . 0 N--CA 1.462 0.164 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.8 mt -124.07 126.82 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.586 0.231 . . . . 0.0 111.108 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -130.98 117.25 18.94 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.534 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.3 151.16 18.43 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -140.77 161.02 38.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 110.125 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 1.2 mm? -109.29 143.37 38.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.847 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.07 160.58 40.43 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 126' ' ' ASN . 73.2 Cg_endo -73.32 -46.09 0.39 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.623 2.215 . . . . 0.0 113.25 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.566 ' N ' HD21 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -72.95 45.19 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.204 -179.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 124' ' ' PRO . 67.4 m-20 44.65 63.38 1.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.424 0.631 . . . . 0.0 111.023 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.469 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 77.3 mt-30 -139.52 158.57 43.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.912 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.6 mt -138.5 117.59 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.68 122.3 31.97 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.655 -0.418 . . . . 0.0 109.988 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.3 tp -119.26 133.35 55.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.052 0.453 . . . . 0.0 111.456 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -116.94 122.56 44.62 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 40.6 t80 . . . . . 0 N--CA 1.466 0.363 0 CA-C-O 120.558 0.218 . . . . 0.0 111.329 -178.546 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 tp . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.234 0.54 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 172' ' ' CYS . 3.5 m -44.5 -49.25 10.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.69 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -44.23 -42.29 6.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.937 0.399 . . . . 0.0 110.58 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.3 t -63.76 -42.02 97.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.191 0.519 . . . . 0.0 109.61 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -45.6 -52.48 10.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.666 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -58.99 -50.98 72.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.471 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.24 -44.97 34.94 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.8 mt -62.78 -52.52 62.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.659 0.266 . . . . 0.0 111.48 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.9 mt -55.45 -57.09 13.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.854 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -50.75 -47.78 59.33 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.767 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.06 -51.33 58.98 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.05 -59.75 2.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.867 0.365 . . . . 0.0 110.749 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -50.45 -52.02 41.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -50.77 -47.29 59.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.667 0.27 . . . . 0.0 111.015 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -49.48 -49.71 44.46 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.516 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 69.4 t80 -88.31 38.49 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.891 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 38.26 56.58 1.72 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 111.253 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.687 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 41.7 tp60 -129.74 141.12 50.94 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.687 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 60.7 mmtt -113.07 124.94 53.77 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.89 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.0 pt -137.96 171.86 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.633 0.73 . . . . 0.0 111.853 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -135.56 127.35 29.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.406 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mt -110.53 118.38 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.0 t -100.98 105.48 16.7 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.479 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.548 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 18.2 p80 -102.58 75.67 1.46 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.553 0.692 . . . . 0.0 111.951 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -76.57 -29.14 56.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.456 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.7 103.94 15.65 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.586 ' O ' ' N ' ' A' ' 166' ' ' HIS . 38.7 t -132.45 112.71 12.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.662 0.267 . . . . 0.0 110.803 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 8.0 tpt -37.65 -18.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.102 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.586 ' N ' ' O ' ' A' ' 164' ' ' CYS . 57.4 t-80 -54.66 -25.93 30.05 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.0 t -86.37 -44.42 12.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.096 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.478 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 146.55 15.42 0.16 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.303 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.499 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -71.18 157.63 37.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.628 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -74.67 -5.09 41.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.612 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -176.08 -149.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 3.4 m -131.77 146.26 52.05 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.197 0.522 . . . . 0.0 111.59 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 10.6 tpp -119.56 124.11 45.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.277 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -126.95 105.32 8.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.411 0.624 . . . . 0.0 111.379 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.479 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -92.46 127.06 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.403 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.1 mp -110.32 151.64 12.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.29 0.567 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -139.45 137.24 35.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.294 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.2 mt . . . . . 0 N--CA 1.464 0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.351 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.468 ' CD1' ' NE ' ' A' ' 80' ' ' ARG . 2.5 tp . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 121.025 0.44 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 mm -58.56 -47.88 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -73.77 -21.72 60.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -66.98 -50.42 62.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.762 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.02 -39.68 81.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.197 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.7 tp -63.49 -40.73 97.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -55.62 -46.43 77.36 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.639 -0.424 . . . . 0.0 109.892 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -61.19 -50.72 71.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.997 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.7 OUTLIER -52.49 -40.57 62.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.6 t -71.4 -34.74 54.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.551 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.9 t -61.62 -23.66 31.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.253 0.549 . . . . 0.0 109.95 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.82 -34.47 21.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.098 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -84.31 -75.74 0.33 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.5 m -92.49 -20.82 20.58 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.189 0.518 . . . . 0.0 110.964 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.87 170.84 25.36 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.821 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.3 ttt -66.84 -27.09 67.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.926 -1.137 . . . . 0.0 110.444 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -63.7 -42.53 97.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.052 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.21 -35.07 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 -51.83 -45.29 63.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -73.95 -28.86 61.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.329 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -67.54 -50.3 59.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.492 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -81.33 -26.57 35.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.69 0.281 . . . . 0.0 110.553 -179.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.472 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 7.7 tt -70.08 -71.8 0.22 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.439 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.456 ' N ' ' CD2' ' A' ' 26' ' ' LEU . 82.4 tt0 -50.51 -23.34 2.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.543 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.38 -42.99 21.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m80 . . . . . 0 N--CA 1.467 0.411 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.96 -179.735 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 120.632 0.253 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -56.62 -36.91 70.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.138 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -40.84 -56.4 2.22 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.895 0.379 . . . . 0.0 111.056 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -39.43 -40.41 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.18 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.2 t -72.15 -34.57 68.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.225 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 47' ' ' LEU . 1.9 mp -67.78 -54.9 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.28 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -55.52 -23.95 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.784 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -76.05 -40.2 53.87 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.097 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -60.26 -56.86 16.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.408 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.82 -36.76 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.87 87.5 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.174 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -63.52 -31.0 72.03 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.62 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -73.96 -42.94 59.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.619 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.9 mt -80.7 -7.11 59.23 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.879 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 56.22 49.23 15.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.556 0.693 . . . . 0.0 109.207 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mmt -127.73 149.75 71.32 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.967 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.99 137.73 63.87 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.451 1.434 . . . . 0.0 110.978 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 tt -51.28 -29.48 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.776 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -71.24 -30.13 65.96 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.143 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -78.41 -34.03 48.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.112 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.1 t -70.04 -56.41 11.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.7 p -52.93 -41.39 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.248 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -53.25 -49.28 67.18 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.52 91.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.656 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -53.12 -33.07 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.566 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.05 -50.48 60.31 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.98 -50.31 66.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.064 0.459 . . . . 0.0 110.222 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -59.81 -42.58 93.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.632 0.729 . . . . 0.0 110.781 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.4 tp -56.37 -38.93 72.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.314 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 20.1 t80 -68.37 -43.77 76.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.369 0.604 . . . . 0.0 109.503 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.75 -71.65 0.08 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.289 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.424 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -49.11 -39.65 27.24 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.926 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.6 mt -61.81 -39.23 91.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.412 0.606 . . . . 0.0 112.027 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.94 -24.68 39.48 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.232 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 82' ' ' THR . 45.6 p -77.11 -53.84 7.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.438 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.468 ' NE ' ' CD1' ' A' ' 4' ' ' ILE . 1.1 mtm105 -68.75 -49.75 56.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.159 0.504 . . . . 0.0 110.343 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -83.72 22.75 1.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.444 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 79' ' ' SER . 61.4 m -49.38 -38.08 27.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.654 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -62.35 -35.85 80.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.721 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 81' ' ' HIS . 3.6 t -83.58 -17.88 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.426 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 87' ' ' LYS . 56.1 t -65.24 -38.04 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.807 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -57.93 -6.41 0.56 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.769 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.509 ' NZ ' ' OE1' ' A' ' 105' ' ' GLU . 30.0 mmtp -76.71 -25.72 53.88 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.59 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.524 ' C ' ' H ' ' A' ' 90' ' ' ASP . 26.9 p90 -129.18 -45.77 1.24 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.707 0.289 . . . . 0.0 111.006 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 19.1 t70 58.16 -0.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.534 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 88' ' ' PHE . 34.0 m-20 -152.07 164.63 36.84 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.35 0.595 . . . . 0.0 111.237 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -66.12 -61.25 2.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.7 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.6 m -50.82 -53.16 34.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.716 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.4 m -59.75 -35.79 75.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.309 0.576 . . . . 0.0 110.976 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.1 tt -66.36 -47.97 71.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.956 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 90.2 t -60.92 -36.31 71.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.394 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -88.8 -5.85 57.78 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.134 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -110.88 -15.14 11.18 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.476 -0.625 . . . . 0.0 112.78 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 97' ' ' GLY . 13.1 mt -28.87 -104.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 117.568 0.684 . . . . 0.0 112.703 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -38.62 -48.66 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 0.0 111.54 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -45.71 -87.27 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.484 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.5 m -71.17 -52.1 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.484 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 4.1 mp -60.99 -47.25 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.452 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.05 -55.6 28.69 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.5 tp -47.88 -50.03 27.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.125 0.488 . . . . 0.0 110.358 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.509 ' OE1' ' NZ ' ' A' ' 87' ' ' LYS . 42.8 tp10 -55.71 -44.76 77.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.407 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.28 -52.15 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -49.37 -44.14 44.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.034 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt . . . . . 0 C--N 1.33 -0.272 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.432 -179.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 83.8 t60 . . . . . 0 C--O 1.231 0.095 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.9 mt -121.69 127.28 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.617 0.246 . . . . 0.0 110.891 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -130.81 113.02 13.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.945 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.99 138.55 15.06 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -132.26 158.51 41.63 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.3 mp -103.44 146.44 28.5 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.47 161.42 39.45 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 126' ' ' ASN . 68.5 Cg_endo -72.77 -45.58 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.552 2.168 . . . . 0.0 113.398 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -72.9 38.49 0.08 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.974 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.505 ' H ' ' C ' ' A' ' 124' ' ' PRO . 80.9 m-20 50.44 64.31 1.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.213 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -142.49 163.15 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.992 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.8 mt -137.59 118.09 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.21 120.42 27.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.0 tp -117.53 132.68 56.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.202 0.525 . . . . 0.0 110.952 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -121.22 126.38 49.47 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.505 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 120.936 0.398 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.0 t -41.68 -53.13 3.68 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.461 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -46.68 -33.64 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.165 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 7.0 t -68.38 -44.38 75.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.04 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.74 -49.99 18.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.907 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -62.13 -50.7 70.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.902 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.39 -42.6 18.81 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.04 -49.82 73.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 111.361 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.4 mt -58.87 -57.61 12.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.574 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -49.58 -48.71 48.53 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.641 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.26 -51.58 57.24 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -42.86 -60.08 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.775 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.84 56.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.866 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -49.47 -48.09 47.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.665 0.269 . . . . 0.0 110.956 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -49.56 -49.64 45.56 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.827 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 65.2 t80 -85.69 35.87 0.63 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.348 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 44.25 46.76 7.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.126 0.488 . . . . 0.0 110.553 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.478 HE21 ' H ' ' A' ' 156' ' ' LYS . 51.0 tp60 -127.32 142.65 51.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.478 ' H ' HE21 ' A' ' 155' ' ' GLN . 65.6 mttm -124.65 117.48 24.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.43 163.52 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.365 0.602 . . . . 0.0 111.121 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -118.29 131.95 56.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.1 mt -110.32 119.35 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.0 m -103.64 114.72 29.2 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.578 0.228 . . . . 0.0 111.311 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.539 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.6 p-80 -96.03 79.01 3.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.512 0.672 . . . . 0.0 111.565 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -82.22 -0.07 43.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.164 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.516 ' HG1' ' CB ' ' A' ' 173' ' ' MET . 0.3 OUTLIER -144.86 111.12 5.57 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.425 ' CB ' ' CD2' ' A' ' 166' ' ' HIS . 13.6 m -114.14 178.79 4.16 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.112 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 168' ' ' GLY . 77.4 mtp -93.9 -28.94 15.55 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.476 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 4.3 p80 -52.77 -21.21 3.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.673 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.418 ' N ' ' ND1' ' A' ' 166' ' ' HIS . 3.8 t -90.06 -28.04 19.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.561 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 99.63 19.9 18.77 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.072 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.38 167.8 9.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 110.792 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -52.15 -33.85 42.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.263 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -174.76 -170.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 1.7 m -94.31 140.34 29.91 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.253 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.516 ' CB ' ' HG1' ' A' ' 163' ' ' THR . 1.6 tpp -118.6 123.61 45.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.26 102.44 6.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.477 0.656 . . . . 0.0 110.86 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.44 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -91.52 126.73 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.647 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.51 147.07 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.19 0.519 . . . . 0.0 110.197 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -137.25 135.69 37.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.307 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 21.5 mt . . . . . 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.193 179.427 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.5 tp . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.869 0.366 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.2 mm -71.43 -56.08 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.093 0.473 . . . . 0.0 110.29 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -67.3 -18.73 65.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.079 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -75.24 -58.87 3.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.408 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.0 t -52.65 -35.26 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.5 tp -73.08 -43.06 62.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.723 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -51.11 -44.71 61.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -60.36 -52.46 65.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.924 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.556 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 92.6 mtp -50.05 -43.63 51.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.131 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.9 t -68.55 -37.29 77.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.95 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.7 -23.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.226 0.536 . . . . 0.0 110.261 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.48 -34.01 18.81 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.262 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -83.81 -77.57 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.1 m -92.43 -19.11 22.38 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.216 0.532 . . . . 0.0 110.627 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.22 -179.38 24.82 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.0 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.1 ttm -72.57 -30.12 64.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.76 -1.22 . . . . 0.0 110.647 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -60.06 -38.81 83.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.872 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -77.69 -38.91 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 59.4 t-105 -54.48 -48.4 71.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.446 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.24 -25.14 57.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.707 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -74.7 -47.0 33.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.679 -0.408 . . . . 0.0 112.039 -178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.54 -28.13 37.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.313 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 7.9 tt -66.82 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.624 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.76 -22.98 49.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.089 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -80.94 -44.6 17.98 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.523 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 86.7 m-70 . . . . . 0 N--CA 1.467 0.421 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.115 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 76.4 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.835 0.35 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.23 -30.95 70.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.741 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -39.71 -58.54 1.31 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.978 0.418 . . . . 0.0 110.852 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -38.4 -45.14 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.211 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.3 m -67.96 -35.3 78.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.15 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.1 mp -68.68 -58.34 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 119.979 -0.689 . . . . 0.0 109.32 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -52.12 -21.32 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.993 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -79.41 -42.56 25.22 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.196 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.523 ' OD2' ' CD2' ' A' ' 29' ' ' HIS . 32.7 m-20 -57.95 -57.67 11.78 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.789 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.04 -38.88 69.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.641 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.74 84.91 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.081 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -63.35 -31.32 72.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -74.68 -45.26 45.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.63 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.3 mt -77.08 -6.54 53.2 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.853 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.22 48.17 17.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.51 0.672 . . . . 0.0 109.492 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.8 mmm -126.62 149.5 68.28 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.074 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.36 134.44 45.09 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.454 1.436 . . . . 0.0 111.182 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 tt -48.51 -27.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.06 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -72.56 -33.91 67.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.163 0.506 . . . . 0.0 111.327 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -76.38 -31.8 58.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.227 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.548 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 78.5 t -72.61 -56.18 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.46 -43.97 31.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.245 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -51.85 -51.73 54.58 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.06 -58.26 8.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.874 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.6 m-30 -44.33 -29.28 0.65 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.527 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.18 -47.75 77.53 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -58.52 -54.19 49.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.02 0.438 . . . . 0.0 110.446 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.556 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 34.8 m-85 -55.12 -40.71 70.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.736 0.779 . . . . 0.0 110.619 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.6 tp -58.68 -38.16 77.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.198 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 34.4 t80 -68.4 -39.49 81.64 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.041 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -57.19 -71.05 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.328 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.11 -39.82 50.49 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.017 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.412 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 17.7 mt -57.53 -47.4 82.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.332 0.566 . . . . 0.0 111.585 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -47.44 -20.84 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.41 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.409 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.4 t -79.17 -42.28 26.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.105 0.478 . . . . 0.0 110.072 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.429 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.3 mmp_? -65.9 -71.47 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.462 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.413 ' HD1' ' HB ' ' A' ' 84' ' ' VAL . 17.4 p80 -84.16 36.92 0.59 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.831 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 26.5 m -51.11 -46.81 61.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.886 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -49.3 -36.66 21.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.248 0.547 . . . . 0.0 109.66 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.413 ' HB ' ' HD1' ' A' ' 81' ' ' HIS . 11.3 t -76.67 -22.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.999 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 87' ' ' LYS . 57.3 t -68.54 -44.62 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.245 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -54.4 -4.96 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.81 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.547 ' H ' ' C ' ' A' ' 85' ' ' VAL . 60.9 mmtt -81.39 -29.46 33.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.009 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -95.21 117.53 30.41 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.255 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 91.2 m-20 -84.98 -15.44 44.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.482 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 89' ' ' ASP . 63.8 m-20 -161.63 172.02 17.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.192 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -59.42 -53.92 52.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.713 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.6 m -53.51 -36.48 61.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.261 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.3 m -64.79 -39.5 93.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.154 0.502 . . . . 0.0 110.491 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.2 tt -64.19 -47.58 79.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.509 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.33 -36.14 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.758 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.1 mmm -86.34 -5.3 59.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.445 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.38 -15.69 8.75 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.345 -0.697 . . . . 0.0 113.165 -178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 97' ' ' GLY . 16.2 mt -28.07 -105.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 117.716 0.758 . . . . 0.0 112.662 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -39.97 -47.55 2.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.092 0.472 . . . . 0.0 111.351 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -47.04 -88.44 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.0 m -69.77 -51.78 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.49 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 4.4 mp -61.22 -45.61 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.539 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.89 -53.99 40.66 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.8 tp -52.0 -51.55 56.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.86 0.362 . . . . 0.0 110.782 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.48 -45.37 76.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.128 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.2 t -54.07 -52.38 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -47.41 -43.48 23.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.858 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.788 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.1 m80 . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.447 0.165 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.3 mt -134.03 131.51 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.709 0.29 . . . . 0.0 110.682 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -135.41 130.21 34.5 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.659 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -123.4 150.66 16.89 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -138.04 164.71 28.42 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.08 145.09 36.23 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.354 -0.384 . . . . 0.0 109.966 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.35 160.55 41.14 Favored Pre-proline 0 N--CA 1.467 0.377 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.26 -40.11 1.81 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.57 2.18 . . . . 0.0 113.155 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.521 ' ND2' ' OE1' ' A' ' 127' ' ' GLN . 19.8 p30 -78.97 47.44 0.77 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.229 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.9 p30 42.52 61.1 2.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.464 0.65 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.521 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 66.5 mt-30 -137.73 159.44 41.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.895 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.5 mt -135.61 116.52 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.82 122.95 31.41 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.057 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.7 tp -117.66 135.06 54.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.99 0.424 . . . . 0.0 111.168 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -120.01 123.8 44.35 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.456 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.47 0.567 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.566 -178.896 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 26.4 p -40.55 -50.69 2.97 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.568 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.489 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 90.0 m-85 -43.13 -38.06 2.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 110.114 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 28.6 t -69.08 -45.96 68.96 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -45.64 -49.27 14.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.188 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -57.03 -50.39 72.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.677 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.64 -52.63 40.66 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.9 mt -55.16 -55.38 31.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.798 0.333 . . . . 0.0 110.498 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.3 mt -54.08 -55.75 24.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -49.74 -47.97 50.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.73 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.26 60.21 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.95 -60.53 1.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.844 0.354 . . . . 0.0 110.87 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.61 -49.85 45.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -52.98 -47.64 68.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.083 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -50.06 -50.51 47.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 70.6 t80 -85.55 36.77 0.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.992 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 38.8 55.01 2.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.918 0.389 . . . . 0.0 111.134 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.555 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 48.0 tp60 -129.86 141.24 50.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.555 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 19.9 tptm -110.79 126.54 54.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.128 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.0 pt -137.37 177.04 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.524 0.678 . . . . 0.0 111.837 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -143.84 125.84 15.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.202 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mt -111.76 120.74 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.624 0.25 . . . . 0.0 110.613 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 m -105.66 115.37 30.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.112 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 17.0 p80 -102.13 72.95 1.34 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.738 0.78 . . . . 0.0 111.526 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -73.63 -30.86 63.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.844 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.67 113.76 27.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 7.7 t -117.89 -175.38 2.83 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.305 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 165' ' ' MET . 12.6 tmm? -93.8 -25.5 17.36 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -56.09 -23.95 37.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.473 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.6 t -86.54 -25.29 25.14 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.3 21.97 25.91 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.908 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.73 163.18 24.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.025 0.441 . . . . 0.0 110.693 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -45.11 -33.35 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.021 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -176.53 -168.97 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 20.8 t -95.45 141.87 28.48 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.221 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.2 tpt -121.59 119.72 32.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.726 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.98 107.15 11.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.873 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.4 mp -88.98 126.36 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.372 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.66 152.48 13.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.135 0.493 . . . . 0.0 110.458 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -142.96 141.45 31.43 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.494 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 N--CA 1.462 0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.877 -179.69 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 tp . . . . . 0 CA--C 1.532 0.259 0 CA-C-O 120.757 0.313 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.96 -49.42 81.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 109.788 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -70.11 -23.39 63.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.003 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -68.12 -56.53 8.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.971 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.69 -38.65 76.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.043 0.449 . . . . 0.0 109.847 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.401 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 27.5 tp -65.89 -39.73 90.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.558 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -58.03 -43.8 87.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.989 0.423 . . . . 0.0 110.626 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.46 -63.9 1.14 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.361 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.8 ptm -46.19 -41.43 12.69 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.422 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.7 t -64.84 -38.36 82.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.609 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 49.2 t -59.9 -22.74 24.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.498 0.666 . . . . 0.0 109.407 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.76 -34.98 21.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.382 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -84.28 -76.67 0.29 Allowed 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.8 m -91.94 -21.44 20.57 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.294 0.569 . . . . 0.0 110.672 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.81 175.43 23.84 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.05 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.3 ttp -68.85 -28.07 66.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.648 -1.276 . . . . 0.0 110.368 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -61.75 -38.85 89.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.639 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.39 -38.67 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -55.3 -47.57 75.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.048 0.451 . . . . 0.0 110.096 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.04 -24.81 55.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.944 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -74.17 -47.31 36.61 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.93 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.494 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -80.71 -26.51 37.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 6.6 tt -73.04 -54.93 7.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.009 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -61.25 -23.98 66.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.475 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.51 ' NZ ' ' CE1' ' A' ' 29' ' ' HIS . 30.4 tttm -82.37 -39.04 23.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.51 ' CE1' ' NZ ' ' A' ' 28' ' ' LYS . 67.8 m80 . . . . . 0 N--CA 1.465 0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.063 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.8 0.333 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -67.9 -37.25 81.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.598 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -52.44 -57.54 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.194 0.521 . . . . 0.0 110.771 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -39.0 -42.38 0.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.671 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.8 p -74.53 -30.4 61.76 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.861 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 47' ' ' LEU . 17.9 mt -71.42 -52.96 22.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.745 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.97 -26.31 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.668 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -76.53 -41.1 47.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.547 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -59.47 -56.05 26.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.963 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.9 p -58.35 -37.08 61.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.981 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.54 -38.28 86.84 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.061 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -63.52 -31.63 72.84 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.6 mmt-85 -73.54 -42.76 61.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.378 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.4 mt -81.54 -7.27 59.56 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.668 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.8 t30 57.02 49.82 13.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.807 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.7 mmt -128.69 149.44 72.03 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.214 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.62 137.76 65.95 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.404 1.403 . . . . 0.0 110.981 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 tt -51.22 -28.5 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.254 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -71.82 -34.2 69.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 0.0 111.58 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -76.17 -31.98 58.82 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.89 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.4 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 95.9 t -71.08 -56.66 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.56 -43.87 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.372 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -51.61 -51.06 58.66 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.39 -54.12 50.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.559 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.401 ' CE2' ' CD1' ' A' ' 9' ' ' LEU . 5.7 m-30 -44.12 -28.94 0.55 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.464 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.91 63.3 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.03 -54.35 48.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.768 0.318 . . . . 0.0 110.461 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -55.28 -41.33 72.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.813 0.816 . . . . 0.0 110.693 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.4 tp -57.95 -38.69 76.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.553 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 26.1 t80 -70.25 -39.53 74.94 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.162 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -55.33 -73.82 0.05 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.091 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.82 -38.21 29.74 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.203 -0.523 . . . . 0.0 112.572 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 20.8 mt -57.45 -46.52 83.52 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.028 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -48.41 -20.7 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.296 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.0 t -81.46 -41.92 21.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.15 0.5 . . . . 0.0 110.205 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.425 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.3 mmp_? -65.17 -71.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.778 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.463 ' HD1' ' HB ' ' A' ' 84' ' ' VAL . 18.5 p80 -85.25 34.61 0.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.985 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 38.9 m -47.2 -45.2 23.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.817 0.341 . . . . 0.0 110.574 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -54.55 -31.06 55.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.463 ' HB ' ' HD1' ' A' ' 81' ' ' HIS . 19.1 t -80.4 -24.58 11.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.093 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.0 t -62.49 -37.65 79.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.356 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.08 -15.95 2.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.653 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -65.75 -31.22 72.08 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.58 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 15.3 p90 -119.01 115.98 25.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.039 0.447 . . . . 0.0 110.708 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -83.68 -0.64 51.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.283 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 13.8 p-10 -163.11 155.25 18.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.128 0.49 . . . . 0.0 111.569 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -44.86 -52.0 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.876 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.7 m -55.01 -43.0 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.752 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -61.77 -36.11 80.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.233 0.54 . . . . 0.0 110.614 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.9 tt -67.05 -56.82 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.858 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.3 t -54.55 -38.46 42.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.847 0.356 . . . . 0.0 111.659 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.5 ppp? -88.44 -6.75 57.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -112.27 -14.73 10.43 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 119.712 -0.493 . . . . 0.0 112.909 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 94' ' ' LEU . 3.8 mt -34.25 -83.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 117.867 0.833 . . . . 0.0 111.705 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -44.76 -54.16 6.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.26 0.553 . . . . 0.0 110.742 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -46.69 -88.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.43 ' O ' ' OE2' ' A' ' 105' ' ' GLU . 3.7 m -71.01 -49.98 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -176.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.7 mp -65.91 -39.79 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.383 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.74 -56.0 14.86 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.4 ' CD1' ' NZ ' ' A' ' 108' ' ' LYS . 58.7 tp -49.91 -55.97 12.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.972 0.415 . . . . 0.0 110.709 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -52.69 -44.88 66.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.476 -178.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 17.8 t -54.13 -53.42 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -47.14 -43.01 20.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.79 0.328 . . . . 0.0 110.827 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.4 ' NZ ' ' CD1' ' A' ' 104' ' ' LEU . 26.0 mmtm . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.572 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.66 0.267 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.49 126.34 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.962 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -133.14 121.12 22.14 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.579 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.3 126.97 7.17 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -117.05 166.07 12.62 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 1.6 mm? -109.88 130.46 55.52 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.27 160.43 37.56 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.28 178.11 6.47 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.995 1.797 . . . . 0.0 112.127 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.523 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 19.5 t-20 56.6 37.26 28.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.949 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 8.6 p30 50.0 69.31 0.62 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.614 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 126' ' ' ASN . 82.8 mm-40 -136.85 161.61 35.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.513 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.1 mt -145.07 121.3 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.78 122.33 35.06 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.288 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.0 tp -117.64 134.73 54.57 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.125 0.488 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.67 HH21 ' CD2' ' A' ' 171' ' ' HIS . 58.7 ttt180 -117.56 121.61 41.44 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.477 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.485 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 37.4 t80 . . . . . 0 N--CA 1.467 0.378 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.531 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 31.0 p -43.17 -49.82 6.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.372 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.555 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 73.3 m-85 -46.76 -40.23 13.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.083 0.468 . . . . 0.0 110.335 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.3 t -62.93 -42.73 99.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.61 -54.95 8.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.663 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.64 -51.21 63.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.316 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.09 -48.13 47.25 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.05 -53.69 55.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.683 0.278 . . . . 0.0 111.302 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.4 mt -55.59 -54.93 37.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.699 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -49.17 -49.1 44.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.902 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.04 -50.58 66.32 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.42 -59.91 2.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.74 0.305 . . . . 0.0 110.941 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.44 -52.08 49.37 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.314 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -52.13 -47.88 65.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.215 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -47.74 -50.0 26.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.709 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -85.39 38.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.844 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 38.45 62.31 1.02 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.038 0.447 . . . . 0.0 111.309 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.504 ' NE2' ' N ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -132.93 151.11 52.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.504 ' N ' ' NE2' ' A' ' 155' ' ' GLN . 84.4 tttt -118.27 118.9 33.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.499 ' CG2' HE21 ' A' ' 155' ' ' GLN . 33.9 pt -133.32 170.86 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.539 0.685 . . . . 0.0 112.186 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -138.25 127.77 24.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.52 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mt -111.41 117.56 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.911 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.9 t -98.72 103.34 15.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.819 0.343 . . . . 0.0 110.47 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.576 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 20.3 p80 -94.02 65.12 3.43 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.615 0.721 . . . . 0.0 111.017 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 163' ' ' THR . 37.3 p30 -69.0 -33.05 73.04 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.113 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.512 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 1.6 m -99.95 107.54 19.53 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.066 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.59 ' O ' ' N ' ' A' ' 166' ' ' HIS . 55.9 m -134.71 114.22 12.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.653 0.263 . . . . 0.0 110.785 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.2 ttt -36.62 -20.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.19 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.59 ' N ' ' O ' ' A' ' 164' ' ' CYS . 83.7 t60 -52.23 -23.33 5.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.6 t -88.77 -43.18 11.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.01 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.469 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 130.48 13.9 2.02 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.09 162.51 14.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 110.729 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.554 ' O ' ' CG ' ' A' ' 171' ' ' HIS . 28.9 p-10 -55.55 -41.16 72.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.343 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.67 ' CD2' HH21 ' A' ' 131' ' ' ARG . 82.5 m-70 -161.52 -173.33 3.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.6 m -96.31 137.96 34.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.439 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.424 ' H ' ' HB ' ' A' ' 163' ' ' THR . 12.3 ttm -126.19 92.76 3.64 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.609 0.719 . . . . 0.0 109.608 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.19 113.9 26.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.912 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.1 mm -90.49 127.98 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.366 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.07 148.99 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.432 0.634 . . . . 0.0 110.727 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -137.82 135.88 36.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.555 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 19.0 mt . . . . . 0 N--CA 1.465 0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.702 -179.687 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.436 HD13 HG21 ' A' ' 4' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mm -68.56 -52.73 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.395 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.45 -22.81 64.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.006 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -69.83 -49.59 51.1 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.716 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.08 -36.36 77.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.922 0.392 . . . . 0.0 110.158 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.1 tp -71.02 -35.46 72.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.241 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.15 -45.73 86.91 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.045 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -61.61 -52.32 64.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.428 ' SD ' ' CE1' ' A' ' 69' ' ' PHE . 7.8 ttp -49.73 -43.27 47.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.54 -35.17 69.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.663 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -61.93 -22.16 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.218 0.533 . . . . 0.0 109.756 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.9 -35.11 20.74 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.343 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -84.35 -77.13 0.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.4 m -90.99 -20.04 22.56 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.265 0.555 . . . . 0.0 110.738 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.95 173.59 26.54 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.77 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.8 ttt -68.57 -28.37 66.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.831 -1.184 . . . . 0.0 110.477 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.8 m -62.76 -42.5 99.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.164 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.96 -36.03 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -52.03 -46.23 64.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -70.14 -30.98 68.28 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.138 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -65.31 -50.62 64.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.469 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -83.14 -18.89 37.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.871 0.367 . . . . 0.0 110.792 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.5 tt -77.97 -61.43 2.0 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.371 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -58.68 -21.91 55.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.319 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -80.64 -38.58 28.91 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.502 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 72.1 m80 . . . . . 0 N--CA 1.465 0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.508 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.9 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.792 0.33 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.96 -30.38 67.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.808 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.6 -57.46 2.26 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.038 0.447 . . . . 0.0 110.684 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -38.0 -43.47 0.72 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.516 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.3 m -72.94 -32.41 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.527 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.2 mp -70.74 -52.84 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.503 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -24.67 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.885 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -77.01 -41.37 43.02 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.466 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.502 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 37.9 m-20 -58.55 -56.43 22.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.864 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.0 p -57.13 -39.32 66.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.065 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.72 86.81 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.134 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -62.84 -31.51 72.54 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -74.54 -45.79 43.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.491 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.0 mt -76.8 -8.6 57.61 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.621 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 58.1 52.33 7.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.748 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.2 mmt -132.43 149.95 74.56 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.382 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.31 140.64 89.45 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.441 1.427 . . . . 0.0 111.194 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 tt -56.55 -30.76 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.744 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -72.91 -29.75 63.37 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.297 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 50.2 t0 -78.77 -36.62 42.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.699 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.448 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.2 t -63.74 -58.96 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.94 -39.89 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.756 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -52.59 -47.33 66.97 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.86 89.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.448 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 6.2 m-30 -52.81 -29.96 30.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.613 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.17 -50.41 57.06 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -55.62 -50.06 71.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.924 0.392 . . . . 0.0 110.2 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -59.16 -41.53 88.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.802 0.81 . . . . 0.0 110.431 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.73 -38.88 79.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.449 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 36.6 t80 -69.54 -39.15 77.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.136 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -56.9 -69.87 0.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.97 -38.13 54.75 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.581 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.514 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 18.8 mt -57.07 -48.22 79.11 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.451 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.16 -21.28 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.552 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t -80.41 -40.51 26.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.24 0.543 . . . . 0.0 110.109 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.41 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.9 mmp_? -66.55 -70.55 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.68 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 23.7 p80 -83.66 32.99 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.97 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 55.0 m -47.93 -43.27 28.92 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.941 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -52.67 -31.76 38.85 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 81' ' ' HIS . 16.7 t -82.47 -25.26 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.675 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.528 ' C ' ' H ' ' A' ' 87' ' ' LYS . 44.5 t -63.27 -38.2 81.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -47.33 -12.86 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.875 0.369 . . . . 0.0 110.924 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.528 ' H ' ' C ' ' A' ' 85' ' ' VAL . 85.5 mttt -79.63 -28.41 40.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.895 0.855 . . . . 0.0 109.721 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 85' ' ' VAL . 39.7 t80 -57.78 100.21 0.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.232 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.453 ' H ' ' HG ' ' A' ' 93' ' ' SER . 83.5 m-20 -88.39 -32.91 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 54.2 t0 -174.73 155.51 2.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.759 -1.564 . . . . 0.0 109.923 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.504 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 78.0 t80 -42.56 -46.27 4.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.319 0.58 . . . . 0.0 110.49 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.2 m -61.76 -37.3 83.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.795 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.453 ' HG ' ' H ' ' A' ' 89' ' ' ASP . 84.1 p -65.54 -40.83 93.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.343 0.592 . . . . 0.0 110.579 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 98' ' ' ILE . 6.5 tt -65.35 -49.92 67.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.318 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.5 t -57.13 -37.78 57.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.262 0.554 . . . . 0.0 110.623 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 120' ' ' GLY . 95.3 mmm -86.49 -5.98 59.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.192 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.89 -15.56 8.52 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.096 -0.836 . . . . 0.0 113.202 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.521 ' O ' ' O ' ' A' ' 97' ' ' GLY . 13.6 mt -27.27 -106.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 117.945 0.873 . . . . 0.0 112.66 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -40.64 -49.89 3.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.26 0.552 . . . . 0.0 111.259 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -43.25 -86.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.516 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.0 m -72.82 -51.86 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.516 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.5 mp -64.77 -50.04 77.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.51 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -53.46 -50.98 50.76 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.439 ' CD1' ' HZ2' ' A' ' 108' ' ' LYS . 30.1 tp -48.83 -50.28 35.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.085 0.469 . . . . 0.0 110.228 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.506 ' CG ' ' NZ ' ' A' ' 87' ' ' LYS . 68.9 mm-40 -55.85 -45.08 78.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.141 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 72.3 t -51.99 -51.0 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -50.11 -42.49 50.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.708 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.439 ' HZ2' ' CD1' ' A' ' 104' ' ' LEU . 26.4 mmtm . . . . . 0 C--N 1.331 -0.203 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.26 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 . . . . . 0 C--O 1.232 0.147 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 91.3 mt -121.26 126.69 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.631 0.253 . . . . 0.0 110.981 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -130.66 112.18 12.88 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.861 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.443 ' C ' ' SD ' ' A' ' 96' ' ' MET . . . -110.39 128.46 8.83 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -118.95 164.66 15.13 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.944 0.402 . . . . 0.0 110.468 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.24 144.73 36.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.661 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.41 160.56 41.21 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.01 -31.43 9.81 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.549 2.166 . . . . 0.0 113.261 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -86.51 44.97 1.19 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.24 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 m120 45.06 51.34 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.286 0.565 . . . . 0.0 110.575 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -127.44 158.46 37.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.701 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.1 mt -135.72 117.91 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.65 122.77 32.43 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.749 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.7 tp -117.26 133.79 55.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.058 0.456 . . . . 0.0 110.439 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -119.38 126.59 51.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.529 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 121.256 0.551 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.4 m -41.93 -50.82 4.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.93 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -45.43 -36.74 4.56 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.552 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.82 -44.17 74.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.949 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -44.77 -47.52 10.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.603 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -65.13 -49.42 69.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.376 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.65 -47.45 45.75 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.9 mt -58.84 -53.28 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.65 0.262 . . . . 0.0 111.192 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.8 mt -55.64 -54.73 40.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.606 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -50.42 -47.14 56.72 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.658 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.94 -50.94 62.41 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.61 -59.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.743 0.306 . . . . 0.0 110.736 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.25 -51.51 58.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.667 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -51.52 -47.24 63.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.067 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -49.4 -49.73 43.45 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.743 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.517 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 67.4 t80 -88.03 38.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.891 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 38.51 55.28 1.87 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.966 0.412 . . . . 0.0 111.134 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.575 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 46.4 tp60 -128.84 141.18 51.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.575 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 15.7 mtpp -110.85 131.35 55.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.173 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.4 pt -142.99 170.12 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.631 0.729 . . . . 0.0 112.268 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -134.77 125.69 27.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.93 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.7 mt -111.63 118.84 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.618 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.2 m -98.95 99.83 10.93 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.008 0.433 . . . . 0.0 110.248 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 163' ' ' THR . 23.3 t-160 -98.59 70.12 1.92 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.388 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -77.11 -45.84 25.56 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.904 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.466 ' O ' ' CD2' ' A' ' 161' ' ' HIS . 2.4 m -77.83 118.91 20.62 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.863 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 166' ' ' HIS . 34.0 t -143.78 116.27 8.6 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.009 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.432 ' C ' ' N ' ' A' ' 167' ' ' THR . 26.1 ttt -35.25 -23.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.073 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.575 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.9 t60 -50.11 -20.66 1.04 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.432 ' N ' ' C ' ' A' ' 165' ' ' MET . 6.0 t -93.97 -36.4 12.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.139 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.66 13.34 8.07 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.56 165.69 7.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 110.809 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -52.83 -35.91 57.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.428 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -172.13 -171.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.4 m -93.68 138.83 31.5 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.547 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.3 tpt -117.65 122.08 42.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.064 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -126.13 102.21 7.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.029 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.457 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -90.35 126.95 43.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.511 178.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.46 151.83 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.188 0.518 . . . . 0.0 110.599 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -139.26 137.84 36.26 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.48 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 N--CA 1.464 0.238 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.937 -179.636 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tp . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 120.769 0.319 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.0 mm -58.7 -49.15 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.112 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -67.26 -25.91 66.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.275 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -66.95 -54.63 20.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.192 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.76 -35.19 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.401 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.8 tp -68.48 -51.33 44.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.399 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -47.0 -44.15 20.02 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.09 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -61.14 -52.71 63.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.999 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.8 ttt -51.31 -40.17 58.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.73 -35.69 66.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.418 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.78 -22.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.336 0.589 . . . . 0.0 109.883 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.77 -34.7 19.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.225 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -84.48 -77.06 0.28 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.0 m -90.81 -20.12 22.68 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.247 0.546 . . . . 0.0 110.705 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.6 173.78 26.99 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.719 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.4 ttt -69.53 -25.02 63.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.937 -1.131 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -65.27 -43.21 91.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.148 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -34.31 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -51.57 -45.97 63.28 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -69.15 -32.66 72.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.015 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -64.33 -50.97 65.68 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.473 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -82.78 -19.6 37.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.958 0.408 . . . . 0.0 110.965 -179.229 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tt -75.34 -57.61 3.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.692 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -62.89 -21.09 65.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.62 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -80.72 -39.29 27.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.526 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 43.5 m170 . . . . . 0 N--CA 1.468 0.458 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.861 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.713 0.292 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -62.09 -40.82 97.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.769 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -41.19 -55.01 2.77 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.946 0.403 . . . . 0.0 110.595 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.14 -38.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.914 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.9 m -72.41 -34.53 67.93 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.837 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 47' ' ' LEU . 1.8 mp -68.33 -56.93 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.207 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -51.89 -26.25 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.831 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -75.24 -41.18 58.1 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.763 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.526 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 51.3 m-20 -59.4 -56.62 19.69 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.073 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 p -56.39 -38.1 54.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.08 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.07 -38.75 87.33 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.251 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -62.8 -32.22 73.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.55 -43.32 60.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 41.6 mt -79.3 -8.47 59.08 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.612 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.1 t30 57.32 50.4 11.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.555 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.0 mmt -129.79 149.75 73.91 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.208 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.74 139.83 82.68 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.407 1.405 . . . . 0.0 111.171 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 tt -54.37 -30.89 21.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.363 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -72.0 -29.72 64.49 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.405 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 37.5 t0 -78.69 -35.48 45.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.956 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.45 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 72.0 t -66.29 -58.03 8.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -51.34 -39.49 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.959 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -53.35 -47.83 69.05 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.88 -43.96 97.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.65 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.45 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 6.8 m-30 -55.1 -32.07 61.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.17 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.4 -50.18 56.99 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -57.63 -47.77 81.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.066 0.46 . . . . 0.0 109.896 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.03 -42.58 94.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.85 0.833 . . . . 0.0 110.363 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.8 tp -56.15 -39.0 71.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.388 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -70.49 -40.8 73.38 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.286 -0.565 . . . . 0.0 109.936 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -57.08 -71.87 0.09 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.914 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.5 -37.58 19.62 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.223 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.527 ' C ' ' HD1' ' A' ' 81' ' ' HIS . 18.2 mt -58.67 -41.6 86.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.121 0.46 . . . . 0.0 111.732 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.46 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -55.16 -15.86 2.62 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.672 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.431 ' O ' ' OG1' ' A' ' 82' ' ' THR . 29.0 t -83.69 -46.85 11.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.324 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.87 -47.4 9.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.977 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.549 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -84.42 26.48 0.78 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.201 0.524 . . . . 0.0 109.982 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 3.8 m -58.21 -40.38 81.44 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.329 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -56.01 -31.87 63.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.3 t -85.54 -20.84 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.923 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 81' ' ' HIS . 43.3 t -64.69 -41.22 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.213 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.82 -19.15 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -66.23 -28.91 69.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.557 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 1.8 p90 -120.35 114.32 21.68 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.107 0.48 . . . . 0.0 110.77 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -85.28 -3.33 58.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.372 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.427 ' O ' ' OG ' ' A' ' 93' ' ' SER . 4.3 p-10 -163.04 154.57 17.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.092 0.472 . . . . 0.0 111.602 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -45.4 -56.38 5.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.001 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.0 m -52.08 -44.01 64.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.795 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.442 ' HG ' ' N ' ' A' ' 94' ' ' LEU . 80.9 p -61.63 -35.47 77.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.18 0.514 . . . . 0.0 110.825 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.9 tt -68.64 -48.78 63.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.589 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.78 -39.1 75.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.069 0.461 . . . . 0.0 111.145 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -88.61 -4.86 58.48 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -111.03 -15.07 11.08 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 119.569 -0.573 . . . . 0.0 112.761 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 94' ' ' LEU . 12.8 mt -30.37 -100.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 117.75 0.775 . . . . 0.0 112.269 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -39.31 -51.61 2.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.15 0.5 . . . . 0.0 111.374 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -43.32 -87.21 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.5 m -72.51 -53.65 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.496 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.9 mp -62.27 -46.89 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.688 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.19 -52.57 48.61 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.441 ' CD1' ' HZ2' ' A' ' 108' ' ' LYS . 42.4 tp -52.43 -51.47 58.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.359 . . . . 0.0 110.665 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -54.88 -45.84 74.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.755 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.68 -51.99 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -47.11 -43.23 20.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.757 0.313 . . . . 0.0 110.754 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.441 ' HZ2' ' CD1' ' A' ' 104' ' ' LEU . 26.7 mmtm . . . . . 0 C--N 1.329 -0.305 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.144 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.834 ' NE2' HH22 ' A' ' 131' ' ' ARG . 20.4 t60 . . . . . 0 CA--C 1.528 0.121 0 N-CA-C 111.515 0.191 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.71 129.62 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -134.53 119.75 18.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.886 0.374 . . . . 0.0 111.591 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -108.2 126.06 8.1 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -116.77 165.27 13.49 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.117 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 1.2 mm? -111.8 139.19 47.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.186 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.95 160.25 41.51 Favored Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 69.9 Cg_endo -73.51 158.71 47.43 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.264 1.976 . . . . 0.0 112.109 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 124' ' ' PRO . 3.4 t-20 92.24 -60.92 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.217 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 14.1 m-20 154.31 59.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -135.14 163.28 30.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.05 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.7 mt -140.2 121.16 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.34 122.77 33.52 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.276 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.0 tp -116.05 136.55 52.92 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.033 0.444 . . . . 0.0 110.745 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.834 HH22 ' NE2' ' A' ' 117' ' ' HIS . 61.0 ttp85 -123.08 124.28 42.75 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.595 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.428 ' C ' ' CD1' ' A' ' 132' ' ' TYR . 25.4 t80 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.19 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.541 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.4 mm? . . . . . 0 CA--C 1.532 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 65.5 m -40.86 -54.61 2.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.601 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -47.07 -30.07 2.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.957 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.456 ' N ' ' O ' ' A' ' 138' ' ' LEU . 4.7 t -71.38 -45.19 63.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.794 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.65 -48.79 14.8 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.588 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -63.35 -48.26 78.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.206 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.33 -46.22 44.42 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.3 -52.58 64.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.64 0.257 . . . . 0.0 111.351 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.2 mt -55.53 -56.51 19.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.819 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -51.33 -47.55 62.65 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.644 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.33 -52.23 54.46 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.52 -60.21 1.84 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.0 110.784 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.34 -51.63 52.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.563 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -51.24 -46.37 62.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.636 0.255 . . . . 0.0 110.961 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -50.23 -50.35 50.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.515 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 71.3 t80 -86.2 37.15 0.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.998 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 40.69 53.0 3.15 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.92 0.39 . . . . 0.0 111.062 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.519 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 46.0 tp60 -127.72 139.52 52.63 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.519 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 2.3 mptp? -112.95 128.06 56.38 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.7 pt -139.18 175.72 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.663 0.744 . . . . 0.0 111.638 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -137.78 127.09 24.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.195 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.3 mt -112.31 116.69 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.462 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.3 m -97.0 101.94 13.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.497 ' NE2' ' O ' ' A' ' 163' ' ' THR . 10.8 t-160 -104.62 74.97 1.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.91 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -81.27 -40.68 23.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.82 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.497 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 1.9 m -78.97 117.72 20.31 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.146 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 166' ' ' HIS . 14.7 t -142.16 117.35 10.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.693 0.282 . . . . 0.0 111.08 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.475 ' C ' ' N ' ' A' ' 167' ' ' THR . 24.5 ttt -33.88 -25.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.225 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.568 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.6 t60 -49.42 -19.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.568 0.699 . . . . 0.0 109.147 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.475 ' N ' ' C ' ' A' ' 165' ' ' MET . 5.9 t -94.73 -34.2 12.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.958 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 112.54 16.05 9.07 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.34 166.48 8.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.064 0.459 . . . . 0.0 110.782 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -55.56 -33.91 64.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.456 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.417 ' HD1' ' N ' ' A' ' 172' ' ' CYS . 22.0 p80 -171.89 -169.63 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.417 ' N ' ' HD1' ' A' ' 171' ' ' HIS . 3.7 m -94.7 141.94 28.04 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.562 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.5 tpt -118.02 123.6 46.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.104 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.2 100.35 5.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.162 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.479 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -88.26 126.6 41.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.702 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.84 149.74 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.183 0.516 . . . . 0.0 110.588 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -144.57 139.28 28.04 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.421 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.462 0.172 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.116 179.601 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 tp . . . . . 0 CA--C 1.529 0.172 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.4 -48.4 80.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.423 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 3.2 m-85 -67.42 -24.11 65.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.753 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -71.18 -57.31 4.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.49 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.15 -35.84 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.012 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.7 tp -72.03 -41.94 66.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.413 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -53.87 -46.61 71.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.935 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.16 -45.29 93.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.927 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.599 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 3.3 tpp -58.05 -47.31 83.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.4 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.55 -36.71 76.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.828 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -63.17 -22.94 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.278 0.561 . . . . 0.0 109.661 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.77 -34.76 18.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.85 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -86.78 -76.93 0.34 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.8 m -89.84 -17.08 28.77 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.408 0.623 . . . . 0.0 110.723 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.2 -179.97 31.15 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.565 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 ttt -72.85 -31.68 64.93 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.053 -1.074 . . . . 0.0 111.098 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -60.22 -39.53 86.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.165 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.83 -37.76 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -55.13 -47.38 75.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.07 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.33 -24.89 54.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.898 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -76.01 -46.42 29.53 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.819 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.37 -28.22 41.93 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.742 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.509 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 6.8 tt -71.23 -45.86 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.232 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.4 -23.89 63.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.639 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -82.14 -40.59 21.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.423 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 59.6 m-70 . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.177 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.777 0.322 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.54 -28.89 70.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.644 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.9 OUTLIER -47.82 -57.95 4.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.203 0.525 . . . . 0.0 110.354 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -37.14 -44.82 0.58 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.98 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.5 m -71.91 -32.26 67.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.123 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 14.1 mt -71.6 -52.3 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.31 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.63 -21.89 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.445 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -80.34 -41.03 25.53 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.423 ' OD2' ' CD2' ' A' ' 29' ' ' HIS . 37.2 m-20 -58.53 -57.32 13.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.71 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.41 -37.61 64.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.555 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.55 87.98 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.236 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -63.4 -31.4 72.55 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.498 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -73.21 -46.24 51.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.541 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.6 mt -76.31 -7.48 55.03 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.879 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.59 48.59 16.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.439 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 18.3 mmt -127.7 149.81 71.43 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.131 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.08 137.48 66.99 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.475 1.45 . . . . 0.0 111.233 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tt -52.82 -29.72 14.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.023 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -73.45 -29.54 62.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.497 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -79.4 -34.65 41.64 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.06 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.535 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 55.7 t -66.14 -58.79 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.53 -38.8 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.662 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.55 -44.31 72.77 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.739 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.31 -59.32 5.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.305 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.535 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 5.5 m-30 -45.98 -29.98 1.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.289 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.88 -52.64 51.09 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -57.02 -51.74 68.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.962 0.411 . . . . 0.0 110.143 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.599 ' CD1' ' SD ' ' A' ' 12' ' ' MET . 55.5 m-85 -56.73 -43.02 80.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.798 0.808 . . . . 0.0 110.595 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.0 tp -55.45 -38.38 68.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.614 -1.176 . . . . 0.0 112.057 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 43.6 t80 -68.91 -40.26 79.23 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.965 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -57.22 -70.2 0.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.038 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.87 -41.68 36.69 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.789 -178.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.2 mt -57.4 -44.83 84.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.274 0.537 . . . . 0.0 111.615 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -49.17 -20.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.903 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 t -81.77 -41.62 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.119 0.485 . . . . 0.0 109.834 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -65.41 -74.52 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.696 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.512 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 0.2 OUTLIER -84.39 37.28 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.596 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 24.8 m -48.11 -46.43 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.111 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -54.22 -34.02 59.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.049 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.54 -21.93 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.685 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' A' ' 87' ' ' LYS . 73.7 t -70.96 -41.49 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.765 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -54.75 -0.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.467 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.605 ' HZ2' ' CG ' ' A' ' 105' ' ' GLU . 77.6 mttt -84.25 -28.01 27.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.52 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.12 119.47 36.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.587 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 58.2 t0 -84.02 -13.66 52.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.118 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.454 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 60.8 m-20 -162.02 167.63 24.1 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.431 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -53.83 -52.65 59.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.685 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.9 m -53.04 -37.68 61.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.259 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.4 m -60.88 -40.65 93.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.337 0.589 . . . . 0.0 110.14 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 98' ' ' ILE . 8.4 tt -60.76 -59.3 5.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.318 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.9 t -52.72 -37.4 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.229 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 91.8 mmm -86.23 -5.68 59.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.731 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -114.93 -15.14 8.08 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.377 -0.68 . . . . 0.0 113.112 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 97' ' ' GLY . 10.3 mt -28.03 -104.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 117.763 0.782 . . . . 0.0 112.763 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 118' ' ' ILE . 8.1 p80 -39.39 -49.88 2.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.075 0.464 . . . . 0.0 111.229 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -44.47 -87.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.511 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.3 m -71.52 -51.89 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.511 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mp -63.92 -45.48 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.756 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.38 -52.73 51.03 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.7 tp -51.67 -52.36 48.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.791 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.605 ' CG ' ' HZ2' ' A' ' 87' ' ' LYS . 58.3 mm-40 -53.85 -46.0 71.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.329 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.4 t -55.29 -51.39 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -48.69 -42.74 35.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.684 0.278 . . . . 0.0 110.883 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.746 -179.855 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.6 m80 . . . . . 0 N--CA 1.466 0.362 0 CA-C-O 120.475 0.178 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 1.5 mp -130.43 128.61 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.657 0.265 . . . . 0.0 110.308 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -135.22 127.08 29.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.714 0.293 . . . . 0.0 110.859 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.56 135.01 11.49 Favored Glycine 0 N--CA 1.466 0.692 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -131.96 126.19 33.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 tp -72.47 136.32 45.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.97 0.414 . . . . 0.0 110.885 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.56 160.58 28.04 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 59.6 Cg_endo -72.15 165.7 31.86 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.284 1.99 . . . . 0.0 111.898 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' PRO . 15.4 t-20 86.46 -62.66 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.103 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 125' ' ' ASN . 5.7 p30 154.84 52.59 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.162 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -128.46 159.34 35.71 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.675 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.9 mt -134.38 117.16 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.95 123.03 31.62 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.63 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.6 tp -116.94 137.24 52.35 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.111 0.481 . . . . 0.0 111.011 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.486 ' NE ' ' NE2' ' A' ' 171' ' ' HIS . 42.1 ttm180 -127.14 126.12 42.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.832 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 132' ' ' TYR . 33.2 t80 . . . . . 0 N--CA 1.471 0.609 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.521 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.8 mm? . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 21.7 p -40.76 -52.75 2.94 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.12 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.463 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 62.4 m-85 -47.78 -35.82 10.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 138' ' ' LEU . 6.7 t -76.46 -51.78 11.11 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -43.31 -45.74 6.08 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.941 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -62.72 -46.46 87.98 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.167 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.24 -52.95 40.66 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.8 mt -54.38 -55.85 24.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.706 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.3 mt -54.3 -55.43 28.42 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.097 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -50.43 -48.49 56.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.678 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.18 -51.1 60.47 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.58 -59.61 2.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.887 0.375 . . . . 0.0 110.625 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -48.16 -50.23 29.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.87 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -52.81 -47.4 67.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.155 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -49.79 -50.32 45.27 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.668 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 70.6 t80 -86.01 37.19 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.025 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 39.73 54.11 2.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.993 0.425 . . . . 0.0 111.109 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.451 HE21 ' H ' ' A' ' 156' ' ' LYS . 50.1 tp60 -129.52 141.86 50.9 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.451 ' H ' HE21 ' A' ' 155' ' ' GLN . 67.9 mttm -118.71 107.54 13.8 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.998 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 38.7 pt -114.56 -178.19 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.507 0.67 . . . . 0.0 111.559 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -145.18 126.38 14.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.252 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.2 mt -110.76 119.08 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 120.69 0.281 . . . . 0.0 110.828 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.2 t -101.07 103.71 14.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.834 0.35 . . . . 0.0 110.276 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 163' ' ' THR . 21.0 t-160 -100.15 73.62 1.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.454 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -79.26 -48.68 13.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.478 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 1.0 OUTLIER -73.63 124.53 26.13 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.914 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 70.8 m -126.55 174.11 8.92 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.801 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 168' ' ' GLY . 1.1 tmt? -90.18 -27.35 19.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.092 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -52.57 -23.16 5.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.489 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.1 t -88.91 -25.28 22.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.454 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 97.74 23.27 14.03 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.012 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.09 168.71 11.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 110.768 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -54.22 -34.16 59.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.52 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.486 ' NE2' ' NE ' ' A' ' 131' ' ' ARG . 5.5 p-80 -174.52 -169.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 92.5 m -93.28 138.7 31.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.7 tpt -117.98 124.25 47.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.169 0.509 . . . . 0.0 110.074 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.4 mt -126.26 102.87 7.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.701 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.463 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -87.33 128.72 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.67 151.45 14.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.416 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -143.13 141.33 31.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.598 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 N--CA 1.463 0.19 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.837 -179.924 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tp . . . . . 0 CA--C 1.532 0.281 0 CA-C-O 120.677 0.275 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.1 mm -59.88 -50.18 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.88 0.372 . . . . 0.0 110.147 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -67.52 -24.28 65.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.424 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.463 ' C ' HD21 ' A' ' 7' ' ' ASN . 0.4 OUTLIER -67.77 -53.17 29.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.974 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.6 t -65.68 -35.99 76.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.364 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.6 -45.4 68.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.562 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -50.39 -43.9 54.76 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.661 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -62.78 -51.31 67.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.928 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.6 tmt? -51.18 -39.98 57.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.84 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.7 t -71.38 -34.78 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.557 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.98 -22.53 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.227 0.537 . . . . 0.0 109.957 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.64 -34.65 19.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.237 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -84.52 -76.99 0.28 Allowed 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.3 m -91.33 -19.19 23.21 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.211 0.529 . . . . 0.0 110.708 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.18 173.72 27.52 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.772 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 ttt -69.32 -27.65 65.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.888 -1.156 . . . . 0.0 110.516 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 t -63.21 -42.57 99.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.0 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.73 -36.57 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -50.68 -45.48 58.17 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -71.88 -30.64 65.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.238 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -66.5 -51.14 59.88 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.485 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -80.44 -24.77 39.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.275 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 8.1 tt -71.92 -46.03 59.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.131 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -71.69 -25.25 62.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.841 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -81.32 -40.67 23.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.524 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 80.2 m80 . . . . . 0 N--CA 1.465 0.306 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.267 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.944 0.402 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -70.37 -27.45 64.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.594 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -38.52 -55.83 1.36 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.808 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.66 -40.98 1.0 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.029 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -72.61 -34.3 67.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.972 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 47' ' ' LEU . 1.9 mp -68.63 -55.27 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.293 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -53.86 -26.39 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.967 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -75.41 -41.06 57.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.646 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.524 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 40.4 m-20 -59.34 -56.79 17.65 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.968 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.4 p -56.77 -38.27 57.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.073 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.88 -38.88 87.15 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.256 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -62.76 -32.07 73.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -74.08 -43.0 59.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.569 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 39.0 mt -79.6 -8.04 58.92 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.669 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.5 t30 57.23 49.87 12.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.607 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.9 mmt -129.06 149.53 72.84 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.182 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.39 138.93 74.1 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.539 1.493 . . . . 0.0 110.996 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 tt -53.05 -29.38 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.281 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -72.13 -31.14 65.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 111.206 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.92 -32.36 51.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.474 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 82.6 t -70.82 -56.94 9.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 p -52.06 -41.81 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.267 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -53.59 -50.86 64.72 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.47 82.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.684 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.474 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.7 m-30 -52.91 -29.62 29.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.382 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.15 -49.57 56.87 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -55.26 -52.14 64.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 110.054 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -57.83 -42.74 84.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.773 0.796 . . . . 0.0 110.649 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.9 tp -56.47 -39.9 73.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.537 -1.21 . . . . 0.0 112.223 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 21.7 t80 -66.52 -44.29 82.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.31 0.576 . . . . 0.0 109.863 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -53.58 -68.73 0.15 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.241 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.05 -48.57 25.32 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.967 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.1 mt -52.38 -41.52 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.24 0.52 . . . . 0.0 112.063 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -56.34 -27.48 55.99 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.507 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.421 ' O ' ' OG1' ' A' ' 82' ' ' THR . 23.0 t -73.52 -55.38 6.4 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.048 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -43.31 55.75 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.034 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -89.18 28.1 1.28 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.779 0.323 . . . . 0.0 110.577 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 87.2 m -54.11 -37.26 64.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.079 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.523 ' O ' ' NZ ' ' A' ' 87' ' ' LYS . 88.3 m-20 -57.58 -30.54 65.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -85.88 -18.42 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.569 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.426 ' C ' ' N ' ' A' ' 87' ' ' LYS . 49.7 t -70.53 -45.28 75.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.418 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -51.2 -15.49 0.37 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.014 0.435 . . . . 0.0 110.354 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 83' ' ' ASP . 42.8 mmtm -69.08 -28.63 66.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.975 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 8.8 p90 -121.94 115.61 22.88 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.072 0.463 . . . . 0.0 110.732 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 55.2 t0 -84.48 -6.08 59.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.448 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.643 ' H ' ' HG ' ' A' ' 93' ' ' SER . 38.0 m-20 -158.13 158.69 35.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.141 0.496 . . . . 0.0 111.681 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -50.38 -50.29 51.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.653 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.9 m -57.88 -42.99 85.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.534 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.643 ' HG ' ' H ' ' A' ' 90' ' ' ASP . 90.2 p -62.89 -35.59 80.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.077 0.465 . . . . 0.0 110.3 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.6 tt -67.28 -50.13 61.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.345 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 88.1 t -59.87 -36.58 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.223 0.535 . . . . 0.0 110.648 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 81.3 mmm -86.34 -8.67 57.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.34 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -111.57 -12.26 15.33 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 119.704 -0.498 . . . . 0.0 113.073 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 97' ' ' GLY . 9.4 mt -33.59 -92.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 117.777 0.789 . . . . 0.0 111.937 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.414 ' H ' ' HB ' ' A' ' 98' ' ' ILE . 47.9 t-80 -41.08 -51.67 3.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.512 . . . . 0.0 111.267 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -46.63 -91.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.061 0.764 . . . . 0.0 113.061 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.443 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.8 m -68.42 -50.71 54.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.443 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 3.6 mp -63.78 -42.06 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.423 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.74 -56.8 19.11 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -49.55 -53.66 22.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.012 0.434 . . . . 0.0 110.494 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -54.05 -46.36 71.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.094 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.1 -51.72 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -44.52 -44.63 8.79 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.351 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.928 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 85.4 t60 . . . . . 0 N--CA 1.464 0.23 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.414 HD12 HG21 ' A' ' 118' ' ' ILE . 96.9 mt -125.18 127.76 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.703 0.287 . . . . 0.0 110.723 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -135.39 127.89 30.57 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.701 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -132.18 151.95 20.03 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -144.06 157.65 44.19 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.1 tp -95.27 148.96 21.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 0.0 110.791 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.66 160.24 43.05 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.85 -39.07 2.58 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.544 2.163 . . . . 0.0 113.532 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -79.8 45.52 0.71 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.334 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.4 ' N ' HD21 ' A' ' 126' ' ' ASN . 2.8 m120 44.3 59.33 3.31 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.541 0.686 . . . . 0.0 110.716 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -136.04 159.42 41.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.958 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.6 mt -138.86 113.63 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.53 121.84 28.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 46.4 tp -114.88 135.13 54.53 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.859 0.361 . . . . 0.0 110.579 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.618 ' HE ' ' CD2' ' A' ' 171' ' ' HIS . 62.0 ttt180 -119.46 123.44 44.06 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.994 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 57.7 t80 . . . . . 0 N--CA 1.464 0.235 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.765 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.468 0.428 0 CA-C-O 120.963 0.411 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 98.6 m -42.94 -51.02 5.75 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.587 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -46.76 -36.1 6.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.047 0.451 . . . . 0.0 110.229 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 10.2 t -66.81 -43.35 84.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.1 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.56 -50.83 16.72 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.864 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -61.36 -51.9 66.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.019 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.44 -43.28 20.18 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.51 -51.16 68.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.579 0.228 . . . . 0.0 111.551 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.3 mt -57.06 -56.37 22.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.739 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -49.92 -47.99 51.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.673 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.02 -51.79 56.33 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.67 -60.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.057 0.456 . . . . 0.0 110.708 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.61 -51.09 39.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.919 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -50.92 -46.27 60.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.073 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -50.11 -49.95 50.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.735 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.525 ' CZ ' ' OD1' ' A' ' 90' ' ' ASP . 65.8 t80 -86.22 37.46 0.73 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.247 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 42.35 49.26 4.53 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 110.739 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.459 HE21 ' H ' ' A' ' 156' ' ' LYS . 49.8 tp60 -128.61 143.77 51.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.459 ' H ' HE21 ' A' ' 155' ' ' GLN . 56.0 tttp -127.51 107.22 9.75 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.72 164.14 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.392 0.615 . . . . 0.0 110.892 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -119.51 132.42 55.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.1 mt -110.44 118.27 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.6 t -103.41 116.01 31.61 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.555 0.217 . . . . 0.0 111.238 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 56.7 p-80 -98.16 79.11 2.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.385 0.612 . . . . 0.0 111.714 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -82.43 -1.02 48.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.158 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.469 ' HG1' ' CB ' ' A' ' 173' ' ' MET . 0.2 OUTLIER -142.09 109.82 5.77 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 14.2 m -112.71 -179.9 3.79 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.901 0.381 . . . . 0.0 110.26 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 168' ' ' GLY . 0.5 OUTLIER -92.18 -27.96 17.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -54.42 -23.82 17.44 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.791 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.5 t -87.11 -25.37 24.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.173 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 95.34 21.92 23.47 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.026 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.05 164.93 16.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.973 0.415 . . . . 0.0 110.773 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -50.41 -32.93 18.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.237 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.618 ' CD2' ' HE ' ' A' ' 131' ' ' ARG . 34.1 p80 -173.19 -172.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 2.8 m -94.1 141.23 28.77 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.469 ' CB ' ' HG1' ' A' ' 163' ' ' THR . 0.0 OUTLIER -118.4 124.04 46.71 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.434 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.36 101.11 6.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.631 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.402 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -89.27 126.43 42.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.603 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.61 149.32 11.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.967 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -139.8 136.53 34.16 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.44 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.234 179.5 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 tp . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 120.734 0.302 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 mm -62.29 -50.1 81.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -69.57 -21.91 63.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.846 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -70.57 -51.52 27.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.827 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.77 -33.79 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.029 0.442 . . . . 0.0 109.944 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.6 tp -74.64 -42.74 57.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.367 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -51.85 -45.71 64.14 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.605 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.58 -49.95 74.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.793 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.495 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 10.9 tpt -52.49 -41.35 63.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.682 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.72 -35.52 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.565 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.0 t -61.19 -23.37 29.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.343 0.592 . . . . 0.0 110.109 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.68 -34.31 19.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.078 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -84.78 -75.82 0.34 Allowed 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.4 m -92.34 -20.26 21.27 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.708 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.48 172.36 25.87 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.724 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.6 ttt -68.01 -28.4 67.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.867 -1.166 . . . . 0.0 110.424 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.0 m -63.21 -41.69 99.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.139 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.86 -36.32 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -53.26 -45.19 68.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.773 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -74.24 -26.97 60.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.41 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -69.38 -49.5 54.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.87 -23.06 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 110.243 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.49 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 7.1 tt -75.3 -59.01 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.519 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -60.12 -21.66 61.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.391 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 tttp -80.92 -38.13 28.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.467 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 13.7 m80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.522 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 CA--C 1.526 0.043 0 CA-C-O 120.708 0.29 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -66.94 -54.29 23.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.701 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -40.69 -55.1 2.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.022 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -41.0 -41.8 1.74 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.255 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 m -74.82 -28.82 60.86 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' A' ' 47' ' ' LEU . 25.3 mm -70.21 -53.17 24.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.916 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.31 -22.42 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.189 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -80.87 -42.12 22.03 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.064 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.467 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 45.2 m-20 -58.69 -56.69 18.88 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.665 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.4 p -59.13 -38.43 74.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.471 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.88 -38.74 83.09 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.128 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -63.91 -32.09 73.5 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.645 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -73.12 -42.43 62.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.563 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.0 mt -80.74 -7.18 59.29 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.831 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.6 t30 55.9 47.76 19.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.578 0.704 . . . . 0.0 109.406 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.8 mmt -125.38 149.49 64.58 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.031 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.56 135.58 53.84 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.353 1.368 . . . . 0.0 111.054 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 tt -50.54 -30.73 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.271 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -71.37 -30.46 66.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.871 0.367 . . . . 0.0 111.227 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.19 -32.37 50.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.131 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 78.1 t -71.37 -56.2 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.38 -43.43 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.263 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -52.73 -51.25 61.24 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.224 0.535 . . . . 0.0 109.569 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.75 -51.35 67.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.963 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.549 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.7 m-30 -51.57 -30.73 21.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.565 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.66 -53.91 35.03 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -53.71 -49.8 67.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.153 0.501 . . . . 0.0 109.781 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.495 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 8.3 m-85 -58.44 -41.04 84.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.709 0.766 . . . . 0.0 110.307 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.04 -38.45 82.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.484 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.58 -35.99 73.35 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.168 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.526 ' CG ' ' HE2' ' A' ' 152' ' ' HIS . 4.3 m120 -58.94 -69.52 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.059 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.426 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -52.63 -41.65 57.3 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.501 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 19.9 mt -57.2 -46.48 82.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.056 0.428 . . . . 0.0 111.269 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.402 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -50.3 -12.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.119 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 77' ' ' LEU . 8.5 p -89.2 -43.92 10.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.202 0.525 . . . . 0.0 110.173 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.43 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.0 mmp_? -65.07 -55.26 19.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.505 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.4 p80 -101.77 31.19 3.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.296 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 6.9 m -46.31 -43.32 15.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.302 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.443 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 83.8 m-20 -55.82 -30.73 61.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.208 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' HIS . 40.0 t -78.5 -23.53 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.847 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.517 ' C ' ' H ' ' A' ' 87' ' ' LYS . 72.0 t -76.06 -42.42 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.34 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 83' ' ' ASP . 1.4 p30 -54.9 -8.67 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' A' ' 85' ' ' VAL . 63.4 mmtt -67.35 -28.13 67.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.204 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.42 ' CD1' ' OG ' ' A' ' 93' ' ' SER . 8.1 m-85 -129.39 128.71 43.58 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.056 0.455 . . . . 0.0 111.161 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -87.52 16.01 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -167.75 165.45 14.14 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 119.219 -0.993 . . . . 0.0 113.075 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.2 -63.18 1.21 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.789 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.6 m -45.91 -43.84 14.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.307 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.42 ' OG ' ' CD1' ' A' ' 88' ' ' PHE . 16.1 p -64.37 -38.03 89.61 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.491 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 97' ' ' GLY . 6.7 tt -62.51 -55.29 28.88 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.781 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.9 t -50.05 -38.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.087 0.47 . . . . 0.0 110.438 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 85.0 mmm -84.84 -7.45 59.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.362 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -109.17 -12.86 19.12 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.873 -0.404 . . . . 0.0 112.694 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 97' ' ' GLY . 43.0 mt -32.46 -103.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 99' ' ' HIS . 2.1 p80 -38.17 -43.8 0.79 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -48.65 -88.87 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 3.0 m -69.05 -51.15 46.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.471 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 3.7 mp -59.79 -45.77 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.047 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.33 -55.49 25.51 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.7 tp -50.4 -53.91 25.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.023 0.439 . . . . 0.0 110.75 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -53.1 -45.4 68.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.463 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 37.9 t -53.11 -52.35 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -46.87 -42.66 17.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.835 0.35 . . . . 0.0 110.657 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 -179.866 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 mm -120.39 126.29 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.712 0.291 . . . . 0.0 110.675 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -124.97 105.43 9.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.119 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.62 159.66 13.63 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -151.28 158.5 43.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.755 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.59 146.06 30.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -118.69 160.73 39.09 Favored Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.23 -37.08 3.59 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.592 2.195 . . . . 0.0 113.083 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -81.52 45.74 0.9 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.151 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.8 m120 43.76 58.62 3.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.339 0.59 . . . . 0.0 110.742 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -135.09 159.99 39.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.017 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.2 mt -136.96 116.41 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.07 121.46 30.5 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 21.9 tp -118.62 130.99 56.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.251 0.548 . . . . 0.0 110.632 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -126.54 131.22 51.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.442 ' OH ' ' SG ' ' A' ' 139' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 120.818 0.342 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.559 ' SG ' ' SG ' ' A' ' 172' ' ' CYS . 62.5 m -48.88 -64.26 0.86 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.121 0.486 . . . . 0.0 111.38 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -46.73 -37.12 7.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.335 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 5.1 t -65.51 -43.18 90.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -44.54 -51.99 8.42 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.669 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.474 ' OE2' ' CB ' ' A' ' 161' ' ' HIS . 40.0 mt-10 -60.34 -49.34 78.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.281 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.5 -48.75 41.42 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.7 mt -57.89 -54.89 41.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.515 0.198 . . . . 0.0 111.495 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 28.0 mt -54.61 -54.86 35.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.713 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -49.79 -50.79 43.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.943 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -56.92 -51.72 55.46 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.794 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.52 -54.59 4.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.441 . . . . 0.0 110.613 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -53.06 -48.86 67.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.053 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -50.59 -53.66 28.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.901 0.381 . . . . 0.0 111.04 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.526 ' HE2' ' CG ' ' A' ' 75' ' ' ASN . 85.6 m-70 -45.73 -49.89 14.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.161 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.61 33.75 0.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 40.75 51.72 3.1 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.148 0.499 . . . . 0.0 110.657 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.485 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 48.7 tp60 -126.86 140.71 52.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.275 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.485 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 29.8 mmtp -115.74 124.77 51.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.8 pt -136.16 170.84 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.665 0.745 . . . . 0.0 112.143 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -132.7 125.74 30.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.852 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 mt -110.94 117.47 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.676 0.274 . . . . 0.0 110.5 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.3 t -97.65 101.02 12.43 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.959 0.409 . . . . 0.0 109.979 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.52 ' NE2' ' O ' ' A' ' 163' ' ' THR . 11.7 t-160 -104.52 75.4 1.23 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.869 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -80.61 -42.76 21.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.895 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.52 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.4 m -76.05 117.98 18.33 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.913 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 166' ' ' HIS . 1.6 p -144.13 113.79 7.14 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.048 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.8 ttt -37.3 -21.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.853 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.572 ' N ' ' O ' ' A' ' 164' ' ' CYS . 83.3 t60 -52.49 -26.81 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.454 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 4.5 t -88.17 -42.88 12.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.141 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.454 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 133.72 10.26 1.86 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.5 162.33 10.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.041 0.448 . . . . 0.0 110.939 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -58.88 -33.18 70.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.616 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -170.05 -170.45 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.559 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 85.0 m -94.61 137.04 34.21 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.971 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.6 tpt -115.68 123.89 49.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.05 103.37 6.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.422 0.629 . . . . 0.0 111.577 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.477 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -92.89 126.19 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.329 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.64 153.17 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.549 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -139.5 138.84 36.69 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.571 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 N--CA 1.463 0.222 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.8 -179.921 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tp . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 120.968 0.413 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.4 mm -62.46 -44.57 99.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.096 0.474 . . . . 0.0 109.912 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -71.34 -25.41 62.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.54 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -69.4 -52.51 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.071 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.26 -35.0 70.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.6 tp -67.44 -40.82 85.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.773 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -55.54 -45.47 77.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.039 0.447 . . . . 0.0 109.839 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.81 -53.75 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.569 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.608 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 49.1 mtm -52.3 -44.28 64.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.118 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.17 -36.61 77.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.75 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.29 -25.83 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.151 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.36 -33.79 21.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.173 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -84.2 -76.16 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.8 m -93.22 -21.84 19.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.26 0.552 . . . . 0.0 110.805 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.7 173.96 22.97 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 122.129 0.85 . . . . 0.0 112.962 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.1 ttt -68.14 -28.38 67.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.65 -1.275 . . . . 0.0 110.408 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -61.83 -39.27 91.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.841 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -77.53 -38.52 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -56.13 -47.84 77.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.128 0.489 . . . . 0.0 110.31 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -75.63 -22.97 56.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.584 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -76.29 -47.11 24.84 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.604 -0.439 . . . . 0.0 112.04 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -80.61 -25.53 38.38 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.485 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 8.3 tt -73.65 -44.15 57.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.492 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -73.05 -21.1 60.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.964 0.411 . . . . 0.0 110.555 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 tttt -87.15 -42.0 13.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.866 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.6 m80 . . . . . 0 N--CA 1.471 0.617 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.569 -179.117 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.81 0.338 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -75.96 -36.46 59.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.95 -58.42 5.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.198 0.523 . . . . 0.0 110.805 -179.605 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -38.64 -43.09 0.85 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.055 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.6 p -74.14 -30.03 62.09 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.035 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 47' ' ' LEU . 18.6 mt -72.98 -50.66 30.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.123 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -60.66 -22.42 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.0 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.49 -40.68 25.68 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.898 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -58.83 -57.4 13.21 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.837 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.21 -39.41 78.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.582 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.1 79.54 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.857 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -64.64 -32.94 74.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -72.6 -41.78 65.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.196 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.508 ' O ' ' SD ' ' A' ' 60' ' ' MET . 30.1 mt -79.27 -3.96 48.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.503 ' O ' ' SD ' ' A' ' 60' ' ' MET . 10.6 t-20 52.72 46.62 26.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.475 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -125.56 153.05 72.66 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.863 179.308 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.48 136.68 47.63 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.717 1.612 . . . . 0.0 110.816 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 tt -51.19 -28.76 7.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.819 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.629 ' NE2' ' CZ ' ' A' ' 140' ' ' PHE . 3.0 tp-100 -76.04 -32.22 59.24 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.973 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -80.15 -31.61 38.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.86 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.499 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 63.5 t -67.84 -58.17 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.86 -40.86 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 ttpp -51.65 -47.18 63.84 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.896 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.36 -59.76 4.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.171 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 5.1 m-30 -45.15 -29.0 0.83 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.763 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.94 -52.15 50.21 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -55.51 -51.4 67.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.075 0.464 . . . . 0.0 110.302 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.608 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 45.5 m-85 -59.19 -43.38 92.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.757 0.789 . . . . 0.0 110.909 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 tp -52.06 -38.32 56.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.296 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 22.6 t80 -70.87 -41.48 71.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.106 0.479 . . . . 0.0 110.014 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -54.22 -74.52 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.14 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -50.64 -37.18 33.41 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.767 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 19.2 mt -58.56 -47.25 84.86 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.337 0.569 . . . . 0.0 112.139 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -47.43 -20.94 0.26 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.231 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' ' 82' ' ' THR . 19.7 t -77.8 -50.17 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 111.003 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -64.28 -64.74 0.8 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.571 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.4 p80 -83.64 31.21 0.47 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.737 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 94.3 m -48.29 -45.85 35.32 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.452 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -53.16 -29.78 33.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.052 0.453 . . . . 0.0 109.863 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 3.3 t -83.21 -23.98 8.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.41 ' C ' ' H ' ' A' ' 87' ' ' LYS . 27.5 t -63.31 -39.68 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -53.48 -13.59 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.434 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 84' ' ' VAL . 37.8 mmtm -66.6 -31.08 71.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.51 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 20.5 p90 -120.39 117.13 26.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.059 0.457 . . . . 0.0 110.931 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.36 0.78 48.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.317 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 48.6 t0 -163.86 157.74 19.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.626 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.507 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 82.5 t80 -48.13 -51.44 24.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.712 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 83.9 m -56.32 -41.86 76.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.522 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.3 m -62.74 -36.54 83.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.411 0.624 . . . . 0.0 110.563 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 98' ' ' ILE . 2.2 tt -65.91 -62.52 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.289 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.5 t -47.43 -41.44 7.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 O-C-N 123.337 0.398 . . . . 0.0 111.879 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.6 ppp? -85.67 -8.11 58.4 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.278 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -107.77 -14.21 18.11 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.461 -0.4 . . . . 0.0 112.334 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 94' ' ' LEU . 33.4 mt -31.87 -97.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 117.398 0.599 . . . . 0.0 111.997 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -39.95 -49.99 2.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.173 0.511 . . . . 0.0 111.377 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -46.89 -90.02 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.447 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.6 m -68.97 -50.75 51.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 4.1 mp -64.19 -42.52 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.493 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.56 -57.98 10.22 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.509 ' CD1' ' HZ1' ' A' ' 108' ' ' LYS . 56.7 tp -46.73 -55.11 8.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.143 0.496 . . . . 0.0 110.438 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -52.41 -44.52 65.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.8 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 30.4 t -55.44 -52.32 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -47.04 -44.75 20.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.64 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.509 ' HZ1' ' CD1' ' A' ' 104' ' ' LEU . 27.0 mmtm . . . . . 0 C--N 1.33 -0.261 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.932 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 120.503 0.192 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -128.48 129.1 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.674 0.273 . . . . 0.0 110.886 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -134.08 123.34 24.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.718 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.91 127.01 7.04 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -117.33 166.34 12.41 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.2 mp -109.31 133.96 52.39 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.93 160.71 28.84 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 58.5 Cg_endo -71.78 159.02 51.83 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.188 1.925 . . . . 0.0 111.883 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.581 HD21 HD22 ' A' ' 126' ' ' ASN . 11.0 t30 90.91 -59.17 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.296 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.612 ' N ' HD21 ' A' ' 126' ' ' ASN . 0.0 OUTLIER 151.83 53.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.894 0.747 . . . . 0.0 109.499 179.285 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -127.74 164.06 22.96 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.976 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.4 mt -141.24 119.2 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.67 123.33 33.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.083 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 47.4 tp -118.24 132.34 56.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.074 0.464 . . . . 0.0 110.965 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -115.7 122.81 46.65 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.234 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.8 t80 . . . . . 0 N--CA 1.468 0.456 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.585 -179.085 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 121.332 0.587 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 32.9 m -41.73 -48.29 4.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.702 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.629 ' CZ ' ' NE2' ' A' ' 63' ' ' GLN . 98.2 m-85 -48.13 -39.88 21.93 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.708 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.3 t -64.44 -43.23 94.95 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.97 -52.97 10.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.436 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -55.14 -50.07 70.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.08 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.97 -48.22 46.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.09 -54.23 49.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.743 0.306 . . . . 0.0 111.369 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.8 mt -54.88 -55.66 27.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.849 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -49.75 -48.53 50.14 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.817 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.95 -51.31 59.94 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.35 -60.13 2.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.736 0.303 . . . . 0.0 110.832 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.34 -51.09 57.56 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.317 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -52.98 -48.75 67.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.053 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -47.97 -49.15 31.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.504 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 73.3 t80 -83.42 36.28 0.52 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.71 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 40.78 58.25 2.48 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.939 0.399 . . . . 0.0 111.228 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.52 ' NE2' ' N ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -132.63 152.59 51.61 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.52 ' N ' ' NE2' ' A' ' 155' ' ' GLN . 62.6 mttp -120.8 117.94 28.71 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.497 ' CG2' HE21 ' A' ' 155' ' ' GLN . 36.5 pt -130.68 169.7 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.624 0.726 . . . . 0.0 112.63 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -134.73 127.12 30.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.898 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mt -110.42 118.65 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.8 m -103.01 111.55 23.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.398 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 16.7 p80 -96.61 77.22 2.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.513 0.673 . . . . 0.0 111.558 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 54.7 t0 -82.1 -3.3 54.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.415 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.56 114.6 8.64 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 92.3 m -118.62 -175.93 2.99 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.628 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 72.7 mtp -94.73 -26.47 16.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -55.61 -23.66 28.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.798 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.0 t -87.16 -29.69 21.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.5 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.41 18.0 22.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.63 167.03 9.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.847 0.356 . . . . 0.0 110.423 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.544 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 94.4 m-20 -45.55 -49.6 13.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.69 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.544 ' ND1' ' O ' ' A' ' 170' ' ' ASP . 73.6 m-70 -160.76 -168.14 2.03 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.5 t -93.85 144.27 25.59 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.149 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.2 120.93 36.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.061 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.53 103.62 7.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.469 0.652 . . . . 0.0 110.502 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.4 mp -89.95 127.12 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.379 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.93 150.51 13.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.32 0.581 . . . . 0.0 110.869 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -136.17 136.08 39.71 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.897 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.464 0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.62 -179.742 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.41 ' CD1' ' NH1' ' A' ' 80' ' ' ARG . 2.5 tp . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 121.029 0.443 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.3 -54.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -60.99 -31.22 70.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.267 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -59.94 -60.33 4.0 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.075 0.464 . . . . 0.0 111.428 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.18 -24.26 29.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.474 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.8 tp -74.29 -41.75 60.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.516 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.16 -39.25 78.35 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.316 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -60.9 -56.04 25.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.532 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 18.1 tpt -50.73 -41.66 56.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.203 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.31 -34.45 62.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.692 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.36 -23.96 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.22 0.533 . . . . 0.0 110.055 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.65 -33.99 18.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.96 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -85.63 -76.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.7 m -91.37 -19.2 23.17 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.52 171.85 28.12 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.847 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.7 ttt -67.37 -29.51 69.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.776 -1.212 . . . . 0.0 110.327 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 t -61.92 -41.5 98.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.947 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.78 -38.64 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -51.64 -45.89 63.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.0 109.732 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -71.76 -29.8 64.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.011 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.525 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 75.5 mt-10 -68.12 -51.64 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.91 -23.2 48.76 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.436 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 8.7 tt -74.26 -41.88 60.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.528 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -66.97 -19.08 65.66 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 24' ' ' GLU . 1.1 ptpp? -91.66 -29.0 17.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.505 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 3.4 m-70 . . . . . 0 N--CA 1.463 0.182 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.82 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 95.3 p . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.772 0.32 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -68.32 -33.79 74.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.027 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -43.17 -57.5 2.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.165 0.507 . . . . 0.0 110.641 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -38.8 -43.43 0.92 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.724 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.1 m -71.84 -32.44 67.54 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.42 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.6 mp -71.71 -53.81 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.667 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -55.9 -23.37 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.374 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.411 ' O ' ' OE1' ' A' ' 56' ' ' GLN . 4.7 tt0 -79.79 -40.1 29.39 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.14 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 4.4 m-20 -59.69 -57.01 14.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.586 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.8 p -56.17 -41.09 68.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.522 -0.763 . . . . 0.0 108.998 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.05 -39.1 74.22 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.944 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -64.93 -34.6 78.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.4 mmt-85 -70.52 -38.26 74.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.178 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.518 ' O ' ' SD ' ' A' ' 60' ' ' MET . 49.0 mt -82.7 -4.9 58.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.519 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.1 t-20 51.76 44.52 29.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.244 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -125.82 155.81 72.24 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.854 179.188 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.19 140.53 71.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.015 1.81 . . . . 0.0 111.036 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 tt -55.44 -27.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.859 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.417 ' CD ' ' CZ ' ' A' ' 140' ' ' PHE . 88.6 mt-30 -76.36 -33.46 58.93 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.45 -30.07 42.06 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.088 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.443 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 96.8 t -72.06 -56.07 11.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -50.98 -40.12 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -52.66 -50.98 62.15 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.895 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.28 -53.98 42.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.721 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 2.9 m-30 -54.25 -27.98 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.92 -52.78 45.57 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -56.44 -47.93 78.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 0.8 OUTLIER -59.33 -43.97 92.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.866 0.841 . . . . 0.0 110.337 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -53.35 -38.68 63.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.809 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.455 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 26.2 t80 -69.84 -41.25 75.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.934 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -55.15 -71.87 0.08 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.781 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.61 -44.48 22.91 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.405 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.8 mt -56.36 -40.63 74.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.0 0.4 . . . . 0.0 111.431 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -59.31 -29.29 67.51 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.879 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.436 ' O ' ' OG1' ' A' ' 82' ' ' THR . 32.9 t -72.83 -54.17 9.52 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.828 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.41 ' NH1' ' CD1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -72.59 -49.48 31.95 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.222 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -83.97 25.44 0.82 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.442 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 79' ' ' SER . 52.6 m -50.44 -38.92 46.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.045 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -57.14 -32.41 66.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.18 -22.07 9.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.547 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 87' ' ' LYS . 40.9 t -69.25 -42.63 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.649 -0.421 . . . . 0.0 109.952 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -52.51 -15.02 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.034 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.416 ' N ' ' C ' ' A' ' 85' ' ' VAL . 38.4 mmtm -67.58 -29.92 69.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.648 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.565 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 13.1 p90 -120.85 119.84 33.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.063 0.459 . . . . 0.0 110.967 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -86.28 1.88 49.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.447 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.48 ' OD1' ' CE2' ' A' ' 153' ' ' PHE . 45.4 t0 -166.75 160.15 14.48 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.22 0.533 . . . . 0.0 111.627 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -51.54 -51.05 58.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.941 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.8 m -55.67 -45.38 77.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.734 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 90' ' ' ASP . 54.9 p -61.66 -36.45 80.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.408 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.2 tt -65.89 -52.16 52.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.23 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.8 t -56.31 -36.69 47.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.208 0.527 . . . . 0.0 110.43 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.5 mmm -86.61 -6.89 58.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.33 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -112.9 -14.82 9.75 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.982 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 97' ' ' GLY . 10.3 mt -30.05 -100.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 117.648 0.724 . . . . 0.0 112.348 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -40.35 -49.05 2.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.023 0.44 . . . . 0.0 111.182 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -46.22 -88.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.6 m -70.67 -52.88 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.493 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 3.3 mp -60.62 -46.12 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.302 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.92 -55.25 30.8 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.7 tp -51.74 -53.45 39.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -53.5 -47.36 69.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.159 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.6 t -52.44 -49.22 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -50.13 -41.44 48.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.778 0.323 . . . . 0.0 110.637 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.722 -179.98 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 70.3 m80 . . . . . 0 C--O 1.23 0.076 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.5 mt -127.5 128.25 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.728 0.299 . . . . 0.0 110.879 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -132.61 119.66 20.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.744 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.72 137.88 14.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -135.04 128.31 32.08 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.565 0.221 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 tp -76.89 149.52 36.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.756 0.312 . . . . 0.0 111.07 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.18 160.47 43.16 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.12 -36.43 4.28 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.578 2.185 . . . . 0.0 113.059 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -80.65 46.41 0.87 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.046 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 43.49 55.87 4.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.52 0.676 . . . . 0.0 110.739 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -133.48 159.22 41.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.876 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.0 mt -136.65 114.65 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.5 121.58 29.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.084 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.7 tp -116.16 134.7 54.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.094 0.473 . . . . 0.0 110.619 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -120.58 124.55 45.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.0 t80 . . . . . 0 C--N 1.33 -0.27 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.808 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 121.112 0.482 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.9 t -40.05 -48.21 2.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.638 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.417 ' CZ ' ' CD ' ' A' ' 63' ' ' GLN . 90.7 m-85 -48.2 -36.87 14.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.613 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 53.8 t -68.53 -44.4 74.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.023 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.78 -45.71 14.83 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.507 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -63.97 -48.96 74.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.217 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.08 -48.12 39.73 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.4 mt -59.96 -53.55 56.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.734 0.302 . . . . 0.0 111.535 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.9 mt -54.81 -55.88 25.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.078 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -51.68 -48.14 63.59 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.978 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.69 -51.66 56.63 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.21 -60.27 1.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.754 0.311 . . . . 0.0 111.008 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.38 -50.87 38.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.005 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -52.44 -47.14 66.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.249 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -50.01 -50.69 46.47 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.704 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.51 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 69.5 t80 -86.11 37.03 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.933 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 39.17 55.71 2.14 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.937 0.398 . . . . 0.0 111.061 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.548 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 49.0 tp60 -129.87 141.65 50.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.548 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 62.4 tttm -112.34 125.61 54.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.259 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 26.1 pt -137.07 170.15 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.61 0.719 . . . . 0.0 111.993 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -134.96 126.62 28.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.116 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.5 mt -110.52 116.8 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.669 0.271 . . . . 0.0 110.328 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.3 t -101.46 107.94 19.38 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.383 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.559 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.8 p-80 -93.97 65.79 3.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.605 0.717 . . . . 0.0 111.065 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -68.25 -25.35 65.14 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.823 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.422 ' HB ' ' H ' ' A' ' 173' ' ' MET . 1.8 m -112.52 112.0 23.24 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 166' ' ' HIS . 49.9 t -137.3 115.26 11.5 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.602 0.239 . . . . 0.0 110.839 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.412 ' C ' ' N ' ' A' ' 167' ' ' THR . 24.0 ttt -35.18 -22.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.261 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 164' ' ' CYS . 57.7 t-80 -51.11 -21.45 1.92 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.443 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.7 t -90.08 -41.35 11.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.913 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.443 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 124.81 15.0 3.3 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.08 155.86 30.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.976 0.417 . . . . 0.0 110.821 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.92 -27.93 21.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.379 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -172.49 178.87 2.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 6.3 m -94.46 139.72 30.77 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.66 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.422 ' H ' ' HB ' ' A' ' 163' ' ' THR . 16.2 ttm -127.62 94.99 4.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.525 0.679 . . . . 0.0 109.68 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.1 mt -93.12 113.07 25.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.523 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.9 mm -89.14 126.16 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.585 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.38 148.72 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.25 0.548 . . . . 0.0 110.268 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -137.8 136.8 37.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.339 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 N--CA 1.463 0.188 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.863 -179.828 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.6 mpp? . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 3' ' ' GLY . 46.0 mtmt 56.2 86.94 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.738 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 56.47 117.23 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 tp -52.19 -42.05 35.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.581 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.43 -51.41 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.168 0.509 . . . . 0.0 109.87 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -69.12 -22.26 63.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.495 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 3' ' ' GLY . 64.9 t-20 -69.64 -54.13 15.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.6 t -61.71 -35.81 69.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.01 0.433 . . . . 0.0 109.835 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.8 tp -70.98 -43.25 68.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.097 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -51.95 -46.09 64.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -61.28 -48.2 82.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.681 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.588 ' SD ' ' CZ ' ' A' ' 72' ' ' PHE . 10.9 tpt -53.84 -43.04 69.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.726 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.15 -35.25 67.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.403 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.01 -23.36 31.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.239 0.542 . . . . 0.0 110.028 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.17 -34.39 19.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.156 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -84.69 -76.62 0.3 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.8 m -91.66 -19.83 22.25 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.282 0.563 . . . . 0.0 110.786 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.02 173.99 26.48 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.825 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.3 ttt -68.74 -29.76 68.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.796 -1.202 . . . . 0.0 110.518 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -62.06 -41.71 98.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.065 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.52 -37.83 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 -51.82 -45.22 63.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -71.73 -29.27 64.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.144 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -67.46 -50.49 58.91 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -81.26 -22.93 38.31 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.454 -179.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 30' ' ' ALA . 8.3 tt -74.32 -56.0 5.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.145 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CG ' ' HZ2' ' A' ' 32' ' ' LYS . 8.7 tm-20 -61.55 -22.98 65.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.547 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -81.35 -38.27 26.94 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.526 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 78.7 m-70 -99.59 -77.91 0.51 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.792 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 26' ' ' LEU . . . -64.06 160.07 50.95 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.442 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.43 144.07 44.53 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.873 2.382 . . . . 0.0 112.504 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' CB ' ' NZ ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -93.55 -18.23 22.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.278 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 24.6 p-10 -90.24 -52.46 4.93 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.992 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.13 132.4 47.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.498 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.2 t -125.57 134.58 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.263 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -109.45 179.7 4.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.669 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 39' ' ' ALA . 2.4 m -129.41 167.83 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.884 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 m -73.93 28.87 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.058 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 37' ' ' VAL . . . -149.09 -8.94 0.34 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.733 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -85.61 -179.74 6.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.903 0.382 . . . . 0.0 110.499 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 p -47.18 157.86 0.17 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.055 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.25 61.7 0.7 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.193 0.52 . . . . 0.0 110.445 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' O ' ' OE1' ' A' ' 46' ' ' GLU . . . -53.36 104.98 0.11 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.166 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' OE1' ' O2A' ' A' ' 182' ' ' HEM . 96.4 mt-10 -63.45 -20.5 65.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.7 p -49.0 -40.99 32.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.799 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 43' ' ' ALA . 41.4 mp0 -72.65 -32.81 66.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.812 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.98 -58.26 5.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.134 0.492 . . . . 0.0 110.66 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -37.67 -44.1 0.68 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.042 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.1 t -73.24 -31.23 64.0 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.156 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.9 mt -71.42 -51.25 34.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.129 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.39 -21.7 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.84 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -80.17 -41.52 25.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.002 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 29' ' ' HIS . 72.5 m-20 -58.62 -57.14 14.28 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.834 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 p -58.63 -39.05 74.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.483 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.56 -39.65 84.72 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.221 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -63.61 -31.85 73.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -74.28 -41.31 61.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.562 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.0 mt -80.98 -6.37 58.67 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.652 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 56.11 47.79 18.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.488 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mmt -126.54 149.05 66.79 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.066 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -63.11 135.77 52.69 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.381 1.387 . . . . 0.0 111.092 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 tt -49.11 -28.3 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.156 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -71.78 -34.5 69.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.055 0.455 . . . . 0.0 111.582 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -76.03 -31.77 59.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.066 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.2 t -71.83 -56.16 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.734 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.63 -44.45 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.396 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -52.33 -50.45 62.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.255 0.55 . . . . 0.0 109.518 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.14 -57.39 12.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.925 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.549 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 8.1 m-30 -45.53 -29.72 1.24 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.391 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.19 -48.07 73.98 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -58.24 -52.34 65.98 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.067 0.46 . . . . 0.0 110.054 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 12' ' ' MET . 63.1 m-85 -56.59 -40.18 74.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.747 0.785 . . . . 0.0 110.616 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.9 tp -59.22 -37.85 78.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.387 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -70.54 -37.9 74.11 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.968 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -58.11 -71.31 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.887 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.07 -41.79 30.2 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.296 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.402 ' C ' ' N ' ' A' ' 79' ' ' SER . 24.2 mt -58.39 -43.37 88.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.368 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -51.75 -17.56 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.161 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.43 ' O ' ' OG1' ' A' ' 82' ' ' THR . 8.0 t -85.73 -40.88 15.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.247 0.546 . . . . 0.0 109.62 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -65.44 -72.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.471 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.536 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -87.84 36.91 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.399 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 6.8 m -49.45 -48.99 47.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.926 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -51.43 -33.67 31.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.18 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.538 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 7.1 t -73.82 -29.24 25.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.499 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.582 ' C ' ' H ' ' A' ' 87' ' ' LYS . 89.3 t -76.22 -44.68 36.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.562 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 54.7 t0 -58.24 3.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.366 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.582 ' H ' ' C ' ' A' ' 85' ' ' VAL . 30.6 mtmt -90.57 -22.45 21.27 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.538 ' CZ ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -104.13 125.83 50.76 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.794 -179.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 56.6 p30 -88.44 -6.07 57.87 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 58.8 m-20 -160.29 164.12 32.84 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.636 0.731 . . . . 0.0 112.535 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -55.1 -44.29 74.77 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.979 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.9 m -57.71 -59.72 4.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.352 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 97.4 p -45.67 -40.14 8.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.367 0.604 . . . . 0.0 110.792 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.44 -41.59 96.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.428 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.89 -40.84 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.384 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.9 ptm -83.25 -3.16 57.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.307 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -116.41 -15.74 6.89 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 119.123 -0.82 . . . . 0.0 113.357 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 97' ' ' GLY . 18.8 mt -25.09 -104.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 118.04 0.92 . . . . 0.0 112.477 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -40.38 -49.0 2.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.068 0.461 . . . . 0.0 111.466 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -45.63 -83.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 3.8 m -73.31 -53.81 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.48 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 3.3 mp -59.27 -49.84 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.939 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.33 -55.13 32.41 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.8 tp -49.18 -48.0 45.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.154 0.502 . . . . 0.0 109.769 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -57.59 -46.46 83.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.042 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.6 t -54.22 -50.15 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 110' ' ' TYR . 49.4 t30 -49.07 -43.59 41.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.717 0.294 . . . . 0.0 110.803 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -61.79 -37.44 84.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.211 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.4 tp -65.14 -40.69 94.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.368 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 111' ' ' HIS . 25.7 t80 -154.84 158.13 38.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.389 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.564 ' N ' ' CD1' ' A' ' 110' ' ' TYR . 57.2 t-80 -49.69 -77.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.078 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 111' ' ' HIS . 23.2 mt-10 60.52 147.78 0.08 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.201 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.33 -94.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.025 1.816 . . . . 0.0 111.872 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.2 t -144.78 140.99 28.85 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.153 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 116' ' ' PRO . 15.9 mt -81.59 150.6 66.92 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 115' ' ' LEU . 80.3 Cg_exo -41.0 168.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.264 1.976 . . . . 0.0 112.342 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -85.78 108.62 18.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.98 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.1 128.54 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.716 0.293 . . . . 0.0 110.959 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -133.58 123.57 25.35 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.652 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.12 158.22 14.64 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -149.95 160.1 43.87 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.568 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 1.4 mm? -106.74 146.02 31.34 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.99 160.4 40.99 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.25 -38.12 2.9 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.596 2.197 . . . . 0.0 113.054 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -79.49 44.83 0.63 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.953 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 44.39 58.29 3.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.413 0.625 . . . . 0.0 110.72 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -135.11 159.94 39.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.107 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 45.0 mt -137.41 117.12 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.3 122.86 32.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.049 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.1 tp -118.8 133.03 56.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.044 0.45 . . . . 0.0 111.205 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -114.79 122.98 48.03 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.481 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 62.1 t80 -126.16 123.73 38.9 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.786 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.48 124.37 24.08 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.2 p -156.04 146.01 15.67 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.256 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.77 -7.87 17.74 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.032 1.821 . . . . 0.0 112.215 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 -79.17 -15.68 57.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.085 0.469 . . . . 0.0 110.369 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 56.23 28.84 13.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.52 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.1 tp -82.74 14.6 3.09 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.215 0.531 . . . . 0.0 110.029 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 172' ' ' CYS . 74.4 m -42.08 -43.87 3.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.469 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -48.87 -41.98 35.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.961 0.41 . . . . 0.0 110.375 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.6 t -64.29 -43.27 95.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -44.52 -50.1 9.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.59 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.03 -49.56 77.17 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.164 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.01 -48.96 50.89 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.0 -55.1 39.36 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.58 0.229 . . . . 0.0 111.315 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.7 mt -54.14 -54.38 40.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.909 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -51.52 -48.02 63.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.952 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.49 -51.54 57.18 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.8 -59.76 2.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.881 0.372 . . . . 0.0 110.844 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -48.28 -51.68 24.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.873 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -52.03 -47.86 64.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.218 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -49.48 -49.9 43.64 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.64 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.507 ' CZ ' ' OD1' ' A' ' 90' ' ' ASP . 71.5 t80 -85.48 37.17 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.939 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 39.21 57.57 1.99 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.021 0.439 . . . . 0.0 111.199 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.468 HE21 ' H ' ' A' ' 156' ' ' LYS . 51.7 tp60 -131.59 143.43 50.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.468 ' H ' HE21 ' A' ' 155' ' ' GLN . 59.9 mttp -118.85 105.25 11.32 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.8 pt -114.47 175.49 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.596 0.712 . . . . 0.0 111.718 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -138.08 127.67 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.407 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mt -111.31 117.76 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.602 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.1 t -98.28 98.89 10.09 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.602 ' CD2' ' SG ' ' A' ' 164' ' ' CYS . 23.7 t-160 -92.14 69.92 5.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.005 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.52 -57.28 3.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.56 119.53 21.26 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.464 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 1.7 m -143.64 119.06 10.28 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.122 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 38.0 ttp -36.11 -21.69 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.036 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 164' ' ' CYS . 58.3 t-80 -51.19 -22.0 2.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.438 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.3 t -91.43 -41.42 10.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.103 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.438 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 126.5 12.25 3.46 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.86 171.6 6.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.0 0.429 . . . . 0.0 110.817 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 171' ' ' HIS . 42.1 p-10 -53.31 -35.65 60.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.273 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.519 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 5.1 p-80 -174.52 -167.06 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 1.7 m -94.9 142.97 26.85 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.758 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 28.3 ttm -119.49 116.12 25.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.058 0.456 . . . . 0.0 109.954 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mt -118.15 99.53 6.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.491 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.5 mm -85.27 126.24 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.939 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.31 149.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.35 0.595 . . . . 0.0 110.375 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -144.14 142.48 30.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.349 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.7 mt -87.67 141.2 28.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.35 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -52.47 146.4 9.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.271 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 18.4 m120 53.34 43.75 31.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.678 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 47.9 p30 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.666 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.489 ' CBC' ' ND1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.539 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 3' ' ' GLY . 55.9 mttp -86.42 112.61 21.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.485 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 57.27 120.41 0.01 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 tp -61.84 -36.81 76.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.773 0.321 . . . . 0.0 110.574 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.1 mm -72.31 -41.07 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 1.2 m-30 -75.48 -25.45 57.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.643 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 3' ' ' GLY . 27.3 t-20 -69.16 -52.77 24.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.821 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.71 -39.13 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.061 0.457 . . . . 0.0 109.855 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.9 tp -67.02 -47.62 70.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.87 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -50.37 -44.5 54.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.958 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.18 -54.37 46.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.383 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.439 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 28.5 ttt -51.05 -41.45 59.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.061 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.15 -36.71 77.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.509 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.7 t -62.04 -23.12 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.264 0.554 . . . . 0.0 110.032 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.04 -34.31 18.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.026 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -85.88 -76.51 0.33 Allowed 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.1 m -90.69 -17.71 26.31 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.314 0.578 . . . . 0.0 110.599 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.87 179.19 30.56 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.741 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.8 ttp -72.95 -30.5 63.91 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.004 -1.098 . . . . 0.0 110.701 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.2 t -60.55 -39.31 87.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.981 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.04 -38.61 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 55.4 t-105 -55.26 -47.47 75.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.204 0.526 . . . . 0.0 110.071 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -74.76 -25.8 59.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.494 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.64 -47.48 26.23 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.978 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.495 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -78.34 -23.34 47.02 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.861 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 6.9 tt -76.35 -43.4 41.1 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.366 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -67.74 -18.89 65.04 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.26 -30.83 18.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.474 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -94.12 -88.93 0.23 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.637 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.39 153.86 74.45 Favored Pre-proline 0 C--N 1.327 -0.383 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.264 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.67 136.95 52.03 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.613 2.209 . . . . 0.0 112.0 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -84.42 -19.14 33.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.501 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -88.84 -53.61 4.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -73.92 134.56 43.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.25 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.4 155.59 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.56 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -115.66 -175.44 2.72 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.329 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.433 ' C ' ' H ' ' A' ' 3' ' ' GLY . 1.6 m -128.72 166.2 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.107 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 1' ' ' MET . 2.0 m -80.14 37.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.711 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.26 2.78 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.044 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -92.87 143.84 25.86 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.04 0.448 . . . . 0.0 110.31 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 42' ' ' TYR . 80.7 p -71.71 -88.33 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.019 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.419 ' O ' ' O ' ' A' ' 41' ' ' SER . 12.6 m-85 55.99 160.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.315 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.2 119.76 17.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -83.88 -1.36 54.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.239 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t -51.99 -32.26 33.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.828 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -56.62 -29.56 62.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.874 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.8 OUTLIER -51.18 -56.52 12.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.081 0.467 . . . . 0.0 110.978 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -39.87 -42.17 1.27 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.867 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 m -74.05 -29.78 62.07 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.919 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 47' ' ' LEU . 17.8 mt -73.4 -51.4 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.275 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -59.15 -25.08 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.155 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.43 ' O ' ' OE1' ' A' ' 56' ' ' GLN . 6.7 tt0 -77.2 -40.83 43.74 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.735 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -59.3 -56.97 15.33 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.858 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.26 -39.55 52.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.86 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.01 -38.58 83.09 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.479 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.437 ' NE2' ' N ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -63.03 -31.94 73.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -73.28 -40.6 64.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.672 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.7 mt -83.15 -8.91 59.44 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.615 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 58.1 51.54 8.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.453 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.6 mmt -131.14 149.89 74.99 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.448 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.18 138.48 72.52 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.534 1.489 . . . . 0.0 111.27 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 tt -53.18 -28.75 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.654 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -74.59 -29.65 61.4 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.302 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -78.64 -35.22 45.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.034 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.538 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.0 t -65.06 -59.65 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -48.99 -38.8 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.793 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -45.15 70.25 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.18 -57.44 10.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.898 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.538 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 6.3 m-30 -45.18 -29.15 0.88 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.313 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.67 -51.29 58.48 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.515 ' NE2' ' OE1' ' A' ' 151' ' ' GLN . 39.9 tt0 -58.0 -52.93 63.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.995 0.426 . . . . 0.0 110.32 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.439 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 61.1 m-85 -55.0 -41.3 71.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.722 0.772 . . . . 0.0 110.507 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.5 tp -59.05 -38.68 79.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.411 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -67.48 -40.38 85.29 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.139 -0.625 . . . . 0.0 109.896 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -57.93 -69.37 0.18 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.305 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.11 -42.01 30.83 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.74 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.88 -43.27 81.09 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.376 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -52.94 -27.45 18.97 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.424 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.8 t -74.42 -38.61 63.01 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -65.05 -69.22 0.3 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.802 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.563 ' CD2' ' CBC' ' A' ' 182' ' ' HEM . 9.7 m-70 -98.49 47.03 0.99 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.036 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 7.2 m -51.49 -44.41 62.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.767 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 92.7 m-20 -56.8 -30.13 63.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.609 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.7 t -79.15 -20.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.767 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.526 ' C ' ' H ' ' A' ' 87' ' ' LYS . 49.0 t -75.88 -40.47 38.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.306 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 83' ' ' ASP . 29.8 p-10 -52.82 -8.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.045 0.45 . . . . 0.0 110.661 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 85' ' ' VAL . 56.9 mttm -73.02 -29.96 63.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.468 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.612 ' CZ ' ' CE2' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -97.56 119.6 36.41 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.021 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 53.4 p30 -88.24 -19.09 27.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.498 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 49.4 p30 -156.44 148.04 22.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.752 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -37.67 -40.65 0.43 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.04 0.447 . . . . 0.0 111.176 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.6 m -63.74 -41.67 98.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.869 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.433 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 38.7 m -61.34 -36.67 80.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.527 0.68 . . . . 0.0 110.375 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 98' ' ' ILE . 7.2 tt -65.53 -63.28 1.13 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.462 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.6 t -48.65 -41.72 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.789 0.328 . . . . 0.0 111.722 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.429 ' C ' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -85.49 -6.03 59.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.448 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -110.28 -14.38 13.28 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.659 -0.523 . . . . 0.0 112.439 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.495 ' O ' ' O ' ' A' ' 97' ' ' GLY . 39.8 mt -29.58 -104.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 117.395 0.597 . . . . 0.0 112.58 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.504 ' HD1' ' H ' ' A' ' 99' ' ' HIS . 9.0 p-80 -39.47 -48.33 1.97 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.06 0.457 . . . . 0.0 111.494 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -44.99 -87.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.506 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.5 m -71.05 -51.66 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.506 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mp -63.63 -47.81 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.651 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.14 -52.6 46.03 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.42 ' CD1' ' HZ3' ' A' ' 108' ' ' LYS . 31.9 tp -49.51 -48.17 48.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.119 0.485 . . . . 0.0 110.31 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -57.43 -45.37 84.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.118 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 82.3 t -52.37 -51.92 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 110' ' ' TYR . 18.0 t-20 -49.42 -41.66 40.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.803 0.335 . . . . 0.0 110.547 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.42 ' HZ3' ' CD1' ' A' ' 104' ' ' LEU . 24.4 mmtm -65.44 -41.94 92.93 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.495 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.0 tp -67.75 -44.05 78.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.767 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.538 ' CD2' ' N ' ' A' ' 111' ' ' HIS . 53.6 t80 -145.35 170.06 17.06 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.298 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.538 ' N ' ' CD2' ' A' ' 110' ' ' TYR . 38.3 m80 -37.82 -96.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.263 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 39.89 62.18 5.71 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.088 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.49 -8.34 23.35 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.407 2.071 . . . . 0.0 111.868 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 83.1 p -149.78 147.79 28.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.387 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.478 ' CD2' ' O2D' ' A' ' 182' ' ' HEM . 8.5 mt -133.09 154.32 81.22 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.911 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 115' ' ' LEU . 85.6 Cg_exo -41.38 170.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.277 1.985 . . . . 0.0 112.386 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -88.47 110.12 20.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.251 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.6 mt -124.63 128.75 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.71 0.29 . . . . 0.0 110.707 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.619 ' ND2' ' NH2' ' A' ' 131' ' ' ARG . 4.3 m-80 -132.62 115.1 15.0 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.427 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.84 123.68 5.9 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -116.99 152.27 34.97 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 8.8 mp -99.67 148.0 24.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.06 160.67 42.13 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.35 -40.61 2.19 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.573 2.182 . . . . 0.0 113.062 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -77.77 43.67 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.874 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 46.03 60.86 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.267 0.556 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -138.0 160.83 38.31 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.085 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.1 mt -141.84 117.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.69 121.47 31.1 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.845 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.5 tp -114.54 134.85 54.72 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.908 0.385 . . . . 0.0 110.137 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.619 ' NH2' ' ND2' ' A' ' 119' ' ' ASN . 23.5 ttp-105 -120.79 125.22 47.02 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.108 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.584 ' CE1' ' CZ ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -121.06 99.32 6.43 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 134' ' ' SER . 1.3 m -108.03 119.82 40.56 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.913 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.527 ' C ' ' H ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER 165.62 158.35 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.81 37.05 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.42 2.08 . . . . 0.0 111.301 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.584 ' CZ ' ' CE1' ' A' ' 132' ' ' TYR . 0.8 OUTLIER -87.19 97.3 10.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.858 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -77.14 3.2 13.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 141' ' ' CYS . 1.0 OUTLIER -85.39 12.47 8.24 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.214 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 85.5 m -39.9 -44.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.624 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.601 ' CE2' ' NE2' ' A' ' 166' ' ' HIS . 94.4 m-85 -53.75 -34.76 60.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.629 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 138' ' ' LEU . 43.8 t -69.79 -46.29 66.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.118 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.27 -46.07 12.41 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.384 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.49 -47.81 80.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.732 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.19 -52.47 40.1 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.1 mt -53.32 -55.73 22.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.746 0.308 . . . . 0.0 110.805 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 20.2 mt -54.82 -54.67 39.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.4 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -50.15 -50.58 48.45 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.093 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.11 -49.99 67.8 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.358 -0.448 . . . . 0.0 111.996 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.03 -59.74 2.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.891 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -53.9 -51.99 61.95 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.477 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.515 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 86.6 mt-30 -51.83 -56.68 12.49 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 120.853 0.359 . . . . 0.0 111.164 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -41.5 -47.52 3.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.921 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.612 ' CE2' ' CZ ' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -86.17 36.46 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.665 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 151' ' ' GLN . 6.5 tt0 42.29 57.77 3.23 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.395 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.544 ' NE2' ' N ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -131.76 153.62 49.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.544 ' N ' ' NE2' ' A' ' 155' ' ' GLN . 56.4 mttp -121.7 116.44 24.54 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 31.4 pt -130.2 173.82 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.369 0.604 . . . . 0.0 111.728 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -140.37 126.85 20.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.927 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mt -110.97 118.42 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.4 t -101.81 110.92 23.01 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.667 0.27 . . . . 0.0 111.016 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.553 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 50.1 p-80 -102.57 73.57 1.31 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.688 0.756 . . . . 0.0 111.494 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -76.56 -18.88 58.43 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.801 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 108.4 13.21 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.587 ' SG ' ' CD2' ' A' ' 166' ' ' HIS . 9.1 t -133.68 118.82 18.59 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.608 0.242 . . . . 0.0 110.868 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 44.4 ttm -35.8 -22.36 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.214 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.601 ' NE2' ' CE2' ' A' ' 140' ' ' PHE . 28.3 m-70 -51.43 -23.28 3.7 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.1 t -89.31 -41.89 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.021 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.458 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 127.88 13.3 2.75 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.83 159.43 19.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.998 0.428 . . . . 0.0 110.831 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -56.7 -27.76 59.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.399 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -168.87 175.88 5.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 9.5 m -91.72 143.81 26.16 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.805 0.335 . . . . 0.0 110.627 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.2 tpp -121.99 120.52 34.64 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.44 104.83 8.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.394 0.616 . . . . 0.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.479 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -91.23 125.36 43.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.4 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.32 152.59 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.999 0.428 . . . . 0.0 110.27 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -143.95 141.99 30.51 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.995 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.8 mt -95.61 136.23 36.26 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.926 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -71.13 158.14 36.96 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.573 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -57.08 -33.64 67.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.522 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.565 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.564 ' C3A' ' NH2' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.687 ' H1 ' ' H ' ' A' ' 36' ' ' TYR . 1.1 tmt? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 3' ' ' GLY . 1.7 tpmt? -80.67 -84.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.555 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 56.94 112.28 0.01 OUTLIER Glycine 0 C--N 1.333 0.413 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -47.23 -47.77 9.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 49.6 mm -57.78 -53.89 38.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 0.0 109.755 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -67.56 -18.75 65.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.568 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 3' ' ' GLY . 43.9 t-20 -73.39 -56.2 5.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.471 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t -56.99 -36.03 49.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -72.09 -41.75 66.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.752 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -51.82 -44.38 63.5 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -61.53 -50.65 71.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.987 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.476 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 13.5 ttt -52.55 -42.89 64.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 86.8 t -68.89 -35.91 71.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.462 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -61.01 -23.42 29.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.336 0.589 . . . . 0.0 109.799 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.22 -34.43 20.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.174 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -85.06 -75.86 0.34 Allowed 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.7 m -92.03 -20.75 21.0 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.234 0.54 . . . . 0.0 110.741 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.8 172.04 25.52 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.819 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 ttt -66.92 -29.08 68.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.798 -1.201 . . . . 0.0 110.55 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t -62.51 -41.54 98.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.133 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.68 -35.87 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -51.97 -45.82 64.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.223 0.535 . . . . 0.0 109.578 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -72.24 -29.65 64.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.211 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -67.39 -49.24 64.69 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -82.38 -23.46 34.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.793 0.33 . . . . 0.0 110.651 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 30' ' ' ALA . 7.6 tt -72.62 -61.8 1.68 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.401 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.2 -22.11 60.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.687 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -81.2 -41.15 22.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.488 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 91.7 m-70 -102.17 -88.74 0.38 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.554 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -50.83 157.13 1.42 Allowed Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.03 148.2 62.81 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.67 2.246 . . . . 0.0 112.109 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.566 ' CD ' ' H ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -113.03 -0.85 14.62 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.562 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 35' ' ' VAL . 49.0 t0 -110.8 -36.83 5.59 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.409 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.52 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 92.3 mtt180 -75.23 44.98 0.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.45 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.415 ' H ' ' C ' ' A' ' 33' ' ' ASP . 3.5 p -48.24 128.91 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.435 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.687 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 82.9 m-85 -116.59 -171.65 2.05 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.59 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' A' ' 39' ' ' ALA . 2.4 m -125.41 168.27 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.806 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -76.92 34.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.834 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.458 ' H ' ' C ' ' A' ' 37' ' ' VAL . . . -156.58 -5.17 0.11 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.238 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -85.95 172.2 10.86 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.028 0.442 . . . . 0.0 110.541 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 m -76.81 144.69 38.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.456 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -154.47 156.56 36.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.559 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.48 120.31 29.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.464 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.544 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 11.1 pm0 -75.12 -24.58 58.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.643 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -58.91 -36.02 74.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.42 ' O ' ' OG ' ' A' ' 49' ' ' SER . 98.4 mt-10 -61.27 -42.57 98.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.83 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -40.82 -58.76 1.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.928 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -37.68 -43.36 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.539 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 91.5 p -72.48 -33.32 66.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.272 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.0 mp -68.38 -54.83 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.028 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -24.61 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.878 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.427 ' O ' ' OE1' ' A' ' 56' ' ' GLN . 5.8 tt0 -75.56 -41.79 53.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.598 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.488 ' OD2' ' CD2' ' A' ' 29' ' ' HIS . 19.5 m-20 -58.62 -56.83 17.11 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.136 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.19 -38.82 63.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.096 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.11 -38.5 79.71 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.179 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.502 ' NE2' ' N ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -63.77 -31.68 72.94 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -73.79 -40.56 63.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.9 mt -85.25 -6.75 59.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.085 0.469 . . . . 0.0 110.004 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.489 ' O ' ' SD ' ' A' ' 60' ' ' MET . 20.7 m120 56.47 61.18 2.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.973 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 52.3 mmm -139.76 149.84 60.79 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.708 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.21 136.86 53.68 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.405 1.403 . . . . 0.0 110.778 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 tt -50.21 -27.66 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.042 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -73.44 -31.38 63.79 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.481 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.7 -34.05 52.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.995 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.469 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 84.8 t -69.5 -57.21 9.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.506 ' CG2' ' SG ' ' A' ' 141' ' ' CYS . 9.3 p -51.99 -42.23 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.308 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -52.75 -50.3 63.75 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.38 -48.22 81.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.757 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.469 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.0 m-30 -52.12 -30.42 26.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.632 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.44 -48.13 71.82 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -56.89 -51.74 67.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.931 0.396 . . . . 0.0 109.98 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 55.4 m-85 -58.68 -42.53 88.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.818 0.818 . . . . 0.0 110.447 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.8 tp -56.8 -39.26 73.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.335 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 38.1 t80 -69.0 -41.31 77.97 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.002 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -55.9 -69.28 0.15 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.199 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.63 -46.89 30.37 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.397 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.8 mt -51.0 -43.69 60.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.724 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -54.7 -25.9 30.27 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.277 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 82' ' ' THR . 32.9 t -74.4 -55.68 5.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.045 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.17 -38.04 63.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.781 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -94.26 25.43 3.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.555 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 55.9 m -52.83 -39.0 62.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 110.002 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -57.91 -31.12 66.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.22 -20.17 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.55 -40.81 89.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -53.22 -19.66 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.387 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -64.72 -29.47 70.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.797 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 7.0 p90 -122.54 115.27 21.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.887 0.375 . . . . 0.0 110.843 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 54.8 p30 -85.69 -3.41 58.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.451 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.601 ' H ' ' HG ' ' A' ' 93' ' ' SER . 61.7 m-20 -160.86 156.96 25.83 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.088 0.471 . . . . 0.0 111.452 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -48.12 -53.05 17.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.812 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.8 m -55.69 -42.41 75.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.655 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.601 ' HG ' ' H ' ' A' ' 90' ' ' ASP . 91.0 p -63.0 -38.27 90.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.447 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.0 tt -64.12 -48.97 74.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.004 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.5 t -58.25 -37.39 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 0.0 110.776 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 120' ' ' GLY . 95.6 mmm -87.24 -4.89 59.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.088 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.7 -16.93 7.75 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.163 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.507 ' O ' ' O ' ' A' ' 97' ' ' GLY . 11.2 mt -27.43 -106.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 117.828 0.814 . . . . 0.0 112.645 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -40.45 -48.35 2.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.118 0.485 . . . . 0.0 111.074 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -44.46 -86.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.2 m -72.86 -52.17 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.494 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.8 mp -63.97 -48.3 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.617 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.02 -54.63 35.96 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.9 tp -48.8 -50.58 33.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.138 0.495 . . . . 0.0 110.101 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -54.26 -46.38 72.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.389 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 64.3 t -53.87 -53.38 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 110' ' ' TYR . 18.1 t-20 -46.54 -43.51 17.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.804 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -61.29 -36.58 80.46 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.516 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.3 mt -70.54 -30.7 67.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.683 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 107' ' ' ASN . 51.9 m-85 -139.15 -129.3 0.12 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.52 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -167.04 141.74 3.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.881 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.462 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 0.9 OUTLIER 45.85 62.3 11.25 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.054 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.88 163.58 28.49 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.783 2.322 . . . . 0.0 111.796 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.7 p -86.2 75.49 9.87 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.231 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 116' ' ' PRO . 43.9 mt -116.7 90.68 32.29 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.325 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 115' ' ' LEU . 52.4 Cg_exo -54.1 -150.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.59 2.194 . . . . 0.0 113.003 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -96.63 115.61 27.73 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.119 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.44 123.96 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.45 99.41 5.82 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.892 0.377 . . . . 0.0 110.927 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.479 ' O ' ' SD ' ' A' ' 96' ' ' MET . . . -102.89 123.41 7.83 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -118.87 162.11 19.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.897 0.379 . . . . 0.0 110.447 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -108.12 143.76 36.45 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.12 160.37 41.39 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.77 -38.06 3.38 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.538 2.159 . . . . 0.0 113.343 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -81.0 46.17 0.88 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.27 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 43.7 59.31 3.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 110.685 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -135.52 157.98 45.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.884 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.0 mt -137.06 117.52 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.33 119.99 27.2 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.755 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.5 tp -114.04 125.89 54.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 110.789 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.677 HH21 ' NE2' ' A' ' 171' ' ' HIS . 9.4 tpt180 -111.18 119.73 39.92 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.465 ' OH ' ' C3A' ' A' ' 182' ' ' HEM . 2.2 t80 -125.86 112.06 15.55 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 116' ' ' PRO . 12.2 m -95.89 102.71 14.54 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.529 ' C ' ' H ' ' A' ' 136' ' ' ARG . 36.5 t -125.1 82.34 61.92 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.492 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -48.02 -11.8 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.911 1.741 . . . . 0.0 110.865 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.529 ' H ' ' C ' ' A' ' 134' ' ' SER . 58.3 mtt180 -91.81 142.3 27.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.719 ' HE ' ' HE2' ' A' ' 166' ' ' HIS . 49.5 ttt180 -69.1 39.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.557 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.479 ' H ' ' C ' ' A' ' 136' ' ' ARG . 3.4 mm? -98.89 0.83 44.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.298 0.57 . . . . 0.0 110.08 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 15.8 p -42.14 -46.57 4.39 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.794 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.596 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 88.6 m-85 -51.49 -38.5 54.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.086 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.506 ' SG ' ' CG2' ' A' ' 66' ' ' VAL . 68.4 m -65.8 -43.29 89.15 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.162 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.54 -49.86 18.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.947 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -62.64 -51.2 68.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.087 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.53 -46.39 37.41 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.5 mt -59.11 -54.29 48.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.707 0.289 . . . . 0.0 111.428 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 mt -55.26 -56.12 23.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.983 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -50.58 -47.6 57.88 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.841 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.02 -50.84 63.57 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.41 -58.48 2.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.002 0.43 . . . . 0.0 110.613 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.7 -52.01 57.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.701 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -50.48 -48.78 56.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.113 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.4 ' ND1' ' C ' ' A' ' 152' ' ' HIS . 16.8 t-80 -48.66 -48.92 39.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.689 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -89.22 39.12 0.92 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.236 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 37.49 57.53 1.37 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.943 0.401 . . . . 0.0 111.379 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.682 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 42.1 tp60 -129.82 141.0 50.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.682 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 21.4 tptp -112.61 124.62 52.95 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.3 pt -138.1 170.3 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.735 0.779 . . . . 0.0 111.975 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -133.63 127.65 33.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.335 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mt -110.0 120.62 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.653 0.263 . . . . 0.0 110.447 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.6 t -103.69 103.81 13.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.771 0.32 . . . . 0.0 110.894 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.1 p-80 -97.14 74.17 2.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.435 0.636 . . . . 0.0 111.338 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -77.29 -7.5 56.08 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.442 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.505 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 4.7 m -123.94 105.79 9.89 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.594 ' O ' ' N ' ' A' ' 166' ' ' HIS . 20.7 t -137.23 114.34 10.74 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.305 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 38.9 ttm -36.34 -18.24 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.719 ' HE2' ' HE ' ' A' ' 137' ' ' ARG . 51.9 m80 -58.15 -28.08 64.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.499 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.2 t -82.41 -46.13 13.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.799 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.499 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 152.65 15.17 0.07 OUTLIER Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.247 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.19 145.64 32.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.907 0.384 . . . . 0.0 110.532 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.469 ' C ' ' ND1' ' A' ' 171' ' ' HIS . 85.7 m-20 -83.44 19.27 1.59 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.021 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.677 ' NE2' HH21 ' A' ' 131' ' ' ARG . 8.5 p-80 174.65 -163.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 163' ' ' THR . 46.6 t -136.48 150.51 48.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.276 0.56 . . . . 0.0 111.426 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.402 ' H ' ' HB ' ' A' ' 163' ' ' THR . 14.8 ttp -126.89 109.95 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.325 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -108.62 111.95 24.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.319 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.6 mp -93.84 128.64 45.06 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.478 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.4 mp -109.63 150.65 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.477 0.656 . . . . 0.0 110.63 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -136.21 134.67 38.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.773 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.42 ' O ' ' OE1' ' A' ' 179' ' ' GLN . 16.7 mt -93.88 142.41 27.41 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.524 ' O ' ' ND2' ' A' ' 180' ' ' ASN . 15.1 mm100 -135.3 -175.22 3.86 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.856 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 179' ' ' GLN . 29.1 m120 -149.93 23.65 0.86 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.776 0.322 . . . . 0.0 110.592 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 52.9 p30 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.617 179.966 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.465 ' C3A' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 mtt . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.7 mttp 54.44 47.3 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.25 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . -157.71 -126.8 0.92 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.464 ' CD1' ' NE ' ' A' ' 80' ' ' ARG . 2.4 tp -50.06 -53.69 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 110.385 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.1 mm -51.14 -47.5 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.53 -23.96 61.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.742 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 3' ' ' GLY . 36.2 t-20 -69.48 -51.26 37.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.426 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.51 -50.86 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.34 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.7 tp -55.46 -44.19 76.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -52.09 -50.88 60.71 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.825 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -57.6 -52.55 64.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.029 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.438 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.5 OUTLIER -47.72 -37.11 12.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.469 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -73.73 -34.76 41.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.403 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.5 t -61.33 -23.69 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.68 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.76 -34.91 22.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.982 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -84.5 -73.88 0.41 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.3 m -93.87 -21.52 19.2 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.089 0.471 . . . . 0.0 111.076 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.68 -178.82 23.3 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.827 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.0 mtm -74.07 -30.41 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.063 -1.069 . . . . 0.0 110.193 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 m -61.99 -42.82 99.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.85 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.7 -38.42 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -51.84 -45.83 64.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.309 0.576 . . . . 0.0 109.453 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -70.93 -28.84 64.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.116 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -67.9 -49.89 59.4 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.472 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -82.69 -20.23 36.54 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.934 0.397 . . . . 0.0 110.659 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 30' ' ' ALA . 7.8 tt -76.31 -63.32 1.35 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.316 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.73 -21.93 43.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.596 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -80.01 -39.93 28.93 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -103.41 -89.26 0.39 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.702 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -54.36 154.9 7.74 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.129 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.01 139.38 56.02 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.429 2.086 . . . . 0.0 112.046 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -79.77 -21.81 43.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.48 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.53 -46.22 83.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.557 ' NE ' ' CZ ' ' A' ' 42' ' ' TYR . 92.1 mtt-85 -90.93 102.35 15.12 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.718 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.5 m -155.27 52.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.382 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 37' ' ' VAL . 72.8 m-85 -149.49 -134.82 0.07 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.554 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.491 ' O ' ' O ' ' A' ' 36' ' ' TYR . 16.4 m 29.05 -154.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 123.792 0.682 . . . . 0.0 112.479 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 37' ' ' VAL . 2.6 m -168.01 11.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.368 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.97 76.45 0.17 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.931 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -120.21 -172.38 2.34 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.183 0.515 . . . . 0.0 110.702 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 42' ' ' TYR . 28.8 t -75.98 -136.99 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.955 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.557 ' CZ ' ' NE ' ' A' ' 34' ' ' ARG . 96.4 m-85 58.57 134.1 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.55 151.73 43.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.147 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -80.52 -6.27 57.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.592 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.0 t -47.94 -35.02 10.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.69 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -59.44 -30.98 68.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.707 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -49.55 -56.2 10.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.107 0.48 . . . . 0.0 110.576 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -38.79 -43.37 0.92 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.808 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.1 p -74.3 -29.3 61.57 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.157 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 47' ' ' LEU . 15.7 mt -72.89 -52.67 21.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.109 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.8 -24.37 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.627 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -78.03 -39.43 41.98 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.43 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -60.28 -56.85 16.48 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.282 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.66 -41.05 73.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.553 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.1 -38.98 74.16 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.887 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -63.73 -30.79 71.84 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -76.94 -38.56 53.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.583 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.74 -7.09 59.34 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.82 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 47.7 t30 56.36 49.28 15.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.54 0.686 . . . . 0.0 109.302 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.4 mmm -126.94 150.02 70.67 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.133 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.29 137.16 59.27 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 121.513 1.475 . . . . 0.0 110.912 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 tt -50.71 -29.68 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.887 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -69.98 -34.18 73.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.225 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -75.47 -32.91 60.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.104 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.1 t -71.6 -55.89 12.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.109 0.48 . . . . 0.0 110.003 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -51.91 -42.86 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.132 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -53.89 -49.85 67.64 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.03 -52.3 66.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.655 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.69 -30.95 4.2 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.707 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.24 -50.94 41.51 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -55.12 -49.72 71.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.04 0.448 . . . . 0.0 109.899 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -58.84 -42.57 89.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.7 0.762 . . . . 0.0 110.733 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.2 tp -54.99 -38.62 68.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.309 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 34.2 t80 -71.27 -40.33 71.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.01 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -57.07 -71.92 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.785 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.76 -40.38 18.29 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.286 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 79' ' ' SER . 44.4 mt -61.81 -39.2 90.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.177 0.489 . . . . 0.0 111.796 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.446 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -54.38 -11.6 0.55 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.697 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.453 ' O ' ' OG1' ' A' ' 82' ' ' THR . 9.3 t -91.91 -48.54 6.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.934 0.397 . . . . 0.0 110.483 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.464 ' NE ' ' CD1' ' A' ' 4' ' ' ILE . 5.5 mtm105 -68.64 -65.95 0.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.315 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.561 ' ND1' ' CAC' ' A' ' 182' ' ' HEM . 0.0 OUTLIER -81.19 28.78 0.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.19 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 79' ' ' SER . 96.5 m -49.01 -45.49 42.6 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.571 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -52.48 -25.6 10.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.404 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 2.8 t -85.91 -24.57 6.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.828 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.8 t -63.05 -40.43 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.529 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -53.84 -16.19 1.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.448 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.404 ' CG ' ' O ' ' A' ' 84' ' ' VAL . 39.0 mmtm -64.85 -30.87 71.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.488 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 12.9 p90 -119.3 119.32 33.69 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.101 0.477 . . . . 0.0 111.126 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 22.1 t70 -83.87 -5.1 59.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.257 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.492 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 67.8 m-20 -159.59 156.34 27.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.089 0.471 . . . . 0.0 111.485 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -45.39 -46.98 13.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.818 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.9 m -56.9 -58.77 6.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.368 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.7 t -45.27 -40.06 7.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.12 0.485 . . . . 0.0 111.145 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.6 tt -63.81 -48.31 77.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.326 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.2 t -59.32 -40.25 80.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.573 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 9.0 ptm -87.96 -1.52 58.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.6 -18.07 7.21 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.327 -0.707 . . . . 0.0 112.851 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 94' ' ' LEU . 13.5 mt -27.41 -105.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 117.77 0.785 . . . . 0.0 112.493 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -40.56 -48.88 2.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.064 0.459 . . . . 0.0 111.141 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -44.02 -85.84 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.509 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.4 m -73.2 -52.27 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.509 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mp -64.71 -48.75 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.7 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.17 -54.49 36.62 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 tp -48.62 -49.83 35.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.191 0.52 . . . . 0.0 109.854 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -55.04 -47.17 75.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.547 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 71.8 t -51.0 -51.04 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -51.72 -40.63 60.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -63.96 -40.19 95.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.692 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.482 ' C ' ' CG ' ' A' ' 110' ' ' TYR . 8.8 mp -61.04 -55.94 26.91 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.482 ' CG ' ' C ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER 169.19 170.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.622 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 110' ' ' TYR . 3.6 t-160 58.43 145.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.929 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -149.49 68.33 9.16 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.326 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -82.77 21.26 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.96 2.44 . . . . 0.0 112.224 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.7 t 57.62 107.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.344 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.67 152.35 93.55 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.128 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.5 172.47 5.46 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.459 2.106 . . . . 0.0 112.414 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -80.03 105.44 11.3 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.871 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.0 mm -115.65 124.93 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -131.94 116.63 17.39 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.756 0.312 . . . . 0.0 110.962 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.83 158.86 14.06 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -152.79 154.65 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.3 mp -104.72 150.25 24.9 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.13 160.52 38.87 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.74 -56.62 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.627 2.218 . . . . 0.0 112.797 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.466 ' C ' ' ND2' ' A' ' 126' ' ' ASN . 22.0 m120 -45.67 -64.65 0.68 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.501 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.65 ' N ' HD21 ' A' ' 126' ' ' ASN . 0.0 OUTLIER 155.54 63.5 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.57 0.7 . . . . 0.0 109.181 179.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -142.36 165.83 26.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.694 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.6 mt -138.28 117.95 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.76 121.3 30.01 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.83 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 60.2 tp -115.61 136.42 53.09 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.984 0.421 . . . . 0.0 110.607 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -119.99 124.24 45.45 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.093 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.478 ' HH ' ' HG ' ' A' ' 134' ' ' SER . 45.9 t80 -123.09 113.97 19.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.778 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.96 122.71 36.72 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 121.168 -0.213 . . . . 0.0 110.435 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.478 ' HG ' ' HH ' ' A' ' 132' ' ' TYR . 4.9 p -173.06 149.47 1.78 Allowed Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.714 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.82 12.7 1.12 Allowed 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.111 1.874 . . . . 0.0 110.813 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 138' ' ' LEU . 39.0 mtp180 -92.74 107.66 19.39 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.483 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -69.49 38.58 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.081 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 136' ' ' ARG . 1.4 tp -101.72 8.76 41.42 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.066 0.46 . . . . 0.0 110.483 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 71.2 m -41.78 -46.54 3.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.499 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -49.07 -38.39 24.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.454 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.62 -42.84 86.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 109.949 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.84 -49.79 14.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.613 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -61.33 -50.17 74.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.252 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.98 -46.58 41.25 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.75 -53.26 59.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.597 0.237 . . . . 0.0 111.258 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.8 mt -55.02 -56.49 19.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.979 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -50.76 -47.87 59.43 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.751 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.06 -51.65 57.06 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.59 -59.81 2.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.864 0.364 . . . . 0.0 110.839 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -50.51 -51.23 49.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.994 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -51.13 -47.48 62.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.1 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -49.99 -49.74 49.52 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.641 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.517 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 67.9 t80 -87.68 38.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 38.38 55.95 1.79 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.983 0.421 . . . . 0.0 111.185 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.68 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 42.0 tp60 -129.12 141.03 51.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.68 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 50.5 mtmt -113.74 124.48 52.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.05 170.47 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.635 0.731 . . . . 0.0 111.898 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -134.0 127.38 32.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.494 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.3 mt -110.17 117.44 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.3 t -105.19 119.63 39.54 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.065 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.6 p-80 -96.67 74.82 2.75 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.657 0.741 . . . . 0.0 111.376 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -76.9 -19.92 56.85 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.989 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.472 ' HG1' ' CB ' ' A' ' 173' ' ' MET . 0.4 OUTLIER -124.78 111.07 15.1 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 20.1 p -114.23 -178.91 3.49 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.563 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.492 ' O ' ' SD ' ' A' ' 165' ' ' MET . 1.1 tmt? -93.87 -26.77 16.76 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -54.83 -24.05 21.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.577 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.5 t -87.25 -25.37 24.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.286 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.04 21.73 24.71 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.946 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.4 166.17 12.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.86 0.362 . . . . 0.0 110.651 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 171' ' ' HIS . 50.4 p-10 -52.22 -31.13 30.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.427 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.524 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 5.3 p-80 -173.98 -174.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.3 m -93.06 143.41 26.27 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.155 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.472 ' CB ' ' HG1' ' A' ' 163' ' ' THR . 30.1 ttp -121.92 116.3 24.12 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.184 0.516 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.4 mt -116.05 99.49 7.29 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.203 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 13.3 mm -84.37 123.82 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.137 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.92 144.0 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.28 0.562 . . . . 0.0 110.28 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -132.17 133.69 44.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.986 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.83 144.4 25.32 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -137.95 178.16 7.32 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.748 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.428 ' O ' ' OD1' ' A' ' 181' ' ' ASP . 48.7 t30 55.57 45.4 24.97 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.567 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 180' ' ' ASN . 68.7 m-20 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.52 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.561 ' CAC' ' ND1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' N ' ' OE1' ' A' ' 112' ' ' GLU . 23.4 ttt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' NZ ' ' O ' ' A' ' 40' ' ' LYS . 9.1 mtmp? 56.19 99.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.443 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.54 115.22 0.69 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 tp 170.09 -39.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mm -59.18 -47.81 88.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.77 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -64.19 -28.44 69.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.244 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.589 ' ND2' ' NH2' ' A' ' 80' ' ' ARG . 64.2 t30 -67.06 -55.05 15.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.016 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t -66.31 -39.0 83.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.17 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.66 -48.6 74.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.961 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -47.42 -44.87 25.01 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.882 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -62.16 -50.54 71.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.863 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.5 tmt? -52.61 -39.62 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.978 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.26 -34.97 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.426 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.0 t -62.06 -22.67 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.322 0.582 . . . . 0.0 110.05 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.35 -34.88 20.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.217 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -84.57 -77.06 0.28 Allowed 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.3 m -90.72 -19.97 22.95 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.309 0.576 . . . . 0.0 110.696 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.79 173.92 26.76 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.738 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.5 ttt -69.37 -25.81 64.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.866 -1.167 . . . . 0.0 110.494 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.0 t -64.94 -43.59 92.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.149 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -34.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -51.52 -45.77 63.03 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -69.8 -31.63 69.64 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.012 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -64.98 -51.07 63.76 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -82.34 -19.6 38.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.921 0.391 . . . . 0.0 110.732 -179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 30' ' ' ALA . 7.2 tt -76.72 -57.16 4.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.357 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.39 -22.48 66.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.507 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -81.13 -39.4 25.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.508 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 72.8 m80 -101.57 -88.74 0.37 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.188 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -50.28 162.57 0.5 Allowed Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.46 148.39 93.09 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.501 2.134 . . . . 0.0 112.083 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -70.47 -11.73 61.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.512 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 34' ' ' ARG . 91.9 m-20 -52.64 -45.65 66.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 33' ' ' ASP . 67.1 ttp85 40.39 95.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.094 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.419 ' O ' ' OH ' ' A' ' 42' ' ' TYR . 3.9 m -146.64 72.05 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.075 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 36' ' ' TYR . 43.0 p90 -72.0 114.38 10.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.863 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.3 m -138.73 5.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-O 121.521 0.677 . . . . 0.0 110.012 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 m 38.92 40.05 0.41 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.758 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.32 26.44 0.52 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.94 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.455 ' O ' ' NZ ' ' A' ' 2' ' ' LYS . 5.2 mmpt? -122.24 -134.53 0.3 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.8 t -152.36 100.55 2.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.825 0.345 . . . . 0.0 110.839 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 35' ' ' VAL . 80.8 m-85 -112.01 161.15 16.77 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.33 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.15 112.55 19.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.325 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.435 ' CD ' ' N ' ' A' ' 45' ' ' SER . 3.0 pp20? -69.65 -29.48 66.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.723 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.435 ' N ' ' CD ' ' A' ' 44' ' ' GLU . 16.5 m -61.31 -35.31 77.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.761 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -62.88 -30.94 71.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.65 -55.79 2.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.027 0.441 . . . . 0.0 110.49 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -39.01 -42.79 0.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.419 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.2 m -72.29 -33.24 67.28 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.335 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.2 mp -71.04 -53.92 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.586 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.97 -24.86 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.124 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -77.6 -39.87 44.02 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.505 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 79.1 m-20 -59.52 -56.21 24.84 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.968 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 p -57.18 -39.2 65.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.026 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.73 -38.42 85.07 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.29 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -63.27 -32.03 73.34 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -73.87 -40.46 63.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.517 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -83.18 -7.72 59.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.218 0.533 . . . . 0.0 109.748 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.1 t30 56.95 49.57 13.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.549 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.9 mmt -128.43 149.52 71.83 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.151 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.24 137.93 68.89 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.49 1.46 . . . . 0.0 111.124 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tt -51.79 -29.18 10.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.014 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -71.4 -34.18 70.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.161 0.505 . . . . 0.0 111.244 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -75.51 -32.89 60.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.884 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.509 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 71.9 t -70.78 -56.53 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.441 ' CG2' ' SG ' ' A' ' 141' ' ' CYS . 7.2 p -52.56 -44.57 45.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.217 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -51.08 -50.13 59.3 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.92 -47.94 81.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.74 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.509 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 8.3 m-30 -53.77 -30.62 45.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.529 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.71 -49.86 61.77 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -56.9 -50.02 73.81 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -58.61 -42.54 88.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.775 0.797 . . . . 0.0 110.555 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.6 tp -55.73 -38.39 69.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.306 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 37.1 t80 -71.55 -39.61 70.55 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.954 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -56.44 -71.05 0.1 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.762 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.06 -45.13 33.3 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.78 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 mt -52.34 -44.41 65.15 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.181 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.458 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -54.37 -23.71 16.68 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.178 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.427 ' O ' ' OG1' ' A' ' 82' ' ' THR . 22.1 t -76.74 -53.86 7.41 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.988 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.589 ' NH2' ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -75.54 -27.84 58.82 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.764 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -107.14 22.68 15.61 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.684 0.278 . . . . 0.0 110.384 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 6.4 m -50.88 -40.72 57.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -57.56 -35.53 70.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.508 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.3 -21.85 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.674 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.588 ' C ' ' H ' ' A' ' 87' ' ' LYS . 95.4 t -85.52 -46.86 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.695 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -55.68 -2.05 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.686 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.588 ' H ' ' C ' ' A' ' 85' ' ' VAL . 86.0 mttt -78.79 -33.95 45.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.58 130.98 55.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.999 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 52.1 t0 -93.0 11.39 27.64 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 93' ' ' SER . 10.2 p-10 -167.8 163.16 14.08 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 118.987 -1.085 . . . . 0.0 113.485 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -62.13 -61.55 2.4 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.786 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.5 m -45.15 -49.3 12.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.209 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 56.9 m -59.86 -38.16 81.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.296 0.57 . . . . 0.0 110.743 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.19 -55.12 31.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.016 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.7 t -49.73 -42.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 O-C-N 123.142 0.276 . . . . 0.0 111.696 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -83.23 -6.28 59.42 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.736 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -109.24 -13.35 17.7 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.46 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 97' ' ' GLY . 49.4 mt -29.93 -104.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.431 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 2.3 p80 -37.36 -48.32 0.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 59.6 t0 -45.42 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 3.3 m -70.56 -52.9 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.524 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.8 mp -58.8 -48.47 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.71 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.58 -55.1 31.85 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 tp -50.12 -48.55 53.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 110.167 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.514 ' OE1' ' NZ ' ' A' ' 87' ' ' LYS . 37.7 tp10 -55.94 -45.78 78.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.315 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.3 t -53.5 -51.16 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -50.0 -43.35 50.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.829 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -62.5 -39.23 92.83 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.268 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.09 -41.18 97.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.059 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.48 ' CD2' ' N ' ' A' ' 111' ' ' HIS . 55.7 t80 -159.7 161.49 34.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.378 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.48 ' N ' ' CD2' ' A' ' 110' ' ' TYR . 94.4 m-70 -79.75 107.12 12.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.496 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 1' ' ' MET . 10.0 pt-20 -174.45 58.15 0.2 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.723 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 115' ' ' LEU . 65.0 Cg_endo -73.1 24.68 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.658 2.238 . . . . 0.0 111.722 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 112' ' ' GLU . 72.2 m -76.6 23.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.865 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 113' ' ' PRO . 26.7 mt -71.1 147.83 93.84 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.105 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -74.77 -166.55 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.253 1.968 . . . . 0.0 112.657 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -101.51 129.62 47.61 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.666 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.7 mt -131.22 129.82 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.687 0.28 . . . . 0.0 110.654 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -125.98 98.51 5.54 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.87 0.367 . . . . 0.0 110.371 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -103.98 119.49 6.33 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -116.58 153.5 32.13 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 8.8 mp -101.18 147.2 26.53 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.25 160.51 41.1 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.15 -38.43 3.81 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.58 2.187 . . . . 0.0 113.105 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -79.54 45.9 0.71 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.918 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 44.22 61.06 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.366 0.603 . . . . 0.0 110.562 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -139.13 158.38 44.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.095 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.6 mt -138.67 116.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.67 28.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 39.9 tp -117.09 132.39 56.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.137 0.494 . . . . 0.0 110.859 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -118.71 125.26 49.28 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.991 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.624 ' HH ' ' CGA' ' A' ' 182' ' ' HEM . 29.6 t80 -126.43 121.63 33.0 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.03 124.9 31.88 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.846 0.355 . . . . 0.0 110.689 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.7 p -163.07 147.96 9.3 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.292 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.63 6.84 3.0 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.829 1.686 . . . . 0.0 110.837 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.553 ' HE ' ' CBA' ' A' ' 182' ' ' HEM . 74.8 mtm-85 -94.44 112.3 24.07 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.416 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -70.12 54.15 0.13 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.556 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 tp -114.21 9.77 17.14 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.183 0.516 . . . . 0.0 110.559 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.422 ' SG ' ' NE2' ' A' ' 161' ' ' HIS . 9.4 t -41.9 -42.61 2.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.344 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -49.47 -41.69 41.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.454 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.441 ' SG ' ' CG2' ' A' ' 66' ' ' VAL . 56.7 m -65.25 -41.44 94.31 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -44.44 -49.93 9.57 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.674 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -63.78 -48.8 75.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.51 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.35 -46.63 52.02 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.147 -1.025 . . . . 0.0 110.785 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.3 mt -58.77 -55.92 28.88 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.5 mt -53.29 -55.91 20.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.749 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -50.71 -48.15 58.92 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.667 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.03 55.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.72 -60.36 1.82 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.862 0.363 . . . . 0.0 110.821 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.98 -51.01 45.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.847 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -51.36 -46.95 62.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.064 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -50.54 -50.37 53.47 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.344 -0.543 . . . . 0.0 109.563 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.518 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 66.2 t80 -86.04 37.43 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.851 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 39.2 55.65 2.16 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.992 0.425 . . . . 0.0 111.168 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.685 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 40.7 tp60 -128.88 139.8 51.97 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.685 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 11.7 mptt -112.48 124.1 51.77 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.8 pt -137.32 171.15 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.724 0.773 . . . . 0.0 111.896 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -134.24 127.69 32.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.095 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mt -110.43 115.71 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.0 m -96.16 100.06 11.74 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.929 0.395 . . . . 0.0 110.018 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.544 ' NE2' ' SG ' ' A' ' 164' ' ' CYS . 0.9 OUTLIER -100.69 71.49 1.49 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.019 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -81.2 -56.12 4.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.486 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 90.0 m -82.72 112.41 19.55 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.528 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.589 ' O ' ' N ' ' A' ' 166' ' ' HIS . 6.0 t -139.17 130.63 27.08 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.049 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 76.8 mtp -36.27 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.312 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.1 t60 -53.0 -24.44 9.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 5.9 t -90.15 -43.38 10.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.106 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.464 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 132.46 11.98 1.87 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.74 169.56 6.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.928 0.394 . . . . 0.0 110.847 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.539 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 89.5 m-20 -56.44 -44.24 80.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.582 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 170' ' ' ASP . 62.6 m-70 -157.68 -169.81 2.99 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.8 m -92.33 138.31 31.63 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 tpt -115.73 123.65 48.83 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 110.523 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -128.39 100.61 5.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.651 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.6 mp -89.02 127.54 41.68 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.619 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.9 mp -110.45 150.82 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.438 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -144.66 141.47 29.37 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.925 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.2 mt -95.74 133.96 39.23 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.152 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.515 ' O ' ' ND2' ' A' ' 180' ' ' ASN . 84.9 mt-30 -49.14 147.14 3.13 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.501 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 179' ' ' GLN . 29.2 m120 -150.45 22.81 0.82 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.461 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 62.2 t0 . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.616 179.967 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.624 ' CGA' ' HH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.562 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.6 mpp? . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -80.62 3.11 23.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.554 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 4' ' ' ILE . . . -65.32 -164.04 1.06 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.437 ' CB ' ' O ' ' A' ' 3' ' ' GLY . 0.3 OUTLIER 94.12 -23.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.861 0.864 . . . . 0.0 109.483 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.3 mm -67.75 -51.97 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.448 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.616 ' CZ ' ' NH1' ' A' ' 34' ' ' ARG . 93.3 m-85 -68.1 -24.55 65.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.204 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -70.16 -49.93 45.55 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.915 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.08 -35.43 75.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.621 -0.431 . . . . 0.0 109.903 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.6 tp -71.1 -40.38 71.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.109 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -53.66 -44.93 70.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.634 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -62.66 -48.13 80.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.966 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.8 tmt? -53.86 -41.38 67.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.819 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.7 t -71.02 -34.94 57.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.446 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.96 -26.22 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.191 0.52 . . . . 0.0 110.249 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.26 -34.51 28.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.112 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -83.74 -73.74 0.4 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.4 m -95.29 -22.4 17.8 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.933 0.397 . . . . 0.0 111.332 -177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.06 170.15 22.32 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 121.891 0.717 . . . . 0.0 112.996 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -27.19 67.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.07 -1.065 . . . . 0.0 109.553 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -63.8 -43.6 95.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.531 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.31 -37.24 31.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -51.02 -44.97 61.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -71.66 -29.01 64.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.068 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -66.73 -50.85 61.45 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -82.57 -20.64 36.12 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.596 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 29' ' ' HIS . 8.5 tt -76.66 -69.55 0.51 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.241 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -50.82 -21.43 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.162 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -80.93 -39.25 26.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 26' ' ' LEU . 89.1 m-70 -107.27 -88.98 0.46 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.752 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -58.22 155.51 25.68 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.449 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.42 155.55 69.9 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.619 2.213 . . . . 0.0 112.036 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -78.34 -24.77 46.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 3.0 p30 -65.34 -35.7 81.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.908 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.616 ' NH1' ' CZ ' ' A' ' 6' ' ' PHE . 38.7 ttp180 -78.19 103.06 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.772 0.32 . . . . 0.0 110.15 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.3 p -155.13 144.92 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.597 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.483 ' O ' ' O ' ' A' ' 37' ' ' VAL . 60.0 m-85 50.81 -118.3 1.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.971 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 36' ' ' TYR . 4.5 m 27.84 -154.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 123.655 0.597 . . . . 0.0 112.594 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.402 ' OG ' ' C ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER 175.8 25.23 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.483 -179.072 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.99 21.31 2.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.634 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -112.5 -151.14 0.48 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.119 0.485 . . . . 0.0 111.254 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.9 p -42.92 156.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.692 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.536 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 13.4 p90 -133.57 61.63 1.67 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.19 0.519 . . . . 0.0 110.362 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' A' ' 46' ' ' GLU . . . -73.24 37.59 0.09 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.597 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.521 ' OE2' ' NH2' ' A' ' 136' ' ' ARG . 73.8 tt0 -42.42 -23.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.061 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 43' ' ' ALA . 17.5 m -76.59 -38.46 54.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.922 0.391 . . . . 0.0 110.742 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 6.4 mp0 -65.59 -29.23 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.53 -57.34 2.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 110.741 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.64 -40.21 0.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.533 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.9 m -75.22 -31.11 60.77 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.892 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 47' ' ' LEU . 13.7 mt -70.94 -50.73 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -26.15 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.398 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -76.0 -40.79 52.9 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.543 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -59.27 -57.0 14.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.005 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.96 -38.33 59.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.221 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.35 86.62 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.218 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -62.9 -32.02 73.2 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.47 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.69 -45.33 53.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.534 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.0 mt -77.77 -7.26 56.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.656 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 t30 56.94 49.75 13.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.934 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.7 mmt -128.45 149.14 70.82 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.225 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.28 139.21 76.3 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.441 1.428 . . . . 0.0 110.892 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 tt -52.84 -29.86 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.433 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -71.7 -31.48 66.79 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.578 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.6 -31.6 47.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.921 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.483 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.4 t -71.04 -57.1 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.0 p -52.03 -41.37 31.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.201 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -53.98 -50.75 65.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.78 83.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.73 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.9 m-30 -53.81 -31.11 47.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.286 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.63 -50.1 60.8 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -55.69 -50.09 71.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.006 0.432 . . . . 0.0 109.941 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -59.93 -41.84 92.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.826 0.822 . . . . 0.0 110.493 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -58.55 -39.81 81.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.597 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 35.1 t80 -68.28 -41.5 80.93 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.904 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -55.07 -68.81 0.16 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.224 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.16 -47.6 33.32 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.618 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.6 mt -52.06 -42.93 63.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.052 0.426 . . . . 0.0 111.991 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -55.11 -24.17 24.54 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.394 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.423 ' O ' ' OG1' ' A' ' 82' ' ' THR . 22.8 t -76.37 -53.1 8.65 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.082 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -39.98 49.15 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.772 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -92.96 27.01 2.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.41 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 34.8 m -53.71 -37.7 63.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.05 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.442 ' O ' ' NZ ' ' A' ' 87' ' ' LYS . 89.9 m-20 -58.09 -30.81 66.53 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.6 -19.7 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.688 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.35 -43.5 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.353 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.34 -16.62 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.994 0.426 . . . . 0.0 110.35 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 83' ' ' ASP . 42.5 mmtm -67.61 -29.07 68.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.022 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 8.9 p90 -120.56 116.5 25.49 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.175 0.512 . . . . 0.0 110.991 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -84.82 -2.37 57.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.369 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.434 ' OD1' ' OG ' ' A' ' 93' ' ' SER . 50.5 p30 -163.48 159.48 22.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.186 0.517 . . . . 0.0 111.637 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -48.7 -46.05 39.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.305 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.2 m -59.08 -61.35 2.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.904 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.496 ' HG ' ' N ' ' A' ' 94' ' ' LEU . 93.8 p -45.4 -37.78 5.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.151 0.501 . . . . 0.0 111.022 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.496 ' N ' ' HG ' ' A' ' 93' ' ' SER . 4.5 tt -65.03 -46.03 82.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.199 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.1 t -62.6 -39.6 85.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.253 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 12.8 ptm -87.2 -1.85 58.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.82 -16.85 7.74 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.353 -0.693 . . . . 0.0 112.891 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 97' ' ' GLY . 12.2 mt -29.12 -102.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 117.868 0.834 . . . . 0.0 112.454 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.489 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 13.3 p-80 -39.75 -50.15 2.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.035 0.445 . . . . 0.0 111.364 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.489 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 80.2 m-20 -44.54 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.5 m -72.18 -53.19 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.498 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 3.1 mp -61.15 -48.41 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.22 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.0 -53.7 43.42 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.9 tp -50.62 -50.85 53.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.92 0.39 . . . . 0.0 110.456 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -55.85 -45.27 78.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.318 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.67 -50.77 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 110' ' ' TYR . 22.7 t-20 -50.05 -43.19 50.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.746 0.308 . . . . 0.0 111.055 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -66.98 -41.87 86.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.612 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.0 tp -64.29 -40.42 95.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.607 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 107' ' ' ASN . 66.1 m-85 -140.32 145.28 37.0 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.602 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.657 ' CG ' ' H ' ' A' ' 112' ' ' GLU . 84.4 t60 -85.62 176.88 7.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.393 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.657 ' H ' ' CG ' ' A' ' 111' ' ' HIS . 66.3 tt0 60.47 62.05 3.28 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.67 153.64 38.82 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.663 2.242 . . . . 0.0 111.927 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.1 t -156.66 43.0 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.483 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.6 mt -72.5 148.08 90.23 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.261 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.98 -173.53 1.71 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.395 2.063 . . . . 0.0 112.335 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.858 ' NE2' HD22 ' A' ' 119' ' ' ASN . 75.8 t60 -89.99 115.72 27.49 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.237 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.2 mt -129.82 130.04 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.582 0.229 . . . . 0.0 111.02 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.858 HD22 ' NE2' ' A' ' 117' ' ' HIS . 11.6 m-20 -132.51 119.42 20.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.42 137.53 13.4 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -128.71 159.49 35.47 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -107.14 145.84 32.03 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.28 160.46 41.35 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.62 -41.07 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.638 2.225 . . . . 0.0 113.222 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -77.65 46.59 0.56 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.088 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 17.7 p30 43.29 62.21 1.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.545 0.688 . . . . 0.0 110.837 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -139.25 158.31 44.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.964 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 128' ' ' ILE . 51.0 mt -139.04 119.19 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.85 122.3 33.45 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.269 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.1 tp -117.76 134.81 54.54 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.997 0.427 . . . . 0.0 110.689 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -120.73 125.16 46.93 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.49 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.469 ' OH ' ' C3A' ' A' ' 182' ' ' HEM . 1.7 t80 -123.78 112.47 17.35 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 m -124.14 125.2 44.06 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.18 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 136' ' ' ARG . 2.1 p 174.62 153.2 0.28 Allowed Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.532 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.86 25.33 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.364 2.043 . . . . 0.0 111.19 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.533 ' C ' ' H ' ' A' ' 138' ' ' LEU . 21.2 mmm180 -95.72 106.0 18.06 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.853 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -71.77 15.07 0.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.39 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.5 mm? -84.21 8.21 16.55 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 110.485 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.0 t -42.44 -49.49 5.25 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -47.68 -35.03 8.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.096 0.474 . . . . 0.0 109.895 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.69 -43.55 79.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.936 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.48 -51.19 15.78 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.515 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -59.28 -51.66 69.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.43 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.53 -46.49 37.34 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.9 mt -61.45 -52.1 65.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 111.204 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 45.4 mt -55.53 -56.85 15.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.839 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -50.31 -47.86 55.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.764 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.13 -51.69 57.76 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.5 -54.99 4.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.937 0.398 . . . . 0.0 110.54 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -54.55 -51.42 65.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.631 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -51.09 -46.77 61.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.931 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -50.0 -50.06 48.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.514 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 67.7 t80 -87.81 37.89 0.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.014 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 38.76 55.66 1.95 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.93 0.395 . . . . 0.0 111.081 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.686 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 41.9 tp60 -128.83 141.24 51.36 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.686 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 67.2 mttm -114.85 124.04 50.7 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.8 pt -136.89 173.84 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.714 0.769 . . . . 0.0 111.99 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.443 ' NE2' ' OE1' ' A' ' 177' ' ' GLU . 13.0 pt20 -137.02 129.25 29.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.427 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mt -111.77 120.05 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.297 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -102.2 106.12 16.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.821 0.343 . . . . 0.0 110.754 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.533 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 16.6 p80 -102.08 73.12 1.36 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.385 0.612 . . . . 0.0 111.45 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -77.74 -12.84 60.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.33 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.425 ' HB ' ' H ' ' A' ' 173' ' ' MET . 3.2 m -116.45 104.23 11.23 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.589 ' O ' ' N ' ' A' ' 166' ' ' HIS . 38.0 t -136.63 116.36 13.04 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.576 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.5 ptm -39.94 -15.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.23 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 164' ' ' CYS . 56.0 t-80 -58.53 -30.37 67.04 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.498 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.0 t -81.04 -46.22 15.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.053 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.498 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 153.84 12.68 0.07 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.09 149.19 35.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.65 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -85.1 8.85 16.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.088 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -174.71 -173.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 92.3 m -129.18 148.07 51.09 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.182 0.515 . . . . 0.0 111.569 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.425 ' H ' ' HB ' ' A' ' 163' ' ' THR . 7.8 ttm -126.43 111.86 14.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.111 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.27 110.6 21.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.344 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -92.24 127.54 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.775 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.31 150.57 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.075 0.465 . . . . 0.0 110.095 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.443 ' OE1' ' NE2' ' A' ' 158' ' ' GLN . 28.1 mt-10 -145.71 142.59 29.12 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.734 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 17.6 mt -94.05 131.69 39.3 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.192 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -52.55 153.42 3.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.656 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -55.25 -34.41 64.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.599 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 60.5 t0 . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.54 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.469 ' C3A' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.545 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.553 ' HZ3' ' CMD' ' A' ' 182' ' ' HEM . 38.2 tptt -138.42 134.23 33.83 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.378 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -158.97 -24.04 0.03 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.524 ' CD1' ' HE ' ' A' ' 80' ' ' ARG . 1.9 tp -42.39 -41.42 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.996 0.427 . . . . 0.0 110.487 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.19 -50.87 76.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -64.23 -29.19 70.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.196 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -62.02 -59.3 5.29 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.26 0.553 . . . . 0.0 110.847 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.98 -26.98 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.165 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 tp -72.03 -41.17 67.83 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.085 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.79 -41.06 81.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.256 -0.977 . . . . 0.0 109.541 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -60.3 -57.95 10.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.653 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.601 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 68.0 mtm -48.43 -43.64 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.35 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.8 -36.28 75.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.854 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.53 -22.54 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.275 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.82 -34.41 17.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.13 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -84.75 -78.03 0.26 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.9 m -90.61 -17.54 26.74 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.341 0.591 . . . . 0.0 110.57 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.68 178.86 29.54 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.827 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 ttt -72.49 -30.87 64.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.837 -1.181 . . . . 0.0 110.708 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 t -61.5 -41.87 97.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.119 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.18 -38.12 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -51.73 -45.71 63.73 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.89 -29.05 63.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.339 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -67.27 -50.76 59.21 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.475 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -82.07 -22.38 36.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.85 0.357 . . . . 0.0 110.413 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 30' ' ' ALA . 7.8 tt -73.91 -66.59 0.69 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.117 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -52.44 -21.78 4.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.527 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -81.38 -38.97 25.73 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.45 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 12.8 m-70 -89.11 -62.81 1.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.319 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 26' ' ' LEU . . . -60.64 153.48 62.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.77 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.02 -176.91 2.61 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.737 2.292 . . . . 0.0 111.918 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -69.81 -22.67 63.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.349 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -77.19 6.72 6.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.543 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -46.65 133.83 10.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.048 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.474 ' H ' ' HH ' ' A' ' 42' ' ' TYR . 3.7 m -148.56 163.53 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.177 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -102.28 117.58 35.06 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.326 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -153.29 -160.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.618 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -142.48 9.45 1.82 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.271 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.02 86.94 0.1 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.455 -0.498 . . . . 0.0 112.027 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.492 ' C ' ' H ' ' A' ' 42' ' ' TYR . 17.4 mmtt -134.59 -177.05 4.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.083 0.468 . . . . 0.0 110.232 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.1 m -74.34 18.94 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.911 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 40' ' ' LYS . 4.2 m-85 -62.3 142.4 57.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.035 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.33 128.04 33.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.549 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -67.45 -34.47 77.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.4 p -63.27 -27.54 69.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.479 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -59.04 -37.92 78.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.64 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -44.53 -53.54 6.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.148 0.499 . . . . 0.0 110.713 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -41.1 -40.94 1.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.387 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.2 m -73.24 -31.13 63.93 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 47' ' ' LEU . 25.8 mm -68.48 -55.35 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.714 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.11 -22.41 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.983 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -79.65 -43.18 23.29 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.383 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.45 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 33.0 m-20 -58.4 -57.08 14.49 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.675 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.95 -41.16 76.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.409 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.24 -38.69 71.43 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.309 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -64.51 -32.97 74.84 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -73.44 -37.98 65.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.781 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -84.21 -7.5 59.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.105 0.479 . . . . 0.0 109.844 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.27 48.36 17.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.573 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.5 mmm -127.19 149.55 69.88 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.073 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.68 135.56 49.47 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.442 1.428 . . . . 0.0 110.94 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 tt -49.54 -27.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.097 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -73.44 -30.93 63.53 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.086 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -78.05 -31.83 50.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.258 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.416 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 73.5 t -72.03 -56.3 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.63 -43.69 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.32 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -52.38 -51.98 56.07 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.76 -55.71 30.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.278 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.5 m-30 -44.53 -28.03 0.53 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.375 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.12 -47.46 59.09 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -56.46 -53.45 57.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.042 0.448 . . . . 0.0 110.273 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.601 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 78.7 m-85 -57.23 -42.14 80.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.755 0.788 . . . . 0.0 110.854 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.1 tp -55.25 -37.5 67.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.654 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 28.8 t80 -69.77 -40.7 75.92 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -57.05 -72.96 0.07 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.847 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.87 -40.65 19.52 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.396 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.7 mt -60.02 -41.56 92.44 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.345 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.447 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -54.09 -22.79 11.8 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.926 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.438 ' O ' ' OG1' ' A' ' 82' ' ' THR . 8.7 t -80.45 -52.56 7.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.212 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.524 ' HE ' ' CD1' ' A' ' 4' ' ' ILE . 4.4 mtt-85 -65.97 -52.66 47.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.188 0.518 . . . . 0.0 110.884 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -93.95 36.47 1.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.567 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 39.6 m -56.92 -45.3 82.78 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.066 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -50.79 -31.09 15.88 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 t -82.75 -19.59 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.699 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' A' ' 87' ' ' LYS . 68.1 t -72.21 -47.05 55.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.569 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 56.1 t0 -52.66 -7.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.808 0.337 . . . . 0.0 110.759 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.545 ' H ' ' C ' ' A' ' 85' ' ' VAL . 43.1 mmtm -80.23 -28.9 38.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.071 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.62 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -95.77 118.12 31.83 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.474 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -84.85 -13.45 50.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.169 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 15.3 p-10 -164.67 171.42 14.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.256 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -58.07 -46.74 84.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.872 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.8 m -59.84 -44.78 93.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.443 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.7 t -55.63 -39.84 71.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.248 0.547 . . . . 0.0 110.304 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tt -64.71 -45.56 86.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.998 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.57 -38.13 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.421 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 83.7 mtp -83.99 -4.42 58.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.427 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -116.75 -14.97 7.05 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.044 -0.865 . . . . 0.0 113.663 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.509 ' O ' ' O ' ' A' ' 97' ' ' GLY . 13.7 mt -26.72 -106.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 117.954 0.877 . . . . 0.0 112.697 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.482 ' CE1' ' O ' ' A' ' 118' ' ' ILE . 8.7 p-80 -41.4 -46.34 3.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.019 0.438 . . . . 0.0 111.271 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -47.46 -87.34 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.1 m -69.89 -51.38 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.499 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 4.5 mp -63.28 -47.61 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.699 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.33 -54.06 40.05 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.3 tp -49.47 -48.03 48.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.934 0.397 . . . . 0.0 109.947 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -56.9 -45.82 82.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.035 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' LEU . 76.0 t -54.85 -56.06 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -43.94 -45.43 7.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.125 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -60.08 -36.13 76.71 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.84 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 106' ' ' VAL . 3.7 tt -75.29 -56.21 4.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.965 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.471 ' OH ' ' SD ' ' A' ' 1' ' ' MET . 15.0 t80 -69.0 -80.54 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.424 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.401 ' CG ' ' N ' ' A' ' 112' ' ' GLU . 79.8 t60 -174.45 -98.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.14 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.62 ' H ' ' CD ' ' A' ' 113' ' ' PRO . 13.3 tm-20 -119.81 -32.61 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.62 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 83.8 Cg_exo -47.9 139.93 19.03 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.861 1.707 . . . . 0.0 112.454 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.6 t -103.77 157.12 17.29 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.918 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.505 ' O ' ' O ' ' A' ' 116' ' ' PRO . 10.8 mp -84.4 157.33 61.94 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.013 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 115' ' ' LEU . 98.1 Cg_exo -42.69 -176.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 122.704 2.269 . . . . 0.0 113.382 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -87.08 122.35 30.79 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.518 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.482 ' O ' ' CE1' ' A' ' 99' ' ' HIS . 4.0 mp -138.48 133.15 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -138.5 130.01 27.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.712 0.291 . . . . 0.0 111.212 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.58 120.8 4.53 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -117.55 130.34 56.35 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.651 0.262 . . . . 0.0 110.819 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 tp -76.19 150.35 37.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 111.383 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -121.43 160.32 46.5 Favored Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.317 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.45 -36.83 3.61 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.668 2.245 . . . . 0.0 113.309 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -79.96 46.7 0.82 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.144 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.6 m120 43.35 58.39 3.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 0.0 110.443 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -137.11 159.06 43.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.057 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.4 mt -135.4 114.6 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.19 120.09 25.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 61.5 tp -114.92 132.73 56.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.166 0.508 . . . . 0.0 111.298 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.67 ' HE ' ' CE1' ' A' ' 171' ' ' HIS . 64.0 ttt-85 -116.95 120.43 38.4 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.008 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.491 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 72.3 t80 -127.29 124.53 38.99 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.948 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.08 123.6 24.75 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.459 ' OG ' ' CZ ' ' A' ' 132' ' ' TYR . 71.7 m -145.56 148.4 36.77 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.63 -20.29 12.24 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.071 1.847 . . . . 0.0 112.673 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.574 ' NH2' ' CGA' ' A' ' 182' ' ' HEM . 84.5 mtm-85 -79.04 -14.08 59.39 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.922 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.544 ' C ' ' H ' ' A' ' 139' ' ' CYS . 52.0 mtp180 64.01 25.2 13.79 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.147 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -73.53 18.14 0.13 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.544 ' H ' ' C ' ' A' ' 137' ' ' ARG . 9.2 t -44.83 -49.75 10.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.582 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -45.76 -41.29 10.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.113 0.482 . . . . 0.0 110.2 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 22.8 t -62.34 -41.46 98.59 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -45.54 -54.18 7.93 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.561 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -56.58 -50.74 71.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.35 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.8 -47.9 45.79 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.37 -54.81 41.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.2 mt -53.4 -55.22 26.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.745 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -51.61 -47.7 63.54 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.897 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.31 -51.99 54.29 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.26 -60.11 2.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.846 0.355 . . . . 0.0 110.916 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -47.84 -50.66 25.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.966 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -52.45 -47.97 66.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.623 0.249 . . . . 0.0 111.237 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -49.38 -49.96 42.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.667 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.25 37.3 0.72 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.968 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 38.76 57.5 1.83 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.976 0.417 . . . . 0.0 111.196 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.488 HE21 ' H ' ' A' ' 156' ' ' LYS . 52.8 tp60 -131.72 142.98 49.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.488 ' H ' HE21 ' A' ' 155' ' ' GLN . 58.4 tttp -118.17 112.31 19.99 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.078 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 17.8 pt -122.53 173.48 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.513 0.673 . . . . 0.0 111.78 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -137.13 128.74 28.62 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.547 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mt -112.04 120.97 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.649 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.9 t -105.19 112.19 25.21 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.705 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 53.8 p-80 -101.97 76.7 1.63 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.983 0.897 . . . . 0.0 111.822 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 4.9 p30 -75.89 -27.56 57.77 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.716 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.409 ' HG1' ' CB ' ' A' ' 173' ' ' MET . 0.4 OUTLIER -108.56 110.44 21.92 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.386 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 6.4 p -113.08 176.33 5.06 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 168' ' ' GLY . 72.5 mtp -91.52 -28.18 17.75 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -53.72 -22.51 9.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.825 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.4 t -88.63 -26.77 21.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.446 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 98.58 21.92 15.51 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.136 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.31 162.68 24.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.04 0.447 . . . . 0.0 110.681 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -45.97 -34.38 3.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.308 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.67 ' CE1' ' HE ' ' A' ' 131' ' ' ARG . 9.0 p-80 -175.49 -167.78 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.2 m -95.18 139.71 31.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.171 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.409 ' CB ' ' HG1' ' A' ' 163' ' ' THR . 12.8 tpp -120.7 116.7 25.79 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.1 107.15 12.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.472 0.654 . . . . 0.0 111.047 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.482 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -89.95 126.98 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.561 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.8 mp -110.83 151.49 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.189 0.519 . . . . 0.0 110.171 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.56 144.0 28.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.933 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 11.7 mt -94.41 134.58 36.78 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.072 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -54.21 154.9 4.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.695 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -55.32 -32.52 62.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.622 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 53.0 p30 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.523 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.574 ' CGA' ' NH2' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . 0.429 ' C4 ' ' CD2' ' A' ' 115' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.471 ' N ' ' OG ' ' A' ' 38' ' ' SER . 9.0 ptt? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.5 ' HZ2' ' C ' ' A' ' 34' ' ' ARG . 60.3 mmtt 62.95 54.9 2.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 57.4 125.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 tp -55.03 -44.61 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.623 -0.339 . . . . 0.0 110.853 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 mm -64.45 -56.76 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.426 0.631 . . . . 0.0 109.461 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -62.26 -27.7 69.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.658 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 3' ' ' GLY . 25.7 t-20 -62.35 -60.79 3.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.131 0.491 . . . . 0.0 110.939 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -56.96 -27.16 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.115 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.9 tp -71.8 -50.5 29.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.463 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -49.36 -40.22 34.84 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.562 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -60.48 -49.09 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.695 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.579 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 10.4 tpt -56.87 -42.58 80.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.005 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.79 -34.98 58.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.648 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -62.16 -25.0 36.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.216 0.531 . . . . 0.0 110.018 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.93 -34.58 22.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.134 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -85.75 -74.44 0.41 Allowed 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.7 m -92.27 -21.66 20.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.166 0.508 . . . . 0.0 110.966 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.51 170.96 24.72 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.865 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.0 ttp -66.5 -28.67 68.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.904 -1.148 . . . . 0.0 110.347 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 t -62.49 -42.24 99.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.208 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.63 -36.27 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -51.94 -45.86 64.49 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -70.31 -30.6 67.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.986 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -66.05 -50.77 62.99 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.477 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -82.19 -20.53 37.62 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.844 0.354 . . . . 0.0 110.617 -179.26 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 30' ' ' ALA . 7.3 tt -75.47 -57.64 3.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.345 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.05 -23.16 67.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.675 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -80.45 -40.63 25.93 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -101.67 -87.51 0.4 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.326 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -49.42 161.46 0.48 Allowed Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.49 131.94 31.57 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.546 2.164 . . . . 0.0 111.761 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -70.78 -19.45 62.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.717 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -53.0 -38.32 62.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.483 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.5 ' C ' ' HZ2' ' A' ' 2' ' ' LYS . 81.9 mtp180 44.92 91.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.627 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.8 m -153.12 30.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.624 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -97.47 151.36 20.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.566 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.473 ' C ' ' H ' ' A' ' 39' ' ' ALA . 1.4 m -110.83 171.7 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.097 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.471 ' OG ' ' N ' ' A' ' 1' ' ' MET . 2.1 m -76.87 27.92 0.13 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.715 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 37' ' ' VAL . . . -164.26 40.2 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.339 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 41' ' ' SER . 18.9 mmtt -136.4 150.97 49.04 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.161 0.505 . . . . 0.0 110.702 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 40' ' ' LYS . 77.5 p 40.36 -164.81 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.085 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.534 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 10.3 p90 -171.82 61.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.309 0.576 . . . . 0.0 110.482 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.66 40.13 0.05 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.727 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.503 ' H ' ' C ' ' A' ' 42' ' ' TYR . 86.4 tt0 -45.89 -24.64 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.505 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 85.6 p -70.72 -38.68 73.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.882 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -66.37 -33.13 75.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -48.2 -58.15 4.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.105 0.479 . . . . 0.0 110.634 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -39.01 -41.1 0.74 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.541 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.3 p -74.53 -31.87 62.28 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.971 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 47' ' ' LEU . 17.1 mt -70.26 -53.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.789 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.89 -25.03 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.518 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -76.61 -41.28 46.66 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.633 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -59.02 -56.8 17.54 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.744 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.96 -37.53 55.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.016 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.09 88.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.276 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -62.4 -32.83 73.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -72.04 -44.53 63.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.554 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.3 mt -79.14 -7.37 58.13 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.864 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.01 49.85 13.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.678 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.5 mmt -128.55 149.12 70.91 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.182 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.58 138.73 71.86 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.347 1.365 . . . . 0.0 110.967 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tt -52.38 -29.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.428 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -72.46 -31.53 65.52 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.562 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -78.2 -31.85 49.65 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.944 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 82.2 t -70.5 -57.08 8.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -51.58 -43.22 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.34 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -53.32 -50.33 65.19 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.14 80.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.644 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.9 m-30 -52.16 -29.49 22.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.298 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.26 -50.35 56.83 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -55.17 -50.71 68.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.023 0.44 . . . . 0.0 110.049 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.579 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 59.4 m-85 -59.67 -41.19 90.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.883 0.849 . . . . 0.0 110.74 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.62 -40.46 83.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.451 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.401 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 41.9 t80 -68.7 -39.87 80.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 110.229 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -55.27 -70.44 0.11 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.377 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.92 -37.62 53.4 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.385 -0.436 . . . . 0.0 112.637 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.521 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 16.5 mt -55.23 -51.06 67.81 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.086 0.443 . . . . 0.0 111.716 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.85 -15.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.805 -0.56 . . . . 0.0 111.36 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 77' ' ' LEU . 9.3 t -83.75 -49.08 9.44 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -59.48 2.73 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.083 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.0 p80 -81.85 30.22 0.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.815 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 79' ' ' SER . 91.8 m -49.53 -40.07 36.71 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -55.65 -30.38 60.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.455 ' HB ' ' HD1' ' A' ' 81' ' ' HIS . 5.1 t -85.89 -22.8 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.534 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.492 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 54.1 t -61.66 -40.48 86.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -49.6 -20.34 0.76 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.873 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -70.15 -5.03 24.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.381 0.61 . . . . 0.0 109.865 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.607 ' CG ' ' N ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER -89.05 -150.26 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.508 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.607 ' N ' ' CG ' ' A' ' 88' ' ' PHE . 1.1 p-10 159.63 -30.25 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -170.23 155.1 5.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.365 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -46.08 -57.46 4.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.237 0.541 . . . . 0.0 111.29 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.5 m -50.41 -47.12 56.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.108 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.458 ' OG ' ' OD2' ' A' ' 89' ' ' ASP . 32.6 m -61.42 -37.17 82.52 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.151 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.1 tt -64.3 -45.49 87.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.001 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.52 -36.11 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 121.226 0.536 . . . . 0.0 110.639 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.7 mmm -86.19 -6.79 58.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.53 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -111.42 -13.16 13.52 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.894 -0.392 . . . . 0.0 112.654 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 97' ' ' GLY . 15.8 mt -33.0 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 117.509 0.655 . . . . 0.0 111.963 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -39.8 -50.27 2.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.213 0.53 . . . . 0.0 111.498 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -48.12 -91.25 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.7 m -66.71 -51.21 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.442 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 3.7 mp -61.72 -40.97 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.392 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.16 -57.52 10.45 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.4 tp -49.21 -58.05 5.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.15 0.5 . . . . 0.0 110.491 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -50.6 -45.95 57.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.236 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.7 t -54.59 -51.41 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 110' ' ' TYR . 48.9 t30 -46.85 -42.91 18.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.792 0.329 . . . . 0.0 110.607 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -62.48 -36.89 83.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.69 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.05 -49.17 15.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.376 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 107' ' ' ASN . 57.7 m-85 -123.62 151.43 43.02 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.471 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 112' ' ' GLU . 76.1 m80 -92.93 160.17 15.01 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.735 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 111' ' ' HIS . 8.2 pt-20 32.39 61.38 1.38 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.811 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.23 -20.77 18.45 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.508 2.139 . . . . 0.0 111.93 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.6 m 43.87 69.42 0.41 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.806 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.5 mt -79.05 152.98 77.27 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.074 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.1 169.73 18.66 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.374 2.05 . . . . 0.0 111.905 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -78.23 100.99 6.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.526 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 31.7 mm -117.25 124.14 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.373 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.568 HD21 ' NH2' ' A' ' 131' ' ' ARG . 52.9 t30 -132.89 120.02 20.95 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.735 0.302 . . . . 0.0 110.857 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.8 119.21 5.17 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -117.78 125.65 50.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 tp -72.21 140.04 48.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.886 0.374 . . . . 0.0 110.825 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.29 161.01 41.18 Favored Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.6 178.63 6.48 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.312 2.008 . . . . 0.0 111.992 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.527 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 95.7 m-20 55.23 36.01 26.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.347 0.594 . . . . 0.0 109.832 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.527 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 47.5 m-20 54.35 56.51 6.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.794 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 125' ' ' ASN . 3.8 mp0 -125.98 156.43 39.85 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.1 mt -139.39 115.32 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.87 122.82 31.27 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.844 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 47.8 tp -117.78 132.7 56.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 111.279 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.568 ' NH2' HD21 ' A' ' 119' ' ' ASN . 41.5 ttp180 -112.87 120.24 40.76 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.602 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.494 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 30.6 t80 -122.71 120.2 32.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.621 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.45 124.93 23.49 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.0 t -156.06 142.57 13.28 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.41 -7.42 20.35 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.871 1.714 . . . . 0.0 112.208 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.51 ' N ' ' CD ' ' A' ' 136' ' ' ARG . 0.8 OUTLIER -80.91 -14.37 58.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.035 0.445 . . . . 0.0 109.985 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 56.28 30.35 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.619 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.57 16.49 1.71 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.011 0.434 . . . . 0.0 109.995 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.538 ' HG ' ' H ' ' A' ' 140' ' ' PHE . 26.4 p -43.57 -49.13 7.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.586 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.538 ' H ' ' HG ' ' A' ' 139' ' ' CYS . 80.8 m-85 -45.64 -41.89 10.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.973 0.416 . . . . 0.0 110.409 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 48.5 t -64.09 -42.23 96.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.774 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.55 -52.5 10.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.579 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -59.19 -51.85 68.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.613 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.35 -46.99 35.74 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.3 -54.18 48.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.641 0.258 . . . . 0.0 111.638 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 31.2 mt -54.51 -56.13 21.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.026 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -50.59 -47.26 58.14 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.743 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.64 -51.7 57.33 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.14 -59.95 2.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.684 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.0 -52.29 44.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.76 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -50.41 -47.26 56.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.908 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -49.57 -49.38 46.71 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.712 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -88.24 37.97 0.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.851 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 39.11 55.02 2.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 111.16 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.681 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 41.0 tp60 -127.91 140.11 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.681 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 68.7 mttm -112.39 124.1 51.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.998 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.6 pt -137.41 169.41 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.694 0.759 . . . . 0.0 111.9 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -132.99 127.32 33.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.296 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.9 mt -110.54 117.01 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 6.0 t -98.32 100.58 11.87 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.981 0.419 . . . . 0.0 110.16 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -96.43 71.22 2.71 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.209 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -78.1 -51.9 9.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.246 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.72 123.27 22.96 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.715 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.416 ' CB ' ' CD2' ' A' ' 166' ' ' HIS . 61.1 m -125.97 176.5 6.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.948 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 168' ' ' GLY . 1.0 OUTLIER -93.12 -30.18 15.39 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.007 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.472 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 3.5 p80 -51.18 -21.13 1.83 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.732 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.435 ' N ' ' ND1' ' A' ' 166' ' ' HIS . 3.6 t -90.38 -28.24 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.763 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 101.7 20.05 14.06 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.59 169.56 9.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 110.733 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -52.33 -35.07 49.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.304 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -177.39 -165.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.0 OUTLIER -94.85 140.25 30.18 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.4 tpt -119.17 120.87 38.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 109.909 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mt -122.58 103.62 8.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.982 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.464 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -88.19 127.81 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.355 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mp -111.24 149.84 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.298 0.57 . . . . 0.0 110.775 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.72 134.77 37.52 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.951 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.1 mt -94.58 145.76 24.6 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.945 0.403 . . . . 0.0 110.686 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.512 ' O ' ' ND2' ' A' ' 180' ' ' ASN . 92.0 mt-30 -139.69 -179.4 5.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.97 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 179' ' ' GLN . 27.9 m120 -148.57 25.42 0.96 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.792 0.33 . . . . 0.0 110.469 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 180' ' ' ASN . 69.0 m-20 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.549 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.419 ' O1A' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 40' ' ' LYS . 68.1 mttm -68.78 124.95 25.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.489 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 4' ' ' ILE . . . -172.47 167.32 40.21 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.409 ' CB ' ' O ' ' A' ' 3' ' ' GLY . 0.3 OUTLIER 92.45 -27.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.921 0.889 . . . . 0.0 108.981 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.419 HD12 HG21 ' A' ' 5' ' ' ILE . 46.5 mm -64.23 -62.1 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.852 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -58.71 -29.51 66.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.702 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -61.73 -60.86 3.03 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.211 0.529 . . . . 0.0 111.48 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.4 -27.39 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.431 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 tp -70.87 -42.4 70.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.351 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.525 ' OE2' ' CE2' ' A' ' 36' ' ' TYR . 4.1 mt-10 -56.6 -39.64 73.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.497 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -60.97 -52.61 64.28 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.166 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 14.4 tpt -53.18 -41.39 65.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.983 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.06 -34.66 55.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.74 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.13 -22.28 30.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 0.0 110.068 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.17 -34.5 19.01 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.259 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -85.77 -76.94 0.31 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.0 m -89.77 -19.11 25.12 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.385 0.612 . . . . 0.0 110.627 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.02 175.14 29.13 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.7 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.5 ttt -69.91 -26.96 64.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.888 -1.156 . . . . 0.0 110.67 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.6 m -64.34 -42.95 95.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.045 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -35.89 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.0 t-105 -51.21 -46.04 62.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -69.68 -31.74 69.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.083 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -65.24 -51.39 61.21 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -81.21 -20.17 41.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.93 0.395 . . . . 0.0 110.69 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 tt -76.27 -47.75 22.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.381 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -70.57 -24.41 62.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.67 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -80.35 -40.14 27.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.51 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 73.9 m80 -96.99 -85.45 0.35 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.305 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.67 161.27 0.53 Allowed Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.38 152.09 82.88 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.624 2.216 . . . . 0.0 112.196 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' O ' ' NH1' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -81.75 -10.97 59.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.194 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.49 -36.05 68.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.367 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 32' ' ' LYS . 88.0 mtm-85 52.46 72.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.619 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.419 ' O ' ' OH ' ' A' ' 42' ' ' TYR . 20.5 t -146.31 69.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.087 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.525 ' CE2' ' OE2' ' A' ' 10' ' ' GLU . 52.3 p90 -127.64 155.0 44.59 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.621 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.23 175.78 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.991 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -84.48 33.73 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.776 0.322 . . . . 0.0 110.788 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.35 52.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.848 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 41' ' ' SER . 20.0 mmtt -139.49 173.82 11.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.077 0.465 . . . . 0.0 110.62 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 42' ' ' TYR . 77.3 p -50.65 -105.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.223 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 41' ' ' SER . 74.8 m-85 56.43 116.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.05 141.86 52.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.788 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.518 ' OE1' ' NH2' ' A' ' 136' ' ' ARG . 23.0 pt-20 -73.79 -23.31 59.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.778 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p -60.29 -29.41 68.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.054 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -59.7 -36.63 76.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.727 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -51.12 -56.94 10.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.028 0.442 . . . . 0.0 110.794 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -39.61 -43.34 1.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.659 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 m -72.25 -30.58 65.01 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.082 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 47' ' ' LEU . 13.3 mt -72.36 -54.84 15.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.156 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -55.65 -24.09 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.727 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -77.51 -40.56 42.42 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.477 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.51 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 55.2 m-20 -59.42 -56.2 25.02 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.92 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 p -57.56 -37.68 59.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.917 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.92 88.23 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.2 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -62.79 -32.31 73.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -72.35 -43.63 63.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.6 mt -80.71 -8.13 59.56 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.839 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.96 51.49 8.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.628 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 22.3 mmt -130.8 149.39 73.51 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.392 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.79 139.42 80.17 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.461 1.441 . . . . 0.0 111.096 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.3 tt -54.66 -28.81 19.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.851 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -73.91 -29.99 62.34 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.438 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -79.1 -35.61 42.0 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.745 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.65 -59.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -49.1 -38.89 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.611 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.28 -45.57 72.53 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.82 -55.82 17.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.296 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -44.78 -29.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.976 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.88 -59.38 8.68 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -49.49 -48.24 48.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.922 0.391 . . . . 0.0 110.127 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 52.1 m-85 -60.15 -39.85 87.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.704 0.764 . . . . 0.0 110.687 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.1 tp -59.61 -38.27 80.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.815 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 30.6 t80 -69.54 -39.02 77.73 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.159 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.676 ' ND2' ' HE2' ' A' ' 152' ' ' HIS . 6.0 m120 -55.89 -70.55 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.69 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.81 -47.87 30.62 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.474 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.6 mt -50.64 -44.22 57.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.041 0.421 . . . . 0.0 111.765 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -55.78 -26.01 43.9 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.405 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.42 ' O ' ' OG1' ' A' ' 82' ' ' THR . 26.0 t -74.89 -55.1 6.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.05 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -36.67 66.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.797 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -97.17 25.25 5.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.777 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 31.5 m -52.51 -38.1 58.91 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -58.62 -34.13 70.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.868 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.6 -19.65 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.669 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.476 ' C ' ' H ' ' A' ' 87' ' ' LYS . 38.6 t -71.5 -43.6 71.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.949 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -51.5 -12.7 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.069 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 85' ' ' VAL . 41.9 mmtm -69.09 -29.46 67.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.822 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 18.8 p90 -120.49 122.53 40.84 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.136 0.493 . . . . 0.0 111.328 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -87.29 -0.76 57.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.514 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 153' ' ' PHE . 45.7 t0 -162.31 165.58 26.41 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.583 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -57.04 -42.2 80.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.219 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.0 m -63.24 -59.34 4.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.46 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.1 m -46.81 -37.39 8.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.253 0.549 . . . . 0.0 110.649 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 tt -64.25 -44.36 92.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.431 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.4 t -66.77 -39.37 83.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.405 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 6.9 ptm -86.9 -1.43 57.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -113.43 -16.23 8.36 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.746 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.442 ' C ' ' O ' ' A' ' 97' ' ' GLY . 9.4 mt -34.26 -82.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 117.809 0.804 . . . . 0.0 111.712 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -45.17 -53.5 8.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.146 0.498 . . . . 0.0 110.915 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -46.99 -89.19 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 m -70.04 -49.84 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.29 -39.5 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.586 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.47 -57.62 11.03 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.4 tp -47.68 -54.67 11.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.136 0.493 . . . . 0.0 110.185 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -52.59 -46.52 66.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.775 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.509 ' CG1' ' CE1' ' A' ' 111' ' ' HIS . 24.7 t -52.66 -54.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -45.09 -43.46 9.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.749 0.309 . . . . 0.0 110.666 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.512 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 63.5 mmtt -58.36 -36.31 73.28 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 106' ' ' VAL . 53.7 mt -71.21 -19.58 62.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.988 0.423 . . . . 0.0 109.892 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.512 ' CD2' ' O ' ' A' ' 108' ' ' LYS . 69.8 m-85 58.17 116.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.049 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.658 ' ND1' ' H ' ' A' ' 112' ' ' GLU . 1.2 p-80 -166.28 -37.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.272 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.658 ' H ' ' ND1' ' A' ' 111' ' ' HIS . 40.7 tt0 -173.39 73.56 0.38 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.049 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -46.07 162.91 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.914 2.41 . . . . 0.0 112.54 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.2 m 65.66 79.24 0.25 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.874 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 116' ' ' PRO . 17.5 mt -79.24 144.25 62.11 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.038 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 115' ' ' LEU . 92.9 Cg_exo -43.12 175.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.135 1.89 . . . . 0.0 112.666 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -80.98 118.07 22.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.439 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.28 129.74 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -136.66 121.32 18.46 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.939 0.399 . . . . 0.0 111.726 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.35 123.48 5.73 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' A' ' 122' ' ' LEU . 37.9 tt0 -115.73 160.92 19.45 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -107.89 145.57 33.56 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.45 160.48 41.64 Favored Pre-proline 0 N--CA 1.468 0.461 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 126' ' ' ASN . 70.5 Cg_endo -72.8 -44.57 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.578 2.185 . . . . 0.0 113.247 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.641 HD22 ' NE2' ' A' ' 127' ' ' GLN . 47.7 p-10 -74.58 45.46 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.184 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 124' ' ' PRO . 15.3 m120 44.99 60.72 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 0.0 111.102 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.641 ' NE2' HD22 ' A' ' 125' ' ' ASN . 21.8 mt-30 -136.72 158.83 43.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.913 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.6 mt -138.85 118.56 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.16 122.5 33.85 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.389 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.3 tp -115.42 136.24 53.29 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.111 0.481 . . . . 0.0 110.726 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -122.58 123.17 40.58 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.409 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -125.75 115.01 19.39 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.257 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.74 122.15 36.65 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 136' ' ' ARG . 1.9 p -174.91 151.17 1.38 Allowed Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.367 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.7 20.5 0.38 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.027 1.818 . . . . 0.0 110.878 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.548 ' C ' ' H ' ' A' ' 138' ' ' LEU . 65.5 mtp85 -93.04 105.07 17.22 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.341 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -68.78 16.32 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.054 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.9 mm? -82.86 15.12 2.84 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.651 0.262 . . . . 0.0 110.395 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 93.6 m -41.41 -54.75 3.0 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 111.58 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -47.96 -30.26 4.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.935 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 138' ' ' LEU . 5.3 t -71.11 -44.59 65.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.772 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.66 -47.28 15.0 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.407 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -64.59 -48.86 73.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.349 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.74 -49.12 35.26 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 31.2 mt -59.16 -53.93 52.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.602 0.239 . . . . 0.0 111.507 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 31.3 mt -54.62 -55.66 27.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.947 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -51.43 -47.78 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.862 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.01 -52.0 54.95 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.08 -59.83 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.926 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.85 -49.9 47.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -52.03 -50.1 62.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.565 0.221 . . . . 0.0 111.323 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.676 ' HE2' ' ND2' ' A' ' 75' ' ' ASN . 43.4 m80 -48.87 -49.35 40.02 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.826 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.526 ' CE2' ' OD1' ' A' ' 90' ' ' ASP . 64.7 t80 -85.43 35.68 0.61 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.949 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 39.22 55.17 2.21 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.056 0.455 . . . . 0.0 110.983 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.504 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 50.5 tp60 -130.5 141.79 50.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.504 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 30.9 mtmm -113.84 123.25 49.36 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.844 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 28.9 pt -133.3 172.45 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.65 0.738 . . . . 0.0 112.347 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -136.58 126.77 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.566 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mt -111.51 120.35 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.685 0.278 . . . . 0.0 110.61 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.6 t -105.38 112.36 25.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.821 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.559 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 18.5 p80 -101.0 74.79 1.63 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.651 0.739 . . . . 0.0 111.503 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -76.21 -29.3 57.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.805 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.04 109.13 20.93 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.432 ' SG ' ' N ' ' A' ' 165' ' ' MET . 13.4 t -111.88 177.0 4.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.84 0.353 . . . . 0.0 110.417 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.432 ' N ' ' SG ' ' A' ' 164' ' ' CYS . 81.1 mtp -91.37 -28.26 17.82 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -53.62 -22.8 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.957 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 169' ' ' ALA . 3.4 t -88.76 -28.15 20.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.466 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.59 20.35 15.22 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.099 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.402 ' H ' HG22 ' A' ' 167' ' ' THR . . . -66.03 163.14 17.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.722 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -49.44 -34.31 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.344 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.497 ' HD1' ' N ' ' A' ' 172' ' ' CYS . 8.0 p80 -172.25 -170.84 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.497 ' N ' ' HD1' ' A' ' 171' ' ' HIS . 3.2 m -93.65 140.4 29.68 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 tpt -122.87 114.67 20.79 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -119.05 105.59 11.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.826 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.466 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -88.17 125.77 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.344 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.17 149.35 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.258 0.552 . . . . 0.0 110.385 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.499 ' OE2' ' N ' ' A' ' 178' ' ' LEU . 9.3 tp10 -136.47 135.47 38.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.993 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.499 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 13.0 mt -96.14 150.44 20.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.77 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -140.11 175.54 9.51 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.041 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 56.05 44.51 25.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 62.1 t0 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.534 -179.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.639 ' H3 ' ' NE ' ' A' ' 34' ' ' ARG . 15.8 mmt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.621 ' H ' ' CD ' ' A' ' 34' ' ' ARG . 78.9 mttt 58.94 149.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.469 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.07 172.09 29.03 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.42 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 tp -78.65 -37.67 21.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.81 0.338 . . . . 0.0 110.39 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.4 mm -60.77 -45.24 98.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.612 ' CE1' ' NH2' ' A' ' 34' ' ' ARG . 91.0 m-85 -70.99 -26.39 63.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.211 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -67.61 -53.23 29.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.016 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.35 -31.83 55.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.072 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.3 tp -71.86 -42.03 67.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.694 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -54.28 -43.92 71.46 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.566 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -61.02 -51.14 70.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.326 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.615 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 58.2 mtm -54.01 -43.26 69.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.79 -36.43 75.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.666 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.7 -25.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.265 0.555 . . . . 0.0 110.143 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.97 -34.45 22.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.199 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -84.33 -75.56 0.34 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.8 m -92.78 -22.88 19.08 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.199 0.524 . . . . 0.0 110.935 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.8 171.23 22.63 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.806 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 30.3 ttm -66.91 -27.45 67.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.707 -1.246 . . . . 0.0 110.292 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -63.25 -42.85 99.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.221 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.82 -35.56 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -53.42 -44.74 69.03 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.98 -28.13 64.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.09 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -66.27 -51.17 60.1 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -83.47 -18.88 37.06 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.705 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 29' ' ' HIS . 9.0 tt -78.1 -70.66 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -49.58 -22.31 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.995 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 tttp -80.94 -37.27 29.75 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 26' ' ' LEU . 21.8 m80 -97.72 -81.79 0.43 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.893 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -81.96 154.05 69.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.79 150.93 74.35 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.193 1.929 . . . . 0.0 111.556 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -59.44 -29.0 67.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.837 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.96 -9.41 55.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.679 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.639 ' NE ' ' H3 ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -73.45 69.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.448 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.537 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 4.3 p -174.53 85.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.44 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 57.2 m-85 -160.24 -114.96 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.404 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 36' ' ' TYR . 19.2 m -47.19 179.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 111.603 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 m -154.04 47.91 0.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.412 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.51 -4.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.599 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -77.38 -167.58 0.95 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.532 0.682 . . . . 0.0 110.675 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.8 p -90.15 152.26 21.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.6 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 2' ' ' LYS . 14.0 p90 -175.7 151.22 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.836 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 46' ' ' GLU . . . -92.43 123.67 35.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.336 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 136' ' ' ARG . 95.4 mt-10 -75.61 -10.4 59.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.508 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.4 m -55.57 -40.46 72.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.75 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 43' ' ' ALA . 39.3 mp0 -63.58 -30.64 71.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.634 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.43 -57.21 7.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 110.559 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -38.36 -43.81 0.85 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.122 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 m -74.32 -30.13 61.92 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.092 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.7 mt -72.96 -51.76 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.152 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -58.05 -26.0 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.816 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -77.18 -41.36 41.86 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.682 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -58.77 -56.35 23.39 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.725 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.454 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 7.2 p -57.67 -34.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.066 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.44 -35.45 79.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.73 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -60.21 -47.76 84.59 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.21 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.504 HH22 ' CD1' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -69.09 -39.79 78.8 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.663 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.6 mt -70.59 -10.8 60.18 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.091 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.5 t30 56.87 50.12 12.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.28 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.8 mmm -128.74 148.58 69.15 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.32 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.48 138.04 63.16 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.462 1.441 . . . . 0.0 111.028 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 tt -52.09 -29.3 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.291 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -72.35 -34.38 67.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.148 0.499 . . . . 0.0 111.482 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -75.61 -32.46 60.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.068 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.435 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 93.1 t -71.1 -56.31 11.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.01 -44.23 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.348 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -51.7 -50.44 60.49 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.27 -52.11 66.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.529 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.435 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.3 m-30 -46.91 -28.07 1.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.373 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.84 -48.21 42.92 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -55.05 -52.22 63.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.888 0.375 . . . . 0.0 110.635 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.615 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 57.7 m-85 -59.79 -42.17 92.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.695 0.76 . . . . 0.0 110.842 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.9 tp -53.36 -38.15 63.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.621 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 22.6 t80 -70.94 -42.45 69.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.233 0.539 . . . . 0.0 109.746 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -54.34 -72.83 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.653 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.06 -47.6 20.1 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.298 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.4 mt -50.71 -42.0 56.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.99 0.395 . . . . 0.0 112.013 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -54.95 -25.43 29.47 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.362 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.428 ' O ' ' OG1' ' A' ' 82' ' ' THR . 22.4 t -74.03 -55.94 5.52 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.928 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.653 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -71.24 -42.44 68.86 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.05 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -92.92 28.54 2.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.077 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 42.8 m -54.81 -38.45 67.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.015 0.436 . . . . 0.0 109.992 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.64 -34.78 73.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.235 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.23 -20.9 12.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.8 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 87' ' ' LYS . 38.9 t -69.9 -40.93 79.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.139 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -53.03 -14.0 0.53 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.408 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.622 ' HZ1' ' CG ' ' A' ' 105' ' ' GLU . 21.6 mmtp -68.69 -29.6 68.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.034 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 15.8 p90 -119.75 121.27 38.79 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.171 0.51 . . . . 0.0 111.235 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -86.71 2.4 48.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.167 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.426 ' OD1' ' CD2' ' A' ' 153' ' ' PHE . 45.0 t0 -167.2 162.46 15.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.183 0.516 . . . . 0.0 111.522 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.408 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 80.0 t80 -51.49 -49.88 60.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.953 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.6 m -55.11 -58.34 8.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.519 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.5 t -46.73 -40.69 13.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.126 0.488 . . . . 0.0 111.217 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.0 tt -63.56 -43.92 95.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.396 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.6 t -64.3 -39.1 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.396 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 8.9 ptm -87.99 -1.09 57.78 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -114.08 -17.46 7.27 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 119.398 -0.668 . . . . 0.0 112.843 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.503 ' O ' ' O ' ' A' ' 97' ' ' GLY . 13.1 mt -28.12 -104.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 117.735 0.768 . . . . 0.0 112.494 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -39.6 -49.12 2.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.039 0.447 . . . . 0.0 111.341 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -45.08 -86.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.505 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.4 m -72.44 -52.61 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.505 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 3.0 mp -62.23 -47.99 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.38 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.34 -53.08 48.74 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.4 tp -49.32 -50.86 37.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.622 ' CG ' ' HZ1' ' A' ' 87' ' ' LYS . 65.2 mm-40 -55.46 -44.88 76.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.134 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.95 -53.7 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 110' ' ' TYR . 6.0 t-20 -45.65 -44.56 13.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.666 0.27 . . . . 0.0 110.958 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -62.02 -36.12 80.61 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.399 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.4 tt -65.79 -52.98 46.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.177 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.451 ' CG ' ' N ' ' A' ' 111' ' ' HIS . 17.6 t80 -98.68 -165.55 1.25 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.394 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.531 ' CG ' ' N ' ' A' ' 112' ' ' GLU . 86.1 t60 -61.1 -108.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.432 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.531 ' N ' ' CG ' ' A' ' 111' ' ' HIS . 33.0 mt-10 -150.91 62.88 5.44 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.708 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -83.85 148.79 12.34 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.951 2.434 . . . . 0.0 112.189 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.8 t -87.87 120.14 28.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.052 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 116' ' ' PRO . 14.7 mt -81.56 152.62 70.11 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.653 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 115' ' ' LEU . 80.2 Cg_exo -41.72 170.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.273 1.982 . . . . 0.0 112.272 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -88.06 110.55 20.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.131 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.8 mt -124.07 126.82 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.586 0.231 . . . . 0.0 111.108 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -130.98 117.25 18.94 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.534 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.3 151.16 18.43 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -140.77 161.02 38.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 110.125 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 1.2 mm? -109.29 143.37 38.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.847 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.07 160.58 40.43 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 126' ' ' ASN . 73.2 Cg_endo -73.32 -46.09 0.39 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.623 2.215 . . . . 0.0 113.25 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.566 ' N ' HD21 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -72.95 45.19 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.204 -179.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 124' ' ' PRO . 67.4 m-20 44.65 63.38 1.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.424 0.631 . . . . 0.0 111.023 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.469 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 77.3 mt-30 -139.52 158.57 43.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.912 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.6 mt -138.5 117.59 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.68 122.3 31.97 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.655 -0.418 . . . . 0.0 109.988 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.3 tp -119.26 133.35 55.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.052 0.453 . . . . 0.0 111.456 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -116.94 122.56 44.62 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.464 ' OH ' ' C3A' ' A' ' 182' ' ' HEM . 40.6 t80 -127.94 126.35 41.29 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.558 0.218 . . . . 0.0 111.329 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.05 120.24 22.11 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 m -132.57 153.08 81.01 Favored Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.628 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.48 -37.49 2.39 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.324 2.016 . . . . 0.0 112.235 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.566 ' NH2' ' CGA' ' A' ' 182' ' ' HEM . 93.9 mtm-85 -74.54 -13.18 60.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.151 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.55 ' C ' ' H ' ' A' ' 139' ' ' CYS . 52.1 mtt-85 63.53 29.01 15.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 tp -73.94 24.58 0.08 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.234 0.54 . . . . 0.0 110.209 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 172' ' ' CYS . 3.5 m -44.5 -49.25 10.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.69 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -44.23 -42.29 6.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.937 0.399 . . . . 0.0 110.58 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.3 t -63.76 -42.02 97.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.191 0.519 . . . . 0.0 109.61 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -45.6 -52.48 10.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.666 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -58.99 -50.98 72.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.471 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.24 -44.97 34.94 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.8 mt -62.78 -52.52 62.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.659 0.266 . . . . 0.0 111.48 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.9 mt -55.45 -57.09 13.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.854 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -50.75 -47.78 59.33 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.767 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.06 -51.33 58.98 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.05 -59.75 2.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.867 0.365 . . . . 0.0 110.749 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -50.45 -52.02 41.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -50.77 -47.29 59.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.667 0.27 . . . . 0.0 111.015 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -49.48 -49.71 44.46 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.516 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 69.4 t80 -88.31 38.49 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.891 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 38.26 56.58 1.72 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 111.253 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.687 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 41.7 tp60 -129.74 141.12 50.94 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.687 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 60.7 mmtt -113.07 124.94 53.77 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.89 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.0 pt -137.96 171.86 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.633 0.73 . . . . 0.0 111.853 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -135.56 127.35 29.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.406 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mt -110.53 118.38 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.0 t -100.98 105.48 16.7 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.479 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.548 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 18.2 p80 -102.58 75.67 1.46 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.553 0.692 . . . . 0.0 111.951 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -76.57 -29.14 56.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.456 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.7 103.94 15.65 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.586 ' O ' ' N ' ' A' ' 166' ' ' HIS . 38.7 t -132.45 112.71 12.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.662 0.267 . . . . 0.0 110.803 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 8.0 tpt -37.65 -18.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.102 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.586 ' N ' ' O ' ' A' ' 164' ' ' CYS . 57.4 t-80 -54.66 -25.93 30.05 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.0 t -86.37 -44.42 12.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.096 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.478 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 146.55 15.42 0.16 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.303 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.499 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -71.18 157.63 37.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.628 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -74.67 -5.09 41.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.612 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -176.08 -149.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.564 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 3.4 m -131.77 146.26 52.05 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.197 0.522 . . . . 0.0 111.59 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 10.6 tpp -119.56 124.11 45.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.277 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -126.95 105.32 8.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.411 0.624 . . . . 0.0 111.379 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.479 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -92.46 127.06 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.403 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.1 mp -110.32 151.64 12.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.29 0.567 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -139.45 137.24 35.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.294 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.2 mt -90.6 142.5 27.68 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.351 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -156.07 82.36 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.35 0.595 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -56.12 -33.43 65.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.478 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 58.0 t0 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.617 -179.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.566 ' CGA' ' NH2' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.9 ttm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.524 ' O ' ' CE1' ' A' ' 42' ' ' TYR . 12.8 ptpt -170.2 108.43 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.539 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . -73.56 19.54 1.48 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.473 ' H ' ' C ' ' A' ' 2' ' ' LYS . 2.5 tp -48.66 -43.3 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.025 0.44 . . . . 0.0 109.857 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 mm -58.56 -47.88 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -73.77 -21.72 60.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 3' ' ' GLY . 42.5 t-20 -66.98 -50.42 62.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.762 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.02 -39.68 81.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.197 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.7 tp -63.49 -40.73 97.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -55.62 -46.43 77.36 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.639 -0.424 . . . . 0.0 109.892 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -61.19 -50.72 71.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.997 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.7 OUTLIER -52.49 -40.57 62.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.6 t -71.4 -34.74 54.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.551 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.9 t -61.62 -23.66 31.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.253 0.549 . . . . 0.0 109.95 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.82 -34.47 21.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.098 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -84.31 -75.74 0.33 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.5 m -92.49 -20.82 20.58 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.189 0.518 . . . . 0.0 110.964 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.87 170.84 25.36 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.821 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.3 ttt -66.84 -27.09 67.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.926 -1.137 . . . . 0.0 110.444 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -63.7 -42.53 97.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.052 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.21 -35.07 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 -51.83 -45.29 63.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -73.95 -28.86 61.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.329 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -67.54 -50.3 59.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -81.33 -26.57 35.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.69 0.281 . . . . 0.0 110.553 -179.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.472 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 7.7 tt -70.08 -71.8 0.22 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.439 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.456 ' N ' ' CD2' ' A' ' 26' ' ' LEU . 82.4 tt0 -50.51 -23.34 2.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.543 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.38 -42.99 21.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -105.82 -88.9 0.44 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.96 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -43.63 161.99 0.19 Allowed Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.464 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -35.02 156.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.918 2.412 . . . . 0.0 112.286 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 10.4 ptmm? -64.5 -48.34 75.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.722 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 32' ' ' LYS . 56.9 m-20 -162.34 19.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.743 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -75.95 -36.86 59.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.74 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.527 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 12.6 p -82.3 129.82 36.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.757 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.527 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 9.1 m-85 -173.4 -172.83 0.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.06 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 36' ' ' TYR . 1.0 OUTLIER 33.08 -160.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.962 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.431 ' OG ' ' ND2' ' A' ' 7' ' ' ASN . 2.0 m -128.0 37.33 4.19 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.009 0.433 . . . . 0.0 110.566 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.8 7.26 0.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.736 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -93.67 172.71 8.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.807 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.8 t -78.97 147.44 32.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.655 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.532 ' CE2' ' OE2' ' A' ' 44' ' ' GLU . 6.1 p90 -161.69 158.5 26.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.053 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.84 132.87 36.13 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.549 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.532 ' OE2' ' CE2' ' A' ' 42' ' ' TYR . 17.1 mm-40 -82.3 -34.09 28.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.863 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.1 t -79.36 -36.31 39.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.504 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -56.62 -36.91 70.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.138 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -40.84 -56.4 2.22 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.895 0.379 . . . . 0.0 111.056 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -39.43 -40.41 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.18 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.2 t -72.15 -34.57 68.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.225 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 47' ' ' LEU . 1.9 mp -67.78 -54.9 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.28 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -55.52 -23.95 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.784 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -76.05 -40.2 53.87 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.097 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -60.26 -56.86 16.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.408 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.82 -36.76 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.87 87.5 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.174 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -63.52 -31.0 72.03 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.62 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -73.96 -42.94 59.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.619 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.9 mt -80.7 -7.11 59.23 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.879 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 56.22 49.23 15.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.556 0.693 . . . . 0.0 109.207 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mmt -127.73 149.75 71.32 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.967 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.99 137.73 63.87 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.451 1.434 . . . . 0.0 110.978 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 tt -51.28 -29.48 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.776 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -71.24 -30.13 65.96 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.143 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -78.41 -34.03 48.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.112 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.1 t -70.04 -56.41 11.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.7 p -52.93 -41.39 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.248 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -53.25 -49.28 67.18 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.52 91.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.656 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -53.12 -33.07 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.566 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.05 -50.48 60.31 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.98 -50.31 66.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.064 0.459 . . . . 0.0 110.222 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -59.81 -42.58 93.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.632 0.729 . . . . 0.0 110.781 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.4 tp -56.37 -38.93 72.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.314 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 20.1 t80 -68.37 -43.77 76.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.369 0.604 . . . . 0.0 109.503 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.75 -71.65 0.08 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.289 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -49.11 -39.65 27.24 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.926 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.6 mt -61.81 -39.23 91.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.412 0.606 . . . . 0.0 112.027 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.94 -24.68 39.48 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.232 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 82' ' ' THR . 45.6 p -77.11 -53.84 7.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.438 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.468 ' NE ' ' CD1' ' A' ' 4' ' ' ILE . 1.1 mtm105 -68.75 -49.75 56.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.159 0.504 . . . . 0.0 110.343 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.431 ' CD2' ' CBC' ' A' ' 182' ' ' HEM . 0.1 OUTLIER -83.72 22.75 1.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.444 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 79' ' ' SER . 61.4 m -49.38 -38.08 27.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.654 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -62.35 -35.85 80.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.721 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 81' ' ' HIS . 3.6 t -83.58 -17.88 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.426 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 87' ' ' LYS . 56.1 t -65.24 -38.04 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.807 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -57.93 -6.41 0.56 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.769 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.509 ' NZ ' ' OE1' ' A' ' 105' ' ' GLU . 30.0 mmtp -76.71 -25.72 53.88 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.59 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.524 ' C ' ' H ' ' A' ' 90' ' ' ASP . 26.9 p90 -129.18 -45.77 1.24 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.707 0.289 . . . . 0.0 111.006 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 19.1 t70 58.16 -0.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.534 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 88' ' ' PHE . 34.0 m-20 -152.07 164.63 36.84 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.35 0.595 . . . . 0.0 111.237 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -66.12 -61.25 2.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.7 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.6 m -50.82 -53.16 34.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.716 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.4 m -59.75 -35.79 75.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.309 0.576 . . . . 0.0 110.976 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.1 tt -66.36 -47.97 71.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.956 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 90.2 t -60.92 -36.31 71.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.394 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -88.8 -5.85 57.78 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.134 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -110.88 -15.14 11.18 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.476 -0.625 . . . . 0.0 112.78 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 97' ' ' GLY . 13.1 mt -28.87 -104.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 117.568 0.684 . . . . 0.0 112.703 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -38.62 -48.66 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 0.0 111.54 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -45.71 -87.27 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.484 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.5 m -71.17 -52.1 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.484 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 4.1 mp -60.99 -47.25 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.452 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.05 -55.6 28.69 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.5 tp -47.88 -50.03 27.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.125 0.488 . . . . 0.0 110.358 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.509 ' OE1' ' NZ ' ' A' ' 87' ' ' LYS . 42.8 tp10 -55.71 -44.76 77.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.407 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.28 -52.15 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -49.37 -44.14 44.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.034 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 110' ' ' TYR . 58.5 mmtt -59.53 -35.03 73.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.432 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.5 mt -77.68 13.34 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.458 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 111' ' ' HIS . 11.1 m-85 64.5 163.17 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.763 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 110' ' ' TYR . 70.2 m-70 59.84 142.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.614 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 60.2 61.55 3.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.77 -59.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.462 2.108 . . . . 0.0 111.81 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.7 m -82.4 147.04 29.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.175 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 116' ' ' PRO . 17.0 mt -133.73 152.11 78.26 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.426 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 115' ' ' LEU . 98.0 Cg_exo -40.79 170.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.429 2.086 . . . . 0.0 112.701 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -86.1 109.24 18.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.09 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.9 mt -121.69 127.28 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.617 0.246 . . . . 0.0 110.891 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -130.81 113.02 13.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.945 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.99 138.55 15.06 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -132.26 158.51 41.63 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.3 mp -103.44 146.44 28.5 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.47 161.42 39.45 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 126' ' ' ASN . 68.5 Cg_endo -72.77 -45.58 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.552 2.168 . . . . 0.0 113.398 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -72.9 38.49 0.08 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.974 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.505 ' H ' ' C ' ' A' ' 124' ' ' PRO . 80.9 m-20 50.44 64.31 1.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.213 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -142.49 163.15 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.992 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.8 mt -137.59 118.09 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.21 120.42 27.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.0 tp -117.53 132.68 56.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.202 0.525 . . . . 0.0 110.952 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -121.22 126.38 49.47 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -129.35 129.77 45.22 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.54 126.82 30.12 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.773 0.321 . . . . 0.0 110.69 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.425 ' C ' ' H ' ' A' ' 136' ' ' ARG . 1.9 p -163.87 145.47 7.22 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.393 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.35 9.58 1.77 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.921 1.747 . . . . 0.0 110.644 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.521 ' C ' ' H ' ' A' ' 138' ' ' LEU . 94.5 mtt180 -93.91 110.5 22.17 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.169 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.9 ttt-85 -67.67 38.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.457 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.521 ' H ' ' C ' ' A' ' 136' ' ' ARG . 3.3 mm? -99.76 14.16 31.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.936 0.398 . . . . 0.0 110.252 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.0 t -41.68 -53.13 3.68 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.461 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -46.68 -33.64 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.165 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 7.0 t -68.38 -44.38 75.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.04 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.74 -49.99 18.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.907 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -62.13 -50.7 70.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.902 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.39 -42.6 18.81 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.04 -49.82 73.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 111.361 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.4 mt -58.87 -57.61 12.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.574 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -49.58 -48.71 48.53 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.641 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.26 -51.58 57.24 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -42.86 -60.08 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.775 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.84 56.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.866 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -49.47 -48.09 47.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.665 0.269 . . . . 0.0 110.956 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -49.56 -49.64 45.56 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.827 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 65.2 t80 -85.69 35.87 0.63 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.348 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 44.25 46.76 7.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.126 0.488 . . . . 0.0 110.553 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.478 HE21 ' H ' ' A' ' 156' ' ' LYS . 51.0 tp60 -127.32 142.65 51.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.478 ' H ' HE21 ' A' ' 155' ' ' GLN . 65.6 mttm -124.65 117.48 24.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.43 163.52 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.365 0.602 . . . . 0.0 111.121 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -118.29 131.95 56.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.1 mt -110.32 119.35 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.0 m -103.64 114.72 29.2 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.578 0.228 . . . . 0.0 111.311 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.539 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.6 p-80 -96.03 79.01 3.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.512 0.672 . . . . 0.0 111.565 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -82.22 -0.07 43.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.164 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.516 ' HG1' ' CB ' ' A' ' 173' ' ' MET . 0.3 OUTLIER -144.86 111.12 5.57 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.425 ' CB ' ' CD2' ' A' ' 166' ' ' HIS . 13.6 m -114.14 178.79 4.16 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.112 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 168' ' ' GLY . 77.4 mtp -93.9 -28.94 15.55 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.476 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 4.3 p80 -52.77 -21.21 3.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.673 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.418 ' N ' ' ND1' ' A' ' 166' ' ' HIS . 3.8 t -90.06 -28.04 19.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.561 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 99.63 19.9 18.77 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.072 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.38 167.8 9.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 110.792 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -52.15 -33.85 42.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.263 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -174.76 -170.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 1.7 m -94.31 140.34 29.91 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.253 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.516 ' CB ' ' HG1' ' A' ' 163' ' ' THR . 1.6 tpp -118.6 123.61 45.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.26 102.44 6.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.477 0.656 . . . . 0.0 110.86 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.44 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -91.52 126.73 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.647 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.51 147.07 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.19 0.519 . . . . 0.0 110.197 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -137.25 135.69 37.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.307 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 21.5 mt -89.8 130.93 35.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.193 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.521 ' O ' ' ND2' ' A' ' 180' ' ' ASN . 25.4 mt-30 -55.84 152.86 9.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.443 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 179' ' ' GLN . 27.4 m120 -148.48 27.37 0.91 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.439 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 61.6 t0 . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.533 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.431 ' CBC' ' CD2' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.439 ' O ' ' O ' ' A' ' 37' ' ' VAL . 65.2 mtm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 3' ' ' GLY . 69.7 mttt -79.73 119.64 22.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.447 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 56.88 133.06 0.01 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.5 tp -54.16 -40.05 45.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.335 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.2 mm -71.43 -56.08 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.093 0.473 . . . . 0.0 110.29 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -67.3 -18.73 65.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.079 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 3' ' ' GLY . 24.5 t-20 -75.24 -58.87 3.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.408 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.0 t -52.65 -35.26 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.5 tp -73.08 -43.06 62.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.723 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -51.11 -44.71 61.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -60.36 -52.46 65.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.924 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.556 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 92.6 mtp -50.05 -43.63 51.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.131 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.9 t -68.55 -37.29 77.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.95 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.7 -23.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.226 0.536 . . . . 0.0 110.261 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.48 -34.01 18.81 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.262 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -83.81 -77.57 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.1 m -92.43 -19.11 22.38 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.216 0.532 . . . . 0.0 110.627 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.22 -179.38 24.82 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.0 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.1 ttm -72.57 -30.12 64.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.76 -1.22 . . . . 0.0 110.647 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -60.06 -38.81 83.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.872 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -77.69 -38.91 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 59.4 t-105 -54.48 -48.4 71.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.446 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.24 -25.14 57.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.707 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -74.7 -47.0 33.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.679 -0.408 . . . . 0.0 112.039 -178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.54 -28.13 37.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.313 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 7.9 tt -66.82 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.624 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.76 -22.98 49.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.089 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -80.94 -44.6 17.98 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.523 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 86.7 m-70 -98.83 -89.2 0.31 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.115 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.438 ' CB ' HH21 ' A' ' 34' ' ' ARG . . . -49.2 153.32 1.71 Allowed Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.542 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.08 150.83 54.84 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.664 2.243 . . . . 0.0 111.928 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.57 -6.84 58.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.192 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -63.8 -48.92 74.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.438 HH21 ' CB ' ' A' ' 30' ' ' ALA . 28.2 ptt180 -73.04 131.77 42.53 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.084 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 36' ' ' TYR . 4.7 p -170.61 164.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.393 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.498 ' O ' ' O ' ' A' ' 37' ' ' VAL . 30.4 m-85 63.73 -143.3 0.32 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.639 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 36' ' ' TYR . 2.5 m 29.59 -157.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 O-C-N 123.806 0.692 . . . . 0.0 112.496 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 37' ' ' VAL . 39.2 m -178.82 -21.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.807 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 40' ' ' LYS . . . -75.82 -27.0 57.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.086 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' ALA . 7.6 mmpt? -55.14 -166.0 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.396 0.617 . . . . 0.0 110.642 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 42' ' ' TYR . 21.4 t -151.23 -54.35 0.14 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.862 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 44' ' ' GLU . 54.1 m-85 52.63 171.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.917 0.389 . . . . 0.0 110.375 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.61 84.12 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.62 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' TYR . 83.4 tt0 -61.35 -25.95 67.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.665 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 76.4 p -50.22 -27.66 6.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.607 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.23 -30.95 70.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.741 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -39.71 -58.54 1.31 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.978 0.418 . . . . 0.0 110.852 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -38.4 -45.14 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.211 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.3 m -67.96 -35.3 78.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.15 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.1 mp -68.68 -58.34 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 119.979 -0.689 . . . . 0.0 109.32 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -52.12 -21.32 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.993 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -79.41 -42.56 25.22 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.196 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.523 ' OD2' ' CD2' ' A' ' 29' ' ' HIS . 32.7 m-20 -57.95 -57.67 11.78 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.789 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.04 -38.88 69.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.641 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.74 84.91 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.081 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -63.35 -31.32 72.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -74.68 -45.26 45.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.63 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.3 mt -77.08 -6.54 53.2 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.853 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.22 48.17 17.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.51 0.672 . . . . 0.0 109.492 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.8 mmm -126.62 149.5 68.28 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.074 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.36 134.44 45.09 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.454 1.436 . . . . 0.0 111.182 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 tt -48.51 -27.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.06 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -72.56 -33.91 67.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.163 0.506 . . . . 0.0 111.327 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -76.38 -31.8 58.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.227 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.548 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 78.5 t -72.61 -56.18 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.46 -43.97 31.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.245 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -51.85 -51.73 54.58 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.06 -58.26 8.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.874 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.6 m-30 -44.33 -29.28 0.65 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.527 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.18 -47.75 77.53 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -58.52 -54.19 49.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.02 0.438 . . . . 0.0 110.446 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.556 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 34.8 m-85 -55.12 -40.71 70.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.736 0.779 . . . . 0.0 110.619 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.6 tp -58.68 -38.16 77.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.198 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 34.4 t80 -68.4 -39.49 81.64 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.041 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -57.19 -71.05 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.328 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.11 -39.82 50.49 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.017 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.412 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 17.7 mt -57.53 -47.4 82.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.332 0.566 . . . . 0.0 111.585 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -47.44 -20.84 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.41 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.409 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.4 t -79.17 -42.28 26.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.105 0.478 . . . . 0.0 110.072 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.429 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.3 mmp_? -65.9 -71.47 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.462 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.486 ' CE1' ' CMC' ' A' ' 182' ' ' HEM . 17.4 p80 -84.16 36.92 0.59 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.831 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 26.5 m -51.11 -46.81 61.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.886 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -49.3 -36.66 21.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.248 0.547 . . . . 0.0 109.66 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.413 ' HB ' ' HD1' ' A' ' 81' ' ' HIS . 11.3 t -76.67 -22.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.999 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 87' ' ' LYS . 57.3 t -68.54 -44.62 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.245 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -54.4 -4.96 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.81 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.547 ' H ' ' C ' ' A' ' 85' ' ' VAL . 60.9 mmtt -81.39 -29.46 33.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.009 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -95.21 117.53 30.41 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.255 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 91.2 m-20 -84.98 -15.44 44.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.482 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 89' ' ' ASP . 63.8 m-20 -161.63 172.02 17.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.192 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -59.42 -53.92 52.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.713 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.6 m -53.51 -36.48 61.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.261 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.3 m -64.79 -39.5 93.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.154 0.502 . . . . 0.0 110.491 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.2 tt -64.19 -47.58 79.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.509 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.33 -36.14 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.758 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.1 mmm -86.34 -5.3 59.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.445 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.38 -15.69 8.75 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.345 -0.697 . . . . 0.0 113.165 -178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 97' ' ' GLY . 16.2 mt -28.07 -105.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 117.716 0.758 . . . . 0.0 112.662 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -39.97 -47.55 2.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.092 0.472 . . . . 0.0 111.351 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -47.04 -88.44 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.0 m -69.77 -51.78 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.49 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 4.4 mp -61.22 -45.61 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.539 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.89 -53.99 40.66 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.8 tp -52.0 -51.55 56.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.86 0.362 . . . . 0.0 110.782 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.48 -45.37 76.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.128 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.2 t -54.07 -52.38 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 110' ' ' TYR . 20.5 t-20 -47.41 -43.48 23.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.858 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -65.52 -41.54 93.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.788 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.0 tp -63.53 -43.02 98.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.808 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 107' ' ' ASN . 76.5 m-85 -102.77 -177.13 3.29 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.611 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -68.65 -67.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.585 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -172.51 58.7 0.24 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.879 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.18 148.02 30.38 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.669 2.246 . . . . 0.0 111.829 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 58.0 p -80.92 153.06 27.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.587 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.2 mt -128.66 153.6 79.63 Favored Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.949 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.88 167.32 19.91 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.456 2.104 . . . . 0.0 112.139 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -86.3 116.56 24.55 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.759 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.3 mt -134.03 131.51 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.709 0.29 . . . . 0.0 110.682 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -135.41 130.21 34.5 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.659 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -123.4 150.66 16.89 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -138.04 164.71 28.42 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.08 145.09 36.23 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.354 -0.384 . . . . 0.0 109.966 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.35 160.55 41.14 Favored Pre-proline 0 N--CA 1.467 0.377 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.26 -40.11 1.81 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.57 2.18 . . . . 0.0 113.155 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.521 ' ND2' ' OE1' ' A' ' 127' ' ' GLN . 19.8 p30 -78.97 47.44 0.77 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.229 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.9 p30 42.52 61.1 2.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.464 0.65 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.521 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 66.5 mt-30 -137.73 159.44 41.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.895 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.5 mt -135.61 116.52 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.82 122.95 31.41 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.057 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.7 tp -117.66 135.06 54.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.99 0.424 . . . . 0.0 111.168 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -120.01 123.8 44.35 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.456 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -126.15 123.45 38.29 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.566 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.71 130.73 23.21 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.221 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.586 ' HG ' ' N ' ' A' ' 135' ' ' PRO . 0.8 OUTLIER -163.1 -179.68 1.06 Allowed Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.214 179.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.586 ' N ' ' HG ' ' A' ' 134' ' ' SER . 24.6 Cg_exo -61.45 -48.74 8.82 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.231 1.954 . . . . 0.0 111.558 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 138' ' ' LEU . 82.8 mtm-85 -124.78 40.84 3.65 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 136' ' ' ARG . 58.1 mtt85 -5.26 -57.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.547 1.154 . . . . 0.0 113.975 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 136' ' ' ARG . 3.3 tp 67.24 30.13 7.32 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 26.4 p -40.55 -50.69 2.97 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.568 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.489 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 90.0 m-85 -43.13 -38.06 2.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 110.114 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 28.6 t -69.08 -45.96 68.96 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -45.64 -49.27 14.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.188 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -57.03 -50.39 72.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.677 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.64 -52.63 40.66 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.9 mt -55.16 -55.38 31.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.798 0.333 . . . . 0.0 110.498 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.3 mt -54.08 -55.75 24.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -49.74 -47.97 50.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.73 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.26 60.21 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.95 -60.53 1.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.844 0.354 . . . . 0.0 110.87 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.61 -49.85 45.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -52.98 -47.64 68.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.083 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -50.06 -50.51 47.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 70.6 t80 -85.55 36.77 0.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.992 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 38.8 55.01 2.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.918 0.389 . . . . 0.0 111.134 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.555 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 48.0 tp60 -129.86 141.24 50.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.555 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 19.9 tptm -110.79 126.54 54.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.128 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.0 pt -137.37 177.04 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.524 0.678 . . . . 0.0 111.837 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -143.84 125.84 15.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.202 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mt -111.76 120.74 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.624 0.25 . . . . 0.0 110.613 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 m -105.66 115.37 30.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.112 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 17.0 p80 -102.13 72.95 1.34 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.738 0.78 . . . . 0.0 111.526 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -73.63 -30.86 63.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.844 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.67 113.76 27.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 7.7 t -117.89 -175.38 2.83 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.305 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 165' ' ' MET . 12.6 tmm? -93.8 -25.5 17.36 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -56.09 -23.95 37.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.473 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.6 t -86.54 -25.29 25.14 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.3 21.97 25.91 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.908 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.73 163.18 24.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.025 0.441 . . . . 0.0 110.693 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -45.11 -33.35 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.021 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -176.53 -168.97 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 20.8 t -95.45 141.87 28.48 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.221 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.2 tpt -121.59 119.72 32.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.726 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.98 107.15 11.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.873 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.4 mp -88.98 126.36 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.372 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.66 152.48 13.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.135 0.493 . . . . 0.0 110.458 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -142.96 141.45 31.43 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.494 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.1 mt -94.0 149.04 21.59 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.877 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.429 ' O ' ' OD1' ' A' ' 180' ' ' ASN . 91.2 mt-30 -142.1 -176.49 4.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.752 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 179' ' ' GLN . 83.3 m-20 -147.87 24.46 1.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.858 0.361 . . . . 0.0 110.41 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.2 t70 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.508 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.486 ' CMC' ' CE1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' O ' ' O ' ' A' ' 2' ' ' LYS . 10.7 ptp . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.647 ' NZ ' ' HE1' ' A' ' 22' ' ' TRP . 86.7 mttt 57.89 150.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.7 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -41.7 140.81 1.52 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 tp -44.62 -39.51 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.412 -0.394 . . . . 0.0 110.595 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.96 -49.42 81.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 109.788 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -70.11 -23.39 63.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.003 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -68.12 -56.53 8.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.971 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.69 -38.65 76.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.043 0.449 . . . . 0.0 109.847 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.401 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 27.5 tp -65.89 -39.73 90.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.558 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -58.03 -43.8 87.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.989 0.423 . . . . 0.0 110.626 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.46 -63.9 1.14 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.361 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.8 ptm -46.19 -41.43 12.69 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.422 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.7 t -64.84 -38.36 82.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.609 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 49.2 t -59.9 -22.74 24.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.498 0.666 . . . . 0.0 109.407 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.76 -34.98 21.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.382 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -84.28 -76.67 0.29 Allowed 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.8 m -91.94 -21.44 20.57 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.294 0.569 . . . . 0.0 110.672 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.81 175.43 23.84 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.05 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.3 ttp -68.85 -28.07 66.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.648 -1.276 . . . . 0.0 110.368 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -61.75 -38.85 89.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.639 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.39 -38.67 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.647 ' HE1' ' NZ ' ' A' ' 2' ' ' LYS . 53.7 t-105 -55.3 -47.57 75.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.048 0.451 . . . . 0.0 110.096 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.04 -24.81 55.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.944 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -74.17 -47.31 36.61 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.93 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.494 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -80.71 -26.51 37.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 6.6 tt -73.04 -54.93 7.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.009 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -61.25 -23.98 66.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.475 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.51 ' NZ ' ' CE1' ' A' ' 29' ' ' HIS . 30.4 tttm -82.37 -39.04 23.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.51 ' CE1' ' NZ ' ' A' ' 28' ' ' LYS . 67.8 m80 -99.86 -88.73 0.34 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.063 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.5 160.03 1.47 Allowed Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.518 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.95 149.38 53.13 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.881 2.388 . . . . 0.0 112.139 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -98.77 -15.42 19.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.622 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.517 ' OD2' ' NH1' ' A' ' 34' ' ' ARG . 24.0 p-10 -101.47 -48.65 4.27 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.865 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.517 ' NH1' ' OD2' ' A' ' 33' ' ' ASP . 16.5 mmp_? -67.56 68.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.536 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' ASP . 3.7 p -80.5 138.63 19.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.275 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 2' ' ' LYS . 85.0 m-85 -114.45 164.3 14.16 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.607 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.525 ' C ' ' H ' ' A' ' 39' ' ' ALA . 2.4 m -101.23 167.4 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.962 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 m -73.04 33.43 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.93 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.525 ' H ' ' C ' ' A' ' 37' ' ' VAL . . . -158.07 3.09 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.874 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -97.82 -176.08 3.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 110.478 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.0 m -45.46 154.06 0.21 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.295 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.495 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -151.79 64.94 0.86 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.1 0.476 . . . . 0.0 110.362 -179.625 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.26 102.86 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.295 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 43.7 mp0 -59.75 -24.83 64.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.695 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m -53.44 -41.31 65.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.63 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -67.9 -37.25 81.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.598 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -52.44 -57.54 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.194 0.521 . . . . 0.0 110.771 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -39.0 -42.38 0.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.671 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.8 p -74.53 -30.4 61.76 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.861 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 47' ' ' LEU . 17.9 mt -71.42 -52.96 22.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.745 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.97 -26.31 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.668 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -76.53 -41.1 47.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.547 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -59.47 -56.05 26.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.963 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.9 p -58.35 -37.08 61.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.981 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.54 -38.28 86.84 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.061 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -63.52 -31.63 72.84 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.6 mmt-85 -73.54 -42.76 61.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.378 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.4 mt -81.54 -7.27 59.56 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.668 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.8 t30 57.02 49.82 13.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.807 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.7 mmt -128.69 149.44 72.03 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.214 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.62 137.76 65.95 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.404 1.403 . . . . 0.0 110.981 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 tt -51.22 -28.5 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.254 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -71.82 -34.2 69.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 0.0 111.58 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -76.17 -31.98 58.82 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.89 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.4 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 95.9 t -71.08 -56.66 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.56 -43.87 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.372 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -51.61 -51.06 58.66 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.39 -54.12 50.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.559 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.401 ' CE2' ' CD1' ' A' ' 9' ' ' LEU . 5.7 m-30 -44.12 -28.94 0.55 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.464 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.91 63.3 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.03 -54.35 48.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.768 0.318 . . . . 0.0 110.461 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -55.28 -41.33 72.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.813 0.816 . . . . 0.0 110.693 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.4 tp -57.95 -38.69 76.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.553 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 26.1 t80 -70.25 -39.53 74.94 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.162 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -55.33 -73.82 0.05 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.091 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.82 -38.21 29.74 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.203 -0.523 . . . . 0.0 112.572 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 20.8 mt -57.45 -46.52 83.52 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.028 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -48.41 -20.7 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.296 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.0 t -81.46 -41.92 21.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.15 0.5 . . . . 0.0 110.205 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.425 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.3 mmp_? -65.17 -71.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.778 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.463 ' HD1' ' HB ' ' A' ' 84' ' ' VAL . 18.5 p80 -85.25 34.61 0.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.985 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 38.9 m -47.2 -45.2 23.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.817 0.341 . . . . 0.0 110.574 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -54.55 -31.06 55.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.463 ' HB ' ' HD1' ' A' ' 81' ' ' HIS . 19.1 t -80.4 -24.58 11.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.093 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.0 t -62.49 -37.65 79.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.356 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.08 -15.95 2.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.653 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -65.75 -31.22 72.08 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.58 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 15.3 p90 -119.01 115.98 25.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.039 0.447 . . . . 0.0 110.708 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -83.68 -0.64 51.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.283 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 13.8 p-10 -163.11 155.25 18.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.128 0.49 . . . . 0.0 111.569 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -44.86 -52.0 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.876 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.7 m -55.01 -43.0 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.752 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -61.77 -36.11 80.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.233 0.54 . . . . 0.0 110.614 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.9 tt -67.05 -56.82 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.858 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.3 t -54.55 -38.46 42.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.847 0.356 . . . . 0.0 111.659 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.5 ppp? -88.44 -6.75 57.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -112.27 -14.73 10.43 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 119.712 -0.493 . . . . 0.0 112.909 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 94' ' ' LEU . 3.8 mt -34.25 -83.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 117.867 0.833 . . . . 0.0 111.705 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -44.76 -54.16 6.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.26 0.553 . . . . 0.0 110.742 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -46.69 -88.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.43 ' O ' ' OE2' ' A' ' 105' ' ' GLU . 3.7 m -71.01 -49.98 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -176.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.7 mp -65.91 -39.79 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.383 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.74 -56.0 14.86 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.4 ' CD1' ' NZ ' ' A' ' 108' ' ' LYS . 58.7 tp -49.91 -55.97 12.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.972 0.415 . . . . 0.0 110.709 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -52.69 -44.88 66.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.476 -178.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 17.8 t -54.13 -53.42 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -47.14 -43.01 20.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.79 0.328 . . . . 0.0 110.827 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.4 ' NZ ' ' CD1' ' A' ' 104' ' ' LEU . 26.0 mmtm -64.89 -40.36 94.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.572 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.6 tp -59.96 -41.95 93.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.474 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.462 ' CE2' ' O ' ' A' ' 111' ' ' HIS . 58.1 t80 -156.06 157.07 35.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.506 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.462 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 96.9 m-70 -92.87 124.2 36.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.483 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 113' ' ' PRO . 5.6 pt-20 -164.61 152.14 10.24 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.204 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 112' ' ' GLU . 74.1 Cg_exo -37.2 160.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.284 1.99 . . . . 0.0 112.178 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.5 m -58.84 148.71 29.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.668 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 116' ' ' PRO . 17.6 mt -74.57 151.88 87.3 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.189 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 115' ' ' LEU . 79.8 Cg_exo -38.15 162.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.144 1.896 . . . . 0.0 112.227 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -75.85 105.29 6.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.431 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.449 ' CD1' ' N3 ' ' A' ' 184' ' ' IMD . 72.4 mt -123.49 126.34 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.962 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -133.14 121.12 22.14 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.579 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.3 126.97 7.17 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -117.05 166.07 12.62 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 1.6 mm? -109.88 130.46 55.52 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.27 160.43 37.56 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.28 178.11 6.47 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.995 1.797 . . . . 0.0 112.127 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.523 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 19.5 t-20 56.6 37.26 28.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.949 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 8.6 p30 50.0 69.31 0.62 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.614 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 126' ' ' ASN . 82.8 mm-40 -136.85 161.61 35.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.513 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.1 mt -145.07 121.3 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.78 122.33 35.06 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.288 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.0 tp -117.64 134.73 54.57 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.125 0.488 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.67 HH21 ' CD2' ' A' ' 171' ' ' HIS . 58.7 ttt180 -117.56 121.61 41.44 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.477 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.485 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 37.4 t80 -125.74 125.53 43.14 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.531 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.31 123.75 23.38 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.43 ' HG ' HH11 ' A' ' 136' ' ' ARG . 7.3 t -153.68 143.37 15.17 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.15 -8.13 18.54 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.947 1.765 . . . . 0.0 112.37 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.43 HH11 ' HG ' ' A' ' 134' ' ' SER . 53.7 mtt85 -79.88 -22.4 42.87 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.208 0.528 . . . . 0.0 110.339 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.5 ' C ' ' H ' ' A' ' 139' ' ' CYS . 20.7 ttm180 67.55 23.28 8.96 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.643 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.73 17.02 0.33 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 31.0 p -43.17 -49.82 6.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.372 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.555 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 73.3 m-85 -46.76 -40.23 13.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.083 0.468 . . . . 0.0 110.335 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.3 t -62.93 -42.73 99.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.61 -54.95 8.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.663 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.64 -51.21 63.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.316 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.09 -48.13 47.25 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.05 -53.69 55.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.683 0.278 . . . . 0.0 111.302 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.4 mt -55.59 -54.93 37.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.699 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -49.17 -49.1 44.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.902 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.04 -50.58 66.32 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.42 -59.91 2.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.74 0.305 . . . . 0.0 110.941 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.44 -52.08 49.37 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.314 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -52.13 -47.88 65.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.215 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -47.74 -50.0 26.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.709 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -85.39 38.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.844 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 38.45 62.31 1.02 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.038 0.447 . . . . 0.0 111.309 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.504 ' NE2' ' N ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -132.93 151.11 52.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.504 ' N ' ' NE2' ' A' ' 155' ' ' GLN . 84.4 tttt -118.27 118.9 33.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.499 ' CG2' HE21 ' A' ' 155' ' ' GLN . 33.9 pt -133.32 170.86 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.539 0.685 . . . . 0.0 112.186 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -138.25 127.77 24.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.52 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mt -111.41 117.56 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.911 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.9 t -98.72 103.34 15.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.819 0.343 . . . . 0.0 110.47 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.576 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 20.3 p80 -94.02 65.12 3.43 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.615 0.721 . . . . 0.0 111.017 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 163' ' ' THR . 37.3 p30 -69.0 -33.05 73.04 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.113 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.512 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 1.6 m -99.95 107.54 19.53 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.066 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.59 ' O ' ' N ' ' A' ' 166' ' ' HIS . 55.9 m -134.71 114.22 12.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.653 0.263 . . . . 0.0 110.785 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.2 ttt -36.62 -20.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.19 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.59 ' N ' ' O ' ' A' ' 164' ' ' CYS . 83.7 t60 -52.23 -23.33 5.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.6 t -88.77 -43.18 11.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.01 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.469 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 130.48 13.9 2.02 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.09 162.51 14.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 110.729 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.554 ' O ' ' CG ' ' A' ' 171' ' ' HIS . 28.9 p-10 -55.55 -41.16 72.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.343 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.67 ' CD2' HH21 ' A' ' 131' ' ' ARG . 82.5 m-70 -161.52 -173.33 3.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.6 m -96.31 137.96 34.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.439 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.424 ' H ' ' HB ' ' A' ' 163' ' ' THR . 12.3 ttm -126.19 92.76 3.64 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.609 0.719 . . . . 0.0 109.608 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.19 113.9 26.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.912 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.1 mm -90.49 127.98 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.366 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.07 148.99 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.432 0.634 . . . . 0.0 110.727 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -137.82 135.88 36.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.555 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.524 ' O ' ' NE2' ' A' ' 179' ' ' GLN . 19.0 mt -93.1 145.94 24.02 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.702 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 178' ' ' LEU . 90.7 mm-40 -139.28 -179.49 5.9 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.801 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 181' ' ' ASP . 46.9 p-10 -153.7 20.85 0.53 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.854 0.359 . . . . 0.0 110.578 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 180' ' ' ASN . 3.3 p30 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.851 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . 0.449 ' N3 ' ' CD1' ' A' ' 118' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.2 mtp . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.635 ' HZ2' ' CG ' ' A' ' 111' ' ' HIS . 28.8 mmtm 48.23 -172.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.434 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 4' ' ' ILE . . . -159.26 -118.71 0.52 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.438 ' CB ' ' O ' ' A' ' 3' ' ' GLY . 0.3 OUTLIER 94.45 -24.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.9 0.88 . . . . 0.0 109.576 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mm -68.56 -52.73 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.395 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.45 -22.81 64.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.006 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -69.83 -49.59 51.1 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.716 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.08 -36.36 77.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.922 0.392 . . . . 0.0 110.158 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.1 tp -71.02 -35.46 72.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.241 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.15 -45.73 86.91 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.045 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -61.61 -52.32 64.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.428 ' SD ' ' CE1' ' A' ' 69' ' ' PHE . 7.8 ttp -49.73 -43.27 47.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.54 -35.17 69.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.663 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -61.93 -22.16 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.218 0.533 . . . . 0.0 109.756 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.9 -35.11 20.74 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.343 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -84.35 -77.13 0.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.4 m -90.99 -20.04 22.56 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.265 0.555 . . . . 0.0 110.738 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.95 173.59 26.54 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.77 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.8 ttt -68.57 -28.37 66.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.831 -1.184 . . . . 0.0 110.477 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.8 m -62.76 -42.5 99.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.164 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.96 -36.03 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.645 ' HE1' ' HH ' ' A' ' 36' ' ' TYR . 51.9 t-105 -52.03 -46.23 64.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -70.14 -30.98 68.28 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.138 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -65.31 -50.62 64.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -83.14 -18.89 37.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.871 0.367 . . . . 0.0 110.792 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.5 tt -77.97 -61.43 2.0 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.371 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.407 ' OE1' ' CB ' ' A' ' 32' ' ' LYS . 78.5 mm-40 -58.68 -21.91 55.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.319 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -80.64 -38.58 28.91 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.502 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 72.1 m80 -99.03 -84.9 0.4 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.508 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -50.23 158.91 0.9 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.087 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.33 143.05 68.77 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.732 2.288 . . . . 0.0 112.218 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' CB ' ' OE1' ' A' ' 27' ' ' GLU . 36.5 pttt -90.04 -20.61 23.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.709 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -91.74 -51.7 5.1 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.749 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -70.88 90.49 0.81 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.211 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -56.51 137.83 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.61 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.645 ' HH ' ' HE1' ' A' ' 22' ' ' TRP . 28.8 p90 -102.88 131.88 49.49 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.497 ' C ' ' H ' ' A' ' 39' ' ' ALA . 1.5 m -143.42 166.72 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.843 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 m -76.63 29.26 0.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.578 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 37' ' ' VAL . . . -153.18 16.47 0.55 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -114.99 156.46 25.04 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.019 0.437 . . . . 0.0 110.428 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.3 p -92.75 130.86 38.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.464 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -164.89 172.2 13.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.595 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.2 110.69 14.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.642 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.01 -29.9 63.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.654 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.9 m -52.16 -26.03 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.647 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.96 -30.38 67.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.808 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.6 -57.46 2.26 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.038 0.447 . . . . 0.0 110.684 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -38.0 -43.47 0.72 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.516 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.3 m -72.94 -32.41 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.527 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.2 mp -70.74 -52.84 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.503 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -24.67 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.885 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -77.01 -41.37 43.02 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.466 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.502 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 37.9 m-20 -58.55 -56.43 22.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.864 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.0 p -57.13 -39.32 66.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.065 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.72 86.81 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.134 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -62.84 -31.51 72.54 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -74.54 -45.79 43.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.491 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.0 mt -76.8 -8.6 57.61 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.621 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 58.1 52.33 7.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.748 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.2 mmt -132.43 149.95 74.56 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.382 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.31 140.64 89.45 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.441 1.427 . . . . 0.0 111.194 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 tt -56.55 -30.76 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.744 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -72.91 -29.75 63.37 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.297 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 50.2 t0 -78.77 -36.62 42.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.699 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.448 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.2 t -63.74 -58.96 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.94 -39.89 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.756 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -52.59 -47.33 66.97 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.86 89.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.448 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 6.2 m-30 -52.81 -29.96 30.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.613 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.17 -50.41 57.06 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -55.62 -50.06 71.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.924 0.392 . . . . 0.0 110.2 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -59.16 -41.53 88.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.802 0.81 . . . . 0.0 110.431 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.73 -38.88 79.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.449 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 36.6 t80 -69.54 -39.15 77.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.136 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -56.9 -69.87 0.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.97 -38.13 54.75 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.581 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.514 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 18.8 mt -57.07 -48.22 79.11 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.451 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.16 -21.28 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.552 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t -80.41 -40.51 26.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.24 0.543 . . . . 0.0 110.109 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.41 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.9 mmp_? -66.55 -70.55 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.68 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 23.7 p80 -83.66 32.99 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.97 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 55.0 m -47.93 -43.27 28.92 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.941 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -52.67 -31.76 38.85 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 81' ' ' HIS . 16.7 t -82.47 -25.26 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.675 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.528 ' C ' ' H ' ' A' ' 87' ' ' LYS . 44.5 t -63.27 -38.2 81.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -47.33 -12.86 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.875 0.369 . . . . 0.0 110.924 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.528 ' H ' ' C ' ' A' ' 85' ' ' VAL . 85.5 mttt -79.63 -28.41 40.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.895 0.855 . . . . 0.0 109.721 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 85' ' ' VAL . 39.7 t80 -57.78 100.21 0.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.232 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.453 ' H ' ' HG ' ' A' ' 93' ' ' SER . 83.5 m-20 -88.39 -32.91 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 54.2 t0 -174.73 155.51 2.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.759 -1.564 . . . . 0.0 109.923 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.504 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 78.0 t80 -42.56 -46.27 4.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.319 0.58 . . . . 0.0 110.49 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.2 m -61.76 -37.3 83.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.795 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.453 ' HG ' ' H ' ' A' ' 89' ' ' ASP . 84.1 p -65.54 -40.83 93.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.343 0.592 . . . . 0.0 110.579 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 98' ' ' ILE . 6.5 tt -65.35 -49.92 67.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.318 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.5 t -57.13 -37.78 57.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.262 0.554 . . . . 0.0 110.623 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 120' ' ' GLY . 95.3 mmm -86.49 -5.98 59.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.192 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.89 -15.56 8.52 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.096 -0.836 . . . . 0.0 113.202 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.521 ' O ' ' O ' ' A' ' 97' ' ' GLY . 13.6 mt -27.27 -106.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 117.945 0.873 . . . . 0.0 112.66 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -40.64 -49.89 3.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.26 0.552 . . . . 0.0 111.259 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -43.25 -86.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.516 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.0 m -72.82 -51.86 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.516 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.5 mp -64.77 -50.04 77.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.51 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -53.46 -50.98 50.76 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.439 ' CD1' ' HZ2' ' A' ' 108' ' ' LYS . 30.1 tp -48.83 -50.28 35.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.085 0.469 . . . . 0.0 110.228 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.506 ' CG ' ' NZ ' ' A' ' 87' ' ' LYS . 68.9 mm-40 -55.85 -45.08 78.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.141 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.445 ' CG1' ' OE2' ' A' ' 112' ' ' GLU . 72.3 t -51.99 -51.0 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -50.11 -42.49 50.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.708 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.439 ' HZ2' ' CD1' ' A' ' 104' ' ' LEU . 26.4 mmtm -58.94 -36.14 74.28 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.26 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.523 ' O ' ' CD2' ' A' ' 111' ' ' HIS . 3.7 mm? -74.11 1.73 10.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.532 ' O ' ' CG ' ' A' ' 111' ' ' HIS . 12.5 t80 70.25 -167.68 0.16 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.74 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.635 ' CG ' ' HZ2' ' A' ' 2' ' ' LYS . 20.5 p80 42.14 76.82 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.916 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.445 ' OE2' ' CG1' ' A' ' 106' ' ' VAL . 28.0 tt0 -159.99 81.58 2.36 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.493 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' O ' ' OG ' ' A' ' 114' ' ' SER . 80.3 Cg_exo -47.22 -60.85 0.73 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.414 2.076 . . . . 0.0 112.213 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 113' ' ' PRO . 45.3 m -170.28 128.2 0.85 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.852 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 mt -80.01 153.94 75.03 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.35 173.19 11.87 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.412 2.075 . . . . 0.0 112.291 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -84.15 108.86 17.3 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.349 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 91.3 mt -121.26 126.69 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.631 0.253 . . . . 0.0 110.981 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -130.66 112.18 12.88 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.861 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.443 ' C ' ' SD ' ' A' ' 96' ' ' MET . . . -110.39 128.46 8.83 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -118.95 164.66 15.13 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.944 0.402 . . . . 0.0 110.468 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.24 144.73 36.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.661 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.41 160.56 41.21 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.01 -31.43 9.81 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.549 2.166 . . . . 0.0 113.261 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -86.51 44.97 1.19 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.24 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 m120 45.06 51.34 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.286 0.565 . . . . 0.0 110.575 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -127.44 158.46 37.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.701 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.1 mt -135.72 117.91 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.65 122.77 32.43 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.749 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.7 tp -117.26 133.79 55.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.058 0.456 . . . . 0.0 110.439 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -119.38 126.59 51.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.529 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -125.89 123.55 38.89 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.09 132.27 29.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.739 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.525 ' OG ' ' NE ' ' A' ' 136' ' ' ARG . 0.4 OUTLIER 169.82 154.61 0.18 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.292 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.43 68.4 1.5 Allowed 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.434 2.089 . . . . 0.0 111.163 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.575 ' C ' ' H ' ' A' ' 138' ' ' LEU . 10.0 ptp180 -150.51 101.68 2.97 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.476 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -69.9 36.88 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.139 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.575 ' H ' ' C ' ' A' ' 136' ' ' ARG . 2.5 tp -97.01 7.29 46.98 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.256 0.551 . . . . 0.0 110.143 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.4 m -41.93 -50.82 4.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.93 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -45.43 -36.74 4.56 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.552 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.82 -44.17 74.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.949 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -44.77 -47.52 10.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.603 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -65.13 -49.42 69.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.376 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.65 -47.45 45.75 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.9 mt -58.84 -53.28 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.65 0.262 . . . . 0.0 111.192 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.8 mt -55.64 -54.73 40.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.606 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -50.42 -47.14 56.72 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.658 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.94 -50.94 62.41 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.61 -59.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.743 0.306 . . . . 0.0 110.736 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.25 -51.51 58.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.667 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -51.52 -47.24 63.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.067 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -49.4 -49.73 43.45 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.743 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.517 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 67.4 t80 -88.03 38.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.891 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 38.51 55.28 1.87 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.966 0.412 . . . . 0.0 111.134 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.575 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 46.4 tp60 -128.84 141.18 51.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.575 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 15.7 mtpp -110.85 131.35 55.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.173 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.4 pt -142.99 170.12 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.631 0.729 . . . . 0.0 112.268 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.416 ' NE2' HE22 ' A' ' 179' ' ' GLN . 94.1 mt-30 -134.77 125.69 27.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.93 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.7 mt -111.63 118.84 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.618 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.2 m -98.95 99.83 10.93 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.008 0.433 . . . . 0.0 110.248 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 163' ' ' THR . 23.3 t-160 -98.59 70.12 1.92 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.388 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -77.11 -45.84 25.56 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.904 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.466 ' O ' ' CD2' ' A' ' 161' ' ' HIS . 2.4 m -77.83 118.91 20.62 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.863 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 166' ' ' HIS . 34.0 t -143.78 116.27 8.6 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.009 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.432 ' C ' ' N ' ' A' ' 167' ' ' THR . 26.1 ttt -35.25 -23.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.073 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.575 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.9 t60 -50.11 -20.66 1.04 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.432 ' N ' ' C ' ' A' ' 165' ' ' MET . 6.0 t -93.97 -36.4 12.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.139 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.66 13.34 8.07 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.56 165.69 7.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 110.809 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -52.83 -35.91 57.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.428 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -172.13 -171.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.4 m -93.68 138.83 31.5 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.547 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.3 tpt -117.65 122.08 42.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.064 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -126.13 102.21 7.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.029 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.457 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -90.35 126.95 43.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.511 178.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.46 151.83 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.188 0.518 . . . . 0.0 110.599 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -139.26 137.84 36.26 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.48 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 11.9 mt -94.77 150.04 20.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.937 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.416 HE22 ' NE2' ' A' ' 158' ' ' GLN . 54.1 mt-30 -143.24 175.57 9.79 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.823 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 181' ' ' ASP . 16.8 m-80 53.73 43.44 31.05 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.532 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 180' ' ' ASN . 3.2 p30 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.535 ' O1A' ' NH1' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.527 ' N ' ' O ' ' A' ' 40' ' ' LYS . 67.4 mmm . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.658 ' HZ1' ' NH2' ' A' ' 136' ' ' ARG . 65.3 tttt -89.29 -5.34 57.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.965 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -51.67 -25.19 14.12 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tp -51.84 -39.86 26.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 0.0 110.517 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.0 mm -58.7 -49.15 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.112 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -67.26 -25.91 66.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.275 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -66.95 -54.63 20.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.192 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.76 -35.19 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.401 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.8 tp -68.48 -51.33 44.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.399 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -47.0 -44.15 20.02 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.09 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -61.14 -52.71 63.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.999 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.8 ttt -51.31 -40.17 58.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.73 -35.69 66.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.418 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.78 -22.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.336 0.589 . . . . 0.0 109.883 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.77 -34.7 19.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.225 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -84.48 -77.06 0.28 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.0 m -90.81 -20.12 22.68 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.247 0.546 . . . . 0.0 110.705 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.6 173.78 26.99 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.719 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.4 ttt -69.53 -25.02 63.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.937 -1.131 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -65.27 -43.21 91.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.148 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -34.31 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.514 ' HE1' HH12 ' A' ' 34' ' ' ARG . 51.5 t-105 -51.57 -45.97 63.28 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.47 ' OD1' ' CZ ' ' A' ' 34' ' ' ARG . 45.6 m-20 -69.15 -32.66 72.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.015 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -64.33 -50.97 65.68 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.473 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -82.78 -19.6 37.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.958 0.408 . . . . 0.0 110.965 -179.229 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tt -75.34 -57.61 3.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.692 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -62.89 -21.09 65.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.62 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -80.72 -39.29 27.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.526 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 43.5 m170 -101.32 -88.12 0.38 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.861 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -43.76 163.88 0.16 Allowed Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.65 150.97 73.27 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.477 2.118 . . . . 0.0 112.192 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -65.89 -17.47 64.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.542 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 34' ' ' ARG . 50.5 t0 -48.2 -44.62 32.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.232 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.514 HH12 ' HE1' ' A' ' 22' ' ' TRP . 37.5 ttt85 45.03 97.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.781 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.0 t -145.25 129.27 12.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.328 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.522 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 36.6 p90 -81.51 113.83 19.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.147 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.8 m -147.46 164.5 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 121.18 0.514 . . . . 0.0 110.933 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.1 m -142.58 24.44 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.255 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.489 ' O ' ' SD ' ' A' ' 1' ' ' MET . . . -130.98 11.97 5.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.662 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 1' ' ' MET . 20.8 mttt -101.44 179.42 4.36 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.455 0.645 . . . . 0.0 112.017 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.9 t -129.93 67.51 1.46 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.235 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -77.34 163.27 26.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.301 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.38 121.77 15.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.6 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.522 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -72.32 -36.29 68.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.691 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.482 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 22.9 t -58.78 -31.68 68.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.564 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -62.09 -40.82 97.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.769 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -41.19 -55.01 2.77 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.946 0.403 . . . . 0.0 110.595 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.14 -38.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.914 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.9 m -72.41 -34.53 67.93 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.837 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 47' ' ' LEU . 1.8 mp -68.33 -56.93 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.207 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -51.89 -26.25 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.831 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -75.24 -41.18 58.1 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.763 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.526 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 51.3 m-20 -59.4 -56.62 19.69 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.073 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 p -56.39 -38.1 54.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.08 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.07 -38.75 87.33 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.251 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -62.8 -32.22 73.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.55 -43.32 60.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 41.6 mt -79.3 -8.47 59.08 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.612 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.1 t30 57.32 50.4 11.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.555 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.0 mmt -129.79 149.75 73.91 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.208 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.74 139.83 82.68 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.407 1.405 . . . . 0.0 111.171 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 tt -54.37 -30.89 21.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.363 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -72.0 -29.72 64.49 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.405 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 37.5 t0 -78.69 -35.48 45.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.956 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.45 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 72.0 t -66.29 -58.03 8.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -51.34 -39.49 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.959 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -53.35 -47.83 69.05 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.88 -43.96 97.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.65 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.45 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 6.8 m-30 -55.1 -32.07 61.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.17 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.4 -50.18 56.99 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -57.63 -47.77 81.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.066 0.46 . . . . 0.0 109.896 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.03 -42.58 94.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.85 0.833 . . . . 0.0 110.363 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.8 tp -56.15 -39.0 71.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.388 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -70.49 -40.8 73.38 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.286 -0.565 . . . . 0.0 109.936 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -57.08 -71.87 0.09 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.914 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.5 -37.58 19.62 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.223 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.527 ' C ' ' HD1' ' A' ' 81' ' ' HIS . 18.2 mt -58.67 -41.6 86.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.121 0.46 . . . . 0.0 111.732 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.46 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -55.16 -15.86 2.62 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.672 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.431 ' O ' ' OG1' ' A' ' 82' ' ' THR . 29.0 t -83.69 -46.85 11.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.324 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.87 -47.4 9.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.977 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.549 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -84.42 26.48 0.78 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.201 0.524 . . . . 0.0 109.982 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 3.8 m -58.21 -40.38 81.44 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.329 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -56.01 -31.87 63.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.3 t -85.54 -20.84 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.923 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 81' ' ' HIS . 43.3 t -64.69 -41.22 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.213 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.82 -19.15 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -66.23 -28.91 69.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.557 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 1.8 p90 -120.35 114.32 21.68 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.107 0.48 . . . . 0.0 110.77 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -85.28 -3.33 58.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.372 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.427 ' O ' ' OG ' ' A' ' 93' ' ' SER . 4.3 p-10 -163.04 154.57 17.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.092 0.472 . . . . 0.0 111.602 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -45.4 -56.38 5.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.001 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.0 m -52.08 -44.01 64.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.795 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.442 ' HG ' ' N ' ' A' ' 94' ' ' LEU . 80.9 p -61.63 -35.47 77.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.18 0.514 . . . . 0.0 110.825 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.9 tt -68.64 -48.78 63.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.589 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.78 -39.1 75.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.069 0.461 . . . . 0.0 111.145 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -88.61 -4.86 58.48 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -111.03 -15.07 11.08 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 119.569 -0.573 . . . . 0.0 112.761 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 94' ' ' LEU . 12.8 mt -30.37 -100.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 117.75 0.775 . . . . 0.0 112.269 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -39.31 -51.61 2.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.15 0.5 . . . . 0.0 111.374 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -43.32 -87.21 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.5 m -72.51 -53.65 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.496 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.9 mp -62.27 -46.89 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.688 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.19 -52.57 48.61 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.441 ' CD1' ' HZ2' ' A' ' 108' ' ' LYS . 42.4 tp -52.43 -51.47 58.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.359 . . . . 0.0 110.665 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -54.88 -45.84 74.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.755 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.68 -51.99 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 110' ' ' TYR . 19.3 t-20 -47.11 -43.23 20.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.757 0.313 . . . . 0.0 110.754 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.441 ' HZ2' ' CD1' ' A' ' 104' ' ' LEU . 26.7 mmtm -60.99 -37.15 81.47 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.144 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -42.85 82.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.896 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.514 ' CD2' ' O ' ' A' ' 111' ' ' HIS . 64.0 t80 -143.16 144.31 32.15 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.444 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.514 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 79.3 m80 -83.53 150.89 25.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.731 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 59.68 59.11 4.76 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.487 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.11 -22.49 16.88 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.726 2.284 . . . . 0.0 111.839 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 114' ' ' SER . 23.2 p 42.67 62.07 1.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.923 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 116' ' ' PRO . 11.3 mt -81.41 115.1 54.44 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.191 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 115' ' ' LEU . 80.2 Cg_exo -44.23 178.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.228 1.952 . . . . 0.0 113.033 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.834 ' NE2' HH22 ' A' ' 131' ' ' ARG . 20.4 t60 -80.1 118.83 22.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.515 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.71 129.62 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -134.53 119.75 18.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.886 0.374 . . . . 0.0 111.591 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -108.2 126.06 8.1 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -116.77 165.27 13.49 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.117 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 1.2 mm? -111.8 139.19 47.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.186 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.95 160.25 41.51 Favored Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 69.9 Cg_endo -73.51 158.71 47.43 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.264 1.976 . . . . 0.0 112.109 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 124' ' ' PRO . 3.4 t-20 92.24 -60.92 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.217 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 14.1 m-20 154.31 59.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -135.14 163.28 30.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.05 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.7 mt -140.2 121.16 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.34 122.77 33.52 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.276 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.0 tp -116.05 136.55 52.92 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.033 0.444 . . . . 0.0 110.745 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.834 HH22 ' NE2' ' A' ' 117' ' ' HIS . 61.0 ttp85 -123.08 124.28 42.75 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.595 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.428 ' C ' ' CD1' ' A' ' 132' ' ' TYR . 25.4 t80 -126.84 123.1 36.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.19 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.62 122.53 29.25 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.546 ' C ' ' H ' ' A' ' 136' ' ' ARG . 3.6 t -172.69 145.15 1.34 Allowed Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.759 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -73.36 19.07 0.38 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.908 1.739 . . . . 0.0 110.382 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.658 ' NH2' ' HZ1' ' A' ' 2' ' ' LYS . 15.7 mmm180 -91.24 108.54 19.95 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.719 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -69.03 18.84 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.626 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.582 ' H ' ' C ' ' A' ' 136' ' ' ARG . 2.4 mm? -86.31 11.02 13.12 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 110.299 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 65.5 m -40.86 -54.61 2.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.601 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -47.07 -30.07 2.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.957 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.456 ' N ' ' O ' ' A' ' 138' ' ' LEU . 4.7 t -71.38 -45.19 63.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.794 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.65 -48.79 14.8 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.588 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -63.35 -48.26 78.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.206 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.33 -46.22 44.42 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.3 -52.58 64.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.64 0.257 . . . . 0.0 111.351 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.2 mt -55.53 -56.51 19.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.819 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -51.33 -47.55 62.65 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.644 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.33 -52.23 54.46 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.52 -60.21 1.84 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.0 110.784 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.34 -51.63 52.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.563 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -51.24 -46.37 62.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.636 0.255 . . . . 0.0 110.961 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -50.23 -50.35 50.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.515 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 71.3 t80 -86.2 37.15 0.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.998 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 40.69 53.0 3.15 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.92 0.39 . . . . 0.0 111.062 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.519 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 46.0 tp60 -127.72 139.52 52.63 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.519 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 2.3 mptp? -112.95 128.06 56.38 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.7 pt -139.18 175.72 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.663 0.744 . . . . 0.0 111.638 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -137.78 127.09 24.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.195 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.3 mt -112.31 116.69 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.462 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.3 m -97.0 101.94 13.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.497 ' NE2' ' O ' ' A' ' 163' ' ' THR . 10.8 t-160 -104.62 74.97 1.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.91 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -81.27 -40.68 23.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.82 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.497 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 1.9 m -78.97 117.72 20.31 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.146 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 166' ' ' HIS . 14.7 t -142.16 117.35 10.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.693 0.282 . . . . 0.0 111.08 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.475 ' C ' ' N ' ' A' ' 167' ' ' THR . 24.5 ttt -33.88 -25.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.225 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.568 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.6 t60 -49.42 -19.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.568 0.699 . . . . 0.0 109.147 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.475 ' N ' ' C ' ' A' ' 165' ' ' MET . 5.9 t -94.73 -34.2 12.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.958 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 112.54 16.05 9.07 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.34 166.48 8.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.064 0.459 . . . . 0.0 110.782 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -55.56 -33.91 64.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.456 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.417 ' HD1' ' N ' ' A' ' 172' ' ' CYS . 22.0 p80 -171.89 -169.63 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.417 ' N ' ' HD1' ' A' ' 171' ' ' HIS . 3.7 m -94.7 141.94 28.04 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.562 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.5 tpt -118.02 123.6 46.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.104 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.2 100.35 5.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.162 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.479 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -88.26 126.6 41.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.702 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.84 149.74 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.183 0.516 . . . . 0.0 110.588 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -144.57 139.28 28.04 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.421 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 10.9 mt -92.65 136.55 33.13 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.116 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -46.37 143.42 2.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.439 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -155.26 21.4 0.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.522 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 61.2 t0 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.589 179.984 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.608 ' N ' ' ND2' ' A' ' 7' ' ' ASN . 49.2 ttp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' GLY . 59.8 mttp 55.11 90.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.5 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 58.5 117.71 0.01 OUTLIER Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 tp -53.55 -41.33 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.4 -48.4 80.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.423 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 3.2 m-85 -67.42 -24.11 65.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.753 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.608 ' ND2' ' N ' ' A' ' 1' ' ' MET . 52.9 t30 -71.18 -57.31 4.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.49 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.15 -35.84 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.012 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.7 tp -72.03 -41.94 66.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.413 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -53.87 -46.61 71.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.935 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.16 -45.29 93.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.927 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.599 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 3.3 tpp -58.05 -47.31 83.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.4 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.55 -36.71 76.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.828 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -63.17 -22.94 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.278 0.561 . . . . 0.0 109.661 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.77 -34.76 18.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.85 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -86.78 -76.93 0.34 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.8 m -89.84 -17.08 28.77 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.408 0.623 . . . . 0.0 110.723 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.2 -179.97 31.15 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.565 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 ttt -72.85 -31.68 64.93 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.053 -1.074 . . . . 0.0 111.098 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -60.22 -39.53 86.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.165 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.83 -37.76 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -55.13 -47.38 75.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.07 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.33 -24.89 54.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.898 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -76.01 -46.42 29.53 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.819 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.37 -28.22 41.93 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.742 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.509 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 6.8 tt -71.23 -45.86 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.232 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.4 -23.89 63.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.639 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -82.14 -40.59 21.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.423 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 59.6 m-70 -91.58 -87.37 0.21 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.177 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.99 160.65 2.15 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.087 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.448 ' CG ' ' OH ' ' A' ' 36' ' ' TYR . 59.9 Cg_endo -70.45 153.99 65.34 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.702 2.268 . . . . 0.0 112.035 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.51 ' NZ ' ' OD1' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -80.26 -2.66 46.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.262 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.51 ' OD1' ' NZ ' ' A' ' 32' ' ' LYS . 86.9 m-20 -59.4 -38.49 80.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.567 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 49.76 40.39 20.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.624 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.7 m -95.78 31.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.577 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.448 ' OH ' ' CG ' ' A' ' 31' ' ' PRO . 73.1 m-85 -94.16 151.6 19.36 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.521 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.515 ' C ' ' H ' ' A' ' 3' ' ' GLY . 0.9 OUTLIER -131.98 155.04 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.862 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 1' ' ' MET . 1.5 m -81.5 39.75 0.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.715 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.72 3.04 0.27 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.824 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' CB ' ' CE2' ' A' ' 42' ' ' TYR . 14.5 mmtt -93.93 149.54 21.14 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.08 0.467 . . . . 0.0 110.343 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 65.8 m -88.9 39.62 0.94 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.27 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.404 ' CE2' ' CB ' ' A' ' 40' ' ' LYS . 49.6 m-85 -56.42 158.11 4.56 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.375 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.3 129.59 36.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.663 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -81.95 -3.31 54.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.66 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.2 m -51.79 -36.79 48.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.694 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.54 -28.89 70.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.644 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.9 OUTLIER -47.82 -57.95 4.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.203 0.525 . . . . 0.0 110.354 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -37.14 -44.82 0.58 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.98 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.5 m -71.91 -32.26 67.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.123 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 14.1 mt -71.6 -52.3 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.31 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.63 -21.89 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.445 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -80.34 -41.03 25.53 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.423 ' OD2' ' CD2' ' A' ' 29' ' ' HIS . 37.2 m-20 -58.53 -57.32 13.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.71 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.41 -37.61 64.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.555 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.55 87.98 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.236 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -63.4 -31.4 72.55 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.498 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -73.21 -46.24 51.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.541 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.6 mt -76.31 -7.48 55.03 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.879 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.59 48.59 16.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.439 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 18.3 mmt -127.7 149.81 71.43 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.131 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.08 137.48 66.99 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.475 1.45 . . . . 0.0 111.233 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tt -52.82 -29.72 14.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.023 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -73.45 -29.54 62.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.497 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -79.4 -34.65 41.64 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.06 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.535 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 55.7 t -66.14 -58.79 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.53 -38.8 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.662 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.55 -44.31 72.77 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.739 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.31 -59.32 5.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.305 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.535 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 5.5 m-30 -45.98 -29.98 1.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.289 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.88 -52.64 51.09 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -57.02 -51.74 68.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.962 0.411 . . . . 0.0 110.143 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.599 ' CD1' ' SD ' ' A' ' 12' ' ' MET . 55.5 m-85 -56.73 -43.02 80.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.798 0.808 . . . . 0.0 110.595 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.0 tp -55.45 -38.38 68.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.614 -1.176 . . . . 0.0 112.057 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 43.6 t80 -68.91 -40.26 79.23 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.965 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -57.22 -70.2 0.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.038 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.87 -41.68 36.69 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.789 -178.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.2 mt -57.4 -44.83 84.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.274 0.537 . . . . 0.0 111.615 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -49.17 -20.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.903 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 t -81.77 -41.62 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.119 0.485 . . . . 0.0 109.834 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -65.41 -74.52 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.696 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.512 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 0.2 OUTLIER -84.39 37.28 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.596 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 24.8 m -48.11 -46.43 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.111 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -54.22 -34.02 59.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.049 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.54 -21.93 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.685 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' A' ' 87' ' ' LYS . 73.7 t -70.96 -41.49 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.765 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -54.75 -0.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.467 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.605 ' HZ2' ' CG ' ' A' ' 105' ' ' GLU . 77.6 mttt -84.25 -28.01 27.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.52 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.12 119.47 36.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.587 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 58.2 t0 -84.02 -13.66 52.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.118 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.454 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 60.8 m-20 -162.02 167.63 24.1 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.431 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -53.83 -52.65 59.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.685 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.9 m -53.04 -37.68 61.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.259 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.4 m -60.88 -40.65 93.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.337 0.589 . . . . 0.0 110.14 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 98' ' ' ILE . 8.4 tt -60.76 -59.3 5.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.318 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.9 t -52.72 -37.4 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.229 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 91.8 mmm -86.23 -5.68 59.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.731 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -114.93 -15.14 8.08 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.377 -0.68 . . . . 0.0 113.112 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 97' ' ' GLY . 10.3 mt -28.03 -104.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 117.763 0.782 . . . . 0.0 112.763 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 118' ' ' ILE . 8.1 p80 -39.39 -49.88 2.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.075 0.464 . . . . 0.0 111.229 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -44.47 -87.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.511 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.3 m -71.52 -51.89 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.511 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mp -63.92 -45.48 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.756 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.38 -52.73 51.03 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.7 tp -51.67 -52.36 48.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.791 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.605 ' CG ' ' HZ2' ' A' ' 87' ' ' LYS . 58.3 mm-40 -53.85 -46.0 71.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.329 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.4 t -55.29 -51.39 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 110' ' ' TYR . 20.2 t-20 -48.69 -42.74 35.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.684 0.278 . . . . 0.0 110.883 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -63.39 -36.69 84.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.746 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.7 tp -56.56 -32.55 65.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.66 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 107' ' ' ASN . 14.0 t80 -150.81 -133.94 0.06 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.335 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -152.67 161.33 42.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.528 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 46.66 59.93 15.37 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.534 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.11 -29.01 8.51 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.679 2.253 . . . . 0.0 111.998 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.5 t 43.26 59.6 2.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.759 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.6 mt -76.08 152.58 84.35 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.205 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.19 -172.86 0.37 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.285 1.99 . . . . 0.0 111.842 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -100.32 116.11 31.53 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.815 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 1.5 mp -130.43 128.61 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.657 0.265 . . . . 0.0 110.308 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -135.22 127.08 29.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.714 0.293 . . . . 0.0 110.859 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.56 135.01 11.49 Favored Glycine 0 N--CA 1.466 0.692 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -131.96 126.19 33.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 tp -72.47 136.32 45.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.97 0.414 . . . . 0.0 110.885 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.56 160.58 28.04 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 59.6 Cg_endo -72.15 165.7 31.86 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.284 1.99 . . . . 0.0 111.898 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' PRO . 15.4 t-20 86.46 -62.66 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.103 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.654 ' ND2' HD22 ' A' ' 180' ' ' ASN . 5.7 p30 154.84 52.59 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.162 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -128.46 159.34 35.71 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.675 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.9 mt -134.38 117.16 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.95 123.03 31.62 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.63 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.6 tp -116.94 137.24 52.35 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.111 0.481 . . . . 0.0 111.011 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.486 ' NE ' ' NE2' ' A' ' 171' ' ' HIS . 42.1 ttm180 -127.14 126.12 42.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.832 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.473 ' OH ' ' CGA' ' A' ' 182' ' ' HEM . 33.2 t80 -128.62 129.87 46.49 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.521 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.33 133.6 24.56 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.066 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.566 ' H ' ' NH1' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -176.01 171.4 1.11 Allowed Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -39.39 -70.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.978 1.786 . . . . 0.0 110.103 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 79.8 mtm-85 -89.09 170.26 10.79 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.566 ' NH1' ' H ' ' A' ' 134' ' ' SER . 22.5 mmt180 -114.48 -32.82 5.78 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.799 0.727 . . . . 0.0 110.867 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.8 mm? 48.18 15.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.499 ' H ' ' C ' ' A' ' 137' ' ' ARG . 21.7 p -40.76 -52.75 2.94 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.12 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.463 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 62.4 m-85 -47.78 -35.82 10.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 138' ' ' LEU . 6.7 t -76.46 -51.78 11.11 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -43.31 -45.74 6.08 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.941 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -62.72 -46.46 87.98 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.167 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.24 -52.95 40.66 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.8 mt -54.38 -55.85 24.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.706 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.3 mt -54.3 -55.43 28.42 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.097 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -50.43 -48.49 56.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.678 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.18 -51.1 60.47 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.58 -59.61 2.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.887 0.375 . . . . 0.0 110.625 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -48.16 -50.23 29.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.87 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -52.81 -47.4 67.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.155 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -49.79 -50.32 45.27 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.668 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 70.6 t80 -86.01 37.19 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.025 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 39.73 54.11 2.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.993 0.425 . . . . 0.0 111.109 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.451 HE21 ' H ' ' A' ' 156' ' ' LYS . 50.1 tp60 -129.52 141.86 50.9 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.662 ' H ' HE21 ' A' ' 179' ' ' GLN . 67.9 mttm -118.71 107.54 13.8 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.998 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 38.7 pt -114.56 -178.19 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.507 0.67 . . . . 0.0 111.559 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -145.18 126.38 14.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.252 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.2 mt -110.76 119.08 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 120.69 0.281 . . . . 0.0 110.828 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.2 t -101.07 103.71 14.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.834 0.35 . . . . 0.0 110.276 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 163' ' ' THR . 21.0 t-160 -100.15 73.62 1.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.454 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -79.26 -48.68 13.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.478 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 1.0 OUTLIER -73.63 124.53 26.13 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.914 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 70.8 m -126.55 174.11 8.92 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.801 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 168' ' ' GLY . 1.1 tmt? -90.18 -27.35 19.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.092 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -52.57 -23.16 5.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.489 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.1 t -88.91 -25.28 22.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.454 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 97.74 23.27 14.03 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.012 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.09 168.71 11.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 110.768 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -54.22 -34.16 59.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.52 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.486 ' NE2' ' NE ' ' A' ' 131' ' ' ARG . 5.5 p-80 -174.52 -169.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 92.5 m -93.28 138.7 31.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.7 tpt -117.98 124.25 47.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.169 0.509 . . . . 0.0 110.074 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.4 mt -126.26 102.87 7.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.701 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.463 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -87.33 128.72 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.67 151.45 14.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.416 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -143.13 141.33 31.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.598 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 179' ' ' GLN . 14.0 mt -92.07 174.18 7.45 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.837 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.662 HE21 ' H ' ' A' ' 156' ' ' LYS . 83.2 mt-30 -55.82 -155.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.187 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.654 HD22 ' ND2' ' A' ' 126' ' ' ASN . 6.1 p-10 42.87 43.94 3.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.726 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 51.9 p30 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.59 -179.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.473 ' CGA' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' O ' ' A' ' 36' ' ' TYR . 20.6 tpp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -60.44 -31.1 70.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.423 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.96 -172.61 31.65 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' SER . 2.2 tp -55.92 -42.49 71.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.677 0.275 . . . . 0.0 110.849 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.1 mm -59.88 -50.18 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.88 0.372 . . . . 0.0 110.147 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -67.52 -24.28 65.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.424 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.463 ' C ' HD21 ' A' ' 7' ' ' ASN . 0.4 OUTLIER -67.77 -53.17 29.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.974 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.6 t -65.68 -35.99 76.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.364 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.6 -45.4 68.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.562 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -50.39 -43.9 54.76 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.661 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -62.78 -51.31 67.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.928 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.6 tmt? -51.18 -39.98 57.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.84 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.7 t -71.38 -34.78 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.557 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.98 -22.53 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.227 0.537 . . . . 0.0 109.957 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.64 -34.65 19.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.237 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -84.52 -76.99 0.28 Allowed 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.3 m -91.33 -19.19 23.21 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.211 0.529 . . . . 0.0 110.708 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.18 173.72 27.52 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.772 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 ttt -69.32 -27.65 65.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.888 -1.156 . . . . 0.0 110.516 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 t -63.21 -42.57 99.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.0 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.73 -36.57 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -50.68 -45.48 58.17 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -71.88 -30.64 65.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.238 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -66.5 -51.14 59.88 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.485 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -80.44 -24.77 39.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.275 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 8.1 tt -71.92 -46.03 59.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.131 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -71.69 -25.25 62.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.841 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -81.32 -40.67 23.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.524 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 80.2 m80 -95.09 -84.79 0.33 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.267 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 31' ' ' PRO . . . -54.42 164.53 1.05 Allowed Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.194 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 30' ' ' ALA . 89.2 Cg_exo -35.45 160.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 123.124 2.55 . . . . 0.0 112.648 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 22.7 pttm -58.83 -44.87 91.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.124 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 32' ' ' LYS . 64.0 m-20 -160.09 12.43 0.12 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.009 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.468 ' NE ' ' OH ' ' A' ' 36' ' ' TYR . 50.3 ttt85 -79.57 117.05 20.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.776 0.322 . . . . 0.0 110.365 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.6 166.59 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.515 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.468 ' OH ' ' NE ' ' A' ' 34' ' ' ARG . 25.3 m-85 -136.68 -171.07 2.83 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.489 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.8 m -82.42 -169.69 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 4' ' ' ILE . 44.0 m -71.64 -41.12 69.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.095 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.402 ' H ' HG22 ' A' ' 37' ' ' VAL . . . -97.32 46.04 1.03 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.715 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 41' ' ' SER . 20.5 mmtt -135.44 156.25 49.22 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.123 0.487 . . . . 0.0 110.691 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 40' ' ' LYS . 42.1 m 44.81 -173.49 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.729 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.526 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 10.6 p90 -171.72 61.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.34 0.591 . . . . 0.0 110.574 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 45' ' ' SER . . . -82.21 24.05 0.69 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.468 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.523 ' CD ' HH22 ' A' ' 136' ' ' ARG . 78.4 tt0 -44.83 -18.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.435 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' ALA . 21.7 m -69.08 -42.96 75.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.314 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -70.37 -27.45 64.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.594 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -38.52 -55.83 1.36 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.808 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.66 -40.98 1.0 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.029 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -72.61 -34.3 67.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.972 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 47' ' ' LEU . 1.9 mp -68.63 -55.27 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.293 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -53.86 -26.39 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.967 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -75.41 -41.06 57.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.646 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.524 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 40.4 m-20 -59.34 -56.79 17.65 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.968 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.4 p -56.77 -38.27 57.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.073 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.88 -38.88 87.15 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.256 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -62.76 -32.07 73.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -74.08 -43.0 59.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.569 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 39.0 mt -79.6 -8.04 58.92 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.669 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.5 t30 57.23 49.87 12.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.607 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 23.9 mmt -129.06 149.53 72.84 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.182 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.39 138.93 74.1 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.539 1.493 . . . . 0.0 110.996 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 tt -53.05 -29.38 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.281 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -72.13 -31.14 65.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 111.206 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.92 -32.36 51.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.474 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 82.6 t -70.82 -56.94 9.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 p -52.06 -41.81 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.267 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -53.59 -50.86 64.72 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.47 82.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.684 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.474 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.7 m-30 -52.91 -29.62 29.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.382 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.15 -49.57 56.87 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -55.26 -52.14 64.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 110.054 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -57.83 -42.74 84.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.773 0.796 . . . . 0.0 110.649 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.9 tp -56.47 -39.9 73.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.537 -1.21 . . . . 0.0 112.223 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 21.7 t80 -66.52 -44.29 82.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.31 0.576 . . . . 0.0 109.863 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -53.58 -68.73 0.15 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.241 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.05 -48.57 25.32 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.967 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.1 mt -52.38 -41.52 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.24 0.52 . . . . 0.0 112.063 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -56.34 -27.48 55.99 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.507 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.421 ' O ' ' OG1' ' A' ' 82' ' ' THR . 23.0 t -73.52 -55.38 6.4 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.048 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -43.31 55.75 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.034 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.443 ' CE1' ' CBC' ' A' ' 182' ' ' HEM . 94.7 m-70 -89.18 28.1 1.28 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.779 0.323 . . . . 0.0 110.577 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 87.2 m -54.11 -37.26 64.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.079 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.523 ' O ' ' NZ ' ' A' ' 87' ' ' LYS . 88.3 m-20 -57.58 -30.54 65.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -85.88 -18.42 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.569 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.426 ' C ' ' N ' ' A' ' 87' ' ' LYS . 49.7 t -70.53 -45.28 75.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.418 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -51.2 -15.49 0.37 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.014 0.435 . . . . 0.0 110.354 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 83' ' ' ASP . 42.8 mmtm -69.08 -28.63 66.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.975 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 8.8 p90 -121.94 115.61 22.88 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.072 0.463 . . . . 0.0 110.732 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 55.2 t0 -84.48 -6.08 59.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.448 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.643 ' H ' ' HG ' ' A' ' 93' ' ' SER . 38.0 m-20 -158.13 158.69 35.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.141 0.496 . . . . 0.0 111.681 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -50.38 -50.29 51.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.653 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.9 m -57.88 -42.99 85.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.534 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.643 ' HG ' ' H ' ' A' ' 90' ' ' ASP . 90.2 p -62.89 -35.59 80.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.077 0.465 . . . . 0.0 110.3 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.6 tt -67.28 -50.13 61.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.345 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 88.1 t -59.87 -36.58 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.223 0.535 . . . . 0.0 110.648 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 81.3 mmm -86.34 -8.67 57.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.34 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -111.57 -12.26 15.33 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 119.704 -0.498 . . . . 0.0 113.073 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 97' ' ' GLY . 9.4 mt -33.59 -92.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 117.777 0.789 . . . . 0.0 111.937 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.414 ' H ' ' HB ' ' A' ' 98' ' ' ILE . 47.9 t-80 -41.08 -51.67 3.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.512 . . . . 0.0 111.267 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -46.63 -91.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.061 0.764 . . . . 0.0 113.061 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.443 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.8 m -68.42 -50.71 54.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.443 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 3.6 mp -63.78 -42.06 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.423 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.74 -56.8 19.11 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -49.55 -53.66 22.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.012 0.434 . . . . 0.0 110.494 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -54.05 -46.36 71.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.094 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 109' ' ' LEU . 39.4 t -55.1 -51.72 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -44.52 -44.63 8.79 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.351 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.466 ' C ' ' H ' ' A' ' 110' ' ' TYR . 30.3 mmtp -58.11 -36.47 72.94 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 106' ' ' VAL . 48.0 mt -80.91 23.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.87 178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.466 ' H ' ' C ' ' A' ' 108' ' ' LYS . 36.8 p90 -28.81 143.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.34 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -159.92 -62.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.297 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.594 ' H ' ' CD ' ' A' ' 113' ' ' PRO . 31.3 tt0 -173.88 -38.67 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.857 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.594 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 23.2 Cg_exo -64.22 151.76 84.04 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 122.291 1.994 . . . . 0.0 112.504 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.9 m -119.88 148.08 43.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.007 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.28 144.48 29.87 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.92 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -81.44 -160.04 0.12 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.45 2.1 . . . . 0.0 112.189 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -98.12 111.86 24.03 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.016 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.414 HD12 HG21 ' A' ' 118' ' ' ILE . 96.9 mt -125.18 127.76 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.703 0.287 . . . . 0.0 110.723 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -135.39 127.89 30.57 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.701 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -132.18 151.95 20.03 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -144.06 157.65 44.19 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.1 tp -95.27 148.96 21.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 0.0 110.791 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.66 160.24 43.05 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.85 -39.07 2.58 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.544 2.163 . . . . 0.0 113.532 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -79.8 45.52 0.71 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.334 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.4 ' N ' HD21 ' A' ' 126' ' ' ASN . 2.8 m120 44.3 59.33 3.31 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.541 0.686 . . . . 0.0 110.716 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -136.04 159.42 41.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.958 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.6 mt -138.86 113.63 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.53 121.84 28.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 46.4 tp -114.88 135.13 54.53 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.859 0.361 . . . . 0.0 110.579 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.618 ' HE ' ' CD2' ' A' ' 171' ' ' HIS . 62.0 ttt180 -119.46 123.44 44.06 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.994 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.433 ' OH ' ' O2A' ' A' ' 182' ' ' HEM . 57.7 t80 -124.13 116.48 22.81 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.765 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.01 123.94 38.24 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.584 0.23 . . . . 0.0 110.828 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 136' ' ' ARG . 5.0 p -170.97 147.54 2.33 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.668 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.7 12.54 1.37 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.175 1.917 . . . . 0.0 110.776 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.624 ' HE ' ' CGA' ' A' ' 182' ' ' HEM . 48.8 mtp85 -94.19 113.27 25.17 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.866 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.3 37.03 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.19 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.526 ' H ' ' C ' ' A' ' 136' ' ' ARG . 3.3 mm? -99.75 7.06 45.37 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.963 0.411 . . . . 0.0 110.531 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 98.6 m -42.94 -51.02 5.75 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.587 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -46.76 -36.1 6.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.047 0.451 . . . . 0.0 110.229 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 10.2 t -66.81 -43.35 84.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.1 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.56 -50.83 16.72 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.864 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -61.36 -51.9 66.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.019 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.44 -43.28 20.18 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.51 -51.16 68.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.579 0.228 . . . . 0.0 111.551 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.3 mt -57.06 -56.37 22.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.739 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -49.92 -47.99 51.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.673 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.02 -51.79 56.33 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.67 -60.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.057 0.456 . . . . 0.0 110.708 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.61 -51.09 39.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.919 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -50.92 -46.27 60.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.073 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -50.11 -49.95 50.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.735 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.525 ' CZ ' ' OD1' ' A' ' 90' ' ' ASP . 65.8 t80 -86.22 37.46 0.73 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.247 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 42.35 49.26 4.53 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 110.739 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.459 HE21 ' H ' ' A' ' 156' ' ' LYS . 49.8 tp60 -128.61 143.77 51.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.459 ' H ' HE21 ' A' ' 155' ' ' GLN . 56.0 tttp -127.51 107.22 9.75 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.72 164.14 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.392 0.615 . . . . 0.0 110.892 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -119.51 132.42 55.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.1 mt -110.44 118.27 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.6 t -103.41 116.01 31.61 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.555 0.217 . . . . 0.0 111.238 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 56.7 p-80 -98.16 79.11 2.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.385 0.612 . . . . 0.0 111.714 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -82.43 -1.02 48.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.158 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.469 ' HG1' ' CB ' ' A' ' 173' ' ' MET . 0.2 OUTLIER -142.09 109.82 5.77 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 14.2 m -112.71 -179.9 3.79 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.901 0.381 . . . . 0.0 110.26 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 168' ' ' GLY . 0.5 OUTLIER -92.18 -27.96 17.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -54.42 -23.82 17.44 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.791 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.5 t -87.11 -25.37 24.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.173 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 95.34 21.92 23.47 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.026 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.05 164.93 16.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.973 0.415 . . . . 0.0 110.773 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -50.41 -32.93 18.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.237 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.618 ' CD2' ' HE ' ' A' ' 131' ' ' ARG . 34.1 p80 -173.19 -172.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 2.8 m -94.1 141.23 28.77 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.469 ' CB ' ' HG1' ' A' ' 163' ' ' THR . 0.0 OUTLIER -118.4 124.04 46.71 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.434 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.36 101.11 6.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.631 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.402 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -89.27 126.43 42.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.603 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.61 149.32 11.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.967 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -139.8 136.53 34.16 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.44 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.6 mt -86.48 135.4 33.48 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.234 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.34 149.65 9.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.499 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 181' ' ' ASP . 36.4 t30 -156.98 92.89 1.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.459 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 180' ' ' ASN . 69.0 m-20 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.514 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.624 ' CGA' ' HE ' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.429 ' N ' ' OG ' ' A' ' 38' ' ' SER . 74.2 mtp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 3' ' ' GLY . 30.9 mmtm -81.99 107.23 14.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.471 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 57.76 122.03 0.01 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 tp -55.16 -46.03 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.459 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 mm -62.29 -50.1 81.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -69.57 -21.91 63.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.846 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 3' ' ' GLY . 25.5 t-20 -70.57 -51.52 27.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.827 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.77 -33.79 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.029 0.442 . . . . 0.0 109.944 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.6 tp -74.64 -42.74 57.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.367 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -51.85 -45.71 64.14 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.605 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.58 -49.95 74.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.793 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.495 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 10.9 tpt -52.49 -41.35 63.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.682 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.72 -35.52 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.565 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.0 t -61.19 -23.37 29.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.343 0.592 . . . . 0.0 110.109 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.68 -34.31 19.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.078 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -84.78 -75.82 0.34 Allowed 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.4 m -92.34 -20.26 21.27 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.708 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.48 172.36 25.87 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.724 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.6 ttt -68.01 -28.4 67.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.867 -1.166 . . . . 0.0 110.424 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.0 m -63.21 -41.69 99.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.139 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.86 -36.32 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -53.26 -45.19 68.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.773 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -74.24 -26.97 60.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.41 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -69.38 -49.5 54.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.87 -23.06 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 110.243 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 7.1 tt -75.3 -59.01 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.519 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -60.12 -21.66 61.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.391 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 tttp -80.92 -38.13 28.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.467 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 13.7 m80 -90.6 -87.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.522 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.34 152.96 71.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.476 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.82 146.87 89.08 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.533 2.155 . . . . 0.0 112.016 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.72 -21.42 21.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.233 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -80.27 -57.17 3.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.708 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.423 ' CD ' ' N ' ' A' ' 34' ' ' ARG . 10.7 mpt_? -69.5 136.99 52.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.243 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.39 150.32 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.274 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -120.16 173.58 7.02 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.563 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.443 ' C ' ' H ' ' A' ' 39' ' ' ALA . 1.7 m -121.89 166.67 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.923 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 1' ' ' MET . 1.9 m -77.43 36.06 0.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.908 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.443 ' H ' ' C ' ' A' ' 37' ' ' VAL . . . -157.9 2.26 0.11 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.063 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -98.02 167.64 10.77 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 110.518 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.5 t -72.86 145.13 47.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.437 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -146.18 155.84 42.99 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.675 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.95 124.95 36.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.422 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -72.34 -23.72 61.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.757 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.7 p -59.13 -32.21 69.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.702 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -66.94 -54.29 23.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.701 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -40.69 -55.1 2.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.022 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -41.0 -41.8 1.74 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.255 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 m -74.82 -28.82 60.86 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' A' ' 47' ' ' LEU . 25.3 mm -70.21 -53.17 24.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.916 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.31 -22.42 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.189 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -80.87 -42.12 22.03 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.064 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.467 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 45.2 m-20 -58.69 -56.69 18.88 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.665 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.4 p -59.13 -38.43 74.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.471 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.88 -38.74 83.09 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.128 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -63.91 -32.09 73.5 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.645 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -73.12 -42.43 62.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.563 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.0 mt -80.74 -7.18 59.29 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.831 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.6 t30 55.9 47.76 19.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.578 0.704 . . . . 0.0 109.406 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.8 mmt -125.38 149.49 64.58 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.031 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.56 135.58 53.84 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.353 1.368 . . . . 0.0 111.054 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 tt -50.54 -30.73 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.271 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -71.37 -30.46 66.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.871 0.367 . . . . 0.0 111.227 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.19 -32.37 50.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.131 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 78.1 t -71.37 -56.2 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.38 -43.43 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.263 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -52.73 -51.25 61.24 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.224 0.535 . . . . 0.0 109.569 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.75 -51.35 67.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.963 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.549 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.7 m-30 -51.57 -30.73 21.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.565 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.66 -53.91 35.03 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -53.71 -49.8 67.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.153 0.501 . . . . 0.0 109.781 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.495 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 8.3 m-85 -58.44 -41.04 84.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.709 0.766 . . . . 0.0 110.307 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.04 -38.45 82.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.484 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.58 -35.99 73.35 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.168 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.526 ' CG ' ' HE2' ' A' ' 152' ' ' HIS . 4.3 m120 -58.94 -69.52 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.059 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.426 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -52.63 -41.65 57.3 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.501 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 19.9 mt -57.2 -46.48 82.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.056 0.428 . . . . 0.0 111.269 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.402 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -50.3 -12.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.119 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 77' ' ' LEU . 8.5 p -89.2 -43.92 10.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.202 0.525 . . . . 0.0 110.173 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.43 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.0 mmp_? -65.07 -55.26 19.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.505 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.4 p80 -101.77 31.19 3.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.296 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 6.9 m -46.31 -43.32 15.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.302 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.443 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 83.8 m-20 -55.82 -30.73 61.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.208 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' HIS . 40.0 t -78.5 -23.53 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.847 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.517 ' C ' ' H ' ' A' ' 87' ' ' LYS . 72.0 t -76.06 -42.42 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.34 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 83' ' ' ASP . 1.4 p30 -54.9 -8.67 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' A' ' 85' ' ' VAL . 63.4 mmtt -67.35 -28.13 67.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.204 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.42 ' CD1' ' OG ' ' A' ' 93' ' ' SER . 8.1 m-85 -129.39 128.71 43.58 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.056 0.455 . . . . 0.0 111.161 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -87.52 16.01 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -167.75 165.45 14.14 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 119.219 -0.993 . . . . 0.0 113.075 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.2 -63.18 1.21 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.789 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.6 m -45.91 -43.84 14.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.307 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.42 ' OG ' ' CD1' ' A' ' 88' ' ' PHE . 16.1 p -64.37 -38.03 89.61 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.491 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 97' ' ' GLY . 6.7 tt -62.51 -55.29 28.88 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.781 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.9 t -50.05 -38.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.087 0.47 . . . . 0.0 110.438 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 85.0 mmm -84.84 -7.45 59.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.362 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -109.17 -12.86 19.12 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.873 -0.404 . . . . 0.0 112.694 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 97' ' ' GLY . 43.0 mt -32.46 -103.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 99' ' ' HIS . 2.1 p80 -38.17 -43.8 0.79 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -48.65 -88.87 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 3.0 m -69.05 -51.15 46.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.471 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 3.7 mp -59.79 -45.77 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.047 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.33 -55.49 25.51 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.7 tp -50.4 -53.91 25.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.023 0.439 . . . . 0.0 110.75 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -53.1 -45.4 68.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.463 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 37.9 t -53.11 -52.35 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 110' ' ' TYR . 20.1 t-20 -46.87 -42.66 17.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.835 0.35 . . . . 0.0 110.657 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -62.23 -37.32 84.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.505 ' O ' ' CG ' ' A' ' 110' ' ' TYR . 7.4 mp -70.05 -40.53 75.06 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.302 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.505 ' CG ' ' O ' ' A' ' 109' ' ' LEU . 91.4 m-85 -157.35 172.85 17.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.548 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -62.82 -143.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.662 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 61.01 59.8 3.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.725 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.08 -25.22 11.94 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.775 2.317 . . . . 0.0 111.917 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.1 m -72.58 54.26 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.671 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 116' ' ' PRO . 10.9 mt -72.55 153.47 91.73 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.279 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 115' ' ' LEU . 75.0 Cg_exo -35.83 161.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.811 2.34 . . . . 0.0 113.074 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -98.28 118.6 35.3 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.144 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 mm -120.39 126.29 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.712 0.291 . . . . 0.0 110.675 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -124.97 105.43 9.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.119 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.62 159.66 13.63 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -151.28 158.5 43.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.755 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.59 146.06 30.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -118.69 160.73 39.09 Favored Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.23 -37.08 3.59 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.592 2.195 . . . . 0.0 113.083 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -81.52 45.74 0.9 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.151 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.8 m120 43.76 58.62 3.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.339 0.59 . . . . 0.0 110.742 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -135.09 159.99 39.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.017 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.2 mt -136.96 116.41 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.07 121.46 30.5 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 21.9 tp -118.62 130.99 56.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.251 0.548 . . . . 0.0 110.632 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -126.54 131.22 51.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.517 ' CD1' ' O1A' ' A' ' 182' ' ' HEM . 0.0 OUTLIER -131.46 137.41 48.59 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.252 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 134' ' ' SER . 10.4 p -140.44 133.75 29.77 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.18 0.514 . . . . 0.0 111.92 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.556 ' C ' ' H ' ' A' ' 136' ' ' ARG . 0.7 OUTLIER 167.09 155.2 0.11 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.955 179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -67.91 31.93 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.268 1.978 . . . . 0.0 111.673 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.556 ' H ' ' C ' ' A' ' 134' ' ' SER . 5.5 mpt_? -101.23 95.67 6.69 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.496 ' C ' ' H ' ' A' ' 139' ' ' CYS . 83.8 mtm180 -64.86 11.07 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.257 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.556 ' H ' ' C ' ' A' ' 136' ' ' ARG . 0.7 OUTLIER -74.67 23.93 0.09 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.818 0.342 . . . . 0.0 110.13 -179.531 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.559 ' SG ' ' SG ' ' A' ' 172' ' ' CYS . 62.5 m -48.88 -64.26 0.86 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.121 0.486 . . . . 0.0 111.38 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -46.73 -37.12 7.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.335 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 5.1 t -65.51 -43.18 90.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -44.54 -51.99 8.42 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.669 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.474 ' OE2' ' CB ' ' A' ' 161' ' ' HIS . 40.0 mt-10 -60.34 -49.34 78.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.281 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.5 -48.75 41.42 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.7 mt -57.89 -54.89 41.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.515 0.198 . . . . 0.0 111.495 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 28.0 mt -54.61 -54.86 35.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.713 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -49.79 -50.79 43.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.943 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -56.92 -51.72 55.46 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.794 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.52 -54.59 4.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.441 . . . . 0.0 110.613 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -53.06 -48.86 67.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.053 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -50.59 -53.66 28.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.901 0.381 . . . . 0.0 111.04 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.526 ' HE2' ' CG ' ' A' ' 75' ' ' ASN . 85.6 m-70 -45.73 -49.89 14.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.161 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.61 33.75 0.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 40.75 51.72 3.1 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.148 0.499 . . . . 0.0 110.657 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.485 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 48.7 tp60 -126.86 140.71 52.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.275 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.485 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 29.8 mmtp -115.74 124.77 51.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.8 pt -136.16 170.84 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.665 0.745 . . . . 0.0 112.143 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -132.7 125.74 30.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.852 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 mt -110.94 117.47 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.676 0.274 . . . . 0.0 110.5 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.3 t -97.65 101.02 12.43 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.959 0.409 . . . . 0.0 109.979 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.52 ' NE2' ' O ' ' A' ' 163' ' ' THR . 11.7 t-160 -104.52 75.4 1.23 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.869 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -80.61 -42.76 21.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.895 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.52 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.4 m -76.05 117.98 18.33 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.913 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 166' ' ' HIS . 1.6 p -144.13 113.79 7.14 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.048 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.8 ttt -37.3 -21.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.853 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.572 ' N ' ' O ' ' A' ' 164' ' ' CYS . 83.3 t60 -52.49 -26.81 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.454 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 4.5 t -88.17 -42.88 12.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.141 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.454 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 133.72 10.26 1.86 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.5 162.33 10.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.041 0.448 . . . . 0.0 110.939 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -58.88 -33.18 70.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.616 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -170.05 -170.45 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.559 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 85.0 m -94.61 137.04 34.21 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.971 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.6 tpt -115.68 123.89 49.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.05 103.37 6.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.422 0.629 . . . . 0.0 111.577 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.477 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.5 mp -92.89 126.19 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.329 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.64 153.17 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.549 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -139.5 138.84 36.69 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.571 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 17.0 mt -90.83 144.1 26.05 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.8 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -154.78 -179.49 8.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.559 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.2 t30 57.57 43.64 22.28 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.52 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 48.9 p30 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.563 179.922 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.517 ' O1A' ' CD1' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.52 ' O ' ' N ' ' A' ' 3' ' ' GLY . 44.4 mmm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.477 ' HZ2' ' CG2' ' A' ' 37' ' ' VAL . 17.9 mtpp -55.32 83.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.129 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -179.9 151.51 10.06 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tp -70.28 -36.28 66.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.968 0.413 . . . . 0.0 110.705 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.4 mm -62.46 -44.57 99.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.096 0.474 . . . . 0.0 109.912 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -71.34 -25.41 62.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.54 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.539 ' ND2' ' OG ' ' A' ' 38' ' ' SER . 95.4 m-20 -69.4 -52.51 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.071 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.26 -35.0 70.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.6 tp -67.44 -40.82 85.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.773 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -55.54 -45.47 77.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.039 0.447 . . . . 0.0 109.839 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.81 -53.75 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.569 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.608 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 49.1 mtm -52.3 -44.28 64.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.118 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.17 -36.61 77.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.75 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.29 -25.83 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.151 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.36 -33.79 21.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.173 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -84.2 -76.16 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.8 m -93.22 -21.84 19.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.26 0.552 . . . . 0.0 110.805 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.7 173.96 22.97 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 122.129 0.85 . . . . 0.0 112.962 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.1 ttt -68.14 -28.38 67.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.65 -1.275 . . . . 0.0 110.408 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -61.83 -39.27 91.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.841 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -77.53 -38.52 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -56.13 -47.84 77.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.128 0.489 . . . . 0.0 110.31 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -75.63 -22.97 56.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.584 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -76.29 -47.11 24.84 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.604 -0.439 . . . . 0.0 112.04 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' CD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -80.61 -25.53 38.38 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 30' ' ' ALA . 8.3 tt -73.65 -44.15 57.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.492 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -73.05 -21.1 60.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.964 0.411 . . . . 0.0 110.555 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 tttt -87.15 -42.0 13.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.866 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -105.49 1.04 27.26 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.569 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.592 ' N ' ' O ' ' A' ' 26' ' ' LEU . . . -152.22 164.62 19.69 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 120.667 0.27 . . . . 0.0 110.792 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 30' ' ' ALA . 97.4 Cg_exo -34.61 169.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 124.061 3.174 . . . . 0.0 114.267 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 42.0 pttt -73.58 37.72 0.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.794 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 32' ' ' LYS . 6.9 t0 83.64 46.71 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -77.29 19.14 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.094 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.536 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 24.2 m -60.65 132.72 26.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.724 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.536 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 41.6 m-85 -163.71 -106.08 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.965 0.412 . . . . 0.0 111.585 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.477 ' CG2' ' HZ2' ' A' ' 2' ' ' LYS . 33.5 m -45.94 -178.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.47 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.539 ' OG ' ' ND2' ' A' ' 7' ' ' ASN . 3.1 m -151.8 47.03 0.79 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.329 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.506 ' O ' ' CD2' ' A' ' 111' ' ' HIS . . . -159.03 -6.23 0.07 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.81 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' C ' ' HE2' ' A' ' 111' ' ' HIS . 5.4 mmpt? -77.28 -168.29 1.09 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.526 0.679 . . . . 0.0 110.834 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.7 t -59.38 137.0 58.15 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.47 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.513 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 54.4 p90 -109.83 127.63 54.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.585 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.39 75.17 4.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.343 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' A' ' 44' ' ' GLU . 0.4 OUTLIER -51.39 -37.85 50.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.721 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.495 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 80.1 p -56.17 -32.51 64.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.708 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -75.96 -36.46 59.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.95 -58.42 5.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.198 0.523 . . . . 0.0 110.805 -179.605 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -38.64 -43.09 0.85 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.055 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.6 p -74.14 -30.03 62.09 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.035 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 47' ' ' LEU . 18.6 mt -72.98 -50.66 30.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.123 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -60.66 -22.42 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.0 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.49 -40.68 25.68 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.898 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -58.83 -57.4 13.21 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.837 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.21 -39.41 78.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.582 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.1 79.54 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.857 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -64.64 -32.94 74.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -72.6 -41.78 65.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.196 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.508 ' O ' ' SD ' ' A' ' 60' ' ' MET . 30.1 mt -79.27 -3.96 48.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.503 ' O ' ' SD ' ' A' ' 60' ' ' MET . 10.6 t-20 52.72 46.62 26.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.475 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -125.56 153.05 72.66 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.863 179.308 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.48 136.68 47.63 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.717 1.612 . . . . 0.0 110.816 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 tt -51.19 -28.76 7.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.819 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.629 ' NE2' ' CZ ' ' A' ' 140' ' ' PHE . 3.0 tp-100 -76.04 -32.22 59.24 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.973 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -80.15 -31.61 38.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.86 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.499 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 63.5 t -67.84 -58.17 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.86 -40.86 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 ttpp -51.65 -47.18 63.84 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.896 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.36 -59.76 4.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.171 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 5.1 m-30 -45.15 -29.0 0.83 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.763 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.94 -52.15 50.21 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -55.51 -51.4 67.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.075 0.464 . . . . 0.0 110.302 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.608 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 45.5 m-85 -59.19 -43.38 92.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.757 0.789 . . . . 0.0 110.909 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 tp -52.06 -38.32 56.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.296 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 22.6 t80 -70.87 -41.48 71.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.106 0.479 . . . . 0.0 110.014 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -54.22 -74.52 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.14 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -50.64 -37.18 33.41 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.767 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 19.2 mt -58.56 -47.25 84.86 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.337 0.569 . . . . 0.0 112.139 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -47.43 -20.94 0.26 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.231 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' ' 82' ' ' THR . 19.7 t -77.8 -50.17 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 111.003 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -64.28 -64.74 0.8 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.571 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.4 p80 -83.64 31.21 0.47 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.737 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 94.3 m -48.29 -45.85 35.32 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.452 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -53.16 -29.78 33.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.052 0.453 . . . . 0.0 109.863 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 3.3 t -83.21 -23.98 8.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.41 ' C ' ' H ' ' A' ' 87' ' ' LYS . 27.5 t -63.31 -39.68 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -53.48 -13.59 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.434 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 84' ' ' VAL . 37.8 mmtm -66.6 -31.08 71.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.51 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 20.5 p90 -120.39 117.13 26.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.059 0.457 . . . . 0.0 110.931 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.36 0.78 48.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.317 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 48.6 t0 -163.86 157.74 19.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.626 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.507 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 82.5 t80 -48.13 -51.44 24.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.712 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 83.9 m -56.32 -41.86 76.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.522 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.3 m -62.74 -36.54 83.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.411 0.624 . . . . 0.0 110.563 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 98' ' ' ILE . 2.2 tt -65.91 -62.52 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.289 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.5 t -47.43 -41.44 7.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 O-C-N 123.337 0.398 . . . . 0.0 111.879 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.6 ppp? -85.67 -8.11 58.4 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.278 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -107.77 -14.21 18.11 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.461 -0.4 . . . . 0.0 112.334 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 94' ' ' LEU . 33.4 mt -31.87 -97.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 117.398 0.599 . . . . 0.0 111.997 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -39.95 -49.99 2.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.173 0.511 . . . . 0.0 111.377 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -46.89 -90.02 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.447 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.6 m -68.97 -50.75 51.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 4.1 mp -64.19 -42.52 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.493 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.56 -57.98 10.22 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.509 ' CD1' ' HZ1' ' A' ' 108' ' ' LYS . 56.7 tp -46.73 -55.11 8.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.143 0.496 . . . . 0.0 110.438 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -52.41 -44.52 65.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.8 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 30.4 t -55.44 -52.32 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -47.04 -44.75 20.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.64 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.509 ' HZ1' ' CD1' ' A' ' 104' ' ' LEU . 27.0 mmtm -58.9 -34.79 72.07 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.932 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -57.9 -35.24 70.76 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.435 ' CB ' ' O ' ' A' ' 109' ' ' LEU . 9.5 t80 82.04 102.42 0.06 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.694 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 36.0 t-80 -173.6 -0.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.458 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 111' ' ' HIS . 7.1 pt-20 32.81 61.46 1.48 Allowed Pre-proline 0 N--CA 1.468 0.456 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.68 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.53 -15.51 13.82 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.827 2.352 . . . . 0.0 112.159 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.7 t 57.54 84.51 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.505 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.4 mt -74.36 147.98 85.62 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.502 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.89 -177.14 2.7 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.246 1.964 . . . . 0.0 111.95 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -84.55 113.5 21.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.557 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -128.48 129.1 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.674 0.273 . . . . 0.0 110.886 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -134.08 123.34 24.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.718 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.91 127.01 7.04 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -117.33 166.34 12.41 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.2 mp -109.31 133.96 52.39 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.93 160.71 28.84 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 58.5 Cg_endo -71.78 159.02 51.83 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.188 1.925 . . . . 0.0 111.883 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.581 HD21 HD22 ' A' ' 126' ' ' ASN . 11.0 t30 90.91 -59.17 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.296 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.612 ' N ' HD21 ' A' ' 126' ' ' ASN . 0.0 OUTLIER 151.83 53.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.894 0.747 . . . . 0.0 109.499 179.285 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -127.74 164.06 22.96 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.976 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.4 mt -141.24 119.2 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.67 123.33 33.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.083 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 47.4 tp -118.24 132.34 56.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.074 0.464 . . . . 0.0 110.965 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -115.7 122.81 46.65 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.234 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.462 ' HH ' ' CB ' ' A' ' 134' ' ' SER . 22.8 t80 -125.63 124.58 41.5 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.585 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.05 122.15 23.73 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.765 0.316 . . . . 0.0 110.199 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.462 ' CB ' ' HH ' ' A' ' 132' ' ' TYR . 7.8 t -153.76 143.01 14.87 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.047 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.95 -6.93 18.71 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.962 1.775 . . . . 0.0 112.012 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -78.42 -20.3 51.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.124 0.488 . . . . 0.0 110.339 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 60.39 29.63 19.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.984 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp -83.46 15.2 3.17 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.332 0.587 . . . . 0.0 109.94 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 32.9 m -41.73 -48.29 4.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.702 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.629 ' CZ ' ' NE2' ' A' ' 63' ' ' GLN . 98.2 m-85 -48.13 -39.88 21.93 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.708 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.3 t -64.44 -43.23 94.95 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.97 -52.97 10.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.436 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -55.14 -50.07 70.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.08 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.97 -48.22 46.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.09 -54.23 49.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.743 0.306 . . . . 0.0 111.369 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.8 mt -54.88 -55.66 27.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.849 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -49.75 -48.53 50.14 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.817 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.95 -51.31 59.94 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.35 -60.13 2.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.736 0.303 . . . . 0.0 110.832 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.34 -51.09 57.56 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.317 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -52.98 -48.75 67.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.053 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -47.97 -49.15 31.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.504 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 73.3 t80 -83.42 36.28 0.52 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.71 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 40.78 58.25 2.48 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.939 0.399 . . . . 0.0 111.228 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.52 ' NE2' ' N ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -132.63 152.59 51.61 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.522 ' NZ ' ' OXT' ' A' ' 181' ' ' ASP . 62.6 mttp -120.8 117.94 28.71 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.497 ' CG2' HE21 ' A' ' 155' ' ' GLN . 36.5 pt -130.68 169.7 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.624 0.726 . . . . 0.0 112.63 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -134.73 127.12 30.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.898 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mt -110.42 118.65 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.8 m -103.01 111.55 23.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.398 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 16.7 p80 -96.61 77.22 2.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.513 0.673 . . . . 0.0 111.558 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 54.7 t0 -82.1 -3.3 54.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.415 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.56 114.6 8.64 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 92.3 m -118.62 -175.93 2.99 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.628 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 72.7 mtp -94.73 -26.47 16.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -55.61 -23.66 28.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.798 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.0 t -87.16 -29.69 21.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.5 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.41 18.0 22.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.63 167.03 9.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.847 0.356 . . . . 0.0 110.423 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.544 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 94.4 m-20 -45.55 -49.6 13.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.69 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.544 ' ND1' ' O ' ' A' ' 170' ' ' ASP . 73.6 m-70 -160.76 -168.14 2.03 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.5 t -93.85 144.27 25.59 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.149 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.2 120.93 36.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.061 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.53 103.62 7.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.469 0.652 . . . . 0.0 110.502 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 175' ' ' ILE . 1.4 mp -89.95 127.12 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.379 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.93 150.51 13.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.32 0.581 . . . . 0.0 110.869 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -136.17 136.08 39.71 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.897 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.2 mt -96.83 159.72 14.76 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.62 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -138.93 167.66 21.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.845 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -71.59 -40.03 70.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.731 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.522 ' OXT' ' NZ ' ' A' ' 156' ' ' LYS . 91.8 m-20 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.561 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.431 ' CMC' ' CE1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' H2 ' ' C ' ' A' ' 39' ' ' ALA . 86.9 mtp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.478 ' HZ3' ' CD ' ' A' ' 112' ' ' GLU . 55.2 mttp -148.09 -155.85 0.67 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.538 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.16 -16.3 61.37 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.41 ' CD1' ' NH1' ' A' ' 80' ' ' ARG . 2.5 tp -53.9 -38.46 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.029 0.443 . . . . 0.0 109.881 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.3 -54.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -60.99 -31.22 70.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.267 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -59.94 -60.33 4.0 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.075 0.464 . . . . 0.0 111.428 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.18 -24.26 29.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.474 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.8 tp -74.29 -41.75 60.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.516 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.533 ' OE2' ' CG ' ' A' ' 36' ' ' TYR . 3.4 mt-10 -58.16 -39.25 78.35 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.316 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -60.9 -56.04 25.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.532 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 18.1 tpt -50.73 -41.66 56.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.203 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.31 -34.45 62.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.692 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.36 -23.96 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.22 0.533 . . . . 0.0 110.055 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.65 -33.99 18.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.96 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -85.63 -76.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.7 m -91.37 -19.2 23.17 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.52 171.85 28.12 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.847 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.7 ttt -67.37 -29.51 69.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.776 -1.212 . . . . 0.0 110.327 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 t -61.92 -41.5 98.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.947 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.78 -38.64 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -51.64 -45.89 63.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.0 109.732 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -71.76 -29.8 64.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.011 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.525 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 75.5 mt-10 -68.12 -51.64 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.91 -23.2 48.76 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.436 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 8.7 tt -74.26 -41.88 60.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.528 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -66.97 -19.08 65.66 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 24' ' ' GLU . 1.1 ptpp? -91.66 -29.0 17.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.505 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 3.4 m-70 -94.2 -88.4 0.24 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.82 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -74.85 151.9 86.71 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.57 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -67.46 147.85 78.02 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.626 2.218 . . . . 0.0 111.95 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -83.06 -22.63 33.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.726 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -67.43 -46.15 73.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.929 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.431 ' O ' ' OH ' ' A' ' 42' ' ' TYR . 30.9 mmm-85 -71.82 94.52 1.42 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.134 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -61.06 138.63 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.483 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.533 ' CG ' ' OE2' ' A' ' 10' ' ' GLU . 49.6 p90 -78.95 125.79 29.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.966 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -143.9 148.67 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.614 179.58 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.7 m -77.09 39.31 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.854 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' ' 37' ' ' VAL . . . -151.63 -2.15 0.31 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.008 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.423 ' HZ1' HH21 ' A' ' 34' ' ' ARG . 14.2 mmtt -87.37 167.97 13.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.049 0.452 . . . . 0.0 110.423 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.5 t -91.49 44.32 1.18 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.01 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' A' ' 34' ' ' ARG . 3.2 m-85 -57.28 137.32 56.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.21 123.07 27.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.588 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 36.8 mp0 -65.68 -28.97 69.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 95.3 p -56.93 -33.76 67.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.821 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -68.32 -33.79 74.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.027 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -43.17 -57.5 2.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.165 0.507 . . . . 0.0 110.641 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -38.8 -43.43 0.92 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.724 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.1 m -71.84 -32.44 67.54 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.42 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.6 mp -71.71 -53.81 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.667 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -55.9 -23.37 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.374 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.411 ' O ' ' OE1' ' A' ' 56' ' ' GLN . 4.7 tt0 -79.79 -40.1 29.39 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.14 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 4.4 m-20 -59.69 -57.01 14.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.586 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.8 p -56.17 -41.09 68.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.522 -0.763 . . . . 0.0 108.998 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.05 -39.1 74.22 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.944 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -64.93 -34.6 78.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.4 mmt-85 -70.52 -38.26 74.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.178 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.518 ' O ' ' SD ' ' A' ' 60' ' ' MET . 49.0 mt -82.7 -4.9 58.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.519 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.1 t-20 51.76 44.52 29.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.244 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -125.82 155.81 72.24 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.854 179.188 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.19 140.53 71.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.015 1.81 . . . . 0.0 111.036 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 tt -55.44 -27.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.859 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' CD ' ' CZ ' ' A' ' 140' ' ' PHE . 88.6 mt-30 -76.36 -33.46 58.93 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.45 -30.07 42.06 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.088 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.443 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 96.8 t -72.06 -56.07 11.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -50.98 -40.12 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -52.66 -50.98 62.15 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.895 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.28 -53.98 42.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.721 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 2.9 m-30 -54.25 -27.98 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.92 -52.78 45.57 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -56.44 -47.93 78.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 0.8 OUTLIER -59.33 -43.97 92.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.866 0.841 . . . . 0.0 110.337 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -53.35 -38.68 63.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.809 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.455 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 26.2 t80 -69.84 -41.25 75.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.934 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -55.15 -71.87 0.08 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.781 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.61 -44.48 22.91 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.405 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.8 mt -56.36 -40.63 74.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.0 0.4 . . . . 0.0 111.431 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -59.31 -29.29 67.51 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.879 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.436 ' O ' ' OG1' ' A' ' 82' ' ' THR . 32.9 t -72.83 -54.17 9.52 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.828 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.41 ' NH1' ' CD1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -72.59 -49.48 31.95 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.222 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -83.97 25.44 0.82 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.442 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 79' ' ' SER . 52.6 m -50.44 -38.92 46.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.045 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -57.14 -32.41 66.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.18 -22.07 9.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.547 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 87' ' ' LYS . 40.9 t -69.25 -42.63 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.649 -0.421 . . . . 0.0 109.952 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -52.51 -15.02 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.034 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' N ' ' C ' ' A' ' 85' ' ' VAL . 38.4 mmtm -67.58 -29.92 69.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.648 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.565 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 13.1 p90 -120.85 119.84 33.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.063 0.459 . . . . 0.0 110.967 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -86.28 1.88 49.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.447 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.48 ' OD1' ' CE2' ' A' ' 153' ' ' PHE . 45.4 t0 -166.75 160.15 14.48 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.22 0.533 . . . . 0.0 111.627 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -51.54 -51.05 58.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.941 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.8 m -55.67 -45.38 77.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.734 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 90' ' ' ASP . 54.9 p -61.66 -36.45 80.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.408 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.2 tt -65.89 -52.16 52.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.23 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.8 t -56.31 -36.69 47.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.208 0.527 . . . . 0.0 110.43 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.5 mmm -86.61 -6.89 58.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.33 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -112.9 -14.82 9.75 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.982 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 97' ' ' GLY . 10.3 mt -30.05 -100.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 117.648 0.724 . . . . 0.0 112.348 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -40.35 -49.05 2.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.023 0.44 . . . . 0.0 111.182 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -46.22 -88.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.6 m -70.67 -52.88 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.493 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 3.3 mp -60.62 -46.12 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.302 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.92 -55.25 30.8 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.7 tp -51.74 -53.45 39.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -53.5 -47.36 69.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.159 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.6 t -52.44 -49.22 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -50.13 -41.44 48.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.778 0.323 . . . . 0.0 110.637 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -62.32 -38.61 90.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.722 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.14 -40.94 77.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -158.64 144.64 16.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.419 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -63.6 -154.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.478 ' CD ' ' HZ3' ' A' ' 2' ' ' LYS . 36.0 tt0 61.09 60.67 3.15 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.752 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.509 ' C ' ' H ' ' A' ' 115' ' ' LEU . 73.7 Cg_endo -75.23 35.84 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.69 2.26 . . . . 0.0 111.701 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 112' ' ' GLU . 64.7 m -70.8 38.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.853 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 113' ' ' PRO . 11.2 mt -71.59 152.32 93.7 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.97 168.63 22.6 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.384 2.056 . . . . 0.0 112.08 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -81.53 116.29 21.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.323 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.5 mt -127.5 128.25 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.728 0.299 . . . . 0.0 110.879 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -132.61 119.66 20.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.744 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.72 137.88 14.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -135.04 128.31 32.08 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.565 0.221 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 tp -76.89 149.52 36.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.756 0.312 . . . . 0.0 111.07 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.18 160.47 43.16 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.12 -36.43 4.28 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.578 2.185 . . . . 0.0 113.059 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -80.65 46.41 0.87 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.046 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 43.49 55.87 4.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.52 0.676 . . . . 0.0 110.739 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -133.48 159.22 41.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.876 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.0 mt -136.65 114.65 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.5 121.58 29.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.084 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.7 tp -116.16 134.7 54.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.094 0.473 . . . . 0.0 110.619 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -120.58 124.55 45.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -122.34 105.99 10.69 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.68 121.19 41.78 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 121.198 -0.201 . . . . 0.0 110.539 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.714 ' HG ' ' H ' ' A' ' 136' ' ' ARG . 4.8 p -174.64 149.25 1.29 Allowed Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.374 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.9 18.09 0.37 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.086 1.858 . . . . 0.0 110.817 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.714 ' H ' ' HG ' ' A' ' 134' ' ' SER . 25.1 mtp180 -95.83 104.65 16.59 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.64 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -71.15 40.37 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.634 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 136' ' ' ARG . 1.6 tp -102.09 9.67 40.1 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.112 0.482 . . . . 0.0 110.268 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.9 t -40.05 -48.21 2.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.638 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.417 ' CZ ' ' CD ' ' A' ' 63' ' ' GLN . 90.7 m-85 -48.2 -36.87 14.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.613 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 53.8 t -68.53 -44.4 74.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.023 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.78 -45.71 14.83 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.507 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -63.97 -48.96 74.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.217 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.08 -48.12 39.73 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.4 mt -59.96 -53.55 56.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.734 0.302 . . . . 0.0 111.535 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.9 mt -54.81 -55.88 25.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.078 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -51.68 -48.14 63.59 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.978 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.69 -51.66 56.63 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.21 -60.27 1.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.754 0.311 . . . . 0.0 111.008 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.38 -50.87 38.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.005 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -52.44 -47.14 66.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.249 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -50.01 -50.69 46.47 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.704 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.51 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 69.5 t80 -86.11 37.03 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.933 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 39.17 55.71 2.14 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.937 0.398 . . . . 0.0 111.061 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.548 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 49.0 tp60 -129.87 141.65 50.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.548 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 62.4 tttm -112.34 125.61 54.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.259 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 26.1 pt -137.07 170.15 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.61 0.719 . . . . 0.0 111.993 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -134.96 126.62 28.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.116 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.5 mt -110.52 116.8 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.669 0.271 . . . . 0.0 110.328 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.3 t -101.46 107.94 19.38 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.383 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.559 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.8 p-80 -93.97 65.79 3.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.605 0.717 . . . . 0.0 111.065 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -68.25 -25.35 65.14 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.823 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.422 ' HB ' ' H ' ' A' ' 173' ' ' MET . 1.8 m -112.52 112.0 23.24 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 166' ' ' HIS . 49.9 t -137.3 115.26 11.5 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.602 0.239 . . . . 0.0 110.839 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.412 ' C ' ' N ' ' A' ' 167' ' ' THR . 24.0 ttt -35.18 -22.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.261 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 164' ' ' CYS . 57.7 t-80 -51.11 -21.45 1.92 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.443 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.7 t -90.08 -41.35 11.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.913 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.443 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 124.81 15.0 3.3 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.08 155.86 30.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.976 0.417 . . . . 0.0 110.821 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.92 -27.93 21.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.379 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -172.49 178.87 2.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 6.3 m -94.46 139.72 30.77 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.66 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.422 ' H ' ' HB ' ' A' ' 163' ' ' THR . 16.2 ttm -127.62 94.99 4.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.525 0.679 . . . . 0.0 109.68 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.1 mt -93.12 113.07 25.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.523 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.9 mm -89.14 126.16 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.585 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.38 148.72 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.25 0.548 . . . . 0.0 110.268 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -137.8 136.8 37.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.339 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.3 mt -93.9 146.05 24.19 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.863 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -141.56 178.2 7.62 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.858 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 15.1 m120 54.35 43.62 30.19 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.59 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 51.0 p30 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.591 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.553 ' CGA' ' NE ' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 tp . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.637 0.256 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.43 -51.41 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.168 0.509 . . . . 0.0 109.87 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -69.12 -22.26 63.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.495 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -69.64 -54.13 15.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.6 t -61.71 -35.81 69.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.01 0.433 . . . . 0.0 109.835 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.492 HD13 ' CE2' ' A' ' 69' ' ' PHE . 21.8 tp -70.98 -43.25 68.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.097 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -51.95 -46.09 64.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -61.28 -48.2 82.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.681 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.588 ' SD ' ' CZ ' ' A' ' 72' ' ' PHE . 10.9 tpt -53.84 -43.04 69.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.726 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.15 -35.25 67.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.403 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.01 -23.36 31.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.239 0.542 . . . . 0.0 110.028 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.17 -34.39 19.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.156 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -84.69 -76.62 0.3 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' HD21 ' A' ' 58' ' ' LEU . 97.8 m -91.66 -19.83 22.25 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.282 0.563 . . . . 0.0 110.786 -178.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.02 173.99 26.48 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.825 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.3 ttt -68.74 -29.76 68.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.796 -1.202 . . . . 0.0 110.518 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -62.06 -41.71 98.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.065 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.52 -37.83 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 -51.82 -45.22 63.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -71.73 -29.27 64.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.144 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -67.46 -50.49 58.91 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.782 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.26 -22.93 38.31 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.454 -179.478 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.782 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.3 tt -74.32 -56.0 5.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.145 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -61.55 -22.98 65.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.547 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -81.35 -38.27 26.94 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.3 m80 . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.792 179.701 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.777 0.323 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 41.4 mp0 -72.65 -32.81 66.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.812 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.98 -58.26 5.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.134 0.492 . . . . 0.0 110.66 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CZ ' HD12 ' A' ' 138' ' ' LEU . 84.6 m-85 -37.67 -44.1 0.68 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.042 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.1 t -73.24 -31.23 64.0 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.156 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.9 mt -71.42 -51.25 34.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.129 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -60.39 -21.7 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.84 178.519 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.691 ' HG3' HD12 ' A' ' 62' ' ' ILE . 1.6 tt0 -80.17 -41.52 25.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.002 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -58.62 -57.14 14.28 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.834 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 55' ' ' ALA . 7.8 p -58.63 -39.05 74.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.483 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.412 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -59.56 -39.65 84.72 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.221 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -63.61 -31.85 73.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -74.28 -41.31 61.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.562 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 17' ' ' CYS . 29.0 mt -80.98 -6.37 58.67 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.652 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 56.11 47.79 18.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.488 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mmt -126.54 149.05 66.79 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.066 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -63.11 135.77 52.69 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.381 1.387 . . . . 0.0 111.092 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.691 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.0 tt -49.11 -28.3 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.156 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -71.78 -34.5 69.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.055 0.455 . . . . 0.0 111.582 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -76.03 -31.77 59.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.066 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.2 t -71.83 -56.16 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.734 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.524 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -51.63 -44.45 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.396 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.524 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.9 mtpt -52.33 -50.45 62.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.255 0.55 . . . . 0.0 109.518 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.14 -57.39 12.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.925 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.549 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 8.1 m-30 -45.53 -29.72 1.24 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.391 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.19 -48.07 73.98 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -58.24 -52.34 65.98 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.067 0.46 . . . . 0.0 110.054 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 12' ' ' MET . 63.1 m-85 -56.59 -40.18 74.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.747 0.785 . . . . 0.0 110.616 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.9 tp -59.22 -37.85 78.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.387 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -70.54 -37.9 74.11 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.968 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -58.11 -71.31 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.887 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.07 -41.79 30.2 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.296 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.402 ' C ' ' N ' ' A' ' 79' ' ' SER . 24.2 mt -58.39 -43.37 88.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.368 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -51.75 -17.56 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.161 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.43 ' O ' ' OG1' ' A' ' 82' ' ' THR . 8.0 t -85.73 -40.88 15.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.247 0.546 . . . . 0.0 109.62 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.431 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.3 mmp_? -65.44 -72.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.471 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.536 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -87.84 36.91 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.399 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 6.8 m -49.45 -48.99 47.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.926 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -51.43 -33.67 31.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.18 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.538 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 7.1 t -73.82 -29.24 25.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.499 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.536 ' C ' ' H ' ' A' ' 87' ' ' LYS . 89.3 t -76.22 -44.68 36.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.562 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 54.7 t0 -58.24 3.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.366 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' A' ' 85' ' ' VAL . 30.6 mtmt -90.57 -22.45 21.27 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.541 ' CE1' HG21 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -104.13 125.83 50.76 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.794 -179.246 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 56.6 p30 -88.44 -6.07 57.87 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 58.8 m-20 -160.29 164.12 32.84 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.636 0.731 . . . . 0.0 112.535 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.402 ' CE2' HG21 ' A' ' 95' ' ' VAL . 64.4 t80 -55.1 -44.29 74.77 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.979 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.9 m -57.71 -59.72 4.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.352 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 97.4 p -45.67 -40.14 8.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.367 0.604 . . . . 0.0 110.792 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.44 -41.59 96.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.428 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 91' ' ' PHE . 69.5 t -67.89 -40.84 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.384 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.9 ptm -83.25 -3.16 57.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.307 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -116.41 -15.74 6.89 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 119.123 -0.82 . . . . 0.0 113.357 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.599 ' HA ' HD13 ' A' ' 102' ' ' ILE . 18.8 mt -25.09 -104.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 118.04 0.92 . . . . 0.0 112.477 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -40.38 -49.0 2.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.068 0.461 . . . . 0.0 111.466 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -45.63 -83.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.61 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.8 m -73.31 -53.81 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.61 ' N ' HG23 ' A' ' 101' ' ' VAL . 3.3 mp -59.27 -49.84 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.939 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.33 -55.13 32.41 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.8 tp -49.18 -48.0 45.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.154 0.502 . . . . 0.0 109.769 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -57.59 -46.46 83.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.042 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.6 t -54.22 -50.15 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -49.07 -43.59 41.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.717 0.294 . . . . 0.0 110.803 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp . . . . . 0 C--N 1.33 -0.278 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.211 179.778 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 C--O 1.231 0.108 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.1 128.54 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.716 0.293 . . . . 0.0 110.959 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -133.58 123.57 25.35 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.652 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.12 158.22 14.64 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.442 ' C ' HD22 ' A' ' 122' ' ' LEU . 52.3 tt0 -149.95 160.1 43.87 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.824 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.4 mm? -106.74 146.02 31.34 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.99 160.4 40.99 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.25 -38.12 2.9 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.596 2.197 . . . . 0.0 113.054 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -79.49 44.83 0.63 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.953 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 44.39 58.29 3.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.413 0.625 . . . . 0.0 110.72 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -135.11 159.94 39.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.107 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 45.0 mt -137.41 117.12 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.3 122.86 32.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.049 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.1 tp -118.8 133.03 56.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.044 0.45 . . . . 0.0 111.205 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -114.79 122.98 48.03 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.481 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 62.1 t80 . . . . . 0 N--CA 1.469 0.486 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.786 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.413 HD12 ' CZ ' ' A' ' 48' ' ' PHE . 4.1 tp . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 121.215 0.531 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 74.4 m -42.08 -43.87 3.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.469 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -48.87 -41.98 35.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.961 0.41 . . . . 0.0 110.375 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.6 t -64.29 -43.27 95.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -44.52 -50.1 9.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.59 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.03 -49.56 77.17 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.164 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.01 -48.96 50.89 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.0 -55.1 39.36 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.58 0.229 . . . . 0.0 111.315 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.7 mt -54.14 -54.38 40.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.909 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.54 ' CE2' HD12 ' A' ' 159' ' ' ILE . 12.1 m-85 -51.52 -48.02 63.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.952 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.49 -51.54 57.18 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.8 -59.76 2.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.881 0.372 . . . . 0.0 110.844 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -48.28 -51.68 24.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.873 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -52.03 -47.86 64.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.218 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -49.48 -49.9 43.64 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.64 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.507 ' CZ ' ' OD1' ' A' ' 90' ' ' ASP . 71.5 t80 -85.48 37.17 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.939 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 39.21 57.57 1.99 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.021 0.439 . . . . 0.0 111.199 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -131.59 143.43 50.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -118.85 105.25 11.32 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.8 pt -114.47 175.49 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.596 0.712 . . . . 0.0 111.718 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -138.08 127.67 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.407 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.54 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.7 mt -111.31 117.76 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.602 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.1 t -98.28 98.89 10.09 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.602 ' CD2' ' SG ' ' A' ' 164' ' ' CYS . 23.7 t-160 -92.14 69.92 5.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.005 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.52 -57.28 3.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.56 119.53 21.26 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.464 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 1.7 m -143.64 119.06 10.28 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.122 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 38.0 ttp -36.11 -21.69 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.036 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 164' ' ' CYS . 58.3 t-80 -51.19 -22.0 2.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.45 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.3 t -91.43 -41.42 10.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.103 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.45 ' N ' HG23 ' A' ' 167' ' ' THR . . . 126.5 12.25 3.46 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.86 171.6 6.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.0 0.429 . . . . 0.0 110.817 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 171' ' ' HIS . 42.1 p-10 -53.31 -35.65 60.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.273 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.52 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 9.8 p80 -174.52 -167.06 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.7 m -94.9 142.97 26.85 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.758 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.573 ' CG ' HD11 ' A' ' 175' ' ' ILE . 28.3 ttm -119.49 116.12 25.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.058 0.456 . . . . 0.0 109.954 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 176' ' ' ILE . 1.3 mt -118.15 99.53 6.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.491 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.573 HD11 ' CG ' ' A' ' 173' ' ' MET . 8.5 mm -85.27 126.24 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.939 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 174' ' ' LEU . 5.1 mp -112.31 149.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.35 0.595 . . . . 0.0 110.375 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -144.14 142.48 30.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.349 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.35 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 tp . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.773 0.321 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.1 mm -72.31 -41.07 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 1.2 m-30 -75.48 -25.45 57.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.643 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -69.16 -52.77 24.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.821 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.71 -39.13 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.061 0.457 . . . . 0.0 109.855 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.521 HD13 ' CE2' ' A' ' 69' ' ' PHE . 20.9 tp -67.02 -47.62 70.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.87 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -50.37 -44.5 54.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.958 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.18 -54.37 46.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.383 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.439 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 28.5 ttt -51.05 -41.45 59.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.061 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.15 -36.71 77.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.509 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.7 t -62.04 -23.12 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.264 0.554 . . . . 0.0 110.032 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.04 -34.31 18.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.026 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -85.88 -76.51 0.33 Allowed 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 58' ' ' LEU . 98.1 m -90.69 -17.71 26.31 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.314 0.578 . . . . 0.0 110.599 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.87 179.19 30.56 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.741 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.8 ttp -72.95 -30.5 63.91 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.004 -1.098 . . . . 0.0 110.701 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.2 t -60.55 -39.31 87.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.981 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.04 -38.61 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 55.4 t-105 -55.26 -47.47 75.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.204 0.526 . . . . 0.0 110.071 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -74.76 -25.8 59.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.494 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.64 -47.48 26.23 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.978 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.996 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -78.34 -23.34 47.02 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.861 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.996 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.9 tt -76.35 -43.4 41.1 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.366 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -67.74 -18.89 65.04 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.26 -30.83 18.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.474 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.2 m80 . . . . . 0 N--CA 1.463 0.195 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.637 -179.767 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.782 0.325 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -56.62 -29.56 62.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.874 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.554 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -51.18 -56.52 12.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.081 0.467 . . . . 0.0 110.978 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -39.87 -42.17 1.27 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.867 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 m -74.05 -29.78 62.07 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.919 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 47' ' ' LEU . 17.8 mt -73.4 -51.4 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.275 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.1 m -59.15 -25.08 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.155 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.657 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.7 tt0 -77.2 -40.83 43.74 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.735 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -59.3 -56.97 15.33 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.858 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.26 -39.55 52.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.86 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.01 -38.58 83.09 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.479 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.437 ' NE2' ' N ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -63.03 -31.94 73.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -73.28 -40.6 64.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.672 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 ' SG ' ' A' ' 17' ' ' CYS . 37.7 mt -83.15 -8.91 59.44 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.615 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 58.1 51.54 8.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.453 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.42 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 20.6 mmt -131.14 149.89 74.99 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.448 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.18 138.48 72.52 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.534 1.489 . . . . 0.0 111.27 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.657 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.4 tt -53.18 -28.75 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.654 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -74.59 -29.65 61.4 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.302 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -78.64 -35.22 45.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.034 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.538 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.0 t -65.06 -59.65 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.7 p -48.99 -38.8 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.793 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -53.68 -45.15 70.25 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.18 -57.44 10.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.898 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.538 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 6.3 m-30 -45.18 -29.15 0.88 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.313 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.67 -51.29 58.48 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.515 ' NE2' ' OE1' ' A' ' 151' ' ' GLN . 39.9 tt0 -58.0 -52.93 63.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.995 0.426 . . . . 0.0 110.32 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.439 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 61.1 m-85 -55.0 -41.3 71.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.722 0.772 . . . . 0.0 110.507 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.5 tp -59.05 -38.68 79.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.411 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -67.48 -40.38 85.29 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.139 -0.625 . . . . 0.0 109.896 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -57.93 -69.37 0.18 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.305 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.11 -42.01 30.83 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.74 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.88 -43.27 81.09 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.376 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.94 -27.45 18.97 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.424 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.8 t -74.42 -38.61 63.01 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -65.05 -69.22 0.3 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.802 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -98.49 47.03 0.99 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.036 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 m -51.49 -44.41 62.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.767 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 92.7 m-20 -56.8 -30.13 63.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.609 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.7 t -79.15 -20.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.767 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' A' ' 87' ' ' LYS . 49.0 t -75.88 -40.47 38.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.306 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 83' ' ' ASP . 29.8 p-10 -52.82 -8.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.045 0.45 . . . . 0.0 110.661 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 85' ' ' VAL . 56.9 mttm -73.02 -29.96 63.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.468 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.612 ' CZ ' ' CE2' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -97.56 119.6 36.41 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.021 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 53.4 p30 -88.24 -19.09 27.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.498 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 49.4 p30 -156.44 148.04 22.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.752 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -37.67 -40.65 0.43 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.04 0.447 . . . . 0.0 111.176 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.6 m -63.74 -41.67 98.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.869 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.433 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 38.7 m -61.34 -36.67 80.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.527 0.68 . . . . 0.0 110.375 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 98' ' ' ILE . 7.2 tt -65.53 -63.28 1.13 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.462 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.6 t -48.65 -41.72 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.789 0.328 . . . . 0.0 111.722 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.429 ' C ' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -85.49 -6.03 59.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.448 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -110.28 -14.38 13.28 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.659 -0.523 . . . . 0.0 112.439 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.495 ' O ' ' O ' ' A' ' 97' ' ' GLY . 39.8 mt -29.58 -104.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 117.395 0.597 . . . . 0.0 112.58 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.462 ' N ' ' ND1' ' A' ' 99' ' ' HIS . 9.0 p-80 -39.47 -48.33 1.97 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.06 0.457 . . . . 0.0 111.494 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -44.99 -87.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -71.05 -51.66 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.562 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mp -63.63 -47.81 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.651 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.14 -52.6 46.03 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.585 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 31.9 tp -49.51 -48.17 48.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.119 0.485 . . . . 0.0 110.31 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -57.43 -45.37 84.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.118 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 82.3 t -52.37 -51.92 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -49.42 -41.66 40.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.803 0.335 . . . . 0.0 110.547 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.585 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 24.4 mmtm . . . . . 0 C--N 1.329 -0.312 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.495 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 79.2 m80 . . . . . 0 C--O 1.232 0.132 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.6 mt -124.63 128.75 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.71 0.29 . . . . 0.0 110.707 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.469 ' OD1' ' NH2' ' A' ' 131' ' ' ARG . 4.1 m120 -132.62 115.1 15.0 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.427 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.84 123.68 5.9 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.401 ' C ' HD12 ' A' ' 122' ' ' LEU . 37.1 tt0 -116.99 152.27 34.97 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.605 ' N ' HD12 ' A' ' 122' ' ' LEU . 8.8 mp -99.67 148.0 24.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.06 160.67 42.13 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.35 -40.61 2.19 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.573 2.182 . . . . 0.0 113.062 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -77.77 43.67 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.874 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 46.03 60.86 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.267 0.556 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -138.0 160.83 38.31 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.085 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.1 mt -141.84 117.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.69 121.47 31.1 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.845 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.5 tp -114.54 134.85 54.72 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.908 0.385 . . . . 0.0 110.137 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.469 ' NH2' ' OD1' ' A' ' 119' ' ' ASN . 23.5 ttp-105 -120.79 125.22 47.02 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.108 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 141' ' ' CYS . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 121.067 0.46 . . . . 0.0 110.214 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 85.5 m -39.9 -44.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.624 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.798 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 94.4 m-85 -53.75 -34.76 60.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.629 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 138' ' ' LEU . 43.8 t -69.79 -46.29 66.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.118 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.27 -46.07 12.41 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.384 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.49 -47.81 80.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.732 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.19 -52.47 40.1 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.1 mt -53.32 -55.73 22.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.746 0.308 . . . . 0.0 110.805 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 20.2 mt -54.82 -54.67 39.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.4 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.545 ' CE2' HD12 ' A' ' 159' ' ' ILE . 6.4 m-85 -50.15 -50.58 48.45 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.093 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.11 -49.99 67.8 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.358 -0.448 . . . . 0.0 111.996 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.03 -59.74 2.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.891 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 155' ' ' GLN . . . -53.9 -51.99 61.95 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.477 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.515 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 86.6 mt-30 -51.83 -56.68 12.49 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 120.853 0.359 . . . . 0.0 111.164 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -41.5 -47.52 3.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.921 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.612 ' CE2' ' CZ ' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -86.17 36.46 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.665 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 151' ' ' GLN . 48.4 tt0 42.29 57.77 3.23 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.395 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.505 ' CD ' ' H ' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -131.76 153.62 49.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.505 ' H ' ' CD ' ' A' ' 155' ' ' GLN . 56.4 mttp -121.7 116.44 24.54 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 31.4 pt -130.2 173.82 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.369 0.604 . . . . 0.0 111.728 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -140.37 126.85 20.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.927 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.545 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.6 mt -110.97 118.42 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.4 t -101.81 110.92 23.01 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.667 0.27 . . . . 0.0 111.016 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.553 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 50.1 p-80 -102.57 73.57 1.31 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.688 0.756 . . . . 0.0 111.494 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -76.56 -18.88 58.43 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.801 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 108.4 13.21 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.577 ' O ' ' N ' ' A' ' 166' ' ' HIS . 9.1 t -133.68 118.82 18.59 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.608 0.242 . . . . 0.0 110.868 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 44.4 ttm -35.8 -22.36 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.214 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.798 ' CE1' ' CE2' ' A' ' 140' ' ' PHE . 32.6 m170 -51.43 -23.28 3.7 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.1 t -89.31 -41.89 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.021 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.458 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 127.88 13.3 2.75 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.83 159.43 19.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.998 0.428 . . . . 0.0 110.831 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -56.7 -27.76 59.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.399 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -168.87 175.88 5.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 9.5 m -91.72 143.81 26.16 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.805 0.335 . . . . 0.0 110.627 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.2 tpp -121.99 120.52 34.64 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.44 104.83 8.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.394 0.616 . . . . 0.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -91.23 125.36 43.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.4 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 177' ' ' GLU . 5.2 mp -110.32 152.59 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.999 0.428 . . . . 0.0 110.27 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.42 ' N ' HG22 ' A' ' 176' ' ' ILE . 21.5 mt-10 -143.95 141.99 30.51 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.995 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.463 0.193 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.926 179.306 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.49 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 49.6 mm -57.78 -53.89 38.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 0.0 109.755 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -67.56 -18.75 65.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.568 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -73.39 -56.2 5.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.471 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t -56.99 -36.03 49.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.466 HD13 ' CE2' ' A' ' 69' ' ' PHE . 18.1 tp -72.09 -41.75 66.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.752 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -51.82 -44.38 63.5 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -61.53 -50.65 71.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.987 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.476 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 13.5 ttt -52.55 -42.89 64.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 86.8 t -68.89 -35.91 71.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.462 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -61.01 -23.42 29.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.336 0.589 . . . . 0.0 109.799 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.22 -34.43 20.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.174 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -85.06 -75.86 0.34 Allowed 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.546 ' SG ' HD21 ' A' ' 58' ' ' LEU . 87.7 m -92.03 -20.75 21.0 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.234 0.54 . . . . 0.0 110.741 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.8 172.04 25.52 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.819 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 ttt -66.92 -29.08 68.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.798 -1.201 . . . . 0.0 110.55 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t -62.51 -41.54 98.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.133 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.68 -35.87 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -51.97 -45.82 64.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.223 0.535 . . . . 0.0 109.578 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -72.24 -29.65 64.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.211 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -67.39 -49.24 64.69 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.824 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.38 -23.46 34.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.793 0.33 . . . . 0.0 110.651 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.824 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.6 tt -72.62 -61.8 1.68 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.401 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.489 ' N ' HD23 ' A' ' 26' ' ' LEU . 96.9 mt-10 -59.2 -22.11 60.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.687 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -81.2 -41.15 22.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.5 m80 . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.554 179.716 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.729 0.299 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.27 -42.57 98.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.83 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -40.82 -58.76 1.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.928 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -37.68 -43.36 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.539 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.5 p -72.48 -33.32 66.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.272 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.0 mp -68.38 -54.83 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.028 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -55.32 -24.61 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.878 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.649 ' HG3' HD12 ' A' ' 62' ' ' ILE . 5.8 tt0 -75.56 -41.79 53.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.598 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -58.62 -56.83 17.11 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.136 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.19 -38.82 63.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.096 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.534 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -59.11 -38.5 79.71 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.179 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.502 ' NE2' ' N ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -63.77 -31.68 72.94 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -73.79 -40.56 63.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.546 HD21 ' SG ' ' A' ' 17' ' ' CYS . 30.9 mt -85.25 -6.75 59.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.085 0.469 . . . . 0.0 110.004 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.489 ' O ' ' SD ' ' A' ' 60' ' ' MET . 84.9 m-20 56.47 61.18 2.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.973 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 52.3 mmm -139.76 149.84 60.79 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.708 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.21 136.86 53.68 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.405 1.403 . . . . 0.0 110.778 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.649 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.6 tt -50.21 -27.66 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.042 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -73.44 -31.38 63.79 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.481 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.7 -34.05 52.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.995 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.534 HG21 ' HB2' ' A' ' 55' ' ' ALA . 84.8 t -69.5 -57.21 9.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.3 p -51.99 -42.23 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.308 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.515 ' N ' HG13 ' A' ' 66' ' ' VAL . 33.0 mtpt -52.75 -50.3 63.75 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.38 -48.22 81.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.757 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.469 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.0 m-30 -52.12 -30.42 26.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.632 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.44 -48.13 71.82 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -56.89 -51.74 67.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.931 0.396 . . . . 0.0 109.98 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 55.4 m-85 -58.68 -42.53 88.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.818 0.818 . . . . 0.0 110.447 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.8 tp -56.8 -39.26 73.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.335 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 38.1 t80 -69.0 -41.31 77.97 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.002 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -55.9 -69.28 0.15 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.199 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.63 -46.89 30.37 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.397 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.8 mt -51.0 -43.69 60.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.724 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.7 -25.9 30.27 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.277 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 82' ' ' THR . 32.9 t -74.4 -55.68 5.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.045 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.409 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -74.17 -38.04 63.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.781 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -94.26 25.43 3.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.555 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 79' ' ' SER . 55.9 m -52.83 -39.0 62.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 110.002 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -57.91 -31.12 66.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.432 HG22 ' HG2' ' A' ' 105' ' ' GLU . 2.8 t -86.22 -20.17 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.55 -40.81 89.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -53.22 -19.66 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.387 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -64.72 -29.47 70.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.797 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 7.0 p90 -122.54 115.27 21.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.887 0.375 . . . . 0.0 110.843 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 54.8 p30 -85.69 -3.41 58.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.451 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 89' ' ' ASP . 61.7 m-20 -160.86 156.96 25.83 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.088 0.471 . . . . 0.0 111.452 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.407 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 69.6 t80 -48.12 -53.05 17.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.812 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.8 m -55.69 -42.41 75.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.655 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.0 p -63.0 -38.27 90.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.447 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.0 tt -64.12 -48.97 74.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.004 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.5 t -58.25 -37.39 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 0.0 110.776 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 120' ' ' GLY . 95.6 mmm -87.24 -4.89 59.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.088 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.7 -16.93 7.75 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.163 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.507 ' O ' ' O ' ' A' ' 97' ' ' GLY . 11.2 mt -27.43 -106.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 117.828 0.814 . . . . 0.0 112.645 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -40.45 -48.35 2.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.118 0.485 . . . . 0.0 111.074 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -44.46 -86.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.564 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.2 m -72.86 -52.17 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.564 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.8 mp -63.97 -48.3 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.617 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.02 -54.63 35.96 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.9 tp -48.8 -50.58 33.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.138 0.495 . . . . 0.0 110.101 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.432 ' HG2' HG22 ' A' ' 84' ' ' VAL . 37.5 tp10 -54.26 -46.38 72.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.389 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 64.3 t -53.87 -53.38 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -46.54 -43.51 17.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.804 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp . . . . . 0 C--N 1.329 -0.301 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.516 -179.909 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 76.4 m80 . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 120.484 0.183 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.44 123.96 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.45 99.41 5.82 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.892 0.377 . . . . 0.0 110.927 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.479 ' O ' ' SD ' ' A' ' 96' ' ' MET . . . -102.89 123.41 7.83 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -118.87 162.11 19.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.897 0.379 . . . . 0.0 110.447 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -108.12 143.76 36.45 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.12 160.37 41.39 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.77 -38.06 3.38 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.538 2.159 . . . . 0.0 113.343 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -81.0 46.17 0.88 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.27 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 43.7 59.31 3.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 110.685 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -135.52 157.98 45.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.884 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.0 mt -137.06 117.52 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.33 119.99 27.2 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.755 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.5 tp -114.04 125.89 54.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 110.789 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.675 HH21 ' CD2' ' A' ' 171' ' ' HIS . 9.4 tpt180 -111.18 119.73 39.92 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 t80 . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.127 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 3.4 mm? . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 121.298 0.57 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 15.8 p -42.14 -46.57 4.39 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.794 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.596 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 88.6 m-85 -51.49 -38.5 54.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.086 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.506 ' SG ' ' CG2' ' A' ' 66' ' ' VAL . 68.4 m -65.8 -43.29 89.15 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.162 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.54 -49.86 18.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.947 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -62.64 -51.2 68.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.087 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.53 -46.39 37.41 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.5 mt -59.11 -54.29 48.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.707 0.289 . . . . 0.0 111.428 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 mt -55.26 -56.12 23.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.983 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.567 ' CE2' HD12 ' A' ' 159' ' ' ILE . 23.0 m-85 -50.58 -47.6 57.88 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.841 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.02 -50.84 63.57 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.41 -58.48 2.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.002 0.43 . . . . 0.0 110.613 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.7 -52.01 57.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.701 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -50.48 -48.78 56.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.113 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.4 ' ND1' ' C ' ' A' ' 152' ' ' HIS . 16.8 t-80 -48.66 -48.92 39.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.689 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -89.22 39.12 0.92 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.236 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 37.49 57.53 1.37 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.943 0.401 . . . . 0.0 111.379 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -129.82 141.0 50.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -112.61 124.62 52.95 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.407 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 10.3 pt -138.1 170.3 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.735 0.779 . . . . 0.0 111.975 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -133.63 127.65 33.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.335 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.567 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.7 mt -110.0 120.62 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.653 0.263 . . . . 0.0 110.447 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.6 t -103.69 103.81 13.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.771 0.32 . . . . 0.0 110.894 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.1 p-80 -97.14 74.17 2.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.435 0.636 . . . . 0.0 111.338 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -77.29 -7.5 56.08 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.442 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.482 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 4.7 m -123.94 105.79 9.89 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.594 ' O ' ' N ' ' A' ' 166' ' ' HIS . 20.7 t -137.23 114.34 10.74 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.305 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 38.9 ttm -36.34 -18.24 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' CYS . 51.9 m80 -58.15 -28.08 64.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.499 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.2 t -82.41 -46.13 13.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.799 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.499 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 152.65 15.17 0.07 OUTLIER Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.247 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.19 145.64 32.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.907 0.384 . . . . 0.0 110.532 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.469 ' C ' ' ND1' ' A' ' 171' ' ' HIS . 85.7 m-20 -83.44 19.27 1.59 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.021 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.675 ' CD2' HH21 ' A' ' 131' ' ' ARG . 8.5 p-80 174.65 -163.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 163' ' ' THR . 46.6 t -136.48 150.51 48.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.276 0.56 . . . . 0.0 111.426 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.468 ' H ' ' HB ' ' A' ' 163' ' ' THR . 14.8 ttp -126.89 109.95 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.325 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -108.62 111.95 24.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.319 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.6 mp -93.84 128.64 45.06 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.478 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.4 mp -109.63 150.65 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.477 0.656 . . . . 0.0 110.63 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -136.21 134.67 38.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.773 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.463 0.224 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.632 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.59 HD13 ' NE ' ' A' ' 80' ' ' ARG . 2.4 tp . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.682 0.277 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.511 ' H ' HG23 ' A' ' 4' ' ' ILE . 36.1 mm -51.14 -47.5 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.53 -23.96 61.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.742 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -69.48 -51.26 37.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.426 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.51 -50.86 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.34 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.7 tp -55.46 -44.19 76.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -52.09 -50.88 60.71 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.825 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -57.6 -52.55 64.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.029 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.438 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.5 OUTLIER -47.72 -37.11 12.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.469 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -73.73 -34.76 41.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.403 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.4 HG13 ' CG ' ' A' ' 19' ' ' MET . 83.5 t -61.33 -23.69 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.68 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.76 -34.91 22.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.982 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -84.5 -73.88 0.41 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.541 ' SG ' HD21 ' A' ' 58' ' ' LEU . 74.3 m -93.87 -21.52 19.2 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.089 0.471 . . . . 0.0 111.076 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.68 -178.82 23.3 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.827 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.4 ' CG ' HG13 ' A' ' 14' ' ' VAL . 24.0 mtm -74.07 -30.41 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.063 -1.069 . . . . 0.0 110.193 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 m -61.99 -42.82 99.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.85 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.7 -38.42 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -51.84 -45.83 64.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.309 0.576 . . . . 0.0 109.453 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -70.93 -28.84 64.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.116 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -67.9 -49.89 59.4 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.797 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.69 -20.23 36.54 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.934 0.397 . . . . 0.0 110.659 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.8 tt -76.31 -63.32 1.35 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.316 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.509 ' N ' HD23 ' A' ' 26' ' ' LEU . 96.7 mt-10 -57.73 -21.93 43.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.596 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -80.01 -39.93 28.93 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.702 179.772 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.729 0.299 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -59.44 -30.98 68.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.707 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -49.55 -56.2 10.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.107 0.48 . . . . 0.0 110.576 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -38.79 -43.37 0.92 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.808 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.1 p -74.3 -29.3 61.57 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.157 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 47' ' ' LEU . 15.7 mt -72.89 -52.67 21.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.109 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.405 ' H ' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -57.8 -24.37 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.627 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.678 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.4 tt0 -78.03 -39.43 41.98 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.43 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.528 ' OD2' HD23 ' A' ' 25' ' ' LEU . 64.9 m-20 -60.28 -56.85 16.48 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.282 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 55' ' ' ALA . 8.2 p -56.66 -41.05 73.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.553 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -57.1 -38.98 74.16 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.887 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -63.73 -30.79 71.84 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -76.94 -38.56 53.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.583 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.541 HD21 ' SG ' ' A' ' 17' ' ' CYS . 30.1 mt -84.74 -7.09 59.34 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.82 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 47.7 t30 56.36 49.28 15.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.54 0.686 . . . . 0.0 109.302 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.4 mmm -126.94 150.02 70.67 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.133 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.29 137.16 59.27 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 121.513 1.475 . . . . 0.0 110.912 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.678 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.0 tt -50.71 -29.68 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.887 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -69.98 -34.18 73.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.225 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -75.47 -32.91 60.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.104 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.521 HG21 ' HB2' ' A' ' 55' ' ' ALA . 89.1 t -71.6 -55.89 12.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.109 0.48 . . . . 0.0 110.003 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -51.91 -42.86 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.132 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.507 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.5 mtpt -53.89 -49.85 67.64 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.03 -52.3 66.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.655 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.69 -30.95 4.2 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.707 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.24 -50.94 41.51 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -55.12 -49.72 71.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.04 0.448 . . . . 0.0 109.899 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -58.84 -42.57 89.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.7 0.762 . . . . 0.0 110.733 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.2 tp -54.99 -38.62 68.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.309 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 34.2 t80 -71.27 -40.33 71.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.01 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -57.07 -71.92 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.785 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.76 -40.38 18.29 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.286 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.403 ' C ' ' N ' ' A' ' 79' ' ' SER . 44.4 mt -61.81 -39.2 90.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.177 0.489 . . . . 0.0 111.796 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.38 -11.6 0.55 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.697 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.453 ' O ' ' OG1' ' A' ' 82' ' ' THR . 9.3 t -91.91 -48.54 6.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.934 0.397 . . . . 0.0 110.483 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.59 ' NE ' HD13 ' A' ' 4' ' ' ILE . 5.5 mtm105 -68.64 -65.95 0.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.315 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.531 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -81.19 28.78 0.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.19 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 79' ' ' SER . 96.5 m -49.01 -45.49 42.6 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.571 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -52.48 -25.6 10.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.404 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 2.8 t -85.91 -24.57 6.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.828 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.8 t -63.05 -40.43 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.529 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -53.84 -16.19 1.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.448 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.404 ' CG ' ' O ' ' A' ' 84' ' ' VAL . 39.0 mmtm -64.85 -30.87 71.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.488 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 12.9 p90 -119.3 119.32 33.69 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.101 0.477 . . . . 0.0 111.126 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 22.1 t70 -83.87 -5.1 59.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.257 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.492 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 67.8 m-20 -159.59 156.34 27.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.089 0.471 . . . . 0.0 111.485 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -45.39 -46.98 13.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.818 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.9 m -56.9 -58.77 6.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.368 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.7 t -45.27 -40.06 7.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.12 0.485 . . . . 0.0 111.145 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.6 tt -63.81 -48.31 77.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.326 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.2 t -59.32 -40.25 80.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.573 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 9.0 ptm -87.96 -1.52 58.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.6 -18.07 7.21 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.327 -0.707 . . . . 0.0 112.851 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 94' ' ' LEU . 13.5 mt -27.41 -105.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 117.77 0.785 . . . . 0.0 112.493 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -40.56 -48.88 2.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.064 0.459 . . . . 0.0 111.141 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -44.02 -85.84 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.565 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -73.2 -52.27 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.565 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mp -64.71 -48.75 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.7 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.17 -54.49 36.62 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 tp -48.62 -49.83 35.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.191 0.52 . . . . 0.0 109.854 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -55.04 -47.17 75.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.547 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 71.8 t -51.0 -51.04 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -51.72 -40.63 60.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.692 -179.784 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.3 m80 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.696 0.284 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.0 mm -115.65 124.93 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -131.94 116.63 17.39 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.756 0.312 . . . . 0.0 110.962 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.83 158.86 14.06 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -152.79 154.65 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 122' ' ' LEU . 10.3 mp -104.72 150.25 24.9 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.13 160.52 38.87 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.74 -56.62 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.627 2.218 . . . . 0.0 112.797 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 22.0 m120 -45.67 -64.65 0.68 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.501 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 125' ' ' ASN . 3.5 p30 155.54 63.5 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.57 0.7 . . . . 0.0 109.181 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -142.36 165.83 26.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.694 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.6 mt -138.28 117.95 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.76 121.3 30.01 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.83 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 60.2 tp -115.61 136.42 53.09 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.984 0.421 . . . . 0.0 110.607 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -119.99 124.24 45.45 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.093 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.9 t80 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.778 179.882 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.066 0.46 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 71.2 m -41.78 -46.54 3.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.499 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -49.07 -38.39 24.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.454 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.62 -42.84 86.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 109.949 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.84 -49.79 14.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.613 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -61.33 -50.17 74.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.252 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.98 -46.58 41.25 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.75 -53.26 59.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.597 0.237 . . . . 0.0 111.258 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.8 mt -55.02 -56.49 19.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.979 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.597 ' CE2' HD12 ' A' ' 159' ' ' ILE . 22.6 m-85 -50.76 -47.87 59.43 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.751 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.06 -51.65 57.06 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.59 -59.81 2.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.864 0.364 . . . . 0.0 110.839 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -50.51 -51.23 49.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.994 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -51.13 -47.48 62.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.1 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -49.99 -49.74 49.52 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.641 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.517 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 67.9 t80 -87.68 38.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 38.38 55.95 1.79 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.983 0.421 . . . . 0.0 111.185 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -129.12 141.03 51.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -113.74 124.48 52.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.05 170.47 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.635 0.731 . . . . 0.0 111.898 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -134.0 127.38 32.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.494 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.597 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.3 mt -110.17 117.44 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.3 t -105.19 119.63 39.54 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.065 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.6 p-80 -96.67 74.82 2.75 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.657 0.741 . . . . 0.0 111.376 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -76.9 -19.92 56.85 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.989 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.78 111.07 15.1 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.484 ' O ' HG22 ' A' ' 167' ' ' THR . 20.1 p -114.23 -178.91 3.49 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.563 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.492 ' O ' ' SD ' ' A' ' 165' ' ' MET . 1.1 tmt? -93.87 -26.77 16.76 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -54.83 -24.05 21.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.577 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.5 t -87.25 -25.37 24.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.286 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.04 21.73 24.71 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.946 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.4 166.17 12.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.86 0.362 . . . . 0.0 110.651 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 171' ' ' HIS . 50.4 p-10 -52.22 -31.13 30.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.427 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.524 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 15.1 p80 -173.98 -174.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.3 m -93.06 143.41 26.27 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.155 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.559 ' CG ' HD11 ' A' ' 175' ' ' ILE . 30.1 ttp -121.92 116.3 24.12 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.184 0.516 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 176' ' ' ILE . 1.4 mt -116.05 99.49 7.29 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.203 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.559 HD11 ' CG ' ' A' ' 173' ' ' MET . 13.3 mm -84.37 123.82 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.137 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 174' ' ' LEU . 5.0 mp -106.92 144.0 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.28 0.562 . . . . 0.0 110.28 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -132.17 133.69 44.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.986 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.463 0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 -179.853 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.414 HG12 HD21 ' A' ' 77' ' ' LEU . 1.5 tp . . . . . 0 N--CA 1.465 0.275 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mm -59.18 -47.81 88.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.77 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -64.19 -28.44 69.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.244 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.454 ' OD1' ' NH2' ' A' ' 80' ' ' ARG . 4.7 t-20 -67.06 -55.05 15.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.016 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t -66.31 -39.0 83.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.17 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.505 HD13 ' CE2' ' A' ' 69' ' ' PHE . 19.0 tp -64.66 -48.6 74.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.961 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -47.42 -44.87 25.01 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.882 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -62.16 -50.54 71.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.863 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.5 tmt? -52.61 -39.62 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.978 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.26 -34.97 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.426 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.0 t -62.06 -22.67 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.322 0.582 . . . . 0.0 110.05 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.35 -34.88 20.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.217 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -84.57 -77.06 0.28 Allowed 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 58' ' ' LEU . 94.3 m -90.72 -19.97 22.95 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.309 0.576 . . . . 0.0 110.696 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.79 173.92 26.76 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.738 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.5 ttt -69.37 -25.81 64.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.866 -1.167 . . . . 0.0 110.494 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.0 t -64.94 -43.59 92.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.149 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -34.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -51.52 -45.77 63.03 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -69.8 -31.63 69.64 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.012 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -64.98 -51.07 63.76 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.791 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.34 -19.6 38.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.921 0.391 . . . . 0.0 110.732 -179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.791 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.2 tt -76.72 -57.16 4.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.357 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.39 -22.48 66.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.507 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -81.13 -39.4 25.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.508 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 72.8 m80 . . . . . 0 N--CA 1.467 0.388 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.188 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.795 0.331 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -62.88 -30.94 71.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.65 -55.79 2.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.027 0.441 . . . . 0.0 110.49 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -39.01 -42.79 0.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.419 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.2 m -72.29 -33.24 67.28 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.335 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.2 mp -71.04 -53.92 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.586 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.97 -24.86 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.124 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.672 ' HG3' HD12 ' A' ' 62' ' ' ILE . 2.2 tt0 -77.6 -39.87 44.02 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.505 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 79.1 m-20 -59.52 -56.21 24.84 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.968 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 p -57.18 -39.2 65.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.026 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.73 -38.42 85.07 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.29 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -63.27 -32.03 73.34 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -73.87 -40.46 63.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.517 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 ' SG ' ' A' ' 17' ' ' CYS . 36.6 mt -83.18 -7.72 59.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.218 0.533 . . . . 0.0 109.748 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.1 t30 56.95 49.57 13.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.549 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.401 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 25.9 mmt -128.43 149.52 71.83 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.151 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.24 137.93 68.89 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.49 1.46 . . . . 0.0 111.124 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.672 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.7 tt -51.79 -29.18 10.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.014 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -71.4 -34.18 70.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.161 0.505 . . . . 0.0 111.244 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -75.51 -32.89 60.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.884 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 55' ' ' ALA . 71.9 t -70.78 -56.53 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -52.56 -44.57 45.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.217 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.528 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.7 mtpt -51.08 -50.13 59.3 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.92 -47.94 81.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.74 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.509 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 8.3 m-30 -53.77 -30.62 45.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.529 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.71 -49.86 61.77 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -56.9 -50.02 73.81 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -58.61 -42.54 88.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.775 0.797 . . . . 0.0 110.555 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.6 tp -55.73 -38.39 69.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.306 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 37.1 t80 -71.55 -39.61 70.55 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.954 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -56.44 -71.05 0.1 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.762 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.06 -45.13 33.3 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.78 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.414 HD21 HG12 ' A' ' 4' ' ' ILE . 13.6 mt -52.34 -44.41 65.15 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.181 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.37 -23.71 16.68 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.178 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.427 ' O ' ' OG1' ' A' ' 82' ' ' THR . 22.1 t -76.74 -53.86 7.41 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.988 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.454 ' NH2' ' OD1' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -75.54 -27.84 58.82 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.764 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -107.14 22.68 15.61 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.684 0.278 . . . . 0.0 110.384 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 79' ' ' SER . 6.4 m -50.88 -40.72 57.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -57.56 -35.53 70.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.508 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.3 -21.85 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.674 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 87' ' ' LYS . 95.4 t -85.52 -46.86 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.695 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -55.68 -2.05 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.686 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 85' ' ' VAL . 86.0 mttt -78.79 -33.95 45.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.58 130.98 55.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.999 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 52.1 t0 -93.0 11.39 27.64 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.402 ' OD1' ' OG ' ' A' ' 93' ' ' SER . 10.2 p-10 -167.8 163.16 14.08 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 118.987 -1.085 . . . . 0.0 113.485 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.427 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 74.3 t80 -62.13 -61.55 2.4 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.786 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.5 m -45.15 -49.3 12.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.209 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.402 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 56.9 m -59.86 -38.16 81.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.296 0.57 . . . . 0.0 110.743 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.19 -55.12 31.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.016 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.7 t -49.73 -42.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 O-C-N 123.142 0.276 . . . . 0.0 111.696 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.436 ' H ' ' HG3' ' A' ' 96' ' ' MET . 3.3 ppp? -83.23 -6.28 59.42 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.736 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -109.24 -13.35 17.7 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.46 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.605 ' HA ' HD13 ' A' ' 102' ' ' ILE . 49.4 mt -29.93 -104.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.431 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 9.0 p-80 -37.36 -48.32 0.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.431 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 59.6 t0 -45.42 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.612 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.3 m -70.56 -52.9 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.612 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.8 mp -58.8 -48.47 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.71 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.58 -55.1 31.85 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 tp -50.12 -48.55 53.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 110.167 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.514 ' OE1' ' NZ ' ' A' ' 87' ' ' LYS . 37.7 tp10 -55.94 -45.78 78.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.315 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 102' ' ' ILE . 54.3 t -53.5 -51.16 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -50.0 -43.35 50.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.829 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt . . . . . 0 C--N 1.329 -0.289 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.268 179.838 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.6 m80 . . . . . 0 N--CA 1.465 0.277 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.7 mt -131.22 129.82 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.687 0.28 . . . . 0.0 110.654 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -125.98 98.51 5.54 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.87 0.367 . . . . 0.0 110.371 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -103.98 119.49 6.33 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -116.58 153.5 32.13 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 122' ' ' LEU . 8.8 mp -101.18 147.2 26.53 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.25 160.51 41.1 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.15 -38.43 3.81 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.58 2.187 . . . . 0.0 113.105 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -79.54 45.9 0.71 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.918 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 44.22 61.06 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.366 0.603 . . . . 0.0 110.562 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -139.13 158.38 44.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.095 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.6 mt -138.67 116.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.67 28.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 39.9 tp -117.09 132.39 56.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.137 0.494 . . . . 0.0 110.859 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -118.71 125.26 49.28 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.991 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.495 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 29.6 t80 . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 tp . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 121.183 0.516 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 9.4 t -41.9 -42.61 2.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.344 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -49.47 -41.69 41.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.454 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.441 ' SG ' ' CG2' ' A' ' 66' ' ' VAL . 56.7 m -65.25 -41.44 94.31 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -44.44 -49.93 9.57 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.674 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -63.78 -48.8 75.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.51 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.35 -46.63 52.02 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.147 -1.025 . . . . 0.0 110.785 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.3 mt -58.77 -55.92 28.88 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.5 mt -53.29 -55.91 20.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.749 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.538 ' CE2' HD12 ' A' ' 159' ' ' ILE . 15.2 m-85 -50.71 -48.15 58.92 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.667 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.03 55.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.72 -60.36 1.82 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.862 0.363 . . . . 0.0 110.821 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.98 -51.01 45.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.847 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -51.36 -46.95 62.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.064 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -50.54 -50.37 53.47 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.344 -0.543 . . . . 0.0 109.563 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.518 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 66.2 t80 -86.04 37.43 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.851 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 39.2 55.65 2.16 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.992 0.425 . . . . 0.0 111.168 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -128.88 139.8 51.97 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -112.48 124.1 51.77 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.427 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 9.8 pt -137.32 171.15 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.724 0.773 . . . . 0.0 111.896 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -134.24 127.69 32.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.095 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.538 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.7 mt -110.43 115.71 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.0 m -96.16 100.06 11.74 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.929 0.395 . . . . 0.0 110.018 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.472 ' NE2' ' SG ' ' A' ' 164' ' ' CYS . 0.9 OUTLIER -100.69 71.49 1.49 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.019 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -81.2 -56.12 4.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.486 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 90.0 m -82.72 112.41 19.55 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.528 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.589 ' O ' ' N ' ' A' ' 166' ' ' HIS . 6.0 t -139.17 130.63 27.08 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.049 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 76.8 mtp -36.27 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.312 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.1 t60 -53.0 -24.44 9.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.476 HG23 ' N ' ' A' ' 168' ' ' GLY . 5.9 t -90.15 -43.38 10.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.106 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.476 ' N ' HG23 ' A' ' 167' ' ' THR . . . 132.46 11.98 1.87 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.74 169.56 6.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.928 0.394 . . . . 0.0 110.847 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.539 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 89.5 m-20 -56.44 -44.24 80.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.582 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 170' ' ' ASP . 62.6 m-70 -157.68 -169.81 2.99 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.8 m -92.33 138.31 31.63 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 tpt -115.73 123.65 48.83 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 110.523 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -128.39 100.61 5.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.651 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.6 mp -89.02 127.54 41.68 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.619 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.9 mp -110.45 150.82 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.438 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -144.66 141.47 29.37 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.925 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 N--CA 1.462 0.156 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.152 179.543 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.3 mm -67.75 -51.97 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.448 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -68.1 -24.55 65.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.204 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -70.16 -49.93 45.55 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.915 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.08 -35.43 75.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.621 -0.431 . . . . 0.0 109.903 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.459 HD13 ' CE2' ' A' ' 69' ' ' PHE . 21.6 tp -71.1 -40.38 71.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.109 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -53.66 -44.93 70.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.634 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -62.66 -48.13 80.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.966 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.8 tmt? -53.86 -41.38 67.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.819 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.7 t -71.02 -34.94 57.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.446 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.96 -26.22 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.191 0.52 . . . . 0.0 110.249 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.26 -34.51 28.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.112 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -83.74 -73.74 0.4 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.539 ' SG ' HD21 ' A' ' 58' ' ' LEU . 89.4 m -95.29 -22.4 17.8 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.933 0.397 . . . . 0.0 111.332 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.06 170.15 22.32 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 121.891 0.717 . . . . 0.0 112.996 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -27.19 67.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.07 -1.065 . . . . 0.0 109.553 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -63.8 -43.6 95.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.531 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.31 -37.24 31.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 52.4 t-105 -51.02 -44.97 61.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -71.66 -29.01 64.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.068 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -66.73 -50.85 61.45 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.752 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.57 -20.64 36.12 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.596 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.752 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.5 tt -76.66 -69.55 0.51 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.241 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.618 ' N ' HD23 ' A' ' 26' ' ' LEU . 93.8 mt-10 -50.82 -21.43 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.162 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -80.93 -39.25 26.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 26' ' ' LEU . 41.3 m80 . . . . . 0 N--CA 1.469 0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.752 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.922 0.391 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 6.4 mp0 -65.59 -29.23 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.53 -57.34 2.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 110.741 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.64 -40.21 0.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.533 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.9 m -75.22 -31.11 60.77 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.892 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 47' ' ' LEU . 13.7 mt -70.94 -50.73 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -26.15 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.398 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.661 ' HG3' HD12 ' A' ' 62' ' ' ILE . 3.5 tt0 -76.0 -40.79 52.9 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.543 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -59.27 -57.0 14.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.005 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.96 -38.33 59.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.221 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.517 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.34 -38.35 86.62 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.218 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.9 -32.02 73.2 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.47 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.69 -45.33 53.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.534 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.539 HD21 ' SG ' ' A' ' 17' ' ' CYS . 32.0 mt -77.77 -7.26 56.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.656 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 t30 56.94 49.75 13.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.934 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.414 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 7.7 mmt -128.45 149.14 70.82 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.225 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.28 139.21 76.3 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.441 1.428 . . . . 0.0 110.892 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.661 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.5 tt -52.84 -29.86 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.433 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -71.7 -31.48 66.79 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.578 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.6 -31.6 47.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.921 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' ' 55' ' ' ALA . 69.4 t -71.04 -57.1 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.0 p -52.03 -41.37 31.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.201 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.503 ' N ' HG13 ' A' ' 66' ' ' VAL . 32.2 mtpt -53.98 -50.75 65.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.78 83.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.73 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.9 m-30 -53.81 -31.11 47.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.286 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.63 -50.1 60.8 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -55.69 -50.09 71.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.006 0.432 . . . . 0.0 109.941 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -59.93 -41.84 92.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.826 0.822 . . . . 0.0 110.493 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -58.55 -39.81 81.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.597 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 35.1 t80 -68.28 -41.5 80.93 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.904 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -55.07 -68.81 0.16 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.224 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.16 -47.6 33.32 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.618 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.6 mt -52.06 -42.93 63.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.052 0.426 . . . . 0.0 111.991 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -55.11 -24.17 24.54 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.394 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.8 t -76.37 -53.1 8.65 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.082 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -76.87 -39.98 49.15 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.772 -179.39 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -92.96 27.01 2.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.41 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 34.8 m -53.71 -37.7 63.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.05 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.442 ' O ' ' NZ ' ' A' ' 87' ' ' LYS . 89.9 m-20 -58.09 -30.81 66.53 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.6 -19.7 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.688 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.35 -43.5 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.353 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.34 -16.62 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.994 0.426 . . . . 0.0 110.35 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 83' ' ' ASP . 42.5 mmtm -67.61 -29.07 68.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.022 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 8.9 p90 -120.56 116.5 25.49 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.175 0.512 . . . . 0.0 110.991 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -84.82 -2.37 57.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.369 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.433 ' OD1' ' OG ' ' A' ' 93' ' ' SER . 50.5 p30 -163.48 159.48 22.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.186 0.517 . . . . 0.0 111.637 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.447 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 85.8 t80 -48.7 -46.05 39.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.305 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.2 m -59.08 -61.35 2.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.904 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.433 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 93.8 p -45.4 -37.78 5.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.151 0.501 . . . . 0.0 111.022 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.5 tt -65.03 -46.03 82.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.199 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.1 t -62.6 -39.6 85.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.253 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 12.8 ptm -87.2 -1.85 58.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.82 -16.85 7.74 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.353 -0.693 . . . . 0.0 112.891 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.549 ' HA ' HD13 ' A' ' 102' ' ' ILE . 12.2 mt -29.12 -102.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 117.868 0.834 . . . . 0.0 112.454 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.489 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 13.3 p-80 -39.75 -50.15 2.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.035 0.445 . . . . 0.0 111.364 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.489 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 80.2 m-20 -44.54 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -72.18 -53.19 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 101' ' ' VAL . 3.1 mp -61.15 -48.41 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.22 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.0 -53.7 43.42 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.9 tp -50.62 -50.85 53.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.92 0.39 . . . . 0.0 110.456 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -55.85 -45.27 78.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.318 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.67 -50.77 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -50.05 -43.19 50.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.746 0.308 . . . . 0.0 111.055 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.612 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.662 ' CD2' HD21 ' A' ' 119' ' ' ASN . 75.8 t60 . . . . . 0 N--CA 1.461 0.124 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.2 mt -129.82 130.04 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.582 0.229 . . . . 0.0 111.02 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.662 HD21 ' CD2' ' A' ' 117' ' ' HIS . 11.6 m-20 -132.51 119.42 20.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.42 137.53 13.4 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -128.71 159.49 35.47 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.823 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -107.14 145.84 32.03 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.28 160.46 41.35 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.62 -41.07 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.638 2.225 . . . . 0.0 113.222 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.538 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 31.3 t30 -77.65 46.59 0.56 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.088 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 0.6 OUTLIER 43.29 62.21 1.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.545 0.688 . . . . 0.0 110.837 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -139.25 158.31 44.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.964 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 51.0 mt -139.04 119.19 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.85 122.3 33.45 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.269 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.1 tp -117.76 134.81 54.54 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.997 0.427 . . . . 0.0 110.689 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -120.73 125.16 46.93 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.49 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 C--N 1.331 -0.232 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.872 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.5 mm? . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.0 t -42.44 -49.49 5.25 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -47.68 -35.03 8.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.096 0.474 . . . . 0.0 109.895 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.69 -43.55 79.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.936 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.48 -51.19 15.78 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.515 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -59.28 -51.66 69.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.43 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.53 -46.49 37.34 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.9 mt -61.45 -52.1 65.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 111.204 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 45.4 mt -55.53 -56.85 15.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.839 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.563 ' CE2' HD12 ' A' ' 159' ' ' ILE . 22.4 m-85 -50.31 -47.86 55.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.764 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.13 -51.69 57.76 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.5 -54.99 4.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.937 0.398 . . . . 0.0 110.54 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -54.55 -51.42 65.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.631 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -51.09 -46.77 61.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.931 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -50.0 -50.06 48.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.514 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 67.7 t80 -87.81 37.89 0.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.014 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 38.76 55.66 1.95 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.93 0.395 . . . . 0.0 111.081 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -128.83 141.24 51.36 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -114.85 124.04 50.7 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.447 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 8.8 pt -136.89 173.84 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.714 0.769 . . . . 0.0 111.99 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.443 ' NE2' ' OE1' ' A' ' 177' ' ' GLU . 13.0 pt20 -137.02 129.25 29.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.427 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.563 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.5 mt -111.77 120.05 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.297 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -102.2 106.12 16.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.821 0.343 . . . . 0.0 110.754 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.533 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 16.6 p80 -102.08 73.12 1.36 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.385 0.612 . . . . 0.0 111.45 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -77.74 -12.84 60.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.33 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.48 ' HB ' ' H ' ' A' ' 173' ' ' MET . 3.2 m -116.45 104.23 11.23 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.589 ' O ' ' N ' ' A' ' 166' ' ' HIS . 38.0 t -136.63 116.36 13.04 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.576 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.5 ptm -39.94 -15.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.23 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 164' ' ' CYS . 56.0 t-80 -58.53 -30.37 67.04 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.503 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.0 t -81.04 -46.22 15.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.053 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.503 ' N ' HG23 ' A' ' 167' ' ' THR . . . 153.84 12.68 0.07 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.09 149.19 35.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.65 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -85.1 8.85 16.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.088 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -174.71 -173.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 92.3 m -129.18 148.07 51.09 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.182 0.515 . . . . 0.0 111.569 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.48 ' H ' ' HB ' ' A' ' 163' ' ' THR . 7.8 ttm -126.43 111.86 14.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.111 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.27 110.6 21.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.344 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -92.24 127.54 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.775 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.31 150.57 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.075 0.465 . . . . 0.0 110.095 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.443 ' OE1' ' NE2' ' A' ' 158' ' ' GLN . 28.1 mt-10 -145.71 142.59 29.12 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.734 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 N--CA 1.463 0.218 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.192 179.566 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.558 ' CD1' ' HE ' ' A' ' 80' ' ' ARG . 1.9 tp . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.996 0.427 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.19 -50.87 76.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -64.23 -29.19 70.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.196 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -62.02 -59.3 5.29 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.26 0.553 . . . . 0.0 110.847 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.98 -26.98 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.165 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.509 HD13 ' CE2' ' A' ' 69' ' ' PHE . 36.9 tp -72.03 -41.17 67.83 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.085 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.44 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.9 mt-10 -57.79 -41.06 81.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.256 -0.977 . . . . 0.0 109.541 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -60.3 -57.95 10.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.653 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.601 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 68.0 mtm -48.43 -43.64 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.35 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.8 -36.28 75.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.854 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 10' ' ' GLU . 47.6 t -62.53 -22.54 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.275 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.82 -34.41 17.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.13 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -84.75 -78.03 0.26 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' HD21 ' A' ' 58' ' ' LEU . 89.9 m -90.61 -17.54 26.74 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.341 0.591 . . . . 0.0 110.57 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.68 178.86 29.54 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.827 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 ttt -72.49 -30.87 64.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.837 -1.181 . . . . 0.0 110.708 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 t -61.5 -41.87 97.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.119 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.18 -38.12 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.417 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 51.1 t-105 -51.73 -45.71 63.73 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.89 -29.05 63.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.339 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -67.27 -50.76 59.21 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.915 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.07 -22.38 36.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.85 0.357 . . . . 0.0 110.413 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.915 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.8 tt -73.91 -66.59 0.69 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.117 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.599 ' N ' HD23 ' A' ' 26' ' ' LEU . 75.9 tt0 -52.44 -21.78 4.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.527 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -81.38 -38.97 25.73 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.45 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 12.8 m-70 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.319 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.934 0.397 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -59.04 -37.92 78.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.64 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -44.53 -53.54 6.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.148 0.499 . . . . 0.0 110.713 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -41.1 -40.94 1.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.387 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.2 m -73.24 -31.13 63.93 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 47' ' ' LEU . 25.8 mm -68.48 -55.35 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.714 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.431 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -58.11 -22.41 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.983 178.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.687 ' HG3' HD12 ' A' ' 62' ' ' ILE . 4.5 tt0 -79.65 -43.18 23.29 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.383 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.45 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 33.0 m-20 -58.4 -57.08 14.49 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.675 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 55' ' ' ALA . 7.5 p -56.95 -41.16 76.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.409 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.427 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -56.24 -38.69 71.43 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.309 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -64.51 -32.97 74.84 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -73.44 -37.98 65.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.781 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 17' ' ' CYS . 36.6 mt -84.21 -7.5 59.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.105 0.479 . . . . 0.0 109.844 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 56.27 48.36 17.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.573 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.5 mmm -127.19 149.55 69.88 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.073 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.68 135.56 49.47 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.442 1.428 . . . . 0.0 110.94 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.687 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.6 tt -49.54 -27.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.097 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -73.44 -30.93 63.53 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.086 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -78.05 -31.83 50.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.258 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.416 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 73.5 t -72.03 -56.3 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.532 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -51.63 -43.69 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.32 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.532 ' N ' HG13 ' A' ' 66' ' ' VAL . 34.7 mtpt -52.38 -51.98 56.07 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.76 -55.71 30.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.278 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.509 ' CE2' HD13 ' A' ' 9' ' ' LEU . 7.5 m-30 -44.53 -28.03 0.53 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.375 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.12 -47.46 59.09 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -56.46 -53.45 57.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.042 0.448 . . . . 0.0 110.273 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.601 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 78.7 m-85 -57.23 -42.14 80.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.755 0.788 . . . . 0.0 110.854 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.1 tp -55.25 -37.5 67.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.654 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 28.8 t80 -69.77 -40.7 75.92 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -57.05 -72.96 0.07 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.847 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.87 -40.65 19.52 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.396 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.421 HD21 HG12 ' A' ' 4' ' ' ILE . 23.7 mt -60.02 -41.56 92.44 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.345 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.09 -22.79 11.8 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.926 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.438 ' O ' ' OG1' ' A' ' 82' ' ' THR . 8.7 t -80.45 -52.56 7.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.212 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.558 ' HE ' ' CD1' ' A' ' 4' ' ' ILE . 4.4 mtt-85 -65.97 -52.66 47.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.188 0.518 . . . . 0.0 110.884 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -93.95 36.47 1.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.567 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 79' ' ' SER . 39.6 m -56.92 -45.3 82.78 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.066 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -50.79 -31.09 15.88 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 t -82.75 -19.59 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.699 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.513 ' C ' ' H ' ' A' ' 87' ' ' LYS . 68.1 t -72.21 -47.05 55.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.569 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 56.1 t0 -52.66 -7.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.808 0.337 . . . . 0.0 110.759 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 85' ' ' VAL . 43.1 mmtm -80.23 -28.9 38.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.071 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.62 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -95.77 118.12 31.83 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.474 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -84.85 -13.45 50.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.169 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 15.3 p-10 -164.67 171.42 14.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.256 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.424 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 68.8 t80 -58.07 -46.74 84.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.872 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.8 m -59.84 -44.78 93.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.443 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.7 t -55.63 -39.84 71.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.248 0.547 . . . . 0.0 110.304 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.419 HD12 ' CD2' ' A' ' 88' ' ' PHE . 3.0 tt -64.71 -45.56 86.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.998 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.57 -38.13 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.421 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.556 ' SD ' HD13 ' A' ' 122' ' ' LEU . 83.7 mtp -83.99 -4.42 58.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.427 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -116.75 -14.97 7.05 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.044 -0.865 . . . . 0.0 113.663 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.669 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.7 mt -26.72 -106.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 117.954 0.877 . . . . 0.0 112.697 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.482 ' CE1' ' O ' ' A' ' 118' ' ' ILE . 8.7 p-80 -41.4 -46.34 3.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.019 0.438 . . . . 0.0 111.271 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -47.46 -87.34 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 102' ' ' ILE . 2.1 m -69.89 -51.38 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.669 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.5 mp -63.28 -47.61 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.699 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.33 -54.06 40.05 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.3 tp -49.47 -48.03 48.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.934 0.397 . . . . 0.0 109.947 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -56.9 -45.82 82.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.035 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 76.0 t -54.85 -56.06 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -43.94 -45.43 7.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.125 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp . . . . . 0 C--N 1.33 -0.244 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.84 179.621 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.5 m80 . . . . . 0 N--CA 1.463 0.18 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.482 ' O ' ' CE1' ' A' ' 99' ' ' HIS . 4.0 mp -138.48 133.15 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -138.5 130.01 27.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.712 0.291 . . . . 0.0 111.212 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.58 120.8 4.53 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -117.55 130.34 56.35 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.651 0.262 . . . . 0.0 110.819 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.556 HD13 ' SD ' ' A' ' 96' ' ' MET . 3.9 tp -76.19 150.35 37.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 111.383 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -121.43 160.32 46.5 Favored Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.317 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.45 -36.83 3.61 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.668 2.245 . . . . 0.0 113.309 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -79.96 46.7 0.82 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.144 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.6 m120 43.35 58.39 3.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 0.0 110.443 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -137.11 159.06 43.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.057 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.4 mt -135.4 114.6 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.19 120.09 25.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 61.5 tp -114.92 132.73 56.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.166 0.508 . . . . 0.0 111.298 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.711 ' HE ' ' CE1' ' A' ' 171' ' ' HIS . 64.0 ttt-85 -116.95 120.43 38.4 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.008 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.491 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 72.3 t80 . . . . . 0 N--CA 1.467 0.407 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.948 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 9.2 t -44.83 -49.75 10.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.582 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -45.76 -41.29 10.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.113 0.482 . . . . 0.0 110.2 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 22.8 t -62.34 -41.46 98.59 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.54 -54.18 7.93 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.561 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -56.58 -50.74 71.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.35 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.8 -47.9 45.79 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.37 -54.81 41.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.2 mt -53.4 -55.22 26.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.745 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.548 ' CE2' HD12 ' A' ' 159' ' ' ILE . 14.5 m-85 -51.61 -47.7 63.54 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.897 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.31 -51.99 54.29 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.26 -60.11 2.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.846 0.355 . . . . 0.0 110.916 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -47.84 -50.66 25.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.966 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -52.45 -47.97 66.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.623 0.249 . . . . 0.0 111.237 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -49.38 -49.96 42.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.667 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.25 37.3 0.72 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.968 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 38.76 57.5 1.83 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.976 0.417 . . . . 0.0 111.196 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -131.72 142.98 49.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -118.17 112.31 19.99 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.078 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.424 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 17.8 pt -122.53 173.48 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.513 0.673 . . . . 0.0 111.78 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -137.13 128.74 28.62 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.547 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.548 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.5 mt -112.04 120.97 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.649 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.9 t -105.19 112.19 25.21 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.705 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 53.8 p-80 -101.97 76.7 1.63 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.983 0.897 . . . . 0.0 111.822 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 4.9 p30 -75.89 -27.56 57.77 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.716 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.56 110.44 21.92 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.552 ' O ' HG22 ' A' ' 167' ' ' THR . 6.4 p -113.08 176.33 5.06 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 168' ' ' GLY . 72.5 mtp -91.52 -28.18 17.75 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -53.72 -22.51 9.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.825 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.4 t -88.63 -26.77 21.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.446 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 98.58 21.92 15.51 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.136 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.31 162.68 24.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.04 0.447 . . . . 0.0 110.681 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -45.97 -34.38 3.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.308 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.711 ' CE1' ' HE ' ' A' ' 131' ' ' ARG . 9.0 p-80 -175.49 -167.78 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.2 m -95.18 139.71 31.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.171 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 12.8 tpp -120.7 116.7 25.79 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.1 107.15 12.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.472 0.654 . . . . 0.0 111.047 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -89.95 126.98 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.561 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.8 mp -110.83 151.49 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.189 0.519 . . . . 0.0 110.171 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.56 144.0 28.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.933 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 11.7 mt . . . . . 0 N--CA 1.462 0.164 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.072 179.669 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 5' ' ' ILE . 3.3 tp . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 120.778 0.323 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' N ' HG23 ' A' ' 4' ' ' ILE . 36.3 mm -64.45 -56.76 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.426 0.631 . . . . 0.0 109.461 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -62.26 -27.7 69.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.658 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -62.35 -60.79 3.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.131 0.491 . . . . 0.0 110.939 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -56.96 -27.16 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.115 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.418 HD13 ' CE2' ' A' ' 69' ' ' PHE . 27.9 tp -71.8 -50.5 29.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.463 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.473 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.8 mt-10 -49.36 -40.22 34.84 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.562 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -60.48 -49.09 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.695 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.579 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 10.4 tpt -56.87 -42.58 80.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.005 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.79 -34.98 58.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.648 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 10' ' ' GLU . 40.8 t -62.16 -25.0 36.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.216 0.531 . . . . 0.0 110.018 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.93 -34.58 22.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.134 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -85.75 -74.44 0.41 Allowed 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.499 ' SG ' HD21 ' A' ' 58' ' ' LEU . 91.7 m -92.27 -21.66 20.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.166 0.508 . . . . 0.0 110.966 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.51 170.96 24.72 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.865 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.0 ttp -66.5 -28.67 68.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.904 -1.148 . . . . 0.0 110.347 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 t -62.49 -42.24 99.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.208 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.63 -36.27 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.408 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 50.7 t-105 -51.94 -45.86 64.49 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -70.31 -30.6 67.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.986 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -66.05 -50.77 62.99 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.815 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.19 -20.53 37.62 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.844 0.354 . . . . 0.0 110.617 -179.26 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.815 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.3 tt -75.47 -57.64 3.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.345 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.05 -23.16 67.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.675 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -80.45 -40.63 25.93 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 67.7 m80 . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.326 179.415 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 85.6 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.784 0.326 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -66.37 -33.13 75.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.542 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -48.2 -58.15 4.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.105 0.479 . . . . 0.0 110.634 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -39.01 -41.1 0.74 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.541 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.3 p -74.53 -31.87 62.28 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.971 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 47' ' ' LEU . 17.1 mt -70.26 -53.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.789 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.89 -25.03 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.518 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.657 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.0 tt0 -76.61 -41.28 46.66 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.633 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -59.02 -56.8 17.54 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.744 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.96 -37.53 55.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.016 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.527 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -62.41 -38.09 88.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.276 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -62.4 -32.83 73.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -72.04 -44.53 63.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.554 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.499 HD21 ' SG ' ' A' ' 17' ' ' CYS . 32.3 mt -79.14 -7.37 58.13 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.864 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 57.01 49.85 13.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.678 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.405 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 25.5 mmt -128.55 149.12 70.91 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.182 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.58 138.73 71.86 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.347 1.365 . . . . 0.0 110.967 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.657 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.7 tt -52.38 -29.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.428 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -72.46 -31.53 65.52 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.562 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -78.2 -31.85 49.65 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.944 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 55' ' ' ALA . 82.2 t -70.5 -57.08 8.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -51.58 -43.22 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.34 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.516 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.0 mtpt -53.32 -50.33 65.19 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.14 80.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.644 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.9 m-30 -52.16 -29.49 22.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.298 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.26 -50.35 56.83 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -55.17 -50.71 68.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.023 0.44 . . . . 0.0 110.049 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.579 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 59.4 m-85 -59.67 -41.19 90.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.883 0.849 . . . . 0.0 110.74 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.62 -40.46 83.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.451 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.401 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 41.9 t80 -68.7 -39.87 80.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 110.229 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -55.27 -70.44 0.11 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.377 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.92 -37.62 53.4 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.385 -0.436 . . . . 0.0 112.637 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.521 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 16.5 mt -55.23 -51.06 67.81 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.086 0.443 . . . . 0.0 111.716 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.85 -15.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.805 -0.56 . . . . 0.0 111.36 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 77' ' ' LEU . 9.3 t -83.75 -49.08 9.44 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -59.48 2.73 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.083 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.0 p80 -81.85 30.22 0.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.815 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.8 m -49.53 -40.07 36.71 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -55.65 -30.38 60.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 81' ' ' HIS . 5.1 t -85.89 -22.8 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.534 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.492 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 54.1 t -61.66 -40.48 86.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -49.6 -20.34 0.76 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.873 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -70.15 -5.03 24.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.381 0.61 . . . . 0.0 109.865 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.607 ' CG ' ' N ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER -89.05 -150.26 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.508 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.607 ' N ' ' CG ' ' A' ' 88' ' ' PHE . 1.1 p-10 159.63 -30.25 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -170.23 155.1 5.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.365 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 85.6 t80 -46.08 -57.46 4.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.237 0.541 . . . . 0.0 111.29 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.5 m -50.41 -47.12 56.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.108 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.431 ' CB ' ' OD2' ' A' ' 89' ' ' ASP . 32.6 m -61.42 -37.17 82.52 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.151 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.1 tt -64.3 -45.49 87.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.001 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.52 -36.11 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 121.226 0.536 . . . . 0.0 110.639 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.7 mmm -86.19 -6.79 58.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.53 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -111.42 -13.16 13.52 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.894 -0.392 . . . . 0.0 112.654 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.647 ' HA ' HD13 ' A' ' 102' ' ' ILE . 15.8 mt -33.0 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 117.509 0.655 . . . . 0.0 111.963 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -39.8 -50.27 2.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.213 0.53 . . . . 0.0 111.498 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -48.12 -91.25 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.599 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.7 m -66.71 -51.21 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.647 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.7 mp -61.72 -40.97 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.392 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.16 -57.52 10.45 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.4 tp -49.21 -58.05 5.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.15 0.5 . . . . 0.0 110.491 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -50.6 -45.95 57.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.236 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 102' ' ' ILE . 14.7 t -54.59 -51.41 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -46.85 -42.91 18.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.792 0.329 . . . . 0.0 110.607 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.69 -179.903 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.741 0.305 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 31.7 mm -117.25 124.14 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.373 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -132.89 120.02 20.95 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.735 0.302 . . . . 0.0 110.857 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.8 119.21 5.17 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -117.78 125.65 50.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 tp -72.21 140.04 48.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.886 0.374 . . . . 0.0 110.825 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.29 161.01 41.18 Favored Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.6 178.63 6.48 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.312 2.008 . . . . 0.0 111.992 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.527 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 95.7 m-20 55.23 36.01 26.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.347 0.594 . . . . 0.0 109.832 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.527 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 47.5 m-20 54.35 56.51 6.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.794 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 125' ' ' ASN . 3.8 mp0 -125.98 156.43 39.85 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.1 mt -139.39 115.32 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.87 122.82 31.27 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.844 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 47.8 tp -117.78 132.7 56.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 111.279 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -112.87 120.24 40.76 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.602 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.494 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 30.6 t80 . . . . . 0 N--CA 1.465 0.32 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.621 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 CA--C 1.535 0.401 0 CA-C-O 121.011 0.434 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 26.4 p -43.57 -49.13 7.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.586 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.465 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 80.8 m-85 -45.64 -41.89 10.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.973 0.416 . . . . 0.0 110.409 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 48.5 t -64.09 -42.23 96.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.774 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.55 -52.5 10.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.579 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -59.19 -51.85 68.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.613 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.35 -46.99 35.74 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.3 -54.18 48.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.641 0.258 . . . . 0.0 111.638 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 31.2 mt -54.51 -56.13 21.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.026 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.566 ' CE2' HD12 ' A' ' 159' ' ' ILE . 23.4 m-85 -50.59 -47.26 58.14 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.743 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.64 -51.7 57.33 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.14 -59.95 2.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.684 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.0 -52.29 44.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.76 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -50.41 -47.26 56.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.908 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -49.57 -49.38 46.71 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.712 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -88.24 37.97 0.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.851 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 39.11 55.02 2.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 111.16 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -127.91 140.11 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -112.39 124.1 51.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.998 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.446 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 9.6 pt -137.41 169.41 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.694 0.759 . . . . 0.0 111.9 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -132.99 127.32 33.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.296 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.566 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.9 mt -110.54 117.01 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 6.0 t -98.32 100.58 11.87 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.981 0.419 . . . . 0.0 110.16 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -96.43 71.22 2.71 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.209 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -78.1 -51.9 9.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.246 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.72 123.27 22.96 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.715 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.542 ' O ' HG22 ' A' ' 167' ' ' THR . 61.1 m -125.97 176.5 6.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.948 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 168' ' ' GLY . 1.0 OUTLIER -93.12 -30.18 15.39 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.007 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.472 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 3.5 p80 -51.18 -21.13 1.83 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.732 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.6 t -90.38 -28.24 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.763 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 101.7 20.05 14.06 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.59 169.56 9.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 110.733 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -52.33 -35.07 49.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.304 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -177.39 -165.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.0 OUTLIER -94.85 140.25 30.18 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.4 tpt -119.17 120.87 38.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 109.909 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mt -122.58 103.62 8.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.982 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -88.19 127.81 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.355 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mp -111.24 149.84 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.298 0.57 . . . . 0.0 110.775 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.72 134.77 37.52 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.951 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 120.945 0.403 . . . . 0.0 110.686 -179.822 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.436 HG21 HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.23 -62.1 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.852 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -58.71 -29.51 66.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.702 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -61.73 -60.86 3.03 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.211 0.529 . . . . 0.0 111.48 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.4 -27.39 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.431 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 tp -70.87 -42.4 70.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.351 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 14' ' ' VAL . 4.1 mt-10 -56.6 -39.64 73.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.497 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -60.97 -52.61 64.28 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.166 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 14.4 tpt -53.18 -41.39 65.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.983 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.06 -34.66 55.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.74 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 10' ' ' GLU . 41.6 t -63.13 -22.28 30.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 0.0 110.068 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.17 -34.5 19.01 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.259 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -85.77 -76.94 0.31 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.544 ' SG ' HD21 ' A' ' 58' ' ' LEU . 72.0 m -89.77 -19.11 25.12 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.385 0.612 . . . . 0.0 110.627 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.02 175.14 29.13 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.7 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.5 ttt -69.91 -26.96 64.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.888 -1.156 . . . . 0.0 110.67 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.6 m -64.34 -42.95 95.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.045 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -35.89 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.41 ' O ' HD13 ' A' ' 25' ' ' LEU . 51.0 t-105 -51.21 -46.04 62.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -69.68 -31.74 69.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.083 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -65.24 -51.39 61.21 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.8 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.21 -20.17 41.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.93 0.395 . . . . 0.0 110.69 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.8 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.1 tt -76.27 -47.75 22.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.381 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -70.57 -24.41 62.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.67 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -80.35 -40.14 27.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.51 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 73.9 m80 . . . . . 0 N--CA 1.465 0.322 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.305 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.681 0.277 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -59.7 -36.63 76.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.727 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -51.12 -56.94 10.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.028 0.442 . . . . 0.0 110.794 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -39.61 -43.34 1.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.659 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 m -72.25 -30.58 65.01 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.082 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 47' ' ' LEU . 13.3 mt -72.36 -54.84 15.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.156 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -55.65 -24.09 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.727 178.628 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.653 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.4 tt0 -77.51 -40.56 42.42 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.477 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.51 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 55.2 m-20 -59.42 -56.2 25.02 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.92 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 p -57.56 -37.68 59.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.917 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.18 -38.92 88.23 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.2 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -62.79 -32.31 73.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -72.35 -43.63 63.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.544 HD21 ' SG ' ' A' ' 17' ' ' CYS . 27.6 mt -80.71 -8.13 59.56 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.839 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 57.96 51.49 8.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.628 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.429 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 22.3 mmt -130.8 149.39 73.51 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.392 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.79 139.42 80.17 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.461 1.441 . . . . 0.0 111.096 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.653 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.3 tt -54.66 -28.81 19.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.851 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -73.91 -29.99 62.34 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.438 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -79.1 -35.61 42.0 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.745 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' A' ' 55' ' ' ALA . 79.4 t -63.65 -59.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -49.1 -38.89 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.611 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.454 ' N ' HG13 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -54.28 -45.57 72.53 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.82 -55.82 17.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.296 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -44.78 -29.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.976 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.88 -59.38 8.68 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -49.49 -48.24 48.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.922 0.391 . . . . 0.0 110.127 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 52.1 m-85 -60.15 -39.85 87.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.704 0.764 . . . . 0.0 110.687 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.1 tp -59.61 -38.27 80.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.815 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 30.6 t80 -69.54 -39.02 77.73 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.159 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.429 ' OD1' ' NE2' ' A' ' 152' ' ' HIS . 16.7 m-80 -55.89 -70.55 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.69 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.81 -47.87 30.62 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.474 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.436 HD21 HG21 ' A' ' 4' ' ' ILE . 51.6 mt -50.64 -44.22 57.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.041 0.421 . . . . 0.0 111.765 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -55.78 -26.01 43.9 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.405 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.0 t -74.89 -55.1 6.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.05 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -73.37 -36.67 66.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.797 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -97.17 25.25 5.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.777 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 31.5 m -52.51 -38.1 58.91 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -58.62 -34.13 70.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.868 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 105' ' ' GLU . 2.9 t -81.6 -19.65 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.669 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.459 ' C ' ' N ' ' A' ' 87' ' ' LYS . 38.6 t -71.5 -43.6 71.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.949 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -51.5 -12.7 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.069 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.459 ' N ' ' C ' ' A' ' 85' ' ' VAL . 41.9 mmtm -69.09 -29.46 67.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.822 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 18.8 p90 -120.49 122.53 40.84 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.136 0.493 . . . . 0.0 111.328 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -87.29 -0.76 57.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.514 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 153' ' ' PHE . 45.7 t0 -162.31 165.58 26.41 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.583 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.4 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 72.8 t80 -57.04 -42.2 80.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.219 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.0 m -63.24 -59.34 4.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.46 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.1 m -46.81 -37.39 8.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.253 0.549 . . . . 0.0 110.649 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.545 HD12 ' CD2' ' A' ' 88' ' ' PHE . 4.4 tt -64.25 -44.36 92.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.431 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.4 t -66.77 -39.37 83.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.405 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 6.9 ptm -86.9 -1.43 57.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -113.43 -16.23 8.36 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.746 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.566 ' HA ' HD13 ' A' ' 102' ' ' ILE . 9.4 mt -34.26 -82.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 117.809 0.804 . . . . 0.0 111.712 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -45.17 -53.5 8.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.146 0.498 . . . . 0.0 110.915 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -46.99 -89.19 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.616 HG23 HD12 ' A' ' 102' ' ' ILE . 3.8 m -70.04 -49.84 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.616 HD12 HG23 ' A' ' 101' ' ' VAL . 3.8 mp -67.29 -39.5 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.586 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.47 -57.62 11.03 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.4 tp -47.68 -54.67 11.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.136 0.493 . . . . 0.0 110.185 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.423 ' HG2' HG22 ' A' ' 84' ' ' VAL . 34.5 tp10 -52.59 -46.52 66.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.775 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 102' ' ' ILE . 24.7 t -52.66 -54.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -45.09 -43.46 9.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.749 0.309 . . . . 0.0 110.666 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt . . . . . 0 C--N 1.331 -0.197 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.501 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.448 0.166 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.28 129.74 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -136.66 121.32 18.46 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.939 0.399 . . . . 0.0 111.726 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.35 123.48 5.73 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' A' ' 122' ' ' LEU . 37.9 tt0 -115.73 160.92 19.45 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.823 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -107.89 145.57 33.56 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.45 160.48 41.64 Favored Pre-proline 0 N--CA 1.468 0.461 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -72.8 -44.57 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.578 2.185 . . . . 0.0 113.247 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.542 HD21 ' CD ' ' A' ' 127' ' ' GLN . 47.7 p-10 -74.58 45.46 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.184 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.3 m120 44.99 60.72 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 0.0 111.102 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.542 ' CD ' HD21 ' A' ' 125' ' ' ASN . 78.6 mt-30 -136.72 158.83 43.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.913 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.6 mt -138.85 118.56 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.16 122.5 33.85 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.389 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.3 tp -115.42 136.24 53.29 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.111 0.481 . . . . 0.0 110.726 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -122.58 123.17 40.58 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.409 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.6 t80 . . . . . 0 N--CA 1.465 0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.257 -179.438 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.614 ' N ' HD22 ' A' ' 138' ' ' LEU . 2.9 mm? . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.651 0.262 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 93.6 m -41.41 -54.75 3.0 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 111.58 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -47.96 -30.26 4.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.935 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 138' ' ' LEU . 5.3 t -71.11 -44.59 65.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.772 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.66 -47.28 15.0 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.407 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -64.59 -48.86 73.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.349 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.74 -49.12 35.26 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 31.2 mt -59.16 -53.93 52.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.602 0.239 . . . . 0.0 111.507 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 31.3 mt -54.62 -55.66 27.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.947 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.585 ' CE2' HD12 ' A' ' 159' ' ' ILE . 19.6 m-85 -51.43 -47.78 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.862 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.01 -52.0 54.95 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.08 -59.83 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.926 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.85 -49.9 47.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -52.03 -50.1 62.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.565 0.221 . . . . 0.0 111.323 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.429 ' NE2' ' OD1' ' A' ' 75' ' ' ASN . 43.4 m80 -48.87 -49.35 40.02 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.826 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.526 ' CE2' ' OD1' ' A' ' 90' ' ' ASP . 64.7 t80 -85.43 35.68 0.61 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.949 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 39.22 55.17 2.21 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.056 0.455 . . . . 0.0 110.983 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -130.5 141.79 50.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -113.84 123.25 49.36 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.844 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.4 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 28.9 pt -133.3 172.45 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.65 0.738 . . . . 0.0 112.347 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -136.58 126.77 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.566 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.585 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.1 mt -111.51 120.35 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.685 0.278 . . . . 0.0 110.61 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.6 t -105.38 112.36 25.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.821 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.559 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 18.5 p80 -101.0 74.79 1.63 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.651 0.739 . . . . 0.0 111.503 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -76.21 -29.3 57.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.805 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.04 109.13 20.93 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.529 ' O ' HG22 ' A' ' 167' ' ' THR . 13.4 t -111.88 177.0 4.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.84 0.353 . . . . 0.0 110.417 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.44 ' N ' ' SG ' ' A' ' 164' ' ' CYS . 81.1 mtp -91.37 -28.26 17.82 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -53.62 -22.8 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.957 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.4 t -88.76 -28.15 20.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.466 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.59 20.35 15.22 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.099 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.03 163.14 17.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.722 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -49.44 -34.31 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.344 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 171' ' ' HIS . 8.0 p80 -172.25 -170.84 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.2 m -93.65 140.4 29.68 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 tpt -122.87 114.67 20.79 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -119.05 105.59 11.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.826 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.53 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -88.17 125.77 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.344 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.17 149.35 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.258 0.552 . . . . 0.0 110.385 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.499 ' OE2' ' N ' ' A' ' 178' ' ' LEU . 9.3 tp10 -136.47 135.47 38.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.993 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.499 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 13.0 mt . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.77 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 tp . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.81 0.338 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.4 mm -60.77 -45.24 98.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -70.99 -26.39 63.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.211 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -67.61 -53.23 29.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.016 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.35 -31.83 55.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.072 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.506 HD13 ' CE2' ' A' ' 69' ' ' PHE . 31.3 tp -71.86 -42.03 67.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.694 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.2 tt0 -54.28 -43.92 71.46 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.566 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -61.02 -51.14 70.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.326 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.615 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 58.2 mtm -54.01 -43.26 69.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.79 -36.43 75.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.666 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 10' ' ' GLU . 47.3 t -61.7 -25.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.265 0.555 . . . . 0.0 110.143 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.97 -34.45 22.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.199 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -84.33 -75.56 0.34 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.454 ' SG ' HD21 ' A' ' 58' ' ' LEU . 94.8 m -92.78 -22.88 19.08 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.199 0.524 . . . . 0.0 110.935 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.8 171.23 22.63 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.806 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 30.3 ttm -66.91 -27.45 67.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.707 -1.246 . . . . 0.0 110.292 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -63.25 -42.85 99.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.221 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.82 -35.56 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.418 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 51.1 t-105 -53.42 -44.74 69.03 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.98 -28.13 64.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.09 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -66.27 -51.17 60.1 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -83.47 -18.88 37.06 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.705 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 25' ' ' LEU . 9.0 tt -78.1 -70.66 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.581 ' N ' HD23 ' A' ' 26' ' ' LEU . 87.0 tt0 -49.58 -22.31 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.995 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 tttp -80.94 -37.27 29.75 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 26' ' ' LEU . 21.8 m80 . . . . . 0 N--CA 1.464 0.25 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.893 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.802 0.335 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -63.58 -30.64 71.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.634 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.43 -57.21 7.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 110.559 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.406 ' CZ ' HD12 ' A' ' 138' ' ' LEU . 78.9 m-85 -38.36 -43.81 0.85 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.122 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 m -74.32 -30.13 61.92 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.092 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.7 mt -72.96 -51.76 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.152 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -58.05 -26.0 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.816 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.659 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.5 tt0 -77.18 -41.36 41.86 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.682 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -58.77 -56.35 23.39 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.725 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.486 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 7.2 p -57.67 -34.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.066 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.54 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -67.44 -35.45 79.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.73 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -60.21 -47.76 84.59 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.21 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.721 HH22 HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -69.09 -39.79 78.8 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.663 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.454 HD21 ' SG ' ' A' ' 17' ' ' CYS . 84.6 mt -70.59 -10.8 60.18 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.091 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.5 t30 56.87 50.12 12.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.28 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.405 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 55.8 mmm -128.74 148.58 69.15 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.32 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.48 138.04 63.16 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.462 1.441 . . . . 0.0 111.028 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.659 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.8 tt -52.09 -29.3 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.291 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -72.35 -34.38 67.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.148 0.499 . . . . 0.0 111.482 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -75.61 -32.46 60.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.068 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.54 HG21 ' HB2' ' A' ' 55' ' ' ALA . 93.1 t -71.1 -56.31 11.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -53.01 -44.23 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.348 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.525 ' N ' HG13 ' A' ' 66' ' ' VAL . 36.0 mtpt -51.7 -50.44 60.49 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.27 -52.11 66.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.529 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.506 ' CE2' HD13 ' A' ' 9' ' ' LEU . 7.3 m-30 -46.91 -28.07 1.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.373 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.84 -48.21 42.92 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -55.05 -52.22 63.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.888 0.375 . . . . 0.0 110.635 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.615 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 57.7 m-85 -59.79 -42.17 92.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.695 0.76 . . . . 0.0 110.842 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.9 tp -53.36 -38.15 63.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.621 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 22.6 t80 -70.94 -42.45 69.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.233 0.539 . . . . 0.0 109.746 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -54.34 -72.83 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.653 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.06 -47.6 20.1 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.298 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.4 mt -50.71 -42.0 56.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.99 0.395 . . . . 0.0 112.013 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -54.95 -25.43 29.47 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.362 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.4 t -74.03 -55.94 5.52 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.928 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.684 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -71.24 -42.44 68.86 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.05 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -92.92 28.54 2.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.077 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 42.8 m -54.81 -38.45 67.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.015 0.436 . . . . 0.0 109.992 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.64 -34.78 73.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.235 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.23 -20.9 12.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.8 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 87' ' ' LYS . 38.9 t -69.9 -40.93 79.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.139 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -53.03 -14.0 0.53 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.408 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.408 ' N ' ' C ' ' A' ' 85' ' ' VAL . 21.6 mmtp -68.69 -29.6 68.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.034 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 15.8 p90 -119.75 121.27 38.79 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.171 0.51 . . . . 0.0 111.235 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -86.71 2.4 48.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.167 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 45.0 t0 -167.2 162.46 15.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.183 0.516 . . . . 0.0 111.522 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.45 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 80.0 t80 -51.49 -49.88 60.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.953 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.6 m -55.11 -58.34 8.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.519 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.5 t -46.73 -40.69 13.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.126 0.488 . . . . 0.0 111.217 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.443 HD12 ' CD2' ' A' ' 88' ' ' PHE . 5.0 tt -63.56 -43.92 95.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.396 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.6 t -64.3 -39.1 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.396 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 8.9 ptm -87.99 -1.09 57.78 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -114.08 -17.46 7.27 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 119.398 -0.668 . . . . 0.0 112.843 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.518 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.1 mt -28.12 -104.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 117.735 0.768 . . . . 0.0 112.494 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -39.6 -49.12 2.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.039 0.447 . . . . 0.0 111.341 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -45.08 -86.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.567 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -72.44 -52.61 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.567 ' N ' HG23 ' A' ' 101' ' ' VAL . 3.0 mp -62.23 -47.99 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.38 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.34 -53.08 48.74 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.4 tp -49.32 -50.86 37.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -55.46 -44.88 76.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.134 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.95 -53.7 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -45.65 -44.56 13.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.666 0.27 . . . . 0.0 110.958 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt . . . . . 0 C--N 1.328 -0.353 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.399 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.4 m80 . . . . . 0 N--CA 1.462 0.164 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.8 mt -124.07 126.82 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.586 0.231 . . . . 0.0 111.108 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -130.98 117.25 18.94 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.534 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.3 151.16 18.43 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.408 ' C ' HD22 ' A' ' 122' ' ' LEU . 91.7 mt-30 -140.77 161.02 38.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 110.125 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.791 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.2 mm? -109.29 143.37 38.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.847 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.07 160.58 40.43 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.32 -46.09 0.39 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.623 2.215 . . . . 0.0 113.25 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.573 ' ND2' ' OE1' ' A' ' 127' ' ' GLN . 32.2 p30 -72.95 45.19 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.204 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 44.65 63.38 1.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.424 0.631 . . . . 0.0 111.023 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.573 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 77.3 mt-30 -139.52 158.57 43.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.912 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.6 mt -138.5 117.59 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.68 122.3 31.97 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.655 -0.418 . . . . 0.0 109.988 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.3 tp -119.26 133.35 55.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.052 0.453 . . . . 0.0 111.456 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -116.94 122.56 44.62 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 40.6 t80 . . . . . 0 N--CA 1.466 0.363 0 CA-C-O 120.558 0.218 . . . . 0.0 111.329 -178.546 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.406 HD12 ' CZ ' ' A' ' 48' ' ' PHE . 3.1 tp . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.234 0.54 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.59 ' HG ' ' HG ' ' A' ' 172' ' ' CYS . 3.5 m -44.5 -49.25 10.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.69 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -44.23 -42.29 6.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.937 0.399 . . . . 0.0 110.58 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.3 t -63.76 -42.02 97.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.191 0.519 . . . . 0.0 109.61 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.6 -52.48 10.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.666 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -58.99 -50.98 72.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.471 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.24 -44.97 34.94 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.8 mt -62.78 -52.52 62.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.659 0.266 . . . . 0.0 111.48 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.9 mt -55.45 -57.09 13.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.854 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.57 ' CE2' HD12 ' A' ' 159' ' ' ILE . 26.6 m-85 -50.75 -47.78 59.33 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.767 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.06 -51.33 58.98 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.05 -59.75 2.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.867 0.365 . . . . 0.0 110.749 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -50.45 -52.02 41.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -50.77 -47.29 59.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.667 0.27 . . . . 0.0 111.015 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -49.48 -49.71 44.46 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.516 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 69.4 t80 -88.31 38.49 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.891 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 38.26 56.58 1.72 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 111.253 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -129.74 141.12 50.94 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -113.07 124.94 53.77 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.89 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.45 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 9.0 pt -137.96 171.86 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.633 0.73 . . . . 0.0 111.853 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -135.56 127.35 29.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.406 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.57 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.8 mt -110.53 118.38 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.0 t -100.98 105.48 16.7 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.479 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.548 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 18.2 p80 -102.58 75.67 1.46 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.553 0.692 . . . . 0.0 111.951 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -76.57 -29.14 56.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.456 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.7 103.94 15.65 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.586 ' O ' ' N ' ' A' ' 166' ' ' HIS . 38.7 t -132.45 112.71 12.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.662 0.267 . . . . 0.0 110.803 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 8.0 tpt -37.65 -18.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.102 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.586 ' N ' ' O ' ' A' ' 164' ' ' CYS . 57.4 t-80 -54.66 -25.93 30.05 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.487 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.0 t -86.37 -44.42 12.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.096 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 167' ' ' THR . . . 146.55 15.42 0.16 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.303 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.499 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -71.18 157.63 37.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.628 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -74.67 -5.09 41.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.612 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -176.08 -149.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.59 ' HG ' ' HG ' ' A' ' 139' ' ' CYS . 3.4 m -131.77 146.26 52.05 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.197 0.522 . . . . 0.0 111.59 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 10.6 tpp -119.56 124.11 45.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.277 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -126.95 105.32 8.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.411 0.624 . . . . 0.0 111.379 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -92.46 127.06 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.403 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 177' ' ' GLU . 5.1 mp -110.32 151.64 12.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.29 0.567 . . . . 0.0 110.902 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.413 ' N ' HG22 ' A' ' 176' ' ' ILE . 52.0 mt-10 -139.45 137.24 35.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.294 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.2 mt . . . . . 0 N--CA 1.464 0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.351 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.553 HD13 ' NE ' ' A' ' 80' ' ' ARG . 2.5 tp . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 121.025 0.44 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 mm -58.56 -47.88 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -73.77 -21.72 60.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -66.98 -50.42 62.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.762 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.02 -39.68 81.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.197 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.7 tp -63.49 -40.73 97.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -55.62 -46.43 77.36 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.639 -0.424 . . . . 0.0 109.892 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -61.19 -50.72 71.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.997 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.7 OUTLIER -52.49 -40.57 62.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.6 t -71.4 -34.74 54.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.551 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.9 t -61.62 -23.66 31.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.253 0.549 . . . . 0.0 109.95 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.82 -34.47 21.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.098 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -84.31 -75.74 0.33 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 58' ' ' LEU . 95.5 m -92.49 -20.82 20.58 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.189 0.518 . . . . 0.0 110.964 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.87 170.84 25.36 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.821 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.3 ttt -66.84 -27.09 67.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.926 -1.137 . . . . 0.0 110.444 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -63.7 -42.53 97.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.052 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.21 -35.07 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 -51.83 -45.29 63.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -73.95 -28.86 61.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.329 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -67.54 -50.3 59.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.939 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.33 -26.57 35.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.69 0.281 . . . . 0.0 110.553 -179.305 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.939 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.7 tt -70.08 -71.8 0.22 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.439 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.74 ' N ' HD23 ' A' ' 26' ' ' LEU . 82.4 tt0 -50.51 -23.34 2.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.543 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.38 -42.99 21.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m80 . . . . . 0 N--CA 1.467 0.411 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.96 -179.735 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 120.632 0.253 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -56.62 -36.91 70.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.138 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -40.84 -56.4 2.22 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.895 0.379 . . . . 0.0 111.056 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -39.43 -40.41 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.18 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.2 t -72.15 -34.57 68.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.225 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.9 mp -67.78 -54.9 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.28 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.407 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -55.52 -23.95 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.784 178.703 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.691 ' HG3' HD12 ' A' ' 62' ' ' ILE . 1.8 tt0 -76.05 -40.2 53.87 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.097 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.558 ' OD2' HD23 ' A' ' 25' ' ' LEU . 47.7 m-20 -60.26 -56.86 16.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.408 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.82 -36.76 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.87 87.5 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.174 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -63.52 -31.0 72.03 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.62 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -73.96 -42.94 59.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.619 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 ' SG ' ' A' ' 17' ' ' CYS . 25.9 mt -80.7 -7.11 59.23 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.879 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 56.22 49.23 15.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.556 0.693 . . . . 0.0 109.207 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mmt -127.73 149.75 71.32 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.967 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.99 137.73 63.87 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.451 1.434 . . . . 0.0 110.978 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.691 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.1 tt -51.28 -29.48 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.776 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -71.24 -30.13 65.96 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.143 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -78.41 -34.03 48.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.112 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.1 t -70.04 -56.41 11.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 67' ' ' LYS . 11.7 p -52.93 -41.39 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.248 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.512 ' N ' HG13 ' A' ' 66' ' ' VAL . 30.9 mtpt -53.25 -49.28 67.18 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.52 91.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.656 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -53.12 -33.07 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.566 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.05 -50.48 60.31 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.98 -50.31 66.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.064 0.459 . . . . 0.0 110.222 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -59.81 -42.58 93.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.632 0.729 . . . . 0.0 110.781 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.4 tp -56.37 -38.93 72.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.314 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 20.1 t80 -68.37 -43.77 76.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.369 0.604 . . . . 0.0 109.503 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.75 -71.65 0.08 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.289 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.11 -39.65 27.24 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.926 -178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.6 mt -61.81 -39.23 91.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.412 0.606 . . . . 0.0 112.027 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.94 -24.68 39.48 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.232 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.6 p -77.11 -53.84 7.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.438 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.553 ' NE ' HD13 ' A' ' 4' ' ' ILE . 1.1 mtm105 -68.75 -49.75 56.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.159 0.504 . . . . 0.0 110.343 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.608 ' CD2' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -83.72 22.75 1.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.444 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.4 m -49.38 -38.08 27.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.654 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -62.35 -35.85 80.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.721 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.608 HG21 ' CD2' ' A' ' 81' ' ' HIS . 3.6 t -83.58 -17.88 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.426 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 87' ' ' LYS . 56.1 t -65.24 -38.04 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.807 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -57.93 -6.41 0.56 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.769 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 105' ' ' GLU . 30.0 mmtp -76.71 -25.72 53.88 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.59 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.481 ' C ' ' H ' ' A' ' 90' ' ' ASP . 26.9 p90 -129.18 -45.77 1.24 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.707 0.289 . . . . 0.0 111.006 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 19.1 t70 58.16 -0.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.534 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.523 ' OD1' ' CE1' ' A' ' 153' ' ' PHE . 34.0 m-20 -152.07 164.63 36.84 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.35 0.595 . . . . 0.0 111.237 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -66.12 -61.25 2.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.7 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.6 m -50.82 -53.16 34.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.716 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.4 m -59.75 -35.79 75.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.309 0.576 . . . . 0.0 110.976 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.404 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 3.1 tt -66.36 -47.97 71.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.956 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 90.2 t -60.92 -36.31 71.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.394 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -88.8 -5.85 57.78 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.134 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -110.88 -15.14 11.18 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.476 -0.625 . . . . 0.0 112.78 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.665 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.1 mt -28.87 -104.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 117.568 0.684 . . . . 0.0 112.703 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.401 ' H ' ' HB ' ' A' ' 98' ' ' ILE . 13.6 p-80 -38.62 -48.66 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 0.0 111.54 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -45.71 -87.27 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.599 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.5 m -71.17 -52.1 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.665 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.1 mp -60.99 -47.25 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.452 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.05 -55.6 28.69 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.5 tp -47.88 -50.03 27.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.125 0.488 . . . . 0.0 110.358 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 84' ' ' VAL . 42.8 tp10 -55.71 -44.76 77.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.407 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.28 -52.15 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -49.37 -44.14 44.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.034 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt . . . . . 0 C--N 1.33 -0.272 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.432 -179.984 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 83.8 t60 . . . . . 0 C--O 1.231 0.095 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.9 mt -121.69 127.28 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.617 0.246 . . . . 0.0 110.891 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -130.81 113.02 13.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.945 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.99 138.55 15.06 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.437 ' C ' HD12 ' A' ' 122' ' ' LEU . 52.0 tt0 -132.26 158.51 41.63 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 122' ' ' LEU . 10.3 mp -103.44 146.44 28.5 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.47 161.42 39.45 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 126' ' ' ASN . 68.5 Cg_endo -72.77 -45.58 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.552 2.168 . . . . 0.0 113.398 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -72.9 38.49 0.08 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.974 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 124' ' ' PRO . 80.9 m-20 50.44 64.31 1.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.213 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -142.49 163.15 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.992 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.8 mt -137.59 118.09 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.21 120.42 27.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.0 tp -117.53 132.68 56.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.202 0.525 . . . . 0.0 110.952 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -121.22 126.38 49.47 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.505 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 120.936 0.398 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.0 t -41.68 -53.13 3.68 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.461 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -46.68 -33.64 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.165 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 7.0 t -68.38 -44.38 75.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.04 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.74 -49.99 18.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.907 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -62.13 -50.7 70.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.902 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.39 -42.6 18.81 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.04 -49.82 73.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 111.361 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.4 mt -58.87 -57.61 12.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.574 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.404 ' CE2' HD12 ' A' ' 159' ' ' ILE . 38.3 m-85 -49.58 -48.71 48.53 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.641 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.26 -51.58 57.24 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -42.86 -60.08 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.775 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.84 56.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.866 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -49.47 -48.09 47.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.665 0.269 . . . . 0.0 110.956 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -49.56 -49.64 45.56 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.827 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 65.2 t80 -85.69 35.87 0.63 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.348 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 44.25 46.76 7.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.126 0.488 . . . . 0.0 110.553 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -127.32 142.65 51.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -124.65 117.48 24.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.77 ' O ' HD13 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -132.43 163.52 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.365 0.602 . . . . 0.0 111.121 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -118.29 131.95 56.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.404 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.1 mt -110.32 119.35 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.0 m -103.64 114.72 29.2 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.578 0.228 . . . . 0.0 111.311 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.539 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.6 p-80 -96.03 79.01 3.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.512 0.672 . . . . 0.0 111.565 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -82.22 -0.07 43.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.164 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.86 111.12 5.57 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.52 ' O ' HG22 ' A' ' 167' ' ' THR . 13.6 m -114.14 178.79 4.16 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.112 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 168' ' ' GLY . 77.4 mtp -93.9 -28.94 15.55 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.476 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 4.3 p80 -52.77 -21.21 3.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.673 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.8 t -90.06 -28.04 19.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.561 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 99.63 19.9 18.77 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.072 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.38 167.8 9.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 110.792 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -52.15 -33.85 42.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.263 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -174.76 -170.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 1.7 m -94.31 140.34 29.91 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.253 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.6 tpp -118.6 123.61 45.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.26 102.44 6.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.477 0.656 . . . . 0.0 110.86 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -91.52 126.73 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.647 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.405 HG23 ' CG1' ' A' ' 157' ' ' ILE . 4.7 mp -108.51 147.07 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.19 0.519 . . . . 0.0 110.197 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -137.25 135.69 37.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.307 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 21.5 mt . . . . . 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.193 179.427 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.421 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.5 tp . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.869 0.366 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.2 mm -71.43 -56.08 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.093 0.473 . . . . 0.0 110.29 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -67.3 -18.73 65.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.079 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -75.24 -58.87 3.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.408 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 4' ' ' ILE . 51.0 t -52.65 -35.26 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.491 HD13 ' CE2' ' A' ' 69' ' ' PHE . 17.5 tp -73.08 -43.06 62.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.723 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -51.11 -44.71 61.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -60.36 -52.46 65.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.924 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.556 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 92.6 mtp -50.05 -43.63 51.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.131 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.9 t -68.55 -37.29 77.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.95 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.7 -23.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.226 0.536 . . . . 0.0 110.261 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.48 -34.01 18.81 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.262 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -83.81 -77.57 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.1 m -92.43 -19.11 22.38 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.216 0.532 . . . . 0.0 110.627 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.22 -179.38 24.82 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.0 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.1 ttm -72.57 -30.12 64.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.76 -1.22 . . . . 0.0 110.647 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -60.06 -38.81 83.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.872 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -77.69 -38.91 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 59.4 t-105 -54.48 -48.4 71.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.446 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.24 -25.14 57.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.707 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -74.7 -47.0 33.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.679 -0.408 . . . . 0.0 112.039 -178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.966 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.54 -28.13 37.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.313 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.966 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.9 tt -66.82 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.624 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.523 ' N ' HD23 ' A' ' 26' ' ' LEU . 96.0 mt-10 -57.76 -22.98 49.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.089 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -80.94 -44.6 17.98 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.7 m80 . . . . . 0 N--CA 1.467 0.421 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.115 -179.791 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 76.4 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.835 0.35 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.23 -30.95 70.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.741 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -39.71 -58.54 1.31 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.978 0.418 . . . . 0.0 110.852 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -38.4 -45.14 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.211 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.3 m -67.96 -35.3 78.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.15 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.1 mp -68.68 -58.34 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 119.979 -0.689 . . . . 0.0 109.32 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -52.12 -21.32 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.993 179.13 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.671 ' HG3' HD12 ' A' ' 62' ' ' ILE . 1.7 tt0 -79.41 -42.56 25.22 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.196 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.549 ' OD2' HD23 ' A' ' 25' ' ' LEU . 32.7 m-20 -57.95 -57.67 11.78 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.789 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.04 -38.88 69.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.641 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.74 84.91 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.081 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -63.35 -31.32 72.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -74.68 -45.26 45.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.63 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.3 mt -77.08 -6.54 53.2 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.853 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.22 48.17 17.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.51 0.672 . . . . 0.0 109.492 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.8 mmm -126.62 149.5 68.28 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.074 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.36 134.44 45.09 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.454 1.436 . . . . 0.0 111.182 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.671 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.9 tt -48.51 -27.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.06 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -72.56 -33.91 67.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.163 0.506 . . . . 0.0 111.327 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -76.38 -31.8 58.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.227 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.548 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 78.5 t -72.61 -56.18 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -51.46 -43.97 31.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.245 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.53 ' N ' HG13 ' A' ' 66' ' ' VAL . 34.5 mtpt -51.85 -51.73 54.58 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.06 -58.26 8.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.874 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.6 m-30 -44.33 -29.28 0.65 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.527 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.18 -47.75 77.53 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -58.52 -54.19 49.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.02 0.438 . . . . 0.0 110.446 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.556 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 34.8 m-85 -55.12 -40.71 70.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.736 0.779 . . . . 0.0 110.619 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.6 tp -58.68 -38.16 77.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.198 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 34.4 t80 -68.4 -39.49 81.64 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.041 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -57.19 -71.05 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.328 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.11 -39.82 50.49 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.017 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.412 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 17.7 mt -57.53 -47.4 82.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.332 0.566 . . . . 0.0 111.585 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.44 -20.84 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.41 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.409 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.4 t -79.17 -42.28 26.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.105 0.478 . . . . 0.0 110.072 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.46 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.3 mmp_? -65.9 -71.47 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.462 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 17.4 p80 -84.16 36.92 0.59 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.831 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 85' ' ' VAL . 26.5 m -51.11 -46.81 61.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.886 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -49.3 -36.66 21.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.248 0.547 . . . . 0.0 109.66 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.788 HG13 ' CD ' ' A' ' 105' ' ' GLU . 11.3 t -76.67 -22.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.999 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 87' ' ' LYS . 57.3 t -68.54 -44.62 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.245 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -54.4 -4.96 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.81 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 85' ' ' VAL . 60.9 mmtt -81.39 -29.46 33.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.009 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -95.21 117.53 30.41 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.255 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 91.2 m-20 -84.98 -15.44 44.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.482 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 89' ' ' ASP . 63.8 m-20 -161.63 172.02 17.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.192 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -59.42 -53.92 52.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.713 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.6 m -53.51 -36.48 61.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.261 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.3 m -64.79 -39.5 93.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.154 0.502 . . . . 0.0 110.491 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.47 HD12 ' CD2' ' A' ' 88' ' ' PHE . 4.2 tt -64.19 -47.58 79.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.509 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.33 -36.14 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.758 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.1 mmm -86.34 -5.3 59.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.445 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.38 -15.69 8.75 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.345 -0.697 . . . . 0.0 113.165 -178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.711 ' HA ' HD13 ' A' ' 102' ' ' ILE . 16.2 mt -28.07 -105.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 117.716 0.758 . . . . 0.0 112.662 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -39.97 -47.55 2.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.092 0.472 . . . . 0.0 111.351 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -47.04 -88.44 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.586 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.0 m -69.77 -51.78 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.4 mp -61.22 -45.61 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.539 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.89 -53.99 40.66 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.577 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 42.8 tp -52.0 -51.55 56.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.86 0.362 . . . . 0.0 110.782 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.788 ' CD ' HG13 ' A' ' 84' ' ' VAL . 34.4 mt-10 -55.48 -45.37 76.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.128 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.2 t -54.07 -52.38 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -47.41 -43.48 23.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.858 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.577 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 23.7 mmtm . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.788 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.1 m80 . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.447 0.165 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.3 mt -134.03 131.51 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.709 0.29 . . . . 0.0 110.682 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -135.41 130.21 34.5 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.659 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -123.4 150.66 16.89 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -138.04 164.71 28.42 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.08 145.09 36.23 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.354 -0.384 . . . . 0.0 109.966 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.35 160.55 41.14 Favored Pre-proline 0 N--CA 1.467 0.377 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.26 -40.11 1.81 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.57 2.18 . . . . 0.0 113.155 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.521 ' ND2' ' OE1' ' A' ' 127' ' ' GLN . 19.8 p30 -78.97 47.44 0.77 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.229 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.521 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 0.7 OUTLIER 42.52 61.1 2.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.464 0.65 . . . . 0.0 110.868 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.521 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 66.5 mt-30 -137.73 159.44 41.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.895 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.5 mt -135.61 116.52 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.82 122.95 31.41 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.057 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.7 tp -117.66 135.06 54.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.99 0.424 . . . . 0.0 111.168 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -120.01 123.8 44.35 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.456 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.47 0.567 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.566 -178.896 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 26.4 p -40.55 -50.69 2.97 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.568 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.489 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 90.0 m-85 -43.13 -38.06 2.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 110.114 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 28.6 t -69.08 -45.96 68.96 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -45.64 -49.27 14.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.188 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -57.03 -50.39 72.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.677 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.64 -52.63 40.66 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.9 mt -55.16 -55.38 31.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.798 0.333 . . . . 0.0 110.498 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.3 mt -54.08 -55.75 24.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.564 ' CE2' HD12 ' A' ' 159' ' ' ILE . 6.3 m-85 -49.74 -47.97 50.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.73 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.26 60.21 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.95 -60.53 1.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.844 0.354 . . . . 0.0 110.87 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.61 -49.85 45.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -52.98 -47.64 68.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.083 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -50.06 -50.51 47.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 70.6 t80 -85.55 36.77 0.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.992 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 38.8 55.01 2.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.918 0.389 . . . . 0.0 111.134 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -129.86 141.24 50.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -110.79 126.54 54.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.128 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.0 pt -137.37 177.04 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.524 0.678 . . . . 0.0 111.837 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -143.84 125.84 15.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.202 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.564 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.4 mt -111.76 120.74 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.624 0.25 . . . . 0.0 110.613 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 m -105.66 115.37 30.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.112 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 17.0 p80 -102.13 72.95 1.34 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.738 0.78 . . . . 0.0 111.526 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -73.63 -30.86 63.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.844 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.67 113.76 27.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.474 ' O ' HG22 ' A' ' 167' ' ' THR . 7.7 t -117.89 -175.38 2.83 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.305 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 165' ' ' MET . 12.6 tmm? -93.8 -25.5 17.36 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -56.09 -23.95 37.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.473 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.6 t -86.54 -25.29 25.14 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.3 21.97 25.91 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.908 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.73 163.18 24.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.025 0.441 . . . . 0.0 110.693 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -45.11 -33.35 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.021 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -176.53 -168.97 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 20.8 t -95.45 141.87 28.48 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.221 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.2 tpt -121.59 119.72 32.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.726 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.98 107.15 11.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.873 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.4 mp -88.98 126.36 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.372 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 177' ' ' GLU . 5.1 mp -111.66 152.48 13.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.135 0.493 . . . . 0.0 110.458 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.421 ' N ' HG22 ' A' ' 176' ' ' ILE . 85.9 tt0 -142.96 141.45 31.43 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.494 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 N--CA 1.462 0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.877 -179.69 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 tp . . . . . 0 CA--C 1.532 0.259 0 CA-C-O 120.757 0.313 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.96 -49.42 81.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 109.788 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -70.11 -23.39 63.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.003 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -68.12 -56.53 8.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.971 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.69 -38.65 76.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.043 0.449 . . . . 0.0 109.847 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.497 HD13 ' CE2' ' A' ' 69' ' ' PHE . 27.5 tp -65.89 -39.73 90.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.558 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -58.03 -43.8 87.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.989 0.423 . . . . 0.0 110.626 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.46 -63.9 1.14 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.361 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.8 ptm -46.19 -41.43 12.69 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.422 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.7 t -64.84 -38.36 82.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.609 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 49.2 t -59.9 -22.74 24.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.498 0.666 . . . . 0.0 109.407 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.76 -34.98 21.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.382 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -84.28 -76.67 0.29 Allowed 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.8 m -91.94 -21.44 20.57 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.294 0.569 . . . . 0.0 110.672 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.81 175.43 23.84 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.05 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.3 ttp -68.85 -28.07 66.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.648 -1.276 . . . . 0.0 110.368 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -61.75 -38.85 89.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.639 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.39 -38.67 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -55.3 -47.57 75.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.048 0.451 . . . . 0.0 110.096 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.04 -24.81 55.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.944 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -74.17 -47.31 36.61 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.93 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.71 -26.51 37.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.986 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.6 tt -73.04 -54.93 7.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.009 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' N ' HD23 ' A' ' 26' ' ' LEU . 82.0 tt0 -61.25 -23.98 66.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.475 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.51 ' NZ ' ' CE1' ' A' ' 29' ' ' HIS . 30.4 tttm -82.37 -39.04 23.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.51 ' CE1' ' NZ ' ' A' ' 28' ' ' LYS . 67.8 m80 . . . . . 0 N--CA 1.465 0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.063 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.8 0.333 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -67.9 -37.25 81.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.598 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -52.44 -57.54 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.194 0.521 . . . . 0.0 110.771 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -39.0 -42.38 0.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.671 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.8 p -74.53 -30.4 61.76 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.861 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 47' ' ' LEU . 17.9 mt -71.42 -52.96 22.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.745 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.97 -26.31 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.668 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.674 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.2 tt0 -76.53 -41.1 47.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.547 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.574 ' OD2' HD23 ' A' ' 25' ' ' LEU . 48.2 m-20 -59.47 -56.05 26.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.963 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 50' ' ' ILE . 5.9 p -58.35 -37.08 61.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.981 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.53 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.54 -38.28 86.84 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.061 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -63.52 -31.63 72.84 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.6 mmt-85 -73.54 -42.76 61.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.378 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.4 mt -81.54 -7.27 59.56 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.668 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.8 t30 57.02 49.82 13.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.807 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.4 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 25.7 mmt -128.69 149.44 72.03 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.214 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.62 137.76 65.95 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.404 1.403 . . . . 0.0 110.981 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.674 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.5 tt -51.22 -28.5 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.254 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -71.82 -34.2 69.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 0.0 111.58 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -76.17 -31.98 58.82 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.89 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 55' ' ' ALA . 95.9 t -71.08 -56.66 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.521 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -52.56 -43.87 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.372 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.521 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.5 mtpt -51.61 -51.06 58.66 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.39 -54.12 50.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.559 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.497 ' CE2' HD13 ' A' ' 9' ' ' LEU . 5.7 m-30 -44.12 -28.94 0.55 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.464 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.91 63.3 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.03 -54.35 48.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.768 0.318 . . . . 0.0 110.461 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -55.28 -41.33 72.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.813 0.816 . . . . 0.0 110.693 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.4 tp -57.95 -38.69 76.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.553 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 26.1 t80 -70.25 -39.53 74.94 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.162 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -55.33 -73.82 0.05 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.091 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.82 -38.21 29.74 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.203 -0.523 . . . . 0.0 112.572 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 20.8 mt -57.45 -46.52 83.52 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.028 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.41 -20.7 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.296 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.0 t -81.46 -41.92 21.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.15 0.5 . . . . 0.0 110.205 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.459 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.3 mmp_? -65.17 -71.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.778 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.459 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 18.5 p80 -85.25 34.61 0.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.985 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.9 m -47.2 -45.2 23.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.817 0.341 . . . . 0.0 110.574 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -54.55 -31.06 55.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 t -80.4 -24.58 11.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.093 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.0 t -62.49 -37.65 79.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.356 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.08 -15.95 2.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.653 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -65.75 -31.22 72.08 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.58 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 15.3 p90 -119.01 115.98 25.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.039 0.447 . . . . 0.0 110.708 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -83.68 -0.64 51.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.283 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 13.8 p-10 -163.11 155.25 18.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.128 0.49 . . . . 0.0 111.569 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -44.86 -52.0 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.876 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.7 m -55.01 -43.0 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.752 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -61.77 -36.11 80.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.233 0.54 . . . . 0.0 110.614 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.9 tt -67.05 -56.82 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.858 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.41 ' HA ' HD11 ' A' ' 98' ' ' ILE . 85.3 t -54.55 -38.46 42.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.847 0.356 . . . . 0.0 111.659 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.5 ppp? -88.44 -6.75 57.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -112.27 -14.73 10.43 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 119.712 -0.493 . . . . 0.0 112.909 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.585 ' HA ' HD13 ' A' ' 102' ' ' ILE . 3.8 mt -34.25 -83.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 117.867 0.833 . . . . 0.0 111.705 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -44.76 -54.16 6.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.26 0.553 . . . . 0.0 110.742 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -46.69 -88.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.63 HG23 HD12 ' A' ' 102' ' ' ILE . 3.7 m -71.01 -49.98 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -176.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.63 HD12 HG23 ' A' ' 101' ' ' VAL . 3.7 mp -65.91 -39.79 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.383 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.74 -56.0 14.86 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.65 HD11 ' HZ1' ' A' ' 108' ' ' LYS . 58.7 tp -49.91 -55.97 12.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.972 0.415 . . . . 0.0 110.709 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -52.69 -44.88 66.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.476 -178.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 102' ' ' ILE . 17.8 t -54.13 -53.42 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -47.14 -43.01 20.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.79 0.328 . . . . 0.0 110.827 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.65 ' HZ1' HD11 ' A' ' 104' ' ' LEU . 26.0 mmtm . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.572 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.66 0.267 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.49 126.34 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.962 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -133.14 121.12 22.14 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.579 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.3 126.97 7.17 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.449 ' C ' HD22 ' A' ' 122' ' ' LEU . 88.6 mt-30 -117.05 166.07 12.62 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.789 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.6 mm? -109.88 130.46 55.52 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.27 160.43 37.56 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.28 178.11 6.47 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.995 1.797 . . . . 0.0 112.127 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.523 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 19.5 t-20 56.6 37.26 28.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.949 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 8.6 p30 50.0 69.31 0.62 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.614 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 126' ' ' ASN . 82.8 mm-40 -136.85 161.61 35.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.513 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.1 mt -145.07 121.3 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.78 122.33 35.06 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.288 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.0 tp -117.64 134.73 54.57 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.125 0.488 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -117.56 121.61 41.44 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.477 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.485 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 37.4 t80 . . . . . 0 N--CA 1.467 0.378 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.531 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 31.0 p -43.17 -49.82 6.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.372 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.555 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 73.3 m-85 -46.76 -40.23 13.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.083 0.468 . . . . 0.0 110.335 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.3 t -62.93 -42.73 99.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -46.61 -54.95 8.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.663 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.64 -51.21 63.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.316 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.09 -48.13 47.25 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.05 -53.69 55.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.683 0.278 . . . . 0.0 111.302 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.4 mt -55.59 -54.93 37.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.699 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.545 ' CE2' HD12 ' A' ' 159' ' ' ILE . 10.6 m-85 -49.17 -49.1 44.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.902 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.04 -50.58 66.32 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.42 -59.91 2.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.74 0.305 . . . . 0.0 110.941 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 155' ' ' GLN . . . -51.44 -52.08 49.37 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.314 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -52.13 -47.88 65.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.215 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -47.74 -50.0 26.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.709 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -85.39 38.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.844 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 38.45 62.31 1.02 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.038 0.447 . . . . 0.0 111.309 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.491 ' HB3' ' HB1' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -132.93 151.11 52.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.465 ' H ' ' CD ' ' A' ' 155' ' ' GLN . 84.4 tttt -118.27 118.9 33.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.9 pt -133.32 170.86 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.539 0.685 . . . . 0.0 112.186 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -138.25 127.77 24.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.52 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.545 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.6 mt -111.41 117.56 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.911 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.9 t -98.72 103.34 15.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.819 0.343 . . . . 0.0 110.47 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.576 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 20.3 p80 -94.02 65.12 3.43 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.615 0.721 . . . . 0.0 111.017 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 163' ' ' THR . 37.3 p30 -69.0 -33.05 73.04 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.113 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.512 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 1.6 m -99.95 107.54 19.53 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.066 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.59 ' O ' ' N ' ' A' ' 166' ' ' HIS . 55.9 m -134.71 114.22 12.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.653 0.263 . . . . 0.0 110.785 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.2 ttt -36.62 -20.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.19 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.59 ' N ' ' O ' ' A' ' 164' ' ' CYS . 83.7 t60 -52.23 -23.33 5.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.482 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.6 t -88.77 -43.18 11.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.01 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 167' ' ' THR . . . 130.48 13.9 2.02 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.09 162.51 14.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 110.729 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.72 ' O ' ' CD2' ' A' ' 171' ' ' HIS . 28.9 p-10 -55.55 -41.16 72.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.343 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.72 ' CD2' ' O ' ' A' ' 170' ' ' ASP . 33.4 m80 -161.52 -173.33 3.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.6 m -96.31 137.96 34.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.439 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.511 ' H ' ' HB ' ' A' ' 163' ' ' THR . 12.3 ttm -126.19 92.76 3.64 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.609 0.719 . . . . 0.0 109.608 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.19 113.9 26.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.912 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.1 mm -90.49 127.98 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.366 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.07 148.99 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.432 0.634 . . . . 0.0 110.727 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -137.82 135.88 36.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.555 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 19.0 mt . . . . . 0 N--CA 1.465 0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.702 -179.687 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.505 HD13 ' O ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mm -68.56 -52.73 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.395 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.45 -22.81 64.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.006 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -69.83 -49.59 51.1 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.716 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.08 -36.36 77.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.922 0.392 . . . . 0.0 110.158 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.453 HD13 ' CE2' ' A' ' 69' ' ' PHE . 24.1 tp -71.02 -35.46 72.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.241 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.15 -45.73 86.91 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.045 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -61.61 -52.32 64.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.428 ' SD ' ' CE1' ' A' ' 69' ' ' PHE . 7.8 ttp -49.73 -43.27 47.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.54 -35.17 69.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.663 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -61.93 -22.16 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.218 0.533 . . . . 0.0 109.756 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.9 -35.11 20.74 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.343 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -84.35 -77.13 0.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.495 ' SG ' HD21 ' A' ' 58' ' ' LEU . 90.4 m -90.99 -20.04 22.56 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.265 0.555 . . . . 0.0 110.738 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.95 173.59 26.54 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.77 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.8 ttt -68.57 -28.37 66.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.831 -1.184 . . . . 0.0 110.477 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.8 m -62.76 -42.5 99.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.164 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.96 -36.03 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -52.03 -46.23 64.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -70.14 -30.98 68.28 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.138 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -65.31 -50.62 64.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -83.14 -18.89 37.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.871 0.367 . . . . 0.0 110.792 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.792 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.5 tt -77.97 -61.43 2.0 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.371 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.489 ' N ' HD23 ' A' ' 26' ' ' LEU . 78.5 mm-40 -58.68 -21.91 55.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.319 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -80.64 -38.58 28.91 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.502 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 72.1 m80 . . . . . 0 N--CA 1.465 0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.508 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.9 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.792 0.33 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.96 -30.38 67.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.808 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.6 -57.46 2.26 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.038 0.447 . . . . 0.0 110.684 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -38.0 -43.47 0.72 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.516 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.3 m -72.94 -32.41 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.527 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.2 mp -70.74 -52.84 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.503 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.4 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -56.44 -24.67 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.885 178.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.681 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.5 tt0 -77.01 -41.37 43.02 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.466 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.502 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 37.9 m-20 -58.55 -56.43 22.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.864 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.0 p -57.13 -39.32 66.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.065 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.02 -39.72 86.81 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.134 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -62.84 -31.51 72.54 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -74.54 -45.79 43.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.491 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.495 HD21 ' SG ' ' A' ' 17' ' ' CYS . 32.0 mt -76.8 -8.6 57.61 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.621 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 58.1 52.33 7.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.748 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.415 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 11.2 mmt -132.43 149.95 74.56 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.382 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.31 140.64 89.45 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.441 1.427 . . . . 0.0 111.194 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.681 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.2 tt -56.55 -30.76 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.744 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -72.91 -29.75 63.37 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.297 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 50.2 t0 -78.77 -36.62 42.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.699 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 55' ' ' ALA . 69.2 t -63.74 -58.96 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -49.94 -39.89 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.756 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' N ' HG13 ' A' ' 66' ' ' VAL . 2.2 ttpt -52.59 -47.33 66.97 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.86 89.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.453 ' CE2' HD13 ' A' ' 9' ' ' LEU . 6.2 m-30 -52.81 -29.96 30.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.613 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.17 -50.41 57.06 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -55.62 -50.06 71.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.924 0.392 . . . . 0.0 110.2 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -59.16 -41.53 88.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.802 0.81 . . . . 0.0 110.431 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.73 -38.88 79.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.449 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 36.6 t80 -69.54 -39.15 77.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.136 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -56.9 -69.87 0.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.97 -38.13 54.75 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.581 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.514 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 18.8 mt -57.07 -48.22 79.11 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.451 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.16 -21.28 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.552 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t -80.41 -40.51 26.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.24 0.543 . . . . 0.0 110.109 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.443 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.9 mmp_? -66.55 -70.55 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.68 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 23.7 p80 -83.66 32.99 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.97 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 55.0 m -47.93 -43.27 28.92 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.941 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -52.67 -31.76 38.85 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 81' ' ' HIS . 16.7 t -82.47 -25.26 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.675 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 87' ' ' LYS . 44.5 t -63.27 -38.2 81.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -47.33 -12.86 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.875 0.369 . . . . 0.0 110.924 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.506 ' NZ ' ' CG ' ' A' ' 105' ' ' GLU . 85.5 mttt -79.63 -28.41 40.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.895 0.855 . . . . 0.0 109.721 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 85' ' ' VAL . 39.7 t80 -57.78 100.21 0.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.232 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -88.39 -32.91 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 54.2 t0 -174.73 155.51 2.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.759 -1.564 . . . . 0.0 109.923 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.504 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 78.0 t80 -42.56 -46.27 4.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.319 0.58 . . . . 0.0 110.49 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.2 m -61.76 -37.3 83.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.795 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -65.54 -40.83 93.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.343 0.592 . . . . 0.0 110.579 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 98' ' ' ILE . 6.5 tt -65.35 -49.92 67.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.318 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.407 HG21 ' CE2' ' A' ' 91' ' ' PHE . 76.5 t -57.13 -37.78 57.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.262 0.554 . . . . 0.0 110.623 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 120' ' ' GLY . 95.3 mmm -86.49 -5.98 59.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.192 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.89 -15.56 8.52 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.096 -0.836 . . . . 0.0 113.202 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.521 ' O ' ' O ' ' A' ' 97' ' ' GLY . 13.6 mt -27.27 -106.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 117.945 0.873 . . . . 0.0 112.66 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -40.64 -49.89 3.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.26 0.552 . . . . 0.0 111.259 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -43.25 -86.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.548 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.0 m -72.82 -51.86 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.548 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mp -64.77 -50.04 77.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.51 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -53.46 -50.98 50.76 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.575 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 30.1 tp -48.83 -50.28 35.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.085 0.469 . . . . 0.0 110.228 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.506 ' CG ' ' NZ ' ' A' ' 87' ' ' LYS . 68.9 mm-40 -55.85 -45.08 78.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.141 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 72.3 t -51.99 -51.0 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -50.11 -42.49 50.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.708 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.575 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 26.4 mmtm . . . . . 0 C--N 1.331 -0.203 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.26 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 . . . . . 0 C--O 1.232 0.147 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 91.3 mt -121.26 126.69 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.631 0.253 . . . . 0.0 110.981 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -130.66 112.18 12.88 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.861 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.443 ' C ' ' SD ' ' A' ' 96' ' ' MET . . . -110.39 128.46 8.83 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -118.95 164.66 15.13 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.944 0.402 . . . . 0.0 110.468 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.24 144.73 36.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.661 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.41 160.56 41.21 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.01 -31.43 9.81 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.549 2.166 . . . . 0.0 113.261 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -86.51 44.97 1.19 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.24 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 m120 45.06 51.34 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.286 0.565 . . . . 0.0 110.575 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -127.44 158.46 37.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.701 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.1 mt -135.72 117.91 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.65 122.77 32.43 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.749 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.7 tp -117.26 133.79 55.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.058 0.456 . . . . 0.0 110.439 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -119.38 126.59 51.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.529 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 121.256 0.551 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.4 m -41.93 -50.82 4.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.93 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -45.43 -36.74 4.56 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.552 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.82 -44.17 74.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.949 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -44.77 -47.52 10.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.603 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -65.13 -49.42 69.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.376 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.65 -47.45 45.75 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.9 mt -58.84 -53.28 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.65 0.262 . . . . 0.0 111.192 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.8 mt -55.64 -54.73 40.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.606 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.669 ' CE2' HD12 ' A' ' 159' ' ' ILE . 18.3 m-85 -50.42 -47.14 56.72 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.658 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.94 -50.94 62.41 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.61 -59.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.743 0.306 . . . . 0.0 110.736 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.25 -51.51 58.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.667 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -51.52 -47.24 63.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.067 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -49.4 -49.73 43.45 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.743 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.517 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 67.4 t80 -88.03 38.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.891 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 38.51 55.28 1.87 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.966 0.412 . . . . 0.0 111.134 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -128.84 141.18 51.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.412 ' HZ2' ' HB3' ' A' ' 156' ' ' LYS . 15.7 mtpp -110.85 131.35 55.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.173 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.4 pt -142.99 170.12 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.631 0.729 . . . . 0.0 112.268 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -134.77 125.69 27.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.93 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.669 HD12 ' CE2' ' A' ' 147' ' ' PHE . 5.7 mt -111.63 118.84 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.618 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.2 m -98.95 99.83 10.93 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.008 0.433 . . . . 0.0 110.248 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 163' ' ' THR . 23.3 t-160 -98.59 70.12 1.92 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.388 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -77.11 -45.84 25.56 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.904 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.466 ' O ' ' CD2' ' A' ' 161' ' ' HIS . 2.4 m -77.83 118.91 20.62 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.863 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 166' ' ' HIS . 34.0 t -143.78 116.27 8.6 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.009 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.432 ' C ' ' N ' ' A' ' 167' ' ' THR . 26.1 ttt -35.25 -23.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.073 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.575 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.9 t60 -50.11 -20.66 1.04 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.432 ' N ' ' C ' ' A' ' 165' ' ' MET . 6.0 t -93.97 -36.4 12.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.139 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.66 13.34 8.07 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.56 165.69 7.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 110.809 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -52.83 -35.91 57.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.428 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -172.13 -171.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.4 m -93.68 138.83 31.5 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.547 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.3 tpt -117.65 122.08 42.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.064 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -126.13 102.21 7.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.029 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -90.35 126.95 43.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.511 178.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.46 151.83 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.188 0.518 . . . . 0.0 110.599 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -139.26 137.84 36.26 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.48 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 N--CA 1.464 0.238 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.937 -179.636 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tp . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 120.769 0.319 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.0 mm -58.7 -49.15 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.112 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -67.26 -25.91 66.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.275 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -66.95 -54.63 20.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.192 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.76 -35.19 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.401 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.505 HD13 ' CE2' ' A' ' 69' ' ' PHE . 17.8 tp -68.48 -51.33 44.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.399 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -47.0 -44.15 20.02 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.09 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -61.14 -52.71 63.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.999 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.8 ttt -51.31 -40.17 58.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.73 -35.69 66.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.418 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.78 -22.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.336 0.589 . . . . 0.0 109.883 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.77 -34.7 19.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.225 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -84.48 -77.06 0.28 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.47 ' SG ' HD21 ' A' ' 58' ' ' LEU . 98.0 m -90.81 -20.12 22.68 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.247 0.546 . . . . 0.0 110.705 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.6 173.78 26.99 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.719 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.4 ttt -69.53 -25.02 63.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.937 -1.131 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -65.27 -43.21 91.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.148 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -34.31 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -51.57 -45.97 63.28 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -69.15 -32.66 72.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.015 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -64.33 -50.97 65.68 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.806 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.78 -19.6 37.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.958 0.408 . . . . 0.0 110.965 -179.229 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.806 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.5 tt -75.34 -57.61 3.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.692 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' N ' HD23 ' A' ' 26' ' ' LEU . 99.4 mt-10 -62.89 -21.09 65.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.62 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -80.72 -39.29 27.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.435 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 2.5 m-70 . . . . . 0 N--CA 1.468 0.458 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.861 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.713 0.292 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -62.09 -40.82 97.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.769 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -41.19 -55.01 2.77 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.946 0.403 . . . . 0.0 110.595 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.14 -38.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.914 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.9 m -72.41 -34.53 67.93 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.837 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.8 mp -68.33 -56.93 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.207 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -51.89 -26.25 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.831 178.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.672 ' HG3' HD12 ' A' ' 62' ' ' ILE . 7.2 tt0 -75.24 -41.18 58.1 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.763 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.435 ' OD2' ' CD2' ' A' ' 29' ' ' HIS . 51.3 m-20 -59.4 -56.62 19.69 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.073 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 p -56.39 -38.1 54.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.08 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.07 -38.75 87.33 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.251 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -62.8 -32.22 73.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.55 -43.32 60.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 17' ' ' CYS . 41.6 mt -79.3 -8.47 59.08 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.612 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.1 t30 57.32 50.4 11.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.555 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.405 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 10.0 mmt -129.79 149.75 73.91 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.208 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.74 139.83 82.68 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.407 1.405 . . . . 0.0 111.171 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.672 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.6 tt -54.37 -30.89 21.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.363 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -72.0 -29.72 64.49 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.405 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 37.5 t0 -78.69 -35.48 45.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.956 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 55' ' ' ALA . 72.0 t -66.29 -58.03 8.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -51.34 -39.49 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.959 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.489 ' N ' HG13 ' A' ' 66' ' ' VAL . 2.4 ttpt -53.35 -47.83 69.05 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.88 -43.96 97.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.65 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.505 ' CE2' HD13 ' A' ' 9' ' ' LEU . 6.8 m-30 -55.1 -32.07 61.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.17 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.4 -50.18 56.99 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -57.63 -47.77 81.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.066 0.46 . . . . 0.0 109.896 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.03 -42.58 94.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.85 0.833 . . . . 0.0 110.363 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.8 tp -56.15 -39.0 71.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.388 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -70.49 -40.8 73.38 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.286 -0.565 . . . . 0.0 109.936 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -57.08 -71.87 0.09 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.914 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.5 -37.58 19.62 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.223 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.67 -41.6 86.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.121 0.46 . . . . 0.0 111.732 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.16 -15.86 2.62 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.672 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.431 ' O ' ' OG1' ' A' ' 82' ' ' THR . 29.0 t -83.69 -46.85 11.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.324 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -86.87 -47.4 9.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.977 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.549 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -84.42 26.48 0.78 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.201 0.524 . . . . 0.0 109.982 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 79' ' ' SER . 3.8 m -58.21 -40.38 81.44 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.329 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -56.01 -31.87 63.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.3 t -85.54 -20.84 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.923 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 81' ' ' HIS . 43.3 t -64.69 -41.22 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.213 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.82 -19.15 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -66.23 -28.91 69.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.557 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 1.8 p90 -120.35 114.32 21.68 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.107 0.48 . . . . 0.0 110.77 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -85.28 -3.33 58.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.372 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -163.04 154.57 17.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.092 0.472 . . . . 0.0 111.602 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.439 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 89.8 t80 -45.4 -56.38 5.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.001 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.0 m -52.08 -44.01 64.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.795 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.9 p -61.63 -35.47 77.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.18 0.514 . . . . 0.0 110.825 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.9 tt -68.64 -48.78 63.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.589 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.78 -39.1 75.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.069 0.461 . . . . 0.0 111.145 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -88.61 -4.86 58.48 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -111.03 -15.07 11.08 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 119.569 -0.573 . . . . 0.0 112.761 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 94' ' ' LEU . 12.8 mt -30.37 -100.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 117.75 0.775 . . . . 0.0 112.269 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -39.31 -51.61 2.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.15 0.5 . . . . 0.0 111.374 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -43.32 -87.21 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -72.51 -53.65 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.587 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.9 mp -62.27 -46.89 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.688 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.19 -52.57 48.61 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.592 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 42.4 tp -52.43 -51.47 58.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.359 . . . . 0.0 110.665 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -54.88 -45.84 74.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.755 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.68 -51.99 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -47.11 -43.23 20.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.757 0.313 . . . . 0.0 110.754 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.592 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 26.7 mmtm . . . . . 0 C--N 1.329 -0.305 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.144 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.547 ' NE2' ' NH2' ' A' ' 131' ' ' ARG . 20.4 t60 . . . . . 0 CA--C 1.528 0.121 0 N-CA-C 111.515 0.191 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.71 129.62 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -134.53 119.75 18.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.886 0.374 . . . . 0.0 111.591 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -108.2 126.06 8.1 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.403 ' C ' HD22 ' A' ' 122' ' ' LEU . 15.0 mm-40 -116.77 165.27 13.49 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.117 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.769 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.2 mm? -111.8 139.19 47.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.186 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.95 160.25 41.51 Favored Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 69.9 Cg_endo -73.51 158.71 47.43 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.264 1.976 . . . . 0.0 112.109 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 124' ' ' PRO . 3.4 t-20 92.24 -60.92 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.217 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 125' ' ' ASN . 2.4 m120 154.31 59.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -135.14 163.28 30.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.05 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.7 mt -140.2 121.16 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.34 122.77 33.52 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.276 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.0 tp -116.05 136.55 52.92 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.033 0.444 . . . . 0.0 110.745 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.547 ' NH2' ' NE2' ' A' ' 117' ' ' HIS . 61.0 ttp85 -123.08 124.28 42.75 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.595 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.428 ' C ' ' CD1' ' A' ' 132' ' ' TYR . 25.4 t80 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.19 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.547 ' N ' HD22 ' A' ' 138' ' ' LEU . 2.4 mm? . . . . . 0 CA--C 1.532 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 65.5 m -40.86 -54.61 2.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.601 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -47.07 -30.07 2.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.957 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.456 ' N ' ' O ' ' A' ' 138' ' ' LEU . 4.7 t -71.38 -45.19 63.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.794 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.65 -48.79 14.8 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.588 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -63.35 -48.26 78.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.206 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.33 -46.22 44.42 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.3 -52.58 64.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.64 0.257 . . . . 0.0 111.351 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.2 mt -55.53 -56.51 19.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.819 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.592 ' CE2' HD12 ' A' ' 159' ' ' ILE . 23.7 m-85 -51.33 -47.55 62.65 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.644 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.33 -52.23 54.46 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.52 -60.21 1.84 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.0 110.784 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.34 -51.63 52.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.563 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -51.24 -46.37 62.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.636 0.255 . . . . 0.0 110.961 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -50.23 -50.35 50.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.515 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 71.3 t80 -86.2 37.15 0.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.998 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 40.69 53.0 3.15 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.92 0.39 . . . . 0.0 111.062 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -127.72 139.52 52.63 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -112.95 128.06 56.38 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.439 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 10.7 pt -139.18 175.72 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.663 0.744 . . . . 0.0 111.638 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -137.78 127.09 24.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.195 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.592 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.3 mt -112.31 116.69 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.462 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.3 m -97.0 101.94 13.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.497 ' NE2' ' O ' ' A' ' 163' ' ' THR . 10.8 t-160 -104.62 74.97 1.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.91 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -81.27 -40.68 23.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.82 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.497 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 1.9 m -78.97 117.72 20.31 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.146 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 166' ' ' HIS . 14.7 t -142.16 117.35 10.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.693 0.282 . . . . 0.0 111.08 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.475 ' C ' ' N ' ' A' ' 167' ' ' THR . 24.5 ttt -33.88 -25.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.225 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.568 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.6 t60 -49.42 -19.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.568 0.699 . . . . 0.0 109.147 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.475 ' N ' ' C ' ' A' ' 165' ' ' MET . 5.9 t -94.73 -34.2 12.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.958 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 112.54 16.05 9.07 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.34 166.48 8.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.064 0.459 . . . . 0.0 110.782 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -55.56 -33.91 64.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.456 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -171.89 -169.63 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.7 m -94.7 141.94 28.04 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.562 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.5 tpt -118.02 123.6 46.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.104 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.2 100.35 5.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.162 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.544 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -88.26 126.6 41.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.702 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.84 149.74 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.183 0.516 . . . . 0.0 110.588 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -144.57 139.28 28.04 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.421 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.462 0.172 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.116 179.601 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 tp . . . . . 0 CA--C 1.529 0.172 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.4 -48.4 80.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.423 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 3.2 m-85 -67.42 -24.11 65.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.753 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -71.18 -57.31 4.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.49 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.15 -35.84 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.012 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.473 HD13 ' CD2' ' A' ' 69' ' ' PHE . 26.7 tp -72.03 -41.94 66.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.413 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -53.87 -46.61 71.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.935 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.16 -45.29 93.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.927 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.599 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 3.3 tpp -58.05 -47.31 83.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.4 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.55 -36.71 76.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.828 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -63.17 -22.94 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.278 0.561 . . . . 0.0 109.661 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.77 -34.76 18.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.85 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -86.78 -76.93 0.34 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.483 ' SG ' HD21 ' A' ' 58' ' ' LEU . 88.8 m -89.84 -17.08 28.77 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.408 0.623 . . . . 0.0 110.723 -177.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.2 -179.97 31.15 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.565 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 ttt -72.85 -31.68 64.93 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.053 -1.074 . . . . 0.0 111.098 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -60.22 -39.53 86.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.165 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.83 -37.76 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -55.13 -47.38 75.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.07 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.33 -24.89 54.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.898 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -76.01 -46.42 29.53 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.819 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.991 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.37 -28.22 41.93 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.742 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.991 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.8 tt -71.23 -45.86 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.232 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.4 -23.89 63.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.639 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -82.14 -40.59 21.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.423 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 59.6 m-70 . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.177 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.777 0.322 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.54 -28.89 70.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.644 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.9 OUTLIER -47.82 -57.95 4.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.203 0.525 . . . . 0.0 110.354 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -37.14 -44.82 0.58 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.98 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.5 m -71.91 -32.26 67.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.123 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 14.1 mt -71.6 -52.3 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.31 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -59.63 -21.89 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.445 178.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.692 ' HG3' HD12 ' A' ' 62' ' ' ILE . 2.1 tt0 -80.34 -41.03 25.53 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.111 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.6 ' OD2' HD23 ' A' ' 25' ' ' LEU . 37.2 m-20 -58.53 -57.32 13.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.71 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.41 -37.61 64.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.555 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.55 87.98 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.236 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -63.4 -31.4 72.55 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.498 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -73.21 -46.24 51.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.541 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.483 HD21 ' SG ' ' A' ' 17' ' ' CYS . 30.6 mt -76.31 -7.48 55.03 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.879 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 56.59 48.59 16.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.439 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 18.3 mmt -127.7 149.81 71.43 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.131 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.08 137.48 66.99 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.475 1.45 . . . . 0.0 111.233 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.692 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.7 tt -52.82 -29.72 14.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.023 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -73.45 -29.54 62.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.497 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -79.4 -34.65 41.64 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.06 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.535 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 55.7 t -66.14 -58.79 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.5 p -48.53 -38.8 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.662 178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -54.55 -44.31 72.77 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.739 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.31 -59.32 5.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.305 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.535 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 5.5 m-30 -45.98 -29.98 1.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.289 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.88 -52.64 51.09 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -57.02 -51.74 68.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.962 0.411 . . . . 0.0 110.143 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.599 ' CD1' ' SD ' ' A' ' 12' ' ' MET . 55.5 m-85 -56.73 -43.02 80.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.798 0.808 . . . . 0.0 110.595 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.0 tp -55.45 -38.38 68.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.614 -1.176 . . . . 0.0 112.057 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 43.6 t80 -68.91 -40.26 79.23 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.965 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -57.22 -70.2 0.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.038 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.87 -41.68 36.69 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.789 -178.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.2 mt -57.4 -44.83 84.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.274 0.537 . . . . 0.0 111.615 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -49.17 -20.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.903 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 t -81.77 -41.62 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.119 0.485 . . . . 0.0 109.834 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.414 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.5 mmp_? -65.41 -74.52 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.696 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.512 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 0.2 OUTLIER -84.39 37.28 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.596 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.8 m -48.11 -46.43 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.111 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -54.22 -34.02 59.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.049 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.54 -21.93 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.685 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 87' ' ' LYS . 73.7 t -70.96 -41.49 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.765 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -54.75 -0.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.467 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.539 ' H ' ' C ' ' A' ' 85' ' ' VAL . 77.6 mttt -84.25 -28.01 27.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.52 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.12 119.47 36.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.587 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 58.2 t0 -84.02 -13.66 52.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.118 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.454 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 60.8 m-20 -162.02 167.63 24.1 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.431 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -53.83 -52.65 59.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.685 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.9 m -53.04 -37.68 61.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.259 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.4 m -60.88 -40.65 93.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.337 0.589 . . . . 0.0 110.14 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 98' ' ' ILE . 8.4 tt -60.76 -59.3 5.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.318 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.9 t -52.72 -37.4 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.229 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 91.8 mmm -86.23 -5.68 59.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.731 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -114.93 -15.14 8.08 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.377 -0.68 . . . . 0.0 113.112 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 97' ' ' GLY . 10.3 mt -28.03 -104.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 117.763 0.782 . . . . 0.0 112.763 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 118' ' ' ILE . 8.1 p80 -39.39 -49.88 2.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.075 0.464 . . . . 0.0 111.229 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -44.47 -87.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -71.52 -51.89 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mp -63.92 -45.48 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.756 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.38 -52.73 51.03 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.7 tp -51.67 -52.36 48.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.791 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.537 ' CD ' ' HZ1' ' A' ' 87' ' ' LYS . 58.3 mm-40 -53.85 -46.0 71.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.329 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.4 t -55.29 -51.39 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -48.69 -42.74 35.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.684 0.278 . . . . 0.0 110.883 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.746 -179.855 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.6 m80 . . . . . 0 N--CA 1.466 0.362 0 CA-C-O 120.475 0.178 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 1.5 mp -130.43 128.61 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.657 0.265 . . . . 0.0 110.308 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -135.22 127.08 29.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.714 0.293 . . . . 0.0 110.859 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.56 135.01 11.49 Favored Glycine 0 N--CA 1.466 0.692 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -131.96 126.19 33.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 tp -72.47 136.32 45.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.97 0.414 . . . . 0.0 110.885 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.405 HD13 ' HB2' ' A' ' 129' ' ' ALA . 5.2 mp -110.56 160.58 28.04 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 59.6 Cg_endo -72.15 165.7 31.86 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.284 1.99 . . . . 0.0 111.898 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' PRO . 15.4 t-20 86.46 -62.66 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.103 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 125' ' ' ASN . 5.7 p30 154.84 52.59 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.162 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -128.46 159.34 35.71 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.675 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.9 mt -134.38 117.16 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.405 ' HB2' HD13 ' A' ' 123' ' ' LEU . . . -86.95 123.03 31.62 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.63 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.6 tp -116.94 137.24 52.35 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.111 0.481 . . . . 0.0 111.011 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.486 ' NE ' ' NE2' ' A' ' 171' ' ' HIS . 42.1 ttm180 -127.14 126.12 42.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.832 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 132' ' ' TYR . 33.2 t80 . . . . . 0 N--CA 1.471 0.609 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.521 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.577 ' N ' HD22 ' A' ' 138' ' ' LEU . 2.8 mm? . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 21.7 p -40.76 -52.75 2.94 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.12 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.463 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 62.4 m-85 -47.78 -35.82 10.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 138' ' ' LEU . 6.7 t -76.46 -51.78 11.11 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -43.31 -45.74 6.08 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.941 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -62.72 -46.46 87.98 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.167 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.24 -52.95 40.66 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.8 mt -54.38 -55.85 24.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.706 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.3 mt -54.3 -55.43 28.42 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.097 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.536 ' CE2' HD12 ' A' ' 159' ' ' ILE . 5.9 m-85 -50.43 -48.49 56.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.678 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.18 -51.1 60.47 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.58 -59.61 2.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.887 0.375 . . . . 0.0 110.625 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -48.16 -50.23 29.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.87 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -52.81 -47.4 67.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.155 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -49.79 -50.32 45.27 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.668 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 70.6 t80 -86.01 37.19 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.025 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 39.73 54.11 2.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.993 0.425 . . . . 0.0 111.109 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -129.52 141.86 50.9 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -118.71 107.54 13.8 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.998 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 38.7 pt -114.56 -178.19 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.507 0.67 . . . . 0.0 111.559 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -145.18 126.38 14.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.252 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.536 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.2 mt -110.76 119.08 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 120.69 0.281 . . . . 0.0 110.828 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.2 t -101.07 103.71 14.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.834 0.35 . . . . 0.0 110.276 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 163' ' ' THR . 21.0 t-160 -100.15 73.62 1.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.454 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -79.26 -48.68 13.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.478 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 1.0 OUTLIER -73.63 124.53 26.13 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.914 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.581 ' O ' HG22 ' A' ' 167' ' ' THR . 70.8 m -126.55 174.11 8.92 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.801 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 168' ' ' GLY . 1.1 tmt? -90.18 -27.35 19.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.092 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -52.57 -23.16 5.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.489 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.1 t -88.91 -25.28 22.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.454 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 97.74 23.27 14.03 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.012 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.09 168.71 11.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 110.768 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -54.22 -34.16 59.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.52 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.486 ' NE2' ' NE ' ' A' ' 131' ' ' ARG . 5.5 p-80 -174.52 -169.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 92.5 m -93.28 138.7 31.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.7 tpt -117.98 124.25 47.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.169 0.509 . . . . 0.0 110.074 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.4 mt -126.26 102.87 7.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.701 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -87.33 128.72 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.67 151.45 14.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.416 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -143.13 141.33 31.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.598 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 N--CA 1.463 0.19 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.837 -179.924 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tp . . . . . 0 CA--C 1.532 0.281 0 CA-C-O 120.677 0.275 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.1 mm -59.88 -50.18 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.88 0.372 . . . . 0.0 110.147 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -67.52 -24.28 65.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.424 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.486 ' C ' HD22 ' A' ' 7' ' ' ASN . 0.4 OUTLIER -67.77 -53.17 29.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.974 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.6 t -65.68 -35.99 76.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.364 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.487 HD13 ' CE2' ' A' ' 69' ' ' PHE . 21.1 tp -69.6 -45.4 68.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.562 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -50.39 -43.9 54.76 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.661 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -62.78 -51.31 67.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.928 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.6 tmt? -51.18 -39.98 57.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.84 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.7 t -71.38 -34.78 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.557 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.98 -22.53 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.227 0.537 . . . . 0.0 109.957 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.64 -34.65 19.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.237 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -84.52 -76.99 0.28 Allowed 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' HD21 ' A' ' 58' ' ' LEU . 96.3 m -91.33 -19.19 23.21 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.211 0.529 . . . . 0.0 110.708 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.18 173.72 27.52 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.772 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 ttt -69.32 -27.65 65.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.888 -1.156 . . . . 0.0 110.516 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 t -63.21 -42.57 99.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.0 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.73 -36.57 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -50.68 -45.48 58.17 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -71.88 -30.64 65.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.238 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -66.5 -51.14 59.88 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.959 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.44 -24.77 39.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.275 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.959 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.1 tt -71.92 -46.03 59.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.131 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -71.69 -25.25 62.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.841 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -81.32 -40.67 23.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.524 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 80.2 m80 . . . . . 0 N--CA 1.465 0.306 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.267 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.944 0.402 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -70.37 -27.45 64.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.594 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -38.52 -55.83 1.36 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.808 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.66 -40.98 1.0 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.029 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -72.61 -34.3 67.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.972 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.566 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.9 mp -68.63 -55.27 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.293 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -53.86 -26.39 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.967 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.672 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.9 tt0 -75.41 -41.06 57.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.646 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.551 ' OD2' HD23 ' A' ' 25' ' ' LEU . 40.4 m-20 -59.34 -56.79 17.65 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.968 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.4 p -56.77 -38.27 57.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.073 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.533 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.88 -38.88 87.15 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.256 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -62.76 -32.07 73.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -74.08 -43.0 59.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.569 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 17' ' ' CYS . 39.0 mt -79.6 -8.04 58.92 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.669 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.5 t30 57.23 49.87 12.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.607 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.4 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 23.9 mmt -129.06 149.53 72.84 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.182 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.39 138.93 74.1 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.539 1.493 . . . . 0.0 110.996 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.672 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.4 tt -53.05 -29.38 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.281 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -72.13 -31.14 65.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 111.206 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.92 -32.36 51.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 55' ' ' ALA . 82.6 t -70.82 -56.94 9.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 67' ' ' LYS . 8.0 p -52.06 -41.81 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.267 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.507 ' N ' HG13 ' A' ' 66' ' ' VAL . 33.7 mtpt -53.59 -50.86 64.72 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.47 82.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.684 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.487 ' CE2' HD13 ' A' ' 9' ' ' LEU . 7.7 m-30 -52.91 -29.62 29.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.382 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.15 -49.57 56.87 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -55.26 -52.14 64.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 110.054 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -57.83 -42.74 84.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.773 0.796 . . . . 0.0 110.649 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.9 tp -56.47 -39.9 73.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.537 -1.21 . . . . 0.0 112.223 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 21.7 t80 -66.52 -44.29 82.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.31 0.576 . . . . 0.0 109.863 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -53.58 -68.73 0.15 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.241 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.05 -48.57 25.32 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.967 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.1 mt -52.38 -41.52 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.24 0.52 . . . . 0.0 112.063 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -56.34 -27.48 55.99 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.507 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -73.52 -55.38 6.4 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.048 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -43.31 55.75 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.034 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -89.18 28.1 1.28 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.779 0.323 . . . . 0.0 110.577 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 87.2 m -54.11 -37.26 64.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.079 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.523 ' O ' ' NZ ' ' A' ' 87' ' ' LYS . 88.3 m-20 -57.58 -30.54 65.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -85.88 -18.42 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.569 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.426 ' C ' ' N ' ' A' ' 87' ' ' LYS . 49.7 t -70.53 -45.28 75.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.418 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -51.2 -15.49 0.37 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.014 0.435 . . . . 0.0 110.354 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 83' ' ' ASP . 42.8 mmtm -69.08 -28.63 66.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.975 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 8.8 p90 -121.94 115.61 22.88 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.072 0.463 . . . . 0.0 110.732 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 55.2 t0 -84.48 -6.08 59.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.448 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.525 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 38.0 m-20 -158.13 158.69 35.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.141 0.496 . . . . 0.0 111.681 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -50.38 -50.29 51.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.653 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.9 m -57.88 -42.99 85.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.534 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 90.2 p -62.89 -35.59 80.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.077 0.465 . . . . 0.0 110.3 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.6 tt -67.28 -50.13 61.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.345 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 88.1 t -59.87 -36.58 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.223 0.535 . . . . 0.0 110.648 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 81.3 mmm -86.34 -8.67 57.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.34 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -111.57 -12.26 15.33 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 119.704 -0.498 . . . . 0.0 113.073 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.601 ' HA ' HD13 ' A' ' 102' ' ' ILE . 9.4 mt -33.59 -92.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 117.777 0.789 . . . . 0.0 111.937 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -41.08 -51.67 3.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.512 . . . . 0.0 111.267 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -46.63 -91.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.061 0.764 . . . . 0.0 113.061 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.546 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.8 m -68.42 -50.71 54.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.6 mp -63.78 -42.06 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.423 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.74 -56.8 19.11 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -49.55 -53.66 22.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.012 0.434 . . . . 0.0 110.494 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -54.05 -46.36 71.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.094 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 102' ' ' ILE . 39.4 t -55.1 -51.72 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -44.52 -44.63 8.79 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.351 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.928 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 85.4 t60 . . . . . 0 N--CA 1.464 0.23 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -125.18 127.76 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.703 0.287 . . . . 0.0 110.723 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -135.39 127.89 30.57 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.701 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -132.18 151.95 20.03 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -144.06 157.65 44.19 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.1 tp -95.27 148.96 21.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 0.0 110.791 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.66 160.24 43.05 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.85 -39.07 2.58 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.544 2.163 . . . . 0.0 113.532 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -79.8 45.52 0.71 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.334 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 44.3 59.33 3.31 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.541 0.686 . . . . 0.0 110.716 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -136.04 159.42 41.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.958 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.6 mt -138.86 113.63 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.53 121.84 28.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 46.4 tp -114.88 135.13 54.53 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.859 0.361 . . . . 0.0 110.579 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.633 ' HE ' ' CD2' ' A' ' 171' ' ' HIS . 62.0 ttt180 -119.46 123.44 44.06 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.994 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 57.7 t80 . . . . . 0 N--CA 1.464 0.235 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.765 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.468 0.428 0 CA-C-O 120.963 0.411 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 98.6 m -42.94 -51.02 5.75 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.587 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -46.76 -36.1 6.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.047 0.451 . . . . 0.0 110.229 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 10.2 t -66.81 -43.35 84.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.1 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.56 -50.83 16.72 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.864 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -61.36 -51.9 66.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.019 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.44 -43.28 20.18 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.51 -51.16 68.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.579 0.228 . . . . 0.0 111.551 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.3 mt -57.06 -56.37 22.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.739 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.445 ' CE2' HD12 ' A' ' 159' ' ' ILE . 33.9 m-85 -49.92 -47.99 51.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.673 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.02 -51.79 56.33 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.67 -60.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.057 0.456 . . . . 0.0 110.708 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.61 -51.09 39.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.919 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -50.92 -46.27 60.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.073 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -50.11 -49.95 50.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.735 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.525 ' CZ ' ' OD1' ' A' ' 90' ' ' ASP . 65.8 t80 -86.22 37.46 0.73 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.247 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 42.35 49.26 4.53 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 110.739 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -128.61 143.77 51.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -127.51 107.22 9.75 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.787 ' O ' HD13 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -119.72 164.14 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.392 0.615 . . . . 0.0 110.892 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -119.51 132.42 55.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.445 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.1 mt -110.44 118.27 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.6 t -103.41 116.01 31.61 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.555 0.217 . . . . 0.0 111.238 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 56.7 p-80 -98.16 79.11 2.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.385 0.612 . . . . 0.0 111.714 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -82.43 -1.02 48.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.158 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.09 109.82 5.77 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.511 ' O ' HG22 ' A' ' 167' ' ' THR . 14.2 m -112.71 -179.9 3.79 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.901 0.381 . . . . 0.0 110.26 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 168' ' ' GLY . 0.5 OUTLIER -92.18 -27.96 17.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.003 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -54.42 -23.82 17.44 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.791 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.5 t -87.11 -25.37 24.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.173 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 95.34 21.92 23.47 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.026 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.05 164.93 16.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.973 0.415 . . . . 0.0 110.773 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -50.41 -32.93 18.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.237 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.633 ' CD2' ' HE ' ' A' ' 131' ' ' ARG . 34.1 p80 -173.19 -172.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 2.8 m -94.1 141.23 28.77 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.4 124.04 46.71 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.36 101.11 6.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.631 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -89.27 126.43 42.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.603 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.61 149.32 11.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.967 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -139.8 136.53 34.16 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.44 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.234 179.5 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 5' ' ' ILE . 3.1 tp . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 120.734 0.302 . . . . 0.0 110.459 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.425 ' N ' HG23 ' A' ' 4' ' ' ILE . 36.7 mm -62.29 -50.1 81.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -69.57 -21.91 63.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.846 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -70.57 -51.52 27.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.827 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.77 -33.79 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.029 0.442 . . . . 0.0 109.944 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.501 HD13 ' CE2' ' A' ' 69' ' ' PHE . 22.6 tp -74.64 -42.74 57.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.367 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -51.85 -45.71 64.14 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.605 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.58 -49.95 74.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.793 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.495 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 10.9 tpt -52.49 -41.35 63.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.682 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.72 -35.52 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.565 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.0 t -61.19 -23.37 29.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.343 0.592 . . . . 0.0 110.109 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.68 -34.31 19.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.078 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -84.78 -75.82 0.34 Allowed 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.517 ' SG ' HD21 ' A' ' 58' ' ' LEU . 98.4 m -92.34 -20.26 21.27 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.708 -178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.48 172.36 25.87 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.724 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.6 ttt -68.01 -28.4 67.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.867 -1.166 . . . . 0.0 110.424 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.0 m -63.21 -41.69 99.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.139 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.86 -36.32 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -53.26 -45.19 68.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.773 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -74.24 -26.97 60.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.41 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -69.38 -49.5 54.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.996 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.87 -23.06 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 110.243 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.996 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.1 tt -75.3 -59.01 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.519 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' N ' HD23 ' A' ' 26' ' ' LEU . 94.5 mt-10 -60.12 -21.66 61.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.391 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 tttp -80.92 -38.13 28.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.467 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 13.7 m80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.522 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 CA--C 1.526 0.043 0 CA-C-O 120.708 0.29 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -66.94 -54.29 23.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.701 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -40.69 -55.1 2.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.022 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -41.0 -41.8 1.74 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.255 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 m -74.82 -28.82 60.86 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' A' ' 47' ' ' LEU . 25.3 mm -70.21 -53.17 24.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.916 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.43 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -61.31 -22.42 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.189 178.853 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.67 ' HG3' HD12 ' A' ' 62' ' ' ILE . 5.0 tt0 -80.87 -42.12 22.03 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.064 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.623 ' OD2' HD23 ' A' ' 25' ' ' LEU . 45.2 m-20 -58.69 -56.69 18.88 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.665 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 55' ' ' ALA . 12.4 p -59.13 -38.43 74.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.471 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.401 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -59.88 -38.74 83.09 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.128 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -63.91 -32.09 73.5 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.645 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -73.12 -42.43 62.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.563 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.517 HD21 ' SG ' ' A' ' 17' ' ' CYS . 29.0 mt -80.74 -7.18 59.29 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.831 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.6 t30 55.9 47.76 19.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.578 0.704 . . . . 0.0 109.406 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.8 mmt -125.38 149.49 64.58 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.031 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.56 135.58 53.84 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.353 1.368 . . . . 0.0 111.054 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.67 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.8 tt -50.54 -30.73 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.271 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -71.37 -30.46 66.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.871 0.367 . . . . 0.0 111.227 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.19 -32.37 50.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.131 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 78.1 t -71.37 -56.2 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.523 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -51.38 -43.43 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.263 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.523 ' N ' HG13 ' A' ' 66' ' ' VAL . 34.6 mtpt -52.73 -51.25 61.24 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.224 0.535 . . . . 0.0 109.569 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.75 -51.35 67.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.963 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.549 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.7 m-30 -51.57 -30.73 21.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.565 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.66 -53.91 35.03 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -53.71 -49.8 67.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.153 0.501 . . . . 0.0 109.781 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.495 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 8.3 m-85 -58.44 -41.04 84.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.709 0.766 . . . . 0.0 110.307 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.04 -38.45 82.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.484 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.58 -35.99 73.35 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.168 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.546 ' CG ' ' HE2' ' A' ' 152' ' ' HIS . 4.3 m120 -58.94 -69.52 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.059 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.63 -41.65 57.3 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.501 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 19.9 mt -57.2 -46.48 82.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.056 0.428 . . . . 0.0 111.269 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.3 -12.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.119 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.479 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.5 p -89.2 -43.92 10.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.202 0.525 . . . . 0.0 110.173 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.463 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.0 mmp_? -65.07 -55.26 19.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.505 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.4 p80 -101.77 31.19 3.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.296 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 m -46.31 -43.32 15.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.302 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.443 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 83.8 m-20 -55.82 -30.73 61.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.208 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.0 t -78.5 -23.53 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.847 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.473 ' C ' ' H ' ' A' ' 87' ' ' LYS . 72.0 t -76.06 -42.42 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.34 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 83' ' ' ASP . 1.4 p30 -54.9 -8.67 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 85' ' ' VAL . 63.4 mmtt -67.35 -28.13 67.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.204 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.417 ' CD1' ' OG ' ' A' ' 93' ' ' SER . 8.1 m-85 -129.39 128.71 43.58 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.056 0.455 . . . . 0.0 111.161 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -87.52 16.01 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -167.75 165.45 14.14 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 119.219 -0.993 . . . . 0.0 113.075 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 80.6 t80 -64.2 -63.18 1.21 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.789 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.6 m -45.91 -43.84 14.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.307 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.417 ' OG ' ' CD1' ' A' ' 88' ' ' PHE . 16.1 p -64.37 -38.03 89.61 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.491 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.51 -55.29 28.88 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.781 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.9 t -50.05 -38.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.087 0.47 . . . . 0.0 110.438 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 85.0 mmm -84.84 -7.45 59.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.362 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -109.17 -12.86 19.12 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.873 -0.404 . . . . 0.0 112.694 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.683 ' HA ' HD13 ' A' ' 102' ' ' ILE . 43.0 mt -32.46 -103.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -38.17 -43.8 0.79 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -48.65 -88.87 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.606 ' CG2' HD12 ' A' ' 102' ' ' ILE . 3.0 m -69.05 -51.15 46.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.683 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.7 mp -59.79 -45.77 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.047 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.33 -55.49 25.51 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.7 tp -50.4 -53.91 25.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.023 0.439 . . . . 0.0 110.75 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -53.1 -45.4 68.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.463 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 102' ' ' ILE . 37.9 t -53.11 -52.35 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -46.87 -42.66 17.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.835 0.35 . . . . 0.0 110.657 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 -179.866 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 mm -120.39 126.29 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.712 0.291 . . . . 0.0 110.675 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -124.97 105.43 9.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.119 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.62 159.66 13.63 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -151.28 158.5 43.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.755 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.59 146.06 30.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -118.69 160.73 39.09 Favored Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.23 -37.08 3.59 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.592 2.195 . . . . 0.0 113.083 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 25.9 t30 -81.52 45.74 0.9 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.151 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.8 m120 43.76 58.62 3.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.339 0.59 . . . . 0.0 110.742 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -135.09 159.99 39.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.017 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.2 mt -136.96 116.41 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.07 121.46 30.5 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 21.9 tp -118.62 130.99 56.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.251 0.548 . . . . 0.0 110.632 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -126.54 131.22 51.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 120.818 0.342 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 172' ' ' CYS . 62.5 m -48.88 -64.26 0.86 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.121 0.486 . . . . 0.0 111.38 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -46.73 -37.12 7.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.335 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 5.1 t -65.51 -43.18 90.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -44.54 -51.99 8.42 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.669 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.474 ' OE2' ' CB ' ' A' ' 161' ' ' HIS . 40.0 mt-10 -60.34 -49.34 78.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.281 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.5 -48.75 41.42 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.7 mt -57.89 -54.89 41.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.515 0.198 . . . . 0.0 111.495 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 28.0 mt -54.61 -54.86 35.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.713 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.654 ' CE2' HD12 ' A' ' 159' ' ' ILE . 13.2 m-85 -49.79 -50.79 43.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.943 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -56.92 -51.72 55.46 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.794 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.52 -54.59 4.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.441 . . . . 0.0 110.613 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -53.06 -48.86 67.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.053 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -50.59 -53.66 28.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.901 0.381 . . . . 0.0 111.04 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.546 ' HE2' ' CG ' ' A' ' 75' ' ' ASN . 85.6 m-70 -45.73 -49.89 14.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.161 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.61 33.75 0.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 40.75 51.72 3.1 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.148 0.499 . . . . 0.0 110.657 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -126.86 140.71 52.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.275 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -115.74 124.77 51.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.472 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 10.8 pt -136.16 170.84 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.665 0.745 . . . . 0.0 112.143 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -132.7 125.74 30.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.852 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.654 HD12 ' CE2' ' A' ' 147' ' ' PHE . 5.3 mt -110.94 117.47 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.676 0.274 . . . . 0.0 110.5 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.3 t -97.65 101.02 12.43 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.959 0.409 . . . . 0.0 109.979 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.52 ' NE2' ' O ' ' A' ' 163' ' ' THR . 11.7 t-160 -104.52 75.4 1.23 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.869 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -80.61 -42.76 21.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.895 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.52 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.4 m -76.05 117.98 18.33 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.913 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 166' ' ' HIS . 1.6 p -144.13 113.79 7.14 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.048 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.8 ttt -37.3 -21.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.853 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.572 ' N ' ' O ' ' A' ' 164' ' ' CYS . 83.3 t60 -52.49 -26.81 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.454 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 4.5 t -88.17 -42.88 12.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.141 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.454 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 133.72 10.26 1.86 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.5 162.33 10.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.041 0.448 . . . . 0.0 110.939 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -58.88 -33.18 70.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.616 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -170.05 -170.45 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 85.0 m -94.61 137.04 34.21 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.971 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.6 tpt -115.68 123.89 49.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.05 103.37 6.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.422 0.629 . . . . 0.0 111.577 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -92.89 126.19 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.329 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 177' ' ' GLU . 4.6 mp -112.64 153.17 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.549 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.403 ' N ' HG22 ' A' ' 176' ' ' ILE . 88.1 tt0 -139.5 138.84 36.69 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.571 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 N--CA 1.463 0.222 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.8 -179.921 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tp . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 120.968 0.413 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.4 mm -62.46 -44.57 99.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.096 0.474 . . . . 0.0 109.912 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -71.34 -25.41 62.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.54 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -69.4 -52.51 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.071 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.26 -35.0 70.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.423 HD13 ' CD2' ' A' ' 69' ' ' PHE . 31.6 tp -67.44 -40.82 85.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.773 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -55.54 -45.47 77.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.039 0.447 . . . . 0.0 109.839 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.81 -53.75 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.569 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.608 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 49.1 mtm -52.3 -44.28 64.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.118 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.17 -36.61 77.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.75 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.29 -25.83 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.151 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.36 -33.79 21.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.173 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -84.2 -76.16 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.8 m -93.22 -21.84 19.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.26 0.552 . . . . 0.0 110.805 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.7 173.96 22.97 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 122.129 0.85 . . . . 0.0 112.962 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.1 ttt -68.14 -28.38 67.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.65 -1.275 . . . . 0.0 110.408 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -61.83 -39.27 91.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.841 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -77.53 -38.52 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -56.13 -47.84 77.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.128 0.489 . . . . 0.0 110.31 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -75.63 -22.97 56.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.584 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -76.29 -47.11 24.84 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.604 -0.439 . . . . 0.0 112.04 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.981 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.61 -25.53 38.38 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.981 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.3 tt -73.65 -44.15 57.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.492 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -73.05 -21.1 60.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.964 0.411 . . . . 0.0 110.555 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 tttt -87.15 -42.0 13.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.866 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.6 m80 . . . . . 0 N--CA 1.471 0.617 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.569 -179.117 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.81 0.338 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -75.96 -36.46 59.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.95 -58.42 5.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.198 0.523 . . . . 0.0 110.805 -179.605 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -38.64 -43.09 0.85 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.055 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.6 p -74.14 -30.03 62.09 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.035 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 47' ' ' LEU . 18.6 mt -72.98 -50.66 30.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.123 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.1 m -60.66 -22.42 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.0 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.694 ' HG3' HD12 ' A' ' 62' ' ' ILE . 2.5 tt0 -80.49 -40.68 25.68 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.898 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.621 ' OD2' HD23 ' A' ' 25' ' ' LEU . 55.9 m-20 -58.83 -57.4 13.21 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.837 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.21 -39.41 78.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.582 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.428 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -58.63 -39.1 79.54 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.857 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -64.64 -32.94 74.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -72.6 -41.78 65.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.196 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.508 ' O ' ' SD ' ' A' ' 60' ' ' MET . 30.1 mt -79.27 -3.96 48.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.503 ' O ' ' SD ' ' A' ' 60' ' ' MET . 10.6 t-20 52.72 46.62 26.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.475 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -125.56 153.05 72.66 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.863 179.308 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.48 136.68 47.63 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.717 1.612 . . . . 0.0 110.816 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.694 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.9 tt -51.19 -28.76 7.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.819 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.629 ' NE2' ' CZ ' ' A' ' 140' ' ' PHE . 3.0 tp-100 -76.04 -32.22 59.24 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.973 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -80.15 -31.61 38.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.86 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.499 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 63.5 t -67.84 -58.17 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -49.86 -40.86 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.495 ' N ' HG13 ' A' ' 66' ' ' VAL . 2.2 ttpp -51.65 -47.18 63.84 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.896 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.36 -59.76 4.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.171 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 5.1 m-30 -45.15 -29.0 0.83 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.763 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.94 -52.15 50.21 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -55.51 -51.4 67.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.075 0.464 . . . . 0.0 110.302 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.608 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 45.5 m-85 -59.19 -43.38 92.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.757 0.789 . . . . 0.0 110.909 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 tp -52.06 -38.32 56.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.296 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 22.6 t80 -70.87 -41.48 71.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.106 0.479 . . . . 0.0 110.014 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -54.22 -74.52 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.14 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -50.64 -37.18 33.41 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.767 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 19.2 mt -58.56 -47.25 84.86 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.337 0.569 . . . . 0.0 112.139 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.43 -20.94 0.26 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.231 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' ' 82' ' ' THR . 19.7 t -77.8 -50.17 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 111.003 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -64.28 -64.74 0.8 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.571 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.4 p80 -83.64 31.21 0.47 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.737 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 79' ' ' SER . 94.3 m -48.29 -45.85 35.32 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.452 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -53.16 -29.78 33.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.052 0.453 . . . . 0.0 109.863 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 3.3 t -83.21 -23.98 8.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 t -63.31 -39.68 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -53.48 -13.59 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.434 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 84' ' ' VAL . 37.8 mmtm -66.6 -31.08 71.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.51 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 20.5 p90 -120.39 117.13 26.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.059 0.457 . . . . 0.0 110.931 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.36 0.78 48.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.317 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 48.6 t0 -163.86 157.74 19.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.626 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.507 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 82.5 t80 -48.13 -51.44 24.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.712 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 83.9 m -56.32 -41.86 76.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.522 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.3 m -62.74 -36.54 83.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.411 0.624 . . . . 0.0 110.563 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.493 HD12 ' CD2' ' A' ' 88' ' ' PHE . 2.2 tt -65.91 -62.52 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.289 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.5 t -47.43 -41.44 7.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 O-C-N 123.337 0.398 . . . . 0.0 111.879 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.6 ppp? -85.67 -8.11 58.4 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.278 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -107.77 -14.21 18.11 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.461 -0.4 . . . . 0.0 112.334 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.606 ' HA ' HD13 ' A' ' 102' ' ' ILE . 33.4 mt -31.87 -97.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 117.398 0.599 . . . . 0.0 111.997 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -39.95 -49.99 2.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.173 0.511 . . . . 0.0 111.377 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -46.89 -90.02 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.568 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.6 m -68.97 -50.75 51.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.606 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.1 mp -64.19 -42.52 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.493 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.56 -57.98 10.22 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.595 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 56.7 tp -46.73 -55.11 8.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.143 0.496 . . . . 0.0 110.438 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -52.41 -44.52 65.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.8 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 102' ' ' ILE . 30.4 t -55.44 -52.32 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -47.04 -44.75 20.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.64 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.595 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 27.0 mmtm . . . . . 0 C--N 1.33 -0.261 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.932 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 120.503 0.192 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -128.48 129.1 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.674 0.273 . . . . 0.0 110.886 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -134.08 123.34 24.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.718 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.91 127.01 7.04 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.458 ' C ' HD12 ' A' ' 122' ' ' LEU . 86.9 mt-30 -117.33 166.34 12.41 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.458 HD12 ' C ' ' A' ' 121' ' ' GLN . 11.2 mp -109.31 133.96 52.39 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.93 160.71 28.84 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 58.5 Cg_endo -71.78 159.02 51.83 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.188 1.925 . . . . 0.0 111.883 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 124' ' ' PRO . 4.1 t-20 90.91 -59.17 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.296 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 125' ' ' ASN . 5.4 p30 151.83 53.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.894 0.747 . . . . 0.0 109.499 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -127.74 164.06 22.96 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.976 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.4 mt -141.24 119.2 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.67 123.33 33.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.083 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 47.4 tp -118.24 132.34 56.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.074 0.464 . . . . 0.0 110.965 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -115.7 122.81 46.65 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.234 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.8 t80 . . . . . 0 N--CA 1.468 0.456 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.585 -179.085 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 121.332 0.587 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 32.9 m -41.73 -48.29 4.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.702 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.629 ' CZ ' ' NE2' ' A' ' 63' ' ' GLN . 98.2 m-85 -48.13 -39.88 21.93 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.708 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.3 t -64.44 -43.23 94.95 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.97 -52.97 10.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.436 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -55.14 -50.07 70.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.08 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.97 -48.22 46.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.09 -54.23 49.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.743 0.306 . . . . 0.0 111.369 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.8 mt -54.88 -55.66 27.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.849 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.563 ' CE2' HD12 ' A' ' 159' ' ' ILE . 14.1 m-85 -49.75 -48.53 50.14 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.817 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.95 -51.31 59.94 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.35 -60.13 2.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.736 0.303 . . . . 0.0 110.832 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' ' 155' ' ' GLN . . . -51.34 -51.09 57.56 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.317 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -52.98 -48.75 67.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.053 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -47.97 -49.15 31.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.504 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 73.3 t80 -83.42 36.28 0.52 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.71 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 40.78 58.25 2.48 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.939 0.399 . . . . 0.0 111.228 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.485 ' HB3' ' HB1' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -132.63 152.59 51.61 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.481 ' H ' ' CD ' ' A' ' 155' ' ' GLN . 62.6 mttp -120.8 117.94 28.71 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.5 pt -130.68 169.7 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.624 0.726 . . . . 0.0 112.63 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -134.73 127.12 30.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.898 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.563 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.8 mt -110.42 118.65 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.8 m -103.01 111.55 23.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.398 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 16.7 p80 -96.61 77.22 2.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.513 0.673 . . . . 0.0 111.558 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 54.7 t0 -82.1 -3.3 54.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.415 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.56 114.6 8.64 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.438 ' O ' HG22 ' A' ' 167' ' ' THR . 92.3 m -118.62 -175.93 2.99 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.628 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 72.7 mtp -94.73 -26.47 16.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -55.61 -23.66 28.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.798 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 164' ' ' CYS . 4.0 t -87.16 -29.69 21.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.5 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.41 18.0 22.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.63 167.03 9.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.847 0.356 . . . . 0.0 110.423 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.544 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 94.4 m-20 -45.55 -49.6 13.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.69 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.544 ' ND1' ' O ' ' A' ' 170' ' ' ASP . 73.6 m-70 -160.76 -168.14 2.03 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.5 t -93.85 144.27 25.59 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.149 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.2 120.93 36.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.061 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.53 103.62 7.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.469 0.652 . . . . 0.0 110.502 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.4 mp -89.95 127.12 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.379 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.93 150.51 13.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.32 0.581 . . . . 0.0 110.869 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -136.17 136.08 39.71 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.897 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.464 0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.62 -179.742 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.654 HD13 ' NH1' ' A' ' 80' ' ' ARG . 2.5 tp . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 121.029 0.443 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.3 -54.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -60.99 -31.22 70.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.267 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -59.94 -60.33 4.0 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.075 0.464 . . . . 0.0 111.428 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.18 -24.26 29.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.474 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.8 tp -74.29 -41.75 60.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.516 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.4 mt-10 -58.16 -39.25 78.35 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.316 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -60.9 -56.04 25.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.532 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 18.1 tpt -50.73 -41.66 56.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.203 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.31 -34.45 62.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.692 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 10' ' ' GLU . 40.8 t -63.36 -23.96 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.22 0.533 . . . . 0.0 110.055 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.65 -33.99 18.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.96 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -85.63 -76.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.7 m -91.37 -19.2 23.17 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.52 171.85 28.12 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.847 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.7 ttt -67.37 -29.51 69.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.776 -1.212 . . . . 0.0 110.327 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 t -61.92 -41.5 98.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.947 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.78 -38.64 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -51.64 -45.89 63.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.0 109.732 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -71.76 -29.8 64.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.011 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.525 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 75.5 mt-10 -68.12 -51.64 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.966 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.91 -23.2 48.76 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.436 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.966 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.7 tt -74.26 -41.88 60.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.528 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -66.97 -19.08 65.66 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 24' ' ' GLU . 1.1 ptpp? -91.66 -29.0 17.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.505 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 3.4 m-70 . . . . . 0 N--CA 1.463 0.182 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.82 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 95.3 p . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.772 0.32 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -68.32 -33.79 74.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.027 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -43.17 -57.5 2.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.165 0.507 . . . . 0.0 110.641 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -38.8 -43.43 0.92 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.724 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.1 m -71.84 -32.44 67.54 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.42 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.6 mp -71.71 -53.81 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.667 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.446 HG13 ' H ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -55.9 -23.37 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.374 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.674 ' HG3' HD12 ' A' ' 62' ' ' ILE . 4.7 tt0 -79.79 -40.1 29.39 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.14 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 4.4 m-20 -59.69 -57.01 14.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.586 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 55' ' ' ALA . 6.8 p -56.17 -41.09 68.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.522 -0.763 . . . . 0.0 108.998 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.412 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -57.05 -39.1 74.22 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.944 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -64.93 -34.6 78.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.649 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.4 mmt-85 -70.52 -38.26 74.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.178 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.518 ' O ' ' SD ' ' A' ' 60' ' ' MET . 49.0 mt -82.7 -4.9 58.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.519 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.1 t-20 51.76 44.52 29.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.244 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -125.82 155.81 72.24 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.854 179.188 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.19 140.53 71.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.015 1.81 . . . . 0.0 111.036 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.674 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.9 tt -55.44 -27.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.859 -178.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.417 ' CD ' ' CZ ' ' A' ' 140' ' ' PHE . 88.6 mt-30 -76.36 -33.46 58.93 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.45 -30.07 42.06 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.088 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG12 ' CZ ' ' A' ' 69' ' ' PHE . 96.8 t -72.06 -56.07 11.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.499 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -50.98 -40.12 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.499 ' N ' HG13 ' A' ' 66' ' ' VAL . 1.9 ttpt -52.66 -50.98 62.15 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.895 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.28 -53.98 42.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.721 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.485 ' CZ ' HG12 ' A' ' 65' ' ' VAL . 2.9 m-30 -54.25 -27.98 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.92 -52.78 45.57 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -56.44 -47.93 78.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 0.8 OUTLIER -59.33 -43.97 92.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.866 0.841 . . . . 0.0 110.337 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -53.35 -38.68 63.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.809 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.455 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 26.2 t80 -69.84 -41.25 75.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.934 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -55.15 -71.87 0.08 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.781 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.61 -44.48 22.91 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.405 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.8 mt -56.36 -40.63 74.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.0 0.4 . . . . 0.0 111.431 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -59.31 -29.29 67.51 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.879 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.9 t -72.83 -54.17 9.52 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.828 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.654 ' NH1' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -72.59 -49.48 31.95 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.222 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -83.97 25.44 0.82 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.442 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 52.6 m -50.44 -38.92 46.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.045 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -57.14 -32.41 66.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.18 -22.07 9.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.547 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 87' ' ' LYS . 40.9 t -69.25 -42.63 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.649 -0.421 . . . . 0.0 109.952 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -52.51 -15.02 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.034 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.416 ' N ' ' C ' ' A' ' 85' ' ' VAL . 38.4 mmtm -67.58 -29.92 69.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.648 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.565 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 13.1 p90 -120.85 119.84 33.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.063 0.459 . . . . 0.0 110.967 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -86.28 1.88 49.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.447 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.48 ' OD1' ' CE2' ' A' ' 153' ' ' PHE . 45.4 t0 -166.75 160.15 14.48 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.22 0.533 . . . . 0.0 111.627 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 95' ' ' VAL . 84.2 t80 -51.54 -51.05 58.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.941 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.8 m -55.67 -45.38 77.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.734 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 90' ' ' ASP . 54.9 p -61.66 -36.45 80.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.408 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.483 HD12 ' CD2' ' A' ' 88' ' ' PHE . 5.2 tt -65.89 -52.16 52.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.23 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.416 HG21 ' CE2' ' A' ' 91' ' ' PHE . 69.8 t -56.31 -36.69 47.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.208 0.527 . . . . 0.0 110.43 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.5 mmm -86.61 -6.89 58.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.33 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -112.9 -14.82 9.75 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.982 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.581 ' HA ' HD13 ' A' ' 102' ' ' ILE . 10.3 mt -30.05 -100.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 117.648 0.724 . . . . 0.0 112.348 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -40.35 -49.05 2.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.023 0.44 . . . . 0.0 111.182 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -46.22 -88.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.577 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.6 m -70.67 -52.88 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.581 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.3 mp -60.62 -46.12 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.302 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.92 -55.25 30.8 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.7 tp -51.74 -53.45 39.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -53.5 -47.36 69.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.159 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 102' ' ' ILE . 33.6 t -52.44 -49.22 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -50.13 -41.44 48.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.778 0.323 . . . . 0.0 110.637 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.722 -179.98 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 70.3 m80 . . . . . 0 C--O 1.23 0.076 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.5 mt -127.5 128.25 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.728 0.299 . . . . 0.0 110.879 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -132.61 119.66 20.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.744 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.72 137.88 14.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -135.04 128.31 32.08 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.565 0.221 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 tp -76.89 149.52 36.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.756 0.312 . . . . 0.0 111.07 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.18 160.47 43.16 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.12 -36.43 4.28 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.578 2.185 . . . . 0.0 113.059 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -80.65 46.41 0.87 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.046 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 43.49 55.87 4.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.52 0.676 . . . . 0.0 110.739 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -133.48 159.22 41.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.876 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.0 mt -136.65 114.65 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.5 121.58 29.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.084 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.7 tp -116.16 134.7 54.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.094 0.473 . . . . 0.0 110.619 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -120.58 124.55 45.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.0 t80 . . . . . 0 C--N 1.33 -0.27 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.808 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 121.112 0.482 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.9 t -40.05 -48.21 2.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.638 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.417 ' CZ ' ' CD ' ' A' ' 63' ' ' GLN . 90.7 m-85 -48.2 -36.87 14.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.613 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 53.8 t -68.53 -44.4 74.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.023 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.78 -45.71 14.83 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.507 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -63.97 -48.96 74.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.217 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.08 -48.12 39.73 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.4 mt -59.96 -53.55 56.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.734 0.302 . . . . 0.0 111.535 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.9 mt -54.81 -55.88 25.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.078 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.594 ' CE2' HD12 ' A' ' 159' ' ' ILE . 21.7 m-85 -51.68 -48.14 63.59 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.978 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.69 -51.66 56.63 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.21 -60.27 1.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.754 0.311 . . . . 0.0 111.008 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.38 -50.87 38.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.005 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -52.44 -47.14 66.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.249 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -50.01 -50.69 46.47 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.704 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.51 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 69.5 t80 -86.11 37.03 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.933 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 39.17 55.71 2.14 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.937 0.398 . . . . 0.0 111.061 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -129.87 141.65 50.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -112.34 125.61 54.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.259 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 26.1 pt -137.07 170.15 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.61 0.719 . . . . 0.0 111.993 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -134.96 126.62 28.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.116 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.594 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.5 mt -110.52 116.8 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.669 0.271 . . . . 0.0 110.328 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.3 t -101.46 107.94 19.38 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.383 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.559 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.8 p-80 -93.97 65.79 3.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.605 0.717 . . . . 0.0 111.065 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -68.25 -25.35 65.14 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.823 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.502 ' HB ' ' H ' ' A' ' 173' ' ' MET . 1.8 m -112.52 112.0 23.24 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 166' ' ' HIS . 49.9 t -137.3 115.26 11.5 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.602 0.239 . . . . 0.0 110.839 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.412 ' C ' ' N ' ' A' ' 167' ' ' THR . 24.0 ttt -35.18 -22.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.261 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 164' ' ' CYS . 57.7 t-80 -51.11 -21.45 1.92 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.464 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.7 t -90.08 -41.35 11.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.913 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.464 ' N ' HG23 ' A' ' 167' ' ' THR . . . 124.81 15.0 3.3 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.08 155.86 30.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.976 0.417 . . . . 0.0 110.821 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.92 -27.93 21.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.379 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -172.49 178.87 2.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 6.3 m -94.46 139.72 30.77 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.66 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.502 ' H ' ' HB ' ' A' ' 163' ' ' THR . 16.2 ttm -127.62 94.99 4.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.525 0.679 . . . . 0.0 109.68 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.1 mt -93.12 113.07 25.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.523 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.9 mm -89.14 126.16 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.585 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.38 148.72 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.25 0.548 . . . . 0.0 110.268 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -137.8 136.8 37.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.339 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 N--CA 1.463 0.188 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.863 -179.828 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.586 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.6 mpp? . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 3' ' ' GLY . 46.0 mtmt 56.2 86.94 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.738 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 56.47 117.23 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 tp -52.19 -42.05 35.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.581 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.43 -51.41 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.168 0.509 . . . . 0.0 109.87 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -69.12 -22.26 63.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.495 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 3' ' ' GLY . 64.9 t-20 -69.64 -54.13 15.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.6 t -61.71 -35.81 69.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.01 0.433 . . . . 0.0 109.835 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.492 HD13 ' CE2' ' A' ' 69' ' ' PHE . 21.8 tp -70.98 -43.25 68.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.097 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -51.95 -46.09 64.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -61.28 -48.2 82.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.681 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.588 ' SD ' ' CZ ' ' A' ' 72' ' ' PHE . 10.9 tpt -53.84 -43.04 69.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.726 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.15 -35.25 67.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.403 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.01 -23.36 31.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.239 0.542 . . . . 0.0 110.028 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.17 -34.39 19.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.156 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -84.69 -76.62 0.3 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' HD21 ' A' ' 58' ' ' LEU . 97.8 m -91.66 -19.83 22.25 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.282 0.563 . . . . 0.0 110.786 -178.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.02 173.99 26.48 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.825 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.3 ttt -68.74 -29.76 68.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.796 -1.202 . . . . 0.0 110.518 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -62.06 -41.71 98.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.065 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.52 -37.83 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 -51.82 -45.22 63.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -71.73 -29.27 64.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.144 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -67.46 -50.49 58.91 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.782 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.26 -22.93 38.31 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.454 -179.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.782 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.3 tt -74.32 -56.0 5.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.145 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -61.55 -22.98 65.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.547 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -81.35 -38.27 26.94 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -99.59 -77.91 0.51 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.792 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.583 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -64.06 160.07 50.95 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.442 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 61.5 Cg_endo -71.43 144.07 44.53 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.873 2.382 . . . . 0.0 112.504 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' CB ' ' NZ ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -93.55 -18.23 22.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.278 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 24.6 p-10 -90.24 -52.46 4.93 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.992 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.13 132.4 47.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.498 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.2 t -125.57 134.58 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.263 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -109.45 179.7 4.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.669 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.65 HG23 ' H ' ' A' ' 39' ' ' ALA . 2.4 m -129.41 167.83 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.884 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 m -73.93 28.87 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.058 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.65 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -149.09 -8.94 0.34 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.733 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.623 ' CG ' HG22 ' A' ' 37' ' ' VAL . 12.9 mmtt -85.61 -179.74 6.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.903 0.382 . . . . 0.0 110.499 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 p -47.18 157.86 0.17 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.055 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.25 61.7 0.7 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.193 0.52 . . . . 0.0 110.445 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' O ' ' OE1' ' A' ' 46' ' ' GLU . . . -53.36 104.98 0.11 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.166 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' OE1' ' O2A' ' A' ' 182' ' ' HEM . 96.4 mt-10 -63.45 -20.5 65.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.7 p -49.0 -40.99 32.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.799 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 43' ' ' ALA . 41.4 mp0 -72.65 -32.81 66.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.812 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.98 -58.26 5.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.134 0.492 . . . . 0.0 110.66 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CZ ' HD12 ' A' ' 138' ' ' LEU . 84.6 m-85 -37.67 -44.1 0.68 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.042 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.1 t -73.24 -31.23 64.0 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.156 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.9 mt -71.42 -51.25 34.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.129 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -60.39 -21.7 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.84 178.519 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.691 ' HG3' HD12 ' A' ' 62' ' ' ILE . 1.6 tt0 -80.17 -41.52 25.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.002 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -58.62 -57.14 14.28 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.834 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 55' ' ' ALA . 7.8 p -58.63 -39.05 74.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.483 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.412 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -59.56 -39.65 84.72 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.221 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -63.61 -31.85 73.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -74.28 -41.31 61.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.562 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 17' ' ' CYS . 29.0 mt -80.98 -6.37 58.67 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.652 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 56.11 47.79 18.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.488 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mmt -126.54 149.05 66.79 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.066 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -63.11 135.77 52.69 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.381 1.387 . . . . 0.0 111.092 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.691 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.0 tt -49.11 -28.3 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.156 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -71.78 -34.5 69.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.055 0.455 . . . . 0.0 111.582 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -76.03 -31.77 59.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.066 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.2 t -71.83 -56.16 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.734 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.524 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -51.63 -44.45 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.396 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.524 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.9 mtpt -52.33 -50.45 62.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.255 0.55 . . . . 0.0 109.518 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.14 -57.39 12.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.925 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.549 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 8.1 m-30 -45.53 -29.72 1.24 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.391 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.19 -48.07 73.98 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -58.24 -52.34 65.98 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.067 0.46 . . . . 0.0 110.054 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 12' ' ' MET . 63.1 m-85 -56.59 -40.18 74.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.747 0.785 . . . . 0.0 110.616 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.9 tp -59.22 -37.85 78.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.387 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -70.54 -37.9 74.11 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.968 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -58.11 -71.31 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.887 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.07 -41.79 30.2 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.296 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.402 ' C ' ' N ' ' A' ' 79' ' ' SER . 24.2 mt -58.39 -43.37 88.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.368 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -51.75 -17.56 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.161 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.43 ' O ' ' OG1' ' A' ' 82' ' ' THR . 8.0 t -85.73 -40.88 15.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.247 0.546 . . . . 0.0 109.62 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.431 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.3 mmp_? -65.44 -72.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.471 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.704 ' CE1' HMC3 ' A' ' 182' ' ' HEM . 0.1 OUTLIER -87.84 36.91 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.399 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 6.8 m -49.45 -48.99 47.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.926 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -51.43 -33.67 31.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.18 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.538 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 7.1 t -73.82 -29.24 25.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.499 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.536 ' C ' ' H ' ' A' ' 87' ' ' LYS . 89.3 t -76.22 -44.68 36.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.562 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 54.7 t0 -58.24 3.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.366 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' A' ' 85' ' ' VAL . 30.6 mtmt -90.57 -22.45 21.27 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.541 ' CE1' HG21 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -104.13 125.83 50.76 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.794 -179.246 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 56.6 p30 -88.44 -6.07 57.87 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 58.8 m-20 -160.29 164.12 32.84 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.636 0.731 . . . . 0.0 112.535 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.402 ' CE2' HG21 ' A' ' 95' ' ' VAL . 64.4 t80 -55.1 -44.29 74.77 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.979 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.9 m -57.71 -59.72 4.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.352 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 97.4 p -45.67 -40.14 8.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.367 0.604 . . . . 0.0 110.792 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.44 -41.59 96.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.428 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 91' ' ' PHE . 69.5 t -67.89 -40.84 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.384 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.9 ptm -83.25 -3.16 57.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.307 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -116.41 -15.74 6.89 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 119.123 -0.82 . . . . 0.0 113.357 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.599 ' HA ' HD13 ' A' ' 102' ' ' ILE . 18.8 mt -25.09 -104.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 118.04 0.92 . . . . 0.0 112.477 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -40.38 -49.0 2.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.068 0.461 . . . . 0.0 111.466 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -45.63 -83.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.61 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.8 m -73.31 -53.81 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.61 ' N ' HG23 ' A' ' 101' ' ' VAL . 3.3 mp -59.27 -49.84 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.939 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.33 -55.13 32.41 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.8 tp -49.18 -48.0 45.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.154 0.502 . . . . 0.0 109.769 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -57.59 -46.46 83.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.042 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.6 t -54.22 -50.15 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 110' ' ' TYR . 49.4 t30 -49.07 -43.59 41.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.717 0.294 . . . . 0.0 110.803 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -61.79 -37.44 84.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.211 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.4 tp -65.14 -40.69 94.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.368 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 111' ' ' HIS . 25.7 t80 -154.84 158.13 38.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.389 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.564 ' N ' ' CD1' ' A' ' 110' ' ' TYR . 57.2 t-80 -49.69 -77.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.078 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 111' ' ' HIS . 23.2 mt-10 60.52 147.78 0.08 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.201 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.33 -94.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.025 1.816 . . . . 0.0 111.872 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.2 t -144.78 140.99 28.85 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.153 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 116' ' ' PRO . 15.9 mt -81.59 150.6 66.92 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 115' ' ' LEU . 80.3 Cg_exo -41.0 168.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.264 1.976 . . . . 0.0 112.342 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -85.78 108.62 18.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.98 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.1 128.54 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.716 0.293 . . . . 0.0 110.959 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -133.58 123.57 25.35 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.652 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.12 158.22 14.64 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.442 ' C ' HD22 ' A' ' 122' ' ' LEU . 52.3 tt0 -149.95 160.1 43.87 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.824 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.4 mm? -106.74 146.02 31.34 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.99 160.4 40.99 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.25 -38.12 2.9 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.596 2.197 . . . . 0.0 113.054 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -79.49 44.83 0.63 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.953 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 44.39 58.29 3.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.413 0.625 . . . . 0.0 110.72 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -135.11 159.94 39.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.107 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 45.0 mt -137.41 117.12 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.3 122.86 32.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.049 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.1 tp -118.8 133.03 56.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.044 0.45 . . . . 0.0 111.205 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -114.79 122.98 48.03 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.481 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 62.1 t80 -126.16 123.73 38.9 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.786 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.48 124.37 24.08 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.2 p -156.04 146.01 15.67 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.256 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.77 -7.87 17.74 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.032 1.821 . . . . 0.0 112.215 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 -79.17 -15.68 57.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.085 0.469 . . . . 0.0 110.369 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 56.23 28.84 13.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.52 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.413 HD12 ' CZ ' ' A' ' 48' ' ' PHE . 4.1 tp -82.74 14.6 3.09 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.215 0.531 . . . . 0.0 110.029 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 74.4 m -42.08 -43.87 3.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.469 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -48.87 -41.98 35.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.961 0.41 . . . . 0.0 110.375 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.6 t -64.29 -43.27 95.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -44.52 -50.1 9.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.59 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.03 -49.56 77.17 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.164 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.01 -48.96 50.89 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.0 -55.1 39.36 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.58 0.229 . . . . 0.0 111.315 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.7 mt -54.14 -54.38 40.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.909 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.54 ' CE2' HD12 ' A' ' 159' ' ' ILE . 12.1 m-85 -51.52 -48.02 63.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.952 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.49 -51.54 57.18 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.8 -59.76 2.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.881 0.372 . . . . 0.0 110.844 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -48.28 -51.68 24.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.873 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -52.03 -47.86 64.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.218 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -49.48 -49.9 43.64 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.64 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.507 ' CZ ' ' OD1' ' A' ' 90' ' ' ASP . 71.5 t80 -85.48 37.17 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.939 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 39.21 57.57 1.99 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.021 0.439 . . . . 0.0 111.199 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -131.59 143.43 50.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -118.85 105.25 11.32 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.8 pt -114.47 175.49 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.596 0.712 . . . . 0.0 111.718 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -138.08 127.67 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.407 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.54 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.7 mt -111.31 117.76 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.602 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.1 t -98.28 98.89 10.09 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.602 ' CD2' ' SG ' ' A' ' 164' ' ' CYS . 23.7 t-160 -92.14 69.92 5.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.005 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.52 -57.28 3.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.56 119.53 21.26 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.464 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 1.7 m -143.64 119.06 10.28 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.122 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 38.0 ttp -36.11 -21.69 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.036 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 164' ' ' CYS . 58.3 t-80 -51.19 -22.0 2.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.45 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.3 t -91.43 -41.42 10.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.103 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.45 ' N ' HG23 ' A' ' 167' ' ' THR . . . 126.5 12.25 3.46 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.86 171.6 6.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.0 0.429 . . . . 0.0 110.817 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 171' ' ' HIS . 42.1 p-10 -53.31 -35.65 60.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.273 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.52 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 9.8 p80 -174.52 -167.06 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.7 m -94.9 142.97 26.85 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.758 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.573 ' CG ' HD11 ' A' ' 175' ' ' ILE . 28.3 ttm -119.49 116.12 25.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.058 0.456 . . . . 0.0 109.954 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 176' ' ' ILE . 1.3 mt -118.15 99.53 6.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.491 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.573 HD11 ' CG ' ' A' ' 173' ' ' MET . 8.5 mm -85.27 126.24 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.939 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 174' ' ' LEU . 5.1 mp -112.31 149.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.35 0.595 . . . . 0.0 110.375 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -144.14 142.48 30.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.349 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.7 mt -87.67 141.2 28.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.35 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -52.47 146.4 9.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.271 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 18.4 m120 53.34 43.75 31.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.678 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 47.9 p30 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.666 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.704 HMC3 ' CE1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.539 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 3' ' ' GLY . 55.9 mttp -86.42 112.61 21.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.485 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 57.27 120.41 0.01 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 tp -61.84 -36.81 76.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.773 0.321 . . . . 0.0 110.574 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.1 mm -72.31 -41.07 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 1.2 m-30 -75.48 -25.45 57.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.643 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 3' ' ' GLY . 27.3 t-20 -69.16 -52.77 24.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.821 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.71 -39.13 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.061 0.457 . . . . 0.0 109.855 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.521 HD13 ' CE2' ' A' ' 69' ' ' PHE . 20.9 tp -67.02 -47.62 70.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.87 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -50.37 -44.5 54.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.958 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.18 -54.37 46.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.383 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.439 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 28.5 ttt -51.05 -41.45 59.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.061 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.15 -36.71 77.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.509 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.7 t -62.04 -23.12 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.264 0.554 . . . . 0.0 110.032 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.04 -34.31 18.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.026 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -85.88 -76.51 0.33 Allowed 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 58' ' ' LEU . 98.1 m -90.69 -17.71 26.31 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.314 0.578 . . . . 0.0 110.599 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.87 179.19 30.56 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.741 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.8 ttp -72.95 -30.5 63.91 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.004 -1.098 . . . . 0.0 110.701 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.2 t -60.55 -39.31 87.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.981 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.04 -38.61 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 55.4 t-105 -55.26 -47.47 75.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.204 0.526 . . . . 0.0 110.071 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -74.76 -25.8 59.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.494 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.64 -47.48 26.23 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.978 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.996 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -78.34 -23.34 47.02 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.861 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.996 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.9 tt -76.35 -43.4 41.1 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.366 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -67.74 -18.89 65.04 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.26 -30.83 18.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.474 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -94.12 -88.93 0.23 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.637 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.39 153.86 74.45 Favored Pre-proline 0 C--N 1.327 -0.383 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.264 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.67 136.95 52.03 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.613 2.209 . . . . 0.0 112.0 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -84.42 -19.14 33.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.501 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -88.84 -53.61 4.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -73.92 134.56 43.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.25 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.4 155.59 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.56 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -115.66 -175.44 2.72 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.329 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.62 HG22 ' CG ' ' A' ' 40' ' ' LYS . 1.6 m -128.72 166.2 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.107 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 1' ' ' MET . 2.0 m -80.14 37.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.711 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.556 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -158.26 2.78 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.044 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.62 ' CG ' HG22 ' A' ' 37' ' ' VAL . 14.2 mmtt -92.87 143.84 25.86 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.04 0.448 . . . . 0.0 110.31 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.443 ' OG ' ' N ' ' A' ' 42' ' ' TYR . 80.7 p -71.71 -88.33 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.019 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.443 ' N ' ' OG ' ' A' ' 41' ' ' SER . 12.6 m-85 55.99 160.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.315 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.2 119.76 17.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -83.88 -1.36 54.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.239 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t -51.99 -32.26 33.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.828 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -56.62 -29.56 62.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.874 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.554 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -51.18 -56.52 12.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.081 0.467 . . . . 0.0 110.978 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -39.87 -42.17 1.27 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.867 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 m -74.05 -29.78 62.07 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.919 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 47' ' ' LEU . 17.8 mt -73.4 -51.4 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.275 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.1 m -59.15 -25.08 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.155 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.657 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.7 tt0 -77.2 -40.83 43.74 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.735 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -59.3 -56.97 15.33 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.858 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.26 -39.55 52.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.86 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.01 -38.58 83.09 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.479 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.437 ' NE2' ' N ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -63.03 -31.94 73.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -73.28 -40.6 64.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.672 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 ' SG ' ' A' ' 17' ' ' CYS . 37.7 mt -83.15 -8.91 59.44 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.615 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 58.1 51.54 8.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.453 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.42 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 20.6 mmt -131.14 149.89 74.99 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.448 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.18 138.48 72.52 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.534 1.489 . . . . 0.0 111.27 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.657 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.4 tt -53.18 -28.75 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.654 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -74.59 -29.65 61.4 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.302 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -78.64 -35.22 45.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.034 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.538 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.0 t -65.06 -59.65 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.7 p -48.99 -38.8 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.793 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -53.68 -45.15 70.25 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.18 -57.44 10.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.898 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.538 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 6.3 m-30 -45.18 -29.15 0.88 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.313 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.67 -51.29 58.48 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.515 ' NE2' ' OE1' ' A' ' 151' ' ' GLN . 39.9 tt0 -58.0 -52.93 63.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.995 0.426 . . . . 0.0 110.32 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.439 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 61.1 m-85 -55.0 -41.3 71.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.722 0.772 . . . . 0.0 110.507 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.5 tp -59.05 -38.68 79.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.411 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -67.48 -40.38 85.29 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.139 -0.625 . . . . 0.0 109.896 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -57.93 -69.37 0.18 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.305 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.11 -42.01 30.83 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.74 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.88 -43.27 81.09 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.376 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.94 -27.45 18.97 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.424 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.8 t -74.42 -38.61 63.01 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -65.05 -69.22 0.3 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.802 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.417 ' CE1' ' HAC' ' A' ' 182' ' ' HEM . 3.5 m80 -98.49 47.03 0.99 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.036 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 m -51.49 -44.41 62.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.767 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 92.7 m-20 -56.8 -30.13 63.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.609 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.7 t -79.15 -20.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.767 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' A' ' 87' ' ' LYS . 49.0 t -75.88 -40.47 38.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.306 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 83' ' ' ASP . 29.8 p-10 -52.82 -8.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.045 0.45 . . . . 0.0 110.661 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 85' ' ' VAL . 56.9 mttm -73.02 -29.96 63.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.468 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.612 ' CZ ' ' CE2' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -97.56 119.6 36.41 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.021 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 53.4 p30 -88.24 -19.09 27.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.498 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 49.4 p30 -156.44 148.04 22.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.752 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -37.67 -40.65 0.43 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.04 0.447 . . . . 0.0 111.176 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.6 m -63.74 -41.67 98.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.869 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.433 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 38.7 m -61.34 -36.67 80.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.527 0.68 . . . . 0.0 110.375 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 98' ' ' ILE . 7.2 tt -65.53 -63.28 1.13 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.462 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.6 t -48.65 -41.72 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.789 0.328 . . . . 0.0 111.722 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.429 ' C ' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -85.49 -6.03 59.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.448 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -110.28 -14.38 13.28 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.659 -0.523 . . . . 0.0 112.439 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.495 ' O ' ' O ' ' A' ' 97' ' ' GLY . 39.8 mt -29.58 -104.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 117.395 0.597 . . . . 0.0 112.58 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.462 ' N ' ' ND1' ' A' ' 99' ' ' HIS . 9.0 p-80 -39.47 -48.33 1.97 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.06 0.457 . . . . 0.0 111.494 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -44.99 -87.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -71.05 -51.66 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.562 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mp -63.63 -47.81 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.651 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.14 -52.6 46.03 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.585 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 31.9 tp -49.51 -48.17 48.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.119 0.485 . . . . 0.0 110.31 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -57.43 -45.37 84.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.118 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 82.3 t -52.37 -51.92 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 110' ' ' TYR . 18.0 t-20 -49.42 -41.66 40.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.803 0.335 . . . . 0.0 110.547 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.585 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 24.4 mmtm -65.44 -41.94 92.93 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.495 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.0 tp -67.75 -44.05 78.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.767 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.538 ' CD2' ' N ' ' A' ' 111' ' ' HIS . 53.6 t80 -145.35 170.06 17.06 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.298 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.538 ' N ' ' CD2' ' A' ' 110' ' ' TYR . 38.3 m80 -37.82 -96.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.263 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 39.89 62.18 5.71 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.088 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.49 -8.34 23.35 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.407 2.071 . . . . 0.0 111.868 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 83.1 p -149.78 147.79 28.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.387 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.478 ' CD2' ' O2D' ' A' ' 182' ' ' HEM . 8.5 mt -133.09 154.32 81.22 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.911 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 115' ' ' LEU . 85.6 Cg_exo -41.38 170.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.277 1.985 . . . . 0.0 112.386 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -88.47 110.12 20.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.251 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.45 HD12 ' HN3' ' A' ' 184' ' ' IMD . 11.6 mt -124.63 128.75 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.71 0.29 . . . . 0.0 110.707 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.469 ' OD1' ' NH2' ' A' ' 131' ' ' ARG . 4.1 m120 -132.62 115.1 15.0 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.427 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.84 123.68 5.9 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.401 ' C ' HD12 ' A' ' 122' ' ' LEU . 37.1 tt0 -116.99 152.27 34.97 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.605 ' N ' HD12 ' A' ' 122' ' ' LEU . 8.8 mp -99.67 148.0 24.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.06 160.67 42.13 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.35 -40.61 2.19 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.573 2.182 . . . . 0.0 113.062 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -77.77 43.67 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.874 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 46.03 60.86 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.267 0.556 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -138.0 160.83 38.31 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.085 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.1 mt -141.84 117.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.69 121.47 31.1 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.845 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.5 tp -114.54 134.85 54.72 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.908 0.385 . . . . 0.0 110.137 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.469 ' NH2' ' OD1' ' A' ' 119' ' ' ASN . 23.5 ttp-105 -120.79 125.22 47.02 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.108 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.584 ' CE1' ' CZ ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -121.06 99.32 6.43 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 134' ' ' SER . 1.3 m -108.03 119.82 40.56 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.913 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER 165.62 158.35 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.81 37.05 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.42 2.08 . . . . 0.0 111.301 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.612 HH12 ' HB2' ' A' ' 142' ' ' ALA . 0.8 OUTLIER -87.19 97.3 10.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.858 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -77.14 3.2 13.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 141' ' ' CYS . 1.0 OUTLIER -85.39 12.47 8.24 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.214 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 85.5 m -39.9 -44.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.624 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.798 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 94.4 m-85 -53.75 -34.76 60.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.629 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 138' ' ' LEU . 43.8 t -69.79 -46.29 66.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.118 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.612 ' HB2' HH12 ' A' ' 136' ' ' ARG . . . -45.27 -46.07 12.41 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.384 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.49 -47.81 80.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.732 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.19 -52.47 40.1 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.1 mt -53.32 -55.73 22.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.746 0.308 . . . . 0.0 110.805 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 20.2 mt -54.82 -54.67 39.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.4 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.545 ' CE2' HD12 ' A' ' 159' ' ' ILE . 6.4 m-85 -50.15 -50.58 48.45 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.093 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.11 -49.99 67.8 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.358 -0.448 . . . . 0.0 111.996 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.03 -59.74 2.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.891 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 155' ' ' GLN . . . -53.9 -51.99 61.95 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.477 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.515 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 86.6 mt-30 -51.83 -56.68 12.49 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 120.853 0.359 . . . . 0.0 111.164 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -41.5 -47.52 3.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.921 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.612 ' CE2' ' CZ ' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -86.17 36.46 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.665 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 151' ' ' GLN . 48.4 tt0 42.29 57.77 3.23 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.395 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.505 ' CD ' ' H ' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -131.76 153.62 49.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.505 ' H ' ' CD ' ' A' ' 155' ' ' GLN . 56.4 mttp -121.7 116.44 24.54 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 31.4 pt -130.2 173.82 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.369 0.604 . . . . 0.0 111.728 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -140.37 126.85 20.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.927 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.545 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.6 mt -110.97 118.42 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.4 t -101.81 110.92 23.01 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.667 0.27 . . . . 0.0 111.016 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.553 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 50.1 p-80 -102.57 73.57 1.31 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.688 0.756 . . . . 0.0 111.494 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -76.56 -18.88 58.43 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.801 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 108.4 13.21 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.577 ' O ' ' N ' ' A' ' 166' ' ' HIS . 9.1 t -133.68 118.82 18.59 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.608 0.242 . . . . 0.0 110.868 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 44.4 ttm -35.8 -22.36 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.214 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.798 ' CE1' ' CE2' ' A' ' 140' ' ' PHE . 32.6 m170 -51.43 -23.28 3.7 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.1 t -89.31 -41.89 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.021 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.458 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 127.88 13.3 2.75 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.83 159.43 19.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.998 0.428 . . . . 0.0 110.831 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -56.7 -27.76 59.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.399 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -168.87 175.88 5.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 9.5 m -91.72 143.81 26.16 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.805 0.335 . . . . 0.0 110.627 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.2 tpp -121.99 120.52 34.64 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.44 104.83 8.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.394 0.616 . . . . 0.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -91.23 125.36 43.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.4 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 177' ' ' GLU . 5.2 mp -110.32 152.59 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.999 0.428 . . . . 0.0 110.27 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.42 ' N ' HG22 ' A' ' 176' ' ' ILE . 21.5 mt-10 -143.95 141.99 30.51 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.995 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.8 mt -95.61 136.23 36.26 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.926 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -71.13 158.14 36.96 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.573 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -57.08 -33.64 67.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.522 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.565 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.564 ' C3A' ' NH2' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 184' ' ' IMD . . . . . 0.45 ' HN3' HD12 ' A' ' 118' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 1' ' ' MET . 1.1 tmt? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 3' ' ' GLY . 1.7 tpmt? -80.67 -84.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.555 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 56.94 112.28 0.01 OUTLIER Glycine 0 C--N 1.333 0.413 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -47.23 -47.77 9.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 49.6 mm -57.78 -53.89 38.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 0.0 109.755 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -67.56 -18.75 65.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.568 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 3' ' ' GLY . 43.9 t-20 -73.39 -56.2 5.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.471 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t -56.99 -36.03 49.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.466 HD13 ' CE2' ' A' ' 69' ' ' PHE . 18.1 tp -72.09 -41.75 66.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.752 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -51.82 -44.38 63.5 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -61.53 -50.65 71.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.987 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.476 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 13.5 ttt -52.55 -42.89 64.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 86.8 t -68.89 -35.91 71.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.462 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -61.01 -23.42 29.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.336 0.589 . . . . 0.0 109.799 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.22 -34.43 20.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.174 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -85.06 -75.86 0.34 Allowed 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.546 ' SG ' HD21 ' A' ' 58' ' ' LEU . 87.7 m -92.03 -20.75 21.0 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.234 0.54 . . . . 0.0 110.741 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.8 172.04 25.52 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.819 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 ttt -66.92 -29.08 68.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.798 -1.201 . . . . 0.0 110.55 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t -62.51 -41.54 98.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.133 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.68 -35.87 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -51.97 -45.82 64.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.223 0.535 . . . . 0.0 109.578 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -72.24 -29.65 64.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.211 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -67.39 -49.24 64.69 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.824 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.38 -23.46 34.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.793 0.33 . . . . 0.0 110.651 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.824 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.6 tt -72.62 -61.8 1.68 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.401 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.489 ' N ' HD23 ' A' ' 26' ' ' LEU . 96.9 mt-10 -59.2 -22.11 60.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.687 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -81.2 -41.15 22.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -102.17 -88.74 0.38 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.554 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -50.83 157.13 1.42 Allowed Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.03 148.2 62.81 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.67 2.246 . . . . 0.0 112.109 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.653 ' CD ' ' H ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -113.03 -0.85 14.62 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.562 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -110.8 -36.83 5.59 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.409 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.52 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 92.3 mtt180 -75.23 44.98 0.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.45 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 p -48.24 128.91 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.435 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.52 ' CE2' ' O ' ' A' ' 34' ' ' ARG . 82.9 m-85 -116.59 -171.65 2.05 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.59 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.625 HG22 ' CG ' ' A' ' 40' ' ' LYS . 2.4 m -125.41 168.27 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.806 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -76.92 34.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.834 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.531 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -156.58 -5.17 0.11 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.238 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.625 ' CG ' HG22 ' A' ' 37' ' ' VAL . 14.4 mmtt -85.95 172.2 10.86 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.028 0.442 . . . . 0.0 110.541 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 m -76.81 144.69 38.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.456 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -154.47 156.56 36.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.559 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.48 120.31 29.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.464 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.604 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 11.1 pm0 -75.12 -24.58 58.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.643 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -58.91 -36.02 74.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.27 -42.57 98.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.83 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -40.82 -58.76 1.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.928 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -37.68 -43.36 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.539 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.5 p -72.48 -33.32 66.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.272 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.0 mp -68.38 -54.83 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.028 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -55.32 -24.61 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.878 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.649 ' HG3' HD12 ' A' ' 62' ' ' ILE . 5.8 tt0 -75.56 -41.79 53.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.598 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -58.62 -56.83 17.11 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.136 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.19 -38.82 63.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.096 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.534 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -59.11 -38.5 79.71 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.179 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.502 ' NE2' ' N ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -63.77 -31.68 72.94 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -73.79 -40.56 63.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.546 HD21 ' SG ' ' A' ' 17' ' ' CYS . 30.9 mt -85.25 -6.75 59.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.085 0.469 . . . . 0.0 110.004 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.489 ' O ' ' SD ' ' A' ' 60' ' ' MET . 84.9 m-20 56.47 61.18 2.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.973 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 52.3 mmm -139.76 149.84 60.79 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.708 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.21 136.86 53.68 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.405 1.403 . . . . 0.0 110.778 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.649 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.6 tt -50.21 -27.66 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.042 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -73.44 -31.38 63.79 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.481 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.7 -34.05 52.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.995 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.534 HG21 ' HB2' ' A' ' 55' ' ' ALA . 84.8 t -69.5 -57.21 9.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.3 p -51.99 -42.23 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.308 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.515 ' N ' HG13 ' A' ' 66' ' ' VAL . 33.0 mtpt -52.75 -50.3 63.75 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.38 -48.22 81.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.757 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.469 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.0 m-30 -52.12 -30.42 26.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.632 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.44 -48.13 71.82 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -56.89 -51.74 67.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.931 0.396 . . . . 0.0 109.98 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 55.4 m-85 -58.68 -42.53 88.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.818 0.818 . . . . 0.0 110.447 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.8 tp -56.8 -39.26 73.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.335 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 38.1 t80 -69.0 -41.31 77.97 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.002 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -55.9 -69.28 0.15 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.199 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.63 -46.89 30.37 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.397 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.8 mt -51.0 -43.69 60.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.724 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.7 -25.9 30.27 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.277 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 82' ' ' THR . 32.9 t -74.4 -55.68 5.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.045 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.409 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -74.17 -38.04 63.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.781 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -94.26 25.43 3.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.555 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 79' ' ' SER . 55.9 m -52.83 -39.0 62.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 110.002 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -57.91 -31.12 66.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.432 HG22 ' HG2' ' A' ' 105' ' ' GLU . 2.8 t -86.22 -20.17 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.55 -40.81 89.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -53.22 -19.66 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.387 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -64.72 -29.47 70.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.797 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 7.0 p90 -122.54 115.27 21.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.887 0.375 . . . . 0.0 110.843 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 54.8 p30 -85.69 -3.41 58.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.451 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 89' ' ' ASP . 61.7 m-20 -160.86 156.96 25.83 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.088 0.471 . . . . 0.0 111.452 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.407 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 69.6 t80 -48.12 -53.05 17.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.812 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.8 m -55.69 -42.41 75.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.655 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.0 p -63.0 -38.27 90.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.447 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.0 tt -64.12 -48.97 74.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.004 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.5 t -58.25 -37.39 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 0.0 110.776 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 120' ' ' GLY . 95.6 mmm -87.24 -4.89 59.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.088 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.7 -16.93 7.75 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.163 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.507 ' O ' ' O ' ' A' ' 97' ' ' GLY . 11.2 mt -27.43 -106.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 117.828 0.814 . . . . 0.0 112.645 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -40.45 -48.35 2.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.118 0.485 . . . . 0.0 111.074 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -44.46 -86.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.564 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.2 m -72.86 -52.17 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.564 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.8 mp -63.97 -48.3 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.617 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.02 -54.63 35.96 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.9 tp -48.8 -50.58 33.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.138 0.495 . . . . 0.0 110.101 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.432 ' HG2' HG22 ' A' ' 84' ' ' VAL . 37.5 tp10 -54.26 -46.38 72.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.389 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 64.3 t -53.87 -53.38 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 110' ' ' TYR . 18.1 t-20 -46.54 -43.51 17.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.804 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -61.29 -36.58 80.46 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.516 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.3 mt -70.54 -30.7 67.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.683 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 107' ' ' ASN . 51.9 m-85 -139.15 -129.3 0.12 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.52 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -167.04 141.74 3.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.881 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.462 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 0.9 OUTLIER 45.85 62.3 11.25 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.054 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.88 163.58 28.49 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.783 2.322 . . . . 0.0 111.796 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.7 p -86.2 75.49 9.87 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.231 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 116' ' ' PRO . 43.9 mt -116.7 90.68 32.29 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.325 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 115' ' ' LEU . 52.4 Cg_exo -54.1 -150.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.59 2.194 . . . . 0.0 113.003 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -96.63 115.61 27.73 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.119 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.44 123.96 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.45 99.41 5.82 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.892 0.377 . . . . 0.0 110.927 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.479 ' O ' ' SD ' ' A' ' 96' ' ' MET . . . -102.89 123.41 7.83 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -118.87 162.11 19.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.897 0.379 . . . . 0.0 110.447 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -108.12 143.76 36.45 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.12 160.37 41.39 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.77 -38.06 3.38 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.538 2.159 . . . . 0.0 113.343 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -81.0 46.17 0.88 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.27 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 43.7 59.31 3.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 110.685 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -135.52 157.98 45.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.884 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.0 mt -137.06 117.52 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.33 119.99 27.2 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.755 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.5 tp -114.04 125.89 54.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 110.789 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.675 HH21 ' CD2' ' A' ' 171' ' ' HIS . 9.4 tpt180 -111.18 119.73 39.92 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -125.86 112.06 15.55 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 116' ' ' PRO . 12.2 m -95.89 102.71 14.54 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 136' ' ' ARG . 36.5 t -125.1 82.34 61.92 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.492 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -48.02 -11.8 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.911 1.741 . . . . 0.0 110.865 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.495 ' H ' ' C ' ' A' ' 134' ' ' SER . 58.3 mtt180 -91.81 142.3 27.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.406 ' C ' HD22 ' A' ' 138' ' ' LEU . 49.5 ttt180 -69.1 39.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.557 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 3.4 mm? -98.89 0.83 44.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.298 0.57 . . . . 0.0 110.08 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 15.8 p -42.14 -46.57 4.39 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.794 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.596 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 88.6 m-85 -51.49 -38.5 54.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.086 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.506 ' SG ' ' CG2' ' A' ' 66' ' ' VAL . 68.4 m -65.8 -43.29 89.15 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.162 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.54 -49.86 18.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.947 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -62.64 -51.2 68.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.087 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.53 -46.39 37.41 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.5 mt -59.11 -54.29 48.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.707 0.289 . . . . 0.0 111.428 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 mt -55.26 -56.12 23.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.983 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.567 ' CE2' HD12 ' A' ' 159' ' ' ILE . 23.0 m-85 -50.58 -47.6 57.88 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.841 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.02 -50.84 63.57 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.41 -58.48 2.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.002 0.43 . . . . 0.0 110.613 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.7 -52.01 57.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.701 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -50.48 -48.78 56.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.113 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.4 ' ND1' ' C ' ' A' ' 152' ' ' HIS . 16.8 t-80 -48.66 -48.92 39.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.689 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -89.22 39.12 0.92 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.236 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 37.49 57.53 1.37 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.943 0.401 . . . . 0.0 111.379 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -129.82 141.0 50.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -112.61 124.62 52.95 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.407 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 10.3 pt -138.1 170.3 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.735 0.779 . . . . 0.0 111.975 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -133.63 127.65 33.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.335 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.567 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.7 mt -110.0 120.62 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.653 0.263 . . . . 0.0 110.447 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.6 t -103.69 103.81 13.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.771 0.32 . . . . 0.0 110.894 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.1 p-80 -97.14 74.17 2.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.435 0.636 . . . . 0.0 111.338 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -77.29 -7.5 56.08 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.442 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.482 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 4.7 m -123.94 105.79 9.89 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.594 ' O ' ' N ' ' A' ' 166' ' ' HIS . 20.7 t -137.23 114.34 10.74 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.305 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 38.9 ttm -36.34 -18.24 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' CYS . 51.9 m80 -58.15 -28.08 64.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.499 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.2 t -82.41 -46.13 13.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.799 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.499 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 152.65 15.17 0.07 OUTLIER Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.247 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.19 145.64 32.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.907 0.384 . . . . 0.0 110.532 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.469 ' C ' ' ND1' ' A' ' 171' ' ' HIS . 85.7 m-20 -83.44 19.27 1.59 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.021 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.675 ' CD2' HH21 ' A' ' 131' ' ' ARG . 8.5 p-80 174.65 -163.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 163' ' ' THR . 46.6 t -136.48 150.51 48.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.276 0.56 . . . . 0.0 111.426 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.468 ' H ' ' HB ' ' A' ' 163' ' ' THR . 14.8 ttp -126.89 109.95 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.325 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -108.62 111.95 24.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.319 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.6 mp -93.84 128.64 45.06 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.478 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.4 mp -109.63 150.65 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.477 0.656 . . . . 0.0 110.63 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -136.21 134.67 38.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.773 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.7 mt -93.88 142.41 27.41 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -135.3 -175.22 3.86 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.856 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -149.93 23.65 0.86 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.776 0.322 . . . . 0.0 110.592 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 52.9 p30 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.617 179.966 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.409 ' O1A' ' CG ' ' A' ' 116' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 mtt . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.7 mttp 54.44 47.3 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.25 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . -157.71 -126.8 0.92 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.59 HD13 ' NE ' ' A' ' 80' ' ' ARG . 2.4 tp -50.06 -53.69 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 110.385 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.511 ' H ' HG23 ' A' ' 4' ' ' ILE . 36.1 mm -51.14 -47.5 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.53 -23.96 61.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.742 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 3' ' ' GLY . 36.2 t-20 -69.48 -51.26 37.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.426 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.51 -50.86 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.34 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.7 tp -55.46 -44.19 76.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -52.09 -50.88 60.71 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.825 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -57.6 -52.55 64.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.029 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.438 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.5 OUTLIER -47.72 -37.11 12.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.469 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -73.73 -34.76 41.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.403 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.4 HG13 ' CG ' ' A' ' 19' ' ' MET . 83.5 t -61.33 -23.69 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.68 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.76 -34.91 22.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.982 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -84.5 -73.88 0.41 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.541 ' SG ' HD21 ' A' ' 58' ' ' LEU . 74.3 m -93.87 -21.52 19.2 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.089 0.471 . . . . 0.0 111.076 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.68 -178.82 23.3 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.827 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.4 ' CG ' HG13 ' A' ' 14' ' ' VAL . 24.0 mtm -74.07 -30.41 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.063 -1.069 . . . . 0.0 110.193 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 m -61.99 -42.82 99.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.85 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.7 -38.42 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -51.84 -45.83 64.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.309 0.576 . . . . 0.0 109.453 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -70.93 -28.84 64.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.116 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -67.9 -49.89 59.4 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.797 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.69 -20.23 36.54 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.934 0.397 . . . . 0.0 110.659 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.8 tt -76.31 -63.32 1.35 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.316 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.509 ' N ' HD23 ' A' ' 26' ' ' LEU . 96.7 mt-10 -57.73 -21.93 43.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.596 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -80.01 -39.93 28.93 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -103.41 -89.26 0.39 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.702 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -54.36 154.9 7.74 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.129 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.01 139.38 56.02 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.429 2.086 . . . . 0.0 112.046 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -79.77 -21.81 43.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.48 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.53 -46.22 83.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.557 ' NE ' ' CZ ' ' A' ' 42' ' ' TYR . 92.1 mtt-85 -90.93 102.35 15.12 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.718 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.5 m -155.27 52.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.382 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 37' ' ' VAL . 72.8 m-85 -149.49 -134.82 0.07 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.554 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.676 HG21 ' HG3' ' A' ' 40' ' ' LYS . 16.4 m 29.05 -154.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 123.792 0.682 . . . . 0.0 112.479 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 37' ' ' VAL . 2.6 m -168.01 11.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.368 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.97 76.45 0.17 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.931 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.676 ' HG3' HG21 ' A' ' 37' ' ' VAL . 16.1 mmtt -120.21 -172.38 2.34 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.183 0.515 . . . . 0.0 110.702 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 42' ' ' TYR . 28.8 t -75.98 -136.99 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.955 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.557 ' CZ ' ' NE ' ' A' ' 34' ' ' ARG . 96.4 m-85 58.57 134.1 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.55 151.73 43.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.147 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -80.52 -6.27 57.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.592 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.0 t -47.94 -35.02 10.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.69 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -59.44 -30.98 68.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.707 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -49.55 -56.2 10.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.107 0.48 . . . . 0.0 110.576 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -38.79 -43.37 0.92 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.808 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.1 p -74.3 -29.3 61.57 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.157 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 47' ' ' LEU . 15.7 mt -72.89 -52.67 21.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.109 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.405 ' H ' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -57.8 -24.37 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.627 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.678 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.4 tt0 -78.03 -39.43 41.98 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.43 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.528 ' OD2' HD23 ' A' ' 25' ' ' LEU . 64.9 m-20 -60.28 -56.85 16.48 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.282 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 55' ' ' ALA . 8.2 p -56.66 -41.05 73.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.553 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -57.1 -38.98 74.16 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.887 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -63.73 -30.79 71.84 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -76.94 -38.56 53.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.583 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.541 HD21 ' SG ' ' A' ' 17' ' ' CYS . 30.1 mt -84.74 -7.09 59.34 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.82 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 47.7 t30 56.36 49.28 15.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.54 0.686 . . . . 0.0 109.302 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.4 mmm -126.94 150.02 70.67 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.133 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.29 137.16 59.27 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 121.513 1.475 . . . . 0.0 110.912 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.678 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.0 tt -50.71 -29.68 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.887 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -69.98 -34.18 73.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.225 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -75.47 -32.91 60.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.104 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.521 HG21 ' HB2' ' A' ' 55' ' ' ALA . 89.1 t -71.6 -55.89 12.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.109 0.48 . . . . 0.0 110.003 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -51.91 -42.86 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.132 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.507 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.5 mtpt -53.89 -49.85 67.64 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.03 -52.3 66.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.655 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.69 -30.95 4.2 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.707 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.24 -50.94 41.51 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -55.12 -49.72 71.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.04 0.448 . . . . 0.0 109.899 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -58.84 -42.57 89.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.7 0.762 . . . . 0.0 110.733 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.2 tp -54.99 -38.62 68.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.309 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 34.2 t80 -71.27 -40.33 71.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.01 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -57.07 -71.92 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.785 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.76 -40.38 18.29 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.286 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.403 ' C ' ' N ' ' A' ' 79' ' ' SER . 44.4 mt -61.81 -39.2 90.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.177 0.489 . . . . 0.0 111.796 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.38 -11.6 0.55 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.697 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.453 ' O ' ' OG1' ' A' ' 82' ' ' THR . 9.3 t -91.91 -48.54 6.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.934 0.397 . . . . 0.0 110.483 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.59 ' NE ' HD13 ' A' ' 4' ' ' ILE . 5.5 mtm105 -68.64 -65.95 0.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.315 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.619 ' CE1' HMC3 ' A' ' 182' ' ' HEM . 0.0 OUTLIER -81.19 28.78 0.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.19 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 79' ' ' SER . 96.5 m -49.01 -45.49 42.6 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.571 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -52.48 -25.6 10.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.404 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 2.8 t -85.91 -24.57 6.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.828 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.8 t -63.05 -40.43 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.529 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -53.84 -16.19 1.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.448 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.404 ' CG ' ' O ' ' A' ' 84' ' ' VAL . 39.0 mmtm -64.85 -30.87 71.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.488 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 12.9 p90 -119.3 119.32 33.69 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.101 0.477 . . . . 0.0 111.126 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 22.1 t70 -83.87 -5.1 59.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.257 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.492 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 67.8 m-20 -159.59 156.34 27.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.089 0.471 . . . . 0.0 111.485 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -45.39 -46.98 13.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.818 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.9 m -56.9 -58.77 6.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.368 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.7 t -45.27 -40.06 7.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.12 0.485 . . . . 0.0 111.145 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.6 tt -63.81 -48.31 77.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.326 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.2 t -59.32 -40.25 80.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.573 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 9.0 ptm -87.96 -1.52 58.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.6 -18.07 7.21 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.327 -0.707 . . . . 0.0 112.851 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 94' ' ' LEU . 13.5 mt -27.41 -105.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 117.77 0.785 . . . . 0.0 112.493 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -40.56 -48.88 2.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.064 0.459 . . . . 0.0 111.141 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -44.02 -85.84 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.565 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -73.2 -52.27 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.565 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mp -64.71 -48.75 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.7 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.17 -54.49 36.62 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 tp -48.62 -49.83 35.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.191 0.52 . . . . 0.0 109.854 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -55.04 -47.17 75.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.547 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 71.8 t -51.0 -51.04 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -51.72 -40.63 60.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -63.96 -40.19 95.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.692 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.482 ' C ' ' CG ' ' A' ' 110' ' ' TYR . 8.8 mp -61.04 -55.94 26.91 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.482 ' CG ' ' C ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER 169.19 170.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.622 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 110' ' ' TYR . 3.6 t-160 58.43 145.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.929 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -149.49 68.33 9.16 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.326 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -82.77 21.26 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.96 2.44 . . . . 0.0 112.224 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.7 t 57.62 107.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.344 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.67 152.35 93.55 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.128 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.5 172.47 5.46 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.459 2.106 . . . . 0.0 112.414 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -80.03 105.44 11.3 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.871 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.0 mm -115.65 124.93 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -131.94 116.63 17.39 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.756 0.312 . . . . 0.0 110.962 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.83 158.86 14.06 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -152.79 154.65 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 122' ' ' LEU . 10.3 mp -104.72 150.25 24.9 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.13 160.52 38.87 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.74 -56.62 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.627 2.218 . . . . 0.0 112.797 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 22.0 m120 -45.67 -64.65 0.68 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.501 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 125' ' ' ASN . 3.5 p30 155.54 63.5 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.57 0.7 . . . . 0.0 109.181 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -142.36 165.83 26.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.694 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.6 mt -138.28 117.95 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.76 121.3 30.01 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.83 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 60.2 tp -115.61 136.42 53.09 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.984 0.421 . . . . 0.0 110.607 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -119.99 124.24 45.45 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.093 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.445 ' HH ' ' CGA' ' A' ' 182' ' ' HEM . 45.9 t80 -123.09 113.97 19.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.778 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.96 122.71 36.72 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 121.168 -0.213 . . . . 0.0 110.435 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 136' ' ' ARG . 4.9 p -173.06 149.47 1.78 Allowed Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.714 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.82 12.7 1.12 Allowed 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.111 1.874 . . . . 0.0 110.813 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.484 ' C ' ' H ' ' A' ' 138' ' ' LEU . 39.0 mtp180 -92.74 107.66 19.39 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.483 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -69.49 38.58 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.081 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 136' ' ' ARG . 1.4 tp -101.72 8.76 41.42 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.066 0.46 . . . . 0.0 110.483 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 71.2 m -41.78 -46.54 3.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.499 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -49.07 -38.39 24.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.454 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.62 -42.84 86.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 109.949 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.84 -49.79 14.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.613 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -61.33 -50.17 74.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.252 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.98 -46.58 41.25 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.75 -53.26 59.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.597 0.237 . . . . 0.0 111.258 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.8 mt -55.02 -56.49 19.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.979 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.597 ' CE2' HD12 ' A' ' 159' ' ' ILE . 22.6 m-85 -50.76 -47.87 59.43 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.751 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.06 -51.65 57.06 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.59 -59.81 2.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.864 0.364 . . . . 0.0 110.839 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -50.51 -51.23 49.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.994 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -51.13 -47.48 62.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.1 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -49.99 -49.74 49.52 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.641 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.517 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 67.9 t80 -87.68 38.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 38.38 55.95 1.79 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.983 0.421 . . . . 0.0 111.185 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -129.12 141.03 51.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -113.74 124.48 52.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.05 170.47 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.635 0.731 . . . . 0.0 111.898 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -134.0 127.38 32.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.494 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.597 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.3 mt -110.17 117.44 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.3 t -105.19 119.63 39.54 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.065 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.6 p-80 -96.67 74.82 2.75 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.657 0.741 . . . . 0.0 111.376 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -76.9 -19.92 56.85 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.989 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.78 111.07 15.1 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.484 ' O ' HG22 ' A' ' 167' ' ' THR . 20.1 p -114.23 -178.91 3.49 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.563 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.492 ' O ' ' SD ' ' A' ' 165' ' ' MET . 1.1 tmt? -93.87 -26.77 16.76 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -54.83 -24.05 21.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.577 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.5 t -87.25 -25.37 24.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.286 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.04 21.73 24.71 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.946 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.4 166.17 12.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.86 0.362 . . . . 0.0 110.651 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 171' ' ' HIS . 50.4 p-10 -52.22 -31.13 30.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.427 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.524 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 15.1 p80 -173.98 -174.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.3 m -93.06 143.41 26.27 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.155 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.559 ' CG ' HD11 ' A' ' 175' ' ' ILE . 30.1 ttp -121.92 116.3 24.12 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.184 0.516 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 176' ' ' ILE . 1.4 mt -116.05 99.49 7.29 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.203 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.559 HD11 ' CG ' ' A' ' 173' ' ' MET . 13.3 mm -84.37 123.82 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.137 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 174' ' ' LEU . 5.0 mp -106.92 144.0 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.28 0.562 . . . . 0.0 110.28 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -132.17 133.69 44.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.986 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.83 144.4 25.32 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -137.95 178.16 7.32 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.748 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.428 ' O ' ' OD1' ' A' ' 181' ' ' ASP . 48.7 t30 55.57 45.4 24.97 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.567 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 180' ' ' ASN . 68.7 m-20 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.52 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.619 HMC3 ' CE1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.597 ' H2 ' ' CD ' ' A' ' 112' ' ' GLU . 23.4 ttt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' NZ ' ' O ' ' A' ' 40' ' ' LYS . 9.1 mtmp? 56.19 99.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.443 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 4' ' ' ILE . . . 84.54 115.22 0.69 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.418 HG22 ' C ' ' A' ' 3' ' ' GLY . 1.5 tp 170.09 -39.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mm -59.18 -47.81 88.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.77 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -64.19 -28.44 69.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.244 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.454 ' OD1' ' NH2' ' A' ' 80' ' ' ARG . 4.7 t-20 -67.06 -55.05 15.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.016 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t -66.31 -39.0 83.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.17 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.505 HD13 ' CE2' ' A' ' 69' ' ' PHE . 19.0 tp -64.66 -48.6 74.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.961 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -47.42 -44.87 25.01 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.882 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -62.16 -50.54 71.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.863 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.5 tmt? -52.61 -39.62 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.978 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.26 -34.97 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.426 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.0 t -62.06 -22.67 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.322 0.582 . . . . 0.0 110.05 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.35 -34.88 20.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.217 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -84.57 -77.06 0.28 Allowed 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 58' ' ' LEU . 94.3 m -90.72 -19.97 22.95 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.309 0.576 . . . . 0.0 110.696 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.79 173.92 26.76 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.738 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.5 ttt -69.37 -25.81 64.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.866 -1.167 . . . . 0.0 110.494 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.0 t -64.94 -43.59 92.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.149 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -34.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -51.52 -45.77 63.03 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -69.8 -31.63 69.64 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.012 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -64.98 -51.07 63.76 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.791 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.34 -19.6 38.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.921 0.391 . . . . 0.0 110.732 -179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.791 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.2 tt -76.72 -57.16 4.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.357 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.39 -22.48 66.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.507 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -81.13 -39.4 25.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.508 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 72.8 m80 -101.57 -88.74 0.37 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.188 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.601 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -50.28 162.57 0.5 Allowed Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 31.0 Cg_endo -61.46 148.39 93.09 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.501 2.134 . . . . 0.0 112.083 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -70.47 -11.73 61.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.512 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 34' ' ' ARG . 91.9 m-20 -52.64 -45.65 66.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 33' ' ' ASP . 67.1 ttp85 40.39 95.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.094 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.419 ' O ' ' OH ' ' A' ' 42' ' ' TYR . 3.9 m -146.64 72.05 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.075 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 36' ' ' TYR . 43.0 p90 -72.0 114.38 10.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.863 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.476 HG23 ' H ' ' A' ' 39' ' ' ALA . 34.3 m -138.73 5.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-O 121.521 0.677 . . . . 0.0 110.012 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 m 38.92 40.05 0.41 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.758 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.476 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -153.32 26.44 0.52 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.94 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.455 ' O ' ' NZ ' ' A' ' 2' ' ' LYS . 5.2 mmpt? -122.24 -134.53 0.3 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.8 t -152.36 100.55 2.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.825 0.345 . . . . 0.0 110.839 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 35' ' ' VAL . 80.8 m-85 -112.01 161.15 16.77 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.33 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.15 112.55 19.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.325 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.435 ' CD ' ' N ' ' A' ' 45' ' ' SER . 3.0 pp20? -69.65 -29.48 66.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.723 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.435 ' N ' ' CD ' ' A' ' 44' ' ' GLU . 16.5 m -61.31 -35.31 77.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.761 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -62.88 -30.94 71.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.65 -55.79 2.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.027 0.441 . . . . 0.0 110.49 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -39.01 -42.79 0.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.419 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.2 m -72.29 -33.24 67.28 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.335 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.2 mp -71.04 -53.92 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.586 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.97 -24.86 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.124 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.672 ' HG3' HD12 ' A' ' 62' ' ' ILE . 2.2 tt0 -77.6 -39.87 44.02 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.505 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 79.1 m-20 -59.52 -56.21 24.84 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.968 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 p -57.18 -39.2 65.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.026 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.73 -38.42 85.07 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.29 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -63.27 -32.03 73.34 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -73.87 -40.46 63.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.517 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 ' SG ' ' A' ' 17' ' ' CYS . 36.6 mt -83.18 -7.72 59.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.218 0.533 . . . . 0.0 109.748 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.1 t30 56.95 49.57 13.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.549 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.401 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 25.9 mmt -128.43 149.52 71.83 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.151 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.24 137.93 68.89 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.49 1.46 . . . . 0.0 111.124 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.672 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.7 tt -51.79 -29.18 10.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.014 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -71.4 -34.18 70.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.161 0.505 . . . . 0.0 111.244 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -75.51 -32.89 60.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.884 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 55' ' ' ALA . 71.9 t -70.78 -56.53 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -52.56 -44.57 45.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.217 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.528 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.7 mtpt -51.08 -50.13 59.3 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.92 -47.94 81.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.74 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.509 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 8.3 m-30 -53.77 -30.62 45.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.529 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.71 -49.86 61.77 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -56.9 -50.02 73.81 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -58.61 -42.54 88.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.775 0.797 . . . . 0.0 110.555 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.6 tp -55.73 -38.39 69.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.306 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 37.1 t80 -71.55 -39.61 70.55 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.954 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -56.44 -71.05 0.1 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.762 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.06 -45.13 33.3 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.78 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.414 HD21 HG12 ' A' ' 4' ' ' ILE . 13.6 mt -52.34 -44.41 65.15 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.181 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.37 -23.71 16.68 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.178 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.427 ' O ' ' OG1' ' A' ' 82' ' ' THR . 22.1 t -76.74 -53.86 7.41 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.988 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.454 ' NH2' ' OD1' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -75.54 -27.84 58.82 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.764 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -107.14 22.68 15.61 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.684 0.278 . . . . 0.0 110.384 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 79' ' ' SER . 6.4 m -50.88 -40.72 57.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -57.56 -35.53 70.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.508 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.3 -21.85 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.674 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 87' ' ' LYS . 95.4 t -85.52 -46.86 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.695 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -55.68 -2.05 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.686 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 85' ' ' VAL . 86.0 mttt -78.79 -33.95 45.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.58 130.98 55.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.999 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 52.1 t0 -93.0 11.39 27.64 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.402 ' OD1' ' OG ' ' A' ' 93' ' ' SER . 10.2 p-10 -167.8 163.16 14.08 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 118.987 -1.085 . . . . 0.0 113.485 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.427 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 74.3 t80 -62.13 -61.55 2.4 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.786 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.5 m -45.15 -49.3 12.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.209 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.402 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 56.9 m -59.86 -38.16 81.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.296 0.57 . . . . 0.0 110.743 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.19 -55.12 31.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.016 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.7 t -49.73 -42.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 O-C-N 123.142 0.276 . . . . 0.0 111.696 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.436 ' H ' ' HG3' ' A' ' 96' ' ' MET . 3.3 ppp? -83.23 -6.28 59.42 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.736 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -109.24 -13.35 17.7 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.46 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.605 ' HA ' HD13 ' A' ' 102' ' ' ILE . 49.4 mt -29.93 -104.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.431 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 9.0 p-80 -37.36 -48.32 0.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 59.6 t0 -45.42 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.612 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.3 m -70.56 -52.9 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.612 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.8 mp -58.8 -48.47 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.71 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.58 -55.1 31.85 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 tp -50.12 -48.55 53.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 110.167 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.514 ' OE1' ' NZ ' ' A' ' 87' ' ' LYS . 37.7 tp10 -55.94 -45.78 78.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.315 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 102' ' ' ILE . 54.3 t -53.5 -51.16 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -50.0 -43.35 50.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.829 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -62.5 -39.23 92.83 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.268 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.09 -41.18 97.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.059 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.48 ' CD2' ' N ' ' A' ' 111' ' ' HIS . 55.7 t80 -159.7 161.49 34.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.378 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.48 ' N ' ' CD2' ' A' ' 110' ' ' TYR . 94.4 m-70 -79.75 107.12 12.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.496 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.597 ' CD ' ' H2 ' ' A' ' 1' ' ' MET . 10.0 pt-20 -174.45 58.15 0.2 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.723 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 115' ' ' LEU . 65.0 Cg_endo -73.1 24.68 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.658 2.238 . . . . 0.0 111.722 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 112' ' ' GLU . 72.2 m -76.6 23.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.865 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 113' ' ' PRO . 26.7 mt -71.1 147.83 93.84 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.105 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -74.77 -166.55 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.253 1.968 . . . . 0.0 112.657 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -101.51 129.62 47.61 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.666 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.7 mt -131.22 129.82 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.687 0.28 . . . . 0.0 110.654 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -125.98 98.51 5.54 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.87 0.367 . . . . 0.0 110.371 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -103.98 119.49 6.33 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -116.58 153.5 32.13 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 122' ' ' LEU . 8.8 mp -101.18 147.2 26.53 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.25 160.51 41.1 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.15 -38.43 3.81 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.58 2.187 . . . . 0.0 113.105 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -79.54 45.9 0.71 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.918 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 44.22 61.06 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.366 0.603 . . . . 0.0 110.562 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -139.13 158.38 44.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.095 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.6 mt -138.67 116.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.67 28.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 39.9 tp -117.09 132.39 56.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.137 0.494 . . . . 0.0 110.859 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -118.71 125.26 49.28 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.991 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.495 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 29.6 t80 -126.43 121.63 33.0 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.03 124.9 31.88 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.846 0.355 . . . . 0.0 110.689 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.7 p -163.07 147.96 9.3 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.292 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.63 6.84 3.0 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.829 1.686 . . . . 0.0 110.837 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.592 ' HE ' ' CBA' ' A' ' 182' ' ' HEM . 74.8 mtm-85 -94.44 112.3 24.07 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.416 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -70.12 54.15 0.13 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.556 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 136' ' ' ARG . 2.2 tp -114.21 9.77 17.14 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.183 0.516 . . . . 0.0 110.559 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 9.4 t -41.9 -42.61 2.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.344 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -49.47 -41.69 41.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.454 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.441 ' SG ' ' CG2' ' A' ' 66' ' ' VAL . 56.7 m -65.25 -41.44 94.31 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -44.44 -49.93 9.57 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.674 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -63.78 -48.8 75.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.51 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.35 -46.63 52.02 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.147 -1.025 . . . . 0.0 110.785 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.3 mt -58.77 -55.92 28.88 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.5 mt -53.29 -55.91 20.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.749 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.538 ' CE2' HD12 ' A' ' 159' ' ' ILE . 15.2 m-85 -50.71 -48.15 58.92 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.667 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.03 55.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.72 -60.36 1.82 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.862 0.363 . . . . 0.0 110.821 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.98 -51.01 45.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.847 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -51.36 -46.95 62.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.064 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -50.54 -50.37 53.47 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.344 -0.543 . . . . 0.0 109.563 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.518 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 66.2 t80 -86.04 37.43 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.851 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 39.2 55.65 2.16 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.992 0.425 . . . . 0.0 111.168 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -128.88 139.8 51.97 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -112.48 124.1 51.77 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.427 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 9.8 pt -137.32 171.15 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.724 0.773 . . . . 0.0 111.896 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -134.24 127.69 32.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.095 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.538 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.7 mt -110.43 115.71 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.0 m -96.16 100.06 11.74 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.929 0.395 . . . . 0.0 110.018 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.472 ' NE2' ' SG ' ' A' ' 164' ' ' CYS . 0.9 OUTLIER -100.69 71.49 1.49 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.019 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -81.2 -56.12 4.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.486 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 90.0 m -82.72 112.41 19.55 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.528 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.589 ' O ' ' N ' ' A' ' 166' ' ' HIS . 6.0 t -139.17 130.63 27.08 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.049 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 76.8 mtp -36.27 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.312 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.1 t60 -53.0 -24.44 9.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.476 HG23 ' N ' ' A' ' 168' ' ' GLY . 5.9 t -90.15 -43.38 10.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.106 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.476 ' N ' HG23 ' A' ' 167' ' ' THR . . . 132.46 11.98 1.87 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.74 169.56 6.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.928 0.394 . . . . 0.0 110.847 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.539 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 89.5 m-20 -56.44 -44.24 80.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.582 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 170' ' ' ASP . 62.6 m-70 -157.68 -169.81 2.99 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.8 m -92.33 138.31 31.63 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 tpt -115.73 123.65 48.83 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 110.523 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -128.39 100.61 5.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.651 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.6 mp -89.02 127.54 41.68 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.619 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.9 mp -110.45 150.82 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.438 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -144.66 141.47 29.37 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.925 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.2 mt -95.74 133.96 39.23 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.152 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -49.14 147.14 3.13 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.501 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -150.45 22.81 0.82 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.461 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 62.2 t0 . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.616 179.967 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.592 ' CBA' ' HE ' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.562 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.6 mpp? . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -80.62 3.11 23.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.554 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.574 ' O ' HG22 ' A' ' 4' ' ' ILE . . . -65.32 -164.04 1.06 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 3' ' ' GLY . 0.3 OUTLIER 94.12 -23.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.861 0.864 . . . . 0.0 109.483 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.3 mm -67.75 -51.97 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.448 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.616 ' CZ ' ' NH1' ' A' ' 34' ' ' ARG . 93.3 m-85 -68.1 -24.55 65.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.204 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -70.16 -49.93 45.55 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.915 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.08 -35.43 75.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.621 -0.431 . . . . 0.0 109.903 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.459 HD13 ' CE2' ' A' ' 69' ' ' PHE . 21.6 tp -71.1 -40.38 71.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.109 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -53.66 -44.93 70.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.634 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -62.66 -48.13 80.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.966 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.8 tmt? -53.86 -41.38 67.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.819 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.7 t -71.02 -34.94 57.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.446 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.96 -26.22 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.191 0.52 . . . . 0.0 110.249 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.26 -34.51 28.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.112 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -83.74 -73.74 0.4 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.539 ' SG ' HD21 ' A' ' 58' ' ' LEU . 89.4 m -95.29 -22.4 17.8 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.933 0.397 . . . . 0.0 111.332 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.06 170.15 22.32 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 121.891 0.717 . . . . 0.0 112.996 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -27.19 67.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.07 -1.065 . . . . 0.0 109.553 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -63.8 -43.6 95.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.531 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.31 -37.24 31.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 52.4 t-105 -51.02 -44.97 61.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -71.66 -29.01 64.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.068 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -66.73 -50.85 61.45 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.752 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.57 -20.64 36.12 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.596 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.752 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.5 tt -76.66 -69.55 0.51 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.241 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.618 ' N ' HD23 ' A' ' 26' ' ' LEU . 93.8 mt-10 -50.82 -21.43 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.162 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -80.93 -39.25 26.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 26' ' ' LEU . 41.3 m80 -107.27 -88.98 0.46 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.752 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -58.22 155.51 25.68 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.449 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.42 155.55 69.9 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.619 2.213 . . . . 0.0 112.036 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -78.34 -24.77 46.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 3.0 p30 -65.34 -35.7 81.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.908 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.616 ' NH1' ' CZ ' ' A' ' 6' ' ' PHE . 38.7 ttp180 -78.19 103.06 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.772 0.32 . . . . 0.0 110.15 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.499 HG22 ' CD2' ' A' ' 36' ' ' TYR . 9.3 p -155.13 144.92 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.597 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.499 ' CD2' HG22 ' A' ' 35' ' ' VAL . 60.0 m-85 50.81 -118.3 1.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.971 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 38' ' ' SER . 4.5 m 27.84 -154.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 123.655 0.597 . . . . 0.0 112.594 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.494 ' N ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER 175.8 25.23 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.483 -179.072 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.99 21.31 2.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.634 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.454 ' CG ' HG21 ' A' ' 37' ' ' VAL . 7.6 mmmt -112.5 -151.14 0.48 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.119 0.485 . . . . 0.0 111.254 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.9 p -42.92 156.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.692 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.536 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 13.4 p90 -133.57 61.63 1.67 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.19 0.519 . . . . 0.0 110.362 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' HB3' ' NH1' ' A' ' 34' ' ' ARG . . . -73.24 37.59 0.09 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.597 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.521 ' OE2' ' NH2' ' A' ' 136' ' ' ARG . 73.8 tt0 -42.42 -23.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.061 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 43' ' ' ALA . 17.5 m -76.59 -38.46 54.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.922 0.391 . . . . 0.0 110.742 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 6.4 mp0 -65.59 -29.23 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.53 -57.34 2.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 110.741 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.64 -40.21 0.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.533 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.9 m -75.22 -31.11 60.77 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.892 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 47' ' ' LEU . 13.7 mt -70.94 -50.73 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -26.15 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.398 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.661 ' HG3' HD12 ' A' ' 62' ' ' ILE . 3.5 tt0 -76.0 -40.79 52.9 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.543 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -59.27 -57.0 14.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.005 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.96 -38.33 59.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.221 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.517 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.34 -38.35 86.62 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.218 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.9 -32.02 73.2 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.47 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.69 -45.33 53.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.534 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.539 HD21 ' SG ' ' A' ' 17' ' ' CYS . 32.0 mt -77.77 -7.26 56.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.656 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 t30 56.94 49.75 13.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.934 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.414 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 7.7 mmt -128.45 149.14 70.82 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.225 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.28 139.21 76.3 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.441 1.428 . . . . 0.0 110.892 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.661 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.5 tt -52.84 -29.86 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.433 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -71.7 -31.48 66.79 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.578 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.6 -31.6 47.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.921 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' ' 55' ' ' ALA . 69.4 t -71.04 -57.1 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.0 p -52.03 -41.37 31.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.201 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.503 ' N ' HG13 ' A' ' 66' ' ' VAL . 32.2 mtpt -53.98 -50.75 65.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.78 83.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.73 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.9 m-30 -53.81 -31.11 47.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.286 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.63 -50.1 60.8 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -55.69 -50.09 71.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.006 0.432 . . . . 0.0 109.941 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -59.93 -41.84 92.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.826 0.822 . . . . 0.0 110.493 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -58.55 -39.81 81.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.597 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 35.1 t80 -68.28 -41.5 80.93 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.904 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -55.07 -68.81 0.16 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.224 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.16 -47.6 33.32 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.618 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.6 mt -52.06 -42.93 63.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.052 0.426 . . . . 0.0 111.991 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -55.11 -24.17 24.54 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.394 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.8 t -76.37 -53.1 8.65 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.082 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -76.87 -39.98 49.15 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.772 -179.39 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -92.96 27.01 2.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.41 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 34.8 m -53.71 -37.7 63.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.05 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.442 ' O ' ' NZ ' ' A' ' 87' ' ' LYS . 89.9 m-20 -58.09 -30.81 66.53 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.6 -19.7 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.688 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.35 -43.5 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.353 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.34 -16.62 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.994 0.426 . . . . 0.0 110.35 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 83' ' ' ASP . 42.5 mmtm -67.61 -29.07 68.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.022 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 8.9 p90 -120.56 116.5 25.49 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.175 0.512 . . . . 0.0 110.991 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -84.82 -2.37 57.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.369 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.433 ' OD1' ' OG ' ' A' ' 93' ' ' SER . 50.5 p30 -163.48 159.48 22.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.186 0.517 . . . . 0.0 111.637 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.447 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 85.8 t80 -48.7 -46.05 39.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.305 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.2 m -59.08 -61.35 2.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.904 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.433 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 93.8 p -45.4 -37.78 5.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.151 0.501 . . . . 0.0 111.022 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.5 tt -65.03 -46.03 82.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.199 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.1 t -62.6 -39.6 85.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.253 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 12.8 ptm -87.2 -1.85 58.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.82 -16.85 7.74 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.353 -0.693 . . . . 0.0 112.891 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.549 ' HA ' HD13 ' A' ' 102' ' ' ILE . 12.2 mt -29.12 -102.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 117.868 0.834 . . . . 0.0 112.454 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.489 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 13.3 p-80 -39.75 -50.15 2.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.035 0.445 . . . . 0.0 111.364 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.489 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 80.2 m-20 -44.54 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -72.18 -53.19 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 101' ' ' VAL . 3.1 mp -61.15 -48.41 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.22 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.0 -53.7 43.42 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.9 tp -50.62 -50.85 53.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.92 0.39 . . . . 0.0 110.456 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -55.85 -45.27 78.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.318 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.67 -50.77 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 110' ' ' TYR . 22.7 t-20 -50.05 -43.19 50.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.746 0.308 . . . . 0.0 111.055 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -66.98 -41.87 86.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.612 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.0 tp -64.29 -40.42 95.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.607 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 107' ' ' ASN . 66.1 m-85 -140.32 145.28 37.0 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.602 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.628 ' CG ' ' H ' ' A' ' 112' ' ' GLU . 47.7 t-80 -85.62 176.88 7.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.393 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.628 ' H ' ' CG ' ' A' ' 111' ' ' HIS . 66.3 tt0 60.47 62.05 3.28 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.67 153.64 38.82 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.663 2.242 . . . . 0.0 111.927 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.1 t -156.66 43.0 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.483 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.6 mt -72.5 148.08 90.23 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.261 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.98 -173.53 1.71 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.395 2.063 . . . . 0.0 112.335 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.662 ' CD2' HD21 ' A' ' 119' ' ' ASN . 75.8 t60 -89.99 115.72 27.49 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.237 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.2 mt -129.82 130.04 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.582 0.229 . . . . 0.0 111.02 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.662 HD21 ' CD2' ' A' ' 117' ' ' HIS . 11.6 m-20 -132.51 119.42 20.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.42 137.53 13.4 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -128.71 159.49 35.47 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.823 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -107.14 145.84 32.03 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.28 160.46 41.35 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.62 -41.07 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.638 2.225 . . . . 0.0 113.222 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.538 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 31.3 t30 -77.65 46.59 0.56 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.088 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 0.6 OUTLIER 43.29 62.21 1.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.545 0.688 . . . . 0.0 110.837 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -139.25 158.31 44.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.964 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 51.0 mt -139.04 119.19 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.85 122.3 33.45 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.269 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.1 tp -117.76 134.81 54.54 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.997 0.427 . . . . 0.0 110.689 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -120.73 125.16 46.93 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.49 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.469 ' OH ' ' C3A' ' A' ' 182' ' ' HEM . 1.7 t80 -123.78 112.47 17.35 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 m -124.14 125.2 44.06 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.18 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 136' ' ' ARG . 2.1 p 174.62 153.2 0.28 Allowed Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.532 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.86 25.33 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.364 2.043 . . . . 0.0 111.19 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.521 ' NH2' ' OE2' ' A' ' 44' ' ' GLU . 21.2 mmm180 -95.72 106.0 18.06 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.853 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -71.77 15.07 0.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.39 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.5 mm? -84.21 8.21 16.55 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 110.485 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.0 t -42.44 -49.49 5.25 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -47.68 -35.03 8.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.096 0.474 . . . . 0.0 109.895 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.69 -43.55 79.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.936 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.48 -51.19 15.78 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.515 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -59.28 -51.66 69.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.43 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.53 -46.49 37.34 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.9 mt -61.45 -52.1 65.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 111.204 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 45.4 mt -55.53 -56.85 15.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.839 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.563 ' CE2' HD12 ' A' ' 159' ' ' ILE . 22.4 m-85 -50.31 -47.86 55.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.764 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.13 -51.69 57.76 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.5 -54.99 4.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.937 0.398 . . . . 0.0 110.54 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -54.55 -51.42 65.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.631 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -51.09 -46.77 61.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.931 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -50.0 -50.06 48.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.514 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 67.7 t80 -87.81 37.89 0.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.014 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 38.76 55.66 1.95 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.93 0.395 . . . . 0.0 111.081 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -128.83 141.24 51.36 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -114.85 124.04 50.7 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.447 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 8.8 pt -136.89 173.84 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.714 0.769 . . . . 0.0 111.99 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.443 ' NE2' ' OE1' ' A' ' 177' ' ' GLU . 13.0 pt20 -137.02 129.25 29.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.427 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.563 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.5 mt -111.77 120.05 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.297 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -102.2 106.12 16.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.821 0.343 . . . . 0.0 110.754 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.533 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 16.6 p80 -102.08 73.12 1.36 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.385 0.612 . . . . 0.0 111.45 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -77.74 -12.84 60.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.33 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.48 ' HB ' ' H ' ' A' ' 173' ' ' MET . 3.2 m -116.45 104.23 11.23 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.589 ' O ' ' N ' ' A' ' 166' ' ' HIS . 38.0 t -136.63 116.36 13.04 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.576 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.5 ptm -39.94 -15.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.23 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 164' ' ' CYS . 56.0 t-80 -58.53 -30.37 67.04 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.503 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.0 t -81.04 -46.22 15.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.053 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.503 ' N ' HG23 ' A' ' 167' ' ' THR . . . 153.84 12.68 0.07 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.09 149.19 35.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.65 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -85.1 8.85 16.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.088 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -174.71 -173.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 92.3 m -129.18 148.07 51.09 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.182 0.515 . . . . 0.0 111.569 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.48 ' H ' ' HB ' ' A' ' 163' ' ' THR . 7.8 ttm -126.43 111.86 14.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.111 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.27 110.6 21.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.344 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -92.24 127.54 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.775 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.31 150.57 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.075 0.465 . . . . 0.0 110.095 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.443 ' OE1' ' NE2' ' A' ' 158' ' ' GLN . 28.1 mt-10 -145.71 142.59 29.12 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.734 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 17.6 mt -94.05 131.69 39.3 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.192 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -52.55 153.42 3.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.656 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -55.25 -34.41 64.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.599 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 60.5 t0 . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.54 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.469 ' C3A' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.545 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.636 ' NZ ' HMD1 ' A' ' 182' ' ' HEM . 38.2 tptt -138.42 134.23 33.83 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.378 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -158.97 -24.04 0.03 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.558 ' CD1' ' HE ' ' A' ' 80' ' ' ARG . 1.9 tp -42.39 -41.42 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.996 0.427 . . . . 0.0 110.487 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.19 -50.87 76.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -64.23 -29.19 70.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.196 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -62.02 -59.3 5.29 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.26 0.553 . . . . 0.0 110.847 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.98 -26.98 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.165 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.509 HD13 ' CE2' ' A' ' 69' ' ' PHE . 36.9 tp -72.03 -41.17 67.83 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.085 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.44 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.9 mt-10 -57.79 -41.06 81.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.256 -0.977 . . . . 0.0 109.541 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -60.3 -57.95 10.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.653 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.601 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 68.0 mtm -48.43 -43.64 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.35 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.8 -36.28 75.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.854 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 10' ' ' GLU . 47.6 t -62.53 -22.54 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.275 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.82 -34.41 17.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.13 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -84.75 -78.03 0.26 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' HD21 ' A' ' 58' ' ' LEU . 89.9 m -90.61 -17.54 26.74 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.341 0.591 . . . . 0.0 110.57 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.68 178.86 29.54 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.827 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 ttt -72.49 -30.87 64.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.837 -1.181 . . . . 0.0 110.708 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 t -61.5 -41.87 97.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.119 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.18 -38.12 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.417 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 51.1 t-105 -51.73 -45.71 63.73 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.89 -29.05 63.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.339 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -67.27 -50.76 59.21 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.915 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.07 -22.38 36.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.85 0.357 . . . . 0.0 110.413 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.915 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.8 tt -73.91 -66.59 0.69 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.117 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.599 ' N ' HD23 ' A' ' 26' ' ' LEU . 75.9 tt0 -52.44 -21.78 4.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.527 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -81.38 -38.97 25.73 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.45 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 12.8 m-70 -89.11 -62.81 1.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.319 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 26' ' ' LEU . . . -60.64 153.48 62.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.77 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.02 -176.91 2.61 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.737 2.292 . . . . 0.0 111.918 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -69.81 -22.67 63.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.349 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -77.19 6.72 6.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.543 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -46.65 133.83 10.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.048 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.56 163.53 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.177 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -102.28 117.58 35.06 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.326 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.689 HG21 ' HG3' ' A' ' 40' ' ' LYS . 31.1 m -153.29 -160.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.618 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -142.48 9.45 1.82 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.271 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.02 86.94 0.1 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.455 -0.498 . . . . 0.0 112.027 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.689 ' HG3' HG21 ' A' ' 37' ' ' VAL . 17.4 mmtt -134.59 -177.05 4.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.083 0.468 . . . . 0.0 110.232 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.1 m -74.34 18.94 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.911 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 40' ' ' LYS . 4.2 m-85 -62.3 142.4 57.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.035 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.33 128.04 33.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.549 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -67.45 -34.47 77.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.4 p -63.27 -27.54 69.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.479 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -59.04 -37.92 78.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.64 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -44.53 -53.54 6.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.148 0.499 . . . . 0.0 110.713 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -41.1 -40.94 1.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.387 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.2 m -73.24 -31.13 63.93 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 47' ' ' LEU . 25.8 mm -68.48 -55.35 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.714 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.431 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -58.11 -22.41 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.983 178.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.687 ' HG3' HD12 ' A' ' 62' ' ' ILE . 4.5 tt0 -79.65 -43.18 23.29 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.383 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.45 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 33.0 m-20 -58.4 -57.08 14.49 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.675 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 55' ' ' ALA . 7.5 p -56.95 -41.16 76.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.409 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.427 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -56.24 -38.69 71.43 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.309 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -64.51 -32.97 74.84 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -73.44 -37.98 65.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.781 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 17' ' ' CYS . 36.6 mt -84.21 -7.5 59.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.105 0.479 . . . . 0.0 109.844 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 56.27 48.36 17.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.573 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.5 mmm -127.19 149.55 69.88 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.073 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.68 135.56 49.47 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.442 1.428 . . . . 0.0 110.94 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.687 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.6 tt -49.54 -27.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.097 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -73.44 -30.93 63.53 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.086 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -78.05 -31.83 50.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.258 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.416 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 73.5 t -72.03 -56.3 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.532 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -51.63 -43.69 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.32 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.532 ' N ' HG13 ' A' ' 66' ' ' VAL . 34.7 mtpt -52.38 -51.98 56.07 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.76 -55.71 30.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.278 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.509 ' CE2' HD13 ' A' ' 9' ' ' LEU . 7.5 m-30 -44.53 -28.03 0.53 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.375 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.12 -47.46 59.09 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -56.46 -53.45 57.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.042 0.448 . . . . 0.0 110.273 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.601 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 78.7 m-85 -57.23 -42.14 80.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.755 0.788 . . . . 0.0 110.854 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.1 tp -55.25 -37.5 67.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.654 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 28.8 t80 -69.77 -40.7 75.92 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -57.05 -72.96 0.07 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.847 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.87 -40.65 19.52 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.396 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.421 HD21 HG12 ' A' ' 4' ' ' ILE . 23.7 mt -60.02 -41.56 92.44 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.345 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.09 -22.79 11.8 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.926 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.438 ' O ' ' OG1' ' A' ' 82' ' ' THR . 8.7 t -80.45 -52.56 7.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.212 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.558 ' HE ' ' CD1' ' A' ' 4' ' ' ILE . 4.4 mtt-85 -65.97 -52.66 47.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.188 0.518 . . . . 0.0 110.884 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.405 ' CE1' HBC1 ' A' ' 182' ' ' HEM . 43.2 m-70 -93.95 36.47 1.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.567 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 79' ' ' SER . 39.6 m -56.92 -45.3 82.78 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.066 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -50.79 -31.09 15.88 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 t -82.75 -19.59 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.699 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.513 ' C ' ' H ' ' A' ' 87' ' ' LYS . 68.1 t -72.21 -47.05 55.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.569 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 56.1 t0 -52.66 -7.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.808 0.337 . . . . 0.0 110.759 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 85' ' ' VAL . 43.1 mmtm -80.23 -28.9 38.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.071 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.62 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -95.77 118.12 31.83 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.474 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -84.85 -13.45 50.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.169 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 15.3 p-10 -164.67 171.42 14.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.256 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.424 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 68.8 t80 -58.07 -46.74 84.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.872 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.8 m -59.84 -44.78 93.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.443 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.7 t -55.63 -39.84 71.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.248 0.547 . . . . 0.0 110.304 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.419 HD12 ' CD2' ' A' ' 88' ' ' PHE . 3.0 tt -64.71 -45.56 86.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.998 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.57 -38.13 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.421 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.556 ' SD ' HD13 ' A' ' 122' ' ' LEU . 83.7 mtp -83.99 -4.42 58.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.427 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -116.75 -14.97 7.05 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.044 -0.865 . . . . 0.0 113.663 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.669 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.7 mt -26.72 -106.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 117.954 0.877 . . . . 0.0 112.697 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.482 ' CE1' ' O ' ' A' ' 118' ' ' ILE . 8.7 p-80 -41.4 -46.34 3.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.019 0.438 . . . . 0.0 111.271 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -47.46 -87.34 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 102' ' ' ILE . 2.1 m -69.89 -51.38 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.669 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.5 mp -63.28 -47.61 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.699 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.33 -54.06 40.05 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.3 tp -49.47 -48.03 48.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.934 0.397 . . . . 0.0 109.947 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -56.9 -45.82 82.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.035 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' LEU . 76.0 t -54.85 -56.06 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -43.94 -45.43 7.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.125 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -60.08 -36.13 76.71 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.84 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 109' ' ' LEU . 3.7 tt -75.29 -56.21 4.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.965 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -69.0 -80.54 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.424 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.401 ' CG ' ' N ' ' A' ' 112' ' ' GLU . 79.8 t60 -174.45 -98.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.14 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.699 ' H ' ' CD ' ' A' ' 113' ' ' PRO . 13.3 tm-20 -119.81 -32.61 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.699 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 83.8 Cg_exo -47.9 139.93 19.03 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.861 1.707 . . . . 0.0 112.454 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.6 t -103.77 157.12 17.29 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.918 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.8 mp -84.4 157.33 61.94 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.013 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.515 ' O ' HD12 ' A' ' 118' ' ' ILE . 98.1 Cg_exo -42.69 -176.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 122.704 2.269 . . . . 0.0 113.382 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -87.08 122.35 30.79 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.518 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 116' ' ' PRO . 4.0 mp -138.48 133.15 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -138.5 130.01 27.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.712 0.291 . . . . 0.0 111.212 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.58 120.8 4.53 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -117.55 130.34 56.35 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.651 0.262 . . . . 0.0 110.819 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.556 HD13 ' SD ' ' A' ' 96' ' ' MET . 3.9 tp -76.19 150.35 37.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 111.383 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -121.43 160.32 46.5 Favored Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.317 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.45 -36.83 3.61 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.668 2.245 . . . . 0.0 113.309 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -79.96 46.7 0.82 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.144 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.6 m120 43.35 58.39 3.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 0.0 110.443 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -137.11 159.06 43.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.057 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.4 mt -135.4 114.6 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.19 120.09 25.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 61.5 tp -114.92 132.73 56.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.166 0.508 . . . . 0.0 111.298 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.711 ' HE ' ' CE1' ' A' ' 171' ' ' HIS . 64.0 ttt-85 -116.95 120.43 38.4 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.008 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.491 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 72.3 t80 -127.29 124.53 38.99 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.948 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.08 123.6 24.75 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 71.7 m -145.56 148.4 36.77 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.63 -20.29 12.24 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.071 1.847 . . . . 0.0 112.673 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.574 ' NH2' ' CGA' ' A' ' 182' ' ' HEM . 84.5 mtm-85 -79.04 -14.08 59.39 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.922 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 139' ' ' CYS . 52.0 mtp180 64.01 25.2 13.79 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.147 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.484 HD23 ' CB ' ' A' ' 136' ' ' ARG . 2.5 mm? -73.53 18.14 0.13 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 9.2 t -44.83 -49.75 10.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.582 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -45.76 -41.29 10.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.113 0.482 . . . . 0.0 110.2 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 22.8 t -62.34 -41.46 98.59 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.54 -54.18 7.93 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.561 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -56.58 -50.74 71.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.35 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.8 -47.9 45.79 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.37 -54.81 41.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.2 mt -53.4 -55.22 26.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.745 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.548 ' CE2' HD12 ' A' ' 159' ' ' ILE . 14.5 m-85 -51.61 -47.7 63.54 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.897 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.31 -51.99 54.29 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.26 -60.11 2.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.846 0.355 . . . . 0.0 110.916 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -47.84 -50.66 25.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.966 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -52.45 -47.97 66.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.623 0.249 . . . . 0.0 111.237 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -49.38 -49.96 42.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.667 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.25 37.3 0.72 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.968 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 38.76 57.5 1.83 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.976 0.417 . . . . 0.0 111.196 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -131.72 142.98 49.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -118.17 112.31 19.99 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.078 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.424 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 17.8 pt -122.53 173.48 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.513 0.673 . . . . 0.0 111.78 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.463 ' NE2' ' OE2' ' A' ' 177' ' ' GLU . 25.5 mt-30 -137.13 128.74 28.62 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.547 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.548 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.5 mt -112.04 120.97 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.649 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.9 t -105.19 112.19 25.21 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.705 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 53.8 p-80 -101.97 76.7 1.63 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.983 0.897 . . . . 0.0 111.822 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 4.9 p30 -75.89 -27.56 57.77 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.716 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.56 110.44 21.92 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.552 ' O ' HG22 ' A' ' 167' ' ' THR . 6.4 p -113.08 176.33 5.06 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 168' ' ' GLY . 72.5 mtp -91.52 -28.18 17.75 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -53.72 -22.51 9.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.825 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.4 t -88.63 -26.77 21.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.446 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 98.58 21.92 15.51 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.136 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.31 162.68 24.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.04 0.447 . . . . 0.0 110.681 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -45.97 -34.38 3.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.308 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.711 ' CE1' ' HE ' ' A' ' 131' ' ' ARG . 9.0 p-80 -175.49 -167.78 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.2 m -95.18 139.71 31.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.171 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 12.8 tpp -120.7 116.7 25.79 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.1 107.15 12.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.472 0.654 . . . . 0.0 111.047 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -89.95 126.98 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.561 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.8 mp -110.83 151.49 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.189 0.519 . . . . 0.0 110.171 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.463 ' OE2' ' NE2' ' A' ' 158' ' ' GLN . 22.3 pt-20 -147.56 144.0 28.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.933 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 11.7 mt -94.41 134.58 36.78 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.072 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -54.21 154.9 4.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.695 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -55.32 -32.52 62.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.622 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 53.0 p30 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.523 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.636 HMD1 ' NZ ' ' A' ' 2' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 184' ' ' IMD . . . . . 0.429 ' C4 ' ' CD2' ' A' ' 115' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ptt? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' NZ ' ' C ' ' A' ' 34' ' ' ARG . 60.3 mmtt 62.95 54.9 2.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 57.4 125.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 5' ' ' ILE . 3.3 tp -55.03 -44.61 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.623 -0.339 . . . . 0.0 110.853 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' N ' HG23 ' A' ' 4' ' ' ILE . 36.3 mm -64.45 -56.76 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.426 0.631 . . . . 0.0 109.461 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -62.26 -27.7 69.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.658 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 3' ' ' GLY . 25.7 t-20 -62.35 -60.79 3.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.131 0.491 . . . . 0.0 110.939 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -56.96 -27.16 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.115 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.418 HD13 ' CE2' ' A' ' 69' ' ' PHE . 27.9 tp -71.8 -50.5 29.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.463 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.8 mt-10 -49.36 -40.22 34.84 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.562 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -60.48 -49.09 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.695 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.579 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 10.4 tpt -56.87 -42.58 80.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.005 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.79 -34.98 58.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.648 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 10' ' ' GLU . 40.8 t -62.16 -25.0 36.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.216 0.531 . . . . 0.0 110.018 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.93 -34.58 22.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.134 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -85.75 -74.44 0.41 Allowed 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.499 ' SG ' HD21 ' A' ' 58' ' ' LEU . 91.7 m -92.27 -21.66 20.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.166 0.508 . . . . 0.0 110.966 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.51 170.96 24.72 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.865 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.0 ttp -66.5 -28.67 68.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.904 -1.148 . . . . 0.0 110.347 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 t -62.49 -42.24 99.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.208 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.63 -36.27 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.408 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 50.7 t-105 -51.94 -45.86 64.49 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -70.31 -30.6 67.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.986 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -66.05 -50.77 62.99 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.815 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.19 -20.53 37.62 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.844 0.354 . . . . 0.0 110.617 -179.26 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.815 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.3 tt -75.47 -57.64 3.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.345 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.05 -23.16 67.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.675 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -80.45 -40.63 25.93 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -101.67 -87.51 0.4 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.326 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.575 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -49.42 161.46 0.48 Allowed Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.532 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 36.6 Cg_endo -64.49 131.94 31.57 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.546 2.164 . . . . 0.0 111.761 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -70.78 -19.45 62.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.717 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -53.0 -38.32 62.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.483 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.465 ' C ' ' NZ ' ' A' ' 2' ' ' LYS . 81.9 mtp180 44.92 91.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.627 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.8 m -153.12 30.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.624 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -97.47 151.36 20.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.566 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.688 HG23 ' H ' ' A' ' 39' ' ' ALA . 1.4 m -110.83 171.7 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.097 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.1 m -76.87 27.92 0.13 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.715 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.688 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -164.26 40.2 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.339 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.612 ' CG ' HG22 ' A' ' 37' ' ' VAL . 18.9 mmtt -136.4 150.97 49.04 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.161 0.505 . . . . 0.0 110.702 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 40' ' ' LYS . 77.5 p 40.36 -164.81 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.085 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.534 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 10.3 p90 -171.82 61.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.309 0.576 . . . . 0.0 110.482 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.66 40.13 0.05 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.727 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.47 ' H ' ' C ' ' A' ' 42' ' ' TYR . 86.4 tt0 -45.89 -24.64 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.505 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 85.6 p -70.72 -38.68 73.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.882 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -66.37 -33.13 75.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.542 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -48.2 -58.15 4.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.105 0.479 . . . . 0.0 110.634 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -39.01 -41.1 0.74 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.541 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.3 p -74.53 -31.87 62.28 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.971 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 47' ' ' LEU . 17.1 mt -70.26 -53.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.789 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.89 -25.03 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.518 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.657 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.0 tt0 -76.61 -41.28 46.66 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.633 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -59.02 -56.8 17.54 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.744 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.96 -37.53 55.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.016 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.527 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -62.41 -38.09 88.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.276 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -62.4 -32.83 73.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -72.04 -44.53 63.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.554 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.499 HD21 ' SG ' ' A' ' 17' ' ' CYS . 32.3 mt -79.14 -7.37 58.13 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.864 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 57.01 49.85 13.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.678 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.405 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 25.5 mmt -128.55 149.12 70.91 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.182 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.58 138.73 71.86 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.347 1.365 . . . . 0.0 110.967 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.657 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.7 tt -52.38 -29.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.428 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -72.46 -31.53 65.52 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.562 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -78.2 -31.85 49.65 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.944 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 55' ' ' ALA . 82.2 t -70.5 -57.08 8.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -51.58 -43.22 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.34 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.516 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.0 mtpt -53.32 -50.33 65.19 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.14 80.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.644 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.9 m-30 -52.16 -29.49 22.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.298 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.26 -50.35 56.83 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -55.17 -50.71 68.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.023 0.44 . . . . 0.0 110.049 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.579 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 59.4 m-85 -59.67 -41.19 90.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.883 0.849 . . . . 0.0 110.74 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.62 -40.46 83.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.451 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.401 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 41.9 t80 -68.7 -39.87 80.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 110.229 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -55.27 -70.44 0.11 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.377 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.92 -37.62 53.4 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.385 -0.436 . . . . 0.0 112.637 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.521 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 16.5 mt -55.23 -51.06 67.81 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.086 0.443 . . . . 0.0 111.716 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.85 -15.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.805 -0.56 . . . . 0.0 111.36 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 77' ' ' LEU . 9.3 t -83.75 -49.08 9.44 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -59.48 2.73 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.083 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.0 p80 -81.85 30.22 0.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.815 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.8 m -49.53 -40.07 36.71 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -55.65 -30.38 60.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 81' ' ' HIS . 5.1 t -85.89 -22.8 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.534 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.492 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 54.1 t -61.66 -40.48 86.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -49.6 -20.34 0.76 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.873 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -70.15 -5.03 24.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.381 0.61 . . . . 0.0 109.865 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.607 ' CG ' ' N ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER -89.05 -150.26 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.508 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.607 ' N ' ' CG ' ' A' ' 88' ' ' PHE . 1.1 p-10 159.63 -30.25 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -170.23 155.1 5.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.365 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 85.6 t80 -46.08 -57.46 4.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.237 0.541 . . . . 0.0 111.29 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.5 m -50.41 -47.12 56.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.108 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.431 ' CB ' ' OD2' ' A' ' 89' ' ' ASP . 32.6 m -61.42 -37.17 82.52 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.151 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.1 tt -64.3 -45.49 87.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.001 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.52 -36.11 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 121.226 0.536 . . . . 0.0 110.639 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.7 mmm -86.19 -6.79 58.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.53 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -111.42 -13.16 13.52 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.894 -0.392 . . . . 0.0 112.654 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.647 ' HA ' HD13 ' A' ' 102' ' ' ILE . 15.8 mt -33.0 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 117.509 0.655 . . . . 0.0 111.963 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -39.8 -50.27 2.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.213 0.53 . . . . 0.0 111.498 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -48.12 -91.25 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.599 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.7 m -66.71 -51.21 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.647 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.7 mp -61.72 -40.97 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.392 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.16 -57.52 10.45 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.4 tp -49.21 -58.05 5.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.15 0.5 . . . . 0.0 110.491 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -50.6 -45.95 57.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.236 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 102' ' ' ILE . 14.7 t -54.59 -51.41 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 110' ' ' TYR . 48.9 t30 -46.85 -42.91 18.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.792 0.329 . . . . 0.0 110.607 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -62.48 -36.89 83.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.69 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.05 -49.17 15.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.376 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 107' ' ' ASN . 57.7 m-85 -123.62 151.43 43.02 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.471 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 112' ' ' GLU . 76.1 m80 -92.93 160.17 15.01 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.735 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 111' ' ' HIS . 8.2 pt-20 32.39 61.38 1.38 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.811 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.23 -20.77 18.45 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.508 2.139 . . . . 0.0 111.93 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.6 m 43.87 69.42 0.41 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.806 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.5 mt -79.05 152.98 77.27 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.074 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.1 169.73 18.66 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.374 2.05 . . . . 0.0 111.905 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -78.23 100.99 6.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.526 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 31.7 mm -117.25 124.14 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.373 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -132.89 120.02 20.95 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.735 0.302 . . . . 0.0 110.857 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.8 119.21 5.17 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -117.78 125.65 50.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 tp -72.21 140.04 48.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.886 0.374 . . . . 0.0 110.825 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.29 161.01 41.18 Favored Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.6 178.63 6.48 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.312 2.008 . . . . 0.0 111.992 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.527 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 95.7 m-20 55.23 36.01 26.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.347 0.594 . . . . 0.0 109.832 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.527 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 47.5 m-20 54.35 56.51 6.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.794 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 125' ' ' ASN . 3.8 mp0 -125.98 156.43 39.85 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.1 mt -139.39 115.32 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.87 122.82 31.27 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.844 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 47.8 tp -117.78 132.7 56.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 111.279 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -112.87 120.24 40.76 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.602 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.494 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 30.6 t80 -122.71 120.2 32.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.621 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.45 124.93 23.49 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.0 t -156.06 142.57 13.28 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.41 -7.42 20.35 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.871 1.714 . . . . 0.0 112.208 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.51 ' N ' ' CD ' ' A' ' 136' ' ' ARG . 0.8 OUTLIER -80.91 -14.37 58.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.035 0.445 . . . . 0.0 109.985 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 56.28 30.35 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.619 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.57 16.49 1.71 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.011 0.434 . . . . 0.0 109.995 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 26.4 p -43.57 -49.13 7.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.586 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.465 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 80.8 m-85 -45.64 -41.89 10.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.973 0.416 . . . . 0.0 110.409 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 48.5 t -64.09 -42.23 96.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.774 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.55 -52.5 10.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.579 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -59.19 -51.85 68.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.613 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.35 -46.99 35.74 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.3 -54.18 48.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.641 0.258 . . . . 0.0 111.638 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 31.2 mt -54.51 -56.13 21.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.026 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.566 ' CE2' HD12 ' A' ' 159' ' ' ILE . 23.4 m-85 -50.59 -47.26 58.14 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.743 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.64 -51.7 57.33 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.14 -59.95 2.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.684 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.0 -52.29 44.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.76 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -50.41 -47.26 56.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.908 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -49.57 -49.38 46.71 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.712 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -88.24 37.97 0.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.851 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 39.11 55.02 2.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 111.16 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -127.91 140.11 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -112.39 124.1 51.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.998 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.446 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 9.6 pt -137.41 169.41 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.694 0.759 . . . . 0.0 111.9 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -132.99 127.32 33.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.296 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.566 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.9 mt -110.54 117.01 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 6.0 t -98.32 100.58 11.87 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.981 0.419 . . . . 0.0 110.16 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -96.43 71.22 2.71 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.209 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -78.1 -51.9 9.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.246 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.72 123.27 22.96 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.715 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.542 ' O ' HG22 ' A' ' 167' ' ' THR . 61.1 m -125.97 176.5 6.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.948 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 168' ' ' GLY . 1.0 OUTLIER -93.12 -30.18 15.39 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.007 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.472 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 3.5 p80 -51.18 -21.13 1.83 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.732 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.6 t -90.38 -28.24 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.763 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 101.7 20.05 14.06 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.59 169.56 9.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 110.733 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -52.33 -35.07 49.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.304 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -177.39 -165.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.0 OUTLIER -94.85 140.25 30.18 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.4 tpt -119.17 120.87 38.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 109.909 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mt -122.58 103.62 8.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.982 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -88.19 127.81 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.355 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mp -111.24 149.84 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.298 0.57 . . . . 0.0 110.775 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.72 134.77 37.52 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.951 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.1 mt -94.58 145.76 24.6 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.945 0.403 . . . . 0.0 110.686 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -139.69 -179.4 5.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.97 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 181' ' ' ASP . 78.9 m-20 -148.57 25.42 0.96 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.792 0.33 . . . . 0.0 110.469 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 180' ' ' ASN . 69.0 m-20 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.549 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.441 HMC3 ' CE1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 40' ' ' LYS . 68.1 mttm -68.78 124.95 25.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.489 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 4' ' ' ILE . . . -172.47 167.32 40.21 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 3' ' ' GLY . 0.3 OUTLIER 92.45 -27.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.921 0.889 . . . . 0.0 108.981 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.23 -62.1 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.852 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -58.71 -29.51 66.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.702 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -61.73 -60.86 3.03 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.211 0.529 . . . . 0.0 111.48 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.4 -27.39 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.431 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 tp -70.87 -42.4 70.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.351 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.525 ' OE2' ' CE2' ' A' ' 36' ' ' TYR . 4.1 mt-10 -56.6 -39.64 73.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.497 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -60.97 -52.61 64.28 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.166 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 14.4 tpt -53.18 -41.39 65.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.983 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.06 -34.66 55.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.74 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 10' ' ' GLU . 41.6 t -63.13 -22.28 30.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 0.0 110.068 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.17 -34.5 19.01 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.259 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -85.77 -76.94 0.31 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.544 ' SG ' HD21 ' A' ' 58' ' ' LEU . 72.0 m -89.77 -19.11 25.12 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.385 0.612 . . . . 0.0 110.627 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.02 175.14 29.13 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.7 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.5 ttt -69.91 -26.96 64.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.888 -1.156 . . . . 0.0 110.67 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.6 m -64.34 -42.95 95.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.045 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -35.89 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.41 ' O ' HD13 ' A' ' 25' ' ' LEU . 51.0 t-105 -51.21 -46.04 62.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -69.68 -31.74 69.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.083 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -65.24 -51.39 61.21 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.8 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.21 -20.17 41.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.93 0.395 . . . . 0.0 110.69 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.8 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.1 tt -76.27 -47.75 22.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.381 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -70.57 -24.41 62.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.67 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -80.35 -40.14 27.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.51 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 73.9 m80 -96.99 -85.45 0.35 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.305 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.547 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -49.67 161.27 0.53 Allowed Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.529 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 37.6 Cg_endo -64.38 152.09 82.88 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.624 2.216 . . . . 0.0 112.196 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' O ' ' NH1' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -81.75 -10.97 59.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.194 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.49 -36.05 68.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.367 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 32' ' ' LYS . 88.0 mtm-85 52.46 72.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.619 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.5 t -146.31 69.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.087 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.525 ' CE2' ' OE2' ' A' ' 10' ' ' GLU . 52.3 p90 -127.64 155.0 44.59 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.621 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.603 HG23 ' H ' ' A' ' 39' ' ' ALA . 1.4 m -140.23 175.78 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.991 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -84.48 33.73 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.776 0.322 . . . . 0.0 110.788 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.603 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -171.35 52.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.848 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.577 ' CG ' HG22 ' A' ' 37' ' ' VAL . 20.0 mmtt -139.49 173.82 11.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.077 0.465 . . . . 0.0 110.62 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 42' ' ' TYR . 77.3 p -50.65 -105.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.223 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 41' ' ' SER . 74.8 m-85 56.43 116.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.05 141.86 52.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.788 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.518 ' OE1' ' NH2' ' A' ' 136' ' ' ARG . 23.0 pt-20 -73.79 -23.31 59.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.778 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p -60.29 -29.41 68.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.054 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -59.7 -36.63 76.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.727 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -51.12 -56.94 10.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.028 0.442 . . . . 0.0 110.794 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -39.61 -43.34 1.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.659 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 m -72.25 -30.58 65.01 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.082 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 47' ' ' LEU . 13.3 mt -72.36 -54.84 15.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.156 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -55.65 -24.09 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.727 178.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.653 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.4 tt0 -77.51 -40.56 42.42 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.477 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.51 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 55.2 m-20 -59.42 -56.2 25.02 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.92 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 p -57.56 -37.68 59.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.917 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.18 -38.92 88.23 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.2 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -62.79 -32.31 73.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -72.35 -43.63 63.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.544 HD21 ' SG ' ' A' ' 17' ' ' CYS . 27.6 mt -80.71 -8.13 59.56 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.839 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 57.96 51.49 8.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.628 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.429 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 22.3 mmt -130.8 149.39 73.51 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.392 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.79 139.42 80.17 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.461 1.441 . . . . 0.0 111.096 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.653 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.3 tt -54.66 -28.81 19.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.851 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -73.91 -29.99 62.34 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.438 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -79.1 -35.61 42.0 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.745 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' A' ' 55' ' ' ALA . 79.4 t -63.65 -59.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -49.1 -38.89 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.611 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.454 ' N ' HG13 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -54.28 -45.57 72.53 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.82 -55.82 17.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.296 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -44.78 -29.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.976 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.88 -59.38 8.68 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -49.49 -48.24 48.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.922 0.391 . . . . 0.0 110.127 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 52.1 m-85 -60.15 -39.85 87.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.704 0.764 . . . . 0.0 110.687 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.1 tp -59.61 -38.27 80.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.815 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 30.6 t80 -69.54 -39.02 77.73 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.159 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.429 ' OD1' ' NE2' ' A' ' 152' ' ' HIS . 16.7 m-80 -55.89 -70.55 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.69 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.81 -47.87 30.62 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.474 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.436 HD21 HG21 ' A' ' 4' ' ' ILE . 51.6 mt -50.64 -44.22 57.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.041 0.421 . . . . 0.0 111.765 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -55.78 -26.01 43.9 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.405 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.0 t -74.89 -55.1 6.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.05 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -73.37 -36.67 66.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.797 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -97.17 25.25 5.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.777 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 31.5 m -52.51 -38.1 58.91 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -58.62 -34.13 70.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.868 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 105' ' ' GLU . 2.9 t -81.6 -19.65 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.669 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.459 ' C ' ' N ' ' A' ' 87' ' ' LYS . 38.6 t -71.5 -43.6 71.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.949 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -51.5 -12.7 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.069 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' N ' ' C ' ' A' ' 85' ' ' VAL . 41.9 mmtm -69.09 -29.46 67.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.822 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 18.8 p90 -120.49 122.53 40.84 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.136 0.493 . . . . 0.0 111.328 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -87.29 -0.76 57.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.514 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 153' ' ' PHE . 45.7 t0 -162.31 165.58 26.41 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.583 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.4 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 72.8 t80 -57.04 -42.2 80.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.219 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.0 m -63.24 -59.34 4.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.46 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.1 m -46.81 -37.39 8.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.253 0.549 . . . . 0.0 110.649 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.545 HD12 ' CD2' ' A' ' 88' ' ' PHE . 4.4 tt -64.25 -44.36 92.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.431 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.4 t -66.77 -39.37 83.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.405 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 6.9 ptm -86.9 -1.43 57.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -113.43 -16.23 8.36 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.746 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.566 ' HA ' HD13 ' A' ' 102' ' ' ILE . 9.4 mt -34.26 -82.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 117.809 0.804 . . . . 0.0 111.712 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -45.17 -53.5 8.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.146 0.498 . . . . 0.0 110.915 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -46.99 -89.19 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.616 HG23 HD12 ' A' ' 102' ' ' ILE . 3.8 m -70.04 -49.84 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.616 HD12 HG23 ' A' ' 101' ' ' VAL . 3.8 mp -67.29 -39.5 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.586 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.47 -57.62 11.03 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.4 tp -47.68 -54.67 11.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.136 0.493 . . . . 0.0 110.185 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.423 ' HG2' HG22 ' A' ' 84' ' ' VAL . 34.5 tp10 -52.59 -46.52 66.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.775 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.509 ' CG1' ' CE1' ' A' ' 111' ' ' HIS . 24.7 t -52.66 -54.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -45.09 -43.46 9.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.749 0.309 . . . . 0.0 110.666 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.512 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 63.5 mmtt -58.36 -36.31 73.28 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 106' ' ' VAL . 53.7 mt -71.21 -19.58 62.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.988 0.423 . . . . 0.0 109.892 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.512 ' CD2' ' O ' ' A' ' 108' ' ' LYS . 69.8 m-85 58.17 116.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.049 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.632 ' ND1' ' N ' ' A' ' 112' ' ' GLU . 1.2 p-80 -166.28 -37.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.272 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.632 ' N ' ' ND1' ' A' ' 111' ' ' HIS . 40.7 tt0 -173.39 73.56 0.38 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.049 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -46.07 162.91 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.914 2.41 . . . . 0.0 112.54 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.2 m 65.66 79.24 0.25 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.874 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 116' ' ' PRO . 17.5 mt -79.24 144.25 62.11 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.038 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 115' ' ' LEU . 92.9 Cg_exo -43.12 175.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.135 1.89 . . . . 0.0 112.666 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -80.98 118.07 22.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.439 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.28 129.74 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -136.66 121.32 18.46 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.939 0.399 . . . . 0.0 111.726 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.35 123.48 5.73 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' A' ' 122' ' ' LEU . 37.9 tt0 -115.73 160.92 19.45 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.823 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -107.89 145.57 33.56 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.45 160.48 41.64 Favored Pre-proline 0 N--CA 1.468 0.461 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -72.8 -44.57 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.578 2.185 . . . . 0.0 113.247 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.542 HD21 ' CD ' ' A' ' 127' ' ' GLN . 47.7 p-10 -74.58 45.46 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.184 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.3 m120 44.99 60.72 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 0.0 111.102 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.542 ' CD ' HD21 ' A' ' 125' ' ' ASN . 78.6 mt-30 -136.72 158.83 43.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.913 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.6 mt -138.85 118.56 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.16 122.5 33.85 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.389 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.3 tp -115.42 136.24 53.29 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.111 0.481 . . . . 0.0 110.726 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -122.58 123.17 40.58 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.409 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -125.75 115.01 19.39 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.257 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.74 122.15 36.65 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 136' ' ' ARG . 1.9 p -174.91 151.17 1.38 Allowed Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.367 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.7 20.5 0.38 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.027 1.818 . . . . 0.0 110.878 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.526 ' C ' ' H ' ' A' ' 138' ' ' LEU . 65.5 mtp85 -93.04 105.07 17.22 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.341 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -68.78 16.32 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.054 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.614 ' N ' HD22 ' A' ' 138' ' ' LEU . 2.9 mm? -82.86 15.12 2.84 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.651 0.262 . . . . 0.0 110.395 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 93.6 m -41.41 -54.75 3.0 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 111.58 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -47.96 -30.26 4.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.935 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 138' ' ' LEU . 5.3 t -71.11 -44.59 65.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.772 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.66 -47.28 15.0 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.407 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -64.59 -48.86 73.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.349 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.74 -49.12 35.26 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 31.2 mt -59.16 -53.93 52.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.602 0.239 . . . . 0.0 111.507 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 31.3 mt -54.62 -55.66 27.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.947 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.585 ' CE2' HD12 ' A' ' 159' ' ' ILE . 19.6 m-85 -51.43 -47.78 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.862 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.01 -52.0 54.95 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.08 -59.83 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.926 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.85 -49.9 47.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -52.03 -50.1 62.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.565 0.221 . . . . 0.0 111.323 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.429 ' NE2' ' OD1' ' A' ' 75' ' ' ASN . 43.4 m80 -48.87 -49.35 40.02 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.826 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.526 ' CE2' ' OD1' ' A' ' 90' ' ' ASP . 64.7 t80 -85.43 35.68 0.61 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.949 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 39.22 55.17 2.21 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.056 0.455 . . . . 0.0 110.983 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -130.5 141.79 50.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -113.84 123.25 49.36 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.844 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.4 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 28.9 pt -133.3 172.45 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.65 0.738 . . . . 0.0 112.347 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -136.58 126.77 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.566 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.585 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.1 mt -111.51 120.35 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.685 0.278 . . . . 0.0 110.61 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.6 t -105.38 112.36 25.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.821 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.559 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 18.5 p80 -101.0 74.79 1.63 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.651 0.739 . . . . 0.0 111.503 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -76.21 -29.3 57.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.805 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.04 109.13 20.93 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.529 ' O ' HG22 ' A' ' 167' ' ' THR . 13.4 t -111.88 177.0 4.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.84 0.353 . . . . 0.0 110.417 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.44 ' N ' ' SG ' ' A' ' 164' ' ' CYS . 81.1 mtp -91.37 -28.26 17.82 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -53.62 -22.8 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.957 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.4 t -88.76 -28.15 20.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.466 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.59 20.35 15.22 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.099 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.03 163.14 17.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.722 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -49.44 -34.31 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.344 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 171' ' ' HIS . 8.0 p80 -172.25 -170.84 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.2 m -93.65 140.4 29.68 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 tpt -122.87 114.67 20.79 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -119.05 105.59 11.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.826 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.53 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -88.17 125.77 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.344 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.17 149.35 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.258 0.552 . . . . 0.0 110.385 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.499 ' OE2' ' N ' ' A' ' 178' ' ' LEU . 9.3 tp10 -136.47 135.47 38.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.993 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.499 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 13.0 mt -96.14 150.44 20.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.77 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -140.11 175.54 9.51 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.041 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 56.05 44.51 25.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 62.1 t0 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.534 -179.984 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.62 ' H2 ' ' NE ' ' A' ' 34' ' ' ARG . 15.8 mmt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.69 ' H ' ' CD ' ' A' ' 34' ' ' ARG . 78.9 mttt 58.94 149.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.469 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.07 172.09 29.03 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.42 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.441 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.9 tp -78.65 -37.67 21.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.81 0.338 . . . . 0.0 110.39 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.4 mm -60.77 -45.24 98.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.612 ' CE1' ' NH2' ' A' ' 34' ' ' ARG . 91.0 m-85 -70.99 -26.39 63.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.211 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -67.61 -53.23 29.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.016 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.35 -31.83 55.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.072 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.506 HD13 ' CE2' ' A' ' 69' ' ' PHE . 31.3 tp -71.86 -42.03 67.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.694 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.2 tt0 -54.28 -43.92 71.46 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.566 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -61.02 -51.14 70.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.326 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.615 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 58.2 mtm -54.01 -43.26 69.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.79 -36.43 75.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.666 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 10' ' ' GLU . 47.3 t -61.7 -25.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.265 0.555 . . . . 0.0 110.143 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.97 -34.45 22.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.199 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -84.33 -75.56 0.34 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.454 ' SG ' HD21 ' A' ' 58' ' ' LEU . 94.8 m -92.78 -22.88 19.08 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.199 0.524 . . . . 0.0 110.935 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.8 171.23 22.63 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.806 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 30.3 ttm -66.91 -27.45 67.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.707 -1.246 . . . . 0.0 110.292 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -63.25 -42.85 99.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.221 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.82 -35.56 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.418 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 51.1 t-105 -53.42 -44.74 69.03 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.98 -28.13 64.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.09 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -66.27 -51.17 60.1 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -83.47 -18.88 37.06 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.705 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 25' ' ' LEU . 9.0 tt -78.1 -70.66 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.581 ' N ' HD23 ' A' ' 26' ' ' LEU . 87.0 tt0 -49.58 -22.31 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.995 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 tttp -80.94 -37.27 29.75 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 26' ' ' LEU . 21.8 m80 -97.72 -81.79 0.43 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.893 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -81.96 154.05 69.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.79 150.93 74.35 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.193 1.929 . . . . 0.0 111.556 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -59.44 -29.0 67.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.837 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.96 -9.41 55.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.679 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.69 ' CD ' ' H ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -73.45 69.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.448 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.537 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 4.3 p -174.53 85.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.44 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 57.2 m-85 -160.24 -114.96 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.404 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.455 HG21 ' HG2' ' A' ' 40' ' ' LYS . 19.2 m -47.19 179.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 111.603 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 m -154.04 47.91 0.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.412 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.51 -4.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.599 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.455 ' HG2' HG21 ' A' ' 37' ' ' VAL . 6.6 mmpt? -77.38 -167.58 0.95 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.532 0.682 . . . . 0.0 110.675 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.8 p -90.15 152.26 21.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.6 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 2' ' ' LYS . 14.0 p90 -175.7 151.22 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.836 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 46' ' ' GLU . . . -92.43 123.67 35.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.336 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 136' ' ' ARG . 95.4 mt-10 -75.61 -10.4 59.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.508 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.4 m -55.57 -40.46 72.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.75 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 43' ' ' ALA . 39.3 mp0 -63.58 -30.64 71.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.634 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.43 -57.21 7.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 110.559 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.406 ' CZ ' HD12 ' A' ' 138' ' ' LEU . 78.9 m-85 -38.36 -43.81 0.85 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.122 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 m -74.32 -30.13 61.92 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.092 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.7 mt -72.96 -51.76 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.152 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -58.05 -26.0 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.816 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.659 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.5 tt0 -77.18 -41.36 41.86 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.682 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -58.77 -56.35 23.39 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.725 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.486 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 7.2 p -57.67 -34.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.066 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.54 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -67.44 -35.45 79.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.73 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -60.21 -47.76 84.59 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.21 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.721 HH22 HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -69.09 -39.79 78.8 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.663 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.454 HD21 ' SG ' ' A' ' 17' ' ' CYS . 84.6 mt -70.59 -10.8 60.18 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.091 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.5 t30 56.87 50.12 12.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.28 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.405 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 55.8 mmm -128.74 148.58 69.15 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.32 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.48 138.04 63.16 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.462 1.441 . . . . 0.0 111.028 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.659 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.8 tt -52.09 -29.3 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.291 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -72.35 -34.38 67.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.148 0.499 . . . . 0.0 111.482 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -75.61 -32.46 60.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.068 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.54 HG21 ' HB2' ' A' ' 55' ' ' ALA . 93.1 t -71.1 -56.31 11.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -53.01 -44.23 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.348 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' N ' HG13 ' A' ' 66' ' ' VAL . 36.0 mtpt -51.7 -50.44 60.49 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.27 -52.11 66.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.529 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.506 ' CE2' HD13 ' A' ' 9' ' ' LEU . 7.3 m-30 -46.91 -28.07 1.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.373 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.84 -48.21 42.92 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -55.05 -52.22 63.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.888 0.375 . . . . 0.0 110.635 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.615 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 57.7 m-85 -59.79 -42.17 92.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.695 0.76 . . . . 0.0 110.842 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.9 tp -53.36 -38.15 63.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.621 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 22.6 t80 -70.94 -42.45 69.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.233 0.539 . . . . 0.0 109.746 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -54.34 -72.83 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.653 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.06 -47.6 20.1 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.298 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.4 mt -50.71 -42.0 56.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.99 0.395 . . . . 0.0 112.013 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -54.95 -25.43 29.47 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.362 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.4 t -74.03 -55.94 5.52 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.928 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.684 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -71.24 -42.44 68.86 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.05 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -92.92 28.54 2.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.077 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 42.8 m -54.81 -38.45 67.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.015 0.436 . . . . 0.0 109.992 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.64 -34.78 73.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.235 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.23 -20.9 12.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.8 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 87' ' ' LYS . 38.9 t -69.9 -40.93 79.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.139 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -53.03 -14.0 0.53 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.408 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.408 ' N ' ' C ' ' A' ' 85' ' ' VAL . 21.6 mmtp -68.69 -29.6 68.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.034 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 15.8 p90 -119.75 121.27 38.79 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.171 0.51 . . . . 0.0 111.235 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -86.71 2.4 48.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.167 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 45.0 t0 -167.2 162.46 15.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.183 0.516 . . . . 0.0 111.522 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.45 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 80.0 t80 -51.49 -49.88 60.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.953 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.6 m -55.11 -58.34 8.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.519 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.5 t -46.73 -40.69 13.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.126 0.488 . . . . 0.0 111.217 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.443 HD12 ' CD2' ' A' ' 88' ' ' PHE . 5.0 tt -63.56 -43.92 95.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.396 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.6 t -64.3 -39.1 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.396 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 8.9 ptm -87.99 -1.09 57.78 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -114.08 -17.46 7.27 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 119.398 -0.668 . . . . 0.0 112.843 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.518 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.1 mt -28.12 -104.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 117.735 0.768 . . . . 0.0 112.494 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -39.6 -49.12 2.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.039 0.447 . . . . 0.0 111.341 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -45.08 -86.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.567 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -72.44 -52.61 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.567 ' N ' HG23 ' A' ' 101' ' ' VAL . 3.0 mp -62.23 -47.99 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.38 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.34 -53.08 48.74 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.4 tp -49.32 -50.86 37.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -55.46 -44.88 76.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.134 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.95 -53.7 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 110' ' ' TYR . 6.0 t-20 -45.65 -44.56 13.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.666 0.27 . . . . 0.0 110.958 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -62.02 -36.12 80.61 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.399 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.496 ' O ' HD23 ' A' ' 109' ' ' LEU . 3.4 tt -65.79 -52.98 46.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.451 ' CG ' ' N ' ' A' ' 111' ' ' HIS . 17.6 t80 -98.68 -165.55 1.25 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.394 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.531 ' CG ' ' N ' ' A' ' 112' ' ' GLU . 41.3 t-80 -61.1 -108.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.432 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.531 ' N ' ' CG ' ' A' ' 111' ' ' HIS . 33.0 mt-10 -150.91 62.88 5.44 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.708 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -83.85 148.79 12.34 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.951 2.434 . . . . 0.0 112.189 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.8 t -87.87 120.14 28.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.052 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 116' ' ' PRO . 14.7 mt -81.56 152.62 70.11 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.653 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 115' ' ' LEU . 80.2 Cg_exo -41.72 170.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.273 1.982 . . . . 0.0 112.272 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -88.06 110.55 20.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.131 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.8 mt -124.07 126.82 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.586 0.231 . . . . 0.0 111.108 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -130.98 117.25 18.94 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.534 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.3 151.16 18.43 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.408 ' C ' HD22 ' A' ' 122' ' ' LEU . 91.7 mt-30 -140.77 161.02 38.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 110.125 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.791 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.2 mm? -109.29 143.37 38.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.847 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.07 160.58 40.43 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.32 -46.09 0.39 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.623 2.215 . . . . 0.0 113.25 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.573 ' ND2' ' OE1' ' A' ' 127' ' ' GLN . 32.2 p30 -72.95 45.19 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.204 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 44.65 63.38 1.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.424 0.631 . . . . 0.0 111.023 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.573 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 77.3 mt-30 -139.52 158.57 43.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.912 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.6 mt -138.5 117.59 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.68 122.3 31.97 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.655 -0.418 . . . . 0.0 109.988 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.3 tp -119.26 133.35 55.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.052 0.453 . . . . 0.0 111.456 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -116.94 122.56 44.62 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.415 ' OH ' ' C3A' ' A' ' 182' ' ' HEM . 40.6 t80 -127.94 126.35 41.29 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.558 0.218 . . . . 0.0 111.329 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.05 120.24 22.11 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 m -132.57 153.08 81.01 Favored Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.628 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.48 -37.49 2.39 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.324 2.016 . . . . 0.0 112.235 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.566 ' NH2' ' CGA' ' A' ' 182' ' ' HEM . 93.9 mtm-85 -74.54 -13.18 60.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.151 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.524 ' C ' ' H ' ' A' ' 139' ' ' CYS . 52.1 mtt-85 63.53 29.01 15.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.406 HD12 ' CZ ' ' A' ' 48' ' ' PHE . 3.1 tp -73.94 24.58 0.08 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.234 0.54 . . . . 0.0 110.209 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.524 ' H ' ' C ' ' A' ' 137' ' ' ARG . 3.5 m -44.5 -49.25 10.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.69 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -44.23 -42.29 6.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.937 0.399 . . . . 0.0 110.58 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.3 t -63.76 -42.02 97.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.191 0.519 . . . . 0.0 109.61 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.6 -52.48 10.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.666 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -58.99 -50.98 72.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.471 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.24 -44.97 34.94 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.8 mt -62.78 -52.52 62.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.659 0.266 . . . . 0.0 111.48 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.9 mt -55.45 -57.09 13.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.854 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.57 ' CE2' HD12 ' A' ' 159' ' ' ILE . 26.6 m-85 -50.75 -47.78 59.33 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.767 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.06 -51.33 58.98 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.05 -59.75 2.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.867 0.365 . . . . 0.0 110.749 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -50.45 -52.02 41.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -50.77 -47.29 59.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.667 0.27 . . . . 0.0 111.015 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -49.48 -49.71 44.46 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.516 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 69.4 t80 -88.31 38.49 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.891 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 38.26 56.58 1.72 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 111.253 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -129.74 141.12 50.94 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -113.07 124.94 53.77 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.89 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.45 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 9.0 pt -137.96 171.86 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.633 0.73 . . . . 0.0 111.853 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -135.56 127.35 29.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.406 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.57 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.8 mt -110.53 118.38 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.0 t -100.98 105.48 16.7 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.479 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.548 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 18.2 p80 -102.58 75.67 1.46 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.553 0.692 . . . . 0.0 111.951 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -76.57 -29.14 56.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.456 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.7 103.94 15.65 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.586 ' O ' ' N ' ' A' ' 166' ' ' HIS . 38.7 t -132.45 112.71 12.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.662 0.267 . . . . 0.0 110.803 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 8.0 tpt -37.65 -18.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.102 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.586 ' N ' ' O ' ' A' ' 164' ' ' CYS . 57.4 t-80 -54.66 -25.93 30.05 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.487 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.0 t -86.37 -44.42 12.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.096 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 167' ' ' THR . . . 146.55 15.42 0.16 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.303 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.499 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -71.18 157.63 37.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.628 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -74.67 -5.09 41.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.612 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -176.08 -149.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.467 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 3.4 m -131.77 146.26 52.05 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.197 0.522 . . . . 0.0 111.59 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 10.6 tpp -119.56 124.11 45.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.277 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -126.95 105.32 8.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.411 0.624 . . . . 0.0 111.379 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -92.46 127.06 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.403 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 177' ' ' GLU . 5.1 mp -110.32 151.64 12.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.29 0.567 . . . . 0.0 110.902 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.413 ' N ' HG22 ' A' ' 176' ' ' ILE . 52.0 mt-10 -139.45 137.24 35.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.294 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.2 mt -90.6 142.5 27.68 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.351 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -156.07 82.36 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.35 0.595 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -56.12 -33.43 65.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.478 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 58.0 t0 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.617 -179.998 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.566 ' CGA' ' NH2' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.9 ttm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.524 ' O ' ' CE1' ' A' ' 42' ' ' TYR . 12.8 ptpt -170.2 108.43 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.539 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . -73.56 19.54 1.48 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.553 HD13 ' NE ' ' A' ' 80' ' ' ARG . 2.5 tp -48.66 -43.3 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.025 0.44 . . . . 0.0 109.857 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 mm -58.56 -47.88 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -73.77 -21.72 60.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 3' ' ' GLY . 42.5 t-20 -66.98 -50.42 62.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.762 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.02 -39.68 81.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.197 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.7 tp -63.49 -40.73 97.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -55.62 -46.43 77.36 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.639 -0.424 . . . . 0.0 109.892 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -61.19 -50.72 71.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.997 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.7 OUTLIER -52.49 -40.57 62.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.6 t -71.4 -34.74 54.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.551 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.9 t -61.62 -23.66 31.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.253 0.549 . . . . 0.0 109.95 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.82 -34.47 21.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.098 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -84.31 -75.74 0.33 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 58' ' ' LEU . 95.5 m -92.49 -20.82 20.58 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.189 0.518 . . . . 0.0 110.964 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.87 170.84 25.36 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.821 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.3 ttt -66.84 -27.09 67.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.926 -1.137 . . . . 0.0 110.444 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -63.7 -42.53 97.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.052 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.21 -35.07 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 -51.83 -45.29 63.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -73.95 -28.86 61.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.329 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -67.54 -50.3 59.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.939 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.33 -26.57 35.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.69 0.281 . . . . 0.0 110.553 -179.305 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.939 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.7 tt -70.08 -71.8 0.22 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.439 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.74 ' N ' HD23 ' A' ' 26' ' ' LEU . 82.4 tt0 -50.51 -23.34 2.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.543 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.38 -42.99 21.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -105.82 -88.9 0.44 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.96 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.597 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -43.63 161.99 0.19 Allowed Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.464 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 90.7 Cg_exo -35.02 156.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.918 2.412 . . . . 0.0 112.286 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 10.4 ptmm? -64.5 -48.34 75.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.722 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 32' ' ' LYS . 56.9 m-20 -162.34 19.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.743 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -75.95 -36.86 59.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.74 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.527 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 12.6 p -82.3 129.82 36.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.757 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.527 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 9.1 m-85 -173.4 -172.83 0.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.06 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.713 HG23 ' H ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER 33.08 -160.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.962 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.6 ' N ' HG23 ' A' ' 37' ' ' VAL . 2.0 m -128.0 37.33 4.19 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.009 0.433 . . . . 0.0 110.566 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.713 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -154.8 7.26 0.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.736 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.468 ' HG3' HG22 ' A' ' 37' ' ' VAL . 11.5 mmtt -93.67 172.71 8.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.807 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.8 t -78.97 147.44 32.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.655 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.532 ' CE2' ' OE2' ' A' ' 44' ' ' GLU . 6.1 p90 -161.69 158.5 26.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.053 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.84 132.87 36.13 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.549 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.532 ' OE2' ' CE2' ' A' ' 42' ' ' TYR . 17.1 mm-40 -82.3 -34.09 28.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.863 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.1 t -79.36 -36.31 39.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.504 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -56.62 -36.91 70.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.138 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -40.84 -56.4 2.22 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.895 0.379 . . . . 0.0 111.056 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -39.43 -40.41 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.18 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.2 t -72.15 -34.57 68.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.225 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.9 mp -67.78 -54.9 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.28 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.407 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -55.52 -23.95 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.784 178.703 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.691 ' HG3' HD12 ' A' ' 62' ' ' ILE . 1.8 tt0 -76.05 -40.2 53.87 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.097 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.558 ' OD2' HD23 ' A' ' 25' ' ' LEU . 47.7 m-20 -60.26 -56.86 16.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.408 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.82 -36.76 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.87 87.5 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.174 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -63.52 -31.0 72.03 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.62 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -73.96 -42.94 59.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.619 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 ' SG ' ' A' ' 17' ' ' CYS . 25.9 mt -80.7 -7.11 59.23 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.879 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 56.22 49.23 15.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.556 0.693 . . . . 0.0 109.207 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mmt -127.73 149.75 71.32 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.967 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.99 137.73 63.87 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.451 1.434 . . . . 0.0 110.978 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.691 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.1 tt -51.28 -29.48 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.776 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -71.24 -30.13 65.96 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.143 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -78.41 -34.03 48.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.112 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.1 t -70.04 -56.41 11.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 67' ' ' LYS . 11.7 p -52.93 -41.39 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.248 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.512 ' N ' HG13 ' A' ' 66' ' ' VAL . 30.9 mtpt -53.25 -49.28 67.18 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.52 91.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.656 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -53.12 -33.07 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.566 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.05 -50.48 60.31 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.98 -50.31 66.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.064 0.459 . . . . 0.0 110.222 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -59.81 -42.58 93.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.632 0.729 . . . . 0.0 110.781 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.4 tp -56.37 -38.93 72.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.314 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 20.1 t80 -68.37 -43.77 76.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.369 0.604 . . . . 0.0 109.503 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.75 -71.65 0.08 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.289 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.11 -39.65 27.24 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.926 -178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.6 mt -61.81 -39.23 91.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.412 0.606 . . . . 0.0 112.027 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.94 -24.68 39.48 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.232 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.6 p -77.11 -53.84 7.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.438 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.553 ' NE ' HD13 ' A' ' 4' ' ' ILE . 1.1 mtm105 -68.75 -49.75 56.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.159 0.504 . . . . 0.0 110.343 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.608 ' CD2' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -83.72 22.75 1.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.444 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.4 m -49.38 -38.08 27.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.654 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -62.35 -35.85 80.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.721 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.608 HG21 ' CD2' ' A' ' 81' ' ' HIS . 3.6 t -83.58 -17.88 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.426 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 87' ' ' LYS . 56.1 t -65.24 -38.04 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.807 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -57.93 -6.41 0.56 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.769 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 105' ' ' GLU . 30.0 mmtp -76.71 -25.72 53.88 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.59 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.481 ' C ' ' H ' ' A' ' 90' ' ' ASP . 26.9 p90 -129.18 -45.77 1.24 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.707 0.289 . . . . 0.0 111.006 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 19.1 t70 58.16 -0.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.534 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.523 ' OD1' ' CE1' ' A' ' 153' ' ' PHE . 34.0 m-20 -152.07 164.63 36.84 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.35 0.595 . . . . 0.0 111.237 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -66.12 -61.25 2.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.7 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.6 m -50.82 -53.16 34.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.716 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.4 m -59.75 -35.79 75.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.309 0.576 . . . . 0.0 110.976 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.476 HD21 ' CBB' ' A' ' 182' ' ' HEM . 3.1 tt -66.36 -47.97 71.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.956 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 90.2 t -60.92 -36.31 71.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.394 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -88.8 -5.85 57.78 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.134 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -110.88 -15.14 11.18 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.476 -0.625 . . . . 0.0 112.78 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.665 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.1 mt -28.87 -104.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 117.568 0.684 . . . . 0.0 112.703 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.401 ' H ' ' HB ' ' A' ' 98' ' ' ILE . 13.6 p-80 -38.62 -48.66 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 0.0 111.54 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -45.71 -87.27 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.599 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.5 m -71.17 -52.1 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.665 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.1 mp -60.99 -47.25 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.452 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.05 -55.6 28.69 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.5 tp -47.88 -50.03 27.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.125 0.488 . . . . 0.0 110.358 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 84' ' ' VAL . 42.8 tp10 -55.71 -44.76 77.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.407 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.28 -52.15 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -49.37 -44.14 44.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.034 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -59.53 -35.03 73.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.432 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.5 mt -77.68 13.34 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.458 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 111' ' ' HIS . 11.1 m-85 64.5 163.17 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.763 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 110' ' ' TYR . 70.2 m-70 59.84 142.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.614 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 60.2 61.55 3.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.77 -59.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.462 2.108 . . . . 0.0 111.81 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.7 m -82.4 147.04 29.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.175 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 116' ' ' PRO . 17.0 mt -133.73 152.11 78.26 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.426 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 115' ' ' LEU . 98.0 Cg_exo -40.79 170.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.429 2.086 . . . . 0.0 112.701 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -86.1 109.24 18.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.09 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.9 mt -121.69 127.28 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.617 0.246 . . . . 0.0 110.891 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -130.81 113.02 13.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.945 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.99 138.55 15.06 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.437 ' C ' HD12 ' A' ' 122' ' ' LEU . 52.0 tt0 -132.26 158.51 41.63 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 122' ' ' LEU . 10.3 mp -103.44 146.44 28.5 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.47 161.42 39.45 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 126' ' ' ASN . 68.5 Cg_endo -72.77 -45.58 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.552 2.168 . . . . 0.0 113.398 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -72.9 38.49 0.08 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.974 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 124' ' ' PRO . 80.9 m-20 50.44 64.31 1.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.213 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -142.49 163.15 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.992 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.8 mt -137.59 118.09 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.21 120.42 27.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.0 tp -117.53 132.68 56.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.202 0.525 . . . . 0.0 110.952 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -121.22 126.38 49.47 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -129.35 129.77 45.22 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.54 126.82 30.12 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.773 0.321 . . . . 0.0 110.69 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.9 p -163.87 145.47 7.22 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.393 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.35 9.58 1.77 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.921 1.747 . . . . 0.0 110.644 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.482 ' C ' ' H ' ' A' ' 138' ' ' LEU . 94.5 mtt180 -93.91 110.5 22.17 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.169 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.408 ' C ' HD22 ' A' ' 138' ' ' LEU . 55.9 ttt-85 -67.67 38.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.457 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 136' ' ' ARG . 3.3 mm? -99.76 14.16 31.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.936 0.398 . . . . 0.0 110.252 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.0 t -41.68 -53.13 3.68 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.461 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -46.68 -33.64 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.165 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 7.0 t -68.38 -44.38 75.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.04 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.74 -49.99 18.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.907 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -62.13 -50.7 70.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.902 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.39 -42.6 18.81 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.04 -49.82 73.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 111.361 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.4 mt -58.87 -57.61 12.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.574 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.404 ' CE2' HD12 ' A' ' 159' ' ' ILE . 38.3 m-85 -49.58 -48.71 48.53 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.641 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.26 -51.58 57.24 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -42.86 -60.08 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.775 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.84 56.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.866 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -49.47 -48.09 47.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.665 0.269 . . . . 0.0 110.956 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -49.56 -49.64 45.56 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.827 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 65.2 t80 -85.69 35.87 0.63 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.348 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 44.25 46.76 7.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.126 0.488 . . . . 0.0 110.553 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -127.32 142.65 51.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -124.65 117.48 24.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.77 ' O ' HD13 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -132.43 163.52 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.365 0.602 . . . . 0.0 111.121 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -118.29 131.95 56.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.404 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.1 mt -110.32 119.35 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.0 m -103.64 114.72 29.2 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.578 0.228 . . . . 0.0 111.311 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.539 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.6 p-80 -96.03 79.01 3.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.512 0.672 . . . . 0.0 111.565 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -82.22 -0.07 43.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.164 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.86 111.12 5.57 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.52 ' O ' HG22 ' A' ' 167' ' ' THR . 13.6 m -114.14 178.79 4.16 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.112 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 168' ' ' GLY . 77.4 mtp -93.9 -28.94 15.55 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.476 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 4.3 p80 -52.77 -21.21 3.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.673 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.8 t -90.06 -28.04 19.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.561 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 99.63 19.9 18.77 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.072 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.38 167.8 9.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 110.792 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -52.15 -33.85 42.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.263 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -174.76 -170.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 1.7 m -94.31 140.34 29.91 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.253 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.6 tpp -118.6 123.61 45.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.26 102.44 6.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.477 0.656 . . . . 0.0 110.86 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -91.52 126.73 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.647 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.405 HG23 ' CG1' ' A' ' 157' ' ' ILE . 4.7 mp -108.51 147.07 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.19 0.519 . . . . 0.0 110.197 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -137.25 135.69 37.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.307 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 21.5 mt -89.8 130.93 35.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.193 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -55.84 152.86 9.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.443 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -148.48 27.37 0.91 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.439 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 61.6 t0 . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.533 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.476 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.439 ' O ' ' O ' ' A' ' 37' ' ' VAL . 65.2 mtm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 3' ' ' GLY . 69.7 mttt -79.73 119.64 22.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.447 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 56.88 133.06 0.01 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.421 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.5 tp -54.16 -40.05 45.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.335 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.2 mm -71.43 -56.08 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.093 0.473 . . . . 0.0 110.29 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -67.3 -18.73 65.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.079 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 3' ' ' GLY . 24.5 t-20 -75.24 -58.87 3.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.408 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 4' ' ' ILE . 51.0 t -52.65 -35.26 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.491 HD13 ' CE2' ' A' ' 69' ' ' PHE . 17.5 tp -73.08 -43.06 62.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.723 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -51.11 -44.71 61.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -60.36 -52.46 65.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.924 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.556 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 92.6 mtp -50.05 -43.63 51.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.131 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.9 t -68.55 -37.29 77.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.95 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.7 -23.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.226 0.536 . . . . 0.0 110.261 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.48 -34.01 18.81 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.262 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -83.81 -77.57 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.1 m -92.43 -19.11 22.38 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.216 0.532 . . . . 0.0 110.627 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.22 -179.38 24.82 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.0 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.1 ttm -72.57 -30.12 64.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.76 -1.22 . . . . 0.0 110.647 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -60.06 -38.81 83.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.872 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -77.69 -38.91 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 59.4 t-105 -54.48 -48.4 71.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.446 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.24 -25.14 57.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.707 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -74.7 -47.0 33.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.679 -0.408 . . . . 0.0 112.039 -178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.966 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.54 -28.13 37.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.313 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.966 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.9 tt -66.82 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.624 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.523 ' N ' HD23 ' A' ' 26' ' ' LEU . 96.0 mt-10 -57.76 -22.98 49.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.089 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -80.94 -44.6 17.98 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -98.83 -89.2 0.31 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.115 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.45 ' CB ' HH21 ' A' ' 34' ' ' ARG . . . -49.2 153.32 1.71 Allowed Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.542 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.08 150.83 54.84 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.664 2.243 . . . . 0.0 111.928 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' CD ' ' H ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -87.57 -6.84 58.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.192 179.584 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -63.8 -48.92 74.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.45 HH21 ' CB ' ' A' ' 30' ' ' ALA . 28.2 ptt180 -73.04 131.77 42.53 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.084 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.535 HG22 ' N ' ' A' ' 36' ' ' TYR . 4.7 p -170.61 164.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.393 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.535 ' N ' HG22 ' A' ' 35' ' ' VAL . 30.4 m-85 63.73 -143.3 0.32 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.639 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.572 HG23 ' N ' ' A' ' 38' ' ' SER . 2.5 m 29.59 -157.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 O-C-N 123.806 0.692 . . . . 0.0 112.496 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.572 ' N ' HG23 ' A' ' 37' ' ' VAL . 39.2 m -178.82 -21.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.807 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 40' ' ' LYS . . . -75.82 -27.0 57.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.086 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.456 ' HG2' HG21 ' A' ' 37' ' ' VAL . 7.6 mmpt? -55.14 -166.0 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.396 0.617 . . . . 0.0 110.642 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 42' ' ' TYR . 21.4 t -151.23 -54.35 0.14 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.862 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 44' ' ' GLU . 54.1 m-85 52.63 171.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.917 0.389 . . . . 0.0 110.375 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.61 84.12 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.62 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' TYR . 83.4 tt0 -61.35 -25.95 67.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.665 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 76.4 p -50.22 -27.66 6.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.607 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.23 -30.95 70.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.741 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -39.71 -58.54 1.31 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.978 0.418 . . . . 0.0 110.852 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -38.4 -45.14 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.211 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.3 m -67.96 -35.3 78.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.15 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.1 mp -68.68 -58.34 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 119.979 -0.689 . . . . 0.0 109.32 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -52.12 -21.32 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.993 179.13 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.671 ' HG3' HD12 ' A' ' 62' ' ' ILE . 1.7 tt0 -79.41 -42.56 25.22 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.196 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.549 ' OD2' HD23 ' A' ' 25' ' ' LEU . 32.7 m-20 -57.95 -57.67 11.78 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.789 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.04 -38.88 69.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.641 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.74 84.91 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.081 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -63.35 -31.32 72.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -74.68 -45.26 45.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.63 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.3 mt -77.08 -6.54 53.2 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.853 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.22 48.17 17.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.51 0.672 . . . . 0.0 109.492 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.8 mmm -126.62 149.5 68.28 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.074 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.36 134.44 45.09 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.454 1.436 . . . . 0.0 111.182 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.671 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.9 tt -48.51 -27.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.06 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -72.56 -33.91 67.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.163 0.506 . . . . 0.0 111.327 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -76.38 -31.8 58.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.227 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.548 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 78.5 t -72.61 -56.18 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -51.46 -43.97 31.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.245 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.53 ' N ' HG13 ' A' ' 66' ' ' VAL . 34.5 mtpt -51.85 -51.73 54.58 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.06 -58.26 8.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.874 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.6 m-30 -44.33 -29.28 0.65 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.527 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.18 -47.75 77.53 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -58.52 -54.19 49.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.02 0.438 . . . . 0.0 110.446 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.556 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 34.8 m-85 -55.12 -40.71 70.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.736 0.779 . . . . 0.0 110.619 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.6 tp -58.68 -38.16 77.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.198 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 34.4 t80 -68.4 -39.49 81.64 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.041 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -57.19 -71.05 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.328 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.11 -39.82 50.49 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.017 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.412 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 17.7 mt -57.53 -47.4 82.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.332 0.566 . . . . 0.0 111.585 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.44 -20.84 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.41 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.409 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.4 t -79.17 -42.28 26.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.105 0.478 . . . . 0.0 110.072 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.46 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.3 mmp_? -65.9 -71.47 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.462 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.486 ' CE1' ' CMC' ' A' ' 182' ' ' HEM . 17.4 p80 -84.16 36.92 0.59 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.831 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 85' ' ' VAL . 26.5 m -51.11 -46.81 61.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.886 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -49.3 -36.66 21.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.248 0.547 . . . . 0.0 109.66 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.788 HG13 ' CD ' ' A' ' 105' ' ' GLU . 11.3 t -76.67 -22.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.999 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 87' ' ' LYS . 57.3 t -68.54 -44.62 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.245 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -54.4 -4.96 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.81 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 85' ' ' VAL . 60.9 mmtt -81.39 -29.46 33.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.009 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -95.21 117.53 30.41 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.255 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 91.2 m-20 -84.98 -15.44 44.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.482 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 89' ' ' ASP . 63.8 m-20 -161.63 172.02 17.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.192 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -59.42 -53.92 52.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.713 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.6 m -53.51 -36.48 61.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.261 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.3 m -64.79 -39.5 93.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.154 0.502 . . . . 0.0 110.491 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.533 HD21 ' CBB' ' A' ' 182' ' ' HEM . 4.2 tt -64.19 -47.58 79.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.509 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.33 -36.14 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.758 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.1 mmm -86.34 -5.3 59.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.445 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.38 -15.69 8.75 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.345 -0.697 . . . . 0.0 113.165 -178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.711 ' HA ' HD13 ' A' ' 102' ' ' ILE . 16.2 mt -28.07 -105.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 117.716 0.758 . . . . 0.0 112.662 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -39.97 -47.55 2.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.092 0.472 . . . . 0.0 111.351 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -47.04 -88.44 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.586 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.0 m -69.77 -51.78 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.4 mp -61.22 -45.61 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.539 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.89 -53.99 40.66 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.577 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 42.8 tp -52.0 -51.55 56.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.86 0.362 . . . . 0.0 110.782 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.788 ' CD ' HG13 ' A' ' 84' ' ' VAL . 34.4 mt-10 -55.48 -45.37 76.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.128 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.2 t -54.07 -52.38 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 110' ' ' TYR . 20.5 t-20 -47.41 -43.48 23.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.858 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.577 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 23.7 mmtm -65.52 -41.54 93.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.788 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.0 tp -63.53 -43.02 98.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.808 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 107' ' ' ASN . 76.5 m-85 -102.77 -177.13 3.29 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.611 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -68.65 -67.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.585 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -172.51 58.7 0.24 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.879 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.18 148.02 30.38 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.669 2.246 . . . . 0.0 111.829 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 58.0 p -80.92 153.06 27.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.587 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.2 mt -128.66 153.6 79.63 Favored Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.949 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.88 167.32 19.91 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.456 2.104 . . . . 0.0 112.139 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -86.3 116.56 24.55 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.759 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.3 mt -134.03 131.51 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.709 0.29 . . . . 0.0 110.682 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -135.41 130.21 34.5 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.659 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -123.4 150.66 16.89 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -138.04 164.71 28.42 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.08 145.09 36.23 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.354 -0.384 . . . . 0.0 109.966 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.35 160.55 41.14 Favored Pre-proline 0 N--CA 1.467 0.377 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.26 -40.11 1.81 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.57 2.18 . . . . 0.0 113.155 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.521 ' ND2' ' OE1' ' A' ' 127' ' ' GLN . 19.8 p30 -78.97 47.44 0.77 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.229 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.521 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 0.7 OUTLIER 42.52 61.1 2.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.464 0.65 . . . . 0.0 110.868 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.521 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 66.5 mt-30 -137.73 159.44 41.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.895 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.5 mt -135.61 116.52 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.82 122.95 31.41 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.057 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.7 tp -117.66 135.06 54.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.99 0.424 . . . . 0.0 111.168 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -120.01 123.8 44.35 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.456 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -126.15 123.45 38.29 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.566 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.71 130.73 23.21 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.221 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.438 ' H ' ' CG ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -163.1 -179.68 1.06 Allowed Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.214 179.473 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' A' ' 134' ' ' SER . 24.6 Cg_exo -61.45 -48.74 8.82 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.231 1.954 . . . . 0.0 111.558 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 138' ' ' LEU . 82.8 mtm-85 -124.78 40.84 3.65 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 136' ' ' ARG . 58.1 mtt85 -5.26 -57.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.547 1.154 . . . . 0.0 113.975 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 136' ' ' ARG . 3.3 tp 67.24 30.13 7.32 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 26.4 p -40.55 -50.69 2.97 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.568 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.489 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 90.0 m-85 -43.13 -38.06 2.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 110.114 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 28.6 t -69.08 -45.96 68.96 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -45.64 -49.27 14.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.188 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -57.03 -50.39 72.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.677 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.64 -52.63 40.66 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.9 mt -55.16 -55.38 31.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.798 0.333 . . . . 0.0 110.498 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.3 mt -54.08 -55.75 24.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.564 ' CE2' HD12 ' A' ' 159' ' ' ILE . 6.3 m-85 -49.74 -47.97 50.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.73 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.26 60.21 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.95 -60.53 1.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.844 0.354 . . . . 0.0 110.87 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.61 -49.85 45.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -52.98 -47.64 68.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.083 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -50.06 -50.51 47.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 70.6 t80 -85.55 36.77 0.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.992 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 38.8 55.01 2.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.918 0.389 . . . . 0.0 111.134 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -129.86 141.24 50.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -110.79 126.54 54.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.128 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.0 pt -137.37 177.04 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.524 0.678 . . . . 0.0 111.837 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -143.84 125.84 15.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.202 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.564 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.4 mt -111.76 120.74 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.624 0.25 . . . . 0.0 110.613 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 m -105.66 115.37 30.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.112 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 17.0 p80 -102.13 72.95 1.34 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.738 0.78 . . . . 0.0 111.526 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -73.63 -30.86 63.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.844 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.67 113.76 27.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.474 ' O ' HG22 ' A' ' 167' ' ' THR . 7.7 t -117.89 -175.38 2.83 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.305 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 165' ' ' MET . 12.6 tmm? -93.8 -25.5 17.36 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -56.09 -23.95 37.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.473 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.6 t -86.54 -25.29 25.14 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.3 21.97 25.91 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.908 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.73 163.18 24.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.025 0.441 . . . . 0.0 110.693 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -45.11 -33.35 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.021 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -176.53 -168.97 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 20.8 t -95.45 141.87 28.48 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.221 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.2 tpt -121.59 119.72 32.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.726 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.98 107.15 11.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.873 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.4 mp -88.98 126.36 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.372 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 177' ' ' GLU . 5.1 mp -111.66 152.48 13.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.135 0.493 . . . . 0.0 110.458 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.421 ' N ' HG22 ' A' ' 176' ' ' ILE . 85.9 tt0 -142.96 141.45 31.43 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.494 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.1 mt -94.0 149.04 21.59 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.877 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.429 ' O ' ' OD1' ' A' ' 180' ' ' ASN . 91.2 mt-30 -142.1 -176.49 4.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.752 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 179' ' ' GLN . 83.3 m-20 -147.87 24.46 1.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.858 0.361 . . . . 0.0 110.41 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.2 t70 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.508 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.533 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' O ' ' O ' ' A' ' 2' ' ' LYS . 10.7 ptp . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.661 ' NZ ' ' HE1' ' A' ' 22' ' ' TRP . 86.7 mttt 57.89 150.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.7 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -41.7 140.81 1.52 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 tp -44.62 -39.51 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.412 -0.394 . . . . 0.0 110.595 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.96 -49.42 81.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 109.788 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -70.11 -23.39 63.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.003 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -68.12 -56.53 8.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.971 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.69 -38.65 76.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.043 0.449 . . . . 0.0 109.847 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.497 HD13 ' CE2' ' A' ' 69' ' ' PHE . 27.5 tp -65.89 -39.73 90.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.558 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -58.03 -43.8 87.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.989 0.423 . . . . 0.0 110.626 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.46 -63.9 1.14 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.361 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.8 ptm -46.19 -41.43 12.69 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.422 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.7 t -64.84 -38.36 82.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.609 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 49.2 t -59.9 -22.74 24.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.498 0.666 . . . . 0.0 109.407 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.76 -34.98 21.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.382 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -84.28 -76.67 0.29 Allowed 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.8 m -91.94 -21.44 20.57 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.294 0.569 . . . . 0.0 110.672 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.81 175.43 23.84 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.05 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.3 ttp -68.85 -28.07 66.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.648 -1.276 . . . . 0.0 110.368 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -61.75 -38.85 89.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.639 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.39 -38.67 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.661 ' HE1' ' NZ ' ' A' ' 2' ' ' LYS . 53.7 t-105 -55.3 -47.57 75.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.048 0.451 . . . . 0.0 110.096 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.04 -24.81 55.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.944 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -74.17 -47.31 36.61 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.93 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.71 -26.51 37.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.986 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.6 tt -73.04 -54.93 7.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.009 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' N ' HD23 ' A' ' 26' ' ' LEU . 82.0 tt0 -61.25 -23.98 66.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.475 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.51 ' NZ ' ' CE1' ' A' ' 29' ' ' HIS . 30.4 tttm -82.37 -39.04 23.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.51 ' CE1' ' NZ ' ' A' ' 28' ' ' LYS . 67.8 m80 -99.86 -88.73 0.34 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.063 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.571 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -52.5 160.03 1.47 Allowed Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.518 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.504 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 67.9 Cg_endo -71.95 149.38 53.13 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.881 2.388 . . . . 0.0 112.139 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -98.77 -15.42 19.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.622 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.517 ' OD2' ' NH1' ' A' ' 34' ' ' ARG . 24.0 p-10 -101.47 -48.65 4.27 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.865 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.517 ' NH1' ' OD2' ' A' ' 33' ' ' ASP . 16.5 mmp_? -67.56 68.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.536 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' ASP . 3.7 p -80.5 138.63 19.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.275 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 2' ' ' LYS . 85.0 m-85 -114.45 164.3 14.16 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.607 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.654 HG22 ' CG ' ' A' ' 40' ' ' LYS . 2.4 m -101.23 167.4 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.962 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 m -73.04 33.43 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.93 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.498 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -158.07 3.09 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.874 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.654 ' CG ' HG22 ' A' ' 37' ' ' VAL . 12.2 mmtt -97.82 -176.08 3.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 110.478 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.0 m -45.46 154.06 0.21 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.295 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.495 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -151.79 64.94 0.86 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.1 0.476 . . . . 0.0 110.362 -179.625 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.26 102.86 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.295 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 43.7 mp0 -59.75 -24.83 64.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.695 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m -53.44 -41.31 65.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.63 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -67.9 -37.25 81.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.598 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -52.44 -57.54 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.194 0.521 . . . . 0.0 110.771 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -39.0 -42.38 0.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.671 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.8 p -74.53 -30.4 61.76 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.861 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 47' ' ' LEU . 17.9 mt -71.42 -52.96 22.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.745 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.97 -26.31 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.668 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.674 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.2 tt0 -76.53 -41.1 47.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.547 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.574 ' OD2' HD23 ' A' ' 25' ' ' LEU . 48.2 m-20 -59.47 -56.05 26.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.963 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 50' ' ' ILE . 5.9 p -58.35 -37.08 61.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.981 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.53 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.54 -38.28 86.84 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.061 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -63.52 -31.63 72.84 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.6 mmt-85 -73.54 -42.76 61.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.378 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.4 mt -81.54 -7.27 59.56 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.668 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.8 t30 57.02 49.82 13.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.807 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.4 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 25.7 mmt -128.69 149.44 72.03 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.214 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.62 137.76 65.95 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.404 1.403 . . . . 0.0 110.981 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.674 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.5 tt -51.22 -28.5 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.254 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -71.82 -34.2 69.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 0.0 111.58 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -76.17 -31.98 58.82 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.89 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 55' ' ' ALA . 95.9 t -71.08 -56.66 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.521 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -52.56 -43.87 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.372 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.5 mtpt -51.61 -51.06 58.66 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.39 -54.12 50.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.559 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.497 ' CE2' HD13 ' A' ' 9' ' ' LEU . 5.7 m-30 -44.12 -28.94 0.55 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.464 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.91 63.3 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.03 -54.35 48.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.768 0.318 . . . . 0.0 110.461 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -55.28 -41.33 72.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.813 0.816 . . . . 0.0 110.693 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.4 tp -57.95 -38.69 76.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.553 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 26.1 t80 -70.25 -39.53 74.94 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.162 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -55.33 -73.82 0.05 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.091 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.82 -38.21 29.74 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.203 -0.523 . . . . 0.0 112.572 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 20.8 mt -57.45 -46.52 83.52 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.028 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.41 -20.7 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.296 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.0 t -81.46 -41.92 21.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.15 0.5 . . . . 0.0 110.205 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.459 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.3 mmp_? -65.17 -71.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.778 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.459 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 18.5 p80 -85.25 34.61 0.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.985 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.9 m -47.2 -45.2 23.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.817 0.341 . . . . 0.0 110.574 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -54.55 -31.06 55.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 t -80.4 -24.58 11.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.093 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.0 t -62.49 -37.65 79.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.356 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.08 -15.95 2.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.653 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -65.75 -31.22 72.08 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.58 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 15.3 p90 -119.01 115.98 25.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.039 0.447 . . . . 0.0 110.708 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -83.68 -0.64 51.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.283 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 13.8 p-10 -163.11 155.25 18.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.128 0.49 . . . . 0.0 111.569 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -44.86 -52.0 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.876 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.7 m -55.01 -43.0 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.752 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -61.77 -36.11 80.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.233 0.54 . . . . 0.0 110.614 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.9 tt -67.05 -56.82 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.858 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.41 ' HA ' HD11 ' A' ' 98' ' ' ILE . 85.3 t -54.55 -38.46 42.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.847 0.356 . . . . 0.0 111.659 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.5 ppp? -88.44 -6.75 57.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -112.27 -14.73 10.43 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 119.712 -0.493 . . . . 0.0 112.909 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.585 ' HA ' HD13 ' A' ' 102' ' ' ILE . 3.8 mt -34.25 -83.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 117.867 0.833 . . . . 0.0 111.705 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -44.76 -54.16 6.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.26 0.553 . . . . 0.0 110.742 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -46.69 -88.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.63 HG23 HD12 ' A' ' 102' ' ' ILE . 3.7 m -71.01 -49.98 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -176.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.63 HD12 HG23 ' A' ' 101' ' ' VAL . 3.7 mp -65.91 -39.79 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.383 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.74 -56.0 14.86 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.65 HD11 ' HZ1' ' A' ' 108' ' ' LYS . 58.7 tp -49.91 -55.97 12.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.972 0.415 . . . . 0.0 110.709 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -52.69 -44.88 66.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.476 -178.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 102' ' ' ILE . 17.8 t -54.13 -53.42 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -47.14 -43.01 20.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.79 0.328 . . . . 0.0 110.827 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.65 ' HZ1' HD11 ' A' ' 104' ' ' LEU . 26.0 mmtm -64.89 -40.36 94.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.572 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.6 tp -59.96 -41.95 93.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.474 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.462 ' CE2' ' O ' ' A' ' 111' ' ' HIS . 58.1 t80 -156.06 157.07 35.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.506 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.462 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 96.9 m-70 -92.87 124.2 36.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.483 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 113' ' ' PRO . 5.6 pt-20 -164.61 152.14 10.24 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.204 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 112' ' ' GLU . 74.1 Cg_exo -37.2 160.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.284 1.99 . . . . 0.0 112.178 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.5 m -58.84 148.71 29.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.668 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 116' ' ' PRO . 17.6 mt -74.57 151.88 87.3 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.189 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 115' ' ' LEU . 79.8 Cg_exo -38.15 162.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.144 1.896 . . . . 0.0 112.227 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -75.85 105.29 6.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.431 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.449 ' CD1' ' N3 ' ' A' ' 184' ' ' IMD . 72.4 mt -123.49 126.34 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.962 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -133.14 121.12 22.14 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.579 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.3 126.97 7.17 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.449 ' C ' HD22 ' A' ' 122' ' ' LEU . 88.6 mt-30 -117.05 166.07 12.62 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.789 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.6 mm? -109.88 130.46 55.52 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.27 160.43 37.56 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.28 178.11 6.47 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.995 1.797 . . . . 0.0 112.127 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.523 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 19.5 t-20 56.6 37.26 28.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.949 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 8.6 p30 50.0 69.31 0.62 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.614 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 126' ' ' ASN . 82.8 mm-40 -136.85 161.61 35.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.513 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.1 mt -145.07 121.3 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.78 122.33 35.06 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.288 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.0 tp -117.64 134.73 54.57 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.125 0.488 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -117.56 121.61 41.44 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.477 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.485 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 37.4 t80 -125.74 125.53 43.14 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.531 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.507 ' HB3' ' CD2' ' A' ' 171' ' ' HIS . 0.9 OUTLIER -135.31 123.75 23.38 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.487 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.408 ' OG ' ' NH1' ' A' ' 136' ' ' ARG . 7.3 t -153.68 143.37 15.17 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.15 -8.13 18.54 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.947 1.765 . . . . 0.0 112.37 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.434 ' CB ' HD23 ' A' ' 138' ' ' LEU . 53.7 mtt85 -79.88 -22.4 42.87 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.208 0.528 . . . . 0.0 110.339 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.476 ' C ' ' H ' ' A' ' 139' ' ' CYS . 20.7 ttm180 67.55 23.28 8.96 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.643 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.434 HD23 ' CB ' ' A' ' 136' ' ' ARG . 3.1 mm? -75.73 17.02 0.33 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 31.0 p -43.17 -49.82 6.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.372 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.555 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 73.3 m-85 -46.76 -40.23 13.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.083 0.468 . . . . 0.0 110.335 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.3 t -62.93 -42.73 99.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -46.61 -54.95 8.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.663 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.64 -51.21 63.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.316 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.09 -48.13 47.25 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.05 -53.69 55.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.683 0.278 . . . . 0.0 111.302 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.4 mt -55.59 -54.93 37.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.699 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.545 ' CE2' HD12 ' A' ' 159' ' ' ILE . 10.6 m-85 -49.17 -49.1 44.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.902 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.04 -50.58 66.32 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.42 -59.91 2.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.74 0.305 . . . . 0.0 110.941 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 155' ' ' GLN . . . -51.44 -52.08 49.37 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.314 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -52.13 -47.88 65.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.215 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -47.74 -50.0 26.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.709 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -85.39 38.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.844 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 38.45 62.31 1.02 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.038 0.447 . . . . 0.0 111.309 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.491 ' HB3' ' HB1' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -132.93 151.11 52.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.465 ' H ' ' CD ' ' A' ' 155' ' ' GLN . 84.4 tttt -118.27 118.9 33.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.9 pt -133.32 170.86 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.539 0.685 . . . . 0.0 112.186 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -138.25 127.77 24.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.52 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.545 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.6 mt -111.41 117.56 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.911 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.9 t -98.72 103.34 15.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.819 0.343 . . . . 0.0 110.47 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.576 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 20.3 p80 -94.02 65.12 3.43 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.615 0.721 . . . . 0.0 111.017 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 163' ' ' THR . 37.3 p30 -69.0 -33.05 73.04 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.113 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.512 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 1.6 m -99.95 107.54 19.53 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.066 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.59 ' O ' ' N ' ' A' ' 166' ' ' HIS . 55.9 m -134.71 114.22 12.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.653 0.263 . . . . 0.0 110.785 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.2 ttt -36.62 -20.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.19 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.59 ' N ' ' O ' ' A' ' 164' ' ' CYS . 83.7 t60 -52.23 -23.33 5.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.482 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.6 t -88.77 -43.18 11.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.01 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 167' ' ' THR . . . 130.48 13.9 2.02 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.09 162.51 14.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 110.729 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.72 ' O ' ' CD2' ' A' ' 171' ' ' HIS . 28.9 p-10 -55.55 -41.16 72.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.343 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.72 ' CD2' ' O ' ' A' ' 170' ' ' ASP . 33.4 m80 -161.52 -173.33 3.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.6 m -96.31 137.96 34.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.439 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.511 ' H ' ' HB ' ' A' ' 163' ' ' THR . 12.3 ttm -126.19 92.76 3.64 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.609 0.719 . . . . 0.0 109.608 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.19 113.9 26.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.912 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.1 mm -90.49 127.98 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.366 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.07 148.99 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.432 0.634 . . . . 0.0 110.727 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -137.82 135.88 36.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.555 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 19.0 mt -93.1 145.94 24.02 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.702 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -139.28 -179.49 5.9 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.801 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 181' ' ' ASP . 46.9 p-10 -153.7 20.85 0.53 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.854 0.359 . . . . 0.0 110.578 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 180' ' ' ASN . 3.3 p30 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.851 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.422 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 184' ' ' IMD . . . . . 0.449 ' N3 ' ' CD1' ' A' ' 118' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.2 mtp . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm 48.23 -172.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.434 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.576 ' O ' HG22 ' A' ' 4' ' ' ILE . . . -159.26 -118.71 0.52 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 3' ' ' GLY . 0.3 OUTLIER 94.45 -24.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.9 0.88 . . . . 0.0 109.576 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mm -68.56 -52.73 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.395 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.45 -22.81 64.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.006 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -69.83 -49.59 51.1 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.716 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.08 -36.36 77.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.922 0.392 . . . . 0.0 110.158 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.453 HD13 ' CE2' ' A' ' 69' ' ' PHE . 24.1 tp -71.02 -35.46 72.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.241 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.15 -45.73 86.91 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.045 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -61.61 -52.32 64.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.428 ' SD ' ' CE1' ' A' ' 69' ' ' PHE . 7.8 ttp -49.73 -43.27 47.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.54 -35.17 69.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.663 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -61.93 -22.16 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.218 0.533 . . . . 0.0 109.756 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.9 -35.11 20.74 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.343 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -84.35 -77.13 0.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.495 ' SG ' HD21 ' A' ' 58' ' ' LEU . 90.4 m -90.99 -20.04 22.56 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.265 0.555 . . . . 0.0 110.738 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.95 173.59 26.54 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.77 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.8 ttt -68.57 -28.37 66.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.831 -1.184 . . . . 0.0 110.477 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.8 m -62.76 -42.5 99.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.164 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.96 -36.03 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -52.03 -46.23 64.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -70.14 -30.98 68.28 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.138 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -65.31 -50.62 64.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -83.14 -18.89 37.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.871 0.367 . . . . 0.0 110.792 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.792 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.5 tt -77.97 -61.43 2.0 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.371 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.489 ' N ' HD23 ' A' ' 26' ' ' LEU . 78.5 mm-40 -58.68 -21.91 55.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.319 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -80.64 -38.58 28.91 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.502 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 72.1 m80 -99.03 -84.9 0.4 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.508 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.472 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -50.23 158.91 0.9 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.087 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.455 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 40.9 Cg_endo -66.33 143.05 68.77 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.732 2.288 . . . . 0.0 112.218 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' CB ' ' OE1' ' A' ' 27' ' ' GLU . 36.5 pttt -90.04 -20.61 23.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.709 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -91.74 -51.7 5.1 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.749 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -70.88 90.49 0.81 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.211 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -56.51 137.83 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.61 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -102.88 131.88 49.49 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.728 HG23 ' H ' ' A' ' 39' ' ' ALA . 1.5 m -143.42 166.72 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.843 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 m -76.63 29.26 0.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.578 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.728 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -153.18 16.47 0.55 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.618 ' CG ' HG22 ' A' ' 37' ' ' VAL . 15.5 mmtt -114.99 156.46 25.04 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.019 0.437 . . . . 0.0 110.428 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.3 p -92.75 130.86 38.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.464 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -164.89 172.2 13.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.595 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.2 110.69 14.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.642 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.01 -29.9 63.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.654 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.9 m -52.16 -26.03 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.647 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.96 -30.38 67.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.808 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.6 -57.46 2.26 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.038 0.447 . . . . 0.0 110.684 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -38.0 -43.47 0.72 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.516 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.3 m -72.94 -32.41 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.527 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.2 mp -70.74 -52.84 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.503 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.4 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -56.44 -24.67 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.885 178.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.681 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.5 tt0 -77.01 -41.37 43.02 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.466 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.502 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 37.9 m-20 -58.55 -56.43 22.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.864 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.0 p -57.13 -39.32 66.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.065 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.02 -39.72 86.81 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.134 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -62.84 -31.51 72.54 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -74.54 -45.79 43.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.491 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.495 HD21 ' SG ' ' A' ' 17' ' ' CYS . 32.0 mt -76.8 -8.6 57.61 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.621 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 58.1 52.33 7.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.748 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.415 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 11.2 mmt -132.43 149.95 74.56 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.382 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.31 140.64 89.45 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.441 1.427 . . . . 0.0 111.194 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.681 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.2 tt -56.55 -30.76 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.744 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -72.91 -29.75 63.37 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.297 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 50.2 t0 -78.77 -36.62 42.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.699 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 55' ' ' ALA . 69.2 t -63.74 -58.96 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -49.94 -39.89 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.756 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' N ' HG13 ' A' ' 66' ' ' VAL . 2.2 ttpt -52.59 -47.33 66.97 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.86 89.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.453 ' CE2' HD13 ' A' ' 9' ' ' LEU . 6.2 m-30 -52.81 -29.96 30.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.613 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.17 -50.41 57.06 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -55.62 -50.06 71.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.924 0.392 . . . . 0.0 110.2 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -59.16 -41.53 88.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.802 0.81 . . . . 0.0 110.431 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.73 -38.88 79.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.449 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 36.6 t80 -69.54 -39.15 77.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.136 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -56.9 -69.87 0.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.97 -38.13 54.75 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.581 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.514 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 18.8 mt -57.07 -48.22 79.11 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.451 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.16 -21.28 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.552 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t -80.41 -40.51 26.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.24 0.543 . . . . 0.0 110.109 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.443 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.9 mmp_? -66.55 -70.55 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.68 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.603 ' CE1' HMC1 ' A' ' 182' ' ' HEM . 23.7 p80 -83.66 32.99 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.97 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 55.0 m -47.93 -43.27 28.92 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.941 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -52.67 -31.76 38.85 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 81' ' ' HIS . 16.7 t -82.47 -25.26 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.675 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 87' ' ' LYS . 44.5 t -63.27 -38.2 81.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -47.33 -12.86 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.875 0.369 . . . . 0.0 110.924 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.506 ' NZ ' ' CG ' ' A' ' 105' ' ' GLU . 85.5 mttt -79.63 -28.41 40.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.895 0.855 . . . . 0.0 109.721 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 85' ' ' VAL . 39.7 t80 -57.78 100.21 0.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.232 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -88.39 -32.91 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 54.2 t0 -174.73 155.51 2.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.759 -1.564 . . . . 0.0 109.923 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.504 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 78.0 t80 -42.56 -46.27 4.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.319 0.58 . . . . 0.0 110.49 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.2 m -61.76 -37.3 83.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.795 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -65.54 -40.83 93.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.343 0.592 . . . . 0.0 110.579 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 98' ' ' ILE . 6.5 tt -65.35 -49.92 67.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.318 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.407 HG21 ' CE2' ' A' ' 91' ' ' PHE . 76.5 t -57.13 -37.78 57.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.262 0.554 . . . . 0.0 110.623 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 120' ' ' GLY . 95.3 mmm -86.49 -5.98 59.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.192 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.89 -15.56 8.52 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.096 -0.836 . . . . 0.0 113.202 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.521 ' O ' ' O ' ' A' ' 97' ' ' GLY . 13.6 mt -27.27 -106.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 117.945 0.873 . . . . 0.0 112.66 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -40.64 -49.89 3.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.26 0.552 . . . . 0.0 111.259 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -43.25 -86.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.548 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.0 m -72.82 -51.86 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.548 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mp -64.77 -50.04 77.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.51 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -53.46 -50.98 50.76 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.575 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 30.1 tp -48.83 -50.28 35.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.085 0.469 . . . . 0.0 110.228 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.506 ' CG ' ' NZ ' ' A' ' 87' ' ' LYS . 68.9 mm-40 -55.85 -45.08 78.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.141 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.445 ' CG1' ' OE2' ' A' ' 112' ' ' GLU . 72.3 t -51.99 -51.0 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -50.11 -42.49 50.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.708 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.575 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 26.4 mmtm -58.94 -36.14 74.28 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.26 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.682 ' O ' ' CE1' ' A' ' 111' ' ' HIS . 3.7 mm? -74.11 1.73 10.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.532 ' O ' ' CG ' ' A' ' 111' ' ' HIS . 12.5 t80 70.25 -167.68 0.16 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.74 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.712 ' CD2' ' O ' ' A' ' 111' ' ' HIS . 13.7 p-80 42.14 76.82 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.916 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.445 ' OE2' ' CG1' ' A' ' 106' ' ' VAL . 28.0 tt0 -159.99 81.58 2.36 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.493 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.22 -60.85 0.73 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.414 2.076 . . . . 0.0 112.213 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.3 m -170.28 128.2 0.85 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD11 ' OE2' ' A' ' 112' ' ' GLU . 10.4 mt -80.01 153.94 75.03 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.35 173.19 11.87 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.412 2.075 . . . . 0.0 112.291 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -84.15 108.86 17.3 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.349 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 91.3 mt -121.26 126.69 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.631 0.253 . . . . 0.0 110.981 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -130.66 112.18 12.88 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.861 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.443 ' C ' ' SD ' ' A' ' 96' ' ' MET . . . -110.39 128.46 8.83 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -118.95 164.66 15.13 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.944 0.402 . . . . 0.0 110.468 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.24 144.73 36.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.661 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.41 160.56 41.21 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.01 -31.43 9.81 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.549 2.166 . . . . 0.0 113.261 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -86.51 44.97 1.19 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.24 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 m120 45.06 51.34 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.286 0.565 . . . . 0.0 110.575 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -127.44 158.46 37.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.701 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.1 mt -135.72 117.91 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.65 122.77 32.43 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.749 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.7 tp -117.26 133.79 55.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.058 0.456 . . . . 0.0 110.439 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -119.38 126.59 51.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.529 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -125.89 123.55 38.89 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.09 132.27 29.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.739 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.525 ' OG ' ' NE ' ' A' ' 136' ' ' ARG . 0.4 OUTLIER 169.82 154.61 0.18 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.292 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.43 68.4 1.5 Allowed 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.434 2.089 . . . . 0.0 111.163 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.548 ' C ' ' H ' ' A' ' 138' ' ' LEU . 10.0 ptp180 -150.51 101.68 2.97 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.476 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -69.9 36.88 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.139 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.548 ' H ' ' C ' ' A' ' 136' ' ' ARG . 2.5 tp -97.01 7.29 46.98 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.256 0.551 . . . . 0.0 110.143 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.4 m -41.93 -50.82 4.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.93 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -45.43 -36.74 4.56 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.552 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.82 -44.17 74.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.949 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -44.77 -47.52 10.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.603 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -65.13 -49.42 69.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.376 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.65 -47.45 45.75 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.9 mt -58.84 -53.28 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.65 0.262 . . . . 0.0 111.192 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.8 mt -55.64 -54.73 40.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.606 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.669 ' CE2' HD12 ' A' ' 159' ' ' ILE . 18.3 m-85 -50.42 -47.14 56.72 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.658 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.94 -50.94 62.41 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.61 -59.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.743 0.306 . . . . 0.0 110.736 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.25 -51.51 58.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.667 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -51.52 -47.24 63.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.067 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -49.4 -49.73 43.45 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.743 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.517 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 67.4 t80 -88.03 38.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.891 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 38.51 55.28 1.87 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.966 0.412 . . . . 0.0 111.134 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -128.84 141.18 51.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.412 ' HZ2' ' HB3' ' A' ' 156' ' ' LYS . 15.7 mtpp -110.85 131.35 55.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.173 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.4 pt -142.99 170.12 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.631 0.729 . . . . 0.0 112.268 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -134.77 125.69 27.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.93 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.669 HD12 ' CE2' ' A' ' 147' ' ' PHE . 5.7 mt -111.63 118.84 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.618 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.2 m -98.95 99.83 10.93 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.008 0.433 . . . . 0.0 110.248 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 163' ' ' THR . 23.3 t-160 -98.59 70.12 1.92 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.388 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -77.11 -45.84 25.56 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.904 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.466 ' O ' ' CD2' ' A' ' 161' ' ' HIS . 2.4 m -77.83 118.91 20.62 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.863 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 166' ' ' HIS . 34.0 t -143.78 116.27 8.6 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.009 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.432 ' C ' ' N ' ' A' ' 167' ' ' THR . 26.1 ttt -35.25 -23.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.073 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.575 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.9 t60 -50.11 -20.66 1.04 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.432 ' N ' ' C ' ' A' ' 165' ' ' MET . 6.0 t -93.97 -36.4 12.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.139 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.66 13.34 8.07 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.56 165.69 7.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 110.809 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -52.83 -35.91 57.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.428 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -172.13 -171.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.4 m -93.68 138.83 31.5 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.547 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.3 tpt -117.65 122.08 42.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.064 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -126.13 102.21 7.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.029 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -90.35 126.95 43.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.511 178.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.46 151.83 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.188 0.518 . . . . 0.0 110.599 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -139.26 137.84 36.26 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.48 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 11.9 mt -94.77 150.04 20.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.937 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -143.24 175.57 9.79 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.823 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 181' ' ' ASP . 13.4 m120 53.73 43.44 31.05 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.532 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 180' ' ' ASN . 3.2 p30 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.603 HMC1 ' CE1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.527 ' N ' ' O ' ' A' ' 40' ' ' LYS . 67.4 mmm . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.557 ' HZ3' ' HB2' ' A' ' 44' ' ' GLU . 65.3 tttt -89.29 -5.34 57.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.965 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -51.67 -25.19 14.12 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tp -51.84 -39.86 26.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 0.0 110.517 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.0 mm -58.7 -49.15 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.112 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -67.26 -25.91 66.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.275 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -66.95 -54.63 20.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.192 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.76 -35.19 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.401 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.505 HD13 ' CE2' ' A' ' 69' ' ' PHE . 17.8 tp -68.48 -51.33 44.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.399 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -47.0 -44.15 20.02 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.09 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -61.14 -52.71 63.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.999 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.8 ttt -51.31 -40.17 58.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.73 -35.69 66.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.418 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.78 -22.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.336 0.589 . . . . 0.0 109.883 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.77 -34.7 19.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.225 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -84.48 -77.06 0.28 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.47 ' SG ' HD21 ' A' ' 58' ' ' LEU . 98.0 m -90.81 -20.12 22.68 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.247 0.546 . . . . 0.0 110.705 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.6 173.78 26.99 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.719 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.4 ttt -69.53 -25.02 63.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.937 -1.131 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -65.27 -43.21 91.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.148 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -34.31 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.538 ' HE1' HH12 ' A' ' 34' ' ' ARG . 51.5 t-105 -51.57 -45.97 63.28 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.47 ' OD1' ' CZ ' ' A' ' 34' ' ' ARG . 45.6 m-20 -69.15 -32.66 72.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.015 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -64.33 -50.97 65.68 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.806 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.78 -19.6 37.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.958 0.408 . . . . 0.0 110.965 -179.229 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.806 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.5 tt -75.34 -57.61 3.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.692 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' N ' HD23 ' A' ' 26' ' ' LEU . 99.4 mt-10 -62.89 -21.09 65.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.62 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -80.72 -39.29 27.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.435 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 2.5 m-70 -101.32 -88.12 0.38 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.861 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.571 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -43.76 163.88 0.16 Allowed Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 27.7 Cg_endo -59.65 150.97 73.27 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.477 2.118 . . . . 0.0 112.192 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -65.89 -17.47 64.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.542 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 34' ' ' ARG . 50.5 t0 -48.2 -44.62 32.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.232 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.538 HH12 ' HE1' ' A' ' 22' ' ' TRP . 37.5 ttt85 45.03 97.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.781 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.0 t -145.25 129.27 12.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.328 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.522 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 36.6 p90 -81.51 113.83 19.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.147 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.503 HG21 ' HG3' ' A' ' 40' ' ' LYS . 34.8 m -147.46 164.5 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 121.18 0.514 . . . . 0.0 110.933 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.1 m -142.58 24.44 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.255 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.489 ' O ' ' SD ' ' A' ' 1' ' ' MET . . . -130.98 11.97 5.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.662 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 1' ' ' MET . 20.8 mttt -101.44 179.42 4.36 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.455 0.645 . . . . 0.0 112.017 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.9 t -129.93 67.51 1.46 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.235 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -77.34 163.27 26.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.301 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.38 121.77 15.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.6 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.594 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -72.32 -36.29 68.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.691 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.459 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 22.9 t -58.78 -31.68 68.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.564 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -62.09 -40.82 97.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.769 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -41.19 -55.01 2.77 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.946 0.403 . . . . 0.0 110.595 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.14 -38.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.914 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.9 m -72.41 -34.53 67.93 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.837 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.8 mp -68.33 -56.93 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.207 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -51.89 -26.25 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.831 178.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.672 ' HG3' HD12 ' A' ' 62' ' ' ILE . 7.2 tt0 -75.24 -41.18 58.1 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.763 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.435 ' OD2' ' CD2' ' A' ' 29' ' ' HIS . 51.3 m-20 -59.4 -56.62 19.69 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.073 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 p -56.39 -38.1 54.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.08 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.07 -38.75 87.33 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.251 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -62.8 -32.22 73.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.55 -43.32 60.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 17' ' ' CYS . 41.6 mt -79.3 -8.47 59.08 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.612 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.1 t30 57.32 50.4 11.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.555 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.405 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 10.0 mmt -129.79 149.75 73.91 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.208 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.74 139.83 82.68 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.407 1.405 . . . . 0.0 111.171 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.672 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.6 tt -54.37 -30.89 21.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.363 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -72.0 -29.72 64.49 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.405 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 37.5 t0 -78.69 -35.48 45.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.956 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 55' ' ' ALA . 72.0 t -66.29 -58.03 8.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -51.34 -39.49 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.959 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.489 ' N ' HG13 ' A' ' 66' ' ' VAL . 2.4 ttpt -53.35 -47.83 69.05 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.88 -43.96 97.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.65 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.505 ' CE2' HD13 ' A' ' 9' ' ' LEU . 6.8 m-30 -55.1 -32.07 61.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.17 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.4 -50.18 56.99 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -57.63 -47.77 81.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.066 0.46 . . . . 0.0 109.896 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.03 -42.58 94.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.85 0.833 . . . . 0.0 110.363 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.8 tp -56.15 -39.0 71.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.388 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -70.49 -40.8 73.38 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.286 -0.565 . . . . 0.0 109.936 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -57.08 -71.87 0.09 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.914 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.5 -37.58 19.62 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.223 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.67 -41.6 86.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.121 0.46 . . . . 0.0 111.732 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.16 -15.86 2.62 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.672 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.431 ' O ' ' OG1' ' A' ' 82' ' ' THR . 29.0 t -83.69 -46.85 11.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.324 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -86.87 -47.4 9.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.977 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.609 ' NE2' HMC3 ' A' ' 182' ' ' HEM . 0.1 OUTLIER -84.42 26.48 0.78 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.201 0.524 . . . . 0.0 109.982 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 79' ' ' SER . 3.8 m -58.21 -40.38 81.44 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.329 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -56.01 -31.87 63.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.3 t -85.54 -20.84 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.923 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 81' ' ' HIS . 43.3 t -64.69 -41.22 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.213 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.82 -19.15 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -66.23 -28.91 69.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.557 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 1.8 p90 -120.35 114.32 21.68 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.107 0.48 . . . . 0.0 110.77 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -85.28 -3.33 58.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.372 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -163.04 154.57 17.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.092 0.472 . . . . 0.0 111.602 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.439 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 89.8 t80 -45.4 -56.38 5.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.001 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.0 m -52.08 -44.01 64.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.795 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.9 p -61.63 -35.47 77.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.18 0.514 . . . . 0.0 110.825 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.9 tt -68.64 -48.78 63.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.589 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.78 -39.1 75.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.069 0.461 . . . . 0.0 111.145 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -88.61 -4.86 58.48 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -111.03 -15.07 11.08 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 119.569 -0.573 . . . . 0.0 112.761 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 94' ' ' LEU . 12.8 mt -30.37 -100.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 117.75 0.775 . . . . 0.0 112.269 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -39.31 -51.61 2.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.15 0.5 . . . . 0.0 111.374 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -43.32 -87.21 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -72.51 -53.65 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.587 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.9 mp -62.27 -46.89 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.688 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.19 -52.57 48.61 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.592 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 42.4 tp -52.43 -51.47 58.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.359 . . . . 0.0 110.665 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -54.88 -45.84 74.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.755 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.68 -51.99 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 110' ' ' TYR . 19.3 t-20 -47.11 -43.23 20.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.757 0.313 . . . . 0.0 110.754 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.592 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 26.7 mmtm -60.99 -37.15 81.47 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.144 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -67.36 -42.85 82.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.896 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.514 ' CD2' ' O ' ' A' ' 111' ' ' HIS . 64.0 t80 -143.16 144.31 32.15 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.444 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.514 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 79.3 m80 -83.53 150.89 25.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.731 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 59.68 59.11 4.76 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.487 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.11 -22.49 16.88 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.726 2.284 . . . . 0.0 111.839 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 114' ' ' SER . 23.2 p 42.67 62.07 1.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.923 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 116' ' ' PRO . 11.3 mt -81.41 115.1 54.44 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.191 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 115' ' ' LEU . 80.2 Cg_exo -44.23 178.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.228 1.952 . . . . 0.0 113.033 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.547 ' NE2' ' NH2' ' A' ' 131' ' ' ARG . 20.4 t60 -80.1 118.83 22.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.515 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.71 129.62 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -134.53 119.75 18.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.886 0.374 . . . . 0.0 111.591 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -108.2 126.06 8.1 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.403 ' C ' HD22 ' A' ' 122' ' ' LEU . 15.0 mm-40 -116.77 165.27 13.49 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.117 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.769 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.2 mm? -111.8 139.19 47.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.186 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.95 160.25 41.51 Favored Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 69.9 Cg_endo -73.51 158.71 47.43 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.264 1.976 . . . . 0.0 112.109 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 124' ' ' PRO . 3.4 t-20 92.24 -60.92 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.217 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 125' ' ' ASN . 2.4 m120 154.31 59.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -135.14 163.28 30.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.05 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.7 mt -140.2 121.16 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.34 122.77 33.52 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.276 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.0 tp -116.05 136.55 52.92 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.033 0.444 . . . . 0.0 110.745 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.547 ' NH2' ' NE2' ' A' ' 117' ' ' HIS . 61.0 ttp85 -123.08 124.28 42.75 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.595 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.428 ' C ' ' CD1' ' A' ' 132' ' ' TYR . 25.4 t80 -126.84 123.1 36.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.19 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.62 122.53 29.25 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 136' ' ' ARG . 3.6 t -172.69 145.15 1.34 Allowed Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.759 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -73.36 19.07 0.38 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.908 1.739 . . . . 0.0 110.382 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.55 ' C ' ' H ' ' A' ' 138' ' ' LEU . 15.7 mmm180 -91.24 108.54 19.95 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.719 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -69.03 18.84 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.626 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.55 ' H ' ' C ' ' A' ' 136' ' ' ARG . 2.4 mm? -86.31 11.02 13.12 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 110.299 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 65.5 m -40.86 -54.61 2.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.601 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -47.07 -30.07 2.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.957 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.456 ' N ' ' O ' ' A' ' 138' ' ' LEU . 4.7 t -71.38 -45.19 63.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.794 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.65 -48.79 14.8 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.588 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -63.35 -48.26 78.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.206 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.33 -46.22 44.42 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.3 -52.58 64.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.64 0.257 . . . . 0.0 111.351 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.2 mt -55.53 -56.51 19.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.819 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.592 ' CE2' HD12 ' A' ' 159' ' ' ILE . 23.7 m-85 -51.33 -47.55 62.65 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.644 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.33 -52.23 54.46 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.52 -60.21 1.84 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.0 110.784 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.34 -51.63 52.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.563 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -51.24 -46.37 62.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.636 0.255 . . . . 0.0 110.961 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -50.23 -50.35 50.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.515 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 71.3 t80 -86.2 37.15 0.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.998 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 40.69 53.0 3.15 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.92 0.39 . . . . 0.0 111.062 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -127.72 139.52 52.63 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -112.95 128.06 56.38 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.439 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 10.7 pt -139.18 175.72 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.663 0.744 . . . . 0.0 111.638 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -137.78 127.09 24.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.195 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.592 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.3 mt -112.31 116.69 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.462 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.3 m -97.0 101.94 13.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.497 ' NE2' ' O ' ' A' ' 163' ' ' THR . 10.8 t-160 -104.62 74.97 1.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.91 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -81.27 -40.68 23.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.82 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.497 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 1.9 m -78.97 117.72 20.31 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.146 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 166' ' ' HIS . 14.7 t -142.16 117.35 10.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.693 0.282 . . . . 0.0 111.08 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.475 ' C ' ' N ' ' A' ' 167' ' ' THR . 24.5 ttt -33.88 -25.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.225 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.568 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.6 t60 -49.42 -19.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.568 0.699 . . . . 0.0 109.147 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.475 ' N ' ' C ' ' A' ' 165' ' ' MET . 5.9 t -94.73 -34.2 12.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.958 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 112.54 16.05 9.07 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.34 166.48 8.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.064 0.459 . . . . 0.0 110.782 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -55.56 -33.91 64.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.456 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -171.89 -169.63 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.7 m -94.7 141.94 28.04 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.562 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.5 tpt -118.02 123.6 46.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.104 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.2 100.35 5.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.162 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.544 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -88.26 126.6 41.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.702 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.84 149.74 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.183 0.516 . . . . 0.0 110.588 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -144.57 139.28 28.04 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.421 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 10.9 mt -92.65 136.55 33.13 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.116 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -46.37 143.42 2.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.439 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -155.26 21.4 0.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.522 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 61.2 t0 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.589 179.984 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.609 HMC3 ' NE2' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.699 ' H3 ' ' CG ' ' A' ' 7' ' ' ASN . 49.2 ttp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' GLY . 59.8 mttp 55.11 90.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.5 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 37' ' ' VAL . . . 58.5 117.71 0.01 OUTLIER Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 tp -53.55 -41.33 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.4 -48.4 80.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.423 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 3.2 m-85 -67.42 -24.11 65.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.753 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.699 ' CG ' ' H3 ' ' A' ' 1' ' ' MET . 1.5 t-20 -71.18 -57.31 4.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.49 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.15 -35.84 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.012 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.473 HD13 ' CD2' ' A' ' 69' ' ' PHE . 26.7 tp -72.03 -41.94 66.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.413 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -53.87 -46.61 71.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.935 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.16 -45.29 93.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.927 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.599 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 3.3 tpp -58.05 -47.31 83.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.4 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.55 -36.71 76.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.828 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -63.17 -22.94 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.278 0.561 . . . . 0.0 109.661 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.77 -34.76 18.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.85 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -86.78 -76.93 0.34 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.483 ' SG ' HD21 ' A' ' 58' ' ' LEU . 88.8 m -89.84 -17.08 28.77 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.408 0.623 . . . . 0.0 110.723 -177.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.2 -179.97 31.15 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.565 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 ttt -72.85 -31.68 64.93 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.053 -1.074 . . . . 0.0 111.098 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -60.22 -39.53 86.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.165 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.83 -37.76 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -55.13 -47.38 75.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.07 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.33 -24.89 54.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.898 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -76.01 -46.42 29.53 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.819 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.991 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.37 -28.22 41.93 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.742 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.991 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.8 tt -71.23 -45.86 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.232 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.4 -23.89 63.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.639 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -82.14 -40.59 21.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.423 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 59.6 m-70 -91.58 -87.37 0.21 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.177 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 31' ' ' PRO . . . -53.99 160.65 2.15 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.087 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 59.9 Cg_endo -70.45 153.99 65.34 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.702 2.268 . . . . 0.0 112.035 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' NZ ' ' OD1' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -80.26 -2.66 46.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.262 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.406 ' OD1' ' NZ ' ' A' ' 32' ' ' LYS . 86.9 m-20 -59.4 -38.49 80.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.567 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 49.76 40.39 20.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.624 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.7 m -95.78 31.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.577 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.448 ' OH ' ' CG ' ' A' ' 31' ' ' PRO . 73.1 m-85 -94.16 151.6 19.36 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.521 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.59 HG23 ' H ' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -131.98 155.04 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.862 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 1' ' ' MET . 1.5 m -81.5 39.75 0.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.715 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.59 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -153.72 3.04 0.27 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.824 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.537 ' CG ' HG22 ' A' ' 37' ' ' VAL . 14.5 mmtt -93.93 149.54 21.14 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.08 0.467 . . . . 0.0 110.343 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 65.8 m -88.9 39.62 0.94 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.27 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.404 ' CE2' ' CB ' ' A' ' 40' ' ' LYS . 49.6 m-85 -56.42 158.11 4.56 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.375 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.3 129.59 36.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.663 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -81.95 -3.31 54.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.66 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.2 m -51.79 -36.79 48.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.694 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.54 -28.89 70.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.644 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.9 OUTLIER -47.82 -57.95 4.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.203 0.525 . . . . 0.0 110.354 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -37.14 -44.82 0.58 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.98 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.5 m -71.91 -32.26 67.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.123 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 14.1 mt -71.6 -52.3 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.31 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -59.63 -21.89 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.445 178.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.692 ' HG3' HD12 ' A' ' 62' ' ' ILE . 2.1 tt0 -80.34 -41.03 25.53 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.111 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.6 ' OD2' HD23 ' A' ' 25' ' ' LEU . 37.2 m-20 -58.53 -57.32 13.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.71 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.41 -37.61 64.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.555 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.55 87.98 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.236 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -63.4 -31.4 72.55 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.498 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -73.21 -46.24 51.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.541 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.483 HD21 ' SG ' ' A' ' 17' ' ' CYS . 30.6 mt -76.31 -7.48 55.03 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.879 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 56.59 48.59 16.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.439 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 18.3 mmt -127.7 149.81 71.43 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.131 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.08 137.48 66.99 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.475 1.45 . . . . 0.0 111.233 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.692 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.7 tt -52.82 -29.72 14.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.023 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -73.45 -29.54 62.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.497 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -79.4 -34.65 41.64 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.06 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.535 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 55.7 t -66.14 -58.79 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.5 p -48.53 -38.8 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.662 178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -54.55 -44.31 72.77 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.739 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.31 -59.32 5.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.305 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.535 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 5.5 m-30 -45.98 -29.98 1.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.289 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.88 -52.64 51.09 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -57.02 -51.74 68.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.962 0.411 . . . . 0.0 110.143 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.599 ' CD1' ' SD ' ' A' ' 12' ' ' MET . 55.5 m-85 -56.73 -43.02 80.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.798 0.808 . . . . 0.0 110.595 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.0 tp -55.45 -38.38 68.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.614 -1.176 . . . . 0.0 112.057 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 43.6 t80 -68.91 -40.26 79.23 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.965 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -57.22 -70.2 0.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.038 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.87 -41.68 36.69 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.789 -178.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.2 mt -57.4 -44.83 84.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.274 0.537 . . . . 0.0 111.615 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -49.17 -20.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.903 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 t -81.77 -41.62 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.119 0.485 . . . . 0.0 109.834 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.414 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.5 mmp_? -65.41 -74.52 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.696 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.53 ' CD2' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -84.39 37.28 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.596 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.8 m -48.11 -46.43 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.111 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -54.22 -34.02 59.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.049 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.53 ' HB ' ' CD2' ' A' ' 81' ' ' HIS . 47.8 t -76.54 -21.93 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.685 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 87' ' ' LYS . 73.7 t -70.96 -41.49 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.765 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -54.75 -0.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.467 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.539 ' H ' ' C ' ' A' ' 85' ' ' VAL . 77.6 mttt -84.25 -28.01 27.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.52 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.12 119.47 36.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.587 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 58.2 t0 -84.02 -13.66 52.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.118 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.454 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 60.8 m-20 -162.02 167.63 24.1 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.431 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -53.83 -52.65 59.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.685 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.9 m -53.04 -37.68 61.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.259 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.4 m -60.88 -40.65 93.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.337 0.589 . . . . 0.0 110.14 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 ' CAB' ' A' ' 182' ' ' HEM . 8.4 tt -60.76 -59.3 5.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.318 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.9 t -52.72 -37.4 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.229 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 91.8 mmm -86.23 -5.68 59.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.731 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -114.93 -15.14 8.08 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.377 -0.68 . . . . 0.0 113.112 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 97' ' ' GLY . 10.3 mt -28.03 -104.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 117.763 0.782 . . . . 0.0 112.763 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 118' ' ' ILE . 8.1 p80 -39.39 -49.88 2.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.075 0.464 . . . . 0.0 111.229 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -44.47 -87.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -71.52 -51.89 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mp -63.92 -45.48 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.756 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.38 -52.73 51.03 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.7 tp -51.67 -52.36 48.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.791 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.537 ' CD ' ' HZ1' ' A' ' 87' ' ' LYS . 58.3 mm-40 -53.85 -46.0 71.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.329 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.4 t -55.29 -51.39 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 110' ' ' TYR . 20.2 t-20 -48.69 -42.74 35.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.684 0.278 . . . . 0.0 110.883 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -63.39 -36.69 84.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.746 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.7 tp -56.56 -32.55 65.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.66 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 107' ' ' ASN . 14.0 t80 -150.81 -133.94 0.06 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.335 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -152.67 161.33 42.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.528 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 46.66 59.93 15.37 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.534 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.11 -29.01 8.51 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.679 2.253 . . . . 0.0 111.998 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.5 t 43.26 59.6 2.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.759 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.6 mt -76.08 152.58 84.35 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.205 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.19 -172.86 0.37 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.285 1.99 . . . . 0.0 111.842 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -100.32 116.11 31.53 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.815 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 1.5 mp -130.43 128.61 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.657 0.265 . . . . 0.0 110.308 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -135.22 127.08 29.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.714 0.293 . . . . 0.0 110.859 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.56 135.01 11.49 Favored Glycine 0 N--CA 1.466 0.692 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -131.96 126.19 33.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 tp -72.47 136.32 45.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.97 0.414 . . . . 0.0 110.885 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.405 HD13 ' HB2' ' A' ' 129' ' ' ALA . 5.2 mp -110.56 160.58 28.04 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 59.6 Cg_endo -72.15 165.7 31.86 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.284 1.99 . . . . 0.0 111.898 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' PRO . 15.4 t-20 86.46 -62.66 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.103 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER 154.84 52.59 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.162 179.334 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -128.46 159.34 35.71 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.675 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.9 mt -134.38 117.16 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.405 ' HB2' HD13 ' A' ' 123' ' ' LEU . . . -86.95 123.03 31.62 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.63 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.6 tp -116.94 137.24 52.35 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.111 0.481 . . . . 0.0 111.011 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.486 ' NE ' ' NE2' ' A' ' 171' ' ' HIS . 42.1 ttm180 -127.14 126.12 42.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.832 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.603 ' HH ' ' CGA' ' A' ' 182' ' ' HEM . 33.2 t80 -128.62 129.87 46.49 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.521 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.33 133.6 24.56 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.066 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.57 ' H ' ' NH1' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -176.01 171.4 1.11 Allowed Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -39.39 -70.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.978 1.786 . . . . 0.0 110.103 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 79.8 mtm-85 -89.09 170.26 10.79 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.57 ' NH1' ' H ' ' A' ' 134' ' ' SER . 22.5 mmt180 -114.48 -32.82 5.78 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.799 0.727 . . . . 0.0 110.867 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.577 ' N ' HD22 ' A' ' 138' ' ' LEU . 2.8 mm? 48.18 15.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.498 ' N ' ' C ' ' A' ' 137' ' ' ARG . 21.7 p -40.76 -52.75 2.94 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.12 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.463 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 62.4 m-85 -47.78 -35.82 10.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 138' ' ' LEU . 6.7 t -76.46 -51.78 11.11 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -43.31 -45.74 6.08 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.941 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -62.72 -46.46 87.98 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.167 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.24 -52.95 40.66 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.8 mt -54.38 -55.85 24.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.706 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.3 mt -54.3 -55.43 28.42 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.097 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.536 ' CE2' HD12 ' A' ' 159' ' ' ILE . 5.9 m-85 -50.43 -48.49 56.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.678 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.18 -51.1 60.47 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.58 -59.61 2.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.887 0.375 . . . . 0.0 110.625 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -48.16 -50.23 29.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.87 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -52.81 -47.4 67.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.155 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -49.79 -50.32 45.27 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.668 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 70.6 t80 -86.01 37.19 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.025 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 39.73 54.11 2.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.993 0.425 . . . . 0.0 111.109 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -129.52 141.86 50.9 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -118.71 107.54 13.8 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.998 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 38.7 pt -114.56 -178.19 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.507 0.67 . . . . 0.0 111.559 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -145.18 126.38 14.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.252 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.536 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.2 mt -110.76 119.08 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 120.69 0.281 . . . . 0.0 110.828 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.2 t -101.07 103.71 14.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.834 0.35 . . . . 0.0 110.276 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 163' ' ' THR . 21.0 t-160 -100.15 73.62 1.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.454 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -79.26 -48.68 13.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.478 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 1.0 OUTLIER -73.63 124.53 26.13 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.914 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.581 ' O ' HG22 ' A' ' 167' ' ' THR . 70.8 m -126.55 174.11 8.92 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.801 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 168' ' ' GLY . 1.1 tmt? -90.18 -27.35 19.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.092 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -52.57 -23.16 5.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.489 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.1 t -88.91 -25.28 22.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.454 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 97.74 23.27 14.03 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.012 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.09 168.71 11.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 110.768 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -54.22 -34.16 59.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.52 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.486 ' NE2' ' NE ' ' A' ' 131' ' ' ARG . 5.5 p-80 -174.52 -169.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 92.5 m -93.28 138.7 31.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.7 tpt -117.98 124.25 47.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.169 0.509 . . . . 0.0 110.074 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.4 mt -126.26 102.87 7.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.701 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -87.33 128.72 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.67 151.45 14.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.416 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -143.13 141.33 31.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.598 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 179' ' ' GLN . 14.0 mt -92.07 174.18 7.45 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.837 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 178' ' ' LEU . 23.9 mt-30 -55.82 -155.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.187 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 179' ' ' GLN . 6.1 p-10 42.87 43.94 3.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.726 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 51.9 p30 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.59 -179.998 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.603 ' CGA' ' HH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' O ' ' A' ' 36' ' ' TYR . 20.6 tpp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -60.44 -31.1 70.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.423 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 6' ' ' PHE . . . -163.96 -172.61 31.65 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' SER . 2.2 tp -55.92 -42.49 71.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.677 0.275 . . . . 0.0 110.849 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.1 mm -59.88 -50.18 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.88 0.372 . . . . 0.0 110.147 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.401 ' HB2' ' H ' ' A' ' 3' ' ' GLY . 88.5 m-85 -67.52 -24.28 65.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.424 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.418 ' ND2' HH22 ' A' ' 80' ' ' ARG . 53.2 t-20 -67.77 -53.17 29.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.974 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.6 t -65.68 -35.99 76.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.364 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.487 HD13 ' CE2' ' A' ' 69' ' ' PHE . 21.1 tp -69.6 -45.4 68.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.562 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -50.39 -43.9 54.76 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.661 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -62.78 -51.31 67.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.928 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.6 tmt? -51.18 -39.98 57.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.84 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.7 t -71.38 -34.78 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.557 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.98 -22.53 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.227 0.537 . . . . 0.0 109.957 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.64 -34.65 19.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.237 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -84.52 -76.99 0.28 Allowed 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' HD21 ' A' ' 58' ' ' LEU . 96.3 m -91.33 -19.19 23.21 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.211 0.529 . . . . 0.0 110.708 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.18 173.72 27.52 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.772 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 ttt -69.32 -27.65 65.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.888 -1.156 . . . . 0.0 110.516 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 t -63.21 -42.57 99.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.0 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.73 -36.57 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -50.68 -45.48 58.17 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -71.88 -30.64 65.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.238 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -66.5 -51.14 59.88 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.959 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.44 -24.77 39.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.275 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.959 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.1 tt -71.92 -46.03 59.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.131 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -71.69 -25.25 62.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.841 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -81.32 -40.67 23.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.524 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 80.2 m80 -95.09 -84.79 0.33 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.267 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 31' ' ' PRO . . . -54.42 164.53 1.05 Allowed Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.194 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 89.2 Cg_exo -35.45 160.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 123.124 2.55 . . . . 0.0 112.648 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 22.7 pttm -58.83 -44.87 91.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.124 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 32' ' ' LYS . 64.0 m-20 -160.09 12.43 0.12 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.009 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.468 ' NE ' ' OH ' ' A' ' 36' ' ' TYR . 50.3 ttt85 -79.57 117.05 20.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.776 0.322 . . . . 0.0 110.365 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.6 166.59 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.515 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.468 ' OH ' ' NE ' ' A' ' 34' ' ' ARG . 25.3 m-85 -136.68 -171.07 2.83 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.489 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.708 HG22 ' CG ' ' A' ' 40' ' ' LYS . 1.8 m -82.42 -169.69 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 4' ' ' ILE . 44.0 m -71.64 -41.12 69.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.095 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.611 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -97.32 46.04 1.03 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.715 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.708 ' CG ' HG22 ' A' ' 37' ' ' VAL . 20.5 mmtt -135.44 156.25 49.22 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.123 0.487 . . . . 0.0 110.691 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 40' ' ' LYS . 42.1 m 44.81 -173.49 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.729 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.526 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 10.6 p90 -171.72 61.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.34 0.591 . . . . 0.0 110.574 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 45' ' ' SER . . . -82.21 24.05 0.69 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.468 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.538 ' CD ' HH22 ' A' ' 136' ' ' ARG . 78.4 tt0 -44.83 -18.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.435 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' ALA . 21.7 m -69.08 -42.96 75.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.314 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -70.37 -27.45 64.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.594 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -38.52 -55.83 1.36 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.808 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.66 -40.98 1.0 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.029 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -72.61 -34.3 67.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.972 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.566 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.9 mp -68.63 -55.27 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.293 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -53.86 -26.39 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.967 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.672 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.9 tt0 -75.41 -41.06 57.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.646 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.551 ' OD2' HD23 ' A' ' 25' ' ' LEU . 40.4 m-20 -59.34 -56.79 17.65 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.968 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.4 p -56.77 -38.27 57.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.073 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.533 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.88 -38.88 87.15 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.256 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -62.76 -32.07 73.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -74.08 -43.0 59.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.569 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 17' ' ' CYS . 39.0 mt -79.6 -8.04 58.92 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.669 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.5 t30 57.23 49.87 12.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.607 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.4 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 23.9 mmt -129.06 149.53 72.84 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.182 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.39 138.93 74.1 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.539 1.493 . . . . 0.0 110.996 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.672 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.4 tt -53.05 -29.38 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.281 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -72.13 -31.14 65.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 111.206 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.92 -32.36 51.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 55' ' ' ALA . 82.6 t -70.82 -56.94 9.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 67' ' ' LYS . 8.0 p -52.06 -41.81 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.267 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.507 ' N ' HG13 ' A' ' 66' ' ' VAL . 33.7 mtpt -53.59 -50.86 64.72 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.47 82.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.684 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.487 ' CE2' HD13 ' A' ' 9' ' ' LEU . 7.7 m-30 -52.91 -29.62 29.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.382 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.15 -49.57 56.87 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -55.26 -52.14 64.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 110.054 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -57.83 -42.74 84.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.773 0.796 . . . . 0.0 110.649 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.9 tp -56.47 -39.9 73.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.537 -1.21 . . . . 0.0 112.223 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 21.7 t80 -66.52 -44.29 82.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.31 0.576 . . . . 0.0 109.863 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -53.58 -68.73 0.15 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.241 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.05 -48.57 25.32 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.967 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.1 mt -52.38 -41.52 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.24 0.52 . . . . 0.0 112.063 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -56.34 -27.48 55.99 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.507 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -73.52 -55.38 6.4 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.048 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.418 HH22 ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -74.71 -43.31 55.75 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.034 -179.262 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.443 ' CE1' ' CBC' ' A' ' 182' ' ' HEM . 94.7 m-70 -89.18 28.1 1.28 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.779 0.323 . . . . 0.0 110.577 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 87.2 m -54.11 -37.26 64.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.079 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.523 ' O ' ' NZ ' ' A' ' 87' ' ' LYS . 88.3 m-20 -57.58 -30.54 65.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -85.88 -18.42 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.569 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.426 ' C ' ' N ' ' A' ' 87' ' ' LYS . 49.7 t -70.53 -45.28 75.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.418 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -51.2 -15.49 0.37 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.014 0.435 . . . . 0.0 110.354 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 83' ' ' ASP . 42.8 mmtm -69.08 -28.63 66.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.975 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 8.8 p90 -121.94 115.61 22.88 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.072 0.463 . . . . 0.0 110.732 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 55.2 t0 -84.48 -6.08 59.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.448 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.525 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 38.0 m-20 -158.13 158.69 35.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.141 0.496 . . . . 0.0 111.681 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -50.38 -50.29 51.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.653 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.9 m -57.88 -42.99 85.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.534 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 90.2 p -62.89 -35.59 80.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.077 0.465 . . . . 0.0 110.3 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.407 HD21 ' CBB' ' A' ' 182' ' ' HEM . 4.6 tt -67.28 -50.13 61.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.345 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 88.1 t -59.87 -36.58 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.223 0.535 . . . . 0.0 110.648 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 81.3 mmm -86.34 -8.67 57.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.34 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -111.57 -12.26 15.33 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 119.704 -0.498 . . . . 0.0 113.073 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.601 ' HA ' HD13 ' A' ' 102' ' ' ILE . 9.4 mt -33.59 -92.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 117.777 0.789 . . . . 0.0 111.937 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -41.08 -51.67 3.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.512 . . . . 0.0 111.267 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -46.63 -91.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.061 0.764 . . . . 0.0 113.061 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.546 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.8 m -68.42 -50.71 54.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.6 mp -63.78 -42.06 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.423 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.74 -56.8 19.11 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -49.55 -53.66 22.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.012 0.434 . . . . 0.0 110.494 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -54.05 -46.36 71.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.094 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 109' ' ' LEU . 39.4 t -55.1 -51.72 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -44.52 -44.63 8.79 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.351 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 110' ' ' TYR . 30.3 mmtp -58.11 -36.47 72.94 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 106' ' ' VAL . 48.0 mt -80.91 23.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.87 178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 110' ' ' TYR . 36.8 p90 -28.81 143.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.34 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -159.92 -62.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.297 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.67 ' H ' ' CD ' ' A' ' 113' ' ' PRO . 31.3 tt0 -173.88 -38.67 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.857 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.67 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 23.2 Cg_exo -64.22 151.76 84.04 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 122.291 1.994 . . . . 0.0 112.504 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.9 m -119.88 148.08 43.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.007 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.28 144.48 29.87 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.92 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -81.44 -160.04 0.12 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.45 2.1 . . . . 0.0 112.189 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -98.12 111.86 24.03 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.016 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -125.18 127.76 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.703 0.287 . . . . 0.0 110.723 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -135.39 127.89 30.57 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.701 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -132.18 151.95 20.03 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -144.06 157.65 44.19 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.1 tp -95.27 148.96 21.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 0.0 110.791 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.66 160.24 43.05 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.85 -39.07 2.58 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.544 2.163 . . . . 0.0 113.532 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -79.8 45.52 0.71 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.334 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 44.3 59.33 3.31 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.541 0.686 . . . . 0.0 110.716 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -136.04 159.42 41.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.958 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.6 mt -138.86 113.63 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.53 121.84 28.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 46.4 tp -114.88 135.13 54.53 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.859 0.361 . . . . 0.0 110.579 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.633 ' HE ' ' CD2' ' A' ' 171' ' ' HIS . 62.0 ttt180 -119.46 123.44 44.06 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.994 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -124.13 116.48 22.81 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.765 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.01 123.94 38.24 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.584 0.23 . . . . 0.0 110.828 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 136' ' ' ARG . 5.0 p -170.97 147.54 2.33 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.668 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.7 12.54 1.37 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.175 1.917 . . . . 0.0 110.776 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.648 ' HE ' ' CGA' ' A' ' 182' ' ' HEM . 48.8 mtp85 -94.19 113.27 25.17 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.866 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.409 ' C ' HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -69.3 37.03 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.19 -179.257 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 136' ' ' ARG . 3.3 mm? -99.75 7.06 45.37 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.963 0.411 . . . . 0.0 110.531 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 98.6 m -42.94 -51.02 5.75 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.587 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -46.76 -36.1 6.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.047 0.451 . . . . 0.0 110.229 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 10.2 t -66.81 -43.35 84.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.1 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.56 -50.83 16.72 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.864 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -61.36 -51.9 66.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.019 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.44 -43.28 20.18 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.51 -51.16 68.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.579 0.228 . . . . 0.0 111.551 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.3 mt -57.06 -56.37 22.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.739 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.445 ' CE2' HD12 ' A' ' 159' ' ' ILE . 33.9 m-85 -49.92 -47.99 51.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.673 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.02 -51.79 56.33 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.67 -60.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.057 0.456 . . . . 0.0 110.708 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.61 -51.09 39.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.919 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -50.92 -46.27 60.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.073 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -50.11 -49.95 50.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.735 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.525 ' CZ ' ' OD1' ' A' ' 90' ' ' ASP . 65.8 t80 -86.22 37.46 0.73 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.247 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 42.35 49.26 4.53 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 110.739 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -128.61 143.77 51.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -127.51 107.22 9.75 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.787 ' O ' HD13 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -119.72 164.14 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.392 0.615 . . . . 0.0 110.892 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -119.51 132.42 55.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.445 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.1 mt -110.44 118.27 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.6 t -103.41 116.01 31.61 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.555 0.217 . . . . 0.0 111.238 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 56.7 p-80 -98.16 79.11 2.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.385 0.612 . . . . 0.0 111.714 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -82.43 -1.02 48.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.158 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.09 109.82 5.77 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.511 ' O ' HG22 ' A' ' 167' ' ' THR . 14.2 m -112.71 -179.9 3.79 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.901 0.381 . . . . 0.0 110.26 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 168' ' ' GLY . 0.5 OUTLIER -92.18 -27.96 17.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.003 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -54.42 -23.82 17.44 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.791 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.5 t -87.11 -25.37 24.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.173 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 95.34 21.92 23.47 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.026 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.05 164.93 16.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.973 0.415 . . . . 0.0 110.773 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -50.41 -32.93 18.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.237 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.633 ' CD2' ' HE ' ' A' ' 131' ' ' ARG . 34.1 p80 -173.19 -172.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 2.8 m -94.1 141.23 28.77 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.4 124.04 46.71 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.36 101.11 6.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.631 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -89.27 126.43 42.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.603 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.61 149.32 11.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.967 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -139.8 136.53 34.16 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.44 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.6 mt -86.48 135.4 33.48 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.234 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -54.34 149.65 9.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.499 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 181' ' ' ASP . 36.4 t30 -156.98 92.89 1.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.459 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 180' ' ' ASN . 69.0 m-20 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.514 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.648 ' CGA' ' HE ' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.2 mtp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 3' ' ' GLY . 30.9 mmtm -81.99 107.23 14.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.471 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 57.76 122.03 0.01 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 5' ' ' ILE . 3.1 tp -55.16 -46.03 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.459 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.425 ' N ' HG23 ' A' ' 4' ' ' ILE . 36.7 mm -62.29 -50.1 81.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -69.57 -21.91 63.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.846 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 3' ' ' GLY . 29.0 t30 -70.57 -51.52 27.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.827 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.77 -33.79 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.029 0.442 . . . . 0.0 109.944 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.501 HD13 ' CE2' ' A' ' 69' ' ' PHE . 22.6 tp -74.64 -42.74 57.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.367 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -51.85 -45.71 64.14 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.605 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.58 -49.95 74.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.793 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.495 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 10.9 tpt -52.49 -41.35 63.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.682 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.72 -35.52 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.565 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.0 t -61.19 -23.37 29.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.343 0.592 . . . . 0.0 110.109 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.68 -34.31 19.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.078 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -84.78 -75.82 0.34 Allowed 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.517 ' SG ' HD21 ' A' ' 58' ' ' LEU . 98.4 m -92.34 -20.26 21.27 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.708 -178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.48 172.36 25.87 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.724 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.6 ttt -68.01 -28.4 67.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.867 -1.166 . . . . 0.0 110.424 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.0 m -63.21 -41.69 99.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.139 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.86 -36.32 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -53.26 -45.19 68.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.773 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -74.24 -26.97 60.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.41 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -69.38 -49.5 54.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.996 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.87 -23.06 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 110.243 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.996 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.1 tt -75.3 -59.01 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.519 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' N ' HD23 ' A' ' 26' ' ' LEU . 94.5 mt-10 -60.12 -21.66 61.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.391 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 tttp -80.92 -38.13 28.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.467 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 13.7 m80 -90.6 -87.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.522 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.34 152.96 71.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.476 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.82 146.87 89.08 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.533 2.155 . . . . 0.0 112.016 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' CD ' ' H ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -90.72 -21.42 21.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.233 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -80.27 -57.17 3.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.708 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.423 ' CD ' ' N ' ' A' ' 34' ' ' ARG . 10.7 mpt_? -69.5 136.99 52.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.243 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.39 150.32 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.274 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -120.16 173.58 7.02 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.563 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.604 HG22 ' CG ' ' A' ' 40' ' ' LYS . 1.7 m -121.89 166.67 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.923 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 m -77.43 36.06 0.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.908 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.534 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -157.9 2.26 0.11 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.063 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.604 ' CG ' HG22 ' A' ' 37' ' ' VAL . 14.7 mmtt -98.02 167.64 10.77 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 110.518 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.5 t -72.86 145.13 47.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.437 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -146.18 155.84 42.99 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.675 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.95 124.95 36.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.422 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -72.34 -23.72 61.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.757 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.7 p -59.13 -32.21 69.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.702 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -66.94 -54.29 23.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.701 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -40.69 -55.1 2.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.022 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -41.0 -41.8 1.74 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.255 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 m -74.82 -28.82 60.86 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' A' ' 47' ' ' LEU . 25.3 mm -70.21 -53.17 24.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.916 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.43 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -61.31 -22.42 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.189 178.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.67 ' HG3' HD12 ' A' ' 62' ' ' ILE . 5.0 tt0 -80.87 -42.12 22.03 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.064 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.623 ' OD2' HD23 ' A' ' 25' ' ' LEU . 45.2 m-20 -58.69 -56.69 18.88 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.665 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 55' ' ' ALA . 12.4 p -59.13 -38.43 74.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.471 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.401 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -59.88 -38.74 83.09 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.128 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -63.91 -32.09 73.5 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.645 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -73.12 -42.43 62.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.563 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.517 HD21 ' SG ' ' A' ' 17' ' ' CYS . 29.0 mt -80.74 -7.18 59.29 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.831 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.6 t30 55.9 47.76 19.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.578 0.704 . . . . 0.0 109.406 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.8 mmt -125.38 149.49 64.58 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.031 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.56 135.58 53.84 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.353 1.368 . . . . 0.0 111.054 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.67 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.8 tt -50.54 -30.73 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.271 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -71.37 -30.46 66.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.871 0.367 . . . . 0.0 111.227 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.19 -32.37 50.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.131 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 78.1 t -71.37 -56.2 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.523 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -51.38 -43.43 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.263 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.523 ' N ' HG13 ' A' ' 66' ' ' VAL . 34.6 mtpt -52.73 -51.25 61.24 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.224 0.535 . . . . 0.0 109.569 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.75 -51.35 67.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.963 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.549 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.7 m-30 -51.57 -30.73 21.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.565 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.66 -53.91 35.03 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -53.71 -49.8 67.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.153 0.501 . . . . 0.0 109.781 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.495 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 8.3 m-85 -58.44 -41.04 84.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.709 0.766 . . . . 0.0 110.307 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.04 -38.45 82.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.484 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.58 -35.99 73.35 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.168 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.546 ' CG ' ' HE2' ' A' ' 152' ' ' HIS . 4.3 m120 -58.94 -69.52 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.059 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.63 -41.65 57.3 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.501 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 19.9 mt -57.2 -46.48 82.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.056 0.428 . . . . 0.0 111.269 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.3 -12.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.119 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.479 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.5 p -89.2 -43.92 10.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.202 0.525 . . . . 0.0 110.173 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.463 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.0 mmp_? -65.07 -55.26 19.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.505 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.4 p80 -101.77 31.19 3.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.296 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 m -46.31 -43.32 15.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.302 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.443 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 83.8 m-20 -55.82 -30.73 61.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.208 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.0 t -78.5 -23.53 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.847 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.473 ' C ' ' H ' ' A' ' 87' ' ' LYS . 72.0 t -76.06 -42.42 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.34 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 83' ' ' ASP . 1.4 p30 -54.9 -8.67 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 85' ' ' VAL . 63.4 mmtt -67.35 -28.13 67.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.204 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.417 ' CD1' ' OG ' ' A' ' 93' ' ' SER . 8.1 m-85 -129.39 128.71 43.58 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.056 0.455 . . . . 0.0 111.161 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -87.52 16.01 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -167.75 165.45 14.14 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 119.219 -0.993 . . . . 0.0 113.075 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 80.6 t80 -64.2 -63.18 1.21 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.789 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.6 m -45.91 -43.84 14.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.307 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.417 ' OG ' ' CD1' ' A' ' 88' ' ' PHE . 16.1 p -64.37 -38.03 89.61 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.491 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.51 -55.29 28.88 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.781 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.9 t -50.05 -38.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.087 0.47 . . . . 0.0 110.438 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 85.0 mmm -84.84 -7.45 59.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.362 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -109.17 -12.86 19.12 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.873 -0.404 . . . . 0.0 112.694 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.683 ' HA ' HD13 ' A' ' 102' ' ' ILE . 43.0 mt -32.46 -103.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -38.17 -43.8 0.79 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -48.65 -88.87 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.606 ' CG2' HD12 ' A' ' 102' ' ' ILE . 3.0 m -69.05 -51.15 46.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.683 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.7 mp -59.79 -45.77 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.047 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.33 -55.49 25.51 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.7 tp -50.4 -53.91 25.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.023 0.439 . . . . 0.0 110.75 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -53.1 -45.4 68.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.463 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 102' ' ' ILE . 37.9 t -53.11 -52.35 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 110' ' ' TYR . 20.1 t-20 -46.87 -42.66 17.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.835 0.35 . . . . 0.0 110.657 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -62.23 -37.32 84.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.505 ' O ' ' CG ' ' A' ' 110' ' ' TYR . 7.4 mp -70.05 -40.53 75.06 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.302 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.505 ' CG ' ' O ' ' A' ' 109' ' ' LEU . 91.4 m-85 -157.35 172.85 17.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.548 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -62.82 -143.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.662 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 61.01 59.8 3.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.725 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.08 -25.22 11.94 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.775 2.317 . . . . 0.0 111.917 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.1 m -72.58 54.26 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.671 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 116' ' ' PRO . 10.9 mt -72.55 153.47 91.73 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.279 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 115' ' ' LEU . 75.0 Cg_exo -35.83 161.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.811 2.34 . . . . 0.0 113.074 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -98.28 118.6 35.3 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.144 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 mm -120.39 126.29 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.712 0.291 . . . . 0.0 110.675 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -124.97 105.43 9.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.119 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.62 159.66 13.63 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -151.28 158.5 43.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.755 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.59 146.06 30.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -118.69 160.73 39.09 Favored Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.23 -37.08 3.59 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.592 2.195 . . . . 0.0 113.083 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 25.9 t30 -81.52 45.74 0.9 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.151 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.8 m120 43.76 58.62 3.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.339 0.59 . . . . 0.0 110.742 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -135.09 159.99 39.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.017 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.2 mt -136.96 116.41 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.07 121.46 30.5 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 21.9 tp -118.62 130.99 56.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.251 0.548 . . . . 0.0 110.632 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -126.54 131.22 51.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.517 ' CD1' ' O1A' ' A' ' 182' ' ' HEM . 0.0 OUTLIER -131.46 137.41 48.59 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.252 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 134' ' ' SER . 10.4 p -140.44 133.75 29.77 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.18 0.514 . . . . 0.0 111.92 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 136' ' ' ARG . 0.7 OUTLIER 167.09 155.2 0.11 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.955 179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -67.91 31.93 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.268 1.978 . . . . 0.0 111.673 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.538 ' C ' ' H ' ' A' ' 138' ' ' LEU . 5.5 mpt_? -101.23 95.67 6.69 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 139' ' ' CYS . 83.8 mtm180 -64.86 11.07 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.257 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 136' ' ' ARG . 0.7 OUTLIER -74.67 23.93 0.09 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.818 0.342 . . . . 0.0 110.13 -179.531 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.562 ' HG ' ' HG ' ' A' ' 172' ' ' CYS . 62.5 m -48.88 -64.26 0.86 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.121 0.486 . . . . 0.0 111.38 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -46.73 -37.12 7.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.335 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 5.1 t -65.51 -43.18 90.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -44.54 -51.99 8.42 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.669 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.474 ' OE2' ' CB ' ' A' ' 161' ' ' HIS . 40.0 mt-10 -60.34 -49.34 78.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.281 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.5 -48.75 41.42 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.7 mt -57.89 -54.89 41.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.515 0.198 . . . . 0.0 111.495 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 28.0 mt -54.61 -54.86 35.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.713 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.654 ' CE2' HD12 ' A' ' 159' ' ' ILE . 13.2 m-85 -49.79 -50.79 43.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.943 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -56.92 -51.72 55.46 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.794 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.52 -54.59 4.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.441 . . . . 0.0 110.613 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -53.06 -48.86 67.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.053 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -50.59 -53.66 28.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.901 0.381 . . . . 0.0 111.04 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.546 ' HE2' ' CG ' ' A' ' 75' ' ' ASN . 85.6 m-70 -45.73 -49.89 14.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.161 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.61 33.75 0.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 40.75 51.72 3.1 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.148 0.499 . . . . 0.0 110.657 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -126.86 140.71 52.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.275 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.41 ' CG ' HD22 ' A' ' 180' ' ' ASN . 29.8 mmtp -115.74 124.77 51.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.472 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 10.8 pt -136.16 170.84 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.665 0.745 . . . . 0.0 112.143 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -132.7 125.74 30.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.852 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.654 HD12 ' CE2' ' A' ' 147' ' ' PHE . 5.3 mt -110.94 117.47 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.676 0.274 . . . . 0.0 110.5 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.3 t -97.65 101.02 12.43 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.959 0.409 . . . . 0.0 109.979 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.52 ' NE2' ' O ' ' A' ' 163' ' ' THR . 11.7 t-160 -104.52 75.4 1.23 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.869 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -80.61 -42.76 21.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.895 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.52 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.4 m -76.05 117.98 18.33 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.913 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 166' ' ' HIS . 1.6 p -144.13 113.79 7.14 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.048 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.8 ttt -37.3 -21.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.853 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.572 ' N ' ' O ' ' A' ' 164' ' ' CYS . 83.3 t60 -52.49 -26.81 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.454 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 4.5 t -88.17 -42.88 12.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.141 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.454 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 133.72 10.26 1.86 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.5 162.33 10.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.041 0.448 . . . . 0.0 110.939 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -58.88 -33.18 70.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.616 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -170.05 -170.45 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.562 ' HG ' ' HG ' ' A' ' 139' ' ' CYS . 85.0 m -94.61 137.04 34.21 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.971 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.6 tpt -115.68 123.89 49.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.05 103.37 6.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.422 0.629 . . . . 0.0 111.577 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -92.89 126.19 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.329 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 177' ' ' GLU . 4.6 mp -112.64 153.17 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.549 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.403 ' N ' HG22 ' A' ' 176' ' ' ILE . 88.1 tt0 -139.5 138.84 36.69 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.571 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 17.0 mt -90.83 144.1 26.05 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.8 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -154.78 -179.49 8.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.559 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.41 HD22 ' CG ' ' A' ' 156' ' ' LYS . 59.2 t30 57.57 43.64 22.28 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.52 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 48.9 p30 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.563 179.922 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.517 ' O1A' ' CD1' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.52 ' O ' ' N ' ' A' ' 3' ' ' GLY . 44.4 mmm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.628 ' HZ2' HG22 ' A' ' 37' ' ' VAL . 17.9 mtpp -55.32 83.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.129 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -179.9 151.51 10.06 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.423 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.0 tp -70.28 -36.28 66.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.968 0.413 . . . . 0.0 110.705 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.4 mm -62.46 -44.57 99.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.096 0.474 . . . . 0.0 109.912 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.503 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 64.7 m-85 -71.34 -25.41 62.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.54 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -69.4 -52.51 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.071 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.26 -35.0 70.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.423 HD13 ' CD2' ' A' ' 69' ' ' PHE . 31.6 tp -67.44 -40.82 85.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.773 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -55.54 -45.47 77.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.039 0.447 . . . . 0.0 109.839 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.81 -53.75 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.569 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.608 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 49.1 mtm -52.3 -44.28 64.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.118 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.17 -36.61 77.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.75 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.29 -25.83 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.151 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.36 -33.79 21.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.173 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -84.2 -76.16 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.8 m -93.22 -21.84 19.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.26 0.552 . . . . 0.0 110.805 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.7 173.96 22.97 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 122.129 0.85 . . . . 0.0 112.962 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.1 ttt -68.14 -28.38 67.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.65 -1.275 . . . . 0.0 110.408 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -61.83 -39.27 91.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.841 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -77.53 -38.52 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -56.13 -47.84 77.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.128 0.489 . . . . 0.0 110.31 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -75.63 -22.97 56.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.584 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -76.29 -47.11 24.84 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.604 -0.439 . . . . 0.0 112.04 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.981 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.61 -25.53 38.38 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.981 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.3 tt -73.65 -44.15 57.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.492 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -73.05 -21.1 60.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.964 0.411 . . . . 0.0 110.555 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 tttt -87.15 -42.0 13.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.866 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -105.49 1.04 27.26 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.569 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 31' ' ' PRO . . . -152.22 164.62 19.69 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 120.667 0.27 . . . . 0.0 110.792 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 97.4 Cg_exo -34.61 169.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 124.061 3.174 . . . . 0.0 114.267 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 42.0 pttt -73.58 37.72 0.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.794 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 32' ' ' LYS . 6.9 t0 83.64 46.71 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -77.29 19.14 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.094 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.536 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 24.2 m -60.65 132.72 26.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.724 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.536 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 41.6 m-85 -163.71 -106.08 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.965 0.412 . . . . 0.0 111.585 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.628 HG22 ' HZ2' ' A' ' 2' ' ' LYS . 33.5 m -45.94 -178.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.47 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 m -151.8 47.03 0.79 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.329 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.506 ' O ' ' CD2' ' A' ' 111' ' ' HIS . . . -159.03 -6.23 0.07 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.81 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HG2' HG21 ' A' ' 37' ' ' VAL . 5.4 mmpt? -77.28 -168.29 1.09 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.526 0.679 . . . . 0.0 110.834 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.7 t -59.38 137.0 58.15 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.47 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.513 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 54.4 p90 -109.83 127.63 54.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.585 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.39 75.17 4.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.343 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' A' ' 44' ' ' GLU . 0.4 OUTLIER -51.39 -37.85 50.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.721 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.475 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 80.1 p -56.17 -32.51 64.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.708 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -75.96 -36.46 59.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.95 -58.42 5.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.198 0.523 . . . . 0.0 110.805 -179.605 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -38.64 -43.09 0.85 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.055 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.6 p -74.14 -30.03 62.09 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.035 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 47' ' ' LEU . 18.6 mt -72.98 -50.66 30.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.123 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.1 m -60.66 -22.42 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.0 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.694 ' HG3' HD12 ' A' ' 62' ' ' ILE . 2.5 tt0 -80.49 -40.68 25.68 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.898 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.621 ' OD2' HD23 ' A' ' 25' ' ' LEU . 55.9 m-20 -58.83 -57.4 13.21 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.837 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.21 -39.41 78.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.582 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.428 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -58.63 -39.1 79.54 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.857 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -64.64 -32.94 74.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -72.6 -41.78 65.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.196 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.508 ' O ' ' SD ' ' A' ' 60' ' ' MET . 30.1 mt -79.27 -3.96 48.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.503 ' O ' ' SD ' ' A' ' 60' ' ' MET . 10.6 t-20 52.72 46.62 26.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.475 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -125.56 153.05 72.66 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.863 179.308 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.48 136.68 47.63 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.717 1.612 . . . . 0.0 110.816 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.694 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.9 tt -51.19 -28.76 7.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.819 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.629 ' NE2' ' CZ ' ' A' ' 140' ' ' PHE . 3.0 tp-100 -76.04 -32.22 59.24 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.973 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -80.15 -31.61 38.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.86 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.499 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 63.5 t -67.84 -58.17 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -49.86 -40.86 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.495 ' N ' HG13 ' A' ' 66' ' ' VAL . 2.2 ttpp -51.65 -47.18 63.84 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.896 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.36 -59.76 4.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.171 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 5.1 m-30 -45.15 -29.0 0.83 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.763 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.94 -52.15 50.21 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -55.51 -51.4 67.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.075 0.464 . . . . 0.0 110.302 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.608 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 45.5 m-85 -59.19 -43.38 92.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.757 0.789 . . . . 0.0 110.909 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 tp -52.06 -38.32 56.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.296 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 22.6 t80 -70.87 -41.48 71.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.106 0.479 . . . . 0.0 110.014 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -54.22 -74.52 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.14 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -50.64 -37.18 33.41 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.767 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 19.2 mt -58.56 -47.25 84.86 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.337 0.569 . . . . 0.0 112.139 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.43 -20.94 0.26 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.231 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' ' 82' ' ' THR . 19.7 t -77.8 -50.17 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 111.003 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -64.28 -64.74 0.8 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.571 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.4 p80 -83.64 31.21 0.47 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.737 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 79' ' ' SER . 94.3 m -48.29 -45.85 35.32 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.452 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -53.16 -29.78 33.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.052 0.453 . . . . 0.0 109.863 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 3.3 t -83.21 -23.98 8.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 t -63.31 -39.68 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -53.48 -13.59 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.434 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 84' ' ' VAL . 37.8 mmtm -66.6 -31.08 71.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.51 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 20.5 p90 -120.39 117.13 26.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.059 0.457 . . . . 0.0 110.931 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.36 0.78 48.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.317 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 48.6 t0 -163.86 157.74 19.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.626 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.507 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 82.5 t80 -48.13 -51.44 24.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.712 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 83.9 m -56.32 -41.86 76.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.522 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.3 m -62.74 -36.54 83.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.411 0.624 . . . . 0.0 110.563 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.493 HD12 ' CD2' ' A' ' 88' ' ' PHE . 2.2 tt -65.91 -62.52 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.289 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.5 t -47.43 -41.44 7.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 O-C-N 123.337 0.398 . . . . 0.0 111.879 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.6 ppp? -85.67 -8.11 58.4 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.278 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -107.77 -14.21 18.11 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.461 -0.4 . . . . 0.0 112.334 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.606 ' HA ' HD13 ' A' ' 102' ' ' ILE . 33.4 mt -31.87 -97.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 117.398 0.599 . . . . 0.0 111.997 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -39.95 -49.99 2.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.173 0.511 . . . . 0.0 111.377 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -46.89 -90.02 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.568 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.6 m -68.97 -50.75 51.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.606 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.1 mp -64.19 -42.52 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.493 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.56 -57.98 10.22 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.595 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 56.7 tp -46.73 -55.11 8.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.143 0.496 . . . . 0.0 110.438 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -52.41 -44.52 65.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.8 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 102' ' ' ILE . 30.4 t -55.44 -52.32 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -47.04 -44.75 20.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.64 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.595 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 27.0 mmtm -58.9 -34.79 72.07 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.932 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -57.9 -35.24 70.76 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.435 ' CB ' ' O ' ' A' ' 109' ' ' LEU . 9.5 t80 82.04 102.42 0.06 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.694 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 36.0 t-80 -173.6 -0.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.458 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 111' ' ' HIS . 7.1 pt-20 32.81 61.46 1.48 Allowed Pre-proline 0 N--CA 1.468 0.456 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.68 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.53 -15.51 13.82 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.827 2.352 . . . . 0.0 112.159 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.7 t 57.54 84.51 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.505 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.4 mt -74.36 147.98 85.62 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.502 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.89 -177.14 2.7 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.246 1.964 . . . . 0.0 111.95 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -84.55 113.5 21.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.557 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -128.48 129.1 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.674 0.273 . . . . 0.0 110.886 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -134.08 123.34 24.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.718 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.91 127.01 7.04 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.458 ' C ' HD12 ' A' ' 122' ' ' LEU . 86.9 mt-30 -117.33 166.34 12.41 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.458 HD12 ' C ' ' A' ' 121' ' ' GLN . 11.2 mp -109.31 133.96 52.39 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.93 160.71 28.84 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 58.5 Cg_endo -71.78 159.02 51.83 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.188 1.925 . . . . 0.0 111.883 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 124' ' ' PRO . 4.1 t-20 90.91 -59.17 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.296 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 125' ' ' ASN . 5.4 p30 151.83 53.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.894 0.747 . . . . 0.0 109.499 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -127.74 164.06 22.96 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.976 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.4 mt -141.24 119.2 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.67 123.33 33.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.083 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 47.4 tp -118.24 132.34 56.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.074 0.464 . . . . 0.0 110.965 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -115.7 122.81 46.65 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.234 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.519 ' CE2' HMA1 ' A' ' 182' ' ' HEM . 22.8 t80 -125.63 124.58 41.5 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.585 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.05 122.15 23.73 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.765 0.316 . . . . 0.0 110.199 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.8 t -153.76 143.01 14.87 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.047 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.95 -6.93 18.71 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.962 1.775 . . . . 0.0 112.012 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -78.42 -20.3 51.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.124 0.488 . . . . 0.0 110.339 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 60.39 29.63 19.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.984 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp -83.46 15.2 3.17 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.332 0.587 . . . . 0.0 109.94 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 32.9 m -41.73 -48.29 4.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.702 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.629 ' CZ ' ' NE2' ' A' ' 63' ' ' GLN . 98.2 m-85 -48.13 -39.88 21.93 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.708 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.3 t -64.44 -43.23 94.95 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.97 -52.97 10.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.436 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -55.14 -50.07 70.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.08 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.97 -48.22 46.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.09 -54.23 49.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.743 0.306 . . . . 0.0 111.369 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.8 mt -54.88 -55.66 27.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.849 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.563 ' CE2' HD12 ' A' ' 159' ' ' ILE . 14.1 m-85 -49.75 -48.53 50.14 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.817 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.95 -51.31 59.94 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.35 -60.13 2.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.736 0.303 . . . . 0.0 110.832 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' ' 155' ' ' GLN . . . -51.34 -51.09 57.56 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.317 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -52.98 -48.75 67.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.053 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -47.97 -49.15 31.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.504 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 73.3 t80 -83.42 36.28 0.52 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.71 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 40.78 58.25 2.48 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.939 0.399 . . . . 0.0 111.228 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.485 ' HB3' ' HB1' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -132.63 152.59 51.61 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.481 ' H ' ' CD ' ' A' ' 155' ' ' GLN . 62.6 mttp -120.8 117.94 28.71 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.5 pt -130.68 169.7 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.624 0.726 . . . . 0.0 112.63 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -134.73 127.12 30.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.898 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.563 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.8 mt -110.42 118.65 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.8 m -103.01 111.55 23.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.398 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 16.7 p80 -96.61 77.22 2.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.513 0.673 . . . . 0.0 111.558 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 54.7 t0 -82.1 -3.3 54.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.415 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.56 114.6 8.64 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.438 ' O ' HG22 ' A' ' 167' ' ' THR . 92.3 m -118.62 -175.93 2.99 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.628 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 72.7 mtp -94.73 -26.47 16.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -55.61 -23.66 28.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.798 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 164' ' ' CYS . 4.0 t -87.16 -29.69 21.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.5 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.41 18.0 22.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.63 167.03 9.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.847 0.356 . . . . 0.0 110.423 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.544 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 94.4 m-20 -45.55 -49.6 13.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.69 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.544 ' ND1' ' O ' ' A' ' 170' ' ' ASP . 73.6 m-70 -160.76 -168.14 2.03 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.5 t -93.85 144.27 25.59 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.149 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.2 120.93 36.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.061 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.53 103.62 7.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.469 0.652 . . . . 0.0 110.502 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.4 mp -89.95 127.12 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.379 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.93 150.51 13.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.32 0.581 . . . . 0.0 110.869 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -136.17 136.08 39.71 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.897 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.2 mt -96.83 159.72 14.76 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.62 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -138.93 167.66 21.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.845 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -71.59 -40.03 70.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.731 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.561 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.519 HMA1 ' CE2' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' H2 ' ' HA ' ' A' ' 39' ' ' ALA . 86.9 mtp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HZ1' ' CD ' ' A' ' 112' ' ' GLU . 55.2 mttp -148.09 -155.85 0.67 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.538 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.16 -16.3 61.37 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.654 HD13 ' NH1' ' A' ' 80' ' ' ARG . 2.5 tp -53.9 -38.46 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.029 0.443 . . . . 0.0 109.881 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.3 -54.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -60.99 -31.22 70.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.267 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -59.94 -60.33 4.0 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.075 0.464 . . . . 0.0 111.428 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.18 -24.26 29.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.474 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.8 tp -74.29 -41.75 60.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.516 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.533 ' OE2' ' CG ' ' A' ' 36' ' ' TYR . 3.4 mt-10 -58.16 -39.25 78.35 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.316 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -60.9 -56.04 25.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.532 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 18.1 tpt -50.73 -41.66 56.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.203 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.31 -34.45 62.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.692 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 10' ' ' GLU . 40.8 t -63.36 -23.96 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.22 0.533 . . . . 0.0 110.055 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.65 -33.99 18.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.96 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -85.63 -76.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.7 m -91.37 -19.2 23.17 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.52 171.85 28.12 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.847 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.7 ttt -67.37 -29.51 69.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.776 -1.212 . . . . 0.0 110.327 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 t -61.92 -41.5 98.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.947 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.78 -38.64 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -51.64 -45.89 63.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.0 109.732 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -71.76 -29.8 64.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.011 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.525 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 75.5 mt-10 -68.12 -51.64 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.966 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.91 -23.2 48.76 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.436 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.966 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.7 tt -74.26 -41.88 60.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.528 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -66.97 -19.08 65.66 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 24' ' ' GLU . 1.1 ptpp? -91.66 -29.0 17.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.505 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 3.4 m-70 -94.2 -88.4 0.24 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.82 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -74.85 151.9 86.71 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.57 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -67.46 147.85 78.02 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.626 2.218 . . . . 0.0 111.95 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -83.06 -22.63 33.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.726 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -67.43 -46.15 73.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.929 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.431 ' O ' ' OH ' ' A' ' 42' ' ' TYR . 30.9 mmm-85 -71.82 94.52 1.42 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.134 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -61.06 138.63 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.483 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.533 ' CG ' ' OE2' ' A' ' 10' ' ' GLU . 49.6 p90 -78.95 125.79 29.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.966 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.554 HG23 ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -143.9 148.67 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.614 179.58 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.7 m -77.09 39.31 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.854 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.554 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -151.63 -2.15 0.31 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.008 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.531 ' CG ' HG22 ' A' ' 37' ' ' VAL . 14.2 mmtt -87.37 167.97 13.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.049 0.452 . . . . 0.0 110.423 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.5 t -91.49 44.32 1.18 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.01 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' A' ' 34' ' ' ARG . 3.2 m-85 -57.28 137.32 56.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.21 123.07 27.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.588 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.501 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 36.8 mp0 -65.68 -28.97 69.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 95.3 p -56.93 -33.76 67.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.821 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -68.32 -33.79 74.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.027 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -43.17 -57.5 2.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.165 0.507 . . . . 0.0 110.641 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -38.8 -43.43 0.92 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.724 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.1 m -71.84 -32.44 67.54 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.42 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.6 mp -71.71 -53.81 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.667 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.446 HG13 ' H ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -55.9 -23.37 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.374 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.674 ' HG3' HD12 ' A' ' 62' ' ' ILE . 4.7 tt0 -79.79 -40.1 29.39 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.14 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 4.4 m-20 -59.69 -57.01 14.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.586 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 55' ' ' ALA . 6.8 p -56.17 -41.09 68.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.522 -0.763 . . . . 0.0 108.998 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.412 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -57.05 -39.1 74.22 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.944 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -64.93 -34.6 78.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.649 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.4 mmt-85 -70.52 -38.26 74.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.178 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.518 ' O ' ' SD ' ' A' ' 60' ' ' MET . 49.0 mt -82.7 -4.9 58.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.519 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.1 t-20 51.76 44.52 29.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.244 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -125.82 155.81 72.24 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.854 179.188 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.19 140.53 71.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.015 1.81 . . . . 0.0 111.036 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.674 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.9 tt -55.44 -27.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.859 -178.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' CD ' ' CZ ' ' A' ' 140' ' ' PHE . 88.6 mt-30 -76.36 -33.46 58.93 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.45 -30.07 42.06 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.088 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG12 ' CZ ' ' A' ' 69' ' ' PHE . 96.8 t -72.06 -56.07 11.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.499 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -50.98 -40.12 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.499 ' N ' HG13 ' A' ' 66' ' ' VAL . 1.9 ttpt -52.66 -50.98 62.15 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.895 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.28 -53.98 42.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.721 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.485 ' CZ ' HG12 ' A' ' 65' ' ' VAL . 2.9 m-30 -54.25 -27.98 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.92 -52.78 45.57 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -56.44 -47.93 78.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 0.8 OUTLIER -59.33 -43.97 92.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.866 0.841 . . . . 0.0 110.337 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -53.35 -38.68 63.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.809 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.455 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 26.2 t80 -69.84 -41.25 75.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.934 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -55.15 -71.87 0.08 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.781 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.61 -44.48 22.91 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.405 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.8 mt -56.36 -40.63 74.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.0 0.4 . . . . 0.0 111.431 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -59.31 -29.29 67.51 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.879 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.9 t -72.83 -54.17 9.52 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.828 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.654 ' NH1' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -72.59 -49.48 31.95 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.222 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -83.97 25.44 0.82 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.442 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 52.6 m -50.44 -38.92 46.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.045 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -57.14 -32.41 66.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.18 -22.07 9.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.547 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 87' ' ' LYS . 40.9 t -69.25 -42.63 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.649 -0.421 . . . . 0.0 109.952 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -52.51 -15.02 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.034 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' N ' ' C ' ' A' ' 85' ' ' VAL . 38.4 mmtm -67.58 -29.92 69.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.648 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.565 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 13.1 p90 -120.85 119.84 33.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.063 0.459 . . . . 0.0 110.967 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -86.28 1.88 49.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.447 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.48 ' OD1' ' CE2' ' A' ' 153' ' ' PHE . 45.4 t0 -166.75 160.15 14.48 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.22 0.533 . . . . 0.0 111.627 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 95' ' ' VAL . 84.2 t80 -51.54 -51.05 58.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.941 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.8 m -55.67 -45.38 77.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.734 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 90' ' ' ASP . 54.9 p -61.66 -36.45 80.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.408 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.483 HD12 ' CD2' ' A' ' 88' ' ' PHE . 5.2 tt -65.89 -52.16 52.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.23 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.416 HG21 ' CE2' ' A' ' 91' ' ' PHE . 69.8 t -56.31 -36.69 47.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.208 0.527 . . . . 0.0 110.43 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.5 mmm -86.61 -6.89 58.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.33 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -112.9 -14.82 9.75 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.982 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.581 ' HA ' HD13 ' A' ' 102' ' ' ILE . 10.3 mt -30.05 -100.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 117.648 0.724 . . . . 0.0 112.348 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -40.35 -49.05 2.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.023 0.44 . . . . 0.0 111.182 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -46.22 -88.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.577 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.6 m -70.67 -52.88 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.581 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.3 mp -60.62 -46.12 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.302 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.92 -55.25 30.8 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.7 tp -51.74 -53.45 39.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -53.5 -47.36 69.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.159 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 102' ' ' ILE . 33.6 t -52.44 -49.22 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -50.13 -41.44 48.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.778 0.323 . . . . 0.0 110.637 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -62.32 -38.61 90.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.722 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.14 -40.94 77.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -158.64 144.64 16.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.419 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -63.6 -154.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.426 ' CD ' ' HZ1' ' A' ' 2' ' ' LYS . 36.0 tt0 61.09 60.67 3.15 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.752 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.471 ' C ' ' H ' ' A' ' 115' ' ' LEU . 73.7 Cg_endo -75.23 35.84 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.69 2.26 . . . . 0.0 111.701 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.7 m -70.8 38.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.853 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.471 ' H ' ' C ' ' A' ' 113' ' ' PRO . 11.2 mt -71.59 152.32 93.7 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.97 168.63 22.6 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.384 2.056 . . . . 0.0 112.08 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -81.53 116.29 21.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.323 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.5 mt -127.5 128.25 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.728 0.299 . . . . 0.0 110.879 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -132.61 119.66 20.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.744 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.72 137.88 14.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -135.04 128.31 32.08 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.565 0.221 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 tp -76.89 149.52 36.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.756 0.312 . . . . 0.0 111.07 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.18 160.47 43.16 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.12 -36.43 4.28 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.578 2.185 . . . . 0.0 113.059 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -80.65 46.41 0.87 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.046 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 43.49 55.87 4.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.52 0.676 . . . . 0.0 110.739 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -133.48 159.22 41.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.876 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.0 mt -136.65 114.65 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.5 121.58 29.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.084 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.7 tp -116.16 134.7 54.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.094 0.473 . . . . 0.0 110.619 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -120.58 124.55 45.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -122.34 105.99 10.69 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.68 121.19 41.78 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 121.198 -0.201 . . . . 0.0 110.539 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 136' ' ' ARG . 4.8 p -174.64 149.25 1.29 Allowed Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.374 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.9 18.09 0.37 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.086 1.858 . . . . 0.0 110.817 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.553 ' NE ' ' CGA' ' A' ' 182' ' ' HEM . 25.1 mtp180 -95.83 104.65 16.59 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.64 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -71.15 40.37 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.634 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.479 ' H ' ' C ' ' A' ' 136' ' ' ARG . 1.6 tp -102.09 9.67 40.1 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.112 0.482 . . . . 0.0 110.268 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.9 t -40.05 -48.21 2.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.638 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.417 ' CZ ' ' CD ' ' A' ' 63' ' ' GLN . 90.7 m-85 -48.2 -36.87 14.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.613 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 53.8 t -68.53 -44.4 74.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.023 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.78 -45.71 14.83 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.507 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -63.97 -48.96 74.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.217 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.08 -48.12 39.73 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.4 mt -59.96 -53.55 56.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.734 0.302 . . . . 0.0 111.535 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.9 mt -54.81 -55.88 25.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.078 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.594 ' CE2' HD12 ' A' ' 159' ' ' ILE . 21.7 m-85 -51.68 -48.14 63.59 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.978 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.69 -51.66 56.63 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.21 -60.27 1.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.754 0.311 . . . . 0.0 111.008 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.38 -50.87 38.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.005 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -52.44 -47.14 66.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.249 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -50.01 -50.69 46.47 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.704 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.51 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 69.5 t80 -86.11 37.03 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.933 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 39.17 55.71 2.14 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.937 0.398 . . . . 0.0 111.061 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -129.87 141.65 50.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -112.34 125.61 54.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.259 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 26.1 pt -137.07 170.15 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.61 0.719 . . . . 0.0 111.993 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -134.96 126.62 28.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.116 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.594 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.5 mt -110.52 116.8 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.669 0.271 . . . . 0.0 110.328 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.3 t -101.46 107.94 19.38 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.383 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.559 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.8 p-80 -93.97 65.79 3.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.605 0.717 . . . . 0.0 111.065 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -68.25 -25.35 65.14 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.823 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.502 ' HB ' ' H ' ' A' ' 173' ' ' MET . 1.8 m -112.52 112.0 23.24 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 166' ' ' HIS . 49.9 t -137.3 115.26 11.5 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.602 0.239 . . . . 0.0 110.839 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.412 ' C ' ' N ' ' A' ' 167' ' ' THR . 24.0 ttt -35.18 -22.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.261 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 164' ' ' CYS . 57.7 t-80 -51.11 -21.45 1.92 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.464 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.7 t -90.08 -41.35 11.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.913 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.464 ' N ' HG23 ' A' ' 167' ' ' THR . . . 124.81 15.0 3.3 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.08 155.86 30.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.976 0.417 . . . . 0.0 110.821 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.92 -27.93 21.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.379 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -172.49 178.87 2.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 6.3 m -94.46 139.72 30.77 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.66 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.502 ' H ' ' HB ' ' A' ' 163' ' ' THR . 16.2 ttm -127.62 94.99 4.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.525 0.679 . . . . 0.0 109.68 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.1 mt -93.12 113.07 25.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.523 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.9 mm -89.14 126.16 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.585 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.38 148.72 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.25 0.548 . . . . 0.0 110.268 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -137.8 136.8 37.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.339 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.3 mt -93.9 146.05 24.19 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.863 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -141.56 178.2 7.62 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.858 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 15.1 m120 54.35 43.62 30.19 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.59 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 51.0 p30 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.591 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.553 ' CGA' ' NE ' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 tp . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.637 0.256 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.43 -51.41 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.168 0.509 . . . . 0.0 109.87 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -69.12 -22.26 63.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.495 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -69.64 -54.13 15.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.6 t -61.71 -35.81 69.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.01 0.433 . . . . 0.0 109.835 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.492 HD13 ' CE2' ' A' ' 69' ' ' PHE . 21.8 tp -70.98 -43.25 68.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.097 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -51.95 -46.09 64.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -61.28 -48.2 82.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.681 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.588 ' SD ' ' CZ ' ' A' ' 72' ' ' PHE . 10.9 tpt -53.84 -43.04 69.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.726 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.15 -35.25 67.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.403 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.01 -23.36 31.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.239 0.542 . . . . 0.0 110.028 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.17 -34.39 19.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.156 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -84.69 -76.62 0.3 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' HD21 ' A' ' 58' ' ' LEU . 97.8 m -91.66 -19.83 22.25 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.282 0.563 . . . . 0.0 110.786 -178.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.02 173.99 26.48 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.825 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.3 ttt -68.74 -29.76 68.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.796 -1.202 . . . . 0.0 110.518 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -62.06 -41.71 98.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.065 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.52 -37.83 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 -51.82 -45.22 63.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -71.73 -29.27 64.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.144 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -67.46 -50.49 58.91 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.782 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.26 -22.93 38.31 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.454 -179.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.782 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.3 tt -74.32 -56.0 5.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.145 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -61.55 -22.98 65.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.547 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -81.35 -38.27 26.94 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.526 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 78.7 m-70 . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.792 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.777 0.323 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 41.4 mp0 -72.65 -32.81 66.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.812 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.98 -58.26 5.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.134 0.492 . . . . 0.0 110.66 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CZ ' HD12 ' A' ' 138' ' ' LEU . 84.6 m-85 -37.67 -44.1 0.68 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.042 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.1 t -73.24 -31.23 64.0 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.156 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.9 mt -71.42 -51.25 34.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.129 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -60.39 -21.7 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.84 178.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.691 ' HG3' HD12 ' A' ' 62' ' ' ILE . 1.6 tt0 -80.17 -41.52 25.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.002 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 29' ' ' HIS . 72.5 m-20 -58.62 -57.14 14.28 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.834 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 55' ' ' ALA . 7.8 p -58.63 -39.05 74.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.483 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.412 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -59.56 -39.65 84.72 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.221 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -63.61 -31.85 73.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -74.28 -41.31 61.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.562 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 17' ' ' CYS . 29.0 mt -80.98 -6.37 58.67 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.652 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 56.11 47.79 18.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.488 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mmt -126.54 149.05 66.79 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.066 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -63.11 135.77 52.69 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.381 1.387 . . . . 0.0 111.092 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.691 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.0 tt -49.11 -28.3 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.156 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -71.78 -34.5 69.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.055 0.455 . . . . 0.0 111.582 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -76.03 -31.77 59.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.066 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.2 t -71.83 -56.16 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.734 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.524 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -51.63 -44.45 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.396 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.524 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.9 mtpt -52.33 -50.45 62.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.255 0.55 . . . . 0.0 109.518 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.14 -57.39 12.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.925 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.549 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 8.1 m-30 -45.53 -29.72 1.24 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.391 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.19 -48.07 73.98 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -58.24 -52.34 65.98 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.067 0.46 . . . . 0.0 110.054 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 12' ' ' MET . 63.1 m-85 -56.59 -40.18 74.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.747 0.785 . . . . 0.0 110.616 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.9 tp -59.22 -37.85 78.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.387 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -70.54 -37.9 74.11 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.968 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -58.11 -71.31 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.887 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.07 -41.79 30.2 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.296 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.402 ' C ' ' N ' ' A' ' 79' ' ' SER . 24.2 mt -58.39 -43.37 88.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.368 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -51.75 -17.56 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.161 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.43 ' O ' ' OG1' ' A' ' 82' ' ' THR . 8.0 t -85.73 -40.88 15.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.247 0.546 . . . . 0.0 109.62 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.431 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.3 mmp_? -65.44 -72.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.471 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.536 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -87.84 36.91 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.399 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 6.8 m -49.45 -48.99 47.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.926 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -51.43 -33.67 31.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.18 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.538 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 7.1 t -73.82 -29.24 25.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.499 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.536 ' C ' ' H ' ' A' ' 87' ' ' LYS . 89.3 t -76.22 -44.68 36.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.562 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 54.7 t0 -58.24 3.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.366 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' A' ' 85' ' ' VAL . 30.6 mtmt -90.57 -22.45 21.27 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.541 ' CE1' HG21 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -104.13 125.83 50.76 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.794 -179.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 56.6 p30 -88.44 -6.07 57.87 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 58.8 m-20 -160.29 164.12 32.84 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.636 0.731 . . . . 0.0 112.535 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.402 ' CE2' HG21 ' A' ' 95' ' ' VAL . 64.4 t80 -55.1 -44.29 74.77 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.979 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.9 m -57.71 -59.72 4.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.352 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 97.4 p -45.67 -40.14 8.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.367 0.604 . . . . 0.0 110.792 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.44 -41.59 96.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.428 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 91' ' ' PHE . 69.5 t -67.89 -40.84 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.384 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.9 ptm -83.25 -3.16 57.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.307 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -116.41 -15.74 6.89 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 119.123 -0.82 . . . . 0.0 113.357 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.599 ' HA ' HD13 ' A' ' 102' ' ' ILE . 18.8 mt -25.09 -104.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 118.04 0.92 . . . . 0.0 112.477 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -40.38 -49.0 2.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.068 0.461 . . . . 0.0 111.466 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -45.63 -83.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.61 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.8 m -73.31 -53.81 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.61 ' N ' HG23 ' A' ' 101' ' ' VAL . 3.3 mp -59.27 -49.84 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.939 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.33 -55.13 32.41 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.8 tp -49.18 -48.0 45.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.154 0.502 . . . . 0.0 109.769 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -57.59 -46.46 83.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.042 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.6 t -54.22 -50.15 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -49.07 -43.59 41.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.717 0.294 . . . . 0.0 110.803 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp . . . . . 0 C--N 1.33 -0.278 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.211 179.778 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 C--O 1.231 0.108 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.1 128.54 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.716 0.293 . . . . 0.0 110.959 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -133.58 123.57 25.35 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.652 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.12 158.22 14.64 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.442 ' C ' HD22 ' A' ' 122' ' ' LEU . 52.3 tt0 -149.95 160.1 43.87 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.824 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.4 mm? -106.74 146.02 31.34 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.99 160.4 40.99 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.25 -38.12 2.9 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.596 2.197 . . . . 0.0 113.054 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -79.49 44.83 0.63 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.953 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 44.39 58.29 3.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.413 0.625 . . . . 0.0 110.72 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -135.11 159.94 39.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.107 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 45.0 mt -137.41 117.12 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.3 122.86 32.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.049 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.1 tp -118.8 133.03 56.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.044 0.45 . . . . 0.0 111.205 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -114.79 122.98 48.03 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.481 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 62.1 t80 . . . . . 0 N--CA 1.469 0.486 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.786 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.413 HD12 ' CZ ' ' A' ' 48' ' ' PHE . 4.1 tp . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 121.215 0.531 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 74.4 m -42.08 -43.87 3.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.469 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -48.87 -41.98 35.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.961 0.41 . . . . 0.0 110.375 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.6 t -64.29 -43.27 95.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -44.52 -50.1 9.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.59 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.03 -49.56 77.17 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.164 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.01 -48.96 50.89 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.0 -55.1 39.36 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.58 0.229 . . . . 0.0 111.315 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.7 mt -54.14 -54.38 40.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.909 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.54 ' CE2' HD12 ' A' ' 159' ' ' ILE . 12.1 m-85 -51.52 -48.02 63.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.952 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.49 -51.54 57.18 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.8 -59.76 2.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.881 0.372 . . . . 0.0 110.844 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -48.28 -51.68 24.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.873 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -52.03 -47.86 64.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.218 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -49.48 -49.9 43.64 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.64 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.507 ' CZ ' ' OD1' ' A' ' 90' ' ' ASP . 71.5 t80 -85.48 37.17 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.939 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 39.21 57.57 1.99 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.021 0.439 . . . . 0.0 111.199 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.511 HE21 ' H ' ' A' ' 156' ' ' LYS . 51.7 tp60 -131.59 143.43 50.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.511 ' H ' HE21 ' A' ' 155' ' ' GLN . 59.9 mttp -118.85 105.25 11.32 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.8 pt -114.47 175.49 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.596 0.712 . . . . 0.0 111.718 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -138.08 127.67 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.407 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.54 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.7 mt -111.31 117.76 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.602 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.1 t -98.28 98.89 10.09 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.602 ' CD2' ' SG ' ' A' ' 164' ' ' CYS . 23.7 t-160 -92.14 69.92 5.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.005 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.52 -57.28 3.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.56 119.53 21.26 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.464 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 1.7 m -143.64 119.06 10.28 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.122 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 38.0 ttp -36.11 -21.69 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.036 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 164' ' ' CYS . 58.3 t-80 -51.19 -22.0 2.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.45 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.3 t -91.43 -41.42 10.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.103 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.45 ' N ' HG23 ' A' ' 167' ' ' THR . . . 126.5 12.25 3.46 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.86 171.6 6.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.0 0.429 . . . . 0.0 110.817 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 171' ' ' HIS . 42.1 p-10 -53.31 -35.65 60.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.273 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.52 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 5.1 p-80 -174.52 -167.06 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.7 m -94.9 142.97 26.85 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.758 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.573 ' CG ' HD11 ' A' ' 175' ' ' ILE . 28.3 ttm -119.49 116.12 25.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.058 0.456 . . . . 0.0 109.954 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 176' ' ' ILE . 1.3 mt -118.15 99.53 6.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.491 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.573 HD11 ' CG ' ' A' ' 173' ' ' MET . 8.5 mm -85.27 126.24 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.939 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 174' ' ' LEU . 5.1 mp -112.31 149.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.35 0.595 . . . . 0.0 110.375 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -144.14 142.48 30.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.349 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.35 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 tp . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.773 0.321 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.1 mm -72.31 -41.07 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 1.2 m-30 -75.48 -25.45 57.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.643 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -69.16 -52.77 24.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.821 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.71 -39.13 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.061 0.457 . . . . 0.0 109.855 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.521 HD13 ' CE2' ' A' ' 69' ' ' PHE . 20.9 tp -67.02 -47.62 70.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.87 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -50.37 -44.5 54.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.958 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.18 -54.37 46.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.383 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.439 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 28.5 ttt -51.05 -41.45 59.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.061 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.15 -36.71 77.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.509 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.7 t -62.04 -23.12 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.264 0.554 . . . . 0.0 110.032 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.04 -34.31 18.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.026 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -85.88 -76.51 0.33 Allowed 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 58' ' ' LEU . 98.1 m -90.69 -17.71 26.31 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.314 0.578 . . . . 0.0 110.599 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.87 179.19 30.56 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.741 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.8 ttp -72.95 -30.5 63.91 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.004 -1.098 . . . . 0.0 110.701 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.2 t -60.55 -39.31 87.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.981 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.04 -38.61 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 55.4 t-105 -55.26 -47.47 75.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.204 0.526 . . . . 0.0 110.071 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -74.76 -25.8 59.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.494 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.64 -47.48 26.23 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.978 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.996 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -78.34 -23.34 47.02 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.861 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.996 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.9 tt -76.35 -43.4 41.1 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.366 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -67.74 -18.89 65.04 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.26 -30.83 18.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.474 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.2 m80 . . . . . 0 N--CA 1.463 0.195 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.637 -179.767 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.782 0.325 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -56.62 -29.56 62.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.874 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.554 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -51.18 -56.52 12.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.081 0.467 . . . . 0.0 110.978 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -39.87 -42.17 1.27 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.867 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 m -74.05 -29.78 62.07 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.919 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 47' ' ' LEU . 17.8 mt -73.4 -51.4 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.275 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.1 m -59.15 -25.08 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.155 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.657 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.7 tt0 -77.2 -40.83 43.74 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.735 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -59.3 -56.97 15.33 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.858 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.26 -39.55 52.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.86 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.01 -38.58 83.09 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.479 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.437 ' NE2' ' N ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -63.03 -31.94 73.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -73.28 -40.6 64.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.672 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 ' SG ' ' A' ' 17' ' ' CYS . 37.7 mt -83.15 -8.91 59.44 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.615 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 58.1 51.54 8.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.453 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.42 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 20.6 mmt -131.14 149.89 74.99 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.448 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.18 138.48 72.52 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.534 1.489 . . . . 0.0 111.27 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.657 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.4 tt -53.18 -28.75 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.654 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -74.59 -29.65 61.4 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.302 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -78.64 -35.22 45.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.034 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.538 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.0 t -65.06 -59.65 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.7 p -48.99 -38.8 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.793 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -53.68 -45.15 70.25 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.18 -57.44 10.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.898 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.538 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 6.3 m-30 -45.18 -29.15 0.88 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.313 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.67 -51.29 58.48 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.515 ' NE2' ' OE1' ' A' ' 151' ' ' GLN . 39.9 tt0 -58.0 -52.93 63.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.995 0.426 . . . . 0.0 110.32 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.439 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 61.1 m-85 -55.0 -41.3 71.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.722 0.772 . . . . 0.0 110.507 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.5 tp -59.05 -38.68 79.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.411 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -67.48 -40.38 85.29 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.139 -0.625 . . . . 0.0 109.896 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -57.93 -69.37 0.18 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.305 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.11 -42.01 30.83 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.74 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.88 -43.27 81.09 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.376 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.94 -27.45 18.97 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.424 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.8 t -74.42 -38.61 63.01 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -65.05 -69.22 0.3 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.802 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -98.49 47.03 0.99 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.036 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 m -51.49 -44.41 62.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.767 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 92.7 m-20 -56.8 -30.13 63.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.609 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.7 t -79.15 -20.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.767 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' A' ' 87' ' ' LYS . 49.0 t -75.88 -40.47 38.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.306 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 83' ' ' ASP . 29.8 p-10 -52.82 -8.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.045 0.45 . . . . 0.0 110.661 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 85' ' ' VAL . 56.9 mttm -73.02 -29.96 63.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.468 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.612 ' CZ ' ' CE2' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -97.56 119.6 36.41 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.021 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 53.4 p30 -88.24 -19.09 27.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.498 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 49.4 p30 -156.44 148.04 22.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.752 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -37.67 -40.65 0.43 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.04 0.447 . . . . 0.0 111.176 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.6 m -63.74 -41.67 98.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.869 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.433 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 38.7 m -61.34 -36.67 80.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.527 0.68 . . . . 0.0 110.375 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 98' ' ' ILE . 7.2 tt -65.53 -63.28 1.13 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.462 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.6 t -48.65 -41.72 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.789 0.328 . . . . 0.0 111.722 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.429 ' C ' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -85.49 -6.03 59.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.448 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -110.28 -14.38 13.28 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.659 -0.523 . . . . 0.0 112.439 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.495 ' O ' ' O ' ' A' ' 97' ' ' GLY . 39.8 mt -29.58 -104.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 117.395 0.597 . . . . 0.0 112.58 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.462 ' N ' ' ND1' ' A' ' 99' ' ' HIS . 9.0 p-80 -39.47 -48.33 1.97 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.06 0.457 . . . . 0.0 111.494 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -44.99 -87.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -71.05 -51.66 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.562 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mp -63.63 -47.81 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.651 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.14 -52.6 46.03 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.585 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 31.9 tp -49.51 -48.17 48.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.119 0.485 . . . . 0.0 110.31 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -57.43 -45.37 84.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.118 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 82.3 t -52.37 -51.92 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -49.42 -41.66 40.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.803 0.335 . . . . 0.0 110.547 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.585 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 24.4 mmtm . . . . . 0 C--N 1.329 -0.312 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.495 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 79.2 m80 . . . . . 0 C--O 1.232 0.132 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.6 mt -124.63 128.75 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.71 0.29 . . . . 0.0 110.707 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.619 ' ND2' ' NH2' ' A' ' 131' ' ' ARG . 4.3 m-80 -132.62 115.1 15.0 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.427 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.84 123.68 5.9 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.401 ' C ' HD12 ' A' ' 122' ' ' LEU . 37.1 tt0 -116.99 152.27 34.97 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.605 ' N ' HD12 ' A' ' 122' ' ' LEU . 8.8 mp -99.67 148.0 24.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.06 160.67 42.13 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.35 -40.61 2.19 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.573 2.182 . . . . 0.0 113.062 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -77.77 43.67 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.874 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 46.03 60.86 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.267 0.556 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -138.0 160.83 38.31 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.085 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.1 mt -141.84 117.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.69 121.47 31.1 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.845 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.5 tp -114.54 134.85 54.72 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.908 0.385 . . . . 0.0 110.137 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.619 ' NH2' ' ND2' ' A' ' 119' ' ' ASN . 23.5 ttp-105 -120.79 125.22 47.02 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.108 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 141' ' ' CYS . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 121.067 0.46 . . . . 0.0 110.214 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 85.5 m -39.9 -44.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.624 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.601 ' CE2' ' NE2' ' A' ' 166' ' ' HIS . 94.4 m-85 -53.75 -34.76 60.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.629 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 138' ' ' LEU . 43.8 t -69.79 -46.29 66.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.118 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.27 -46.07 12.41 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.384 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.49 -47.81 80.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.732 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.19 -52.47 40.1 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.1 mt -53.32 -55.73 22.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.746 0.308 . . . . 0.0 110.805 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 20.2 mt -54.82 -54.67 39.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.4 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.545 ' CE2' HD12 ' A' ' 159' ' ' ILE . 6.4 m-85 -50.15 -50.58 48.45 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.093 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.11 -49.99 67.8 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.358 -0.448 . . . . 0.0 111.996 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.03 -59.74 2.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.891 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 155' ' ' GLN . . . -53.9 -51.99 61.95 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.477 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.515 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 86.6 mt-30 -51.83 -56.68 12.49 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 120.853 0.359 . . . . 0.0 111.164 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -41.5 -47.52 3.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.921 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.612 ' CE2' ' CZ ' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -86.17 36.46 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.665 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 151' ' ' GLN . 6.5 tt0 42.29 57.77 3.23 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.395 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.585 HE21 HG23 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -131.76 153.62 49.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.544 ' N ' ' NE2' ' A' ' 155' ' ' GLN . 56.4 mttp -121.7 116.44 24.54 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.585 HG23 HE21 ' A' ' 155' ' ' GLN . 31.4 pt -130.2 173.82 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.369 0.604 . . . . 0.0 111.728 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -140.37 126.85 20.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.927 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.545 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.6 mt -110.97 118.42 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.4 t -101.81 110.92 23.01 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.667 0.27 . . . . 0.0 111.016 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.553 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 50.1 p-80 -102.57 73.57 1.31 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.688 0.756 . . . . 0.0 111.494 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -76.56 -18.88 58.43 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.801 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 108.4 13.21 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.587 ' SG ' ' CD2' ' A' ' 166' ' ' HIS . 9.1 t -133.68 118.82 18.59 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.608 0.242 . . . . 0.0 110.868 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 44.4 ttm -35.8 -22.36 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.214 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.601 ' NE2' ' CE2' ' A' ' 140' ' ' PHE . 28.3 m-70 -51.43 -23.28 3.7 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.1 t -89.31 -41.89 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.021 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.458 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 127.88 13.3 2.75 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.83 159.43 19.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.998 0.428 . . . . 0.0 110.831 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -56.7 -27.76 59.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.399 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -168.87 175.88 5.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 9.5 m -91.72 143.81 26.16 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.805 0.335 . . . . 0.0 110.627 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.2 tpp -121.99 120.52 34.64 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.44 104.83 8.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.394 0.616 . . . . 0.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -91.23 125.36 43.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.4 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 177' ' ' GLU . 5.2 mp -110.32 152.59 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.999 0.428 . . . . 0.0 110.27 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.42 ' N ' HG22 ' A' ' 176' ' ' ILE . 21.5 mt-10 -143.95 141.99 30.51 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.995 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.463 0.193 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.926 179.306 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.49 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 49.6 mm -57.78 -53.89 38.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 0.0 109.755 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -67.56 -18.75 65.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.568 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -73.39 -56.2 5.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.471 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t -56.99 -36.03 49.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.466 HD13 ' CE2' ' A' ' 69' ' ' PHE . 18.1 tp -72.09 -41.75 66.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.752 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -51.82 -44.38 63.5 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -61.53 -50.65 71.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.987 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.476 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 13.5 ttt -52.55 -42.89 64.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 86.8 t -68.89 -35.91 71.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.462 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -61.01 -23.42 29.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.336 0.589 . . . . 0.0 109.799 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.22 -34.43 20.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.174 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -85.06 -75.86 0.34 Allowed 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.546 ' SG ' HD21 ' A' ' 58' ' ' LEU . 87.7 m -92.03 -20.75 21.0 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.234 0.54 . . . . 0.0 110.741 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.8 172.04 25.52 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.819 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 ttt -66.92 -29.08 68.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.798 -1.201 . . . . 0.0 110.55 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t -62.51 -41.54 98.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.133 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.68 -35.87 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -51.97 -45.82 64.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.223 0.535 . . . . 0.0 109.578 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -72.24 -29.65 64.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.211 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -67.39 -49.24 64.69 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.824 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.38 -23.46 34.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.793 0.33 . . . . 0.0 110.651 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.824 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.6 tt -72.62 -61.8 1.68 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.401 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.489 ' N ' HD23 ' A' ' 26' ' ' LEU . 96.9 mt-10 -59.2 -22.11 60.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.687 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -81.2 -41.15 22.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.488 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 91.7 m-70 . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.554 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.729 0.299 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.27 -42.57 98.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.83 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -40.82 -58.76 1.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.928 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -37.68 -43.36 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.539 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.5 p -72.48 -33.32 66.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.272 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.0 mp -68.38 -54.83 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.028 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -55.32 -24.61 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.878 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.649 ' HG3' HD12 ' A' ' 62' ' ' ILE . 5.8 tt0 -75.56 -41.79 53.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.598 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.488 ' OD2' ' CD2' ' A' ' 29' ' ' HIS . 19.5 m-20 -58.62 -56.83 17.11 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.136 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.19 -38.82 63.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.096 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.534 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -59.11 -38.5 79.71 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.179 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.502 ' NE2' ' N ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -63.77 -31.68 72.94 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -73.79 -40.56 63.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.546 HD21 ' SG ' ' A' ' 17' ' ' CYS . 30.9 mt -85.25 -6.75 59.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.085 0.469 . . . . 0.0 110.004 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.489 ' O ' ' SD ' ' A' ' 60' ' ' MET . 20.7 m120 56.47 61.18 2.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.973 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 52.3 mmm -139.76 149.84 60.79 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.708 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.21 136.86 53.68 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.405 1.403 . . . . 0.0 110.778 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.649 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.6 tt -50.21 -27.66 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.042 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -73.44 -31.38 63.79 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.481 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.7 -34.05 52.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.995 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.534 HG21 ' HB2' ' A' ' 55' ' ' ALA . 84.8 t -69.5 -57.21 9.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.3 p -51.99 -42.23 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.308 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.515 ' N ' HG13 ' A' ' 66' ' ' VAL . 33.0 mtpt -52.75 -50.3 63.75 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.38 -48.22 81.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.757 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.469 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.0 m-30 -52.12 -30.42 26.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.632 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.44 -48.13 71.82 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -56.89 -51.74 67.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.931 0.396 . . . . 0.0 109.98 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 55.4 m-85 -58.68 -42.53 88.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.818 0.818 . . . . 0.0 110.447 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.8 tp -56.8 -39.26 73.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.335 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 38.1 t80 -69.0 -41.31 77.97 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.002 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -55.9 -69.28 0.15 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.199 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.63 -46.89 30.37 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.397 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.8 mt -51.0 -43.69 60.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.724 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.7 -25.9 30.27 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.277 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 82' ' ' THR . 32.9 t -74.4 -55.68 5.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.045 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.409 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -74.17 -38.04 63.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.781 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -94.26 25.43 3.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.555 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 79' ' ' SER . 55.9 m -52.83 -39.0 62.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 110.002 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -57.91 -31.12 66.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.432 HG22 ' HG2' ' A' ' 105' ' ' GLU . 2.8 t -86.22 -20.17 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.55 -40.81 89.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -53.22 -19.66 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.387 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -64.72 -29.47 70.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.797 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 7.0 p90 -122.54 115.27 21.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.887 0.375 . . . . 0.0 110.843 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 54.8 p30 -85.69 -3.41 58.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.451 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 89' ' ' ASP . 61.7 m-20 -160.86 156.96 25.83 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.088 0.471 . . . . 0.0 111.452 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.407 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 69.6 t80 -48.12 -53.05 17.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.812 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.8 m -55.69 -42.41 75.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.655 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.0 p -63.0 -38.27 90.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.447 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.0 tt -64.12 -48.97 74.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.004 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.5 t -58.25 -37.39 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 0.0 110.776 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 120' ' ' GLY . 95.6 mmm -87.24 -4.89 59.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.088 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.7 -16.93 7.75 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.163 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.507 ' O ' ' O ' ' A' ' 97' ' ' GLY . 11.2 mt -27.43 -106.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 117.828 0.814 . . . . 0.0 112.645 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -40.45 -48.35 2.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.118 0.485 . . . . 0.0 111.074 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -44.46 -86.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.564 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.2 m -72.86 -52.17 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.564 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.8 mp -63.97 -48.3 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.617 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.02 -54.63 35.96 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.9 tp -48.8 -50.58 33.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.138 0.495 . . . . 0.0 110.101 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.432 ' HG2' HG22 ' A' ' 84' ' ' VAL . 37.5 tp10 -54.26 -46.38 72.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.389 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 64.3 t -53.87 -53.38 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -46.54 -43.51 17.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.804 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp . . . . . 0 C--N 1.329 -0.301 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.516 -179.909 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 76.4 m80 . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 120.484 0.183 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.44 123.96 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.45 99.41 5.82 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.892 0.377 . . . . 0.0 110.927 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.479 ' O ' ' SD ' ' A' ' 96' ' ' MET . . . -102.89 123.41 7.83 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -118.87 162.11 19.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.897 0.379 . . . . 0.0 110.447 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -108.12 143.76 36.45 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.12 160.37 41.39 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.77 -38.06 3.38 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.538 2.159 . . . . 0.0 113.343 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -81.0 46.17 0.88 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.27 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 43.7 59.31 3.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 110.685 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -135.52 157.98 45.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.884 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.0 mt -137.06 117.52 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.33 119.99 27.2 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.755 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.5 tp -114.04 125.89 54.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 110.789 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.675 HH21 ' CD2' ' A' ' 171' ' ' HIS . 9.4 tpt180 -111.18 119.73 39.92 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 t80 . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.127 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 3.4 mm? . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 121.298 0.57 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 15.8 p -42.14 -46.57 4.39 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.794 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.596 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 88.6 m-85 -51.49 -38.5 54.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.086 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.506 ' SG ' ' CG2' ' A' ' 66' ' ' VAL . 68.4 m -65.8 -43.29 89.15 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.162 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.54 -49.86 18.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.947 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -62.64 -51.2 68.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.087 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.53 -46.39 37.41 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.5 mt -59.11 -54.29 48.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.707 0.289 . . . . 0.0 111.428 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 mt -55.26 -56.12 23.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.983 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.567 ' CE2' HD12 ' A' ' 159' ' ' ILE . 23.0 m-85 -50.58 -47.6 57.88 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.841 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.02 -50.84 63.57 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.41 -58.48 2.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.002 0.43 . . . . 0.0 110.613 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.7 -52.01 57.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.701 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -50.48 -48.78 56.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.113 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.4 ' ND1' ' C ' ' A' ' 152' ' ' HIS . 16.8 t-80 -48.66 -48.92 39.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.689 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -89.22 39.12 0.92 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.236 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 37.49 57.53 1.37 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.943 0.401 . . . . 0.0 111.379 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.679 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 42.1 tp60 -129.82 141.0 50.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.679 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 21.4 tptp -112.61 124.62 52.95 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.407 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 10.3 pt -138.1 170.3 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.735 0.779 . . . . 0.0 111.975 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -133.63 127.65 33.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.335 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.567 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.7 mt -110.0 120.62 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.653 0.263 . . . . 0.0 110.447 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.6 t -103.69 103.81 13.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.771 0.32 . . . . 0.0 110.894 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.1 p-80 -97.14 74.17 2.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.435 0.636 . . . . 0.0 111.338 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -77.29 -7.5 56.08 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.442 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.482 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 4.7 m -123.94 105.79 9.89 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.594 ' O ' ' N ' ' A' ' 166' ' ' HIS . 20.7 t -137.23 114.34 10.74 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.305 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 38.9 ttm -36.34 -18.24 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' CYS . 51.9 m80 -58.15 -28.08 64.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.499 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.2 t -82.41 -46.13 13.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.799 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.499 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 152.65 15.17 0.07 OUTLIER Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.247 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.19 145.64 32.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.907 0.384 . . . . 0.0 110.532 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.469 ' C ' ' ND1' ' A' ' 171' ' ' HIS . 85.7 m-20 -83.44 19.27 1.59 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.021 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.675 ' CD2' HH21 ' A' ' 131' ' ' ARG . 8.5 p-80 174.65 -163.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 163' ' ' THR . 46.6 t -136.48 150.51 48.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.276 0.56 . . . . 0.0 111.426 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.468 ' H ' ' HB ' ' A' ' 163' ' ' THR . 14.8 ttp -126.89 109.95 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.325 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -108.62 111.95 24.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.319 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.6 mp -93.84 128.64 45.06 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.478 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.4 mp -109.63 150.65 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.477 0.656 . . . . 0.0 110.63 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -136.21 134.67 38.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.773 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.463 0.224 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.632 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.59 HD13 ' NE ' ' A' ' 80' ' ' ARG . 2.4 tp . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.682 0.277 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.511 ' H ' HG23 ' A' ' 4' ' ' ILE . 36.1 mm -51.14 -47.5 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.53 -23.96 61.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.742 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -69.48 -51.26 37.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.426 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.51 -50.86 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.34 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.7 tp -55.46 -44.19 76.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -52.09 -50.88 60.71 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.825 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -57.6 -52.55 64.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.029 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.438 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.5 OUTLIER -47.72 -37.11 12.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.469 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -73.73 -34.76 41.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.403 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.4 HG13 ' CG ' ' A' ' 19' ' ' MET . 83.5 t -61.33 -23.69 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.68 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.76 -34.91 22.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.982 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -84.5 -73.88 0.41 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.541 ' SG ' HD21 ' A' ' 58' ' ' LEU . 74.3 m -93.87 -21.52 19.2 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.089 0.471 . . . . 0.0 111.076 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.68 -178.82 23.3 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.827 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.4 ' CG ' HG13 ' A' ' 14' ' ' VAL . 24.0 mtm -74.07 -30.41 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.063 -1.069 . . . . 0.0 110.193 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 m -61.99 -42.82 99.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.85 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.7 -38.42 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -51.84 -45.83 64.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.309 0.576 . . . . 0.0 109.453 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -70.93 -28.84 64.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.116 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -67.9 -49.89 59.4 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.797 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.69 -20.23 36.54 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.934 0.397 . . . . 0.0 110.659 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.8 tt -76.31 -63.32 1.35 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.316 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.509 ' N ' HD23 ' A' ' 26' ' ' LEU . 96.7 mt-10 -57.73 -21.93 43.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.596 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -80.01 -39.93 28.93 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.702 179.772 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.729 0.299 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -59.44 -30.98 68.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.707 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -49.55 -56.2 10.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.107 0.48 . . . . 0.0 110.576 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -38.79 -43.37 0.92 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.808 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.1 p -74.3 -29.3 61.57 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.157 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 47' ' ' LEU . 15.7 mt -72.89 -52.67 21.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.109 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.405 ' H ' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -57.8 -24.37 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.627 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.678 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.4 tt0 -78.03 -39.43 41.98 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.43 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.528 ' OD2' HD23 ' A' ' 25' ' ' LEU . 64.9 m-20 -60.28 -56.85 16.48 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.282 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 55' ' ' ALA . 8.2 p -56.66 -41.05 73.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.553 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -57.1 -38.98 74.16 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.887 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -63.73 -30.79 71.84 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -76.94 -38.56 53.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.583 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.541 HD21 ' SG ' ' A' ' 17' ' ' CYS . 30.1 mt -84.74 -7.09 59.34 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.82 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 47.7 t30 56.36 49.28 15.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.54 0.686 . . . . 0.0 109.302 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.4 mmm -126.94 150.02 70.67 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.133 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.29 137.16 59.27 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 121.513 1.475 . . . . 0.0 110.912 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.678 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.0 tt -50.71 -29.68 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.887 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -69.98 -34.18 73.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.225 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -75.47 -32.91 60.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.104 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.521 HG21 ' HB2' ' A' ' 55' ' ' ALA . 89.1 t -71.6 -55.89 12.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.109 0.48 . . . . 0.0 110.003 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -51.91 -42.86 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.132 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.507 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.5 mtpt -53.89 -49.85 67.64 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.03 -52.3 66.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.655 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.69 -30.95 4.2 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.707 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.24 -50.94 41.51 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -55.12 -49.72 71.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.04 0.448 . . . . 0.0 109.899 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -58.84 -42.57 89.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.7 0.762 . . . . 0.0 110.733 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.2 tp -54.99 -38.62 68.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.309 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 34.2 t80 -71.27 -40.33 71.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.01 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -57.07 -71.92 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.785 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.76 -40.38 18.29 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.286 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.403 ' C ' ' N ' ' A' ' 79' ' ' SER . 44.4 mt -61.81 -39.2 90.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.177 0.489 . . . . 0.0 111.796 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.38 -11.6 0.55 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.697 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.453 ' O ' ' OG1' ' A' ' 82' ' ' THR . 9.3 t -91.91 -48.54 6.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.934 0.397 . . . . 0.0 110.483 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.59 ' NE ' HD13 ' A' ' 4' ' ' ILE . 5.5 mtm105 -68.64 -65.95 0.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.315 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.531 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -81.19 28.78 0.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.19 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 79' ' ' SER . 96.5 m -49.01 -45.49 42.6 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.571 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -52.48 -25.6 10.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.404 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 2.8 t -85.91 -24.57 6.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.828 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.8 t -63.05 -40.43 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.529 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -53.84 -16.19 1.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.448 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.404 ' CG ' ' O ' ' A' ' 84' ' ' VAL . 39.0 mmtm -64.85 -30.87 71.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.488 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 12.9 p90 -119.3 119.32 33.69 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.101 0.477 . . . . 0.0 111.126 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 22.1 t70 -83.87 -5.1 59.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.257 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.492 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 67.8 m-20 -159.59 156.34 27.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.089 0.471 . . . . 0.0 111.485 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -45.39 -46.98 13.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.818 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.9 m -56.9 -58.77 6.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.368 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.7 t -45.27 -40.06 7.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.12 0.485 . . . . 0.0 111.145 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.6 tt -63.81 -48.31 77.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.326 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.2 t -59.32 -40.25 80.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.573 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 9.0 ptm -87.96 -1.52 58.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.6 -18.07 7.21 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.327 -0.707 . . . . 0.0 112.851 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 94' ' ' LEU . 13.5 mt -27.41 -105.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 117.77 0.785 . . . . 0.0 112.493 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -40.56 -48.88 2.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.064 0.459 . . . . 0.0 111.141 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -44.02 -85.84 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.565 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -73.2 -52.27 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.565 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mp -64.71 -48.75 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.7 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.17 -54.49 36.62 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 tp -48.62 -49.83 35.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.191 0.52 . . . . 0.0 109.854 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -55.04 -47.17 75.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.547 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 71.8 t -51.0 -51.04 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -51.72 -40.63 60.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.692 -179.784 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.3 m80 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.696 0.284 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.0 mm -115.65 124.93 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -131.94 116.63 17.39 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.756 0.312 . . . . 0.0 110.962 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.83 158.86 14.06 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -152.79 154.65 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 122' ' ' LEU . 10.3 mp -104.72 150.25 24.9 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.13 160.52 38.87 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.74 -56.62 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.627 2.218 . . . . 0.0 112.797 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.466 ' C ' ' ND2' ' A' ' 126' ' ' ASN . 22.0 m120 -45.67 -64.65 0.68 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.501 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.67 ' N ' HD22 ' A' ' 126' ' ' ASN . 0.0 OUTLIER 155.54 63.5 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.57 0.7 . . . . 0.0 109.181 179.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -142.36 165.83 26.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.694 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.6 mt -138.28 117.95 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.76 121.3 30.01 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.83 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 60.2 tp -115.61 136.42 53.09 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.984 0.421 . . . . 0.0 110.607 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -119.99 124.24 45.45 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.093 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.9 t80 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.778 179.882 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.066 0.46 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 71.2 m -41.78 -46.54 3.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.499 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -49.07 -38.39 24.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.454 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.62 -42.84 86.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 109.949 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.84 -49.79 14.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.613 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -61.33 -50.17 74.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.252 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.98 -46.58 41.25 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.75 -53.26 59.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.597 0.237 . . . . 0.0 111.258 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.8 mt -55.02 -56.49 19.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.979 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.597 ' CE2' HD12 ' A' ' 159' ' ' ILE . 22.6 m-85 -50.76 -47.87 59.43 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.751 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.06 -51.65 57.06 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.59 -59.81 2.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.864 0.364 . . . . 0.0 110.839 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -50.51 -51.23 49.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.994 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -51.13 -47.48 62.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.1 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -49.99 -49.74 49.52 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.641 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.517 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 67.9 t80 -87.68 38.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 38.38 55.95 1.79 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.983 0.421 . . . . 0.0 111.185 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.68 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 42.0 tp60 -129.12 141.03 51.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.68 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 50.5 mtmt -113.74 124.48 52.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.05 170.47 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.635 0.731 . . . . 0.0 111.898 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -134.0 127.38 32.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.494 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.597 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.3 mt -110.17 117.44 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.3 t -105.19 119.63 39.54 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.065 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.6 p-80 -96.67 74.82 2.75 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.657 0.741 . . . . 0.0 111.376 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -76.9 -19.92 56.85 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.989 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.78 111.07 15.1 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.484 ' O ' HG22 ' A' ' 167' ' ' THR . 20.1 p -114.23 -178.91 3.49 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.563 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.492 ' O ' ' SD ' ' A' ' 165' ' ' MET . 1.1 tmt? -93.87 -26.77 16.76 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -54.83 -24.05 21.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.577 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.5 t -87.25 -25.37 24.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.286 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.04 21.73 24.71 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.946 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.4 166.17 12.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.86 0.362 . . . . 0.0 110.651 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 171' ' ' HIS . 50.4 p-10 -52.22 -31.13 30.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.427 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.524 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 5.3 p-80 -173.98 -174.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.3 m -93.06 143.41 26.27 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.155 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.559 ' CG ' HD11 ' A' ' 175' ' ' ILE . 30.1 ttp -121.92 116.3 24.12 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.184 0.516 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 176' ' ' ILE . 1.4 mt -116.05 99.49 7.29 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.203 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.559 HD11 ' CG ' ' A' ' 173' ' ' MET . 13.3 mm -84.37 123.82 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.137 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 174' ' ' LEU . 5.0 mp -106.92 144.0 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.28 0.562 . . . . 0.0 110.28 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -132.17 133.69 44.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.986 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.463 0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 -179.853 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.414 HG12 HD21 ' A' ' 77' ' ' LEU . 1.5 tp . . . . . 0 N--CA 1.465 0.275 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mm -59.18 -47.81 88.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.77 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -64.19 -28.44 69.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.244 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.589 ' ND2' ' NH2' ' A' ' 80' ' ' ARG . 64.2 t30 -67.06 -55.05 15.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.016 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t -66.31 -39.0 83.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.17 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.505 HD13 ' CE2' ' A' ' 69' ' ' PHE . 19.0 tp -64.66 -48.6 74.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.961 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -47.42 -44.87 25.01 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.882 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -62.16 -50.54 71.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.863 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.5 tmt? -52.61 -39.62 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.978 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.26 -34.97 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.426 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.0 t -62.06 -22.67 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.322 0.582 . . . . 0.0 110.05 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.35 -34.88 20.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.217 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -84.57 -77.06 0.28 Allowed 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 58' ' ' LEU . 94.3 m -90.72 -19.97 22.95 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.309 0.576 . . . . 0.0 110.696 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.79 173.92 26.76 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.738 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.5 ttt -69.37 -25.81 64.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.866 -1.167 . . . . 0.0 110.494 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.0 t -64.94 -43.59 92.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.149 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -34.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -51.52 -45.77 63.03 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -69.8 -31.63 69.64 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.012 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -64.98 -51.07 63.76 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.791 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.34 -19.6 38.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.921 0.391 . . . . 0.0 110.732 -179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.791 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.2 tt -76.72 -57.16 4.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.357 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.39 -22.48 66.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.507 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -81.13 -39.4 25.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.508 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 72.8 m80 . . . . . 0 N--CA 1.467 0.388 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.188 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.795 0.331 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -62.88 -30.94 71.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.65 -55.79 2.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.027 0.441 . . . . 0.0 110.49 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -39.01 -42.79 0.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.419 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.2 m -72.29 -33.24 67.28 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.335 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.2 mp -71.04 -53.92 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.586 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.97 -24.86 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.124 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.672 ' HG3' HD12 ' A' ' 62' ' ' ILE . 2.2 tt0 -77.6 -39.87 44.02 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.505 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 79.1 m-20 -59.52 -56.21 24.84 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.968 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 p -57.18 -39.2 65.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.026 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.73 -38.42 85.07 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.29 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -63.27 -32.03 73.34 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -73.87 -40.46 63.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.517 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 ' SG ' ' A' ' 17' ' ' CYS . 36.6 mt -83.18 -7.72 59.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.218 0.533 . . . . 0.0 109.748 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.1 t30 56.95 49.57 13.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.549 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.401 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 25.9 mmt -128.43 149.52 71.83 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.151 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.24 137.93 68.89 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.49 1.46 . . . . 0.0 111.124 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.672 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.7 tt -51.79 -29.18 10.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.014 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -71.4 -34.18 70.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.161 0.505 . . . . 0.0 111.244 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -75.51 -32.89 60.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.884 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 55' ' ' ALA . 71.9 t -70.78 -56.53 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -52.56 -44.57 45.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.217 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.528 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.7 mtpt -51.08 -50.13 59.3 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.92 -47.94 81.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.74 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.509 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 8.3 m-30 -53.77 -30.62 45.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.529 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.71 -49.86 61.77 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -56.9 -50.02 73.81 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -58.61 -42.54 88.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.775 0.797 . . . . 0.0 110.555 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.6 tp -55.73 -38.39 69.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.306 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 37.1 t80 -71.55 -39.61 70.55 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.954 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -56.44 -71.05 0.1 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.762 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.06 -45.13 33.3 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.78 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.414 HD21 HG12 ' A' ' 4' ' ' ILE . 13.6 mt -52.34 -44.41 65.15 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.181 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.37 -23.71 16.68 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.178 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.427 ' O ' ' OG1' ' A' ' 82' ' ' THR . 22.1 t -76.74 -53.86 7.41 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.988 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.589 ' NH2' ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -75.54 -27.84 58.82 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.764 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -107.14 22.68 15.61 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.684 0.278 . . . . 0.0 110.384 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 79' ' ' SER . 6.4 m -50.88 -40.72 57.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -57.56 -35.53 70.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.508 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.3 -21.85 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.674 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 87' ' ' LYS . 95.4 t -85.52 -46.86 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.695 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -55.68 -2.05 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.686 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 85' ' ' VAL . 86.0 mttt -78.79 -33.95 45.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.58 130.98 55.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.999 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 52.1 t0 -93.0 11.39 27.64 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.402 ' OD1' ' OG ' ' A' ' 93' ' ' SER . 10.2 p-10 -167.8 163.16 14.08 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 118.987 -1.085 . . . . 0.0 113.485 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.427 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 74.3 t80 -62.13 -61.55 2.4 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.786 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.5 m -45.15 -49.3 12.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.209 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.402 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 56.9 m -59.86 -38.16 81.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.296 0.57 . . . . 0.0 110.743 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.19 -55.12 31.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.016 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.7 t -49.73 -42.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 O-C-N 123.142 0.276 . . . . 0.0 111.696 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.436 ' H ' ' HG3' ' A' ' 96' ' ' MET . 3.3 ppp? -83.23 -6.28 59.42 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.736 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -109.24 -13.35 17.7 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.46 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.605 ' HA ' HD13 ' A' ' 102' ' ' ILE . 49.4 mt -29.93 -104.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.431 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 2.3 p80 -37.36 -48.32 0.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.431 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 59.6 t0 -45.42 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.612 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.3 m -70.56 -52.9 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.612 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.8 mp -58.8 -48.47 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.71 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.58 -55.1 31.85 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 tp -50.12 -48.55 53.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 110.167 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.514 ' OE1' ' NZ ' ' A' ' 87' ' ' LYS . 37.7 tp10 -55.94 -45.78 78.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.315 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 102' ' ' ILE . 54.3 t -53.5 -51.16 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -50.0 -43.35 50.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.829 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt . . . . . 0 C--N 1.329 -0.289 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.268 179.838 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.6 m80 . . . . . 0 N--CA 1.465 0.277 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.7 mt -131.22 129.82 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.687 0.28 . . . . 0.0 110.654 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -125.98 98.51 5.54 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.87 0.367 . . . . 0.0 110.371 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -103.98 119.49 6.33 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -116.58 153.5 32.13 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 122' ' ' LEU . 8.8 mp -101.18 147.2 26.53 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.25 160.51 41.1 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.15 -38.43 3.81 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.58 2.187 . . . . 0.0 113.105 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -79.54 45.9 0.71 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.918 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 44.22 61.06 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.366 0.603 . . . . 0.0 110.562 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -139.13 158.38 44.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.095 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.6 mt -138.67 116.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.67 28.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 39.9 tp -117.09 132.39 56.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.137 0.494 . . . . 0.0 110.859 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -118.71 125.26 49.28 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.991 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.495 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 29.6 t80 . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 tp . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 121.183 0.516 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 9.4 t -41.9 -42.61 2.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.344 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -49.47 -41.69 41.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.454 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.441 ' SG ' ' CG2' ' A' ' 66' ' ' VAL . 56.7 m -65.25 -41.44 94.31 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -44.44 -49.93 9.57 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.674 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -63.78 -48.8 75.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.51 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.35 -46.63 52.02 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.147 -1.025 . . . . 0.0 110.785 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.3 mt -58.77 -55.92 28.88 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.5 mt -53.29 -55.91 20.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.749 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.538 ' CE2' HD12 ' A' ' 159' ' ' ILE . 15.2 m-85 -50.71 -48.15 58.92 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.667 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.03 55.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.72 -60.36 1.82 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.862 0.363 . . . . 0.0 110.821 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.98 -51.01 45.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.847 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -51.36 -46.95 62.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.064 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -50.54 -50.37 53.47 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.344 -0.543 . . . . 0.0 109.563 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.518 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 66.2 t80 -86.04 37.43 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.851 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 39.2 55.65 2.16 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.992 0.425 . . . . 0.0 111.168 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.688 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 40.7 tp60 -128.88 139.8 51.97 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.688 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 11.7 mptt -112.48 124.1 51.77 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.427 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 9.8 pt -137.32 171.15 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.724 0.773 . . . . 0.0 111.896 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -134.24 127.69 32.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.095 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.538 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.7 mt -110.43 115.71 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.0 m -96.16 100.06 11.74 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.929 0.395 . . . . 0.0 110.018 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.472 ' NE2' ' SG ' ' A' ' 164' ' ' CYS . 0.9 OUTLIER -100.69 71.49 1.49 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.019 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -81.2 -56.12 4.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.486 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 90.0 m -82.72 112.41 19.55 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.528 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.589 ' O ' ' N ' ' A' ' 166' ' ' HIS . 6.0 t -139.17 130.63 27.08 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.049 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 76.8 mtp -36.27 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.312 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.1 t60 -53.0 -24.44 9.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.476 HG23 ' N ' ' A' ' 168' ' ' GLY . 5.9 t -90.15 -43.38 10.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.106 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.476 ' N ' HG23 ' A' ' 167' ' ' THR . . . 132.46 11.98 1.87 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.74 169.56 6.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.928 0.394 . . . . 0.0 110.847 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.539 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 89.5 m-20 -56.44 -44.24 80.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.582 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 170' ' ' ASP . 62.6 m-70 -157.68 -169.81 2.99 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.8 m -92.33 138.31 31.63 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 tpt -115.73 123.65 48.83 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 110.523 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -128.39 100.61 5.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.651 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.6 mp -89.02 127.54 41.68 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.619 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.9 mp -110.45 150.82 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.438 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -144.66 141.47 29.37 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.925 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 N--CA 1.462 0.156 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.152 179.543 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.3 mm -67.75 -51.97 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.448 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -68.1 -24.55 65.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.204 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -70.16 -49.93 45.55 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.915 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.08 -35.43 75.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.621 -0.431 . . . . 0.0 109.903 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.459 HD13 ' CE2' ' A' ' 69' ' ' PHE . 21.6 tp -71.1 -40.38 71.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.109 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -53.66 -44.93 70.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.634 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -62.66 -48.13 80.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.966 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.8 tmt? -53.86 -41.38 67.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.819 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.7 t -71.02 -34.94 57.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.446 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.96 -26.22 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.191 0.52 . . . . 0.0 110.249 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.26 -34.51 28.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.112 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -83.74 -73.74 0.4 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.539 ' SG ' HD21 ' A' ' 58' ' ' LEU . 89.4 m -95.29 -22.4 17.8 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.933 0.397 . . . . 0.0 111.332 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.06 170.15 22.32 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 121.891 0.717 . . . . 0.0 112.996 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -27.19 67.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.07 -1.065 . . . . 0.0 109.553 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -63.8 -43.6 95.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.531 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.31 -37.24 31.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 52.4 t-105 -51.02 -44.97 61.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -71.66 -29.01 64.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.068 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -66.73 -50.85 61.45 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.752 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.57 -20.64 36.12 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.596 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.752 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.5 tt -76.66 -69.55 0.51 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.241 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.618 ' N ' HD23 ' A' ' 26' ' ' LEU . 93.8 mt-10 -50.82 -21.43 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.162 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -80.93 -39.25 26.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 26' ' ' LEU . 89.1 m-70 . . . . . 0 N--CA 1.469 0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.752 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.922 0.391 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 6.4 mp0 -65.59 -29.23 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.53 -57.34 2.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 110.741 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.64 -40.21 0.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.533 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.9 m -75.22 -31.11 60.77 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.892 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 47' ' ' LEU . 13.7 mt -70.94 -50.73 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -26.15 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.398 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.661 ' HG3' HD12 ' A' ' 62' ' ' ILE . 2.1 tt0 -76.0 -40.79 52.9 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.543 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -59.27 -57.0 14.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.005 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.96 -38.33 59.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.221 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.517 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.34 -38.35 86.62 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.218 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -62.9 -32.02 73.2 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.47 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.69 -45.33 53.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.534 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.539 HD21 ' SG ' ' A' ' 17' ' ' CYS . 32.0 mt -77.77 -7.26 56.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.656 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 t30 56.94 49.75 13.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.934 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.414 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 7.7 mmt -128.45 149.14 70.82 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.225 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.28 139.21 76.3 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.441 1.428 . . . . 0.0 110.892 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.661 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.5 tt -52.84 -29.86 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.433 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -71.7 -31.48 66.79 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.578 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.6 -31.6 47.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.921 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' ' 55' ' ' ALA . 69.4 t -71.04 -57.1 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.0 p -52.03 -41.37 31.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.201 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.503 ' N ' HG13 ' A' ' 66' ' ' VAL . 32.2 mtpt -53.98 -50.75 65.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.78 83.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.73 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.9 m-30 -53.81 -31.11 47.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.286 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.63 -50.1 60.8 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -55.69 -50.09 71.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.006 0.432 . . . . 0.0 109.941 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -59.93 -41.84 92.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.826 0.822 . . . . 0.0 110.493 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -58.55 -39.81 81.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.597 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 35.1 t80 -68.28 -41.5 80.93 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.904 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -55.07 -68.81 0.16 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.224 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.16 -47.6 33.32 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.618 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.6 mt -52.06 -42.93 63.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.052 0.426 . . . . 0.0 111.991 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -55.11 -24.17 24.54 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.394 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.8 t -76.37 -53.1 8.65 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.082 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -76.87 -39.98 49.15 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.772 -179.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -92.96 27.01 2.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.41 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 34.8 m -53.71 -37.7 63.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.05 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.442 ' O ' ' NZ ' ' A' ' 87' ' ' LYS . 89.9 m-20 -58.09 -30.81 66.53 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.6 -19.7 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.688 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.35 -43.5 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.353 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.34 -16.62 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.994 0.426 . . . . 0.0 110.35 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 83' ' ' ASP . 42.5 mmtm -67.61 -29.07 68.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.022 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 8.9 p90 -120.56 116.5 25.49 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.175 0.512 . . . . 0.0 110.991 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -84.82 -2.37 57.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.369 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.433 ' OD1' ' OG ' ' A' ' 93' ' ' SER . 50.5 p30 -163.48 159.48 22.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.186 0.517 . . . . 0.0 111.637 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.447 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 85.8 t80 -48.7 -46.05 39.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.305 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.2 m -59.08 -61.35 2.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.904 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.433 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 93.8 p -45.4 -37.78 5.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.151 0.501 . . . . 0.0 111.022 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.5 tt -65.03 -46.03 82.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.199 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.1 t -62.6 -39.6 85.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.253 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 12.8 ptm -87.2 -1.85 58.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.82 -16.85 7.74 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.353 -0.693 . . . . 0.0 112.891 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.549 ' HA ' HD13 ' A' ' 102' ' ' ILE . 12.2 mt -29.12 -102.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 117.868 0.834 . . . . 0.0 112.454 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.489 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 13.3 p-80 -39.75 -50.15 2.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.035 0.445 . . . . 0.0 111.364 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.489 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 80.2 m-20 -44.54 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -72.18 -53.19 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 101' ' ' VAL . 3.1 mp -61.15 -48.41 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.22 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.0 -53.7 43.42 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.9 tp -50.62 -50.85 53.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.92 0.39 . . . . 0.0 110.456 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -55.85 -45.27 78.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.318 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.67 -50.77 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -50.05 -43.19 50.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.746 0.308 . . . . 0.0 111.055 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.612 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.662 ' CD2' HD21 ' A' ' 119' ' ' ASN . 75.8 t60 . . . . . 0 N--CA 1.461 0.124 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.2 mt -129.82 130.04 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.582 0.229 . . . . 0.0 111.02 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.662 HD21 ' CD2' ' A' ' 117' ' ' HIS . 11.6 m-20 -132.51 119.42 20.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.42 137.53 13.4 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -128.71 159.49 35.47 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.823 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -107.14 145.84 32.03 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.28 160.46 41.35 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.62 -41.07 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.638 2.225 . . . . 0.0 113.222 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -77.65 46.59 0.56 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.088 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 17.7 p30 43.29 62.21 1.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.545 0.688 . . . . 0.0 110.837 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -139.25 158.31 44.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.964 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 51.0 mt -139.04 119.19 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.85 122.3 33.45 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.269 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.1 tp -117.76 134.81 54.54 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.997 0.427 . . . . 0.0 110.689 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -120.73 125.16 46.93 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.49 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 C--N 1.331 -0.232 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.872 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.5 mm? . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.0 t -42.44 -49.49 5.25 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -47.68 -35.03 8.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.096 0.474 . . . . 0.0 109.895 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.69 -43.55 79.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.936 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.48 -51.19 15.78 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.515 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -59.28 -51.66 69.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.43 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.53 -46.49 37.34 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.9 mt -61.45 -52.1 65.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 111.204 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 45.4 mt -55.53 -56.85 15.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.839 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.563 ' CE2' HD12 ' A' ' 159' ' ' ILE . 22.4 m-85 -50.31 -47.86 55.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.764 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.13 -51.69 57.76 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.5 -54.99 4.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.937 0.398 . . . . 0.0 110.54 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -54.55 -51.42 65.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.631 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -51.09 -46.77 61.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.931 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -50.0 -50.06 48.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.514 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 67.7 t80 -87.81 37.89 0.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.014 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 38.76 55.66 1.95 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.93 0.395 . . . . 0.0 111.081 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.686 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 41.9 tp60 -128.83 141.24 51.36 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.686 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 67.2 mttm -114.85 124.04 50.7 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.447 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 8.8 pt -136.89 173.84 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.714 0.769 . . . . 0.0 111.99 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.443 ' NE2' ' OE1' ' A' ' 177' ' ' GLU . 13.0 pt20 -137.02 129.25 29.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.427 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.563 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.5 mt -111.77 120.05 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.297 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -102.2 106.12 16.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.821 0.343 . . . . 0.0 110.754 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.533 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 16.6 p80 -102.08 73.12 1.36 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.385 0.612 . . . . 0.0 111.45 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -77.74 -12.84 60.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.33 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.48 ' HB ' ' H ' ' A' ' 173' ' ' MET . 3.2 m -116.45 104.23 11.23 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.589 ' O ' ' N ' ' A' ' 166' ' ' HIS . 38.0 t -136.63 116.36 13.04 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.576 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.5 ptm -39.94 -15.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.23 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 164' ' ' CYS . 56.0 t-80 -58.53 -30.37 67.04 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.503 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.0 t -81.04 -46.22 15.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.053 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.503 ' N ' HG23 ' A' ' 167' ' ' THR . . . 153.84 12.68 0.07 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.09 149.19 35.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.65 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -85.1 8.85 16.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.088 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -174.71 -173.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 92.3 m -129.18 148.07 51.09 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.182 0.515 . . . . 0.0 111.569 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.48 ' H ' ' HB ' ' A' ' 163' ' ' THR . 7.8 ttm -126.43 111.86 14.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.111 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.27 110.6 21.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.344 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -92.24 127.54 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.775 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.31 150.57 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.075 0.465 . . . . 0.0 110.095 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.443 ' OE1' ' NE2' ' A' ' 158' ' ' GLN . 28.1 mt-10 -145.71 142.59 29.12 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.734 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 N--CA 1.463 0.218 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.192 179.566 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.558 ' CD1' ' HE ' ' A' ' 80' ' ' ARG . 1.9 tp . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.996 0.427 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.19 -50.87 76.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -64.23 -29.19 70.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.196 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -62.02 -59.3 5.29 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.26 0.553 . . . . 0.0 110.847 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.98 -26.98 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.165 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.509 HD13 ' CE2' ' A' ' 69' ' ' PHE . 36.9 tp -72.03 -41.17 67.83 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.085 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.44 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.9 mt-10 -57.79 -41.06 81.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.256 -0.977 . . . . 0.0 109.541 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -60.3 -57.95 10.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.653 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.601 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 68.0 mtm -48.43 -43.64 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.35 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.8 -36.28 75.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.854 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 10' ' ' GLU . 47.6 t -62.53 -22.54 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.275 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.82 -34.41 17.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.13 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -84.75 -78.03 0.26 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' HD21 ' A' ' 58' ' ' LEU . 89.9 m -90.61 -17.54 26.74 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.341 0.591 . . . . 0.0 110.57 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.68 178.86 29.54 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.827 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 ttt -72.49 -30.87 64.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.837 -1.181 . . . . 0.0 110.708 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 t -61.5 -41.87 97.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.119 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.18 -38.12 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.417 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 51.1 t-105 -51.73 -45.71 63.73 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.89 -29.05 63.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.339 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -67.27 -50.76 59.21 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.915 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.07 -22.38 36.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.85 0.357 . . . . 0.0 110.413 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.915 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.8 tt -73.91 -66.59 0.69 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.117 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.599 ' N ' HD23 ' A' ' 26' ' ' LEU . 75.9 tt0 -52.44 -21.78 4.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.527 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -81.38 -38.97 25.73 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.45 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 12.8 m-70 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.319 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.934 0.397 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -59.04 -37.92 78.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.64 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -44.53 -53.54 6.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.148 0.499 . . . . 0.0 110.713 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -41.1 -40.94 1.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.387 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.2 m -73.24 -31.13 63.93 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 47' ' ' LEU . 25.8 mm -68.48 -55.35 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.714 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.431 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -58.11 -22.41 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.983 178.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.687 ' HG3' HD12 ' A' ' 62' ' ' ILE . 4.5 tt0 -79.65 -43.18 23.29 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.383 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.45 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 33.0 m-20 -58.4 -57.08 14.49 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.675 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 55' ' ' ALA . 7.5 p -56.95 -41.16 76.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.409 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.427 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -56.24 -38.69 71.43 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.309 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -64.51 -32.97 74.84 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -73.44 -37.98 65.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.781 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 17' ' ' CYS . 36.6 mt -84.21 -7.5 59.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.105 0.479 . . . . 0.0 109.844 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.27 48.36 17.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.573 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.5 mmm -127.19 149.55 69.88 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.073 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.68 135.56 49.47 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.442 1.428 . . . . 0.0 110.94 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.687 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.6 tt -49.54 -27.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.097 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -73.44 -30.93 63.53 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.086 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -78.05 -31.83 50.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.258 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.416 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 73.5 t -72.03 -56.3 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.532 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -51.63 -43.69 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.32 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.532 ' N ' HG13 ' A' ' 66' ' ' VAL . 34.7 mtpt -52.38 -51.98 56.07 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.76 -55.71 30.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.278 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.509 ' CE2' HD13 ' A' ' 9' ' ' LEU . 7.5 m-30 -44.53 -28.03 0.53 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.375 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.12 -47.46 59.09 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -56.46 -53.45 57.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.042 0.448 . . . . 0.0 110.273 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.601 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 78.7 m-85 -57.23 -42.14 80.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.755 0.788 . . . . 0.0 110.854 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.1 tp -55.25 -37.5 67.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.654 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 28.8 t80 -69.77 -40.7 75.92 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -57.05 -72.96 0.07 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.847 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.87 -40.65 19.52 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.396 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.421 HD21 HG12 ' A' ' 4' ' ' ILE . 23.7 mt -60.02 -41.56 92.44 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.345 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.09 -22.79 11.8 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.926 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.438 ' O ' ' OG1' ' A' ' 82' ' ' THR . 8.7 t -80.45 -52.56 7.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.212 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.558 ' HE ' ' CD1' ' A' ' 4' ' ' ILE . 4.4 mtt-85 -65.97 -52.66 47.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.188 0.518 . . . . 0.0 110.884 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -93.95 36.47 1.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.567 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 79' ' ' SER . 39.6 m -56.92 -45.3 82.78 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.066 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -50.79 -31.09 15.88 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 t -82.75 -19.59 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.699 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.513 ' C ' ' H ' ' A' ' 87' ' ' LYS . 68.1 t -72.21 -47.05 55.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.569 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 56.1 t0 -52.66 -7.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.808 0.337 . . . . 0.0 110.759 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 85' ' ' VAL . 43.1 mmtm -80.23 -28.9 38.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.071 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.62 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -95.77 118.12 31.83 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.474 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -84.85 -13.45 50.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.169 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 15.3 p-10 -164.67 171.42 14.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.256 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.424 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 68.8 t80 -58.07 -46.74 84.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.872 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.8 m -59.84 -44.78 93.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.443 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.7 t -55.63 -39.84 71.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.248 0.547 . . . . 0.0 110.304 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.419 HD12 ' CD2' ' A' ' 88' ' ' PHE . 3.0 tt -64.71 -45.56 86.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.998 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.57 -38.13 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.421 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.556 ' SD ' HD13 ' A' ' 122' ' ' LEU . 83.7 mtp -83.99 -4.42 58.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.427 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -116.75 -14.97 7.05 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.044 -0.865 . . . . 0.0 113.663 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.669 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.7 mt -26.72 -106.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 117.954 0.877 . . . . 0.0 112.697 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.482 ' CE1' ' O ' ' A' ' 118' ' ' ILE . 8.7 p-80 -41.4 -46.34 3.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.019 0.438 . . . . 0.0 111.271 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -47.46 -87.34 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 102' ' ' ILE . 2.1 m -69.89 -51.38 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.669 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.5 mp -63.28 -47.61 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.699 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.33 -54.06 40.05 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.3 tp -49.47 -48.03 48.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.934 0.397 . . . . 0.0 109.947 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -56.9 -45.82 82.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.035 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 76.0 t -54.85 -56.06 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -43.94 -45.43 7.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.125 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp . . . . . 0 C--N 1.33 -0.244 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.84 179.621 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.5 m80 . . . . . 0 N--CA 1.463 0.18 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.482 ' O ' ' CE1' ' A' ' 99' ' ' HIS . 4.0 mp -138.48 133.15 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -138.5 130.01 27.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.712 0.291 . . . . 0.0 111.212 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.58 120.8 4.53 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -117.55 130.34 56.35 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.651 0.262 . . . . 0.0 110.819 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.556 HD13 ' SD ' ' A' ' 96' ' ' MET . 3.9 tp -76.19 150.35 37.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 111.383 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -121.43 160.32 46.5 Favored Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.317 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.45 -36.83 3.61 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.668 2.245 . . . . 0.0 113.309 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -79.96 46.7 0.82 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.144 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.6 m120 43.35 58.39 3.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 0.0 110.443 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -137.11 159.06 43.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.057 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.4 mt -135.4 114.6 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.19 120.09 25.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 61.5 tp -114.92 132.73 56.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.166 0.508 . . . . 0.0 111.298 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.711 ' HE ' ' CE1' ' A' ' 171' ' ' HIS . 64.0 ttt-85 -116.95 120.43 38.4 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.008 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.491 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 72.3 t80 . . . . . 0 N--CA 1.467 0.407 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.948 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 9.2 t -44.83 -49.75 10.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.582 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -45.76 -41.29 10.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.113 0.482 . . . . 0.0 110.2 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 22.8 t -62.34 -41.46 98.59 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.54 -54.18 7.93 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.561 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -56.58 -50.74 71.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.35 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.8 -47.9 45.79 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.37 -54.81 41.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.2 mt -53.4 -55.22 26.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.745 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.548 ' CE2' HD12 ' A' ' 159' ' ' ILE . 14.5 m-85 -51.61 -47.7 63.54 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.897 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.31 -51.99 54.29 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.26 -60.11 2.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.846 0.355 . . . . 0.0 110.916 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -47.84 -50.66 25.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.966 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -52.45 -47.97 66.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.623 0.249 . . . . 0.0 111.237 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -49.38 -49.96 42.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.667 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.25 37.3 0.72 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.968 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 38.76 57.5 1.83 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.976 0.417 . . . . 0.0 111.196 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.516 HE21 ' H ' ' A' ' 156' ' ' LYS . 52.8 tp60 -131.72 142.98 49.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.516 ' H ' HE21 ' A' ' 155' ' ' GLN . 58.4 tttp -118.17 112.31 19.99 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.078 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.424 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 17.8 pt -122.53 173.48 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.513 0.673 . . . . 0.0 111.78 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -137.13 128.74 28.62 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.547 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.548 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.5 mt -112.04 120.97 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.649 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.9 t -105.19 112.19 25.21 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.705 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 53.8 p-80 -101.97 76.7 1.63 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.983 0.897 . . . . 0.0 111.822 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 4.9 p30 -75.89 -27.56 57.77 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.716 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.56 110.44 21.92 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.552 ' O ' HG22 ' A' ' 167' ' ' THR . 6.4 p -113.08 176.33 5.06 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 168' ' ' GLY . 72.5 mtp -91.52 -28.18 17.75 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -53.72 -22.51 9.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.825 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.4 t -88.63 -26.77 21.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.446 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 98.58 21.92 15.51 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.136 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.31 162.68 24.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.04 0.447 . . . . 0.0 110.681 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -45.97 -34.38 3.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.308 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.711 ' CE1' ' HE ' ' A' ' 131' ' ' ARG . 9.0 p-80 -175.49 -167.78 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.2 m -95.18 139.71 31.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.171 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 12.8 tpp -120.7 116.7 25.79 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.1 107.15 12.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.472 0.654 . . . . 0.0 111.047 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -89.95 126.98 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.561 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.8 mp -110.83 151.49 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.189 0.519 . . . . 0.0 110.171 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.56 144.0 28.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.933 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 11.7 mt . . . . . 0 N--CA 1.462 0.164 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.072 179.669 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 5' ' ' ILE . 3.3 tp . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 120.778 0.323 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' N ' HG23 ' A' ' 4' ' ' ILE . 36.3 mm -64.45 -56.76 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.426 0.631 . . . . 0.0 109.461 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -62.26 -27.7 69.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.658 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -62.35 -60.79 3.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.131 0.491 . . . . 0.0 110.939 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -56.96 -27.16 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.115 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.418 HD13 ' CE2' ' A' ' 69' ' ' PHE . 27.9 tp -71.8 -50.5 29.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.463 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.473 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.8 mt-10 -49.36 -40.22 34.84 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.562 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -60.48 -49.09 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.695 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.579 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 10.4 tpt -56.87 -42.58 80.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.005 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.79 -34.98 58.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.648 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 10' ' ' GLU . 40.8 t -62.16 -25.0 36.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.216 0.531 . . . . 0.0 110.018 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.93 -34.58 22.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.134 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -85.75 -74.44 0.41 Allowed 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.499 ' SG ' HD21 ' A' ' 58' ' ' LEU . 91.7 m -92.27 -21.66 20.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.166 0.508 . . . . 0.0 110.966 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.51 170.96 24.72 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.865 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.0 ttp -66.5 -28.67 68.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.904 -1.148 . . . . 0.0 110.347 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 t -62.49 -42.24 99.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.208 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.63 -36.27 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.408 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 50.7 t-105 -51.94 -45.86 64.49 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -70.31 -30.6 67.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.986 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -66.05 -50.77 62.99 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.815 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.19 -20.53 37.62 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.844 0.354 . . . . 0.0 110.617 -179.26 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.815 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.3 tt -75.47 -57.64 3.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.345 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.05 -23.16 67.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.675 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -80.45 -40.63 25.93 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 67.7 m80 . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.326 179.415 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 85.6 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.784 0.326 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -66.37 -33.13 75.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.542 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -48.2 -58.15 4.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.105 0.479 . . . . 0.0 110.634 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -39.01 -41.1 0.74 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.541 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.3 p -74.53 -31.87 62.28 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.971 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 47' ' ' LEU . 17.1 mt -70.26 -53.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.789 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.89 -25.03 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.518 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.657 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.0 tt0 -76.61 -41.28 46.66 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.633 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -59.02 -56.8 17.54 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.744 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.96 -37.53 55.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.016 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.527 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -62.41 -38.09 88.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.276 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -62.4 -32.83 73.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -72.04 -44.53 63.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.554 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.499 HD21 ' SG ' ' A' ' 17' ' ' CYS . 32.3 mt -79.14 -7.37 58.13 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.864 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.01 49.85 13.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.678 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.405 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 25.5 mmt -128.55 149.12 70.91 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.182 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.58 138.73 71.86 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.347 1.365 . . . . 0.0 110.967 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.657 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.7 tt -52.38 -29.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.428 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -72.46 -31.53 65.52 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.562 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -78.2 -31.85 49.65 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.944 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 55' ' ' ALA . 82.2 t -70.5 -57.08 8.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -51.58 -43.22 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.34 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.516 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.0 mtpt -53.32 -50.33 65.19 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.14 80.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.644 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.9 m-30 -52.16 -29.49 22.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.298 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.26 -50.35 56.83 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -55.17 -50.71 68.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.023 0.44 . . . . 0.0 110.049 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.579 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 59.4 m-85 -59.67 -41.19 90.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.883 0.849 . . . . 0.0 110.74 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.62 -40.46 83.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.451 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.401 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 41.9 t80 -68.7 -39.87 80.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 110.229 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -55.27 -70.44 0.11 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.377 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.92 -37.62 53.4 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.385 -0.436 . . . . 0.0 112.637 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.521 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 16.5 mt -55.23 -51.06 67.81 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.086 0.443 . . . . 0.0 111.716 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.85 -15.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.805 -0.56 . . . . 0.0 111.36 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 77' ' ' LEU . 9.3 t -83.75 -49.08 9.44 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -59.48 2.73 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.083 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.0 p80 -81.85 30.22 0.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.815 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.8 m -49.53 -40.07 36.71 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -55.65 -30.38 60.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 81' ' ' HIS . 5.1 t -85.89 -22.8 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.534 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.492 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 54.1 t -61.66 -40.48 86.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -49.6 -20.34 0.76 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.873 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -70.15 -5.03 24.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.381 0.61 . . . . 0.0 109.865 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.607 ' CG ' ' N ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER -89.05 -150.26 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.508 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.607 ' N ' ' CG ' ' A' ' 88' ' ' PHE . 1.1 p-10 159.63 -30.25 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -170.23 155.1 5.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.365 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 85.6 t80 -46.08 -57.46 4.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.237 0.541 . . . . 0.0 111.29 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.5 m -50.41 -47.12 56.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.108 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.431 ' CB ' ' OD2' ' A' ' 89' ' ' ASP . 32.6 m -61.42 -37.17 82.52 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.151 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.1 tt -64.3 -45.49 87.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.001 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.52 -36.11 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 121.226 0.536 . . . . 0.0 110.639 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.7 mmm -86.19 -6.79 58.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.53 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -111.42 -13.16 13.52 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.894 -0.392 . . . . 0.0 112.654 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.647 ' HA ' HD13 ' A' ' 102' ' ' ILE . 15.8 mt -33.0 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 117.509 0.655 . . . . 0.0 111.963 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -39.8 -50.27 2.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.213 0.53 . . . . 0.0 111.498 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -48.12 -91.25 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.599 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.7 m -66.71 -51.21 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.647 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.7 mp -61.72 -40.97 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.392 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.16 -57.52 10.45 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.4 tp -49.21 -58.05 5.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.15 0.5 . . . . 0.0 110.491 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -50.6 -45.95 57.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.236 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 102' ' ' ILE . 14.7 t -54.59 -51.41 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -46.85 -42.91 18.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.792 0.329 . . . . 0.0 110.607 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.69 -179.903 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.741 0.305 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 31.7 mm -117.25 124.14 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.373 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.593 HD22 ' NH2' ' A' ' 131' ' ' ARG . 52.9 t30 -132.89 120.02 20.95 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.735 0.302 . . . . 0.0 110.857 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.8 119.21 5.17 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -117.78 125.65 50.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 tp -72.21 140.04 48.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.886 0.374 . . . . 0.0 110.825 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.29 161.01 41.18 Favored Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.6 178.63 6.48 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.312 2.008 . . . . 0.0 111.992 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.527 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 95.7 m-20 55.23 36.01 26.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.347 0.594 . . . . 0.0 109.832 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.527 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 47.5 m-20 54.35 56.51 6.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.794 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 125' ' ' ASN . 3.8 mp0 -125.98 156.43 39.85 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.1 mt -139.39 115.32 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.87 122.82 31.27 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.844 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 47.8 tp -117.78 132.7 56.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 111.279 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.593 ' NH2' HD22 ' A' ' 119' ' ' ASN . 41.5 ttp180 -112.87 120.24 40.76 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.602 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.494 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 30.6 t80 . . . . . 0 N--CA 1.465 0.32 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.621 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 CA--C 1.535 0.401 0 CA-C-O 121.011 0.434 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 26.4 p -43.57 -49.13 7.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.586 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.465 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 80.8 m-85 -45.64 -41.89 10.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.973 0.416 . . . . 0.0 110.409 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 48.5 t -64.09 -42.23 96.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.774 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.55 -52.5 10.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.579 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -59.19 -51.85 68.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.613 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.35 -46.99 35.74 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.3 -54.18 48.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.641 0.258 . . . . 0.0 111.638 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 31.2 mt -54.51 -56.13 21.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.026 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.566 ' CE2' HD12 ' A' ' 159' ' ' ILE . 23.4 m-85 -50.59 -47.26 58.14 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.743 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.64 -51.7 57.33 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.14 -59.95 2.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.684 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.0 -52.29 44.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.76 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -50.41 -47.26 56.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.908 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -49.57 -49.38 46.71 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.712 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -88.24 37.97 0.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.851 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 39.11 55.02 2.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 111.16 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.677 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 41.0 tp60 -127.91 140.11 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.677 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 68.7 mttm -112.39 124.1 51.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.998 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.446 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 9.6 pt -137.41 169.41 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.694 0.759 . . . . 0.0 111.9 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -132.99 127.32 33.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.296 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.566 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.9 mt -110.54 117.01 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 6.0 t -98.32 100.58 11.87 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.981 0.419 . . . . 0.0 110.16 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -96.43 71.22 2.71 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.209 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -78.1 -51.9 9.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.246 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.72 123.27 22.96 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.715 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.542 ' O ' HG22 ' A' ' 167' ' ' THR . 61.1 m -125.97 176.5 6.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.948 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 168' ' ' GLY . 1.0 OUTLIER -93.12 -30.18 15.39 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.472 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 3.5 p80 -51.18 -21.13 1.83 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.732 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.6 t -90.38 -28.24 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.763 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 101.7 20.05 14.06 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.59 169.56 9.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 110.733 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -52.33 -35.07 49.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.304 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -177.39 -165.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.0 OUTLIER -94.85 140.25 30.18 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.4 tpt -119.17 120.87 38.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 109.909 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mt -122.58 103.62 8.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.982 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -88.19 127.81 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.355 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mp -111.24 149.84 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.298 0.57 . . . . 0.0 110.775 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.72 134.77 37.52 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.951 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 120.945 0.403 . . . . 0.0 110.686 -179.822 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.436 HG21 HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.23 -62.1 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.852 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -58.71 -29.51 66.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.702 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -61.73 -60.86 3.03 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.211 0.529 . . . . 0.0 111.48 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.4 -27.39 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.431 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 tp -70.87 -42.4 70.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.351 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 14' ' ' VAL . 4.1 mt-10 -56.6 -39.64 73.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.497 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -60.97 -52.61 64.28 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.166 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 14.4 tpt -53.18 -41.39 65.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.983 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.06 -34.66 55.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.74 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 10' ' ' GLU . 41.6 t -63.13 -22.28 30.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 0.0 110.068 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.17 -34.5 19.01 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.259 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -85.77 -76.94 0.31 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.544 ' SG ' HD21 ' A' ' 58' ' ' LEU . 72.0 m -89.77 -19.11 25.12 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.385 0.612 . . . . 0.0 110.627 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.02 175.14 29.13 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.7 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.5 ttt -69.91 -26.96 64.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.888 -1.156 . . . . 0.0 110.67 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.6 m -64.34 -42.95 95.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.045 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -35.89 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.41 ' O ' HD13 ' A' ' 25' ' ' LEU . 51.0 t-105 -51.21 -46.04 62.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -69.68 -31.74 69.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.083 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -65.24 -51.39 61.21 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.8 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.21 -20.17 41.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.93 0.395 . . . . 0.0 110.69 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.8 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.1 tt -76.27 -47.75 22.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.381 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -70.57 -24.41 62.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.67 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -80.35 -40.14 27.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.51 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 73.9 m80 . . . . . 0 N--CA 1.465 0.322 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.305 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.681 0.277 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -59.7 -36.63 76.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.727 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -51.12 -56.94 10.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.028 0.442 . . . . 0.0 110.794 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -39.61 -43.34 1.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.659 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 m -72.25 -30.58 65.01 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.082 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 47' ' ' LEU . 13.3 mt -72.36 -54.84 15.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.156 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -55.65 -24.09 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.727 178.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.653 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.4 tt0 -77.51 -40.56 42.42 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.477 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.51 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 55.2 m-20 -59.42 -56.2 25.02 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.92 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 p -57.56 -37.68 59.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.917 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.18 -38.92 88.23 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.2 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -62.79 -32.31 73.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -72.35 -43.63 63.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.544 HD21 ' SG ' ' A' ' 17' ' ' CYS . 27.6 mt -80.71 -8.13 59.56 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.839 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.96 51.49 8.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.628 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.429 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 22.3 mmt -130.8 149.39 73.51 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.392 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.79 139.42 80.17 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.461 1.441 . . . . 0.0 111.096 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.653 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.3 tt -54.66 -28.81 19.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.851 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -73.91 -29.99 62.34 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.438 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -79.1 -35.61 42.0 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.745 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' A' ' 55' ' ' ALA . 79.4 t -63.65 -59.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -49.1 -38.89 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.611 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.454 ' N ' HG13 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -54.28 -45.57 72.53 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.82 -55.82 17.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.296 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -44.78 -29.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.976 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.88 -59.38 8.68 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -49.49 -48.24 48.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.922 0.391 . . . . 0.0 110.127 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 52.1 m-85 -60.15 -39.85 87.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.704 0.764 . . . . 0.0 110.687 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.1 tp -59.61 -38.27 80.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.815 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 30.6 t80 -69.54 -39.02 77.73 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.159 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.579 ' ND2' ' NE2' ' A' ' 152' ' ' HIS . 6.0 m120 -55.89 -70.55 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.69 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.81 -47.87 30.62 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.474 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.436 HD21 HG21 ' A' ' 4' ' ' ILE . 51.6 mt -50.64 -44.22 57.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.041 0.421 . . . . 0.0 111.765 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -55.78 -26.01 43.9 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.405 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.0 t -74.89 -55.1 6.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.05 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -73.37 -36.67 66.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.797 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -97.17 25.25 5.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.777 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 31.5 m -52.51 -38.1 58.91 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -58.62 -34.13 70.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.868 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 105' ' ' GLU . 2.9 t -81.6 -19.65 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.669 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.459 ' C ' ' N ' ' A' ' 87' ' ' LYS . 38.6 t -71.5 -43.6 71.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.949 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -51.5 -12.7 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.069 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.459 ' N ' ' C ' ' A' ' 85' ' ' VAL . 41.9 mmtm -69.09 -29.46 67.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.822 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 18.8 p90 -120.49 122.53 40.84 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.136 0.493 . . . . 0.0 111.328 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -87.29 -0.76 57.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.514 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 153' ' ' PHE . 45.7 t0 -162.31 165.58 26.41 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.583 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.4 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 72.8 t80 -57.04 -42.2 80.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.219 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.0 m -63.24 -59.34 4.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.46 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.1 m -46.81 -37.39 8.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.253 0.549 . . . . 0.0 110.649 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.545 HD12 ' CD2' ' A' ' 88' ' ' PHE . 4.4 tt -64.25 -44.36 92.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.431 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.4 t -66.77 -39.37 83.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.405 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 6.9 ptm -86.9 -1.43 57.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -113.43 -16.23 8.36 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.746 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.566 ' HA ' HD13 ' A' ' 102' ' ' ILE . 9.4 mt -34.26 -82.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 117.809 0.804 . . . . 0.0 111.712 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -45.17 -53.5 8.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.146 0.498 . . . . 0.0 110.915 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -46.99 -89.19 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.616 HG23 HD12 ' A' ' 102' ' ' ILE . 3.8 m -70.04 -49.84 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.616 HD12 HG23 ' A' ' 101' ' ' VAL . 3.8 mp -67.29 -39.5 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.586 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.47 -57.62 11.03 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.4 tp -47.68 -54.67 11.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.136 0.493 . . . . 0.0 110.185 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.423 ' HG2' HG22 ' A' ' 84' ' ' VAL . 34.5 tp10 -52.59 -46.52 66.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.775 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 102' ' ' ILE . 24.7 t -52.66 -54.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -45.09 -43.46 9.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.749 0.309 . . . . 0.0 110.666 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt . . . . . 0 C--N 1.331 -0.197 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.501 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.448 0.166 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.28 129.74 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -136.66 121.32 18.46 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.939 0.399 . . . . 0.0 111.726 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.35 123.48 5.73 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' A' ' 122' ' ' LEU . 37.9 tt0 -115.73 160.92 19.45 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.823 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -107.89 145.57 33.56 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.45 160.48 41.64 Favored Pre-proline 0 N--CA 1.468 0.461 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -72.8 -44.57 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.578 2.185 . . . . 0.0 113.247 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.676 HD21 ' NE2' ' A' ' 127' ' ' GLN . 47.7 p-10 -74.58 45.46 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.184 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.3 m120 44.99 60.72 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 0.0 111.102 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.676 ' NE2' HD21 ' A' ' 125' ' ' ASN . 21.8 mt-30 -136.72 158.83 43.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.913 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.6 mt -138.85 118.56 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.16 122.5 33.85 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.389 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.3 tp -115.42 136.24 53.29 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.111 0.481 . . . . 0.0 110.726 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -122.58 123.17 40.58 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.409 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.6 t80 . . . . . 0 N--CA 1.465 0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.257 -179.438 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.614 ' N ' HD22 ' A' ' 138' ' ' LEU . 2.9 mm? . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.651 0.262 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 93.6 m -41.41 -54.75 3.0 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 111.58 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -47.96 -30.26 4.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.935 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 138' ' ' LEU . 5.3 t -71.11 -44.59 65.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.772 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.66 -47.28 15.0 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.407 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -64.59 -48.86 73.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.349 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.74 -49.12 35.26 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 31.2 mt -59.16 -53.93 52.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.602 0.239 . . . . 0.0 111.507 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 31.3 mt -54.62 -55.66 27.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.947 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.585 ' CE2' HD12 ' A' ' 159' ' ' ILE . 19.6 m-85 -51.43 -47.78 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.862 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.01 -52.0 54.95 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.08 -59.83 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.926 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.85 -49.9 47.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -52.03 -50.1 62.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.565 0.221 . . . . 0.0 111.323 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.579 ' NE2' ' ND2' ' A' ' 75' ' ' ASN . 43.4 m80 -48.87 -49.35 40.02 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.826 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.526 ' CE2' ' OD1' ' A' ' 90' ' ' ASP . 64.7 t80 -85.43 35.68 0.61 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.949 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 39.22 55.17 2.21 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.056 0.455 . . . . 0.0 110.983 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.521 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 50.5 tp60 -130.5 141.79 50.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.521 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 30.9 mtmm -113.84 123.25 49.36 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.844 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.4 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 28.9 pt -133.3 172.45 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.65 0.738 . . . . 0.0 112.347 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -136.58 126.77 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.566 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.585 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.1 mt -111.51 120.35 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.685 0.278 . . . . 0.0 110.61 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.6 t -105.38 112.36 25.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.821 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.559 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 18.5 p80 -101.0 74.79 1.63 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.651 0.739 . . . . 0.0 111.503 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -76.21 -29.3 57.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.805 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.04 109.13 20.93 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.529 ' O ' HG22 ' A' ' 167' ' ' THR . 13.4 t -111.88 177.0 4.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.84 0.353 . . . . 0.0 110.417 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.44 ' N ' ' SG ' ' A' ' 164' ' ' CYS . 81.1 mtp -91.37 -28.26 17.82 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -53.62 -22.8 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.957 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.4 t -88.76 -28.15 20.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.466 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.59 20.35 15.22 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.099 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.03 163.14 17.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.722 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -49.44 -34.31 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.344 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 171' ' ' HIS . 8.0 p80 -172.25 -170.84 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.2 m -93.65 140.4 29.68 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 tpt -122.87 114.67 20.79 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -119.05 105.59 11.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.826 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.53 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -88.17 125.77 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.344 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.17 149.35 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.258 0.552 . . . . 0.0 110.385 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.499 ' OE2' ' N ' ' A' ' 178' ' ' LEU . 9.3 tp10 -136.47 135.47 38.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.993 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.499 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 13.0 mt . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.77 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 tp . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.81 0.338 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.4 mm -60.77 -45.24 98.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -70.99 -26.39 63.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.211 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -67.61 -53.23 29.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.016 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.35 -31.83 55.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.072 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.506 HD13 ' CE2' ' A' ' 69' ' ' PHE . 31.3 tp -71.86 -42.03 67.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.694 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.2 tt0 -54.28 -43.92 71.46 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.566 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -61.02 -51.14 70.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.326 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.615 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 58.2 mtm -54.01 -43.26 69.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.79 -36.43 75.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.666 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 10' ' ' GLU . 47.3 t -61.7 -25.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.265 0.555 . . . . 0.0 110.143 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.97 -34.45 22.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.199 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -84.33 -75.56 0.34 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.454 ' SG ' HD21 ' A' ' 58' ' ' LEU . 94.8 m -92.78 -22.88 19.08 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.199 0.524 . . . . 0.0 110.935 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.8 171.23 22.63 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.806 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 30.3 ttm -66.91 -27.45 67.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.707 -1.246 . . . . 0.0 110.292 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -63.25 -42.85 99.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.221 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.82 -35.56 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.418 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 51.1 t-105 -53.42 -44.74 69.03 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.98 -28.13 64.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.09 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -66.27 -51.17 60.1 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -83.47 -18.88 37.06 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.705 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 25' ' ' LEU . 9.0 tt -78.1 -70.66 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.581 ' N ' HD23 ' A' ' 26' ' ' LEU . 87.0 tt0 -49.58 -22.31 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.995 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 tttp -80.94 -37.27 29.75 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 26' ' ' LEU . 21.8 m80 . . . . . 0 N--CA 1.464 0.25 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.893 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.802 0.335 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -63.58 -30.64 71.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.634 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.43 -57.21 7.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 110.559 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.406 ' CZ ' HD12 ' A' ' 138' ' ' LEU . 78.9 m-85 -38.36 -43.81 0.85 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.122 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 m -74.32 -30.13 61.92 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.092 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.7 mt -72.96 -51.76 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.152 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -58.05 -26.0 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.816 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.659 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.5 tt0 -77.18 -41.36 41.86 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.682 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -58.77 -56.35 23.39 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.725 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.486 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 7.2 p -57.67 -34.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.066 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.54 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -67.44 -35.45 79.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.73 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -60.21 -47.76 84.59 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.21 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.721 HH22 HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -69.09 -39.79 78.8 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.663 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.454 HD21 ' SG ' ' A' ' 17' ' ' CYS . 84.6 mt -70.59 -10.8 60.18 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.091 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.5 t30 56.87 50.12 12.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.28 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.405 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 55.8 mmm -128.74 148.58 69.15 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.32 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.48 138.04 63.16 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.462 1.441 . . . . 0.0 111.028 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.659 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.8 tt -52.09 -29.3 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.291 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -72.35 -34.38 67.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.148 0.499 . . . . 0.0 111.482 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -75.61 -32.46 60.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.068 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.54 HG21 ' HB2' ' A' ' 55' ' ' ALA . 93.1 t -71.1 -56.31 11.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -53.01 -44.23 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.348 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.525 ' N ' HG13 ' A' ' 66' ' ' VAL . 36.0 mtpt -51.7 -50.44 60.49 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.27 -52.11 66.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.529 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.506 ' CE2' HD13 ' A' ' 9' ' ' LEU . 7.3 m-30 -46.91 -28.07 1.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.373 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.84 -48.21 42.92 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -55.05 -52.22 63.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.888 0.375 . . . . 0.0 110.635 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.615 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 57.7 m-85 -59.79 -42.17 92.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.695 0.76 . . . . 0.0 110.842 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.9 tp -53.36 -38.15 63.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.621 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 22.6 t80 -70.94 -42.45 69.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.233 0.539 . . . . 0.0 109.746 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -54.34 -72.83 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.653 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.06 -47.6 20.1 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.298 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.4 mt -50.71 -42.0 56.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.99 0.395 . . . . 0.0 112.013 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -54.95 -25.43 29.47 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.362 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.4 t -74.03 -55.94 5.52 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.928 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.684 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -71.24 -42.44 68.86 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.05 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -92.92 28.54 2.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.077 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 42.8 m -54.81 -38.45 67.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.015 0.436 . . . . 0.0 109.992 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.64 -34.78 73.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.235 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.23 -20.9 12.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.8 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 87' ' ' LYS . 38.9 t -69.9 -40.93 79.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.139 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -53.03 -14.0 0.53 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.408 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.408 ' N ' ' C ' ' A' ' 85' ' ' VAL . 21.6 mmtp -68.69 -29.6 68.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.034 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 15.8 p90 -119.75 121.27 38.79 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.171 0.51 . . . . 0.0 111.235 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -86.71 2.4 48.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.167 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 45.0 t0 -167.2 162.46 15.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.183 0.516 . . . . 0.0 111.522 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.45 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 80.0 t80 -51.49 -49.88 60.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.953 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.6 m -55.11 -58.34 8.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.519 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.5 t -46.73 -40.69 13.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.126 0.488 . . . . 0.0 111.217 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.443 HD12 ' CD2' ' A' ' 88' ' ' PHE . 5.0 tt -63.56 -43.92 95.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.396 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.6 t -64.3 -39.1 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.396 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 8.9 ptm -87.99 -1.09 57.78 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -114.08 -17.46 7.27 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 119.398 -0.668 . . . . 0.0 112.843 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.518 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.1 mt -28.12 -104.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 117.735 0.768 . . . . 0.0 112.494 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -39.6 -49.12 2.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.039 0.447 . . . . 0.0 111.341 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -45.08 -86.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.567 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -72.44 -52.61 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.567 ' N ' HG23 ' A' ' 101' ' ' VAL . 3.0 mp -62.23 -47.99 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.38 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.34 -53.08 48.74 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.4 tp -49.32 -50.86 37.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -55.46 -44.88 76.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.134 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.95 -53.7 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -45.65 -44.56 13.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.666 0.27 . . . . 0.0 110.958 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt . . . . . 0 C--N 1.328 -0.353 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.399 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.4 m80 . . . . . 0 N--CA 1.462 0.164 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.8 mt -124.07 126.82 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.586 0.231 . . . . 0.0 111.108 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -130.98 117.25 18.94 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.534 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.3 151.16 18.43 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.408 ' C ' HD22 ' A' ' 122' ' ' LEU . 91.7 mt-30 -140.77 161.02 38.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 110.125 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.791 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.2 mm? -109.29 143.37 38.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.847 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.07 160.58 40.43 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.32 -46.09 0.39 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.623 2.215 . . . . 0.0 113.25 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.586 ' N ' HD22 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -72.95 45.19 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.204 -179.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 44.65 63.38 1.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.424 0.631 . . . . 0.0 111.023 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.469 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 77.3 mt-30 -139.52 158.57 43.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.912 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.6 mt -138.5 117.59 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.68 122.3 31.97 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.655 -0.418 . . . . 0.0 109.988 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.3 tp -119.26 133.35 55.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.052 0.453 . . . . 0.0 111.456 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -116.94 122.56 44.62 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 40.6 t80 . . . . . 0 N--CA 1.466 0.363 0 CA-C-O 120.558 0.218 . . . . 0.0 111.329 -178.546 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.406 HD12 ' CZ ' ' A' ' 48' ' ' PHE . 3.1 tp . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.234 0.54 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.59 ' HG ' ' HG ' ' A' ' 172' ' ' CYS . 3.5 m -44.5 -49.25 10.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.69 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -44.23 -42.29 6.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.937 0.399 . . . . 0.0 110.58 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.3 t -63.76 -42.02 97.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.191 0.519 . . . . 0.0 109.61 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.6 -52.48 10.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.666 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -58.99 -50.98 72.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.471 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.24 -44.97 34.94 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.8 mt -62.78 -52.52 62.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.659 0.266 . . . . 0.0 111.48 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.9 mt -55.45 -57.09 13.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.854 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.57 ' CE2' HD12 ' A' ' 159' ' ' ILE . 26.6 m-85 -50.75 -47.78 59.33 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.767 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.06 -51.33 58.98 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.05 -59.75 2.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.867 0.365 . . . . 0.0 110.749 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -50.45 -52.02 41.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -50.77 -47.29 59.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.667 0.27 . . . . 0.0 111.015 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -49.48 -49.71 44.46 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.516 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 69.4 t80 -88.31 38.49 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.891 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 38.26 56.58 1.72 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 111.253 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.686 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 41.7 tp60 -129.74 141.12 50.94 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.686 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 60.7 mmtt -113.07 124.94 53.77 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.89 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.45 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 9.0 pt -137.96 171.86 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.633 0.73 . . . . 0.0 111.853 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -135.56 127.35 29.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.406 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.57 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.8 mt -110.53 118.38 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.0 t -100.98 105.48 16.7 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.479 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.548 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 18.2 p80 -102.58 75.67 1.46 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.553 0.692 . . . . 0.0 111.951 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -76.57 -29.14 56.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.456 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.7 103.94 15.65 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.586 ' O ' ' N ' ' A' ' 166' ' ' HIS . 38.7 t -132.45 112.71 12.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.662 0.267 . . . . 0.0 110.803 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 8.0 tpt -37.65 -18.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.102 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.586 ' N ' ' O ' ' A' ' 164' ' ' CYS . 57.4 t-80 -54.66 -25.93 30.05 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.487 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.0 t -86.37 -44.42 12.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.096 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 167' ' ' THR . . . 146.55 15.42 0.16 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.303 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.499 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -71.18 157.63 37.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.628 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -74.67 -5.09 41.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.612 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -176.08 -149.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.59 ' HG ' ' HG ' ' A' ' 139' ' ' CYS . 3.4 m -131.77 146.26 52.05 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.197 0.522 . . . . 0.0 111.59 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 10.6 tpp -119.56 124.11 45.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.277 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -126.95 105.32 8.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.411 0.624 . . . . 0.0 111.379 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -92.46 127.06 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.403 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 177' ' ' GLU . 5.1 mp -110.32 151.64 12.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.29 0.567 . . . . 0.0 110.902 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.413 ' N ' HG22 ' A' ' 176' ' ' ILE . 52.0 mt-10 -139.45 137.24 35.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.294 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.2 mt . . . . . 0 N--CA 1.464 0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.351 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.553 HD13 ' NE ' ' A' ' 80' ' ' ARG . 2.5 tp . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 121.025 0.44 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 mm -58.56 -47.88 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -73.77 -21.72 60.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -66.98 -50.42 62.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.762 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.02 -39.68 81.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.197 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.7 tp -63.49 -40.73 97.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -55.62 -46.43 77.36 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.639 -0.424 . . . . 0.0 109.892 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -61.19 -50.72 71.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.997 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.7 OUTLIER -52.49 -40.57 62.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.6 t -71.4 -34.74 54.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.551 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.9 t -61.62 -23.66 31.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.253 0.549 . . . . 0.0 109.95 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.82 -34.47 21.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.098 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -84.31 -75.74 0.33 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 58' ' ' LEU . 95.5 m -92.49 -20.82 20.58 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.189 0.518 . . . . 0.0 110.964 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.87 170.84 25.36 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.821 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.3 ttt -66.84 -27.09 67.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.926 -1.137 . . . . 0.0 110.444 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -63.7 -42.53 97.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.052 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.21 -35.07 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 -51.83 -45.29 63.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -73.95 -28.86 61.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.329 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -67.54 -50.3 59.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.939 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.33 -26.57 35.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.69 0.281 . . . . 0.0 110.553 -179.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.939 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.7 tt -70.08 -71.8 0.22 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.439 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.74 ' N ' HD23 ' A' ' 26' ' ' LEU . 82.4 tt0 -50.51 -23.34 2.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.543 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.38 -42.99 21.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m80 . . . . . 0 N--CA 1.467 0.411 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.96 -179.735 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 120.632 0.253 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -56.62 -36.91 70.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.138 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -40.84 -56.4 2.22 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.895 0.379 . . . . 0.0 111.056 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -39.43 -40.41 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.18 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.2 t -72.15 -34.57 68.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.225 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.9 mp -67.78 -54.9 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.28 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.407 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -55.52 -23.95 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.784 178.703 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.691 ' HG3' HD12 ' A' ' 62' ' ' ILE . 1.8 tt0 -76.05 -40.2 53.87 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.097 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.558 ' OD2' HD23 ' A' ' 25' ' ' LEU . 47.7 m-20 -60.26 -56.86 16.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.408 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.82 -36.76 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.87 87.5 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.174 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -63.52 -31.0 72.03 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.62 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -73.96 -42.94 59.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.619 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 ' SG ' ' A' ' 17' ' ' CYS . 25.9 mt -80.7 -7.11 59.23 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.879 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 56.22 49.23 15.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.556 0.693 . . . . 0.0 109.207 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mmt -127.73 149.75 71.32 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.967 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.99 137.73 63.87 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.451 1.434 . . . . 0.0 110.978 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.691 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.1 tt -51.28 -29.48 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.776 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -71.24 -30.13 65.96 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.143 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -78.41 -34.03 48.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.112 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.1 t -70.04 -56.41 11.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 67' ' ' LYS . 11.7 p -52.93 -41.39 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.248 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.512 ' N ' HG13 ' A' ' 66' ' ' VAL . 30.9 mtpt -53.25 -49.28 67.18 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.52 91.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.656 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -53.12 -33.07 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.566 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.05 -50.48 60.31 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.98 -50.31 66.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.064 0.459 . . . . 0.0 110.222 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -59.81 -42.58 93.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.632 0.729 . . . . 0.0 110.781 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.4 tp -56.37 -38.93 72.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.314 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 20.1 t80 -68.37 -43.77 76.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.369 0.604 . . . . 0.0 109.503 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.75 -71.65 0.08 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.289 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.11 -39.65 27.24 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.926 -178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.6 mt -61.81 -39.23 91.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.412 0.606 . . . . 0.0 112.027 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.94 -24.68 39.48 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.232 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.6 p -77.11 -53.84 7.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.438 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.553 ' NE ' HD13 ' A' ' 4' ' ' ILE . 1.1 mtm105 -68.75 -49.75 56.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.159 0.504 . . . . 0.0 110.343 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.608 ' CD2' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -83.72 22.75 1.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.444 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.4 m -49.38 -38.08 27.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.654 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -62.35 -35.85 80.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.721 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.608 HG21 ' CD2' ' A' ' 81' ' ' HIS . 3.6 t -83.58 -17.88 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.426 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 87' ' ' LYS . 56.1 t -65.24 -38.04 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.807 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -57.93 -6.41 0.56 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.769 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 105' ' ' GLU . 30.0 mmtp -76.71 -25.72 53.88 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.59 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.481 ' C ' ' H ' ' A' ' 90' ' ' ASP . 26.9 p90 -129.18 -45.77 1.24 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.707 0.289 . . . . 0.0 111.006 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 19.1 t70 58.16 -0.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.534 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.523 ' OD1' ' CE1' ' A' ' 153' ' ' PHE . 34.0 m-20 -152.07 164.63 36.84 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.35 0.595 . . . . 0.0 111.237 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -66.12 -61.25 2.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.7 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.6 m -50.82 -53.16 34.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.716 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.4 m -59.75 -35.79 75.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.309 0.576 . . . . 0.0 110.976 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.404 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 3.1 tt -66.36 -47.97 71.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.956 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 90.2 t -60.92 -36.31 71.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.394 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -88.8 -5.85 57.78 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.134 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -110.88 -15.14 11.18 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.476 -0.625 . . . . 0.0 112.78 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.665 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.1 mt -28.87 -104.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 117.568 0.684 . . . . 0.0 112.703 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.401 ' H ' ' HB ' ' A' ' 98' ' ' ILE . 13.6 p-80 -38.62 -48.66 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 0.0 111.54 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -45.71 -87.27 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.599 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.5 m -71.17 -52.1 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.665 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.1 mp -60.99 -47.25 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.452 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.05 -55.6 28.69 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.5 tp -47.88 -50.03 27.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.125 0.488 . . . . 0.0 110.358 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 84' ' ' VAL . 42.8 tp10 -55.71 -44.76 77.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.407 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.28 -52.15 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -49.37 -44.14 44.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.034 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt . . . . . 0 C--N 1.33 -0.272 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.432 -179.984 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 83.8 t60 . . . . . 0 C--O 1.231 0.095 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.9 mt -121.69 127.28 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.617 0.246 . . . . 0.0 110.891 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -130.81 113.02 13.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.945 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.99 138.55 15.06 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.437 ' C ' HD12 ' A' ' 122' ' ' LEU . 52.0 tt0 -132.26 158.51 41.63 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 122' ' ' LEU . 10.3 mp -103.44 146.44 28.5 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.47 161.42 39.45 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 126' ' ' ASN . 68.5 Cg_endo -72.77 -45.58 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.552 2.168 . . . . 0.0 113.398 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -72.9 38.49 0.08 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.974 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 124' ' ' PRO . 80.9 m-20 50.44 64.31 1.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.213 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -142.49 163.15 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.992 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.8 mt -137.59 118.09 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.21 120.42 27.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.0 tp -117.53 132.68 56.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.202 0.525 . . . . 0.0 110.952 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -121.22 126.38 49.47 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.505 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 120.936 0.398 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.0 t -41.68 -53.13 3.68 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.461 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -46.68 -33.64 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.165 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 7.0 t -68.38 -44.38 75.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.04 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.74 -49.99 18.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.907 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -62.13 -50.7 70.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.902 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.39 -42.6 18.81 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.04 -49.82 73.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 111.361 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.4 mt -58.87 -57.61 12.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.574 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.404 ' CE2' HD12 ' A' ' 159' ' ' ILE . 38.3 m-85 -49.58 -48.71 48.53 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.641 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.26 -51.58 57.24 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -42.86 -60.08 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.775 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.84 56.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.866 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -49.47 -48.09 47.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.665 0.269 . . . . 0.0 110.956 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -49.56 -49.64 45.56 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.827 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 65.2 t80 -85.69 35.87 0.63 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.348 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 44.25 46.76 7.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.126 0.488 . . . . 0.0 110.553 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.507 HE21 ' H ' ' A' ' 156' ' ' LYS . 51.0 tp60 -127.32 142.65 51.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.507 ' H ' HE21 ' A' ' 155' ' ' GLN . 65.6 mttm -124.65 117.48 24.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.77 ' O ' HD13 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -132.43 163.52 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.365 0.602 . . . . 0.0 111.121 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -118.29 131.95 56.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.404 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.1 mt -110.32 119.35 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.0 m -103.64 114.72 29.2 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.578 0.228 . . . . 0.0 111.311 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.539 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.6 p-80 -96.03 79.01 3.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.512 0.672 . . . . 0.0 111.565 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -82.22 -0.07 43.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.164 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.86 111.12 5.57 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.52 ' O ' HG22 ' A' ' 167' ' ' THR . 13.6 m -114.14 178.79 4.16 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.112 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 168' ' ' GLY . 77.4 mtp -93.9 -28.94 15.55 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.476 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 4.3 p80 -52.77 -21.21 3.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.673 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.8 t -90.06 -28.04 19.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.561 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 99.63 19.9 18.77 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.072 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.38 167.8 9.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 110.792 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -52.15 -33.85 42.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.263 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -174.76 -170.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 1.7 m -94.31 140.34 29.91 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.253 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.6 tpp -118.6 123.61 45.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.26 102.44 6.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.477 0.656 . . . . 0.0 110.86 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -91.52 126.73 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.647 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.405 HG23 ' CG1' ' A' ' 157' ' ' ILE . 4.7 mp -108.51 147.07 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.19 0.519 . . . . 0.0 110.197 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -137.25 135.69 37.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.307 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 21.5 mt . . . . . 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.193 179.427 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.421 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.5 tp . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.869 0.366 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.2 mm -71.43 -56.08 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.093 0.473 . . . . 0.0 110.29 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -67.3 -18.73 65.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.079 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -75.24 -58.87 3.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.408 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 4' ' ' ILE . 51.0 t -52.65 -35.26 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.491 HD13 ' CE2' ' A' ' 69' ' ' PHE . 17.5 tp -73.08 -43.06 62.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.723 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -51.11 -44.71 61.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -60.36 -52.46 65.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.924 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.556 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 92.6 mtp -50.05 -43.63 51.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.131 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.9 t -68.55 -37.29 77.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.95 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.7 -23.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.226 0.536 . . . . 0.0 110.261 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.48 -34.01 18.81 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.262 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -83.81 -77.57 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.1 m -92.43 -19.11 22.38 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.216 0.532 . . . . 0.0 110.627 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.22 -179.38 24.82 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.0 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.1 ttm -72.57 -30.12 64.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.76 -1.22 . . . . 0.0 110.647 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -60.06 -38.81 83.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.872 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -77.69 -38.91 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 59.4 t-105 -54.48 -48.4 71.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.446 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.24 -25.14 57.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.707 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -74.7 -47.0 33.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.679 -0.408 . . . . 0.0 112.039 -178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.966 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.54 -28.13 37.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.313 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.966 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.9 tt -66.82 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.624 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.523 ' N ' HD23 ' A' ' 26' ' ' LEU . 96.0 mt-10 -57.76 -22.98 49.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.089 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -80.94 -44.6 17.98 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.523 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 86.7 m-70 . . . . . 0 N--CA 1.467 0.421 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.115 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 76.4 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.835 0.35 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.23 -30.95 70.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.741 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -39.71 -58.54 1.31 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.978 0.418 . . . . 0.0 110.852 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -38.4 -45.14 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.211 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.3 m -67.96 -35.3 78.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.15 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.1 mp -68.68 -58.34 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 119.979 -0.689 . . . . 0.0 109.32 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -52.12 -21.32 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.993 179.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.671 ' HG3' HD12 ' A' ' 62' ' ' ILE . 1.7 tt0 -79.41 -42.56 25.22 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.196 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.549 ' OD2' HD23 ' A' ' 25' ' ' LEU . 32.7 m-20 -57.95 -57.67 11.78 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.789 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.04 -38.88 69.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.641 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.74 84.91 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.081 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -63.35 -31.32 72.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -74.68 -45.26 45.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.63 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.3 mt -77.08 -6.54 53.2 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.853 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.22 48.17 17.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.51 0.672 . . . . 0.0 109.492 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.8 mmm -126.62 149.5 68.28 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.074 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.36 134.44 45.09 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.454 1.436 . . . . 0.0 111.182 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.671 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.9 tt -48.51 -27.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.06 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -72.56 -33.91 67.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.163 0.506 . . . . 0.0 111.327 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -76.38 -31.8 58.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.227 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.548 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 78.5 t -72.61 -56.18 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -51.46 -43.97 31.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.245 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.53 ' N ' HG13 ' A' ' 66' ' ' VAL . 34.5 mtpt -51.85 -51.73 54.58 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.06 -58.26 8.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.874 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.6 m-30 -44.33 -29.28 0.65 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.527 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.18 -47.75 77.53 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -58.52 -54.19 49.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.02 0.438 . . . . 0.0 110.446 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.556 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 34.8 m-85 -55.12 -40.71 70.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.736 0.779 . . . . 0.0 110.619 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.6 tp -58.68 -38.16 77.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.198 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 34.4 t80 -68.4 -39.49 81.64 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.041 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -57.19 -71.05 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.328 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.11 -39.82 50.49 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.017 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.412 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 17.7 mt -57.53 -47.4 82.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.332 0.566 . . . . 0.0 111.585 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.44 -20.84 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.41 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.409 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.4 t -79.17 -42.28 26.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.105 0.478 . . . . 0.0 110.072 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.46 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.3 mmp_? -65.9 -71.47 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.462 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 17.4 p80 -84.16 36.92 0.59 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.831 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 85' ' ' VAL . 26.5 m -51.11 -46.81 61.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.886 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -49.3 -36.66 21.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.248 0.547 . . . . 0.0 109.66 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.788 HG13 ' CD ' ' A' ' 105' ' ' GLU . 11.3 t -76.67 -22.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.999 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 87' ' ' LYS . 57.3 t -68.54 -44.62 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.245 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -54.4 -4.96 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.81 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 85' ' ' VAL . 60.9 mmtt -81.39 -29.46 33.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.009 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -95.21 117.53 30.41 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.255 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 91.2 m-20 -84.98 -15.44 44.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.482 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 89' ' ' ASP . 63.8 m-20 -161.63 172.02 17.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.192 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -59.42 -53.92 52.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.713 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.6 m -53.51 -36.48 61.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.261 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.3 m -64.79 -39.5 93.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.154 0.502 . . . . 0.0 110.491 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.47 HD12 ' CD2' ' A' ' 88' ' ' PHE . 4.2 tt -64.19 -47.58 79.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.509 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.33 -36.14 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.758 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.1 mmm -86.34 -5.3 59.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.445 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.38 -15.69 8.75 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.345 -0.697 . . . . 0.0 113.165 -178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.711 ' HA ' HD13 ' A' ' 102' ' ' ILE . 16.2 mt -28.07 -105.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 117.716 0.758 . . . . 0.0 112.662 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -39.97 -47.55 2.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.092 0.472 . . . . 0.0 111.351 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -47.04 -88.44 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.586 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.0 m -69.77 -51.78 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.4 mp -61.22 -45.61 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.539 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.89 -53.99 40.66 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.577 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 42.8 tp -52.0 -51.55 56.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.86 0.362 . . . . 0.0 110.782 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.788 ' CD ' HG13 ' A' ' 84' ' ' VAL . 34.4 mt-10 -55.48 -45.37 76.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.128 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.2 t -54.07 -52.38 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -47.41 -43.48 23.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.858 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.577 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 23.7 mmtm . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.788 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.1 m80 . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.447 0.165 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.3 mt -134.03 131.51 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.709 0.29 . . . . 0.0 110.682 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -135.41 130.21 34.5 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.659 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -123.4 150.66 16.89 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -138.04 164.71 28.42 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.08 145.09 36.23 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.354 -0.384 . . . . 0.0 109.966 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.35 160.55 41.14 Favored Pre-proline 0 N--CA 1.467 0.377 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.26 -40.11 1.81 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.57 2.18 . . . . 0.0 113.155 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.521 ' ND2' ' OE1' ' A' ' 127' ' ' GLN . 19.8 p30 -78.97 47.44 0.77 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.229 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.9 p30 42.52 61.1 2.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.464 0.65 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.521 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 66.5 mt-30 -137.73 159.44 41.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.895 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.5 mt -135.61 116.52 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.82 122.95 31.41 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.057 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.7 tp -117.66 135.06 54.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.99 0.424 . . . . 0.0 111.168 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -120.01 123.8 44.35 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.456 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.47 0.567 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.566 -178.896 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 26.4 p -40.55 -50.69 2.97 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.568 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.489 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 90.0 m-85 -43.13 -38.06 2.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 110.114 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 28.6 t -69.08 -45.96 68.96 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -45.64 -49.27 14.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.188 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -57.03 -50.39 72.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.677 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.64 -52.63 40.66 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.9 mt -55.16 -55.38 31.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.798 0.333 . . . . 0.0 110.498 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.3 mt -54.08 -55.75 24.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.564 ' CE2' HD12 ' A' ' 159' ' ' ILE . 6.3 m-85 -49.74 -47.97 50.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.73 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.26 60.21 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.95 -60.53 1.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.844 0.354 . . . . 0.0 110.87 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.61 -49.85 45.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -52.98 -47.64 68.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.083 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -50.06 -50.51 47.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 70.6 t80 -85.55 36.77 0.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.992 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 38.8 55.01 2.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.918 0.389 . . . . 0.0 111.134 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.567 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 48.0 tp60 -129.86 141.24 50.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.567 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 19.9 tptm -110.79 126.54 54.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.128 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.0 pt -137.37 177.04 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.524 0.678 . . . . 0.0 111.837 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -143.84 125.84 15.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.202 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.564 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.4 mt -111.76 120.74 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.624 0.25 . . . . 0.0 110.613 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 m -105.66 115.37 30.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.112 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 17.0 p80 -102.13 72.95 1.34 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.738 0.78 . . . . 0.0 111.526 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -73.63 -30.86 63.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.844 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.67 113.76 27.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.474 ' O ' HG22 ' A' ' 167' ' ' THR . 7.7 t -117.89 -175.38 2.83 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.305 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 165' ' ' MET . 12.6 tmm? -93.8 -25.5 17.36 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -56.09 -23.95 37.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.473 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.6 t -86.54 -25.29 25.14 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.3 21.97 25.91 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.908 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.73 163.18 24.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.025 0.441 . . . . 0.0 110.693 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -45.11 -33.35 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.021 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -176.53 -168.97 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 20.8 t -95.45 141.87 28.48 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.221 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.2 tpt -121.59 119.72 32.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.726 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.98 107.15 11.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.873 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.4 mp -88.98 126.36 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.372 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 177' ' ' GLU . 5.1 mp -111.66 152.48 13.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.135 0.493 . . . . 0.0 110.458 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.421 ' N ' HG22 ' A' ' 176' ' ' ILE . 85.9 tt0 -142.96 141.45 31.43 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.494 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 N--CA 1.462 0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.877 -179.69 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 tp . . . . . 0 CA--C 1.532 0.259 0 CA-C-O 120.757 0.313 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.96 -49.42 81.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 109.788 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -70.11 -23.39 63.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.003 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -68.12 -56.53 8.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.971 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.69 -38.65 76.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.043 0.449 . . . . 0.0 109.847 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.497 HD13 ' CE2' ' A' ' 69' ' ' PHE . 27.5 tp -65.89 -39.73 90.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.558 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -58.03 -43.8 87.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.989 0.423 . . . . 0.0 110.626 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.46 -63.9 1.14 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.361 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.8 ptm -46.19 -41.43 12.69 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.422 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.7 t -64.84 -38.36 82.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.609 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 49.2 t -59.9 -22.74 24.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.498 0.666 . . . . 0.0 109.407 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.76 -34.98 21.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.382 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -84.28 -76.67 0.29 Allowed 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.8 m -91.94 -21.44 20.57 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.294 0.569 . . . . 0.0 110.672 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.81 175.43 23.84 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.05 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.3 ttp -68.85 -28.07 66.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.648 -1.276 . . . . 0.0 110.368 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -61.75 -38.85 89.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.639 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.39 -38.67 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -55.3 -47.57 75.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.048 0.451 . . . . 0.0 110.096 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.04 -24.81 55.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.944 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -74.17 -47.31 36.61 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.93 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.71 -26.51 37.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.986 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.6 tt -73.04 -54.93 7.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.009 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' N ' HD23 ' A' ' 26' ' ' LEU . 82.0 tt0 -61.25 -23.98 66.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.475 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.51 ' NZ ' ' CE1' ' A' ' 29' ' ' HIS . 30.4 tttm -82.37 -39.04 23.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.51 ' CE1' ' NZ ' ' A' ' 28' ' ' LYS . 67.8 m80 . . . . . 0 N--CA 1.465 0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.063 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.8 0.333 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -67.9 -37.25 81.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.598 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -52.44 -57.54 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.194 0.521 . . . . 0.0 110.771 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -39.0 -42.38 0.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.671 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.8 p -74.53 -30.4 61.76 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.861 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 47' ' ' LEU . 17.9 mt -71.42 -52.96 22.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.745 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.97 -26.31 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.668 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.674 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.2 tt0 -76.53 -41.1 47.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.547 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.574 ' OD2' HD23 ' A' ' 25' ' ' LEU . 48.2 m-20 -59.47 -56.05 26.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.963 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 50' ' ' ILE . 5.9 p -58.35 -37.08 61.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.981 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.53 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.54 -38.28 86.84 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.061 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -63.52 -31.63 72.84 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.6 mmt-85 -73.54 -42.76 61.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.378 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.4 mt -81.54 -7.27 59.56 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.668 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.8 t30 57.02 49.82 13.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.807 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.4 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 25.7 mmt -128.69 149.44 72.03 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.214 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.62 137.76 65.95 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.404 1.403 . . . . 0.0 110.981 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.674 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.5 tt -51.22 -28.5 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.254 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -71.82 -34.2 69.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 0.0 111.58 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -76.17 -31.98 58.82 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.89 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 55' ' ' ALA . 95.9 t -71.08 -56.66 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.521 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -52.56 -43.87 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.372 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.521 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.5 mtpt -51.61 -51.06 58.66 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.39 -54.12 50.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.559 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.497 ' CE2' HD13 ' A' ' 9' ' ' LEU . 5.7 m-30 -44.12 -28.94 0.55 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.464 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.91 63.3 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.03 -54.35 48.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.768 0.318 . . . . 0.0 110.461 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -55.28 -41.33 72.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.813 0.816 . . . . 0.0 110.693 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.4 tp -57.95 -38.69 76.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.553 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 26.1 t80 -70.25 -39.53 74.94 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.162 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -55.33 -73.82 0.05 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.091 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.82 -38.21 29.74 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.203 -0.523 . . . . 0.0 112.572 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 20.8 mt -57.45 -46.52 83.52 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.028 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.41 -20.7 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.296 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.0 t -81.46 -41.92 21.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.15 0.5 . . . . 0.0 110.205 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.459 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.3 mmp_? -65.17 -71.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.778 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.459 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 18.5 p80 -85.25 34.61 0.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.985 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.9 m -47.2 -45.2 23.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.817 0.341 . . . . 0.0 110.574 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -54.55 -31.06 55.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 t -80.4 -24.58 11.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.093 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.0 t -62.49 -37.65 79.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.356 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.08 -15.95 2.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.653 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -65.75 -31.22 72.08 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.58 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 15.3 p90 -119.01 115.98 25.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.039 0.447 . . . . 0.0 110.708 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -83.68 -0.64 51.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.283 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 13.8 p-10 -163.11 155.25 18.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.128 0.49 . . . . 0.0 111.569 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -44.86 -52.0 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.876 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.7 m -55.01 -43.0 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.752 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -61.77 -36.11 80.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.233 0.54 . . . . 0.0 110.614 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.9 tt -67.05 -56.82 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.858 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.41 ' HA ' HD11 ' A' ' 98' ' ' ILE . 85.3 t -54.55 -38.46 42.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.847 0.356 . . . . 0.0 111.659 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.5 ppp? -88.44 -6.75 57.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -112.27 -14.73 10.43 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 119.712 -0.493 . . . . 0.0 112.909 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.585 ' HA ' HD13 ' A' ' 102' ' ' ILE . 3.8 mt -34.25 -83.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 117.867 0.833 . . . . 0.0 111.705 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -44.76 -54.16 6.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.26 0.553 . . . . 0.0 110.742 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -46.69 -88.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.63 HG23 HD12 ' A' ' 102' ' ' ILE . 3.7 m -71.01 -49.98 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -176.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.63 HD12 HG23 ' A' ' 101' ' ' VAL . 3.7 mp -65.91 -39.79 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.383 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.74 -56.0 14.86 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.65 HD11 ' HZ1' ' A' ' 108' ' ' LYS . 58.7 tp -49.91 -55.97 12.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.972 0.415 . . . . 0.0 110.709 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -52.69 -44.88 66.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.476 -178.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 102' ' ' ILE . 17.8 t -54.13 -53.42 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -47.14 -43.01 20.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.79 0.328 . . . . 0.0 110.827 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.65 ' HZ1' HD11 ' A' ' 104' ' ' LEU . 26.0 mmtm . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.572 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.66 0.267 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.49 126.34 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.962 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -133.14 121.12 22.14 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.579 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.3 126.97 7.17 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.449 ' C ' HD22 ' A' ' 122' ' ' LEU . 88.6 mt-30 -117.05 166.07 12.62 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.789 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.6 mm? -109.88 130.46 55.52 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.27 160.43 37.56 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.28 178.11 6.47 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.995 1.797 . . . . 0.0 112.127 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.523 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 19.5 t-20 56.6 37.26 28.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.949 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 8.6 p30 50.0 69.31 0.62 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.614 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 126' ' ' ASN . 82.8 mm-40 -136.85 161.61 35.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.513 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.1 mt -145.07 121.3 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.78 122.33 35.06 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.288 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.0 tp -117.64 134.73 54.57 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.125 0.488 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.688 HH21 ' CD2' ' A' ' 171' ' ' HIS . 58.7 ttt180 -117.56 121.61 41.44 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.477 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.485 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 37.4 t80 . . . . . 0 N--CA 1.467 0.378 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.531 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 31.0 p -43.17 -49.82 6.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.372 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.555 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 73.3 m-85 -46.76 -40.23 13.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.083 0.468 . . . . 0.0 110.335 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.3 t -62.93 -42.73 99.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -46.61 -54.95 8.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.663 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.64 -51.21 63.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.316 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.09 -48.13 47.25 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.05 -53.69 55.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.683 0.278 . . . . 0.0 111.302 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.4 mt -55.59 -54.93 37.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.699 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.545 ' CE2' HD12 ' A' ' 159' ' ' ILE . 10.6 m-85 -49.17 -49.1 44.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.902 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.04 -50.58 66.32 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.42 -59.91 2.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.74 0.305 . . . . 0.0 110.941 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 155' ' ' GLN . . . -51.44 -52.08 49.37 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.314 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -52.13 -47.88 65.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.215 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -47.74 -50.0 26.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.709 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -85.39 38.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.844 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 38.45 62.31 1.02 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.038 0.447 . . . . 0.0 111.309 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.616 HE21 HG23 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -132.93 151.11 52.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.504 ' N ' ' NE2' ' A' ' 155' ' ' GLN . 84.4 tttt -118.27 118.9 33.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.616 HG23 HE21 ' A' ' 155' ' ' GLN . 33.9 pt -133.32 170.86 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.539 0.685 . . . . 0.0 112.186 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -138.25 127.77 24.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.52 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.545 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.6 mt -111.41 117.56 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.911 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.9 t -98.72 103.34 15.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.819 0.343 . . . . 0.0 110.47 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.576 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 20.3 p80 -94.02 65.12 3.43 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.615 0.721 . . . . 0.0 111.017 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 163' ' ' THR . 37.3 p30 -69.0 -33.05 73.04 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.113 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.512 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 1.6 m -99.95 107.54 19.53 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.066 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.59 ' O ' ' N ' ' A' ' 166' ' ' HIS . 55.9 m -134.71 114.22 12.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.653 0.263 . . . . 0.0 110.785 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.2 ttt -36.62 -20.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.19 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.59 ' N ' ' O ' ' A' ' 164' ' ' CYS . 83.7 t60 -52.23 -23.33 5.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.482 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.6 t -88.77 -43.18 11.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.01 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 167' ' ' THR . . . 130.48 13.9 2.02 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.09 162.51 14.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 110.729 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.554 ' O ' ' CG ' ' A' ' 171' ' ' HIS . 28.9 p-10 -55.55 -41.16 72.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.343 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.688 ' CD2' HH21 ' A' ' 131' ' ' ARG . 82.5 m-70 -161.52 -173.33 3.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.6 m -96.31 137.96 34.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.439 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.511 ' H ' ' HB ' ' A' ' 163' ' ' THR . 12.3 ttm -126.19 92.76 3.64 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.609 0.719 . . . . 0.0 109.608 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.19 113.9 26.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.912 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.1 mm -90.49 127.98 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.366 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.07 148.99 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.432 0.634 . . . . 0.0 110.727 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -137.82 135.88 36.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.555 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 19.0 mt . . . . . 0 N--CA 1.465 0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.702 -179.687 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.505 HD13 ' O ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mm -68.56 -52.73 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.395 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.45 -22.81 64.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.006 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -69.83 -49.59 51.1 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.716 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.08 -36.36 77.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.922 0.392 . . . . 0.0 110.158 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.453 HD13 ' CE2' ' A' ' 69' ' ' PHE . 24.1 tp -71.02 -35.46 72.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.241 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.15 -45.73 86.91 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.045 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -61.61 -52.32 64.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.428 ' SD ' ' CE1' ' A' ' 69' ' ' PHE . 7.8 ttp -49.73 -43.27 47.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.54 -35.17 69.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.663 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -61.93 -22.16 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.218 0.533 . . . . 0.0 109.756 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.9 -35.11 20.74 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.343 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -84.35 -77.13 0.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.495 ' SG ' HD21 ' A' ' 58' ' ' LEU . 90.4 m -90.99 -20.04 22.56 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.265 0.555 . . . . 0.0 110.738 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.95 173.59 26.54 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.77 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.8 ttt -68.57 -28.37 66.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.831 -1.184 . . . . 0.0 110.477 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.8 m -62.76 -42.5 99.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.164 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.96 -36.03 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -52.03 -46.23 64.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -70.14 -30.98 68.28 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.138 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -65.31 -50.62 64.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -83.14 -18.89 37.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.871 0.367 . . . . 0.0 110.792 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.792 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.5 tt -77.97 -61.43 2.0 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.371 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.489 ' N ' HD23 ' A' ' 26' ' ' LEU . 78.5 mm-40 -58.68 -21.91 55.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.319 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -80.64 -38.58 28.91 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.502 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 72.1 m80 . . . . . 0 N--CA 1.465 0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.508 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.9 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.792 0.33 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.96 -30.38 67.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.808 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.6 -57.46 2.26 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.038 0.447 . . . . 0.0 110.684 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -38.0 -43.47 0.72 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.516 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.3 m -72.94 -32.41 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.527 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.2 mp -70.74 -52.84 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.503 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.4 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -56.44 -24.67 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.885 178.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.681 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.5 tt0 -77.01 -41.37 43.02 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.466 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.502 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 37.9 m-20 -58.55 -56.43 22.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.864 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.0 p -57.13 -39.32 66.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.065 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.02 -39.72 86.81 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.134 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -62.84 -31.51 72.54 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -74.54 -45.79 43.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.491 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.495 HD21 ' SG ' ' A' ' 17' ' ' CYS . 32.0 mt -76.8 -8.6 57.61 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.621 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 58.1 52.33 7.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.748 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.415 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 11.2 mmt -132.43 149.95 74.56 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.382 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.31 140.64 89.45 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.441 1.427 . . . . 0.0 111.194 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.681 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.2 tt -56.55 -30.76 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.744 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -72.91 -29.75 63.37 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.297 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 50.2 t0 -78.77 -36.62 42.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.699 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 55' ' ' ALA . 69.2 t -63.74 -58.96 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -49.94 -39.89 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.756 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' N ' HG13 ' A' ' 66' ' ' VAL . 2.2 ttpt -52.59 -47.33 66.97 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.86 89.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.453 ' CE2' HD13 ' A' ' 9' ' ' LEU . 6.2 m-30 -52.81 -29.96 30.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.613 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.17 -50.41 57.06 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -55.62 -50.06 71.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.924 0.392 . . . . 0.0 110.2 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -59.16 -41.53 88.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.802 0.81 . . . . 0.0 110.431 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.73 -38.88 79.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.449 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 36.6 t80 -69.54 -39.15 77.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.136 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -56.9 -69.87 0.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.97 -38.13 54.75 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.581 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.514 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 18.8 mt -57.07 -48.22 79.11 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.451 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.16 -21.28 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.552 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t -80.41 -40.51 26.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.24 0.543 . . . . 0.0 110.109 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.443 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.9 mmp_? -66.55 -70.55 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.68 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 23.7 p80 -83.66 32.99 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.97 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 55.0 m -47.93 -43.27 28.92 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.941 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -52.67 -31.76 38.85 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 81' ' ' HIS . 16.7 t -82.47 -25.26 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.675 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 87' ' ' LYS . 44.5 t -63.27 -38.2 81.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -47.33 -12.86 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.875 0.369 . . . . 0.0 110.924 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.506 ' NZ ' ' CG ' ' A' ' 105' ' ' GLU . 85.5 mttt -79.63 -28.41 40.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.895 0.855 . . . . 0.0 109.721 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 85' ' ' VAL . 39.7 t80 -57.78 100.21 0.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.232 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -88.39 -32.91 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 54.2 t0 -174.73 155.51 2.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.759 -1.564 . . . . 0.0 109.923 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.504 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 78.0 t80 -42.56 -46.27 4.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.319 0.58 . . . . 0.0 110.49 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.2 m -61.76 -37.3 83.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.795 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -65.54 -40.83 93.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.343 0.592 . . . . 0.0 110.579 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 98' ' ' ILE . 6.5 tt -65.35 -49.92 67.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.318 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.407 HG21 ' CE2' ' A' ' 91' ' ' PHE . 76.5 t -57.13 -37.78 57.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.262 0.554 . . . . 0.0 110.623 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 120' ' ' GLY . 95.3 mmm -86.49 -5.98 59.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.192 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.89 -15.56 8.52 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.096 -0.836 . . . . 0.0 113.202 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.521 ' O ' ' O ' ' A' ' 97' ' ' GLY . 13.6 mt -27.27 -106.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 117.945 0.873 . . . . 0.0 112.66 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -40.64 -49.89 3.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.26 0.552 . . . . 0.0 111.259 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -43.25 -86.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.548 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.0 m -72.82 -51.86 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.548 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mp -64.77 -50.04 77.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.51 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -53.46 -50.98 50.76 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.575 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 30.1 tp -48.83 -50.28 35.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.085 0.469 . . . . 0.0 110.228 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.506 ' CG ' ' NZ ' ' A' ' 87' ' ' LYS . 68.9 mm-40 -55.85 -45.08 78.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.141 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 72.3 t -51.99 -51.0 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -50.11 -42.49 50.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.708 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.575 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 26.4 mmtm . . . . . 0 C--N 1.331 -0.203 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.26 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 . . . . . 0 C--O 1.232 0.147 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 91.3 mt -121.26 126.69 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.631 0.253 . . . . 0.0 110.981 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -130.66 112.18 12.88 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.861 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.443 ' C ' ' SD ' ' A' ' 96' ' ' MET . . . -110.39 128.46 8.83 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -118.95 164.66 15.13 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.944 0.402 . . . . 0.0 110.468 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.24 144.73 36.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.661 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.41 160.56 41.21 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.01 -31.43 9.81 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.549 2.166 . . . . 0.0 113.261 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -86.51 44.97 1.19 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.24 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 m120 45.06 51.34 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.286 0.565 . . . . 0.0 110.575 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -127.44 158.46 37.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.701 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.1 mt -135.72 117.91 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.65 122.77 32.43 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.749 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.7 tp -117.26 133.79 55.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.058 0.456 . . . . 0.0 110.439 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -119.38 126.59 51.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.529 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 121.256 0.551 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.4 m -41.93 -50.82 4.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.93 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -45.43 -36.74 4.56 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.552 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.82 -44.17 74.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.949 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -44.77 -47.52 10.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.603 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -65.13 -49.42 69.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.376 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.65 -47.45 45.75 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.9 mt -58.84 -53.28 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.65 0.262 . . . . 0.0 111.192 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.8 mt -55.64 -54.73 40.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.606 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.669 ' CE2' HD12 ' A' ' 159' ' ' ILE . 18.3 m-85 -50.42 -47.14 56.72 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.658 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.94 -50.94 62.41 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.61 -59.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.743 0.306 . . . . 0.0 110.736 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.25 -51.51 58.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.667 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -51.52 -47.24 63.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.067 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -49.4 -49.73 43.45 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.743 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.517 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 67.4 t80 -88.03 38.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.891 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 38.51 55.28 1.87 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.966 0.412 . . . . 0.0 111.134 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.596 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 46.4 tp60 -128.84 141.18 51.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.596 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 15.7 mtpp -110.85 131.35 55.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.173 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.4 pt -142.99 170.12 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.631 0.729 . . . . 0.0 112.268 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -134.77 125.69 27.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.93 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.669 HD12 ' CE2' ' A' ' 147' ' ' PHE . 5.7 mt -111.63 118.84 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.618 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.2 m -98.95 99.83 10.93 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.008 0.433 . . . . 0.0 110.248 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 163' ' ' THR . 23.3 t-160 -98.59 70.12 1.92 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.388 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -77.11 -45.84 25.56 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.904 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.466 ' O ' ' CD2' ' A' ' 161' ' ' HIS . 2.4 m -77.83 118.91 20.62 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.863 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 166' ' ' HIS . 34.0 t -143.78 116.27 8.6 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.009 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.432 ' C ' ' N ' ' A' ' 167' ' ' THR . 26.1 ttt -35.25 -23.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.073 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.575 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.9 t60 -50.11 -20.66 1.04 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.432 ' N ' ' C ' ' A' ' 165' ' ' MET . 6.0 t -93.97 -36.4 12.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.139 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.66 13.34 8.07 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.56 165.69 7.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 110.809 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -52.83 -35.91 57.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.428 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -172.13 -171.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.4 m -93.68 138.83 31.5 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.547 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.3 tpt -117.65 122.08 42.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.064 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -126.13 102.21 7.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.029 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -90.35 126.95 43.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.511 178.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.46 151.83 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.188 0.518 . . . . 0.0 110.599 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -139.26 137.84 36.26 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.48 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 N--CA 1.464 0.238 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.937 -179.636 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tp . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 120.769 0.319 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.0 mm -58.7 -49.15 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.112 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -67.26 -25.91 66.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.275 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -66.95 -54.63 20.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.192 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.76 -35.19 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.401 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.505 HD13 ' CE2' ' A' ' 69' ' ' PHE . 17.8 tp -68.48 -51.33 44.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.399 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -47.0 -44.15 20.02 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.09 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -61.14 -52.71 63.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.999 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.8 ttt -51.31 -40.17 58.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.73 -35.69 66.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.418 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.78 -22.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.336 0.589 . . . . 0.0 109.883 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.77 -34.7 19.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.225 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -84.48 -77.06 0.28 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.47 ' SG ' HD21 ' A' ' 58' ' ' LEU . 98.0 m -90.81 -20.12 22.68 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.247 0.546 . . . . 0.0 110.705 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.6 173.78 26.99 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.719 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.4 ttt -69.53 -25.02 63.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.937 -1.131 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -65.27 -43.21 91.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.148 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -34.31 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -51.57 -45.97 63.28 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -69.15 -32.66 72.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.015 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -64.33 -50.97 65.68 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.806 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.78 -19.6 37.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.958 0.408 . . . . 0.0 110.965 -179.229 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.806 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.5 tt -75.34 -57.61 3.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.692 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' N ' HD23 ' A' ' 26' ' ' LEU . 99.4 mt-10 -62.89 -21.09 65.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.62 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -80.72 -39.29 27.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.526 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 43.5 m170 . . . . . 0 N--CA 1.468 0.458 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.861 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.713 0.292 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -62.09 -40.82 97.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.769 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -41.19 -55.01 2.77 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.946 0.403 . . . . 0.0 110.595 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.14 -38.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.914 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.9 m -72.41 -34.53 67.93 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.837 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.8 mp -68.33 -56.93 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.207 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -51.89 -26.25 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.831 178.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.672 ' HG3' HD12 ' A' ' 62' ' ' ILE . 7.2 tt0 -75.24 -41.18 58.1 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.763 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.526 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 51.3 m-20 -59.4 -56.62 19.69 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.073 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 p -56.39 -38.1 54.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.08 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.07 -38.75 87.33 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.251 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -62.8 -32.22 73.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.55 -43.32 60.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 17' ' ' CYS . 41.6 mt -79.3 -8.47 59.08 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.612 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.1 t30 57.32 50.4 11.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.555 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.405 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 10.0 mmt -129.79 149.75 73.91 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.208 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.74 139.83 82.68 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.407 1.405 . . . . 0.0 111.171 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.672 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.6 tt -54.37 -30.89 21.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.363 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -72.0 -29.72 64.49 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.405 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 37.5 t0 -78.69 -35.48 45.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.956 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 55' ' ' ALA . 72.0 t -66.29 -58.03 8.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -51.34 -39.49 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.959 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.489 ' N ' HG13 ' A' ' 66' ' ' VAL . 2.4 ttpt -53.35 -47.83 69.05 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.88 -43.96 97.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.65 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.505 ' CE2' HD13 ' A' ' 9' ' ' LEU . 6.8 m-30 -55.1 -32.07 61.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.17 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.4 -50.18 56.99 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -57.63 -47.77 81.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.066 0.46 . . . . 0.0 109.896 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.03 -42.58 94.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.85 0.833 . . . . 0.0 110.363 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.8 tp -56.15 -39.0 71.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.388 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -70.49 -40.8 73.38 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.286 -0.565 . . . . 0.0 109.936 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -57.08 -71.87 0.09 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.914 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.5 -37.58 19.62 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.223 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.67 -41.6 86.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.121 0.46 . . . . 0.0 111.732 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.16 -15.86 2.62 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.672 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.431 ' O ' ' OG1' ' A' ' 82' ' ' THR . 29.0 t -83.69 -46.85 11.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.324 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -86.87 -47.4 9.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.977 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.549 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -84.42 26.48 0.78 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.201 0.524 . . . . 0.0 109.982 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 79' ' ' SER . 3.8 m -58.21 -40.38 81.44 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.329 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -56.01 -31.87 63.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.3 t -85.54 -20.84 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.923 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 81' ' ' HIS . 43.3 t -64.69 -41.22 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.213 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.82 -19.15 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -66.23 -28.91 69.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.557 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 1.8 p90 -120.35 114.32 21.68 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.107 0.48 . . . . 0.0 110.77 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -85.28 -3.33 58.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.372 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -163.04 154.57 17.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.092 0.472 . . . . 0.0 111.602 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.439 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 89.8 t80 -45.4 -56.38 5.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.001 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.0 m -52.08 -44.01 64.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.795 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.9 p -61.63 -35.47 77.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.18 0.514 . . . . 0.0 110.825 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.9 tt -68.64 -48.78 63.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.589 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.78 -39.1 75.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.069 0.461 . . . . 0.0 111.145 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -88.61 -4.86 58.48 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -111.03 -15.07 11.08 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 119.569 -0.573 . . . . 0.0 112.761 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 94' ' ' LEU . 12.8 mt -30.37 -100.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 117.75 0.775 . . . . 0.0 112.269 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -39.31 -51.61 2.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.15 0.5 . . . . 0.0 111.374 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -43.32 -87.21 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -72.51 -53.65 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.587 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.9 mp -62.27 -46.89 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.688 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.19 -52.57 48.61 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.592 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 42.4 tp -52.43 -51.47 58.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.359 . . . . 0.0 110.665 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -54.88 -45.84 74.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.755 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.68 -51.99 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -47.11 -43.23 20.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.757 0.313 . . . . 0.0 110.754 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.592 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 26.7 mmtm . . . . . 0 C--N 1.329 -0.305 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.144 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.547 ' NE2' ' NH2' ' A' ' 131' ' ' ARG . 20.4 t60 . . . . . 0 CA--C 1.528 0.121 0 N-CA-C 111.515 0.191 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.71 129.62 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -134.53 119.75 18.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.886 0.374 . . . . 0.0 111.591 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -108.2 126.06 8.1 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.403 ' C ' HD22 ' A' ' 122' ' ' LEU . 15.0 mm-40 -116.77 165.27 13.49 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.117 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.769 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.2 mm? -111.8 139.19 47.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.186 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.95 160.25 41.51 Favored Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 69.9 Cg_endo -73.51 158.71 47.43 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.264 1.976 . . . . 0.0 112.109 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 124' ' ' PRO . 3.4 t-20 92.24 -60.92 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.217 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 14.1 m-20 154.31 59.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -135.14 163.28 30.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.05 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.7 mt -140.2 121.16 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.34 122.77 33.52 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.276 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.0 tp -116.05 136.55 52.92 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.033 0.444 . . . . 0.0 110.745 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.547 ' NH2' ' NE2' ' A' ' 117' ' ' HIS . 61.0 ttp85 -123.08 124.28 42.75 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.595 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.428 ' C ' ' CD1' ' A' ' 132' ' ' TYR . 25.4 t80 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.19 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.547 ' N ' HD22 ' A' ' 138' ' ' LEU . 2.4 mm? . . . . . 0 CA--C 1.532 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 65.5 m -40.86 -54.61 2.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.601 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -47.07 -30.07 2.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.957 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.456 ' N ' ' O ' ' A' ' 138' ' ' LEU . 4.7 t -71.38 -45.19 63.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.794 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.65 -48.79 14.8 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.588 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -63.35 -48.26 78.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.206 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.33 -46.22 44.42 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.3 -52.58 64.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.64 0.257 . . . . 0.0 111.351 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.2 mt -55.53 -56.51 19.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.819 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.592 ' CE2' HD12 ' A' ' 159' ' ' ILE . 23.7 m-85 -51.33 -47.55 62.65 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.644 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.33 -52.23 54.46 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.52 -60.21 1.84 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.0 110.784 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.34 -51.63 52.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.563 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -51.24 -46.37 62.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.636 0.255 . . . . 0.0 110.961 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -50.23 -50.35 50.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.515 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 71.3 t80 -86.2 37.15 0.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.998 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 40.69 53.0 3.15 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.92 0.39 . . . . 0.0 111.062 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.525 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 46.0 tp60 -127.72 139.52 52.63 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.525 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 2.3 mptp? -112.95 128.06 56.38 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.439 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 10.7 pt -139.18 175.72 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.663 0.744 . . . . 0.0 111.638 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -137.78 127.09 24.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.195 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.592 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.3 mt -112.31 116.69 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.462 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.3 m -97.0 101.94 13.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.497 ' NE2' ' O ' ' A' ' 163' ' ' THR . 10.8 t-160 -104.62 74.97 1.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.91 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -81.27 -40.68 23.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.82 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.497 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 1.9 m -78.97 117.72 20.31 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.146 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 166' ' ' HIS . 14.7 t -142.16 117.35 10.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.693 0.282 . . . . 0.0 111.08 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.475 ' C ' ' N ' ' A' ' 167' ' ' THR . 24.5 ttt -33.88 -25.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.225 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.568 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.6 t60 -49.42 -19.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.568 0.699 . . . . 0.0 109.147 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.475 ' N ' ' C ' ' A' ' 165' ' ' MET . 5.9 t -94.73 -34.2 12.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.958 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 112.54 16.05 9.07 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.34 166.48 8.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.064 0.459 . . . . 0.0 110.782 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -55.56 -33.91 64.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.456 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -171.89 -169.63 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.7 m -94.7 141.94 28.04 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.562 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.5 tpt -118.02 123.6 46.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.104 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.2 100.35 5.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.162 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.544 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -88.26 126.6 41.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.702 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.84 149.74 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.183 0.516 . . . . 0.0 110.588 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -144.57 139.28 28.04 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.421 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.462 0.172 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.116 179.601 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 tp . . . . . 0 CA--C 1.529 0.172 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.4 -48.4 80.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.423 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 3.2 m-85 -67.42 -24.11 65.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.753 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -71.18 -57.31 4.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.49 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.15 -35.84 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.012 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.473 HD13 ' CD2' ' A' ' 69' ' ' PHE . 26.7 tp -72.03 -41.94 66.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.413 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -53.87 -46.61 71.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.935 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.16 -45.29 93.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.927 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.599 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 3.3 tpp -58.05 -47.31 83.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.4 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.55 -36.71 76.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.828 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -63.17 -22.94 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.278 0.561 . . . . 0.0 109.661 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.77 -34.76 18.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.85 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -86.78 -76.93 0.34 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.483 ' SG ' HD21 ' A' ' 58' ' ' LEU . 88.8 m -89.84 -17.08 28.77 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.408 0.623 . . . . 0.0 110.723 -177.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.2 -179.97 31.15 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.565 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 ttt -72.85 -31.68 64.93 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.053 -1.074 . . . . 0.0 111.098 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -60.22 -39.53 86.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.165 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.83 -37.76 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -55.13 -47.38 75.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.07 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.33 -24.89 54.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.898 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -76.01 -46.42 29.53 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.819 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.991 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.37 -28.22 41.93 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.742 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.991 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.8 tt -71.23 -45.86 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.232 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.4 -23.89 63.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.639 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -82.14 -40.59 21.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.423 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 59.6 m-70 . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.177 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.777 0.322 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.54 -28.89 70.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.644 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.9 OUTLIER -47.82 -57.95 4.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.203 0.525 . . . . 0.0 110.354 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -37.14 -44.82 0.58 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.98 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.5 m -71.91 -32.26 67.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.123 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 14.1 mt -71.6 -52.3 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.31 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -59.63 -21.89 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.445 178.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.692 ' HG3' HD12 ' A' ' 62' ' ' ILE . 1.9 tt0 -80.34 -41.03 25.53 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.111 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.6 ' OD2' HD23 ' A' ' 25' ' ' LEU . 37.2 m-20 -58.53 -57.32 13.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.71 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.41 -37.61 64.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.555 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.55 87.98 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.236 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -63.4 -31.4 72.55 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.498 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -73.21 -46.24 51.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.541 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.483 HD21 ' SG ' ' A' ' 17' ' ' CYS . 30.6 mt -76.31 -7.48 55.03 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.879 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.59 48.59 16.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.439 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 18.3 mmt -127.7 149.81 71.43 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.131 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.08 137.48 66.99 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.475 1.45 . . . . 0.0 111.233 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.692 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.7 tt -52.82 -29.72 14.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.023 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -73.45 -29.54 62.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.497 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -79.4 -34.65 41.64 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.06 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.535 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 55.7 t -66.14 -58.79 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.5 p -48.53 -38.8 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.662 178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -54.55 -44.31 72.77 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.739 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.31 -59.32 5.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.305 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.535 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 5.5 m-30 -45.98 -29.98 1.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.289 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.88 -52.64 51.09 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -57.02 -51.74 68.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.962 0.411 . . . . 0.0 110.143 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.599 ' CD1' ' SD ' ' A' ' 12' ' ' MET . 55.5 m-85 -56.73 -43.02 80.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.798 0.808 . . . . 0.0 110.595 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.0 tp -55.45 -38.38 68.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.614 -1.176 . . . . 0.0 112.057 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 43.6 t80 -68.91 -40.26 79.23 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.965 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -57.22 -70.2 0.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.038 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.87 -41.68 36.69 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.789 -178.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.2 mt -57.4 -44.83 84.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.274 0.537 . . . . 0.0 111.615 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -49.17 -20.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.903 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 t -81.77 -41.62 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.119 0.485 . . . . 0.0 109.834 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.414 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.5 mmp_? -65.41 -74.52 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.696 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.512 ' O ' ' CG ' ' A' ' 81' ' ' HIS . 0.2 OUTLIER -84.39 37.28 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.596 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.8 m -48.11 -46.43 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.111 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -54.22 -34.02 59.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.049 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.54 -21.93 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.685 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 87' ' ' LYS . 73.7 t -70.96 -41.49 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.765 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -54.75 -0.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.467 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.539 ' H ' ' C ' ' A' ' 85' ' ' VAL . 77.6 mttt -84.25 -28.01 27.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.52 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.12 119.47 36.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.587 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 58.2 t0 -84.02 -13.66 52.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.118 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.454 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 60.8 m-20 -162.02 167.63 24.1 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.431 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -53.83 -52.65 59.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.685 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.9 m -53.04 -37.68 61.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.259 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.4 m -60.88 -40.65 93.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.337 0.589 . . . . 0.0 110.14 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 98' ' ' ILE . 8.4 tt -60.76 -59.3 5.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.318 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.9 t -52.72 -37.4 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.229 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 91.8 mmm -86.23 -5.68 59.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.731 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -114.93 -15.14 8.08 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.377 -0.68 . . . . 0.0 113.112 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 97' ' ' GLY . 10.3 mt -28.03 -104.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 117.763 0.782 . . . . 0.0 112.763 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 118' ' ' ILE . 8.1 p80 -39.39 -49.88 2.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.075 0.464 . . . . 0.0 111.229 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -44.47 -87.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -71.52 -51.89 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mp -63.92 -45.48 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.756 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.38 -52.73 51.03 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.7 tp -51.67 -52.36 48.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.791 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.537 ' CD ' ' HZ1' ' A' ' 87' ' ' LYS . 58.3 mm-40 -53.85 -46.0 71.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.329 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.4 t -55.29 -51.39 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -48.69 -42.74 35.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.684 0.278 . . . . 0.0 110.883 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.746 -179.855 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.6 m80 . . . . . 0 N--CA 1.466 0.362 0 CA-C-O 120.475 0.178 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 1.5 mp -130.43 128.61 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.657 0.265 . . . . 0.0 110.308 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -135.22 127.08 29.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.714 0.293 . . . . 0.0 110.859 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.56 135.01 11.49 Favored Glycine 0 N--CA 1.466 0.692 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -131.96 126.19 33.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 tp -72.47 136.32 45.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.97 0.414 . . . . 0.0 110.885 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.405 HD13 ' HB2' ' A' ' 129' ' ' ALA . 5.2 mp -110.56 160.58 28.04 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 59.6 Cg_endo -72.15 165.7 31.86 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.284 1.99 . . . . 0.0 111.898 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' PRO . 15.4 t-20 86.46 -62.66 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.103 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 125' ' ' ASN . 5.7 p30 154.84 52.59 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.162 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -128.46 159.34 35.71 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.675 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.9 mt -134.38 117.16 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.405 ' HB2' HD13 ' A' ' 123' ' ' LEU . . . -86.95 123.03 31.62 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.63 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.6 tp -116.94 137.24 52.35 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.111 0.481 . . . . 0.0 111.011 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.486 ' NE ' ' NE2' ' A' ' 171' ' ' HIS . 42.1 ttm180 -127.14 126.12 42.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.832 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 132' ' ' TYR . 33.2 t80 . . . . . 0 N--CA 1.471 0.609 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.521 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.577 ' N ' HD22 ' A' ' 138' ' ' LEU . 2.8 mm? . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 21.7 p -40.76 -52.75 2.94 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.12 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.463 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 62.4 m-85 -47.78 -35.82 10.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 138' ' ' LEU . 6.7 t -76.46 -51.78 11.11 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -43.31 -45.74 6.08 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.941 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -62.72 -46.46 87.98 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.167 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.24 -52.95 40.66 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.8 mt -54.38 -55.85 24.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.706 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.3 mt -54.3 -55.43 28.42 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.097 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.536 ' CE2' HD12 ' A' ' 159' ' ' ILE . 5.9 m-85 -50.43 -48.49 56.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.678 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.18 -51.1 60.47 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.58 -59.61 2.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.887 0.375 . . . . 0.0 110.625 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -48.16 -50.23 29.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.87 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -52.81 -47.4 67.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.155 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -49.79 -50.32 45.27 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.668 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 70.6 t80 -86.01 37.19 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.025 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 39.73 54.11 2.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.993 0.425 . . . . 0.0 111.109 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.483 HE21 ' H ' ' A' ' 156' ' ' LYS . 50.1 tp60 -129.52 141.86 50.9 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.483 ' H ' HE21 ' A' ' 155' ' ' GLN . 67.9 mttm -118.71 107.54 13.8 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.998 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 38.7 pt -114.56 -178.19 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.507 0.67 . . . . 0.0 111.559 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -145.18 126.38 14.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.252 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.536 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.2 mt -110.76 119.08 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 120.69 0.281 . . . . 0.0 110.828 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.2 t -101.07 103.71 14.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.834 0.35 . . . . 0.0 110.276 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 163' ' ' THR . 21.0 t-160 -100.15 73.62 1.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.454 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -79.26 -48.68 13.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.478 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 1.0 OUTLIER -73.63 124.53 26.13 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.914 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.581 ' O ' HG22 ' A' ' 167' ' ' THR . 70.8 m -126.55 174.11 8.92 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.801 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 168' ' ' GLY . 1.1 tmt? -90.18 -27.35 19.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.092 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -52.57 -23.16 5.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.489 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.1 t -88.91 -25.28 22.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.454 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 97.74 23.27 14.03 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.012 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.09 168.71 11.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 110.768 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -54.22 -34.16 59.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.52 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.486 ' NE2' ' NE ' ' A' ' 131' ' ' ARG . 5.5 p-80 -174.52 -169.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 92.5 m -93.28 138.7 31.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.7 tpt -117.98 124.25 47.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.169 0.509 . . . . 0.0 110.074 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.4 mt -126.26 102.87 7.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.701 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -87.33 128.72 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.67 151.45 14.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.416 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -143.13 141.33 31.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.598 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 N--CA 1.463 0.19 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.837 -179.924 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tp . . . . . 0 CA--C 1.532 0.281 0 CA-C-O 120.677 0.275 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.1 mm -59.88 -50.18 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.88 0.372 . . . . 0.0 110.147 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -67.52 -24.28 65.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.424 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.486 ' C ' HD22 ' A' ' 7' ' ' ASN . 0.4 OUTLIER -67.77 -53.17 29.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.974 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.6 t -65.68 -35.99 76.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.364 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.487 HD13 ' CE2' ' A' ' 69' ' ' PHE . 21.1 tp -69.6 -45.4 68.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.562 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -50.39 -43.9 54.76 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.661 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -62.78 -51.31 67.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.928 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.6 tmt? -51.18 -39.98 57.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.84 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.7 t -71.38 -34.78 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.557 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.98 -22.53 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.227 0.537 . . . . 0.0 109.957 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.64 -34.65 19.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.237 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -84.52 -76.99 0.28 Allowed 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' HD21 ' A' ' 58' ' ' LEU . 96.3 m -91.33 -19.19 23.21 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.211 0.529 . . . . 0.0 110.708 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.18 173.72 27.52 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.772 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 ttt -69.32 -27.65 65.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.888 -1.156 . . . . 0.0 110.516 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 t -63.21 -42.57 99.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.0 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.73 -36.57 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -50.68 -45.48 58.17 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -71.88 -30.64 65.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.238 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -66.5 -51.14 59.88 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.959 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.44 -24.77 39.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.275 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.959 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.1 tt -71.92 -46.03 59.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.131 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -71.69 -25.25 62.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.841 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -81.32 -40.67 23.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.524 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 80.2 m80 . . . . . 0 N--CA 1.465 0.306 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.267 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.944 0.402 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -70.37 -27.45 64.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.594 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -38.52 -55.83 1.36 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.808 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.66 -40.98 1.0 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.029 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -72.61 -34.3 67.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.972 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.566 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.9 mp -68.63 -55.27 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.293 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -53.86 -26.39 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.967 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.672 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.9 tt0 -75.41 -41.06 57.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.646 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.551 ' OD2' HD23 ' A' ' 25' ' ' LEU . 40.4 m-20 -59.34 -56.79 17.65 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.968 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.4 p -56.77 -38.27 57.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.073 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.533 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.88 -38.88 87.15 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.256 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -62.76 -32.07 73.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -74.08 -43.0 59.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.569 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 17' ' ' CYS . 39.0 mt -79.6 -8.04 58.92 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.669 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.5 t30 57.23 49.87 12.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.607 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.4 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 23.9 mmt -129.06 149.53 72.84 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.182 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.39 138.93 74.1 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.539 1.493 . . . . 0.0 110.996 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.672 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.4 tt -53.05 -29.38 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.281 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -72.13 -31.14 65.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 111.206 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.92 -32.36 51.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 55' ' ' ALA . 82.6 t -70.82 -56.94 9.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 67' ' ' LYS . 8.0 p -52.06 -41.81 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.267 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.507 ' N ' HG13 ' A' ' 66' ' ' VAL . 33.7 mtpt -53.59 -50.86 64.72 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.47 82.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.684 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.487 ' CE2' HD13 ' A' ' 9' ' ' LEU . 7.7 m-30 -52.91 -29.62 29.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.382 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.15 -49.57 56.87 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -55.26 -52.14 64.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 110.054 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -57.83 -42.74 84.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.773 0.796 . . . . 0.0 110.649 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.9 tp -56.47 -39.9 73.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.537 -1.21 . . . . 0.0 112.223 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 21.7 t80 -66.52 -44.29 82.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.31 0.576 . . . . 0.0 109.863 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -53.58 -68.73 0.15 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.241 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.05 -48.57 25.32 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.967 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.1 mt -52.38 -41.52 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.24 0.52 . . . . 0.0 112.063 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -56.34 -27.48 55.99 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.507 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -73.52 -55.38 6.4 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.048 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -43.31 55.75 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.034 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -89.18 28.1 1.28 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.779 0.323 . . . . 0.0 110.577 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 87.2 m -54.11 -37.26 64.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.079 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.523 ' O ' ' NZ ' ' A' ' 87' ' ' LYS . 88.3 m-20 -57.58 -30.54 65.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -85.88 -18.42 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.569 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.426 ' C ' ' N ' ' A' ' 87' ' ' LYS . 49.7 t -70.53 -45.28 75.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.418 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -51.2 -15.49 0.37 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.014 0.435 . . . . 0.0 110.354 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 83' ' ' ASP . 42.8 mmtm -69.08 -28.63 66.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.975 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 8.8 p90 -121.94 115.61 22.88 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.072 0.463 . . . . 0.0 110.732 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 55.2 t0 -84.48 -6.08 59.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.448 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.525 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 38.0 m-20 -158.13 158.69 35.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.141 0.496 . . . . 0.0 111.681 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -50.38 -50.29 51.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.653 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.9 m -57.88 -42.99 85.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.534 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 90.2 p -62.89 -35.59 80.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.077 0.465 . . . . 0.0 110.3 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.6 tt -67.28 -50.13 61.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.345 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 88.1 t -59.87 -36.58 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.223 0.535 . . . . 0.0 110.648 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 81.3 mmm -86.34 -8.67 57.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.34 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -111.57 -12.26 15.33 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 119.704 -0.498 . . . . 0.0 113.073 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.601 ' HA ' HD13 ' A' ' 102' ' ' ILE . 9.4 mt -33.59 -92.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 117.777 0.789 . . . . 0.0 111.937 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -41.08 -51.67 3.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.512 . . . . 0.0 111.267 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -46.63 -91.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.061 0.764 . . . . 0.0 113.061 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.546 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.8 m -68.42 -50.71 54.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.6 mp -63.78 -42.06 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.423 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.74 -56.8 19.11 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -49.55 -53.66 22.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.012 0.434 . . . . 0.0 110.494 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -54.05 -46.36 71.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.094 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 102' ' ' ILE . 39.4 t -55.1 -51.72 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -44.52 -44.63 8.79 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.351 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.928 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 85.4 t60 . . . . . 0 N--CA 1.464 0.23 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -125.18 127.76 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.703 0.287 . . . . 0.0 110.723 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -135.39 127.89 30.57 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.701 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -132.18 151.95 20.03 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -144.06 157.65 44.19 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.1 tp -95.27 148.96 21.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 0.0 110.791 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.66 160.24 43.05 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.85 -39.07 2.58 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.544 2.163 . . . . 0.0 113.532 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -79.8 45.52 0.71 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.334 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.419 ' N ' HD22 ' A' ' 126' ' ' ASN . 2.8 m120 44.3 59.33 3.31 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.541 0.686 . . . . 0.0 110.716 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -136.04 159.42 41.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.958 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.6 mt -138.86 113.63 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.53 121.84 28.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 46.4 tp -114.88 135.13 54.53 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.859 0.361 . . . . 0.0 110.579 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.633 ' HE ' ' CD2' ' A' ' 171' ' ' HIS . 62.0 ttt180 -119.46 123.44 44.06 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.994 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 57.7 t80 . . . . . 0 N--CA 1.464 0.235 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.765 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.468 0.428 0 CA-C-O 120.963 0.411 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 98.6 m -42.94 -51.02 5.75 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.587 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -46.76 -36.1 6.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.047 0.451 . . . . 0.0 110.229 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 10.2 t -66.81 -43.35 84.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.1 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.56 -50.83 16.72 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.864 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -61.36 -51.9 66.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.019 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.44 -43.28 20.18 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.51 -51.16 68.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.579 0.228 . . . . 0.0 111.551 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.3 mt -57.06 -56.37 22.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.739 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.445 ' CE2' HD12 ' A' ' 159' ' ' ILE . 33.9 m-85 -49.92 -47.99 51.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.673 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.02 -51.79 56.33 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.67 -60.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.057 0.456 . . . . 0.0 110.708 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.61 -51.09 39.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.919 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -50.92 -46.27 60.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.073 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -50.11 -49.95 50.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.735 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.525 ' CZ ' ' OD1' ' A' ' 90' ' ' ASP . 65.8 t80 -86.22 37.46 0.73 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.247 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 42.35 49.26 4.53 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 110.739 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.519 HE21 ' H ' ' A' ' 156' ' ' LYS . 49.8 tp60 -128.61 143.77 51.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.519 ' H ' HE21 ' A' ' 155' ' ' GLN . 56.0 tttp -127.51 107.22 9.75 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.787 ' O ' HD13 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -119.72 164.14 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.392 0.615 . . . . 0.0 110.892 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -119.51 132.42 55.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.445 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.1 mt -110.44 118.27 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.6 t -103.41 116.01 31.61 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.555 0.217 . . . . 0.0 111.238 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 56.7 p-80 -98.16 79.11 2.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.385 0.612 . . . . 0.0 111.714 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -82.43 -1.02 48.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.158 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.09 109.82 5.77 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.511 ' O ' HG22 ' A' ' 167' ' ' THR . 14.2 m -112.71 -179.9 3.79 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.901 0.381 . . . . 0.0 110.26 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 168' ' ' GLY . 0.5 OUTLIER -92.18 -27.96 17.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -54.42 -23.82 17.44 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.791 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.5 t -87.11 -25.37 24.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.173 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 95.34 21.92 23.47 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.026 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.05 164.93 16.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.973 0.415 . . . . 0.0 110.773 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -50.41 -32.93 18.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.237 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.633 ' CD2' ' HE ' ' A' ' 131' ' ' ARG . 34.1 p80 -173.19 -172.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 2.8 m -94.1 141.23 28.77 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.4 124.04 46.71 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.36 101.11 6.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.631 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -89.27 126.43 42.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.603 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.61 149.32 11.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.967 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -139.8 136.53 34.16 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.44 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.234 179.5 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 5' ' ' ILE . 3.1 tp . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 120.734 0.302 . . . . 0.0 110.459 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.425 ' N ' HG23 ' A' ' 4' ' ' ILE . 36.7 mm -62.29 -50.1 81.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -69.57 -21.91 63.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.846 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -70.57 -51.52 27.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.827 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.77 -33.79 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.029 0.442 . . . . 0.0 109.944 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.501 HD13 ' CE2' ' A' ' 69' ' ' PHE . 22.6 tp -74.64 -42.74 57.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.367 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -51.85 -45.71 64.14 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.605 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.58 -49.95 74.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.793 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.495 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 10.9 tpt -52.49 -41.35 63.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.682 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.72 -35.52 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.565 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.0 t -61.19 -23.37 29.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.343 0.592 . . . . 0.0 110.109 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.68 -34.31 19.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.078 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -84.78 -75.82 0.34 Allowed 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.517 ' SG ' HD21 ' A' ' 58' ' ' LEU . 98.4 m -92.34 -20.26 21.27 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.708 -178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.48 172.36 25.87 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.724 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.6 ttt -68.01 -28.4 67.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.867 -1.166 . . . . 0.0 110.424 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.0 m -63.21 -41.69 99.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.139 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.86 -36.32 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -53.26 -45.19 68.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.773 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -74.24 -26.97 60.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.41 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -69.38 -49.5 54.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.996 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.87 -23.06 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 110.243 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.996 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.1 tt -75.3 -59.01 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.519 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' N ' HD23 ' A' ' 26' ' ' LEU . 94.5 mt-10 -60.12 -21.66 61.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.391 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 tttp -80.92 -38.13 28.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.467 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 13.7 m80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.522 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 CA--C 1.526 0.043 0 CA-C-O 120.708 0.29 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -66.94 -54.29 23.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.701 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -40.69 -55.1 2.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.022 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -41.0 -41.8 1.74 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.255 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 m -74.82 -28.82 60.86 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' A' ' 47' ' ' LEU . 25.3 mm -70.21 -53.17 24.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.916 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.43 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -61.31 -22.42 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.189 178.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.67 ' HG3' HD12 ' A' ' 62' ' ' ILE . 5.0 tt0 -80.87 -42.12 22.03 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.064 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.623 ' OD2' HD23 ' A' ' 25' ' ' LEU . 45.2 m-20 -58.69 -56.69 18.88 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.665 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 55' ' ' ALA . 12.4 p -59.13 -38.43 74.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.471 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.401 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -59.88 -38.74 83.09 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.128 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -63.91 -32.09 73.5 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.645 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -73.12 -42.43 62.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.563 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.517 HD21 ' SG ' ' A' ' 17' ' ' CYS . 29.0 mt -80.74 -7.18 59.29 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.831 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.6 t30 55.9 47.76 19.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.578 0.704 . . . . 0.0 109.406 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.8 mmt -125.38 149.49 64.58 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.031 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.56 135.58 53.84 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.353 1.368 . . . . 0.0 111.054 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.67 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.8 tt -50.54 -30.73 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.271 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -71.37 -30.46 66.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.871 0.367 . . . . 0.0 111.227 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.19 -32.37 50.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.131 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 78.1 t -71.37 -56.2 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.523 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -51.38 -43.43 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.263 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.523 ' N ' HG13 ' A' ' 66' ' ' VAL . 34.6 mtpt -52.73 -51.25 61.24 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.224 0.535 . . . . 0.0 109.569 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.75 -51.35 67.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.963 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.549 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.7 m-30 -51.57 -30.73 21.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.565 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.66 -53.91 35.03 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -53.71 -49.8 67.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.153 0.501 . . . . 0.0 109.781 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.495 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 8.3 m-85 -58.44 -41.04 84.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.709 0.766 . . . . 0.0 110.307 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.04 -38.45 82.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.484 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.58 -35.99 73.35 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.168 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.546 ' CG ' ' HE2' ' A' ' 152' ' ' HIS . 4.3 m120 -58.94 -69.52 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.059 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.63 -41.65 57.3 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.501 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 19.9 mt -57.2 -46.48 82.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.056 0.428 . . . . 0.0 111.269 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.3 -12.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.119 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.479 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.5 p -89.2 -43.92 10.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.202 0.525 . . . . 0.0 110.173 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.463 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.0 mmp_? -65.07 -55.26 19.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.505 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.4 p80 -101.77 31.19 3.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.296 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 m -46.31 -43.32 15.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.302 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.443 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 83.8 m-20 -55.82 -30.73 61.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.208 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.0 t -78.5 -23.53 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.847 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.473 ' C ' ' H ' ' A' ' 87' ' ' LYS . 72.0 t -76.06 -42.42 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.34 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 83' ' ' ASP . 1.4 p30 -54.9 -8.67 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 85' ' ' VAL . 63.4 mmtt -67.35 -28.13 67.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.204 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.417 ' CD1' ' OG ' ' A' ' 93' ' ' SER . 8.1 m-85 -129.39 128.71 43.58 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.056 0.455 . . . . 0.0 111.161 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -87.52 16.01 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -167.75 165.45 14.14 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 119.219 -0.993 . . . . 0.0 113.075 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 80.6 t80 -64.2 -63.18 1.21 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.789 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.6 m -45.91 -43.84 14.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.307 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.417 ' OG ' ' CD1' ' A' ' 88' ' ' PHE . 16.1 p -64.37 -38.03 89.61 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.491 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.51 -55.29 28.88 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.781 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.9 t -50.05 -38.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.087 0.47 . . . . 0.0 110.438 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 85.0 mmm -84.84 -7.45 59.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.362 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -109.17 -12.86 19.12 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.873 -0.404 . . . . 0.0 112.694 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.683 ' HA ' HD13 ' A' ' 102' ' ' ILE . 43.0 mt -32.46 -103.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 99' ' ' HIS . 2.1 p80 -38.17 -43.8 0.79 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -48.65 -88.87 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.606 ' CG2' HD12 ' A' ' 102' ' ' ILE . 3.0 m -69.05 -51.15 46.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.683 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.7 mp -59.79 -45.77 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.047 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.33 -55.49 25.51 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.7 tp -50.4 -53.91 25.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.023 0.439 . . . . 0.0 110.75 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -53.1 -45.4 68.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.463 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 102' ' ' ILE . 37.9 t -53.11 -52.35 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -46.87 -42.66 17.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.835 0.35 . . . . 0.0 110.657 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 -179.866 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 mm -120.39 126.29 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.712 0.291 . . . . 0.0 110.675 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -124.97 105.43 9.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.119 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.62 159.66 13.63 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -151.28 158.5 43.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.755 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.59 146.06 30.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -118.69 160.73 39.09 Favored Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.23 -37.08 3.59 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.592 2.195 . . . . 0.0 113.083 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -81.52 45.74 0.9 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.151 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.8 m120 43.76 58.62 3.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.339 0.59 . . . . 0.0 110.742 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -135.09 159.99 39.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.017 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.2 mt -136.96 116.41 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.07 121.46 30.5 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 21.9 tp -118.62 130.99 56.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.251 0.548 . . . . 0.0 110.632 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -126.54 131.22 51.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 120.818 0.342 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 172' ' ' CYS . 62.5 m -48.88 -64.26 0.86 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.121 0.486 . . . . 0.0 111.38 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -46.73 -37.12 7.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.335 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 5.1 t -65.51 -43.18 90.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -44.54 -51.99 8.42 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.669 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.474 ' OE2' ' CB ' ' A' ' 161' ' ' HIS . 40.0 mt-10 -60.34 -49.34 78.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.281 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.5 -48.75 41.42 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.7 mt -57.89 -54.89 41.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.515 0.198 . . . . 0.0 111.495 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 28.0 mt -54.61 -54.86 35.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.713 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.654 ' CE2' HD12 ' A' ' 159' ' ' ILE . 13.2 m-85 -49.79 -50.79 43.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.943 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -56.92 -51.72 55.46 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.794 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.52 -54.59 4.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.441 . . . . 0.0 110.613 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -53.06 -48.86 67.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.053 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -50.59 -53.66 28.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.901 0.381 . . . . 0.0 111.04 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.546 ' HE2' ' CG ' ' A' ' 75' ' ' ASN . 85.6 m-70 -45.73 -49.89 14.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.161 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.61 33.75 0.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 40.75 51.72 3.1 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.148 0.499 . . . . 0.0 110.657 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.497 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 48.7 tp60 -126.86 140.71 52.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.275 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.497 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 29.8 mmtp -115.74 124.77 51.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.472 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 10.8 pt -136.16 170.84 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.665 0.745 . . . . 0.0 112.143 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -132.7 125.74 30.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.852 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.654 HD12 ' CE2' ' A' ' 147' ' ' PHE . 5.3 mt -110.94 117.47 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.676 0.274 . . . . 0.0 110.5 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.3 t -97.65 101.02 12.43 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.959 0.409 . . . . 0.0 109.979 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.52 ' NE2' ' O ' ' A' ' 163' ' ' THR . 11.7 t-160 -104.52 75.4 1.23 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.869 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -80.61 -42.76 21.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.895 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.52 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.4 m -76.05 117.98 18.33 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.913 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 166' ' ' HIS . 1.6 p -144.13 113.79 7.14 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.048 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.8 ttt -37.3 -21.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.853 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.572 ' N ' ' O ' ' A' ' 164' ' ' CYS . 83.3 t60 -52.49 -26.81 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.454 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 4.5 t -88.17 -42.88 12.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.141 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.454 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 133.72 10.26 1.86 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.5 162.33 10.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.041 0.448 . . . . 0.0 110.939 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -58.88 -33.18 70.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.616 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -170.05 -170.45 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 85.0 m -94.61 137.04 34.21 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.971 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.6 tpt -115.68 123.89 49.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.05 103.37 6.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.422 0.629 . . . . 0.0 111.577 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -92.89 126.19 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.329 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 177' ' ' GLU . 4.6 mp -112.64 153.17 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.549 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.403 ' N ' HG22 ' A' ' 176' ' ' ILE . 88.1 tt0 -139.5 138.84 36.69 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.571 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 N--CA 1.463 0.222 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.8 -179.921 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tp . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 120.968 0.413 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.4 mm -62.46 -44.57 99.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.096 0.474 . . . . 0.0 109.912 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -71.34 -25.41 62.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.54 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -69.4 -52.51 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.071 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.26 -35.0 70.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.423 HD13 ' CD2' ' A' ' 69' ' ' PHE . 31.6 tp -67.44 -40.82 85.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.773 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -55.54 -45.47 77.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.039 0.447 . . . . 0.0 109.839 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.81 -53.75 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.569 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.608 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 49.1 mtm -52.3 -44.28 64.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.118 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.17 -36.61 77.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.75 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.29 -25.83 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.151 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.36 -33.79 21.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.173 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -84.2 -76.16 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.8 m -93.22 -21.84 19.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.26 0.552 . . . . 0.0 110.805 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.7 173.96 22.97 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 122.129 0.85 . . . . 0.0 112.962 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.1 ttt -68.14 -28.38 67.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.65 -1.275 . . . . 0.0 110.408 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -61.83 -39.27 91.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.841 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -77.53 -38.52 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -56.13 -47.84 77.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.128 0.489 . . . . 0.0 110.31 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -75.63 -22.97 56.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.584 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -76.29 -47.11 24.84 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.604 -0.439 . . . . 0.0 112.04 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.981 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.61 -25.53 38.38 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.981 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.3 tt -73.65 -44.15 57.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.492 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -73.05 -21.1 60.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.964 0.411 . . . . 0.0 110.555 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 tttt -87.15 -42.0 13.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.866 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.6 m80 . . . . . 0 N--CA 1.471 0.617 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.569 -179.117 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.81 0.338 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -75.96 -36.46 59.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.95 -58.42 5.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.198 0.523 . . . . 0.0 110.805 -179.605 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -38.64 -43.09 0.85 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.055 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.6 p -74.14 -30.03 62.09 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.035 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 47' ' ' LEU . 18.6 mt -72.98 -50.66 30.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.123 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.1 m -60.66 -22.42 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.0 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.694 ' HG3' HD12 ' A' ' 62' ' ' ILE . 2.0 tt0 -80.49 -40.68 25.68 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.898 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.621 ' OD2' HD23 ' A' ' 25' ' ' LEU . 55.9 m-20 -58.83 -57.4 13.21 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.837 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.21 -39.41 78.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.582 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.428 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -58.63 -39.1 79.54 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.857 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -64.64 -32.94 74.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -72.6 -41.78 65.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.196 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.508 ' O ' ' SD ' ' A' ' 60' ' ' MET . 30.1 mt -79.27 -3.96 48.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.503 ' O ' ' SD ' ' A' ' 60' ' ' MET . 10.6 t-20 52.72 46.62 26.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.475 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -125.56 153.05 72.66 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.863 179.308 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.48 136.68 47.63 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.717 1.612 . . . . 0.0 110.816 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.694 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.9 tt -51.19 -28.76 7.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.819 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.629 ' NE2' ' CZ ' ' A' ' 140' ' ' PHE . 3.0 tp-100 -76.04 -32.22 59.24 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.973 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -80.15 -31.61 38.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.86 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.499 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 63.5 t -67.84 -58.17 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -49.86 -40.86 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.495 ' N ' HG13 ' A' ' 66' ' ' VAL . 2.2 ttpp -51.65 -47.18 63.84 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.896 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.36 -59.76 4.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.171 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 5.1 m-30 -45.15 -29.0 0.83 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.763 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.94 -52.15 50.21 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -55.51 -51.4 67.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.075 0.464 . . . . 0.0 110.302 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.608 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 45.5 m-85 -59.19 -43.38 92.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.757 0.789 . . . . 0.0 110.909 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 tp -52.06 -38.32 56.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.296 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 22.6 t80 -70.87 -41.48 71.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.106 0.479 . . . . 0.0 110.014 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -54.22 -74.52 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.14 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -50.64 -37.18 33.41 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.767 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 19.2 mt -58.56 -47.25 84.86 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.337 0.569 . . . . 0.0 112.139 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.43 -20.94 0.26 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.231 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' ' 82' ' ' THR . 19.7 t -77.8 -50.17 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 111.003 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -64.28 -64.74 0.8 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.571 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.4 p80 -83.64 31.21 0.47 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.737 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 79' ' ' SER . 94.3 m -48.29 -45.85 35.32 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.452 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -53.16 -29.78 33.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.052 0.453 . . . . 0.0 109.863 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 3.3 t -83.21 -23.98 8.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 t -63.31 -39.68 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -53.48 -13.59 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.434 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 84' ' ' VAL . 37.8 mmtm -66.6 -31.08 71.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.51 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 20.5 p90 -120.39 117.13 26.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.059 0.457 . . . . 0.0 110.931 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.36 0.78 48.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.317 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 48.6 t0 -163.86 157.74 19.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.626 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.507 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 82.5 t80 -48.13 -51.44 24.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.712 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 83.9 m -56.32 -41.86 76.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.522 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.3 m -62.74 -36.54 83.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.411 0.624 . . . . 0.0 110.563 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.493 HD12 ' CD2' ' A' ' 88' ' ' PHE . 2.2 tt -65.91 -62.52 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.289 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.5 t -47.43 -41.44 7.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 O-C-N 123.337 0.398 . . . . 0.0 111.879 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.6 ppp? -85.67 -8.11 58.4 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.278 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -107.77 -14.21 18.11 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.461 -0.4 . . . . 0.0 112.334 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.606 ' HA ' HD13 ' A' ' 102' ' ' ILE . 33.4 mt -31.87 -97.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 117.398 0.599 . . . . 0.0 111.997 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -39.95 -49.99 2.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.173 0.511 . . . . 0.0 111.377 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -46.89 -90.02 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.568 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.6 m -68.97 -50.75 51.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.606 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.1 mp -64.19 -42.52 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.493 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.56 -57.98 10.22 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.595 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 56.7 tp -46.73 -55.11 8.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.143 0.496 . . . . 0.0 110.438 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -52.41 -44.52 65.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.8 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 102' ' ' ILE . 30.4 t -55.44 -52.32 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -47.04 -44.75 20.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.64 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.595 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 27.0 mmtm . . . . . 0 C--N 1.33 -0.261 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.932 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 120.503 0.192 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -128.48 129.1 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.674 0.273 . . . . 0.0 110.886 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -134.08 123.34 24.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.718 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.91 127.01 7.04 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.458 ' C ' HD12 ' A' ' 122' ' ' LEU . 86.9 mt-30 -117.33 166.34 12.41 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.458 HD12 ' C ' ' A' ' 121' ' ' GLN . 11.2 mp -109.31 133.96 52.39 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.93 160.71 28.84 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 58.5 Cg_endo -71.78 159.02 51.83 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.188 1.925 . . . . 0.0 111.883 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.605 HD22 HD21 ' A' ' 126' ' ' ASN . 11.0 t30 90.91 -59.17 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.296 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.629 ' N ' HD22 ' A' ' 126' ' ' ASN . 0.0 OUTLIER 151.83 53.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.894 0.747 . . . . 0.0 109.499 179.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -127.74 164.06 22.96 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.976 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.4 mt -141.24 119.2 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.67 123.33 33.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.083 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 47.4 tp -118.24 132.34 56.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.074 0.464 . . . . 0.0 110.965 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -115.7 122.81 46.65 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.234 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.8 t80 . . . . . 0 N--CA 1.468 0.456 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.585 -179.085 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 121.332 0.587 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 32.9 m -41.73 -48.29 4.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.702 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.629 ' CZ ' ' NE2' ' A' ' 63' ' ' GLN . 98.2 m-85 -48.13 -39.88 21.93 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.708 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.3 t -64.44 -43.23 94.95 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.97 -52.97 10.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.436 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -55.14 -50.07 70.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.08 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.97 -48.22 46.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.09 -54.23 49.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.743 0.306 . . . . 0.0 111.369 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.8 mt -54.88 -55.66 27.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.849 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.563 ' CE2' HD12 ' A' ' 159' ' ' ILE . 14.1 m-85 -49.75 -48.53 50.14 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.817 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.95 -51.31 59.94 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.35 -60.13 2.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.736 0.303 . . . . 0.0 110.832 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' ' 155' ' ' GLN . . . -51.34 -51.09 57.56 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.317 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -52.98 -48.75 67.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.053 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -47.97 -49.15 31.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.504 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 73.3 t80 -83.42 36.28 0.52 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.71 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 40.78 58.25 2.48 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.939 0.399 . . . . 0.0 111.228 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.629 HE21 HG23 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -132.63 152.59 51.61 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.52 ' N ' ' NE2' ' A' ' 155' ' ' GLN . 62.6 mttp -120.8 117.94 28.71 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.629 HG23 HE21 ' A' ' 155' ' ' GLN . 36.5 pt -130.68 169.7 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.624 0.726 . . . . 0.0 112.63 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -134.73 127.12 30.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.898 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.563 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.8 mt -110.42 118.65 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.8 m -103.01 111.55 23.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.398 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 16.7 p80 -96.61 77.22 2.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.513 0.673 . . . . 0.0 111.558 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 54.7 t0 -82.1 -3.3 54.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.415 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.56 114.6 8.64 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.438 ' O ' HG22 ' A' ' 167' ' ' THR . 92.3 m -118.62 -175.93 2.99 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.628 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 72.7 mtp -94.73 -26.47 16.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -55.61 -23.66 28.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.798 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 164' ' ' CYS . 4.0 t -87.16 -29.69 21.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.5 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.41 18.0 22.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.63 167.03 9.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.847 0.356 . . . . 0.0 110.423 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.544 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 94.4 m-20 -45.55 -49.6 13.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.69 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.544 ' ND1' ' O ' ' A' ' 170' ' ' ASP . 73.6 m-70 -160.76 -168.14 2.03 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.5 t -93.85 144.27 25.59 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.149 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.2 120.93 36.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.061 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.53 103.62 7.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.469 0.652 . . . . 0.0 110.502 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.4 mp -89.95 127.12 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.379 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.93 150.51 13.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.32 0.581 . . . . 0.0 110.869 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -136.17 136.08 39.71 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.897 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.464 0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.62 -179.742 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.654 HD13 ' NH1' ' A' ' 80' ' ' ARG . 2.5 tp . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 121.029 0.443 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.3 -54.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -60.99 -31.22 70.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.267 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -59.94 -60.33 4.0 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.075 0.464 . . . . 0.0 111.428 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.18 -24.26 29.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.474 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.8 tp -74.29 -41.75 60.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.516 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.4 mt-10 -58.16 -39.25 78.35 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.316 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -60.9 -56.04 25.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.532 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 18.1 tpt -50.73 -41.66 56.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.203 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.31 -34.45 62.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.692 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 10' ' ' GLU . 40.8 t -63.36 -23.96 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.22 0.533 . . . . 0.0 110.055 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.65 -33.99 18.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.96 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -85.63 -76.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.7 m -91.37 -19.2 23.17 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.52 171.85 28.12 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.847 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.7 ttt -67.37 -29.51 69.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.776 -1.212 . . . . 0.0 110.327 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 t -61.92 -41.5 98.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.947 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.78 -38.64 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -51.64 -45.89 63.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.0 109.732 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -71.76 -29.8 64.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.011 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.525 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 75.5 mt-10 -68.12 -51.64 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.966 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.91 -23.2 48.76 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.436 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.966 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.7 tt -74.26 -41.88 60.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.528 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -66.97 -19.08 65.66 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 24' ' ' GLU . 1.1 ptpp? -91.66 -29.0 17.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.505 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 3.4 m-70 . . . . . 0 N--CA 1.463 0.182 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.82 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 95.3 p . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.772 0.32 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -68.32 -33.79 74.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.027 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -43.17 -57.5 2.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.165 0.507 . . . . 0.0 110.641 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -38.8 -43.43 0.92 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.724 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.1 m -71.84 -32.44 67.54 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.42 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.6 mp -71.71 -53.81 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.667 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.446 HG13 ' H ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -55.9 -23.37 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.374 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.674 ' HG3' HD12 ' A' ' 62' ' ' ILE . 4.7 tt0 -79.79 -40.1 29.39 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.14 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 4.4 m-20 -59.69 -57.01 14.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.586 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 55' ' ' ALA . 6.8 p -56.17 -41.09 68.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.522 -0.763 . . . . 0.0 108.998 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.412 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -57.05 -39.1 74.22 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.944 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -64.93 -34.6 78.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.4 mmt-85 -70.52 -38.26 74.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.178 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.518 ' O ' ' SD ' ' A' ' 60' ' ' MET . 49.0 mt -82.7 -4.9 58.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.519 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.1 t-20 51.76 44.52 29.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.244 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -125.82 155.81 72.24 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.854 179.188 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.19 140.53 71.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.015 1.81 . . . . 0.0 111.036 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.674 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.9 tt -55.44 -27.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.859 -178.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.417 ' CD ' ' CZ ' ' A' ' 140' ' ' PHE . 88.6 mt-30 -76.36 -33.46 58.93 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.45 -30.07 42.06 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.088 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG12 ' CZ ' ' A' ' 69' ' ' PHE . 96.8 t -72.06 -56.07 11.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.499 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -50.98 -40.12 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.499 ' N ' HG13 ' A' ' 66' ' ' VAL . 1.9 ttpt -52.66 -50.98 62.15 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.895 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.28 -53.98 42.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.721 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.485 ' CZ ' HG12 ' A' ' 65' ' ' VAL . 2.9 m-30 -54.25 -27.98 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.92 -52.78 45.57 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -56.44 -47.93 78.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 0.8 OUTLIER -59.33 -43.97 92.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.866 0.841 . . . . 0.0 110.337 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -53.35 -38.68 63.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.809 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.455 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 26.2 t80 -69.84 -41.25 75.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.934 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -55.15 -71.87 0.08 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.781 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.61 -44.48 22.91 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.405 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.8 mt -56.36 -40.63 74.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.0 0.4 . . . . 0.0 111.431 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -59.31 -29.29 67.51 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.879 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.9 t -72.83 -54.17 9.52 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.828 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.654 ' NH1' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -72.59 -49.48 31.95 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.222 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -83.97 25.44 0.82 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.442 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 52.6 m -50.44 -38.92 46.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.045 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -57.14 -32.41 66.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.18 -22.07 9.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.547 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 87' ' ' LYS . 40.9 t -69.25 -42.63 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.649 -0.421 . . . . 0.0 109.952 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -52.51 -15.02 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.034 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.416 ' N ' ' C ' ' A' ' 85' ' ' VAL . 38.4 mmtm -67.58 -29.92 69.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.648 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.565 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 13.1 p90 -120.85 119.84 33.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.063 0.459 . . . . 0.0 110.967 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -86.28 1.88 49.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.447 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.48 ' OD1' ' CE2' ' A' ' 153' ' ' PHE . 45.4 t0 -166.75 160.15 14.48 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.22 0.533 . . . . 0.0 111.627 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 95' ' ' VAL . 84.2 t80 -51.54 -51.05 58.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.941 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.8 m -55.67 -45.38 77.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.734 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 90' ' ' ASP . 54.9 p -61.66 -36.45 80.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.408 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.483 HD12 ' CD2' ' A' ' 88' ' ' PHE . 5.2 tt -65.89 -52.16 52.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.23 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.416 HG21 ' CE2' ' A' ' 91' ' ' PHE . 69.8 t -56.31 -36.69 47.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.208 0.527 . . . . 0.0 110.43 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.5 mmm -86.61 -6.89 58.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.33 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -112.9 -14.82 9.75 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.982 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.581 ' HA ' HD13 ' A' ' 102' ' ' ILE . 10.3 mt -30.05 -100.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 117.648 0.724 . . . . 0.0 112.348 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -40.35 -49.05 2.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.023 0.44 . . . . 0.0 111.182 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -46.22 -88.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.577 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.6 m -70.67 -52.88 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.581 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.3 mp -60.62 -46.12 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.302 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.92 -55.25 30.8 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.7 tp -51.74 -53.45 39.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -53.5 -47.36 69.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.159 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 102' ' ' ILE . 33.6 t -52.44 -49.22 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -50.13 -41.44 48.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.778 0.323 . . . . 0.0 110.637 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.722 -179.98 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 70.3 m80 . . . . . 0 C--O 1.23 0.076 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.5 mt -127.5 128.25 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.728 0.299 . . . . 0.0 110.879 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -132.61 119.66 20.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.744 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.72 137.88 14.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -135.04 128.31 32.08 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.565 0.221 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 tp -76.89 149.52 36.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.756 0.312 . . . . 0.0 111.07 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.18 160.47 43.16 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.12 -36.43 4.28 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.578 2.185 . . . . 0.0 113.059 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -80.65 46.41 0.87 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.046 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 43.49 55.87 4.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.52 0.676 . . . . 0.0 110.739 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -133.48 159.22 41.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.876 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.0 mt -136.65 114.65 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.5 121.58 29.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.084 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.7 tp -116.16 134.7 54.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.094 0.473 . . . . 0.0 110.619 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -120.58 124.55 45.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.0 t80 . . . . . 0 C--N 1.33 -0.27 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.808 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 121.112 0.482 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.9 t -40.05 -48.21 2.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.638 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.417 ' CZ ' ' CD ' ' A' ' 63' ' ' GLN . 90.7 m-85 -48.2 -36.87 14.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.613 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 53.8 t -68.53 -44.4 74.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.023 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.78 -45.71 14.83 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.507 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -63.97 -48.96 74.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.217 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.08 -48.12 39.73 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.4 mt -59.96 -53.55 56.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.734 0.302 . . . . 0.0 111.535 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.9 mt -54.81 -55.88 25.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.078 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.594 ' CE2' HD12 ' A' ' 159' ' ' ILE . 21.7 m-85 -51.68 -48.14 63.59 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.978 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.69 -51.66 56.63 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.21 -60.27 1.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.754 0.311 . . . . 0.0 111.008 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.38 -50.87 38.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.005 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -52.44 -47.14 66.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.249 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -50.01 -50.69 46.47 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.704 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.51 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 69.5 t80 -86.11 37.03 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.933 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 39.17 55.71 2.14 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.937 0.398 . . . . 0.0 111.061 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.566 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 49.0 tp60 -129.87 141.65 50.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.566 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 62.4 tttm -112.34 125.61 54.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.259 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 26.1 pt -137.07 170.15 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.61 0.719 . . . . 0.0 111.993 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -134.96 126.62 28.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.116 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.594 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.5 mt -110.52 116.8 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.669 0.271 . . . . 0.0 110.328 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.3 t -101.46 107.94 19.38 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.383 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.559 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.8 p-80 -93.97 65.79 3.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.605 0.717 . . . . 0.0 111.065 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -68.25 -25.35 65.14 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.823 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.502 ' HB ' ' H ' ' A' ' 173' ' ' MET . 1.8 m -112.52 112.0 23.24 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 166' ' ' HIS . 49.9 t -137.3 115.26 11.5 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.602 0.239 . . . . 0.0 110.839 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.412 ' C ' ' N ' ' A' ' 167' ' ' THR . 24.0 ttt -35.18 -22.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.261 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 164' ' ' CYS . 57.7 t-80 -51.11 -21.45 1.92 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.464 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.7 t -90.08 -41.35 11.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.913 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.464 ' N ' HG23 ' A' ' 167' ' ' THR . . . 124.81 15.0 3.3 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.08 155.86 30.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.976 0.417 . . . . 0.0 110.821 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.92 -27.93 21.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.379 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -172.49 178.87 2.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 6.3 m -94.46 139.72 30.77 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.66 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.502 ' H ' ' HB ' ' A' ' 163' ' ' THR . 16.2 ttm -127.62 94.99 4.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.525 0.679 . . . . 0.0 109.68 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.1 mt -93.12 113.07 25.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.523 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.9 mm -89.14 126.16 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.585 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.38 148.72 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.25 0.548 . . . . 0.0 110.268 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -137.8 136.8 37.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.339 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 N--CA 1.463 0.188 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.863 -179.828 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.586 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.6 mpp? . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 3' ' ' GLY . 46.0 mtmt 56.2 86.94 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.738 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 56.47 117.23 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 tp -52.19 -42.05 35.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.581 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.43 -51.41 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.168 0.509 . . . . 0.0 109.87 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -69.12 -22.26 63.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.495 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 3' ' ' GLY . 64.9 t-20 -69.64 -54.13 15.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.6 t -61.71 -35.81 69.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.01 0.433 . . . . 0.0 109.835 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.492 HD13 ' CE2' ' A' ' 69' ' ' PHE . 21.8 tp -70.98 -43.25 68.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.097 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -51.95 -46.09 64.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -61.28 -48.2 82.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.681 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.588 ' SD ' ' CZ ' ' A' ' 72' ' ' PHE . 10.9 tpt -53.84 -43.04 69.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.726 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.15 -35.25 67.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.403 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.01 -23.36 31.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.239 0.542 . . . . 0.0 110.028 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.17 -34.39 19.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.156 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -84.69 -76.62 0.3 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' HD21 ' A' ' 58' ' ' LEU . 97.8 m -91.66 -19.83 22.25 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.282 0.563 . . . . 0.0 110.786 -178.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.02 173.99 26.48 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.825 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.3 ttt -68.74 -29.76 68.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.796 -1.202 . . . . 0.0 110.518 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -62.06 -41.71 98.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.065 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.52 -37.83 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 -51.82 -45.22 63.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -71.73 -29.27 64.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.144 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -67.46 -50.49 58.91 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.782 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.26 -22.93 38.31 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.454 -179.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.782 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.3 tt -74.32 -56.0 5.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.145 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -61.55 -22.98 65.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.547 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -81.35 -38.27 26.94 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.526 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 78.7 m-70 -99.59 -77.91 0.51 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.792 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.583 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -64.06 160.07 50.95 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.442 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 61.5 Cg_endo -71.43 144.07 44.53 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.873 2.382 . . . . 0.0 112.504 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' CB ' ' NZ ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -93.55 -18.23 22.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.278 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 24.6 p-10 -90.24 -52.46 4.93 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.992 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.13 132.4 47.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.498 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.2 t -125.57 134.58 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.263 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -109.45 179.7 4.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.669 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.65 HG23 ' H ' ' A' ' 39' ' ' ALA . 2.4 m -129.41 167.83 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.884 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 m -73.93 28.87 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.058 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.65 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -149.09 -8.94 0.34 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.733 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.623 ' CG ' HG22 ' A' ' 37' ' ' VAL . 12.9 mmtt -85.61 -179.74 6.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.903 0.382 . . . . 0.0 110.499 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 p -47.18 157.86 0.17 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.055 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.25 61.7 0.7 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.193 0.52 . . . . 0.0 110.445 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' O ' ' OE1' ' A' ' 46' ' ' GLU . . . -53.36 104.98 0.11 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.166 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' OE1' ' O2A' ' A' ' 182' ' ' HEM . 96.4 mt-10 -63.45 -20.5 65.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.7 p -49.0 -40.99 32.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.799 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 43' ' ' ALA . 41.4 mp0 -72.65 -32.81 66.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.812 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.98 -58.26 5.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.134 0.492 . . . . 0.0 110.66 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CZ ' HD12 ' A' ' 138' ' ' LEU . 84.6 m-85 -37.67 -44.1 0.68 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.042 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.1 t -73.24 -31.23 64.0 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.156 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.9 mt -71.42 -51.25 34.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.129 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -60.39 -21.7 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.84 178.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.691 ' HG3' HD12 ' A' ' 62' ' ' ILE . 1.6 tt0 -80.17 -41.52 25.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.002 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 29' ' ' HIS . 72.5 m-20 -58.62 -57.14 14.28 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.834 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 55' ' ' ALA . 7.8 p -58.63 -39.05 74.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.483 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.412 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -59.56 -39.65 84.72 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.221 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -63.61 -31.85 73.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -74.28 -41.31 61.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.562 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 17' ' ' CYS . 29.0 mt -80.98 -6.37 58.67 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.652 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 56.11 47.79 18.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.488 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mmt -126.54 149.05 66.79 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.066 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -63.11 135.77 52.69 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.381 1.387 . . . . 0.0 111.092 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.691 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.0 tt -49.11 -28.3 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.156 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -71.78 -34.5 69.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.055 0.455 . . . . 0.0 111.582 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -76.03 -31.77 59.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.066 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.2 t -71.83 -56.16 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.734 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.524 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -51.63 -44.45 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.396 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.524 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.9 mtpt -52.33 -50.45 62.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.255 0.55 . . . . 0.0 109.518 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.14 -57.39 12.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.925 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.549 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 8.1 m-30 -45.53 -29.72 1.24 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.391 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.19 -48.07 73.98 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -58.24 -52.34 65.98 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.067 0.46 . . . . 0.0 110.054 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 12' ' ' MET . 63.1 m-85 -56.59 -40.18 74.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.747 0.785 . . . . 0.0 110.616 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.9 tp -59.22 -37.85 78.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.387 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -70.54 -37.9 74.11 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.968 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -58.11 -71.31 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.887 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.07 -41.79 30.2 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.296 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.402 ' C ' ' N ' ' A' ' 79' ' ' SER . 24.2 mt -58.39 -43.37 88.51 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.368 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -51.75 -17.56 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.161 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.43 ' O ' ' OG1' ' A' ' 82' ' ' THR . 8.0 t -85.73 -40.88 15.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.247 0.546 . . . . 0.0 109.62 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.431 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.3 mmp_? -65.44 -72.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.471 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.704 ' CE1' HMC3 ' A' ' 182' ' ' HEM . 0.1 OUTLIER -87.84 36.91 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.399 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 6.8 m -49.45 -48.99 47.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.926 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -51.43 -33.67 31.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.18 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.538 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 7.1 t -73.82 -29.24 25.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.499 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.536 ' C ' ' H ' ' A' ' 87' ' ' LYS . 89.3 t -76.22 -44.68 36.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.562 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 54.7 t0 -58.24 3.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.366 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' A' ' 85' ' ' VAL . 30.6 mtmt -90.57 -22.45 21.27 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.541 ' CE1' HG21 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -104.13 125.83 50.76 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.794 -179.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 56.6 p30 -88.44 -6.07 57.87 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 58.8 m-20 -160.29 164.12 32.84 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.636 0.731 . . . . 0.0 112.535 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.402 ' CE2' HG21 ' A' ' 95' ' ' VAL . 64.4 t80 -55.1 -44.29 74.77 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.979 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.9 m -57.71 -59.72 4.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.352 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 97.4 p -45.67 -40.14 8.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.367 0.604 . . . . 0.0 110.792 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.44 -41.59 96.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.428 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 91' ' ' PHE . 69.5 t -67.89 -40.84 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.384 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.9 ptm -83.25 -3.16 57.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.307 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -116.41 -15.74 6.89 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 119.123 -0.82 . . . . 0.0 113.357 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.599 ' HA ' HD13 ' A' ' 102' ' ' ILE . 18.8 mt -25.09 -104.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 118.04 0.92 . . . . 0.0 112.477 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -40.38 -49.0 2.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.068 0.461 . . . . 0.0 111.466 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -45.63 -83.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.61 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.8 m -73.31 -53.81 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.61 ' N ' HG23 ' A' ' 101' ' ' VAL . 3.3 mp -59.27 -49.84 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.939 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.33 -55.13 32.41 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.8 tp -49.18 -48.0 45.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.154 0.502 . . . . 0.0 109.769 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -57.59 -46.46 83.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.042 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.6 t -54.22 -50.15 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 110' ' ' TYR . 49.4 t30 -49.07 -43.59 41.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.717 0.294 . . . . 0.0 110.803 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -61.79 -37.44 84.35 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.211 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.4 tp -65.14 -40.69 94.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.368 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 111' ' ' HIS . 25.7 t80 -154.84 158.13 38.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.389 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.564 ' N ' ' CD1' ' A' ' 110' ' ' TYR . 57.2 t-80 -49.69 -77.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.078 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 111' ' ' HIS . 23.2 mt-10 60.52 147.78 0.08 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.201 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.33 -94.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.025 1.816 . . . . 0.0 111.872 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.2 t -144.78 140.99 28.85 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.153 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 116' ' ' PRO . 15.9 mt -81.59 150.6 66.92 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 115' ' ' LEU . 80.3 Cg_exo -41.0 168.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.264 1.976 . . . . 0.0 112.342 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -85.78 108.62 18.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.98 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.1 128.54 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.716 0.293 . . . . 0.0 110.959 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -133.58 123.57 25.35 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.652 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.12 158.22 14.64 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.442 ' C ' HD22 ' A' ' 122' ' ' LEU . 52.3 tt0 -149.95 160.1 43.87 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.824 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.4 mm? -106.74 146.02 31.34 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.99 160.4 40.99 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.25 -38.12 2.9 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.596 2.197 . . . . 0.0 113.054 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -79.49 44.83 0.63 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.953 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 44.39 58.29 3.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.413 0.625 . . . . 0.0 110.72 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -135.11 159.94 39.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.107 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 45.0 mt -137.41 117.12 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.3 122.86 32.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.049 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.1 tp -118.8 133.03 56.12 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.044 0.45 . . . . 0.0 111.205 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -114.79 122.98 48.03 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.481 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 62.1 t80 -126.16 123.73 38.9 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.786 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.48 124.37 24.08 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.2 p -156.04 146.01 15.67 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.256 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.77 -7.87 17.74 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.032 1.821 . . . . 0.0 112.215 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 -79.17 -15.68 57.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.085 0.469 . . . . 0.0 110.369 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 56.23 28.84 13.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.52 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.413 HD12 ' CZ ' ' A' ' 48' ' ' PHE . 4.1 tp -82.74 14.6 3.09 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.215 0.531 . . . . 0.0 110.029 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 74.4 m -42.08 -43.87 3.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.469 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -48.87 -41.98 35.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.961 0.41 . . . . 0.0 110.375 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.6 t -64.29 -43.27 95.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -44.52 -50.1 9.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.59 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.03 -49.56 77.17 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.164 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.01 -48.96 50.89 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.0 -55.1 39.36 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.58 0.229 . . . . 0.0 111.315 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.7 mt -54.14 -54.38 40.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.909 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.54 ' CE2' HD12 ' A' ' 159' ' ' ILE . 12.1 m-85 -51.52 -48.02 63.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.952 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.49 -51.54 57.18 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.8 -59.76 2.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.881 0.372 . . . . 0.0 110.844 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -48.28 -51.68 24.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.873 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -52.03 -47.86 64.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.218 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -49.48 -49.9 43.64 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.64 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.507 ' CZ ' ' OD1' ' A' ' 90' ' ' ASP . 71.5 t80 -85.48 37.17 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.939 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 39.21 57.57 1.99 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.021 0.439 . . . . 0.0 111.199 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.511 HE21 ' H ' ' A' ' 156' ' ' LYS . 51.7 tp60 -131.59 143.43 50.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.511 ' H ' HE21 ' A' ' 155' ' ' GLN . 59.9 mttp -118.85 105.25 11.32 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.8 pt -114.47 175.49 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.596 0.712 . . . . 0.0 111.718 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -138.08 127.67 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.407 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.54 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.7 mt -111.31 117.76 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.602 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.1 t -98.28 98.89 10.09 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.602 ' CD2' ' SG ' ' A' ' 164' ' ' CYS . 23.7 t-160 -92.14 69.92 5.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.005 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.52 -57.28 3.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.56 119.53 21.26 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.464 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.602 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 1.7 m -143.64 119.06 10.28 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.122 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 38.0 ttp -36.11 -21.69 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.036 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 164' ' ' CYS . 58.3 t-80 -51.19 -22.0 2.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.45 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.3 t -91.43 -41.42 10.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.103 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.45 ' N ' HG23 ' A' ' 167' ' ' THR . . . 126.5 12.25 3.46 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.86 171.6 6.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.0 0.429 . . . . 0.0 110.817 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 171' ' ' HIS . 42.1 p-10 -53.31 -35.65 60.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.273 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.52 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 5.1 p-80 -174.52 -167.06 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.7 m -94.9 142.97 26.85 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.758 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.573 ' CG ' HD11 ' A' ' 175' ' ' ILE . 28.3 ttm -119.49 116.12 25.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.058 0.456 . . . . 0.0 109.954 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 176' ' ' ILE . 1.3 mt -118.15 99.53 6.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.491 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.573 HD11 ' CG ' ' A' ' 173' ' ' MET . 8.5 mm -85.27 126.24 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.939 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 174' ' ' LEU . 5.1 mp -112.31 149.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.35 0.595 . . . . 0.0 110.375 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -144.14 142.48 30.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.349 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.7 mt -87.67 141.2 28.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.35 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -52.47 146.4 9.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.271 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 18.4 m120 53.34 43.75 31.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.678 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 47.9 p30 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.666 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.704 HMC3 ' CE1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.539 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 3' ' ' GLY . 55.9 mttp -86.42 112.61 21.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.485 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 57.27 120.41 0.01 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 tp -61.84 -36.81 76.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.773 0.321 . . . . 0.0 110.574 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.1 mm -72.31 -41.07 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 1.2 m-30 -75.48 -25.45 57.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.643 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 3' ' ' GLY . 27.3 t-20 -69.16 -52.77 24.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.821 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.71 -39.13 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.061 0.457 . . . . 0.0 109.855 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.521 HD13 ' CE2' ' A' ' 69' ' ' PHE . 20.9 tp -67.02 -47.62 70.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.87 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -50.37 -44.5 54.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.958 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.18 -54.37 46.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.383 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.439 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 28.5 ttt -51.05 -41.45 59.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.061 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.15 -36.71 77.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.509 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.7 t -62.04 -23.12 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.264 0.554 . . . . 0.0 110.032 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.04 -34.31 18.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.026 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -85.88 -76.51 0.33 Allowed 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 58' ' ' LEU . 98.1 m -90.69 -17.71 26.31 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.314 0.578 . . . . 0.0 110.599 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.87 179.19 30.56 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.741 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.8 ttp -72.95 -30.5 63.91 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.004 -1.098 . . . . 0.0 110.701 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.2 t -60.55 -39.31 87.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.981 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.04 -38.61 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 55.4 t-105 -55.26 -47.47 75.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.204 0.526 . . . . 0.0 110.071 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -74.76 -25.8 59.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.494 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.64 -47.48 26.23 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.978 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.996 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -78.34 -23.34 47.02 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.861 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.996 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.9 tt -76.35 -43.4 41.1 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.366 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -67.74 -18.89 65.04 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.26 -30.83 18.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.474 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -94.12 -88.93 0.23 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.637 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.39 153.86 74.45 Favored Pre-proline 0 C--N 1.327 -0.383 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.264 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.67 136.95 52.03 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.613 2.209 . . . . 0.0 112.0 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -84.42 -19.14 33.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.501 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -88.84 -53.61 4.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -73.92 134.56 43.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.25 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.4 155.59 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.56 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -115.66 -175.44 2.72 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.329 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.62 HG22 ' CG ' ' A' ' 40' ' ' LYS . 1.6 m -128.72 166.2 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.107 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 1' ' ' MET . 2.0 m -80.14 37.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.711 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.556 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -158.26 2.78 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.044 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.62 ' CG ' HG22 ' A' ' 37' ' ' VAL . 14.2 mmtt -92.87 143.84 25.86 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.04 0.448 . . . . 0.0 110.31 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.443 ' OG ' ' N ' ' A' ' 42' ' ' TYR . 80.7 p -71.71 -88.33 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.019 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.443 ' N ' ' OG ' ' A' ' 41' ' ' SER . 12.6 m-85 55.99 160.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.315 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.2 119.76 17.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -83.88 -1.36 54.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.239 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t -51.99 -32.26 33.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.828 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -56.62 -29.56 62.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.874 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.554 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -51.18 -56.52 12.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.081 0.467 . . . . 0.0 110.978 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -39.87 -42.17 1.27 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.867 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 m -74.05 -29.78 62.07 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.919 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 47' ' ' LEU . 17.8 mt -73.4 -51.4 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.275 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.1 m -59.15 -25.08 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.155 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.657 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.7 tt0 -77.2 -40.83 43.74 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.735 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -59.3 -56.97 15.33 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.858 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.26 -39.55 52.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.86 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.01 -38.58 83.09 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.479 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.437 ' NE2' ' N ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -63.03 -31.94 73.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -73.28 -40.6 64.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.672 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 ' SG ' ' A' ' 17' ' ' CYS . 37.7 mt -83.15 -8.91 59.44 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.615 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 58.1 51.54 8.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.453 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.42 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 20.6 mmt -131.14 149.89 74.99 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.448 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.18 138.48 72.52 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.534 1.489 . . . . 0.0 111.27 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.657 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.4 tt -53.18 -28.75 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.654 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -74.59 -29.65 61.4 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.302 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -78.64 -35.22 45.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.034 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.538 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 69.0 t -65.06 -59.65 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.7 p -48.99 -38.8 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.793 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -53.68 -45.15 70.25 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.18 -57.44 10.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.898 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.538 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 6.3 m-30 -45.18 -29.15 0.88 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.313 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.67 -51.29 58.48 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.515 ' NE2' ' OE1' ' A' ' 151' ' ' GLN . 39.9 tt0 -58.0 -52.93 63.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.995 0.426 . . . . 0.0 110.32 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.439 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 61.1 m-85 -55.0 -41.3 71.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.722 0.772 . . . . 0.0 110.507 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.5 tp -59.05 -38.68 79.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.411 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -67.48 -40.38 85.29 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.139 -0.625 . . . . 0.0 109.896 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -57.93 -69.37 0.18 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.305 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.11 -42.01 30.83 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.74 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.88 -43.27 81.09 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.376 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.94 -27.45 18.97 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.424 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.8 t -74.42 -38.61 63.01 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -65.05 -69.22 0.3 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.802 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.563 ' CD2' ' CBC' ' A' ' 182' ' ' HEM . 9.7 m-70 -98.49 47.03 0.99 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.036 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 m -51.49 -44.41 62.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.767 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 92.7 m-20 -56.8 -30.13 63.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.609 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.7 t -79.15 -20.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.767 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' A' ' 87' ' ' LYS . 49.0 t -75.88 -40.47 38.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.306 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 83' ' ' ASP . 29.8 p-10 -52.82 -8.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.045 0.45 . . . . 0.0 110.661 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 85' ' ' VAL . 56.9 mttm -73.02 -29.96 63.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.468 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.612 ' CZ ' ' CE2' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -97.56 119.6 36.41 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.021 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 53.4 p30 -88.24 -19.09 27.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.498 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 49.4 p30 -156.44 148.04 22.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.752 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -37.67 -40.65 0.43 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.04 0.447 . . . . 0.0 111.176 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.6 m -63.74 -41.67 98.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.869 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.433 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 38.7 m -61.34 -36.67 80.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.527 0.68 . . . . 0.0 110.375 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 98' ' ' ILE . 7.2 tt -65.53 -63.28 1.13 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.462 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.6 t -48.65 -41.72 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.789 0.328 . . . . 0.0 111.722 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.429 ' C ' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -85.49 -6.03 59.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.448 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -110.28 -14.38 13.28 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.659 -0.523 . . . . 0.0 112.439 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.495 ' O ' ' O ' ' A' ' 97' ' ' GLY . 39.8 mt -29.58 -104.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 117.395 0.597 . . . . 0.0 112.58 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.462 ' N ' ' ND1' ' A' ' 99' ' ' HIS . 9.0 p-80 -39.47 -48.33 1.97 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.06 0.457 . . . . 0.0 111.494 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -44.99 -87.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -71.05 -51.66 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.562 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mp -63.63 -47.81 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.651 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.14 -52.6 46.03 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.585 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 31.9 tp -49.51 -48.17 48.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.119 0.485 . . . . 0.0 110.31 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -57.43 -45.37 84.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.118 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 82.3 t -52.37 -51.92 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 110' ' ' TYR . 18.0 t-20 -49.42 -41.66 40.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.803 0.335 . . . . 0.0 110.547 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.585 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 24.4 mmtm -65.44 -41.94 92.93 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.495 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.0 tp -67.75 -44.05 78.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.767 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.538 ' CD2' ' N ' ' A' ' 111' ' ' HIS . 53.6 t80 -145.35 170.06 17.06 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.298 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.538 ' N ' ' CD2' ' A' ' 110' ' ' TYR . 38.3 m80 -37.82 -96.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.263 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 39.89 62.18 5.71 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.088 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.49 -8.34 23.35 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.407 2.071 . . . . 0.0 111.868 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 83.1 p -149.78 147.79 28.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.387 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.478 ' CD2' ' O2D' ' A' ' 182' ' ' HEM . 8.5 mt -133.09 154.32 81.22 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.911 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 115' ' ' LEU . 85.6 Cg_exo -41.38 170.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.277 1.985 . . . . 0.0 112.386 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -88.47 110.12 20.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.251 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.45 HD12 ' HN3' ' A' ' 184' ' ' IMD . 11.6 mt -124.63 128.75 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.71 0.29 . . . . 0.0 110.707 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.619 ' ND2' ' NH2' ' A' ' 131' ' ' ARG . 4.3 m-80 -132.62 115.1 15.0 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.427 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.84 123.68 5.9 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.401 ' C ' HD12 ' A' ' 122' ' ' LEU . 37.1 tt0 -116.99 152.27 34.97 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.605 ' N ' HD12 ' A' ' 122' ' ' LEU . 8.8 mp -99.67 148.0 24.81 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.06 160.67 42.13 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.35 -40.61 2.19 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.573 2.182 . . . . 0.0 113.062 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -77.77 43.67 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.874 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 46.03 60.86 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.267 0.556 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -138.0 160.83 38.31 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.085 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.1 mt -141.84 117.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.69 121.47 31.1 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.845 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.5 tp -114.54 134.85 54.72 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.908 0.385 . . . . 0.0 110.137 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.619 ' NH2' ' ND2' ' A' ' 119' ' ' ASN . 23.5 ttp-105 -120.79 125.22 47.02 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.108 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.584 ' CE1' ' CZ ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -121.06 99.32 6.43 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 134' ' ' SER . 1.3 m -108.03 119.82 40.56 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.913 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER 165.62 158.35 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.81 37.05 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.42 2.08 . . . . 0.0 111.301 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.612 HH12 ' HB2' ' A' ' 142' ' ' ALA . 0.8 OUTLIER -87.19 97.3 10.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.858 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -77.14 3.2 13.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 141' ' ' CYS . 1.0 OUTLIER -85.39 12.47 8.24 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.214 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 85.5 m -39.9 -44.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.624 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.601 ' CE2' ' NE2' ' A' ' 166' ' ' HIS . 94.4 m-85 -53.75 -34.76 60.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.629 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 138' ' ' LEU . 43.8 t -69.79 -46.29 66.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.118 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.612 ' HB2' HH12 ' A' ' 136' ' ' ARG . . . -45.27 -46.07 12.41 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.384 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.49 -47.81 80.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.732 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.19 -52.47 40.1 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.1 mt -53.32 -55.73 22.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.746 0.308 . . . . 0.0 110.805 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 20.2 mt -54.82 -54.67 39.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.4 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.545 ' CE2' HD12 ' A' ' 159' ' ' ILE . 6.4 m-85 -50.15 -50.58 48.45 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.093 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.11 -49.99 67.8 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.358 -0.448 . . . . 0.0 111.996 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.03 -59.74 2.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.891 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 155' ' ' GLN . . . -53.9 -51.99 61.95 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.477 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.515 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 86.6 mt-30 -51.83 -56.68 12.49 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 120.853 0.359 . . . . 0.0 111.164 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -41.5 -47.52 3.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.921 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.612 ' CE2' ' CZ ' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -86.17 36.46 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.665 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 151' ' ' GLN . 6.5 tt0 42.29 57.77 3.23 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.395 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.585 HE21 HG23 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -131.76 153.62 49.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.544 ' N ' ' NE2' ' A' ' 155' ' ' GLN . 56.4 mttp -121.7 116.44 24.54 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.585 HG23 HE21 ' A' ' 155' ' ' GLN . 31.4 pt -130.2 173.82 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.369 0.604 . . . . 0.0 111.728 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -140.37 126.85 20.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.927 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.545 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.6 mt -110.97 118.42 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.4 t -101.81 110.92 23.01 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.667 0.27 . . . . 0.0 111.016 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.553 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 50.1 p-80 -102.57 73.57 1.31 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.688 0.756 . . . . 0.0 111.494 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -76.56 -18.88 58.43 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.801 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 108.4 13.21 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.587 ' SG ' ' CD2' ' A' ' 166' ' ' HIS . 9.1 t -133.68 118.82 18.59 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.608 0.242 . . . . 0.0 110.868 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 44.4 ttm -35.8 -22.36 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.214 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.601 ' NE2' ' CE2' ' A' ' 140' ' ' PHE . 28.3 m-70 -51.43 -23.28 3.7 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.1 t -89.31 -41.89 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.021 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.458 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 127.88 13.3 2.75 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.83 159.43 19.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.998 0.428 . . . . 0.0 110.831 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -56.7 -27.76 59.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.399 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -168.87 175.88 5.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 9.5 m -91.72 143.81 26.16 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.805 0.335 . . . . 0.0 110.627 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.2 tpp -121.99 120.52 34.64 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.44 104.83 8.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.394 0.616 . . . . 0.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -91.23 125.36 43.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.4 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 177' ' ' GLU . 5.2 mp -110.32 152.59 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.999 0.428 . . . . 0.0 110.27 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.42 ' N ' HG22 ' A' ' 176' ' ' ILE . 21.5 mt-10 -143.95 141.99 30.51 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.995 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.8 mt -95.61 136.23 36.26 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.926 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -71.13 158.14 36.96 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.573 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -57.08 -33.64 67.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.522 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.565 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.564 ' C3A' ' NH2' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . 0.45 ' HN3' HD12 ' A' ' 118' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 1' ' ' MET . 1.1 tmt? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 3' ' ' GLY . 1.7 tpmt? -80.67 -84.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.555 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 56.94 112.28 0.01 OUTLIER Glycine 0 C--N 1.333 0.413 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -47.23 -47.77 9.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 49.6 mm -57.78 -53.89 38.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 0.0 109.755 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -67.56 -18.75 65.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.568 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 3' ' ' GLY . 43.9 t-20 -73.39 -56.2 5.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.471 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t -56.99 -36.03 49.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.466 HD13 ' CE2' ' A' ' 69' ' ' PHE . 18.1 tp -72.09 -41.75 66.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.752 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -51.82 -44.38 63.5 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -61.53 -50.65 71.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.987 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.476 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 13.5 ttt -52.55 -42.89 64.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 86.8 t -68.89 -35.91 71.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.462 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -61.01 -23.42 29.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.336 0.589 . . . . 0.0 109.799 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.22 -34.43 20.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.174 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -85.06 -75.86 0.34 Allowed 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.546 ' SG ' HD21 ' A' ' 58' ' ' LEU . 87.7 m -92.03 -20.75 21.0 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.234 0.54 . . . . 0.0 110.741 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.8 172.04 25.52 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.819 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 ttt -66.92 -29.08 68.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.798 -1.201 . . . . 0.0 110.55 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t -62.51 -41.54 98.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.133 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.68 -35.87 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -51.97 -45.82 64.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.223 0.535 . . . . 0.0 109.578 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -72.24 -29.65 64.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.211 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -67.39 -49.24 64.69 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.824 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.38 -23.46 34.95 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.793 0.33 . . . . 0.0 110.651 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.824 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.6 tt -72.62 -61.8 1.68 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.401 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.489 ' N ' HD23 ' A' ' 26' ' ' LEU . 96.9 mt-10 -59.2 -22.11 60.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.687 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -81.2 -41.15 22.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.488 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 91.7 m-70 -102.17 -88.74 0.38 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.554 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -50.83 157.13 1.42 Allowed Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.03 148.2 62.81 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.67 2.246 . . . . 0.0 112.109 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.653 ' CD ' ' H ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -113.03 -0.85 14.62 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.562 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -110.8 -36.83 5.59 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.409 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.52 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 92.3 mtt180 -75.23 44.98 0.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.45 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 p -48.24 128.91 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.435 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.52 ' CE2' ' O ' ' A' ' 34' ' ' ARG . 82.9 m-85 -116.59 -171.65 2.05 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.59 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.625 HG22 ' CG ' ' A' ' 40' ' ' LYS . 2.4 m -125.41 168.27 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.806 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -76.92 34.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.834 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.531 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -156.58 -5.17 0.11 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.238 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.625 ' CG ' HG22 ' A' ' 37' ' ' VAL . 14.4 mmtt -85.95 172.2 10.86 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.028 0.442 . . . . 0.0 110.541 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 m -76.81 144.69 38.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.456 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -154.47 156.56 36.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.559 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.48 120.31 29.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.464 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.604 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 11.1 pm0 -75.12 -24.58 58.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.643 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -58.91 -36.02 74.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.27 -42.57 98.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.83 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -40.82 -58.76 1.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.928 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -37.68 -43.36 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.539 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.5 p -72.48 -33.32 66.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.272 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.0 mp -68.38 -54.83 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.028 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -55.32 -24.61 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.878 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.649 ' HG3' HD12 ' A' ' 62' ' ' ILE . 5.8 tt0 -75.56 -41.79 53.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.598 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.488 ' OD2' ' CD2' ' A' ' 29' ' ' HIS . 19.5 m-20 -58.62 -56.83 17.11 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.136 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.19 -38.82 63.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.096 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.534 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -59.11 -38.5 79.71 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.179 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.502 ' NE2' ' N ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -63.77 -31.68 72.94 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -73.79 -40.56 63.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.546 HD21 ' SG ' ' A' ' 17' ' ' CYS . 30.9 mt -85.25 -6.75 59.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.085 0.469 . . . . 0.0 110.004 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.489 ' O ' ' SD ' ' A' ' 60' ' ' MET . 20.7 m120 56.47 61.18 2.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.973 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 52.3 mmm -139.76 149.84 60.79 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.708 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.21 136.86 53.68 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.405 1.403 . . . . 0.0 110.778 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.649 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.6 tt -50.21 -27.66 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.042 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -73.44 -31.38 63.79 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.481 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.7 -34.05 52.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.995 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.534 HG21 ' HB2' ' A' ' 55' ' ' ALA . 84.8 t -69.5 -57.21 9.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.3 p -51.99 -42.23 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.308 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.515 ' N ' HG13 ' A' ' 66' ' ' VAL . 33.0 mtpt -52.75 -50.3 63.75 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.38 -48.22 81.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.757 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.469 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.0 m-30 -52.12 -30.42 26.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.632 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.44 -48.13 71.82 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -56.89 -51.74 67.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.931 0.396 . . . . 0.0 109.98 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 55.4 m-85 -58.68 -42.53 88.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.818 0.818 . . . . 0.0 110.447 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.8 tp -56.8 -39.26 73.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.335 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 38.1 t80 -69.0 -41.31 77.97 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.002 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -55.9 -69.28 0.15 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.199 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.63 -46.89 30.37 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.397 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.8 mt -51.0 -43.69 60.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.724 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.7 -25.9 30.27 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.277 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 82' ' ' THR . 32.9 t -74.4 -55.68 5.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.045 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.409 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -74.17 -38.04 63.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.781 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -94.26 25.43 3.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.555 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 79' ' ' SER . 55.9 m -52.83 -39.0 62.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 110.002 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -57.91 -31.12 66.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.432 HG22 ' HG2' ' A' ' 105' ' ' GLU . 2.8 t -86.22 -20.17 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.55 -40.81 89.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -53.22 -19.66 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.387 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -64.72 -29.47 70.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.797 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 7.0 p90 -122.54 115.27 21.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.887 0.375 . . . . 0.0 110.843 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 54.8 p30 -85.69 -3.41 58.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.451 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 89' ' ' ASP . 61.7 m-20 -160.86 156.96 25.83 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.088 0.471 . . . . 0.0 111.452 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.407 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 69.6 t80 -48.12 -53.05 17.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.812 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.8 m -55.69 -42.41 75.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.655 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.0 p -63.0 -38.27 90.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.447 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.0 tt -64.12 -48.97 74.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.004 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.5 t -58.25 -37.39 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 0.0 110.776 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 120' ' ' GLY . 95.6 mmm -87.24 -4.89 59.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.088 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.7 -16.93 7.75 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.163 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.507 ' O ' ' O ' ' A' ' 97' ' ' GLY . 11.2 mt -27.43 -106.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 117.828 0.814 . . . . 0.0 112.645 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -40.45 -48.35 2.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.118 0.485 . . . . 0.0 111.074 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -44.46 -86.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.564 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.2 m -72.86 -52.17 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.564 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.8 mp -63.97 -48.3 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.617 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.02 -54.63 35.96 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.9 tp -48.8 -50.58 33.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.138 0.495 . . . . 0.0 110.101 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.432 ' HG2' HG22 ' A' ' 84' ' ' VAL . 37.5 tp10 -54.26 -46.38 72.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.389 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 64.3 t -53.87 -53.38 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 110' ' ' TYR . 18.1 t-20 -46.54 -43.51 17.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.804 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -61.29 -36.58 80.46 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.516 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.3 mt -70.54 -30.7 67.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.683 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 107' ' ' ASN . 51.9 m-85 -139.15 -129.3 0.12 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.52 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -167.04 141.74 3.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.881 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.462 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 0.9 OUTLIER 45.85 62.3 11.25 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.054 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.88 163.58 28.49 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.783 2.322 . . . . 0.0 111.796 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.7 p -86.2 75.49 9.87 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.231 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 116' ' ' PRO . 43.9 mt -116.7 90.68 32.29 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.325 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 115' ' ' LEU . 52.4 Cg_exo -54.1 -150.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.59 2.194 . . . . 0.0 113.003 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -96.63 115.61 27.73 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.119 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.44 123.96 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.45 99.41 5.82 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.892 0.377 . . . . 0.0 110.927 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.479 ' O ' ' SD ' ' A' ' 96' ' ' MET . . . -102.89 123.41 7.83 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -118.87 162.11 19.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.897 0.379 . . . . 0.0 110.447 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -108.12 143.76 36.45 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.12 160.37 41.39 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.77 -38.06 3.38 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.538 2.159 . . . . 0.0 113.343 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -81.0 46.17 0.88 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.27 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 43.7 59.31 3.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 110.685 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -135.52 157.98 45.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.884 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.0 mt -137.06 117.52 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.33 119.99 27.2 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.755 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.5 tp -114.04 125.89 54.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 110.789 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.675 HH21 ' CD2' ' A' ' 171' ' ' HIS . 9.4 tpt180 -111.18 119.73 39.92 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -125.86 112.06 15.55 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 116' ' ' PRO . 12.2 m -95.89 102.71 14.54 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 136' ' ' ARG . 36.5 t -125.1 82.34 61.92 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.492 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -48.02 -11.8 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.911 1.741 . . . . 0.0 110.865 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.495 ' H ' ' C ' ' A' ' 134' ' ' SER . 58.3 mtt180 -91.81 142.3 27.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.406 ' C ' HD22 ' A' ' 138' ' ' LEU . 49.5 ttt180 -69.1 39.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.557 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 3.4 mm? -98.89 0.83 44.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.298 0.57 . . . . 0.0 110.08 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 15.8 p -42.14 -46.57 4.39 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.794 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.596 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 88.6 m-85 -51.49 -38.5 54.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.086 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.506 ' SG ' ' CG2' ' A' ' 66' ' ' VAL . 68.4 m -65.8 -43.29 89.15 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.162 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.54 -49.86 18.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.947 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -62.64 -51.2 68.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.087 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.53 -46.39 37.41 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.5 mt -59.11 -54.29 48.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.707 0.289 . . . . 0.0 111.428 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 mt -55.26 -56.12 23.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.983 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.567 ' CE2' HD12 ' A' ' 159' ' ' ILE . 23.0 m-85 -50.58 -47.6 57.88 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.841 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.02 -50.84 63.57 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.41 -58.48 2.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.002 0.43 . . . . 0.0 110.613 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.7 -52.01 57.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.701 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -50.48 -48.78 56.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.113 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.4 ' ND1' ' C ' ' A' ' 152' ' ' HIS . 16.8 t-80 -48.66 -48.92 39.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.689 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -89.22 39.12 0.92 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.236 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 37.49 57.53 1.37 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.943 0.401 . . . . 0.0 111.379 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.679 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 42.1 tp60 -129.82 141.0 50.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.679 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 21.4 tptp -112.61 124.62 52.95 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.407 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 10.3 pt -138.1 170.3 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.735 0.779 . . . . 0.0 111.975 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -133.63 127.65 33.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.335 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.567 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.7 mt -110.0 120.62 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.653 0.263 . . . . 0.0 110.447 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.6 t -103.69 103.81 13.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.771 0.32 . . . . 0.0 110.894 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.1 p-80 -97.14 74.17 2.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.435 0.636 . . . . 0.0 111.338 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -77.29 -7.5 56.08 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.442 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.482 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 4.7 m -123.94 105.79 9.89 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.594 ' O ' ' N ' ' A' ' 166' ' ' HIS . 20.7 t -137.23 114.34 10.74 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.305 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 38.9 ttm -36.34 -18.24 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' CYS . 51.9 m80 -58.15 -28.08 64.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.499 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 6.2 t -82.41 -46.13 13.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.799 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.499 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 152.65 15.17 0.07 OUTLIER Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.247 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.19 145.64 32.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.907 0.384 . . . . 0.0 110.532 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.469 ' C ' ' ND1' ' A' ' 171' ' ' HIS . 85.7 m-20 -83.44 19.27 1.59 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.021 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.675 ' CD2' HH21 ' A' ' 131' ' ' ARG . 8.5 p-80 174.65 -163.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 163' ' ' THR . 46.6 t -136.48 150.51 48.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.276 0.56 . . . . 0.0 111.426 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.468 ' H ' ' HB ' ' A' ' 163' ' ' THR . 14.8 ttp -126.89 109.95 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.325 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -108.62 111.95 24.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.319 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.6 mp -93.84 128.64 45.06 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.478 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.4 mp -109.63 150.65 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.477 0.656 . . . . 0.0 110.63 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -136.21 134.67 38.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.773 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.42 ' O ' ' OE1' ' A' ' 179' ' ' GLN . 16.7 mt -93.88 142.41 27.41 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.524 ' O ' ' ND2' ' A' ' 180' ' ' ASN . 15.1 mm100 -135.3 -175.22 3.86 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.856 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 179' ' ' GLN . 29.1 m120 -149.93 23.65 0.86 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.776 0.322 . . . . 0.0 110.592 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 52.9 p30 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.617 179.966 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.409 ' O1A' ' CG ' ' A' ' 116' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 mtt . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.7 mttp 54.44 47.3 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.25 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . -157.71 -126.8 0.92 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.59 HD13 ' NE ' ' A' ' 80' ' ' ARG . 2.4 tp -50.06 -53.69 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 110.385 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.511 ' H ' HG23 ' A' ' 4' ' ' ILE . 36.1 mm -51.14 -47.5 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.53 -23.96 61.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.742 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 3' ' ' GLY . 36.2 t-20 -69.48 -51.26 37.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.426 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.51 -50.86 69.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.34 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.7 tp -55.46 -44.19 76.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -52.09 -50.88 60.71 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.825 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -57.6 -52.55 64.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.029 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.438 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.5 OUTLIER -47.72 -37.11 12.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.469 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -73.73 -34.76 41.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.403 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.4 HG13 ' CG ' ' A' ' 19' ' ' MET . 83.5 t -61.33 -23.69 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.68 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.76 -34.91 22.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.982 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -84.5 -73.88 0.41 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.541 ' SG ' HD21 ' A' ' 58' ' ' LEU . 74.3 m -93.87 -21.52 19.2 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.089 0.471 . . . . 0.0 111.076 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.68 -178.82 23.3 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.827 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.4 ' CG ' HG13 ' A' ' 14' ' ' VAL . 24.0 mtm -74.07 -30.41 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.063 -1.069 . . . . 0.0 110.193 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 m -61.99 -42.82 99.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.85 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.7 -38.42 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -51.84 -45.83 64.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.309 0.576 . . . . 0.0 109.453 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -70.93 -28.84 64.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.116 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -67.9 -49.89 59.4 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.797 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.69 -20.23 36.54 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.934 0.397 . . . . 0.0 110.659 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.8 tt -76.31 -63.32 1.35 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.316 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.509 ' N ' HD23 ' A' ' 26' ' ' LEU . 96.7 mt-10 -57.73 -21.93 43.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.596 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -80.01 -39.93 28.93 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -103.41 -89.26 0.39 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.702 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -54.36 154.9 7.74 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.129 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.01 139.38 56.02 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.429 2.086 . . . . 0.0 112.046 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -79.77 -21.81 43.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.48 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.53 -46.22 83.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.557 ' NE ' ' CZ ' ' A' ' 42' ' ' TYR . 92.1 mtt-85 -90.93 102.35 15.12 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.718 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.5 m -155.27 52.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.382 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 37' ' ' VAL . 72.8 m-85 -149.49 -134.82 0.07 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.554 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.676 HG21 ' HG3' ' A' ' 40' ' ' LYS . 16.4 m 29.05 -154.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 123.792 0.682 . . . . 0.0 112.479 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 37' ' ' VAL . 2.6 m -168.01 11.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.368 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.97 76.45 0.17 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.931 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.676 ' HG3' HG21 ' A' ' 37' ' ' VAL . 16.1 mmtt -120.21 -172.38 2.34 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.183 0.515 . . . . 0.0 110.702 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 42' ' ' TYR . 28.8 t -75.98 -136.99 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.955 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.557 ' CZ ' ' NE ' ' A' ' 34' ' ' ARG . 96.4 m-85 58.57 134.1 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.55 151.73 43.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.147 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -80.52 -6.27 57.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.592 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.0 t -47.94 -35.02 10.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.69 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -59.44 -30.98 68.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.707 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -49.55 -56.2 10.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.107 0.48 . . . . 0.0 110.576 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -38.79 -43.37 0.92 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.808 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.1 p -74.3 -29.3 61.57 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.157 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 47' ' ' LEU . 15.7 mt -72.89 -52.67 21.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.109 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.405 ' H ' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -57.8 -24.37 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.627 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.678 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.4 tt0 -78.03 -39.43 41.98 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.43 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.528 ' OD2' HD23 ' A' ' 25' ' ' LEU . 64.9 m-20 -60.28 -56.85 16.48 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.282 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 55' ' ' ALA . 8.2 p -56.66 -41.05 73.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.553 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -57.1 -38.98 74.16 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.887 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -63.73 -30.79 71.84 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -76.94 -38.56 53.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.583 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.541 HD21 ' SG ' ' A' ' 17' ' ' CYS . 30.1 mt -84.74 -7.09 59.34 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.82 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 47.7 t30 56.36 49.28 15.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.54 0.686 . . . . 0.0 109.302 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.4 mmm -126.94 150.02 70.67 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.133 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.29 137.16 59.27 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 121.513 1.475 . . . . 0.0 110.912 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.678 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.0 tt -50.71 -29.68 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.887 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -69.98 -34.18 73.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.081 0.467 . . . . 0.0 111.225 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -75.47 -32.91 60.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.104 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.521 HG21 ' HB2' ' A' ' 55' ' ' ALA . 89.1 t -71.6 -55.89 12.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.109 0.48 . . . . 0.0 110.003 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -51.91 -42.86 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.132 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.507 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.5 mtpt -53.89 -49.85 67.64 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.03 -52.3 66.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.655 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.69 -30.95 4.2 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.707 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.24 -50.94 41.51 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -55.12 -49.72 71.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.04 0.448 . . . . 0.0 109.899 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -58.84 -42.57 89.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.7 0.762 . . . . 0.0 110.733 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.2 tp -54.99 -38.62 68.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.309 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 34.2 t80 -71.27 -40.33 71.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.01 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -57.07 -71.92 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.785 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.76 -40.38 18.29 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.286 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.403 ' C ' ' N ' ' A' ' 79' ' ' SER . 44.4 mt -61.81 -39.2 90.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.177 0.489 . . . . 0.0 111.796 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.38 -11.6 0.55 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.697 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.453 ' O ' ' OG1' ' A' ' 82' ' ' THR . 9.3 t -91.91 -48.54 6.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.934 0.397 . . . . 0.0 110.483 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.59 ' NE ' HD13 ' A' ' 4' ' ' ILE . 5.5 mtm105 -68.64 -65.95 0.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.315 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.619 ' CE1' HMC3 ' A' ' 182' ' ' HEM . 0.0 OUTLIER -81.19 28.78 0.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.19 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 79' ' ' SER . 96.5 m -49.01 -45.49 42.6 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.571 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -52.48 -25.6 10.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.404 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 2.8 t -85.91 -24.57 6.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.828 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.8 t -63.05 -40.43 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.529 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -53.84 -16.19 1.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.448 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.404 ' CG ' ' O ' ' A' ' 84' ' ' VAL . 39.0 mmtm -64.85 -30.87 71.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.488 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 12.9 p90 -119.3 119.32 33.69 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.101 0.477 . . . . 0.0 111.126 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 22.1 t70 -83.87 -5.1 59.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.257 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.492 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 67.8 m-20 -159.59 156.34 27.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.089 0.471 . . . . 0.0 111.485 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -45.39 -46.98 13.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.818 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.9 m -56.9 -58.77 6.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.368 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.7 t -45.27 -40.06 7.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.12 0.485 . . . . 0.0 111.145 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 98' ' ' ILE . 5.6 tt -63.81 -48.31 77.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.326 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.2 t -59.32 -40.25 80.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.573 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 9.0 ptm -87.96 -1.52 58.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.6 -18.07 7.21 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.327 -0.707 . . . . 0.0 112.851 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 94' ' ' LEU . 13.5 mt -27.41 -105.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 117.77 0.785 . . . . 0.0 112.493 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -40.56 -48.88 2.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.064 0.459 . . . . 0.0 111.141 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -44.02 -85.84 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.565 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -73.2 -52.27 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.565 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mp -64.71 -48.75 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.7 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.17 -54.49 36.62 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 tp -48.62 -49.83 35.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.191 0.52 . . . . 0.0 109.854 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -55.04 -47.17 75.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.547 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 71.8 t -51.0 -51.04 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -51.72 -40.63 60.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -63.96 -40.19 95.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.692 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.482 ' C ' ' CG ' ' A' ' 110' ' ' TYR . 8.8 mp -61.04 -55.94 26.91 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.482 ' CG ' ' C ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER 169.19 170.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.622 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 110' ' ' TYR . 3.6 t-160 58.43 145.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.929 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -149.49 68.33 9.16 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.326 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -82.77 21.26 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.96 2.44 . . . . 0.0 112.224 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.7 t 57.62 107.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.344 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.67 152.35 93.55 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.128 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.5 172.47 5.46 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.459 2.106 . . . . 0.0 112.414 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -80.03 105.44 11.3 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.871 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.0 mm -115.65 124.93 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -131.94 116.63 17.39 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.756 0.312 . . . . 0.0 110.962 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.83 158.86 14.06 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -152.79 154.65 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 122' ' ' LEU . 10.3 mp -104.72 150.25 24.9 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.13 160.52 38.87 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.74 -56.62 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.627 2.218 . . . . 0.0 112.797 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.466 ' C ' ' ND2' ' A' ' 126' ' ' ASN . 22.0 m120 -45.67 -64.65 0.68 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.501 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.67 ' N ' HD22 ' A' ' 126' ' ' ASN . 0.0 OUTLIER 155.54 63.5 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.57 0.7 . . . . 0.0 109.181 179.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -142.36 165.83 26.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.694 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.6 mt -138.28 117.95 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.76 121.3 30.01 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.83 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 60.2 tp -115.61 136.42 53.09 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.984 0.421 . . . . 0.0 110.607 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -119.99 124.24 45.45 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.093 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.445 ' HH ' ' CGA' ' A' ' 182' ' ' HEM . 45.9 t80 -123.09 113.97 19.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.778 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.96 122.71 36.72 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 121.168 -0.213 . . . . 0.0 110.435 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 136' ' ' ARG . 4.9 p -173.06 149.47 1.78 Allowed Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.714 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.82 12.7 1.12 Allowed 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.111 1.874 . . . . 0.0 110.813 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.484 ' C ' ' H ' ' A' ' 138' ' ' LEU . 39.0 mtp180 -92.74 107.66 19.39 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.483 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -69.49 38.58 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.081 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 136' ' ' ARG . 1.4 tp -101.72 8.76 41.42 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.066 0.46 . . . . 0.0 110.483 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 71.2 m -41.78 -46.54 3.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.499 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -49.07 -38.39 24.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.454 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.62 -42.84 86.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 109.949 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.84 -49.79 14.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.613 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -61.33 -50.17 74.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.252 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.98 -46.58 41.25 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.75 -53.26 59.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.597 0.237 . . . . 0.0 111.258 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.8 mt -55.02 -56.49 19.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.979 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.597 ' CE2' HD12 ' A' ' 159' ' ' ILE . 22.6 m-85 -50.76 -47.87 59.43 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.751 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.06 -51.65 57.06 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.59 -59.81 2.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.864 0.364 . . . . 0.0 110.839 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -50.51 -51.23 49.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.994 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -51.13 -47.48 62.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.1 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -49.99 -49.74 49.52 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.641 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.517 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 67.9 t80 -87.68 38.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 38.38 55.95 1.79 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.983 0.421 . . . . 0.0 111.185 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.68 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 42.0 tp60 -129.12 141.03 51.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.68 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 50.5 mtmt -113.74 124.48 52.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.05 170.47 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.635 0.731 . . . . 0.0 111.898 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -134.0 127.38 32.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.494 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.597 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.3 mt -110.17 117.44 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.3 t -105.19 119.63 39.54 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.065 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.6 p-80 -96.67 74.82 2.75 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.657 0.741 . . . . 0.0 111.376 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -76.9 -19.92 56.85 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.989 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.78 111.07 15.1 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.484 ' O ' HG22 ' A' ' 167' ' ' THR . 20.1 p -114.23 -178.91 3.49 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.563 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.492 ' O ' ' SD ' ' A' ' 165' ' ' MET . 1.1 tmt? -93.87 -26.77 16.76 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -54.83 -24.05 21.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.577 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.5 t -87.25 -25.37 24.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.286 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.04 21.73 24.71 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.946 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.4 166.17 12.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.86 0.362 . . . . 0.0 110.651 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 171' ' ' HIS . 50.4 p-10 -52.22 -31.13 30.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.427 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.524 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 5.3 p-80 -173.98 -174.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.3 m -93.06 143.41 26.27 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.155 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.559 ' CG ' HD11 ' A' ' 175' ' ' ILE . 30.1 ttp -121.92 116.3 24.12 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.184 0.516 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 176' ' ' ILE . 1.4 mt -116.05 99.49 7.29 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.203 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.559 HD11 ' CG ' ' A' ' 173' ' ' MET . 13.3 mm -84.37 123.82 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.137 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 174' ' ' LEU . 5.0 mp -106.92 144.0 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.28 0.562 . . . . 0.0 110.28 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -132.17 133.69 44.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.986 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.83 144.4 25.32 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -137.95 178.16 7.32 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.748 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.428 ' O ' ' OD1' ' A' ' 181' ' ' ASP . 48.7 t30 55.57 45.4 24.97 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.567 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 180' ' ' ASN . 68.7 m-20 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.52 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.619 HMC3 ' CE1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.597 ' H2 ' ' CD ' ' A' ' 112' ' ' GLU . 23.4 ttt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' NZ ' ' O ' ' A' ' 40' ' ' LYS . 9.1 mtmp? 56.19 99.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.443 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 4' ' ' ILE . . . 84.54 115.22 0.69 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.418 HG22 ' C ' ' A' ' 3' ' ' GLY . 1.5 tp 170.09 -39.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mm -59.18 -47.81 88.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.77 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -64.19 -28.44 69.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.244 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.589 ' ND2' ' NH2' ' A' ' 80' ' ' ARG . 64.2 t30 -67.06 -55.05 15.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.016 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t -66.31 -39.0 83.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.17 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.505 HD13 ' CE2' ' A' ' 69' ' ' PHE . 19.0 tp -64.66 -48.6 74.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.961 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -47.42 -44.87 25.01 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.882 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -62.16 -50.54 71.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.863 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.5 tmt? -52.61 -39.62 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.978 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.26 -34.97 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.426 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.0 t -62.06 -22.67 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.322 0.582 . . . . 0.0 110.05 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.35 -34.88 20.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.217 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -84.57 -77.06 0.28 Allowed 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 58' ' ' LEU . 94.3 m -90.72 -19.97 22.95 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.309 0.576 . . . . 0.0 110.696 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.79 173.92 26.76 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.738 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.5 ttt -69.37 -25.81 64.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.866 -1.167 . . . . 0.0 110.494 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.0 t -64.94 -43.59 92.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.149 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -34.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -51.52 -45.77 63.03 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -69.8 -31.63 69.64 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.012 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -64.98 -51.07 63.76 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.791 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.34 -19.6 38.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.921 0.391 . . . . 0.0 110.732 -179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.791 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.2 tt -76.72 -57.16 4.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.357 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.39 -22.48 66.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.507 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -81.13 -39.4 25.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.508 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 72.8 m80 -101.57 -88.74 0.37 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.188 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.601 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -50.28 162.57 0.5 Allowed Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 31.0 Cg_endo -61.46 148.39 93.09 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.501 2.134 . . . . 0.0 112.083 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -70.47 -11.73 61.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.512 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 34' ' ' ARG . 91.9 m-20 -52.64 -45.65 66.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 33' ' ' ASP . 67.1 ttp85 40.39 95.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.094 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.419 ' O ' ' OH ' ' A' ' 42' ' ' TYR . 3.9 m -146.64 72.05 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.075 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 36' ' ' TYR . 43.0 p90 -72.0 114.38 10.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.863 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.476 HG23 ' H ' ' A' ' 39' ' ' ALA . 34.3 m -138.73 5.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-O 121.521 0.677 . . . . 0.0 110.012 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 m 38.92 40.05 0.41 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.758 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.476 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -153.32 26.44 0.52 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.94 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.455 ' O ' ' NZ ' ' A' ' 2' ' ' LYS . 5.2 mmpt? -122.24 -134.53 0.3 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.8 t -152.36 100.55 2.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.825 0.345 . . . . 0.0 110.839 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 35' ' ' VAL . 80.8 m-85 -112.01 161.15 16.77 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.33 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.15 112.55 19.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.325 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.435 ' CD ' ' N ' ' A' ' 45' ' ' SER . 3.0 pp20? -69.65 -29.48 66.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.723 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.435 ' N ' ' CD ' ' A' ' 44' ' ' GLU . 16.5 m -61.31 -35.31 77.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.761 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -62.88 -30.94 71.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.65 -55.79 2.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.027 0.441 . . . . 0.0 110.49 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -39.01 -42.79 0.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.419 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.2 m -72.29 -33.24 67.28 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.335 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.2 mp -71.04 -53.92 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.586 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.97 -24.86 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.124 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.672 ' HG3' HD12 ' A' ' 62' ' ' ILE . 2.2 tt0 -77.6 -39.87 44.02 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.505 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 79.1 m-20 -59.52 -56.21 24.84 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.968 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 p -57.18 -39.2 65.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.026 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.73 -38.42 85.07 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.29 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -63.27 -32.03 73.34 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -73.87 -40.46 63.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.517 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 ' SG ' ' A' ' 17' ' ' CYS . 36.6 mt -83.18 -7.72 59.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.218 0.533 . . . . 0.0 109.748 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.1 t30 56.95 49.57 13.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.549 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.401 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 25.9 mmt -128.43 149.52 71.83 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.151 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.24 137.93 68.89 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.49 1.46 . . . . 0.0 111.124 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.672 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.7 tt -51.79 -29.18 10.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.014 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -71.4 -34.18 70.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.161 0.505 . . . . 0.0 111.244 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -75.51 -32.89 60.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.884 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 55' ' ' ALA . 71.9 t -70.78 -56.53 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -52.56 -44.57 45.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.217 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.528 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.7 mtpt -51.08 -50.13 59.3 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.92 -47.94 81.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.74 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.509 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 8.3 m-30 -53.77 -30.62 45.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.529 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.71 -49.86 61.77 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -56.9 -50.02 73.81 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -58.61 -42.54 88.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.775 0.797 . . . . 0.0 110.555 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.6 tp -55.73 -38.39 69.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.306 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 37.1 t80 -71.55 -39.61 70.55 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.954 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -56.44 -71.05 0.1 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.762 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.06 -45.13 33.3 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.78 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.414 HD21 HG12 ' A' ' 4' ' ' ILE . 13.6 mt -52.34 -44.41 65.15 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.181 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.37 -23.71 16.68 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.178 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.427 ' O ' ' OG1' ' A' ' 82' ' ' THR . 22.1 t -76.74 -53.86 7.41 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.988 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.589 ' NH2' ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -75.54 -27.84 58.82 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.764 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -107.14 22.68 15.61 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.684 0.278 . . . . 0.0 110.384 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 79' ' ' SER . 6.4 m -50.88 -40.72 57.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -57.56 -35.53 70.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.508 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.3 -21.85 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.674 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 87' ' ' LYS . 95.4 t -85.52 -46.86 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.695 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -55.68 -2.05 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.686 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 85' ' ' VAL . 86.0 mttt -78.79 -33.95 45.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.58 130.98 55.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.999 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 52.1 t0 -93.0 11.39 27.64 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.402 ' OD1' ' OG ' ' A' ' 93' ' ' SER . 10.2 p-10 -167.8 163.16 14.08 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 118.987 -1.085 . . . . 0.0 113.485 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.427 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 74.3 t80 -62.13 -61.55 2.4 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.786 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.5 m -45.15 -49.3 12.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.209 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.402 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 56.9 m -59.86 -38.16 81.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.296 0.57 . . . . 0.0 110.743 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.19 -55.12 31.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.016 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.7 t -49.73 -42.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 O-C-N 123.142 0.276 . . . . 0.0 111.696 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.436 ' H ' ' HG3' ' A' ' 96' ' ' MET . 3.3 ppp? -83.23 -6.28 59.42 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.736 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -109.24 -13.35 17.7 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.46 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.605 ' HA ' HD13 ' A' ' 102' ' ' ILE . 49.4 mt -29.93 -104.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.431 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 2.3 p80 -37.36 -48.32 0.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 59.6 t0 -45.42 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.612 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.3 m -70.56 -52.9 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.612 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.8 mp -58.8 -48.47 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.71 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.58 -55.1 31.85 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 tp -50.12 -48.55 53.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.02 0.438 . . . . 0.0 110.167 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.514 ' OE1' ' NZ ' ' A' ' 87' ' ' LYS . 37.7 tp10 -55.94 -45.78 78.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.315 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 102' ' ' ILE . 54.3 t -53.5 -51.16 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -50.0 -43.35 50.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.829 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -62.5 -39.23 92.83 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.268 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.09 -41.18 97.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.059 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.48 ' CD2' ' N ' ' A' ' 111' ' ' HIS . 55.7 t80 -159.7 161.49 34.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.378 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.48 ' N ' ' CD2' ' A' ' 110' ' ' TYR . 94.4 m-70 -79.75 107.12 12.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.496 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.597 ' CD ' ' H2 ' ' A' ' 1' ' ' MET . 10.0 pt-20 -174.45 58.15 0.2 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.723 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 115' ' ' LEU . 65.0 Cg_endo -73.1 24.68 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.658 2.238 . . . . 0.0 111.722 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 112' ' ' GLU . 72.2 m -76.6 23.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.865 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 113' ' ' PRO . 26.7 mt -71.1 147.83 93.84 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.105 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -74.77 -166.55 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.253 1.968 . . . . 0.0 112.657 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -101.51 129.62 47.61 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.666 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.7 mt -131.22 129.82 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.687 0.28 . . . . 0.0 110.654 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -125.98 98.51 5.54 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.87 0.367 . . . . 0.0 110.371 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -103.98 119.49 6.33 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -116.58 153.5 32.13 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 122' ' ' LEU . 8.8 mp -101.18 147.2 26.53 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.25 160.51 41.1 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.15 -38.43 3.81 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.58 2.187 . . . . 0.0 113.105 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -79.54 45.9 0.71 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.918 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 44.22 61.06 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.366 0.603 . . . . 0.0 110.562 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -139.13 158.38 44.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.095 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.6 mt -138.67 116.49 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.79 121.67 28.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 39.9 tp -117.09 132.39 56.69 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.137 0.494 . . . . 0.0 110.859 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -118.71 125.26 49.28 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.991 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.495 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 29.6 t80 -126.43 121.63 33.0 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.03 124.9 31.88 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.846 0.355 . . . . 0.0 110.689 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.7 p -163.07 147.96 9.3 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.292 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.63 6.84 3.0 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.829 1.686 . . . . 0.0 110.837 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.592 ' HE ' ' CBA' ' A' ' 182' ' ' HEM . 74.8 mtm-85 -94.44 112.3 24.07 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.416 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -70.12 54.15 0.13 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.556 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 136' ' ' ARG . 2.2 tp -114.21 9.77 17.14 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.183 0.516 . . . . 0.0 110.559 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 9.4 t -41.9 -42.61 2.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.344 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -49.47 -41.69 41.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.454 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.441 ' SG ' ' CG2' ' A' ' 66' ' ' VAL . 56.7 m -65.25 -41.44 94.31 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -44.44 -49.93 9.57 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.674 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -63.78 -48.8 75.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.51 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.35 -46.63 52.02 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.147 -1.025 . . . . 0.0 110.785 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.3 mt -58.77 -55.92 28.88 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.5 mt -53.29 -55.91 20.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.749 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.538 ' CE2' HD12 ' A' ' 159' ' ' ILE . 15.2 m-85 -50.71 -48.15 58.92 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.667 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.03 55.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.72 -60.36 1.82 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.862 0.363 . . . . 0.0 110.821 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.98 -51.01 45.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.847 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -51.36 -46.95 62.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.064 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -50.54 -50.37 53.47 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.344 -0.543 . . . . 0.0 109.563 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.518 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 66.2 t80 -86.04 37.43 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.851 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 39.2 55.65 2.16 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.992 0.425 . . . . 0.0 111.168 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.688 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 40.7 tp60 -128.88 139.8 51.97 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.688 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 11.7 mptt -112.48 124.1 51.77 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.427 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 9.8 pt -137.32 171.15 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.724 0.773 . . . . 0.0 111.896 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -134.24 127.69 32.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.095 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.538 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.7 mt -110.43 115.71 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.0 m -96.16 100.06 11.74 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.929 0.395 . . . . 0.0 110.018 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.472 ' NE2' ' SG ' ' A' ' 164' ' ' CYS . 0.9 OUTLIER -100.69 71.49 1.49 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.019 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -81.2 -56.12 4.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.486 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 90.0 m -82.72 112.41 19.55 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.528 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.589 ' O ' ' N ' ' A' ' 166' ' ' HIS . 6.0 t -139.17 130.63 27.08 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.049 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 76.8 mtp -36.27 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.312 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.1 t60 -53.0 -24.44 9.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.476 HG23 ' N ' ' A' ' 168' ' ' GLY . 5.9 t -90.15 -43.38 10.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.106 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.476 ' N ' HG23 ' A' ' 167' ' ' THR . . . 132.46 11.98 1.87 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.74 169.56 6.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.928 0.394 . . . . 0.0 110.847 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.539 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 89.5 m-20 -56.44 -44.24 80.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.582 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 170' ' ' ASP . 62.6 m-70 -157.68 -169.81 2.99 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.8 m -92.33 138.31 31.63 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 tpt -115.73 123.65 48.83 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 110.523 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -128.39 100.61 5.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.651 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.6 mp -89.02 127.54 41.68 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.619 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.9 mp -110.45 150.82 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.438 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -144.66 141.47 29.37 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.925 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.2 mt -95.74 133.96 39.23 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.152 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.515 ' O ' ' ND2' ' A' ' 180' ' ' ASN . 84.9 mt-30 -49.14 147.14 3.13 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.501 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 179' ' ' GLN . 29.2 m120 -150.45 22.81 0.82 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.461 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 62.2 t0 . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.616 179.967 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.592 ' CBA' ' HE ' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.562 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.6 mpp? . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -80.62 3.11 23.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.554 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.574 ' O ' HG22 ' A' ' 4' ' ' ILE . . . -65.32 -164.04 1.06 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 3' ' ' GLY . 0.3 OUTLIER 94.12 -23.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.861 0.864 . . . . 0.0 109.483 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.3 mm -67.75 -51.97 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.448 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.616 ' CZ ' ' NH1' ' A' ' 34' ' ' ARG . 93.3 m-85 -68.1 -24.55 65.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.204 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -70.16 -49.93 45.55 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.915 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.08 -35.43 75.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.621 -0.431 . . . . 0.0 109.903 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.459 HD13 ' CE2' ' A' ' 69' ' ' PHE . 21.6 tp -71.1 -40.38 71.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.109 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -53.66 -44.93 70.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.634 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -62.66 -48.13 80.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.966 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.8 tmt? -53.86 -41.38 67.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.819 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.7 t -71.02 -34.94 57.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.446 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.96 -26.22 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.191 0.52 . . . . 0.0 110.249 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.26 -34.51 28.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.112 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -83.74 -73.74 0.4 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.539 ' SG ' HD21 ' A' ' 58' ' ' LEU . 89.4 m -95.29 -22.4 17.8 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.933 0.397 . . . . 0.0 111.332 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.06 170.15 22.32 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 121.891 0.717 . . . . 0.0 112.996 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -27.19 67.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.07 -1.065 . . . . 0.0 109.553 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -63.8 -43.6 95.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.531 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.31 -37.24 31.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 52.4 t-105 -51.02 -44.97 61.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -71.66 -29.01 64.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.068 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -66.73 -50.85 61.45 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.752 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.57 -20.64 36.12 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.596 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.752 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.5 tt -76.66 -69.55 0.51 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.241 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.618 ' N ' HD23 ' A' ' 26' ' ' LEU . 93.8 mt-10 -50.82 -21.43 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.162 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -80.93 -39.25 26.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 26' ' ' LEU . 89.1 m-70 -107.27 -88.98 0.46 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.752 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -58.22 155.51 25.68 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.449 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.42 155.55 69.9 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.619 2.213 . . . . 0.0 112.036 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -78.34 -24.77 46.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 34' ' ' ARG . 3.0 p30 -65.34 -35.7 81.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.908 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.616 ' NH1' ' CZ ' ' A' ' 6' ' ' PHE . 38.7 ttp180 -78.19 103.06 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.772 0.32 . . . . 0.0 110.15 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.499 HG22 ' CD2' ' A' ' 36' ' ' TYR . 9.3 p -155.13 144.92 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.597 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.499 ' CD2' HG22 ' A' ' 35' ' ' VAL . 60.0 m-85 50.81 -118.3 1.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.971 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 38' ' ' SER . 4.5 m 27.84 -154.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 123.655 0.597 . . . . 0.0 112.594 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.494 ' N ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER 175.8 25.23 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.483 -179.072 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.99 21.31 2.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.634 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.454 ' CG ' HG21 ' A' ' 37' ' ' VAL . 7.6 mmmt -112.5 -151.14 0.48 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.119 0.485 . . . . 0.0 111.254 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.9 p -42.92 156.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.692 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.536 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 13.4 p90 -133.57 61.63 1.67 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.19 0.519 . . . . 0.0 110.362 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' HB3' ' NH1' ' A' ' 34' ' ' ARG . . . -73.24 37.59 0.09 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.597 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.521 ' OE2' ' NH2' ' A' ' 136' ' ' ARG . 73.8 tt0 -42.42 -23.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.061 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 43' ' ' ALA . 17.5 m -76.59 -38.46 54.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.922 0.391 . . . . 0.0 110.742 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 6.4 mp0 -65.59 -29.23 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.53 -57.34 2.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 110.741 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.64 -40.21 0.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.533 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.9 m -75.22 -31.11 60.77 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.892 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 47' ' ' LEU . 13.7 mt -70.94 -50.73 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -26.15 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.398 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.661 ' HG3' HD12 ' A' ' 62' ' ' ILE . 2.1 tt0 -76.0 -40.79 52.9 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.543 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -59.27 -57.0 14.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.005 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.96 -38.33 59.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.221 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.517 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.34 -38.35 86.62 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.218 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -62.9 -32.02 73.2 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.47 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.69 -45.33 53.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.534 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.539 HD21 ' SG ' ' A' ' 17' ' ' CYS . 32.0 mt -77.77 -7.26 56.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.656 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 t30 56.94 49.75 13.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.934 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.414 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 7.7 mmt -128.45 149.14 70.82 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.225 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.28 139.21 76.3 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.441 1.428 . . . . 0.0 110.892 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.661 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.5 tt -52.84 -29.86 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.433 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -71.7 -31.48 66.79 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.578 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.6 -31.6 47.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.921 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' ' 55' ' ' ALA . 69.4 t -71.04 -57.1 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.0 p -52.03 -41.37 31.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.201 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.503 ' N ' HG13 ' A' ' 66' ' ' VAL . 32.2 mtpt -53.98 -50.75 65.86 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.78 83.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.73 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.9 m-30 -53.81 -31.11 47.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.286 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.63 -50.1 60.8 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -55.69 -50.09 71.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.006 0.432 . . . . 0.0 109.941 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -59.93 -41.84 92.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.826 0.822 . . . . 0.0 110.493 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -58.55 -39.81 81.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.597 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 35.1 t80 -68.28 -41.5 80.93 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.904 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -55.07 -68.81 0.16 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.224 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.16 -47.6 33.32 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.618 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.6 mt -52.06 -42.93 63.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.052 0.426 . . . . 0.0 111.991 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -55.11 -24.17 24.54 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.394 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.8 t -76.37 -53.1 8.65 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.082 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -76.87 -39.98 49.15 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.772 -179.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -92.96 27.01 2.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.41 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 34.8 m -53.71 -37.7 63.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.05 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.442 ' O ' ' NZ ' ' A' ' 87' ' ' LYS . 89.9 m-20 -58.09 -30.81 66.53 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.6 -19.7 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.688 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.35 -43.5 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.353 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.34 -16.62 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.994 0.426 . . . . 0.0 110.35 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 83' ' ' ASP . 42.5 mmtm -67.61 -29.07 68.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.022 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 8.9 p90 -120.56 116.5 25.49 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.175 0.512 . . . . 0.0 110.991 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -84.82 -2.37 57.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.369 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.433 ' OD1' ' OG ' ' A' ' 93' ' ' SER . 50.5 p30 -163.48 159.48 22.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.186 0.517 . . . . 0.0 111.637 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.447 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 85.8 t80 -48.7 -46.05 39.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.305 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.2 m -59.08 -61.35 2.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.904 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.433 ' OG ' ' OD1' ' A' ' 90' ' ' ASP . 93.8 p -45.4 -37.78 5.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.151 0.501 . . . . 0.0 111.022 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.5 tt -65.03 -46.03 82.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.199 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.1 t -62.6 -39.6 85.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.253 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 12.8 ptm -87.2 -1.85 58.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.82 -16.85 7.74 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.353 -0.693 . . . . 0.0 112.891 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.549 ' HA ' HD13 ' A' ' 102' ' ' ILE . 12.2 mt -29.12 -102.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 117.868 0.834 . . . . 0.0 112.454 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.489 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 13.3 p-80 -39.75 -50.15 2.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.035 0.445 . . . . 0.0 111.364 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.489 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 80.2 m-20 -44.54 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -72.18 -53.19 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 101' ' ' VAL . 3.1 mp -61.15 -48.41 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.22 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.0 -53.7 43.42 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.9 tp -50.62 -50.85 53.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.92 0.39 . . . . 0.0 110.456 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -55.85 -45.27 78.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.318 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.67 -50.77 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 110' ' ' TYR . 22.7 t-20 -50.05 -43.19 50.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.746 0.308 . . . . 0.0 111.055 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -66.98 -41.87 86.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.612 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.0 tp -64.29 -40.42 95.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.607 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 107' ' ' ASN . 66.1 m-85 -140.32 145.28 37.0 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.602 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.628 ' CG ' ' H ' ' A' ' 112' ' ' GLU . 84.4 t60 -85.62 176.88 7.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.393 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.628 ' H ' ' CG ' ' A' ' 111' ' ' HIS . 66.3 tt0 60.47 62.05 3.28 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.517 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.67 153.64 38.82 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.663 2.242 . . . . 0.0 111.927 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.1 t -156.66 43.0 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.483 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.6 mt -72.5 148.08 90.23 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.261 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.98 -173.53 1.71 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.395 2.063 . . . . 0.0 112.335 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.662 ' CD2' HD21 ' A' ' 119' ' ' ASN . 75.8 t60 -89.99 115.72 27.49 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.237 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.2 mt -129.82 130.04 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.582 0.229 . . . . 0.0 111.02 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.662 HD21 ' CD2' ' A' ' 117' ' ' HIS . 11.6 m-20 -132.51 119.42 20.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.42 137.53 13.4 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -128.71 159.49 35.47 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.823 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -107.14 145.84 32.03 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.28 160.46 41.35 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.62 -41.07 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.638 2.225 . . . . 0.0 113.222 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -77.65 46.59 0.56 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.088 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 17.7 p30 43.29 62.21 1.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.545 0.688 . . . . 0.0 110.837 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -139.25 158.31 44.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.964 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 51.0 mt -139.04 119.19 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.85 122.3 33.45 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.269 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.1 tp -117.76 134.81 54.54 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.997 0.427 . . . . 0.0 110.689 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -120.73 125.16 46.93 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.49 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.469 ' OH ' ' C3A' ' A' ' 182' ' ' HEM . 1.7 t80 -123.78 112.47 17.35 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 m -124.14 125.2 44.06 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.18 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 136' ' ' ARG . 2.1 p 174.62 153.2 0.28 Allowed Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.532 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.86 25.33 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.364 2.043 . . . . 0.0 111.19 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.521 ' NH2' ' OE2' ' A' ' 44' ' ' GLU . 21.2 mmm180 -95.72 106.0 18.06 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.853 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -71.77 15.07 0.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.39 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.5 mm? -84.21 8.21 16.55 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 110.485 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.0 t -42.44 -49.49 5.25 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -47.68 -35.03 8.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.096 0.474 . . . . 0.0 109.895 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.69 -43.55 79.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.936 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.48 -51.19 15.78 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.515 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -59.28 -51.66 69.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.43 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.53 -46.49 37.34 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.9 mt -61.45 -52.1 65.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 111.204 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 45.4 mt -55.53 -56.85 15.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.839 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.563 ' CE2' HD12 ' A' ' 159' ' ' ILE . 22.4 m-85 -50.31 -47.86 55.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.764 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.13 -51.69 57.76 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.5 -54.99 4.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.937 0.398 . . . . 0.0 110.54 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -54.55 -51.42 65.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.631 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -51.09 -46.77 61.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.931 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -50.0 -50.06 48.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.514 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 67.7 t80 -87.81 37.89 0.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.014 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 38.76 55.66 1.95 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.93 0.395 . . . . 0.0 111.081 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.686 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 41.9 tp60 -128.83 141.24 51.36 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.686 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 67.2 mttm -114.85 124.04 50.7 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.447 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 8.8 pt -136.89 173.84 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.714 0.769 . . . . 0.0 111.99 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.443 ' NE2' ' OE1' ' A' ' 177' ' ' GLU . 13.0 pt20 -137.02 129.25 29.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.427 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.563 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.5 mt -111.77 120.05 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.297 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -102.2 106.12 16.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.821 0.343 . . . . 0.0 110.754 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.533 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 16.6 p80 -102.08 73.12 1.36 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.385 0.612 . . . . 0.0 111.45 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -77.74 -12.84 60.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.33 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.48 ' HB ' ' H ' ' A' ' 173' ' ' MET . 3.2 m -116.45 104.23 11.23 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.589 ' O ' ' N ' ' A' ' 166' ' ' HIS . 38.0 t -136.63 116.36 13.04 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.576 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.5 ptm -39.94 -15.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.23 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 164' ' ' CYS . 56.0 t-80 -58.53 -30.37 67.04 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.503 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.0 t -81.04 -46.22 15.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.053 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.503 ' N ' HG23 ' A' ' 167' ' ' THR . . . 153.84 12.68 0.07 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.09 149.19 35.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.65 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -85.1 8.85 16.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.088 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -174.71 -173.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 92.3 m -129.18 148.07 51.09 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.182 0.515 . . . . 0.0 111.569 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.48 ' H ' ' HB ' ' A' ' 163' ' ' THR . 7.8 ttm -126.43 111.86 14.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.111 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.27 110.6 21.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.344 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -92.24 127.54 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.775 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.31 150.57 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.075 0.465 . . . . 0.0 110.095 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.443 ' OE1' ' NE2' ' A' ' 158' ' ' GLN . 28.1 mt-10 -145.71 142.59 29.12 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.734 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 17.6 mt -94.05 131.69 39.3 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.192 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -52.55 153.42 3.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.656 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -55.25 -34.41 64.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.599 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 60.5 t0 . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.54 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.469 ' C3A' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.545 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.636 ' NZ ' HMD1 ' A' ' 182' ' ' HEM . 38.2 tptt -138.42 134.23 33.83 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.378 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -158.97 -24.04 0.03 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.558 ' CD1' ' HE ' ' A' ' 80' ' ' ARG . 1.9 tp -42.39 -41.42 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.996 0.427 . . . . 0.0 110.487 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.19 -50.87 76.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -64.23 -29.19 70.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.196 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -62.02 -59.3 5.29 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.26 0.553 . . . . 0.0 110.847 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.98 -26.98 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.165 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.509 HD13 ' CE2' ' A' ' 69' ' ' PHE . 36.9 tp -72.03 -41.17 67.83 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.085 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.44 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.9 mt-10 -57.79 -41.06 81.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.256 -0.977 . . . . 0.0 109.541 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -60.3 -57.95 10.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.653 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.601 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 68.0 mtm -48.43 -43.64 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.35 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.8 -36.28 75.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.854 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 10' ' ' GLU . 47.6 t -62.53 -22.54 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.275 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.82 -34.41 17.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.13 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -84.75 -78.03 0.26 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' HD21 ' A' ' 58' ' ' LEU . 89.9 m -90.61 -17.54 26.74 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.341 0.591 . . . . 0.0 110.57 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.68 178.86 29.54 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.827 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.1 ttt -72.49 -30.87 64.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.837 -1.181 . . . . 0.0 110.708 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 t -61.5 -41.87 97.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.119 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.18 -38.12 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.417 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 51.1 t-105 -51.73 -45.71 63.73 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.89 -29.05 63.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.339 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -67.27 -50.76 59.21 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.915 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.07 -22.38 36.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.85 0.357 . . . . 0.0 110.413 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.915 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.8 tt -73.91 -66.59 0.69 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.117 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.599 ' N ' HD23 ' A' ' 26' ' ' LEU . 75.9 tt0 -52.44 -21.78 4.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.527 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -81.38 -38.97 25.73 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.45 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 12.8 m-70 -89.11 -62.81 1.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.319 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 26' ' ' LEU . . . -60.64 153.48 62.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.77 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.02 -176.91 2.61 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.737 2.292 . . . . 0.0 111.918 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -69.81 -22.67 63.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.349 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -77.19 6.72 6.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.543 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -46.65 133.83 10.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.048 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.56 163.53 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.177 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -102.28 117.58 35.06 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.326 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.689 HG21 ' HG3' ' A' ' 40' ' ' LYS . 31.1 m -153.29 -160.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.618 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -142.48 9.45 1.82 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.271 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.02 86.94 0.1 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.455 -0.498 . . . . 0.0 112.027 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.689 ' HG3' HG21 ' A' ' 37' ' ' VAL . 17.4 mmtt -134.59 -177.05 4.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.083 0.468 . . . . 0.0 110.232 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.1 m -74.34 18.94 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.911 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 40' ' ' LYS . 4.2 m-85 -62.3 142.4 57.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.035 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.33 128.04 33.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.549 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -67.45 -34.47 77.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.4 p -63.27 -27.54 69.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.479 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -59.04 -37.92 78.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.64 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -44.53 -53.54 6.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.148 0.499 . . . . 0.0 110.713 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -41.1 -40.94 1.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.387 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.2 m -73.24 -31.13 63.93 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 47' ' ' LEU . 25.8 mm -68.48 -55.35 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.714 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.431 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -58.11 -22.41 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.983 178.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.687 ' HG3' HD12 ' A' ' 62' ' ' ILE . 4.5 tt0 -79.65 -43.18 23.29 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.383 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.45 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 33.0 m-20 -58.4 -57.08 14.49 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.675 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 55' ' ' ALA . 7.5 p -56.95 -41.16 76.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.409 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.427 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -56.24 -38.69 71.43 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.309 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -64.51 -32.97 74.84 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -73.44 -37.98 65.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.781 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 17' ' ' CYS . 36.6 mt -84.21 -7.5 59.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.105 0.479 . . . . 0.0 109.844 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.27 48.36 17.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.573 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.5 mmm -127.19 149.55 69.88 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.073 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.68 135.56 49.47 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.442 1.428 . . . . 0.0 110.94 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.687 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.6 tt -49.54 -27.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.097 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -73.44 -30.93 63.53 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.086 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -78.05 -31.83 50.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.258 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.416 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 73.5 t -72.03 -56.3 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.532 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -51.63 -43.69 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.32 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.532 ' N ' HG13 ' A' ' 66' ' ' VAL . 34.7 mtpt -52.38 -51.98 56.07 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.76 -55.71 30.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.278 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.509 ' CE2' HD13 ' A' ' 9' ' ' LEU . 7.5 m-30 -44.53 -28.03 0.53 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.375 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.12 -47.46 59.09 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -56.46 -53.45 57.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.042 0.448 . . . . 0.0 110.273 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.601 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 78.7 m-85 -57.23 -42.14 80.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.755 0.788 . . . . 0.0 110.854 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.1 tp -55.25 -37.5 67.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.654 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 28.8 t80 -69.77 -40.7 75.92 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -57.05 -72.96 0.07 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.847 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.87 -40.65 19.52 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.396 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.421 HD21 HG12 ' A' ' 4' ' ' ILE . 23.7 mt -60.02 -41.56 92.44 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.345 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.09 -22.79 11.8 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.926 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.438 ' O ' ' OG1' ' A' ' 82' ' ' THR . 8.7 t -80.45 -52.56 7.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.212 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.558 ' HE ' ' CD1' ' A' ' 4' ' ' ILE . 4.4 mtt-85 -65.97 -52.66 47.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.188 0.518 . . . . 0.0 110.884 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.405 ' CE1' HBC1 ' A' ' 182' ' ' HEM . 43.2 m-70 -93.95 36.47 1.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.567 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 79' ' ' SER . 39.6 m -56.92 -45.3 82.78 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.066 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -50.79 -31.09 15.88 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 t -82.75 -19.59 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.699 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.513 ' C ' ' H ' ' A' ' 87' ' ' LYS . 68.1 t -72.21 -47.05 55.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.569 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 56.1 t0 -52.66 -7.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.808 0.337 . . . . 0.0 110.759 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 85' ' ' VAL . 43.1 mmtm -80.23 -28.9 38.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.071 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.62 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -95.77 118.12 31.83 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.474 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -84.85 -13.45 50.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.169 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 15.3 p-10 -164.67 171.42 14.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.256 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.424 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 68.8 t80 -58.07 -46.74 84.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.872 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.8 m -59.84 -44.78 93.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.443 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.7 t -55.63 -39.84 71.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.248 0.547 . . . . 0.0 110.304 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.419 HD12 ' CD2' ' A' ' 88' ' ' PHE . 3.0 tt -64.71 -45.56 86.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.998 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.57 -38.13 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.421 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.556 ' SD ' HD13 ' A' ' 122' ' ' LEU . 83.7 mtp -83.99 -4.42 58.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.427 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -116.75 -14.97 7.05 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.044 -0.865 . . . . 0.0 113.663 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.669 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.7 mt -26.72 -106.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 117.954 0.877 . . . . 0.0 112.697 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.482 ' CE1' ' O ' ' A' ' 118' ' ' ILE . 8.7 p-80 -41.4 -46.34 3.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.019 0.438 . . . . 0.0 111.271 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -47.46 -87.34 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 102' ' ' ILE . 2.1 m -69.89 -51.38 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.669 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.5 mp -63.28 -47.61 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.699 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.33 -54.06 40.05 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.3 tp -49.47 -48.03 48.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.934 0.397 . . . . 0.0 109.947 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -56.9 -45.82 82.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.035 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' LEU . 76.0 t -54.85 -56.06 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -43.94 -45.43 7.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.125 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -60.08 -36.13 76.71 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.84 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 109' ' ' LEU . 3.7 tt -75.29 -56.21 4.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.965 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -69.0 -80.54 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.424 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.401 ' CG ' ' N ' ' A' ' 112' ' ' GLU . 79.8 t60 -174.45 -98.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.14 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.699 ' H ' ' CD ' ' A' ' 113' ' ' PRO . 13.3 tm-20 -119.81 -32.61 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.699 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 83.8 Cg_exo -47.9 139.93 19.03 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.861 1.707 . . . . 0.0 112.454 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.6 t -103.77 157.12 17.29 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.918 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.8 mp -84.4 157.33 61.94 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.013 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.515 ' O ' HD12 ' A' ' 118' ' ' ILE . 98.1 Cg_exo -42.69 -176.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 122.704 2.269 . . . . 0.0 113.382 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -87.08 122.35 30.79 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.518 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 116' ' ' PRO . 4.0 mp -138.48 133.15 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -138.5 130.01 27.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.712 0.291 . . . . 0.0 111.212 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.58 120.8 4.53 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -117.55 130.34 56.35 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.651 0.262 . . . . 0.0 110.819 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.556 HD13 ' SD ' ' A' ' 96' ' ' MET . 3.9 tp -76.19 150.35 37.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 111.383 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -121.43 160.32 46.5 Favored Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.317 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.45 -36.83 3.61 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.668 2.245 . . . . 0.0 113.309 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -79.96 46.7 0.82 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.144 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.6 m120 43.35 58.39 3.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 0.0 110.443 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -137.11 159.06 43.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.057 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.4 mt -135.4 114.6 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.19 120.09 25.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 61.5 tp -114.92 132.73 56.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.166 0.508 . . . . 0.0 111.298 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.711 ' HE ' ' CE1' ' A' ' 171' ' ' HIS . 64.0 ttt-85 -116.95 120.43 38.4 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.008 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.491 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 72.3 t80 -127.29 124.53 38.99 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.948 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.08 123.6 24.75 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 71.7 m -145.56 148.4 36.77 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.63 -20.29 12.24 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.071 1.847 . . . . 0.0 112.673 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.574 ' NH2' ' CGA' ' A' ' 182' ' ' HEM . 84.5 mtm-85 -79.04 -14.08 59.39 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.922 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 139' ' ' CYS . 52.0 mtp180 64.01 25.2 13.79 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.147 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.484 HD23 ' CB ' ' A' ' 136' ' ' ARG . 2.5 mm? -73.53 18.14 0.13 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 9.2 t -44.83 -49.75 10.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.582 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -45.76 -41.29 10.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.113 0.482 . . . . 0.0 110.2 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 22.8 t -62.34 -41.46 98.59 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.54 -54.18 7.93 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.561 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -56.58 -50.74 71.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.35 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.8 -47.9 45.79 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.37 -54.81 41.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.2 mt -53.4 -55.22 26.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.745 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.548 ' CE2' HD12 ' A' ' 159' ' ' ILE . 14.5 m-85 -51.61 -47.7 63.54 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.897 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.31 -51.99 54.29 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.26 -60.11 2.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.846 0.355 . . . . 0.0 110.916 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -47.84 -50.66 25.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.966 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -52.45 -47.97 66.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.623 0.249 . . . . 0.0 111.237 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -49.38 -49.96 42.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.667 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.25 37.3 0.72 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.968 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 38.76 57.5 1.83 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.976 0.417 . . . . 0.0 111.196 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.516 HE21 ' H ' ' A' ' 156' ' ' LYS . 52.8 tp60 -131.72 142.98 49.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.516 ' H ' HE21 ' A' ' 155' ' ' GLN . 58.4 tttp -118.17 112.31 19.99 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.078 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.424 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 17.8 pt -122.53 173.48 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.513 0.673 . . . . 0.0 111.78 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -137.13 128.74 28.62 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.547 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.548 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.5 mt -112.04 120.97 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.649 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.9 t -105.19 112.19 25.21 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.705 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 53.8 p-80 -101.97 76.7 1.63 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.983 0.897 . . . . 0.0 111.822 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 4.9 p30 -75.89 -27.56 57.77 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.716 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.56 110.44 21.92 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.552 ' O ' HG22 ' A' ' 167' ' ' THR . 6.4 p -113.08 176.33 5.06 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 168' ' ' GLY . 72.5 mtp -91.52 -28.18 17.75 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -53.72 -22.51 9.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.825 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.4 t -88.63 -26.77 21.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.446 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 98.58 21.92 15.51 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.136 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.31 162.68 24.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.04 0.447 . . . . 0.0 110.681 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -45.97 -34.38 3.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.308 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.711 ' CE1' ' HE ' ' A' ' 131' ' ' ARG . 9.0 p-80 -175.49 -167.78 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.2 m -95.18 139.71 31.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.171 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 12.8 tpp -120.7 116.7 25.79 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.1 107.15 12.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.472 0.654 . . . . 0.0 111.047 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -89.95 126.98 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.561 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.8 mp -110.83 151.49 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.189 0.519 . . . . 0.0 110.171 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.56 144.0 28.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.933 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 11.7 mt -94.41 134.58 36.78 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.072 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -54.21 154.9 4.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.695 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -55.32 -32.52 62.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.622 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 53.0 p30 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.523 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.636 HMD1 ' NZ ' ' A' ' 2' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . 0.429 ' C4 ' ' CD2' ' A' ' 115' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ptt? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' NZ ' ' C ' ' A' ' 34' ' ' ARG . 60.3 mmtt 62.95 54.9 2.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 57.4 125.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 5' ' ' ILE . 3.3 tp -55.03 -44.61 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.623 -0.339 . . . . 0.0 110.853 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' N ' HG23 ' A' ' 4' ' ' ILE . 36.3 mm -64.45 -56.76 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.426 0.631 . . . . 0.0 109.461 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -62.26 -27.7 69.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.658 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 3' ' ' GLY . 25.7 t-20 -62.35 -60.79 3.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.131 0.491 . . . . 0.0 110.939 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -56.96 -27.16 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.115 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.418 HD13 ' CE2' ' A' ' 69' ' ' PHE . 27.9 tp -71.8 -50.5 29.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.463 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.8 mt-10 -49.36 -40.22 34.84 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.562 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -60.48 -49.09 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.695 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.579 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 10.4 tpt -56.87 -42.58 80.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.005 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.79 -34.98 58.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.648 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 10' ' ' GLU . 40.8 t -62.16 -25.0 36.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.216 0.531 . . . . 0.0 110.018 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.93 -34.58 22.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.134 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -85.75 -74.44 0.41 Allowed 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.499 ' SG ' HD21 ' A' ' 58' ' ' LEU . 91.7 m -92.27 -21.66 20.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.166 0.508 . . . . 0.0 110.966 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.51 170.96 24.72 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.865 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.0 ttp -66.5 -28.67 68.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.904 -1.148 . . . . 0.0 110.347 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 t -62.49 -42.24 99.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.208 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.63 -36.27 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.408 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 50.7 t-105 -51.94 -45.86 64.49 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -70.31 -30.6 67.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.986 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -66.05 -50.77 62.99 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.815 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.19 -20.53 37.62 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.844 0.354 . . . . 0.0 110.617 -179.26 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.815 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.3 tt -75.47 -57.64 3.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.345 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.05 -23.16 67.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.675 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -80.45 -40.63 25.93 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -101.67 -87.51 0.4 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.326 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.575 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -49.42 161.46 0.48 Allowed Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.532 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 36.6 Cg_endo -64.49 131.94 31.57 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.546 2.164 . . . . 0.0 111.761 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -70.78 -19.45 62.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.717 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -53.0 -38.32 62.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.483 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.465 ' C ' ' NZ ' ' A' ' 2' ' ' LYS . 81.9 mtp180 44.92 91.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.627 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.8 m -153.12 30.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.624 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -97.47 151.36 20.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.566 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.688 HG23 ' H ' ' A' ' 39' ' ' ALA . 1.4 m -110.83 171.7 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.097 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.1 m -76.87 27.92 0.13 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.715 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.688 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -164.26 40.2 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.339 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.612 ' CG ' HG22 ' A' ' 37' ' ' VAL . 18.9 mmtt -136.4 150.97 49.04 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.161 0.505 . . . . 0.0 110.702 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 40' ' ' LYS . 77.5 p 40.36 -164.81 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.085 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.534 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 10.3 p90 -171.82 61.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.309 0.576 . . . . 0.0 110.482 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.66 40.13 0.05 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.727 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.47 ' H ' ' C ' ' A' ' 42' ' ' TYR . 86.4 tt0 -45.89 -24.64 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.505 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 85.6 p -70.72 -38.68 73.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.882 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -66.37 -33.13 75.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.542 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -48.2 -58.15 4.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.105 0.479 . . . . 0.0 110.634 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -39.01 -41.1 0.74 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.541 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.3 p -74.53 -31.87 62.28 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.971 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 47' ' ' LEU . 17.1 mt -70.26 -53.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.789 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.89 -25.03 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.518 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.657 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.0 tt0 -76.61 -41.28 46.66 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.633 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -59.02 -56.8 17.54 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.744 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.96 -37.53 55.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.016 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.527 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -62.41 -38.09 88.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.276 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -62.4 -32.83 73.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -72.04 -44.53 63.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.554 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.499 HD21 ' SG ' ' A' ' 17' ' ' CYS . 32.3 mt -79.14 -7.37 58.13 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.864 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.01 49.85 13.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.678 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.405 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 25.5 mmt -128.55 149.12 70.91 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.182 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.58 138.73 71.86 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.347 1.365 . . . . 0.0 110.967 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.657 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.7 tt -52.38 -29.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.428 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -72.46 -31.53 65.52 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.562 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -78.2 -31.85 49.65 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.944 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 55' ' ' ALA . 82.2 t -70.5 -57.08 8.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -51.58 -43.22 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.34 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.516 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.0 mtpt -53.32 -50.33 65.19 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.14 80.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.644 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.9 m-30 -52.16 -29.49 22.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.298 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.26 -50.35 56.83 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -55.17 -50.71 68.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.023 0.44 . . . . 0.0 110.049 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.579 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 59.4 m-85 -59.67 -41.19 90.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.883 0.849 . . . . 0.0 110.74 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.62 -40.46 83.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.451 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.401 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 41.9 t80 -68.7 -39.87 80.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 110.229 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -55.27 -70.44 0.11 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.377 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.92 -37.62 53.4 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.385 -0.436 . . . . 0.0 112.637 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.521 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 16.5 mt -55.23 -51.06 67.81 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.086 0.443 . . . . 0.0 111.716 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.85 -15.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.805 -0.56 . . . . 0.0 111.36 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 77' ' ' LEU . 9.3 t -83.75 -49.08 9.44 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -59.48 2.73 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.083 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.0 p80 -81.85 30.22 0.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.815 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.8 m -49.53 -40.07 36.71 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -55.65 -30.38 60.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 81' ' ' HIS . 5.1 t -85.89 -22.8 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.534 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.492 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 54.1 t -61.66 -40.48 86.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -49.6 -20.34 0.76 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.873 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -70.15 -5.03 24.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.381 0.61 . . . . 0.0 109.865 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.607 ' CG ' ' N ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER -89.05 -150.26 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.508 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.607 ' N ' ' CG ' ' A' ' 88' ' ' PHE . 1.1 p-10 159.63 -30.25 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -170.23 155.1 5.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.365 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 85.6 t80 -46.08 -57.46 4.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.237 0.541 . . . . 0.0 111.29 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.5 m -50.41 -47.12 56.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.108 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.431 ' CB ' ' OD2' ' A' ' 89' ' ' ASP . 32.6 m -61.42 -37.17 82.52 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.151 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.1 tt -64.3 -45.49 87.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.001 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.52 -36.11 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 121.226 0.536 . . . . 0.0 110.639 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.7 mmm -86.19 -6.79 58.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.53 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -111.42 -13.16 13.52 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.894 -0.392 . . . . 0.0 112.654 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.647 ' HA ' HD13 ' A' ' 102' ' ' ILE . 15.8 mt -33.0 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 117.509 0.655 . . . . 0.0 111.963 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -39.8 -50.27 2.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.213 0.53 . . . . 0.0 111.498 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -48.12 -91.25 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.599 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.7 m -66.71 -51.21 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.647 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.7 mp -61.72 -40.97 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.392 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.16 -57.52 10.45 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.4 tp -49.21 -58.05 5.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.15 0.5 . . . . 0.0 110.491 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -50.6 -45.95 57.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.236 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 102' ' ' ILE . 14.7 t -54.59 -51.41 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 110' ' ' TYR . 48.9 t30 -46.85 -42.91 18.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.792 0.329 . . . . 0.0 110.607 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -62.48 -36.89 83.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.69 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.05 -49.17 15.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.376 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 107' ' ' ASN . 57.7 m-85 -123.62 151.43 43.02 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.471 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 112' ' ' GLU . 76.1 m80 -92.93 160.17 15.01 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.735 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 111' ' ' HIS . 8.2 pt-20 32.39 61.38 1.38 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.811 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.23 -20.77 18.45 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.508 2.139 . . . . 0.0 111.93 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.6 m 43.87 69.42 0.41 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.806 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.5 mt -79.05 152.98 77.27 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.074 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.1 169.73 18.66 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.374 2.05 . . . . 0.0 111.905 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -78.23 100.99 6.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.526 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 31.7 mm -117.25 124.14 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.373 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.593 HD22 ' NH2' ' A' ' 131' ' ' ARG . 52.9 t30 -132.89 120.02 20.95 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.735 0.302 . . . . 0.0 110.857 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.8 119.21 5.17 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -117.78 125.65 50.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 tp -72.21 140.04 48.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.886 0.374 . . . . 0.0 110.825 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.29 161.01 41.18 Favored Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.6 178.63 6.48 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.312 2.008 . . . . 0.0 111.992 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.527 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 95.7 m-20 55.23 36.01 26.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.347 0.594 . . . . 0.0 109.832 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.527 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 47.5 m-20 54.35 56.51 6.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.794 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 125' ' ' ASN . 3.8 mp0 -125.98 156.43 39.85 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.1 mt -139.39 115.32 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.87 122.82 31.27 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.844 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 47.8 tp -117.78 132.7 56.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 111.279 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.593 ' NH2' HD22 ' A' ' 119' ' ' ASN . 41.5 ttp180 -112.87 120.24 40.76 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.602 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.494 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 30.6 t80 -122.71 120.2 32.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.621 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.45 124.93 23.49 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.0 t -156.06 142.57 13.28 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.41 -7.42 20.35 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.871 1.714 . . . . 0.0 112.208 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.51 ' N ' ' CD ' ' A' ' 136' ' ' ARG . 0.8 OUTLIER -80.91 -14.37 58.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.035 0.445 . . . . 0.0 109.985 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 56.28 30.35 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.619 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.57 16.49 1.71 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.011 0.434 . . . . 0.0 109.995 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 26.4 p -43.57 -49.13 7.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.586 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.465 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 80.8 m-85 -45.64 -41.89 10.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.973 0.416 . . . . 0.0 110.409 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 48.5 t -64.09 -42.23 96.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.774 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.55 -52.5 10.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.579 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -59.19 -51.85 68.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.613 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.35 -46.99 35.74 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.3 -54.18 48.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.641 0.258 . . . . 0.0 111.638 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 31.2 mt -54.51 -56.13 21.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.026 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.566 ' CE2' HD12 ' A' ' 159' ' ' ILE . 23.4 m-85 -50.59 -47.26 58.14 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.743 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.64 -51.7 57.33 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.14 -59.95 2.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.684 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.0 -52.29 44.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.76 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -50.41 -47.26 56.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.908 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -49.57 -49.38 46.71 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.712 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -88.24 37.97 0.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.851 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 39.11 55.02 2.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 111.16 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.677 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 41.0 tp60 -127.91 140.11 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.677 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 68.7 mttm -112.39 124.1 51.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.998 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.446 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 9.6 pt -137.41 169.41 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.694 0.759 . . . . 0.0 111.9 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -132.99 127.32 33.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.296 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.566 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.9 mt -110.54 117.01 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 6.0 t -98.32 100.58 11.87 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.981 0.419 . . . . 0.0 110.16 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -96.43 71.22 2.71 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.209 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -78.1 -51.9 9.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.246 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.72 123.27 22.96 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.715 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.542 ' O ' HG22 ' A' ' 167' ' ' THR . 61.1 m -125.97 176.5 6.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.948 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 168' ' ' GLY . 1.0 OUTLIER -93.12 -30.18 15.39 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.472 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 3.5 p80 -51.18 -21.13 1.83 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.732 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.6 t -90.38 -28.24 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.763 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 101.7 20.05 14.06 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.59 169.56 9.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 110.733 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -52.33 -35.07 49.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.304 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -177.39 -165.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.0 OUTLIER -94.85 140.25 30.18 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.4 tpt -119.17 120.87 38.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 109.909 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mt -122.58 103.62 8.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.982 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -88.19 127.81 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.355 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mp -111.24 149.84 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.298 0.57 . . . . 0.0 110.775 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.72 134.77 37.52 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.951 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.1 mt -94.58 145.76 24.6 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.945 0.403 . . . . 0.0 110.686 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.512 ' O ' ' ND2' ' A' ' 180' ' ' ASN . 92.0 mt-30 -139.69 -179.4 5.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.97 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 179' ' ' GLN . 27.9 m120 -148.57 25.42 0.96 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.792 0.33 . . . . 0.0 110.469 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 180' ' ' ASN . 69.0 m-20 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.549 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.441 HMC3 ' CE1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 40' ' ' LYS . 68.1 mttm -68.78 124.95 25.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.489 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 4' ' ' ILE . . . -172.47 167.32 40.21 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 3' ' ' GLY . 0.3 OUTLIER 92.45 -27.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.921 0.889 . . . . 0.0 108.981 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.23 -62.1 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.852 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -58.71 -29.51 66.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.702 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -61.73 -60.86 3.03 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.211 0.529 . . . . 0.0 111.48 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.4 -27.39 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.431 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 tp -70.87 -42.4 70.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.351 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.525 ' OE2' ' CE2' ' A' ' 36' ' ' TYR . 4.1 mt-10 -56.6 -39.64 73.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.497 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -60.97 -52.61 64.28 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.166 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 14.4 tpt -53.18 -41.39 65.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.983 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.06 -34.66 55.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.74 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 10' ' ' GLU . 41.6 t -63.13 -22.28 30.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 0.0 110.068 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.17 -34.5 19.01 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.259 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -85.77 -76.94 0.31 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.544 ' SG ' HD21 ' A' ' 58' ' ' LEU . 72.0 m -89.77 -19.11 25.12 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.385 0.612 . . . . 0.0 110.627 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.02 175.14 29.13 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.7 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.5 ttt -69.91 -26.96 64.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.888 -1.156 . . . . 0.0 110.67 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.6 m -64.34 -42.95 95.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.045 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -35.89 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.41 ' O ' HD13 ' A' ' 25' ' ' LEU . 51.0 t-105 -51.21 -46.04 62.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -69.68 -31.74 69.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.083 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -65.24 -51.39 61.21 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.8 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.21 -20.17 41.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.93 0.395 . . . . 0.0 110.69 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.8 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.1 tt -76.27 -47.75 22.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.381 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -70.57 -24.41 62.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.67 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -80.35 -40.14 27.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.51 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 73.9 m80 -96.99 -85.45 0.35 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.305 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.547 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -49.67 161.27 0.53 Allowed Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.529 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 37.6 Cg_endo -64.38 152.09 82.88 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.624 2.216 . . . . 0.0 112.196 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' O ' ' NH1' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -81.75 -10.97 59.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.194 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.49 -36.05 68.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.367 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 32' ' ' LYS . 88.0 mtm-85 52.46 72.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.619 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.5 t -146.31 69.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.087 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.525 ' CE2' ' OE2' ' A' ' 10' ' ' GLU . 52.3 p90 -127.64 155.0 44.59 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.621 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.603 HG23 ' H ' ' A' ' 39' ' ' ALA . 1.4 m -140.23 175.78 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.991 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -84.48 33.73 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.776 0.322 . . . . 0.0 110.788 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.603 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -171.35 52.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.848 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.577 ' CG ' HG22 ' A' ' 37' ' ' VAL . 20.0 mmtt -139.49 173.82 11.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.077 0.465 . . . . 0.0 110.62 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 42' ' ' TYR . 77.3 p -50.65 -105.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.223 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 41' ' ' SER . 74.8 m-85 56.43 116.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.05 141.86 52.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.788 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.518 ' OE1' ' NH2' ' A' ' 136' ' ' ARG . 23.0 pt-20 -73.79 -23.31 59.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.778 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p -60.29 -29.41 68.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.054 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -59.7 -36.63 76.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.727 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -51.12 -56.94 10.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.028 0.442 . . . . 0.0 110.794 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -39.61 -43.34 1.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.659 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 m -72.25 -30.58 65.01 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.082 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 47' ' ' LEU . 13.3 mt -72.36 -54.84 15.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.156 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -55.65 -24.09 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.727 178.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.653 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.4 tt0 -77.51 -40.56 42.42 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.477 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.51 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 55.2 m-20 -59.42 -56.2 25.02 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.92 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 p -57.56 -37.68 59.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.917 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.18 -38.92 88.23 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.2 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -62.79 -32.31 73.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -72.35 -43.63 63.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.544 HD21 ' SG ' ' A' ' 17' ' ' CYS . 27.6 mt -80.71 -8.13 59.56 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.839 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.96 51.49 8.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.628 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.429 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 22.3 mmt -130.8 149.39 73.51 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.392 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.79 139.42 80.17 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.461 1.441 . . . . 0.0 111.096 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.653 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.3 tt -54.66 -28.81 19.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.851 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -73.91 -29.99 62.34 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.438 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -79.1 -35.61 42.0 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.745 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' A' ' 55' ' ' ALA . 79.4 t -63.65 -59.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -49.1 -38.89 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.611 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.454 ' N ' HG13 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -54.28 -45.57 72.53 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.82 -55.82 17.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.296 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -44.78 -29.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.976 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.88 -59.38 8.68 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -49.49 -48.24 48.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.922 0.391 . . . . 0.0 110.127 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 52.1 m-85 -60.15 -39.85 87.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.704 0.764 . . . . 0.0 110.687 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.1 tp -59.61 -38.27 80.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.815 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 30.6 t80 -69.54 -39.02 77.73 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.159 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.579 ' ND2' ' NE2' ' A' ' 152' ' ' HIS . 6.0 m120 -55.89 -70.55 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.69 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.81 -47.87 30.62 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.474 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.436 HD21 HG21 ' A' ' 4' ' ' ILE . 51.6 mt -50.64 -44.22 57.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.041 0.421 . . . . 0.0 111.765 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -55.78 -26.01 43.9 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.405 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.0 t -74.89 -55.1 6.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.05 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -73.37 -36.67 66.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.797 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -97.17 25.25 5.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.777 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 31.5 m -52.51 -38.1 58.91 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -58.62 -34.13 70.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.868 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 105' ' ' GLU . 2.9 t -81.6 -19.65 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.669 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.459 ' C ' ' N ' ' A' ' 87' ' ' LYS . 38.6 t -71.5 -43.6 71.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.949 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -51.5 -12.7 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.069 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' N ' ' C ' ' A' ' 85' ' ' VAL . 41.9 mmtm -69.09 -29.46 67.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.822 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 18.8 p90 -120.49 122.53 40.84 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.136 0.493 . . . . 0.0 111.328 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -87.29 -0.76 57.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.514 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 153' ' ' PHE . 45.7 t0 -162.31 165.58 26.41 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.583 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.4 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 72.8 t80 -57.04 -42.2 80.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.219 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.0 m -63.24 -59.34 4.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.46 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.1 m -46.81 -37.39 8.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.253 0.549 . . . . 0.0 110.649 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.545 HD12 ' CD2' ' A' ' 88' ' ' PHE . 4.4 tt -64.25 -44.36 92.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.431 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.4 t -66.77 -39.37 83.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.405 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 6.9 ptm -86.9 -1.43 57.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -113.43 -16.23 8.36 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.746 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.566 ' HA ' HD13 ' A' ' 102' ' ' ILE . 9.4 mt -34.26 -82.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 117.809 0.804 . . . . 0.0 111.712 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -45.17 -53.5 8.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.146 0.498 . . . . 0.0 110.915 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -46.99 -89.19 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.616 HG23 HD12 ' A' ' 102' ' ' ILE . 3.8 m -70.04 -49.84 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.616 HD12 HG23 ' A' ' 101' ' ' VAL . 3.8 mp -67.29 -39.5 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.586 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.47 -57.62 11.03 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.4 tp -47.68 -54.67 11.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.136 0.493 . . . . 0.0 110.185 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.423 ' HG2' HG22 ' A' ' 84' ' ' VAL . 34.5 tp10 -52.59 -46.52 66.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.775 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.509 ' CG1' ' CE1' ' A' ' 111' ' ' HIS . 24.7 t -52.66 -54.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -45.09 -43.46 9.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.749 0.309 . . . . 0.0 110.666 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.512 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 63.5 mmtt -58.36 -36.31 73.28 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 106' ' ' VAL . 53.7 mt -71.21 -19.58 62.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.988 0.423 . . . . 0.0 109.892 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.512 ' CD2' ' O ' ' A' ' 108' ' ' LYS . 69.8 m-85 58.17 116.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.049 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.632 ' ND1' ' N ' ' A' ' 112' ' ' GLU . 1.2 p-80 -166.28 -37.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.272 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.632 ' N ' ' ND1' ' A' ' 111' ' ' HIS . 40.7 tt0 -173.39 73.56 0.38 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.049 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -46.07 162.91 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.914 2.41 . . . . 0.0 112.54 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.2 m 65.66 79.24 0.25 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.874 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 116' ' ' PRO . 17.5 mt -79.24 144.25 62.11 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.038 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 115' ' ' LEU . 92.9 Cg_exo -43.12 175.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.135 1.89 . . . . 0.0 112.666 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -80.98 118.07 22.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.439 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.28 129.74 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -136.66 121.32 18.46 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.939 0.399 . . . . 0.0 111.726 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.35 123.48 5.73 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' A' ' 122' ' ' LEU . 37.9 tt0 -115.73 160.92 19.45 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.823 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -107.89 145.57 33.56 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.45 160.48 41.64 Favored Pre-proline 0 N--CA 1.468 0.461 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -72.8 -44.57 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.578 2.185 . . . . 0.0 113.247 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.676 HD21 ' NE2' ' A' ' 127' ' ' GLN . 47.7 p-10 -74.58 45.46 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.184 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.3 m120 44.99 60.72 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 0.0 111.102 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.676 ' NE2' HD21 ' A' ' 125' ' ' ASN . 21.8 mt-30 -136.72 158.83 43.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.913 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.6 mt -138.85 118.56 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.16 122.5 33.85 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.389 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.3 tp -115.42 136.24 53.29 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.111 0.481 . . . . 0.0 110.726 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -122.58 123.17 40.58 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.409 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -125.75 115.01 19.39 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.257 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.74 122.15 36.65 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 136' ' ' ARG . 1.9 p -174.91 151.17 1.38 Allowed Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.367 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.7 20.5 0.38 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.027 1.818 . . . . 0.0 110.878 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.526 ' C ' ' H ' ' A' ' 138' ' ' LEU . 65.5 mtp85 -93.04 105.07 17.22 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.341 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -68.78 16.32 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.054 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.614 ' N ' HD22 ' A' ' 138' ' ' LEU . 2.9 mm? -82.86 15.12 2.84 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.651 0.262 . . . . 0.0 110.395 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 93.6 m -41.41 -54.75 3.0 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 111.58 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -47.96 -30.26 4.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.935 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 138' ' ' LEU . 5.3 t -71.11 -44.59 65.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.772 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.66 -47.28 15.0 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.407 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -64.59 -48.86 73.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.349 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.74 -49.12 35.26 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 31.2 mt -59.16 -53.93 52.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.602 0.239 . . . . 0.0 111.507 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 31.3 mt -54.62 -55.66 27.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.947 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.585 ' CE2' HD12 ' A' ' 159' ' ' ILE . 19.6 m-85 -51.43 -47.78 62.9 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.862 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.01 -52.0 54.95 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.08 -59.83 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.926 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.85 -49.9 47.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -52.03 -50.1 62.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.565 0.221 . . . . 0.0 111.323 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.579 ' NE2' ' ND2' ' A' ' 75' ' ' ASN . 43.4 m80 -48.87 -49.35 40.02 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.826 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.526 ' CE2' ' OD1' ' A' ' 90' ' ' ASP . 64.7 t80 -85.43 35.68 0.61 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.949 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 39.22 55.17 2.21 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.056 0.455 . . . . 0.0 110.983 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.521 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 50.5 tp60 -130.5 141.79 50.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.521 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 30.9 mtmm -113.84 123.25 49.36 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.844 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.4 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 28.9 pt -133.3 172.45 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.65 0.738 . . . . 0.0 112.347 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -136.58 126.77 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.566 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.585 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.1 mt -111.51 120.35 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.685 0.278 . . . . 0.0 110.61 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.6 t -105.38 112.36 25.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.821 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.559 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 18.5 p80 -101.0 74.79 1.63 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.651 0.739 . . . . 0.0 111.503 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -76.21 -29.3 57.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.805 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.04 109.13 20.93 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.529 ' O ' HG22 ' A' ' 167' ' ' THR . 13.4 t -111.88 177.0 4.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.84 0.353 . . . . 0.0 110.417 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.44 ' N ' ' SG ' ' A' ' 164' ' ' CYS . 81.1 mtp -91.37 -28.26 17.82 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -53.62 -22.8 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.957 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.4 t -88.76 -28.15 20.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.466 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.59 20.35 15.22 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.099 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.03 163.14 17.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.722 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -49.44 -34.31 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.344 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 171' ' ' HIS . 8.0 p80 -172.25 -170.84 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.2 m -93.65 140.4 29.68 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 tpt -122.87 114.67 20.79 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -119.05 105.59 11.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.826 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.53 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -88.17 125.77 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.344 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.17 149.35 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.258 0.552 . . . . 0.0 110.385 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.499 ' OE2' ' N ' ' A' ' 178' ' ' LEU . 9.3 tp10 -136.47 135.47 38.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.993 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.499 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 13.0 mt -96.14 150.44 20.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.77 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -140.11 175.54 9.51 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.041 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 56.05 44.51 25.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 62.1 t0 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.534 -179.984 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.62 ' H2 ' ' NE ' ' A' ' 34' ' ' ARG . 15.8 mmt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.69 ' H ' ' CD ' ' A' ' 34' ' ' ARG . 78.9 mttt 58.94 149.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.469 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.07 172.09 29.03 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.42 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.441 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.9 tp -78.65 -37.67 21.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.81 0.338 . . . . 0.0 110.39 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.4 mm -60.77 -45.24 98.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.612 ' CE1' ' NH2' ' A' ' 34' ' ' ARG . 91.0 m-85 -70.99 -26.39 63.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.211 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -67.61 -53.23 29.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.016 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.35 -31.83 55.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.072 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.506 HD13 ' CE2' ' A' ' 69' ' ' PHE . 31.3 tp -71.86 -42.03 67.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.694 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.2 tt0 -54.28 -43.92 71.46 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.566 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -61.02 -51.14 70.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.326 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.615 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 58.2 mtm -54.01 -43.26 69.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.79 -36.43 75.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.666 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 10' ' ' GLU . 47.3 t -61.7 -25.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.265 0.555 . . . . 0.0 110.143 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.97 -34.45 22.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.199 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -84.33 -75.56 0.34 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.454 ' SG ' HD21 ' A' ' 58' ' ' LEU . 94.8 m -92.78 -22.88 19.08 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.199 0.524 . . . . 0.0 110.935 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.8 171.23 22.63 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.806 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 30.3 ttm -66.91 -27.45 67.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.707 -1.246 . . . . 0.0 110.292 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -63.25 -42.85 99.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.221 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.82 -35.56 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.418 ' CZ2' HD12 ' A' ' 26' ' ' LEU . 51.1 t-105 -53.42 -44.74 69.03 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.98 -28.13 64.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.09 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -66.27 -51.17 60.1 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -83.47 -18.88 37.06 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.705 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 25' ' ' LEU . 9.0 tt -78.1 -70.66 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.581 ' N ' HD23 ' A' ' 26' ' ' LEU . 87.0 tt0 -49.58 -22.31 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.995 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 tttp -80.94 -37.27 29.75 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 26' ' ' LEU . 21.8 m80 -97.72 -81.79 0.43 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.893 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -81.96 154.05 69.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.79 150.93 74.35 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.193 1.929 . . . . 0.0 111.556 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -59.44 -29.0 67.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.837 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.96 -9.41 55.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.679 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.69 ' CD ' ' H ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -73.45 69.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.448 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.537 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 4.3 p -174.53 85.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.44 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 57.2 m-85 -160.24 -114.96 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.404 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.455 HG21 ' HG2' ' A' ' 40' ' ' LYS . 19.2 m -47.19 179.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 111.603 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 m -154.04 47.91 0.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.412 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.51 -4.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.599 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.455 ' HG2' HG21 ' A' ' 37' ' ' VAL . 6.6 mmpt? -77.38 -167.58 0.95 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.532 0.682 . . . . 0.0 110.675 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.8 p -90.15 152.26 21.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.6 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 2' ' ' LYS . 14.0 p90 -175.7 151.22 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.836 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 46' ' ' GLU . . . -92.43 123.67 35.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.336 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 136' ' ' ARG . 95.4 mt-10 -75.61 -10.4 59.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.508 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.4 m -55.57 -40.46 72.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.75 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 43' ' ' ALA . 39.3 mp0 -63.58 -30.64 71.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.634 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.43 -57.21 7.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 110.559 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.406 ' CZ ' HD12 ' A' ' 138' ' ' LEU . 78.9 m-85 -38.36 -43.81 0.85 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.122 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 m -74.32 -30.13 61.92 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.092 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.7 mt -72.96 -51.76 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.152 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -58.05 -26.0 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.816 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.659 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.5 tt0 -77.18 -41.36 41.86 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.682 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -58.77 -56.35 23.39 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.725 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.486 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 7.2 p -57.67 -34.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.066 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.54 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -67.44 -35.45 79.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.73 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -60.21 -47.76 84.59 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.21 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.721 HH22 HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -69.09 -39.79 78.8 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.663 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.454 HD21 ' SG ' ' A' ' 17' ' ' CYS . 84.6 mt -70.59 -10.8 60.18 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.091 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.5 t30 56.87 50.12 12.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.28 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.405 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 55.8 mmm -128.74 148.58 69.15 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.32 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.48 138.04 63.16 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.462 1.441 . . . . 0.0 111.028 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.659 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.8 tt -52.09 -29.3 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.291 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -72.35 -34.38 67.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.148 0.499 . . . . 0.0 111.482 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -75.61 -32.46 60.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.068 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.54 HG21 ' HB2' ' A' ' 55' ' ' ALA . 93.1 t -71.1 -56.31 11.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -53.01 -44.23 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.348 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' N ' HG13 ' A' ' 66' ' ' VAL . 36.0 mtpt -51.7 -50.44 60.49 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.27 -52.11 66.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.529 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.506 ' CE2' HD13 ' A' ' 9' ' ' LEU . 7.3 m-30 -46.91 -28.07 1.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.373 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.84 -48.21 42.92 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -55.05 -52.22 63.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.888 0.375 . . . . 0.0 110.635 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.615 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 57.7 m-85 -59.79 -42.17 92.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.695 0.76 . . . . 0.0 110.842 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.9 tp -53.36 -38.15 63.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.621 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 22.6 t80 -70.94 -42.45 69.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.233 0.539 . . . . 0.0 109.746 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -54.34 -72.83 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.653 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.06 -47.6 20.1 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.298 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.4 mt -50.71 -42.0 56.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.99 0.395 . . . . 0.0 112.013 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -54.95 -25.43 29.47 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.362 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.4 t -74.03 -55.94 5.52 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.928 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.684 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -71.24 -42.44 68.86 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.05 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -92.92 28.54 2.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.077 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 42.8 m -54.81 -38.45 67.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.015 0.436 . . . . 0.0 109.992 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.64 -34.78 73.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.235 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.23 -20.9 12.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.8 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 87' ' ' LYS . 38.9 t -69.9 -40.93 79.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.139 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -53.03 -14.0 0.53 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.408 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.408 ' N ' ' C ' ' A' ' 85' ' ' VAL . 21.6 mmtp -68.69 -29.6 68.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.034 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 15.8 p90 -119.75 121.27 38.79 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.171 0.51 . . . . 0.0 111.235 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -86.71 2.4 48.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.167 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 45.0 t0 -167.2 162.46 15.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.183 0.516 . . . . 0.0 111.522 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.45 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 80.0 t80 -51.49 -49.88 60.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.953 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.6 m -55.11 -58.34 8.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.519 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.5 t -46.73 -40.69 13.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.126 0.488 . . . . 0.0 111.217 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.443 HD12 ' CD2' ' A' ' 88' ' ' PHE . 5.0 tt -63.56 -43.92 95.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.396 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.6 t -64.3 -39.1 84.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.396 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 8.9 ptm -87.99 -1.09 57.78 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -114.08 -17.46 7.27 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 119.398 -0.668 . . . . 0.0 112.843 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.518 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.1 mt -28.12 -104.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 117.735 0.768 . . . . 0.0 112.494 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -39.6 -49.12 2.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.039 0.447 . . . . 0.0 111.341 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -45.08 -86.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.567 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -72.44 -52.61 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.567 ' N ' HG23 ' A' ' 101' ' ' VAL . 3.0 mp -62.23 -47.99 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.38 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.34 -53.08 48.74 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.4 tp -49.32 -50.86 37.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -55.46 -44.88 76.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.134 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.95 -53.7 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 110' ' ' TYR . 6.0 t-20 -45.65 -44.56 13.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.666 0.27 . . . . 0.0 110.958 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -62.02 -36.12 80.61 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.399 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.496 ' O ' HD23 ' A' ' 109' ' ' LEU . 3.4 tt -65.79 -52.98 46.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.451 ' CG ' ' N ' ' A' ' 111' ' ' HIS . 17.6 t80 -98.68 -165.55 1.25 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.394 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.531 ' CG ' ' N ' ' A' ' 112' ' ' GLU . 86.1 t60 -61.1 -108.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.432 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.531 ' N ' ' CG ' ' A' ' 111' ' ' HIS . 33.0 mt-10 -150.91 62.88 5.44 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.708 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -83.85 148.79 12.34 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.951 2.434 . . . . 0.0 112.189 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.8 t -87.87 120.14 28.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.052 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 116' ' ' PRO . 14.7 mt -81.56 152.62 70.11 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.653 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 115' ' ' LEU . 80.2 Cg_exo -41.72 170.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.273 1.982 . . . . 0.0 112.272 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -88.06 110.55 20.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.131 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.8 mt -124.07 126.82 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.586 0.231 . . . . 0.0 111.108 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -130.98 117.25 18.94 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.534 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.3 151.16 18.43 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.408 ' C ' HD22 ' A' ' 122' ' ' LEU . 91.7 mt-30 -140.77 161.02 38.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 110.125 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.791 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.2 mm? -109.29 143.37 38.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.847 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.07 160.58 40.43 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.32 -46.09 0.39 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.623 2.215 . . . . 0.0 113.25 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.586 ' N ' HD22 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -72.95 45.19 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.204 -179.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 44.65 63.38 1.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.424 0.631 . . . . 0.0 111.023 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.469 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 77.3 mt-30 -139.52 158.57 43.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.912 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.6 mt -138.5 117.59 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.68 122.3 31.97 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.655 -0.418 . . . . 0.0 109.988 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.3 tp -119.26 133.35 55.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.052 0.453 . . . . 0.0 111.456 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -116.94 122.56 44.62 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.415 ' OH ' ' C3A' ' A' ' 182' ' ' HEM . 40.6 t80 -127.94 126.35 41.29 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.558 0.218 . . . . 0.0 111.329 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.05 120.24 22.11 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 m -132.57 153.08 81.01 Favored Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.628 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.48 -37.49 2.39 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.324 2.016 . . . . 0.0 112.235 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.566 ' NH2' ' CGA' ' A' ' 182' ' ' HEM . 93.9 mtm-85 -74.54 -13.18 60.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.151 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.524 ' C ' ' H ' ' A' ' 139' ' ' CYS . 52.1 mtt-85 63.53 29.01 15.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.406 HD12 ' CZ ' ' A' ' 48' ' ' PHE . 3.1 tp -73.94 24.58 0.08 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.234 0.54 . . . . 0.0 110.209 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.524 ' H ' ' C ' ' A' ' 137' ' ' ARG . 3.5 m -44.5 -49.25 10.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.69 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -44.23 -42.29 6.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.937 0.399 . . . . 0.0 110.58 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.3 t -63.76 -42.02 97.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.191 0.519 . . . . 0.0 109.61 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.6 -52.48 10.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.666 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -58.99 -50.98 72.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.471 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.24 -44.97 34.94 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.8 mt -62.78 -52.52 62.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.659 0.266 . . . . 0.0 111.48 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.9 mt -55.45 -57.09 13.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.854 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.57 ' CE2' HD12 ' A' ' 159' ' ' ILE . 26.6 m-85 -50.75 -47.78 59.33 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.767 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.06 -51.33 58.98 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.05 -59.75 2.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.867 0.365 . . . . 0.0 110.749 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -50.45 -52.02 41.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -50.77 -47.29 59.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.667 0.27 . . . . 0.0 111.015 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -49.48 -49.71 44.46 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.516 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 69.4 t80 -88.31 38.49 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.891 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 38.26 56.58 1.72 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 111.253 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.686 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 41.7 tp60 -129.74 141.12 50.94 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.686 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 60.7 mmtt -113.07 124.94 53.77 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.89 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.45 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 9.0 pt -137.96 171.86 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.633 0.73 . . . . 0.0 111.853 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -135.56 127.35 29.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.406 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.57 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.8 mt -110.53 118.38 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.0 t -100.98 105.48 16.7 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.479 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.548 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 18.2 p80 -102.58 75.67 1.46 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.553 0.692 . . . . 0.0 111.951 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -76.57 -29.14 56.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.456 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.7 103.94 15.65 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.586 ' O ' ' N ' ' A' ' 166' ' ' HIS . 38.7 t -132.45 112.71 12.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.662 0.267 . . . . 0.0 110.803 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 8.0 tpt -37.65 -18.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.102 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.586 ' N ' ' O ' ' A' ' 164' ' ' CYS . 57.4 t-80 -54.66 -25.93 30.05 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.487 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.0 t -86.37 -44.42 12.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.096 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 167' ' ' THR . . . 146.55 15.42 0.16 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.303 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.499 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -71.18 157.63 37.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.628 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -74.67 -5.09 41.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.612 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -176.08 -149.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.467 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 3.4 m -131.77 146.26 52.05 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.197 0.522 . . . . 0.0 111.59 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 10.6 tpp -119.56 124.11 45.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.277 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -126.95 105.32 8.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.411 0.624 . . . . 0.0 111.379 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -92.46 127.06 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.403 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 177' ' ' GLU . 5.1 mp -110.32 151.64 12.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.29 0.567 . . . . 0.0 110.902 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.413 ' N ' HG22 ' A' ' 176' ' ' ILE . 52.0 mt-10 -139.45 137.24 35.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.294 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.2 mt -90.6 142.5 27.68 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.351 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -156.07 82.36 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.35 0.595 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -56.12 -33.43 65.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.478 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 58.0 t0 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.617 -179.998 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.566 ' CGA' ' NH2' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.9 ttm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.524 ' O ' ' CE1' ' A' ' 42' ' ' TYR . 12.8 ptpt -170.2 108.43 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.539 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . -73.56 19.54 1.48 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.553 HD13 ' NE ' ' A' ' 80' ' ' ARG . 2.5 tp -48.66 -43.3 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.025 0.44 . . . . 0.0 109.857 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 mm -58.56 -47.88 87.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -73.77 -21.72 60.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 3' ' ' GLY . 42.5 t-20 -66.98 -50.42 62.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.762 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.02 -39.68 81.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.197 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.7 tp -63.49 -40.73 97.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -55.62 -46.43 77.36 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.639 -0.424 . . . . 0.0 109.892 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -61.19 -50.72 71.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.997 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.7 OUTLIER -52.49 -40.57 62.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.6 t -71.4 -34.74 54.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.551 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.9 t -61.62 -23.66 31.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.253 0.549 . . . . 0.0 109.95 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.82 -34.47 21.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.098 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -84.31 -75.74 0.33 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.518 ' SG ' HD21 ' A' ' 58' ' ' LEU . 95.5 m -92.49 -20.82 20.58 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.189 0.518 . . . . 0.0 110.964 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.87 170.84 25.36 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.821 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.3 ttt -66.84 -27.09 67.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.926 -1.137 . . . . 0.0 110.444 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -63.7 -42.53 97.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.052 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.21 -35.07 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 -51.83 -45.29 63.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -73.95 -28.86 61.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.329 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -67.54 -50.3 59.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.939 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.33 -26.57 35.5 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.69 0.281 . . . . 0.0 110.553 -179.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.939 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.7 tt -70.08 -71.8 0.22 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.439 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.74 ' N ' HD23 ' A' ' 26' ' ' LEU . 82.4 tt0 -50.51 -23.34 2.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.543 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.38 -42.99 21.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -105.82 -88.9 0.44 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.96 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.597 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -43.63 161.99 0.19 Allowed Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.464 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 90.7 Cg_exo -35.02 156.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.918 2.412 . . . . 0.0 112.286 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 10.4 ptmm? -64.5 -48.34 75.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.722 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 32' ' ' LYS . 56.9 m-20 -162.34 19.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.743 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -75.95 -36.86 59.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.74 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.527 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 12.6 p -82.3 129.82 36.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.757 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.527 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 9.1 m-85 -173.4 -172.83 0.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.06 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.713 HG23 ' H ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER 33.08 -160.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.962 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.6 ' N ' HG23 ' A' ' 37' ' ' VAL . 2.0 m -128.0 37.33 4.19 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.009 0.433 . . . . 0.0 110.566 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.713 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -154.8 7.26 0.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.736 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.468 ' HG3' HG22 ' A' ' 37' ' ' VAL . 11.5 mmtt -93.67 172.71 8.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.807 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.8 t -78.97 147.44 32.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.655 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.532 ' CE2' ' OE2' ' A' ' 44' ' ' GLU . 6.1 p90 -161.69 158.5 26.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.053 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.84 132.87 36.13 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.549 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.532 ' OE2' ' CE2' ' A' ' 42' ' ' TYR . 17.1 mm-40 -82.3 -34.09 28.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.863 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.1 t -79.36 -36.31 39.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.504 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -56.62 -36.91 70.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.138 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -40.84 -56.4 2.22 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.895 0.379 . . . . 0.0 111.056 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -39.43 -40.41 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.18 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.2 t -72.15 -34.57 68.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.225 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.9 mp -67.78 -54.9 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.28 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.407 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -55.52 -23.95 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.784 178.703 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.691 ' HG3' HD12 ' A' ' 62' ' ' ILE . 1.8 tt0 -76.05 -40.2 53.87 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.097 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.558 ' OD2' HD23 ' A' ' 25' ' ' LEU . 47.7 m-20 -60.26 -56.86 16.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.408 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.82 -36.76 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.87 87.5 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.174 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -63.52 -31.0 72.03 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.62 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -73.96 -42.94 59.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.619 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.518 HD21 ' SG ' ' A' ' 17' ' ' CYS . 25.9 mt -80.7 -7.11 59.23 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.879 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 56.22 49.23 15.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.556 0.693 . . . . 0.0 109.207 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mmt -127.73 149.75 71.32 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.967 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.99 137.73 63.87 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.451 1.434 . . . . 0.0 110.978 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.691 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.1 tt -51.28 -29.48 8.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.776 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -71.24 -30.13 65.96 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.143 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -78.41 -34.03 48.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.112 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.1 t -70.04 -56.41 11.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 67' ' ' LYS . 11.7 p -52.93 -41.39 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.248 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.512 ' N ' HG13 ' A' ' 66' ' ' VAL . 30.9 mtpt -53.25 -49.28 67.18 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.52 91.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.656 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -53.12 -33.07 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.566 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.05 -50.48 60.31 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.98 -50.31 66.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.064 0.459 . . . . 0.0 110.222 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -59.81 -42.58 93.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.632 0.729 . . . . 0.0 110.781 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.4 tp -56.37 -38.93 72.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.314 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 20.1 t80 -68.37 -43.77 76.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.369 0.604 . . . . 0.0 109.503 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.75 -71.65 0.08 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.289 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.11 -39.65 27.24 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.926 -178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.6 mt -61.81 -39.23 91.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.412 0.606 . . . . 0.0 112.027 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.94 -24.68 39.48 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.232 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.6 p -77.11 -53.84 7.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.438 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.553 ' NE ' HD13 ' A' ' 4' ' ' ILE . 1.1 mtm105 -68.75 -49.75 56.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.159 0.504 . . . . 0.0 110.343 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.608 ' CD2' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -83.72 22.75 1.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.444 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.4 m -49.38 -38.08 27.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.654 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -62.35 -35.85 80.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.721 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.608 HG21 ' CD2' ' A' ' 81' ' ' HIS . 3.6 t -83.58 -17.88 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.426 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 87' ' ' LYS . 56.1 t -65.24 -38.04 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.807 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -57.93 -6.41 0.56 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.769 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 105' ' ' GLU . 30.0 mmtp -76.71 -25.72 53.88 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.59 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.481 ' C ' ' H ' ' A' ' 90' ' ' ASP . 26.9 p90 -129.18 -45.77 1.24 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.707 0.289 . . . . 0.0 111.006 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 19.1 t70 58.16 -0.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.534 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.523 ' OD1' ' CE1' ' A' ' 153' ' ' PHE . 34.0 m-20 -152.07 164.63 36.84 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.35 0.595 . . . . 0.0 111.237 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -66.12 -61.25 2.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.7 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.6 m -50.82 -53.16 34.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.716 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.4 m -59.75 -35.79 75.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.309 0.576 . . . . 0.0 110.976 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.476 HD21 ' CBB' ' A' ' 182' ' ' HEM . 3.1 tt -66.36 -47.97 71.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.956 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 90.2 t -60.92 -36.31 71.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.394 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -88.8 -5.85 57.78 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.134 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -110.88 -15.14 11.18 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.476 -0.625 . . . . 0.0 112.78 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.665 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.1 mt -28.87 -104.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 117.568 0.684 . . . . 0.0 112.703 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.401 ' H ' ' HB ' ' A' ' 98' ' ' ILE . 13.6 p-80 -38.62 -48.66 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 0.0 111.54 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -45.71 -87.27 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.599 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.5 m -71.17 -52.1 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.665 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.1 mp -60.99 -47.25 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.452 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.05 -55.6 28.69 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.5 tp -47.88 -50.03 27.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.125 0.488 . . . . 0.0 110.358 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 84' ' ' VAL . 42.8 tp10 -55.71 -44.76 77.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.407 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.28 -52.15 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -49.37 -44.14 44.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.034 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -59.53 -35.03 73.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.432 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.5 mt -77.68 13.34 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.458 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 111' ' ' HIS . 11.1 m-85 64.5 163.17 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.763 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 110' ' ' TYR . 70.2 m-70 59.84 142.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.614 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 60.2 61.55 3.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.77 -59.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.462 2.108 . . . . 0.0 111.81 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.7 m -82.4 147.04 29.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.175 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 116' ' ' PRO . 17.0 mt -133.73 152.11 78.26 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.426 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 115' ' ' LEU . 98.0 Cg_exo -40.79 170.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.429 2.086 . . . . 0.0 112.701 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -86.1 109.24 18.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.09 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.9 mt -121.69 127.28 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.617 0.246 . . . . 0.0 110.891 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -130.81 113.02 13.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.945 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.99 138.55 15.06 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.437 ' C ' HD12 ' A' ' 122' ' ' LEU . 52.0 tt0 -132.26 158.51 41.63 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 122' ' ' LEU . 10.3 mp -103.44 146.44 28.5 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.47 161.42 39.45 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 126' ' ' ASN . 68.5 Cg_endo -72.77 -45.58 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.552 2.168 . . . . 0.0 113.398 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -72.9 38.49 0.08 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.974 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 124' ' ' PRO . 80.9 m-20 50.44 64.31 1.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.213 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -142.49 163.15 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.992 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.8 mt -137.59 118.09 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.21 120.42 27.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.0 tp -117.53 132.68 56.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.202 0.525 . . . . 0.0 110.952 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -121.22 126.38 49.47 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -129.35 129.77 45.22 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.54 126.82 30.12 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.773 0.321 . . . . 0.0 110.69 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.9 p -163.87 145.47 7.22 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.393 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.35 9.58 1.77 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.921 1.747 . . . . 0.0 110.644 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.482 ' C ' ' H ' ' A' ' 138' ' ' LEU . 94.5 mtt180 -93.91 110.5 22.17 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.169 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.408 ' C ' HD22 ' A' ' 138' ' ' LEU . 55.9 ttt-85 -67.67 38.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.457 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 136' ' ' ARG . 3.3 mm? -99.76 14.16 31.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.936 0.398 . . . . 0.0 110.252 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.0 t -41.68 -53.13 3.68 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.461 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -46.68 -33.64 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.165 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 7.0 t -68.38 -44.38 75.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.04 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.74 -49.99 18.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.907 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -62.13 -50.7 70.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.902 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.39 -42.6 18.81 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 19.7 mt -63.04 -49.82 73.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 111.361 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.4 mt -58.87 -57.61 12.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.574 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.404 ' CE2' HD12 ' A' ' 159' ' ' ILE . 38.3 m-85 -49.58 -48.71 48.53 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.641 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.26 -51.58 57.24 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -42.86 -60.08 1.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.775 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.84 56.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.866 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -49.47 -48.09 47.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.665 0.269 . . . . 0.0 110.956 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -49.56 -49.64 45.56 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.827 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 65.2 t80 -85.69 35.87 0.63 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.348 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 44.25 46.76 7.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.126 0.488 . . . . 0.0 110.553 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.507 HE21 ' H ' ' A' ' 156' ' ' LYS . 51.0 tp60 -127.32 142.65 51.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.507 ' H ' HE21 ' A' ' 155' ' ' GLN . 65.6 mttm -124.65 117.48 24.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.77 ' O ' HD13 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -132.43 163.52 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.365 0.602 . . . . 0.0 111.121 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -118.29 131.95 56.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.404 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.1 mt -110.32 119.35 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.0 m -103.64 114.72 29.2 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.578 0.228 . . . . 0.0 111.311 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.539 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.6 p-80 -96.03 79.01 3.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.512 0.672 . . . . 0.0 111.565 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -82.22 -0.07 43.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.164 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.86 111.12 5.57 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.52 ' O ' HG22 ' A' ' 167' ' ' THR . 13.6 m -114.14 178.79 4.16 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.112 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 168' ' ' GLY . 77.4 mtp -93.9 -28.94 15.55 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.476 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 4.3 p80 -52.77 -21.21 3.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.673 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.8 t -90.06 -28.04 19.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.561 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 99.63 19.9 18.77 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.072 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.38 167.8 9.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 110.792 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -52.15 -33.85 42.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.263 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -174.76 -170.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 1.7 m -94.31 140.34 29.91 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.253 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.6 tpp -118.6 123.61 45.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.26 102.44 6.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.477 0.656 . . . . 0.0 110.86 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -91.52 126.73 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.647 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.405 HG23 ' CG1' ' A' ' 157' ' ' ILE . 4.7 mp -108.51 147.07 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.19 0.519 . . . . 0.0 110.197 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -137.25 135.69 37.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.307 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 21.5 mt -89.8 130.93 35.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.193 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.521 ' O ' ' ND2' ' A' ' 180' ' ' ASN . 25.4 mt-30 -55.84 152.86 9.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.443 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 179' ' ' GLN . 27.4 m120 -148.48 27.37 0.91 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.439 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 61.6 t0 . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.533 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.476 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.439 ' O ' ' O ' ' A' ' 37' ' ' VAL . 65.2 mtm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 3' ' ' GLY . 69.7 mttt -79.73 119.64 22.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.447 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 56.88 133.06 0.01 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.421 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.5 tp -54.16 -40.05 45.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.335 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.2 mm -71.43 -56.08 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.093 0.473 . . . . 0.0 110.29 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -67.3 -18.73 65.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.079 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 3' ' ' GLY . 24.5 t-20 -75.24 -58.87 3.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.408 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 4' ' ' ILE . 51.0 t -52.65 -35.26 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.491 HD13 ' CE2' ' A' ' 69' ' ' PHE . 17.5 tp -73.08 -43.06 62.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.723 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -51.11 -44.71 61.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -60.36 -52.46 65.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.924 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.556 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 92.6 mtp -50.05 -43.63 51.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.131 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.9 t -68.55 -37.29 77.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.95 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.7 -23.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.226 0.536 . . . . 0.0 110.261 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.48 -34.01 18.81 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.262 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -83.81 -77.57 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.1 m -92.43 -19.11 22.38 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.216 0.532 . . . . 0.0 110.627 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.22 -179.38 24.82 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.0 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.1 ttm -72.57 -30.12 64.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.76 -1.22 . . . . 0.0 110.647 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -60.06 -38.81 83.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.872 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -77.69 -38.91 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 59.4 t-105 -54.48 -48.4 71.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.446 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.24 -25.14 57.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.707 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -74.7 -47.0 33.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.679 -0.408 . . . . 0.0 112.039 -178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.966 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.54 -28.13 37.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.313 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.966 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.9 tt -66.82 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.624 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.523 ' N ' HD23 ' A' ' 26' ' ' LEU . 96.0 mt-10 -57.76 -22.98 49.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.089 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -80.94 -44.6 17.98 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.523 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 86.7 m-70 -98.83 -89.2 0.31 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.115 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.45 ' CB ' HH21 ' A' ' 34' ' ' ARG . . . -49.2 153.32 1.71 Allowed Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.542 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.08 150.83 54.84 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.664 2.243 . . . . 0.0 111.928 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' CD ' ' H ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -87.57 -6.84 58.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.192 179.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -63.8 -48.92 74.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.45 HH21 ' CB ' ' A' ' 30' ' ' ALA . 28.2 ptt180 -73.04 131.77 42.53 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.084 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.535 HG22 ' N ' ' A' ' 36' ' ' TYR . 4.7 p -170.61 164.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.393 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.535 ' N ' HG22 ' A' ' 35' ' ' VAL . 30.4 m-85 63.73 -143.3 0.32 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.639 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.572 HG23 ' N ' ' A' ' 38' ' ' SER . 2.5 m 29.59 -157.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 O-C-N 123.806 0.692 . . . . 0.0 112.496 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.572 ' N ' HG23 ' A' ' 37' ' ' VAL . 39.2 m -178.82 -21.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.807 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 40' ' ' LYS . . . -75.82 -27.0 57.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.086 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.456 ' HG2' HG21 ' A' ' 37' ' ' VAL . 7.6 mmpt? -55.14 -166.0 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.396 0.617 . . . . 0.0 110.642 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 42' ' ' TYR . 21.4 t -151.23 -54.35 0.14 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.862 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 44' ' ' GLU . 54.1 m-85 52.63 171.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.917 0.389 . . . . 0.0 110.375 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.61 84.12 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.62 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' TYR . 83.4 tt0 -61.35 -25.95 67.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.665 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 76.4 p -50.22 -27.66 6.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.607 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.23 -30.95 70.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.741 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -39.71 -58.54 1.31 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.978 0.418 . . . . 0.0 110.852 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -38.4 -45.14 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.211 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.3 m -67.96 -35.3 78.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.15 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.1 mp -68.68 -58.34 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 119.979 -0.689 . . . . 0.0 109.32 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -52.12 -21.32 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.993 179.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.671 ' HG3' HD12 ' A' ' 62' ' ' ILE . 1.7 tt0 -79.41 -42.56 25.22 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.196 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.549 ' OD2' HD23 ' A' ' 25' ' ' LEU . 32.7 m-20 -57.95 -57.67 11.78 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.789 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.04 -38.88 69.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.641 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.74 84.91 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.081 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -63.35 -31.32 72.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -74.68 -45.26 45.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.63 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.3 mt -77.08 -6.54 53.2 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.853 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.22 48.17 17.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.51 0.672 . . . . 0.0 109.492 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.8 mmm -126.62 149.5 68.28 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.074 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.36 134.44 45.09 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.454 1.436 . . . . 0.0 111.182 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.671 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.9 tt -48.51 -27.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.06 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -72.56 -33.91 67.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.163 0.506 . . . . 0.0 111.327 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -76.38 -31.8 58.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.227 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.548 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 78.5 t -72.61 -56.18 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -51.46 -43.97 31.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.245 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.53 ' N ' HG13 ' A' ' 66' ' ' VAL . 34.5 mtpt -51.85 -51.73 54.58 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.06 -58.26 8.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.874 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.6 m-30 -44.33 -29.28 0.65 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.527 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.18 -47.75 77.53 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -58.52 -54.19 49.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.02 0.438 . . . . 0.0 110.446 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.556 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 34.8 m-85 -55.12 -40.71 70.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.736 0.779 . . . . 0.0 110.619 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.6 tp -58.68 -38.16 77.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.198 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 34.4 t80 -68.4 -39.49 81.64 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.041 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -57.19 -71.05 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.328 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.11 -39.82 50.49 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.157 -0.474 . . . . 0.0 113.017 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.412 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 17.7 mt -57.53 -47.4 82.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.332 0.566 . . . . 0.0 111.585 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.44 -20.84 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.41 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.409 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.4 t -79.17 -42.28 26.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.105 0.478 . . . . 0.0 110.072 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.46 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.3 mmp_? -65.9 -71.47 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.462 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.486 ' CE1' ' CMC' ' A' ' 182' ' ' HEM . 17.4 p80 -84.16 36.92 0.59 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.831 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 85' ' ' VAL . 26.5 m -51.11 -46.81 61.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.886 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -49.3 -36.66 21.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.248 0.547 . . . . 0.0 109.66 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.788 HG13 ' CD ' ' A' ' 105' ' ' GLU . 11.3 t -76.67 -22.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.999 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 87' ' ' LYS . 57.3 t -68.54 -44.62 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.245 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -54.4 -4.96 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.81 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 85' ' ' VAL . 60.9 mmtt -81.39 -29.46 33.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.009 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -95.21 117.53 30.41 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.255 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 91.2 m-20 -84.98 -15.44 44.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.482 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 89' ' ' ASP . 63.8 m-20 -161.63 172.02 17.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.192 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -59.42 -53.92 52.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.713 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.6 m -53.51 -36.48 61.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.261 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.3 m -64.79 -39.5 93.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.154 0.502 . . . . 0.0 110.491 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.533 HD21 ' CBB' ' A' ' 182' ' ' HEM . 4.2 tt -64.19 -47.58 79.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.509 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.33 -36.14 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.758 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.1 mmm -86.34 -5.3 59.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.445 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.38 -15.69 8.75 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.345 -0.697 . . . . 0.0 113.165 -178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.711 ' HA ' HD13 ' A' ' 102' ' ' ILE . 16.2 mt -28.07 -105.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 117.716 0.758 . . . . 0.0 112.662 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -39.97 -47.55 2.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.092 0.472 . . . . 0.0 111.351 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -47.04 -88.44 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.586 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.0 m -69.77 -51.78 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.4 mp -61.22 -45.61 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.539 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.89 -53.99 40.66 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.577 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 42.8 tp -52.0 -51.55 56.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.86 0.362 . . . . 0.0 110.782 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.788 ' CD ' HG13 ' A' ' 84' ' ' VAL . 34.4 mt-10 -55.48 -45.37 76.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.128 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.2 t -54.07 -52.38 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 110' ' ' TYR . 20.5 t-20 -47.41 -43.48 23.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.858 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.577 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 23.7 mmtm -65.52 -41.54 93.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.788 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.0 tp -63.53 -43.02 98.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.808 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 107' ' ' ASN . 76.5 m-85 -102.77 -177.13 3.29 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.611 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -68.65 -67.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.585 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -172.51 58.7 0.24 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.879 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.18 148.02 30.38 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.669 2.246 . . . . 0.0 111.829 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 58.0 p -80.92 153.06 27.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.587 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.2 mt -128.66 153.6 79.63 Favored Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.949 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.88 167.32 19.91 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.456 2.104 . . . . 0.0 112.139 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -86.3 116.56 24.55 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.759 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.3 mt -134.03 131.51 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.709 0.29 . . . . 0.0 110.682 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -135.41 130.21 34.5 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.659 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -123.4 150.66 16.89 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -138.04 164.71 28.42 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.08 145.09 36.23 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.354 -0.384 . . . . 0.0 109.966 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.35 160.55 41.14 Favored Pre-proline 0 N--CA 1.467 0.377 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.26 -40.11 1.81 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.57 2.18 . . . . 0.0 113.155 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.521 ' ND2' ' OE1' ' A' ' 127' ' ' GLN . 19.8 p30 -78.97 47.44 0.77 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.229 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.9 p30 42.52 61.1 2.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.464 0.65 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.521 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 66.5 mt-30 -137.73 159.44 41.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.895 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.5 mt -135.61 116.52 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.82 122.95 31.41 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.057 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.7 tp -117.66 135.06 54.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.99 0.424 . . . . 0.0 111.168 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -120.01 123.8 44.35 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.456 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -126.15 123.45 38.29 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.566 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.71 130.73 23.21 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.221 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.438 ' H ' ' CG ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -163.1 -179.68 1.06 Allowed Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.214 179.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' A' ' 134' ' ' SER . 24.6 Cg_exo -61.45 -48.74 8.82 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.231 1.954 . . . . 0.0 111.558 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 138' ' ' LEU . 82.8 mtm-85 -124.78 40.84 3.65 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 136' ' ' ARG . 58.1 mtt85 -5.26 -57.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.547 1.154 . . . . 0.0 113.975 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 136' ' ' ARG . 3.3 tp 67.24 30.13 7.32 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 26.4 p -40.55 -50.69 2.97 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.568 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.489 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 90.0 m-85 -43.13 -38.06 2.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 110.114 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 28.6 t -69.08 -45.96 68.96 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -45.64 -49.27 14.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.188 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -57.03 -50.39 72.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.677 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.64 -52.63 40.66 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.9 mt -55.16 -55.38 31.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.798 0.333 . . . . 0.0 110.498 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.3 mt -54.08 -55.75 24.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.564 ' CE2' HD12 ' A' ' 159' ' ' ILE . 6.3 m-85 -49.74 -47.97 50.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.73 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.26 60.21 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.95 -60.53 1.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.844 0.354 . . . . 0.0 110.87 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.61 -49.85 45.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -52.98 -47.64 68.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.083 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -50.06 -50.51 47.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 70.6 t80 -85.55 36.77 0.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.992 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 38.8 55.01 2.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.918 0.389 . . . . 0.0 111.134 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.567 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 48.0 tp60 -129.86 141.24 50.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.567 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 19.9 tptm -110.79 126.54 54.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.128 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.0 pt -137.37 177.04 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.524 0.678 . . . . 0.0 111.837 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -143.84 125.84 15.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.202 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.564 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.4 mt -111.76 120.74 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.624 0.25 . . . . 0.0 110.613 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 m -105.66 115.37 30.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.112 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 17.0 p80 -102.13 72.95 1.34 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.738 0.78 . . . . 0.0 111.526 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -73.63 -30.86 63.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.844 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.67 113.76 27.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.474 ' O ' HG22 ' A' ' 167' ' ' THR . 7.7 t -117.89 -175.38 2.83 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.305 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 165' ' ' MET . 12.6 tmm? -93.8 -25.5 17.36 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -56.09 -23.95 37.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.473 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.6 t -86.54 -25.29 25.14 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.3 21.97 25.91 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.908 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.73 163.18 24.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.025 0.441 . . . . 0.0 110.693 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -45.11 -33.35 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.021 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -176.53 -168.97 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 20.8 t -95.45 141.87 28.48 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.221 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.2 tpt -121.59 119.72 32.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.726 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.98 107.15 11.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.873 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.4 mp -88.98 126.36 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.372 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 177' ' ' GLU . 5.1 mp -111.66 152.48 13.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.135 0.493 . . . . 0.0 110.458 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.421 ' N ' HG22 ' A' ' 176' ' ' ILE . 85.9 tt0 -142.96 141.45 31.43 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.494 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.1 mt -94.0 149.04 21.59 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.877 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.429 ' O ' ' OD1' ' A' ' 180' ' ' ASN . 91.2 mt-30 -142.1 -176.49 4.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.752 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 179' ' ' GLN . 83.3 m-20 -147.87 24.46 1.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.858 0.361 . . . . 0.0 110.41 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.2 t70 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.508 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.533 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' O ' ' O ' ' A' ' 2' ' ' LYS . 10.7 ptp . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.661 ' NZ ' ' HE1' ' A' ' 22' ' ' TRP . 86.7 mttt 57.89 150.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.7 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -41.7 140.81 1.52 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 tp -44.62 -39.51 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.412 -0.394 . . . . 0.0 110.595 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.96 -49.42 81.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 109.788 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -70.11 -23.39 63.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.003 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -68.12 -56.53 8.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.971 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.69 -38.65 76.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.043 0.449 . . . . 0.0 109.847 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.497 HD13 ' CE2' ' A' ' 69' ' ' PHE . 27.5 tp -65.89 -39.73 90.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.558 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -58.03 -43.8 87.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.989 0.423 . . . . 0.0 110.626 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.46 -63.9 1.14 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.361 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.8 ptm -46.19 -41.43 12.69 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.422 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.7 t -64.84 -38.36 82.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.609 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 49.2 t -59.9 -22.74 24.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.498 0.666 . . . . 0.0 109.407 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.76 -34.98 21.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.382 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -84.28 -76.67 0.29 Allowed 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.8 m -91.94 -21.44 20.57 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.294 0.569 . . . . 0.0 110.672 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.81 175.43 23.84 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.05 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.3 ttp -68.85 -28.07 66.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.648 -1.276 . . . . 0.0 110.368 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -61.75 -38.85 89.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.639 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.39 -38.67 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.661 ' HE1' ' NZ ' ' A' ' 2' ' ' LYS . 53.7 t-105 -55.3 -47.57 75.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.048 0.451 . . . . 0.0 110.096 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.04 -24.81 55.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.944 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -74.17 -47.31 36.61 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.93 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.71 -26.51 37.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.986 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.6 tt -73.04 -54.93 7.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.009 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' N ' HD23 ' A' ' 26' ' ' LEU . 82.0 tt0 -61.25 -23.98 66.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.475 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.51 ' NZ ' ' CE1' ' A' ' 29' ' ' HIS . 30.4 tttm -82.37 -39.04 23.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.51 ' CE1' ' NZ ' ' A' ' 28' ' ' LYS . 67.8 m80 -99.86 -88.73 0.34 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.063 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.571 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -52.5 160.03 1.47 Allowed Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.518 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.504 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 67.9 Cg_endo -71.95 149.38 53.13 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.881 2.388 . . . . 0.0 112.139 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -98.77 -15.42 19.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.622 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.517 ' OD2' ' NH1' ' A' ' 34' ' ' ARG . 24.0 p-10 -101.47 -48.65 4.27 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.865 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.517 ' NH1' ' OD2' ' A' ' 33' ' ' ASP . 16.5 mmp_? -67.56 68.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.536 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' ASP . 3.7 p -80.5 138.63 19.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.275 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 2' ' ' LYS . 85.0 m-85 -114.45 164.3 14.16 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.607 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.654 HG22 ' CG ' ' A' ' 40' ' ' LYS . 2.4 m -101.23 167.4 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.962 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 m -73.04 33.43 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.93 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.498 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -158.07 3.09 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.874 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.654 ' CG ' HG22 ' A' ' 37' ' ' VAL . 12.2 mmtt -97.82 -176.08 3.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 110.478 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.0 m -45.46 154.06 0.21 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.295 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.495 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -151.79 64.94 0.86 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.1 0.476 . . . . 0.0 110.362 -179.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.26 102.86 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.295 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 43.7 mp0 -59.75 -24.83 64.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.695 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m -53.44 -41.31 65.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.63 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -67.9 -37.25 81.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.598 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -52.44 -57.54 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.194 0.521 . . . . 0.0 110.771 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -39.0 -42.38 0.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.671 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.8 p -74.53 -30.4 61.76 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.861 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 47' ' ' LEU . 17.9 mt -71.42 -52.96 22.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.745 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.97 -26.31 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.668 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.674 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.2 tt0 -76.53 -41.1 47.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.547 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.574 ' OD2' HD23 ' A' ' 25' ' ' LEU . 48.2 m-20 -59.47 -56.05 26.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.963 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 50' ' ' ILE . 5.9 p -58.35 -37.08 61.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.981 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.53 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.54 -38.28 86.84 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.061 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -63.52 -31.63 72.84 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.6 mmt-85 -73.54 -42.76 61.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.378 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.4 mt -81.54 -7.27 59.56 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.668 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.8 t30 57.02 49.82 13.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.807 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.4 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 25.7 mmt -128.69 149.44 72.03 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.214 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.62 137.76 65.95 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.404 1.403 . . . . 0.0 110.981 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.674 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.5 tt -51.22 -28.5 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.254 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -71.82 -34.2 69.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 0.0 111.58 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -76.17 -31.98 58.82 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.89 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 55' ' ' ALA . 95.9 t -71.08 -56.66 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.521 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -52.56 -43.87 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.372 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' N ' HG13 ' A' ' 66' ' ' VAL . 35.5 mtpt -51.61 -51.06 58.66 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.39 -54.12 50.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.559 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.497 ' CE2' HD13 ' A' ' 9' ' ' LEU . 5.7 m-30 -44.12 -28.94 0.55 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.464 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.91 63.3 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.03 -54.35 48.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.768 0.318 . . . . 0.0 110.461 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -55.28 -41.33 72.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.813 0.816 . . . . 0.0 110.693 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.4 tp -57.95 -38.69 76.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.553 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 26.1 t80 -70.25 -39.53 74.94 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.162 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -55.33 -73.82 0.05 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.091 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.82 -38.21 29.74 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.203 -0.523 . . . . 0.0 112.572 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 20.8 mt -57.45 -46.52 83.52 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.028 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.41 -20.7 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.296 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.0 t -81.46 -41.92 21.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.15 0.5 . . . . 0.0 110.205 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.459 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.3 mmp_? -65.17 -71.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.778 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.459 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 18.5 p80 -85.25 34.61 0.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.985 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.9 m -47.2 -45.2 23.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.817 0.341 . . . . 0.0 110.574 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -54.55 -31.06 55.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 t -80.4 -24.58 11.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.093 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.0 t -62.49 -37.65 79.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.356 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.08 -15.95 2.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.653 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -65.75 -31.22 72.08 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.58 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 15.3 p90 -119.01 115.98 25.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.039 0.447 . . . . 0.0 110.708 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -83.68 -0.64 51.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.283 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 13.8 p-10 -163.11 155.25 18.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.128 0.49 . . . . 0.0 111.569 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -44.86 -52.0 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.876 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 89.7 m -55.01 -43.0 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.752 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -61.77 -36.11 80.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.233 0.54 . . . . 0.0 110.614 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.9 tt -67.05 -56.82 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.858 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.41 ' HA ' HD11 ' A' ' 98' ' ' ILE . 85.3 t -54.55 -38.46 42.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.847 0.356 . . . . 0.0 111.659 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.5 ppp? -88.44 -6.75 57.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -112.27 -14.73 10.43 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 119.712 -0.493 . . . . 0.0 112.909 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.585 ' HA ' HD13 ' A' ' 102' ' ' ILE . 3.8 mt -34.25 -83.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 117.867 0.833 . . . . 0.0 111.705 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -44.76 -54.16 6.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.26 0.553 . . . . 0.0 110.742 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -46.69 -88.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.63 HG23 HD12 ' A' ' 102' ' ' ILE . 3.7 m -71.01 -49.98 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -176.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.63 HD12 HG23 ' A' ' 101' ' ' VAL . 3.7 mp -65.91 -39.79 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.383 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.74 -56.0 14.86 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.65 HD11 ' HZ1' ' A' ' 108' ' ' LYS . 58.7 tp -49.91 -55.97 12.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.972 0.415 . . . . 0.0 110.709 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -52.69 -44.88 66.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.476 -178.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 102' ' ' ILE . 17.8 t -54.13 -53.42 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -47.14 -43.01 20.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.79 0.328 . . . . 0.0 110.827 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.65 ' HZ1' HD11 ' A' ' 104' ' ' LEU . 26.0 mmtm -64.89 -40.36 94.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.572 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.6 tp -59.96 -41.95 93.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.474 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.462 ' CE2' ' O ' ' A' ' 111' ' ' HIS . 58.1 t80 -156.06 157.07 35.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.506 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.462 ' O ' ' CE2' ' A' ' 110' ' ' TYR . 96.9 m-70 -92.87 124.2 36.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.483 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 113' ' ' PRO . 5.6 pt-20 -164.61 152.14 10.24 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.204 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 112' ' ' GLU . 74.1 Cg_exo -37.2 160.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.284 1.99 . . . . 0.0 112.178 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.5 m -58.84 148.71 29.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.668 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 116' ' ' PRO . 17.6 mt -74.57 151.88 87.3 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.189 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 115' ' ' LEU . 79.8 Cg_exo -38.15 162.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.144 1.896 . . . . 0.0 112.227 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -75.85 105.29 6.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.431 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.449 ' CD1' ' N3 ' ' A' ' 184' ' ' IMD . 72.4 mt -123.49 126.34 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.962 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -133.14 121.12 22.14 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.579 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.3 126.97 7.17 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.449 ' C ' HD22 ' A' ' 122' ' ' LEU . 88.6 mt-30 -117.05 166.07 12.62 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.789 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.6 mm? -109.88 130.46 55.52 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.27 160.43 37.56 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.28 178.11 6.47 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.995 1.797 . . . . 0.0 112.127 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.523 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 19.5 t-20 56.6 37.26 28.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.949 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' NE2' ' A' ' 127' ' ' GLN . 8.6 p30 50.0 69.31 0.62 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.614 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 126' ' ' ASN . 82.8 mm-40 -136.85 161.61 35.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.513 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.1 mt -145.07 121.3 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.78 122.33 35.06 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.288 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.0 tp -117.64 134.73 54.57 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.125 0.488 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.688 HH21 ' CD2' ' A' ' 171' ' ' HIS . 58.7 ttt180 -117.56 121.61 41.44 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.477 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.485 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 37.4 t80 -125.74 125.53 43.14 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.531 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.31 123.75 23.38 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.408 ' OG ' ' NH1' ' A' ' 136' ' ' ARG . 7.3 t -153.68 143.37 15.17 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.15 -8.13 18.54 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.947 1.765 . . . . 0.0 112.37 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.434 ' CB ' HD23 ' A' ' 138' ' ' LEU . 53.7 mtt85 -79.88 -22.4 42.87 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.208 0.528 . . . . 0.0 110.339 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.476 ' C ' ' H ' ' A' ' 139' ' ' CYS . 20.7 ttm180 67.55 23.28 8.96 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.643 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.434 HD23 ' CB ' ' A' ' 136' ' ' ARG . 3.1 mm? -75.73 17.02 0.33 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 31.0 p -43.17 -49.82 6.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.372 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.555 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 73.3 m-85 -46.76 -40.23 13.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.083 0.468 . . . . 0.0 110.335 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.3 t -62.93 -42.73 99.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -46.61 -54.95 8.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.663 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.64 -51.21 63.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.316 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.09 -48.13 47.25 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.05 -53.69 55.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.683 0.278 . . . . 0.0 111.302 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.4 mt -55.59 -54.93 37.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.699 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.545 ' CE2' HD12 ' A' ' 159' ' ' ILE . 10.6 m-85 -49.17 -49.1 44.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.902 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.04 -50.58 66.32 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.42 -59.91 2.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.74 0.305 . . . . 0.0 110.941 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 155' ' ' GLN . . . -51.44 -52.08 49.37 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.314 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -52.13 -47.88 65.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.215 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -47.74 -50.0 26.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.709 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -85.39 38.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.844 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 38.45 62.31 1.02 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.038 0.447 . . . . 0.0 111.309 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.616 HE21 HG23 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -132.93 151.11 52.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.504 ' N ' ' NE2' ' A' ' 155' ' ' GLN . 84.4 tttt -118.27 118.9 33.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.616 HG23 HE21 ' A' ' 155' ' ' GLN . 33.9 pt -133.32 170.86 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.539 0.685 . . . . 0.0 112.186 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -138.25 127.77 24.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.52 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.545 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.6 mt -111.41 117.56 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.911 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.9 t -98.72 103.34 15.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.819 0.343 . . . . 0.0 110.47 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.576 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 20.3 p80 -94.02 65.12 3.43 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.615 0.721 . . . . 0.0 111.017 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 163' ' ' THR . 37.3 p30 -69.0 -33.05 73.04 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.113 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.512 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 1.6 m -99.95 107.54 19.53 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.066 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.59 ' O ' ' N ' ' A' ' 166' ' ' HIS . 55.9 m -134.71 114.22 12.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.653 0.263 . . . . 0.0 110.785 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.2 ttt -36.62 -20.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.19 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.59 ' N ' ' O ' ' A' ' 164' ' ' CYS . 83.7 t60 -52.23 -23.33 5.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.482 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.6 t -88.77 -43.18 11.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.01 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 167' ' ' THR . . . 130.48 13.9 2.02 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.09 162.51 14.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 110.729 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.554 ' O ' ' CG ' ' A' ' 171' ' ' HIS . 28.9 p-10 -55.55 -41.16 72.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.343 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.688 ' CD2' HH21 ' A' ' 131' ' ' ARG . 82.5 m-70 -161.52 -173.33 3.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 132' ' ' TYR . 1.6 m -96.31 137.96 34.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.439 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.511 ' H ' ' HB ' ' A' ' 163' ' ' THR . 12.3 ttm -126.19 92.76 3.64 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.609 0.719 . . . . 0.0 109.608 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.19 113.9 26.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.912 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.1 mm -90.49 127.98 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.366 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.07 148.99 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.432 0.634 . . . . 0.0 110.727 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -137.82 135.88 36.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.555 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.524 ' O ' ' NE2' ' A' ' 179' ' ' GLN . 19.0 mt -93.1 145.94 24.02 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.702 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 178' ' ' LEU . 90.7 mm-40 -139.28 -179.49 5.9 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.801 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 181' ' ' ASP . 46.9 p-10 -153.7 20.85 0.53 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.854 0.359 . . . . 0.0 110.578 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 180' ' ' ASN . 3.3 p30 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.851 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.422 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . 0.449 ' N3 ' ' CD1' ' A' ' 118' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.2 mtp . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.596 ' HZ3' ' CG ' ' A' ' 111' ' ' HIS . 28.8 mmtm 48.23 -172.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.434 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.576 ' O ' HG22 ' A' ' 4' ' ' ILE . . . -159.26 -118.71 0.52 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 3' ' ' GLY . 0.3 OUTLIER 94.45 -24.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.9 0.88 . . . . 0.0 109.576 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mm -68.56 -52.73 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.395 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.45 -22.81 64.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.006 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -69.83 -49.59 51.1 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.716 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.08 -36.36 77.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.922 0.392 . . . . 0.0 110.158 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.453 HD13 ' CE2' ' A' ' 69' ' ' PHE . 24.1 tp -71.02 -35.46 72.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.241 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.15 -45.73 86.91 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.045 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -61.61 -52.32 64.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.428 ' SD ' ' CE1' ' A' ' 69' ' ' PHE . 7.8 ttp -49.73 -43.27 47.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.54 -35.17 69.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.663 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -61.93 -22.16 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.218 0.533 . . . . 0.0 109.756 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.9 -35.11 20.74 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.343 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -84.35 -77.13 0.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.495 ' SG ' HD21 ' A' ' 58' ' ' LEU . 90.4 m -90.99 -20.04 22.56 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.265 0.555 . . . . 0.0 110.738 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.95 173.59 26.54 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.77 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.8 ttt -68.57 -28.37 66.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.831 -1.184 . . . . 0.0 110.477 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.8 m -62.76 -42.5 99.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.164 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.96 -36.03 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -52.03 -46.23 64.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -70.14 -30.98 68.28 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.138 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -65.31 -50.62 64.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -83.14 -18.89 37.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.871 0.367 . . . . 0.0 110.792 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.792 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.5 tt -77.97 -61.43 2.0 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.371 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.489 ' N ' HD23 ' A' ' 26' ' ' LEU . 78.5 mm-40 -58.68 -21.91 55.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.319 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -80.64 -38.58 28.91 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.502 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 72.1 m80 -99.03 -84.9 0.4 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.508 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.472 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -50.23 158.91 0.9 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.087 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.455 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 40.9 Cg_endo -66.33 143.05 68.77 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.732 2.288 . . . . 0.0 112.218 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' CB ' ' OE1' ' A' ' 27' ' ' GLU . 36.5 pttt -90.04 -20.61 23.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.709 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -91.74 -51.7 5.1 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.749 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -70.88 90.49 0.81 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.211 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -56.51 137.83 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.61 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -102.88 131.88 49.49 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.728 HG23 ' H ' ' A' ' 39' ' ' ALA . 1.5 m -143.42 166.72 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.843 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 m -76.63 29.26 0.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.578 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.728 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -153.18 16.47 0.55 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.618 ' CG ' HG22 ' A' ' 37' ' ' VAL . 15.5 mmtt -114.99 156.46 25.04 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.019 0.437 . . . . 0.0 110.428 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.3 p -92.75 130.86 38.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.464 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -164.89 172.2 13.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.595 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.2 110.69 14.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.642 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.01 -29.9 63.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.654 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.9 m -52.16 -26.03 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.647 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.96 -30.38 67.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.808 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -41.6 -57.46 2.26 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.038 0.447 . . . . 0.0 110.684 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -38.0 -43.47 0.72 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.516 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.3 m -72.94 -32.41 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.527 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.2 mp -70.74 -52.84 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.503 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.4 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -56.44 -24.67 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.885 178.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.681 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.5 tt0 -77.01 -41.37 43.02 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.466 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.502 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 37.9 m-20 -58.55 -56.43 22.25 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.864 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.0 p -57.13 -39.32 66.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.065 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.02 -39.72 86.81 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.134 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -62.84 -31.51 72.54 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -74.54 -45.79 43.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.491 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.495 HD21 ' SG ' ' A' ' 17' ' ' CYS . 32.0 mt -76.8 -8.6 57.61 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.621 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 58.1 52.33 7.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.748 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.415 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 11.2 mmt -132.43 149.95 74.56 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.382 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.31 140.64 89.45 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.441 1.427 . . . . 0.0 111.194 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.681 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.2 tt -56.55 -30.76 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.744 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -72.91 -29.75 63.37 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.297 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 50.2 t0 -78.77 -36.62 42.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.699 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 55' ' ' ALA . 69.2 t -63.74 -58.96 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -49.94 -39.89 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.756 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' N ' HG13 ' A' ' 66' ' ' VAL . 2.2 ttpt -52.59 -47.33 66.97 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.86 89.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.453 ' CE2' HD13 ' A' ' 9' ' ' LEU . 6.2 m-30 -52.81 -29.96 30.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.613 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.17 -50.41 57.06 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -55.62 -50.06 71.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.924 0.392 . . . . 0.0 110.2 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -59.16 -41.53 88.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.802 0.81 . . . . 0.0 110.431 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.73 -38.88 79.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.449 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 36.6 t80 -69.54 -39.15 77.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.136 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -56.9 -69.87 0.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.97 -38.13 54.75 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.581 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.514 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 18.8 mt -57.07 -48.22 79.11 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.451 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.16 -21.28 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.552 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t -80.41 -40.51 26.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.24 0.543 . . . . 0.0 110.109 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.443 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.9 mmp_? -66.55 -70.55 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.68 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.603 ' CE1' HMC1 ' A' ' 182' ' ' HEM . 23.7 p80 -83.66 32.99 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.97 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 55.0 m -47.93 -43.27 28.92 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.941 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -52.67 -31.76 38.85 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 81' ' ' HIS . 16.7 t -82.47 -25.26 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.675 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 87' ' ' LYS . 44.5 t -63.27 -38.2 81.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -47.33 -12.86 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.875 0.369 . . . . 0.0 110.924 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.506 ' NZ ' ' CG ' ' A' ' 105' ' ' GLU . 85.5 mttt -79.63 -28.41 40.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.895 0.855 . . . . 0.0 109.721 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 85' ' ' VAL . 39.7 t80 -57.78 100.21 0.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.232 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -88.39 -32.91 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 54.2 t0 -174.73 155.51 2.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.759 -1.564 . . . . 0.0 109.923 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.504 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 78.0 t80 -42.56 -46.27 4.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.319 0.58 . . . . 0.0 110.49 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.2 m -61.76 -37.3 83.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.795 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.1 p -65.54 -40.83 93.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.343 0.592 . . . . 0.0 110.579 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 98' ' ' ILE . 6.5 tt -65.35 -49.92 67.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.318 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.407 HG21 ' CE2' ' A' ' 91' ' ' PHE . 76.5 t -57.13 -37.78 57.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.262 0.554 . . . . 0.0 110.623 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 120' ' ' GLY . 95.3 mmm -86.49 -5.98 59.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.192 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -113.89 -15.56 8.52 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.096 -0.836 . . . . 0.0 113.202 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.521 ' O ' ' O ' ' A' ' 97' ' ' GLY . 13.6 mt -27.27 -106.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 117.945 0.873 . . . . 0.0 112.66 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -40.64 -49.89 3.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.26 0.552 . . . . 0.0 111.259 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -43.25 -86.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.548 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.0 m -72.82 -51.86 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.548 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mp -64.77 -50.04 77.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.51 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -53.46 -50.98 50.76 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.575 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 30.1 tp -48.83 -50.28 35.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.085 0.469 . . . . 0.0 110.228 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.506 ' CG ' ' NZ ' ' A' ' 87' ' ' LYS . 68.9 mm-40 -55.85 -45.08 78.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.141 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.445 ' CG1' ' OE2' ' A' ' 112' ' ' GLU . 72.3 t -51.99 -51.0 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -50.11 -42.49 50.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.708 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.575 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 26.4 mmtm -58.94 -36.14 74.28 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.26 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.523 ' O ' ' CD2' ' A' ' 111' ' ' HIS . 3.7 mm? -74.11 1.73 10.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.532 ' O ' ' CG ' ' A' ' 111' ' ' HIS . 12.5 t80 70.25 -167.68 0.16 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.74 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.596 ' CG ' ' HZ3' ' A' ' 2' ' ' LYS . 20.5 p80 42.14 76.82 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.916 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.445 ' OE2' ' CG1' ' A' ' 106' ' ' VAL . 28.0 tt0 -159.99 81.58 2.36 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.493 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.22 -60.85 0.73 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.414 2.076 . . . . 0.0 112.213 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.3 m -170.28 128.2 0.85 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD11 ' OE2' ' A' ' 112' ' ' GLU . 10.4 mt -80.01 153.94 75.03 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.35 173.19 11.87 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.412 2.075 . . . . 0.0 112.291 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -84.15 108.86 17.3 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.349 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 91.3 mt -121.26 126.69 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.631 0.253 . . . . 0.0 110.981 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -130.66 112.18 12.88 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.861 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.443 ' C ' ' SD ' ' A' ' 96' ' ' MET . . . -110.39 128.46 8.83 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -118.95 164.66 15.13 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.944 0.402 . . . . 0.0 110.468 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.24 144.73 36.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.661 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.41 160.56 41.21 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.01 -31.43 9.81 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.549 2.166 . . . . 0.0 113.261 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -86.51 44.97 1.19 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.24 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 m120 45.06 51.34 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.286 0.565 . . . . 0.0 110.575 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -127.44 158.46 37.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.701 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.1 mt -135.72 117.91 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.65 122.77 32.43 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.749 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.7 tp -117.26 133.79 55.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.058 0.456 . . . . 0.0 110.439 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -119.38 126.59 51.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.529 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -125.89 123.55 38.89 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.09 132.27 29.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.739 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.525 ' OG ' ' NE ' ' A' ' 136' ' ' ARG . 0.4 OUTLIER 169.82 154.61 0.18 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.292 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.43 68.4 1.5 Allowed 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.434 2.089 . . . . 0.0 111.163 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.548 ' C ' ' H ' ' A' ' 138' ' ' LEU . 10.0 ptp180 -150.51 101.68 2.97 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.476 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -69.9 36.88 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.139 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.548 ' H ' ' C ' ' A' ' 136' ' ' ARG . 2.5 tp -97.01 7.29 46.98 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.256 0.551 . . . . 0.0 110.143 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.4 m -41.93 -50.82 4.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.93 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -45.43 -36.74 4.56 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.552 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.82 -44.17 74.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.949 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -44.77 -47.52 10.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.603 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -65.13 -49.42 69.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.376 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.65 -47.45 45.75 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.9 mt -58.84 -53.28 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.65 0.262 . . . . 0.0 111.192 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.8 mt -55.64 -54.73 40.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.606 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.669 ' CE2' HD12 ' A' ' 159' ' ' ILE . 18.3 m-85 -50.42 -47.14 56.72 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.658 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.94 -50.94 62.41 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.61 -59.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.743 0.306 . . . . 0.0 110.736 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.25 -51.51 58.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.667 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -51.52 -47.24 63.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.067 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -49.4 -49.73 43.45 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.743 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.517 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 67.4 t80 -88.03 38.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.891 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 38.51 55.28 1.87 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.966 0.412 . . . . 0.0 111.134 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.596 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 46.4 tp60 -128.84 141.18 51.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.596 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 15.7 mtpp -110.85 131.35 55.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.173 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.4 pt -142.99 170.12 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.631 0.729 . . . . 0.0 112.268 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.451 ' NE2' HE22 ' A' ' 179' ' ' GLN . 94.1 mt-30 -134.77 125.69 27.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.93 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.669 HD12 ' CE2' ' A' ' 147' ' ' PHE . 5.7 mt -111.63 118.84 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.618 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.2 m -98.95 99.83 10.93 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.008 0.433 . . . . 0.0 110.248 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 163' ' ' THR . 23.3 t-160 -98.59 70.12 1.92 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.388 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -77.11 -45.84 25.56 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.904 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.466 ' O ' ' CD2' ' A' ' 161' ' ' HIS . 2.4 m -77.83 118.91 20.62 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.863 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.575 ' O ' ' N ' ' A' ' 166' ' ' HIS . 34.0 t -143.78 116.27 8.6 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.009 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.432 ' C ' ' N ' ' A' ' 167' ' ' THR . 26.1 ttt -35.25 -23.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.073 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.575 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.9 t60 -50.11 -20.66 1.04 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.432 ' N ' ' C ' ' A' ' 165' ' ' MET . 6.0 t -93.97 -36.4 12.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.139 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.66 13.34 8.07 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.56 165.69 7.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.041 0.448 . . . . 0.0 110.809 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -52.83 -35.91 57.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.428 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -172.13 -171.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.4 m -93.68 138.83 31.5 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.547 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.3 tpt -117.65 122.08 42.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.064 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 mt -126.13 102.21 7.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.029 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -90.35 126.95 43.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.511 178.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.46 151.83 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.188 0.518 . . . . 0.0 110.599 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -139.26 137.84 36.26 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.48 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 11.9 mt -94.77 150.04 20.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.937 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.451 HE22 ' NE2' ' A' ' 158' ' ' GLN . 54.1 mt-30 -143.24 175.57 9.79 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.823 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 181' ' ' ASP . 16.8 m-80 53.73 43.44 31.05 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.532 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 180' ' ' ASN . 3.2 p30 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.603 HMC1 ' CE1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.527 ' N ' ' O ' ' A' ' 40' ' ' LYS . 67.4 mmm . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.557 ' HZ3' ' HB2' ' A' ' 44' ' ' GLU . 65.3 tttt -89.29 -5.34 57.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.965 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -51.67 -25.19 14.12 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tp -51.84 -39.86 26.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 0.0 110.517 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.0 mm -58.7 -49.15 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.112 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -67.26 -25.91 66.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.275 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -66.95 -54.63 20.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.192 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.76 -35.19 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.401 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.505 HD13 ' CE2' ' A' ' 69' ' ' PHE . 17.8 tp -68.48 -51.33 44.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.399 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -47.0 -44.15 20.02 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.09 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -61.14 -52.71 63.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.999 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.8 ttt -51.31 -40.17 58.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.73 -35.69 66.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.418 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.78 -22.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.336 0.589 . . . . 0.0 109.883 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.77 -34.7 19.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.225 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -84.48 -77.06 0.28 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.47 ' SG ' HD21 ' A' ' 58' ' ' LEU . 98.0 m -90.81 -20.12 22.68 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.247 0.546 . . . . 0.0 110.705 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.6 173.78 26.99 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.719 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.4 ttt -69.53 -25.02 63.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.937 -1.131 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -65.27 -43.21 91.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.148 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -34.31 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.538 ' HE1' HH12 ' A' ' 34' ' ' ARG . 51.5 t-105 -51.57 -45.97 63.28 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.47 ' OD1' ' CZ ' ' A' ' 34' ' ' ARG . 45.6 m-20 -69.15 -32.66 72.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.015 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -64.33 -50.97 65.68 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.806 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.78 -19.6 37.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.958 0.408 . . . . 0.0 110.965 -179.229 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.806 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.5 tt -75.34 -57.61 3.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.692 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' N ' HD23 ' A' ' 26' ' ' LEU . 99.4 mt-10 -62.89 -21.09 65.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.62 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -80.72 -39.29 27.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.526 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 43.5 m170 -101.32 -88.12 0.38 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.861 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.571 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -43.76 163.88 0.16 Allowed Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 27.7 Cg_endo -59.65 150.97 73.27 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.477 2.118 . . . . 0.0 112.192 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -65.89 -17.47 64.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.542 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 34' ' ' ARG . 50.5 t0 -48.2 -44.62 32.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.232 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.538 HH12 ' HE1' ' A' ' 22' ' ' TRP . 37.5 ttt85 45.03 97.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.781 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.0 t -145.25 129.27 12.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.328 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.522 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 36.6 p90 -81.51 113.83 19.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.147 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.503 HG21 ' HG3' ' A' ' 40' ' ' LYS . 34.8 m -147.46 164.5 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 121.18 0.514 . . . . 0.0 110.933 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.1 m -142.58 24.44 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.255 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.489 ' O ' ' SD ' ' A' ' 1' ' ' MET . . . -130.98 11.97 5.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.662 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 1' ' ' MET . 20.8 mttt -101.44 179.42 4.36 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.455 0.645 . . . . 0.0 112.017 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.9 t -129.93 67.51 1.46 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.235 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -77.34 163.27 26.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.301 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.38 121.77 15.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.6 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.594 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -72.32 -36.29 68.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.691 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.459 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 22.9 t -58.78 -31.68 68.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.564 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -62.09 -40.82 97.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.769 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -41.19 -55.01 2.77 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.946 0.403 . . . . 0.0 110.595 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.14 -38.73 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.914 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.9 m -72.41 -34.53 67.93 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.837 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.8 mp -68.33 -56.93 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.207 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -51.89 -26.25 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.831 178.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.672 ' HG3' HD12 ' A' ' 62' ' ' ILE . 7.2 tt0 -75.24 -41.18 58.1 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.763 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.526 ' OD2' ' CE1' ' A' ' 29' ' ' HIS . 51.3 m-20 -59.4 -56.62 19.69 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.073 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 p -56.39 -38.1 54.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.08 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.07 -38.75 87.33 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.251 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -62.8 -32.22 73.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.55 -43.32 60.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 17' ' ' CYS . 41.6 mt -79.3 -8.47 59.08 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.612 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.1 t30 57.32 50.4 11.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.555 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.405 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 10.0 mmt -129.79 149.75 73.91 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.208 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.74 139.83 82.68 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.407 1.405 . . . . 0.0 111.171 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.672 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.6 tt -54.37 -30.89 21.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.363 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -72.0 -29.72 64.49 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.405 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 37.5 t0 -78.69 -35.48 45.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.956 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 55' ' ' ALA . 72.0 t -66.29 -58.03 8.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -51.34 -39.49 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.959 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.489 ' N ' HG13 ' A' ' 66' ' ' VAL . 2.4 ttpt -53.35 -47.83 69.05 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.88 -43.96 97.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.65 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.505 ' CE2' HD13 ' A' ' 9' ' ' LEU . 6.8 m-30 -55.1 -32.07 61.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.17 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.4 -50.18 56.99 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -57.63 -47.77 81.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.066 0.46 . . . . 0.0 109.896 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.03 -42.58 94.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.85 0.833 . . . . 0.0 110.363 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.8 tp -56.15 -39.0 71.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.388 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -70.49 -40.8 73.38 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.286 -0.565 . . . . 0.0 109.936 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -57.08 -71.87 0.09 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.914 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.5 -37.58 19.62 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.223 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.67 -41.6 86.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.121 0.46 . . . . 0.0 111.732 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.16 -15.86 2.62 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.672 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.431 ' O ' ' OG1' ' A' ' 82' ' ' THR . 29.0 t -83.69 -46.85 11.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.324 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -86.87 -47.4 9.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.977 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.609 ' NE2' HMC3 ' A' ' 182' ' ' HEM . 0.1 OUTLIER -84.42 26.48 0.78 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.201 0.524 . . . . 0.0 109.982 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 79' ' ' SER . 3.8 m -58.21 -40.38 81.44 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.329 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -56.01 -31.87 63.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.3 t -85.54 -20.84 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.923 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 81' ' ' HIS . 43.3 t -64.69 -41.22 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.213 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.82 -19.15 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -66.23 -28.91 69.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.557 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 1.8 p90 -120.35 114.32 21.68 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.107 0.48 . . . . 0.0 110.77 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -85.28 -3.33 58.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.372 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -163.04 154.57 17.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.092 0.472 . . . . 0.0 111.602 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.439 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 89.8 t80 -45.4 -56.38 5.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.001 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.0 m -52.08 -44.01 64.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.795 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.9 p -61.63 -35.47 77.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.18 0.514 . . . . 0.0 110.825 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 98' ' ' ILE . 4.9 tt -68.64 -48.78 63.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.589 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.78 -39.1 75.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.069 0.461 . . . . 0.0 111.145 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -88.61 -4.86 58.48 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -111.03 -15.07 11.08 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 119.569 -0.573 . . . . 0.0 112.761 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 94' ' ' LEU . 12.8 mt -30.37 -100.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 117.75 0.775 . . . . 0.0 112.269 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -39.31 -51.61 2.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.15 0.5 . . . . 0.0 111.374 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -43.32 -87.21 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -72.51 -53.65 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.587 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.9 mp -62.27 -46.89 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.688 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.19 -52.57 48.61 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.592 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 42.4 tp -52.43 -51.47 58.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.359 . . . . 0.0 110.665 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -54.88 -45.84 74.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.755 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.68 -51.99 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 110' ' ' TYR . 19.3 t-20 -47.11 -43.23 20.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.757 0.313 . . . . 0.0 110.754 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.592 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 26.7 mmtm -60.99 -37.15 81.47 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.144 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -67.36 -42.85 82.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.896 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.514 ' CD2' ' O ' ' A' ' 111' ' ' HIS . 64.0 t80 -143.16 144.31 32.15 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.444 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.514 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 79.3 m80 -83.53 150.89 25.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.731 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 59.68 59.11 4.76 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.487 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.11 -22.49 16.88 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.726 2.284 . . . . 0.0 111.839 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 114' ' ' SER . 23.2 p 42.67 62.07 1.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.923 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 116' ' ' PRO . 11.3 mt -81.41 115.1 54.44 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.191 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 115' ' ' LEU . 80.2 Cg_exo -44.23 178.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.228 1.952 . . . . 0.0 113.033 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.547 ' NE2' ' NH2' ' A' ' 131' ' ' ARG . 20.4 t60 -80.1 118.83 22.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.515 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.71 129.62 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -134.53 119.75 18.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.886 0.374 . . . . 0.0 111.591 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -108.2 126.06 8.1 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.403 ' C ' HD22 ' A' ' 122' ' ' LEU . 15.0 mm-40 -116.77 165.27 13.49 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.117 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.769 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.2 mm? -111.8 139.19 47.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.186 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.95 160.25 41.51 Favored Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 69.9 Cg_endo -73.51 158.71 47.43 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.264 1.976 . . . . 0.0 112.109 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 124' ' ' PRO . 3.4 t-20 92.24 -60.92 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.217 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 14.1 m-20 154.31 59.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -135.14 163.28 30.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.05 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.7 mt -140.2 121.16 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.34 122.77 33.52 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.276 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.0 tp -116.05 136.55 52.92 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.033 0.444 . . . . 0.0 110.745 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.547 ' NH2' ' NE2' ' A' ' 117' ' ' HIS . 61.0 ttp85 -123.08 124.28 42.75 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.595 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.428 ' C ' ' CD1' ' A' ' 132' ' ' TYR . 25.4 t80 -126.84 123.1 36.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.19 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.62 122.53 29.25 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 136' ' ' ARG . 3.6 t -172.69 145.15 1.34 Allowed Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.759 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -73.36 19.07 0.38 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.908 1.739 . . . . 0.0 110.382 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.55 ' C ' ' H ' ' A' ' 138' ' ' LEU . 15.7 mmm180 -91.24 108.54 19.95 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.719 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -69.03 18.84 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.626 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.55 ' H ' ' C ' ' A' ' 136' ' ' ARG . 2.4 mm? -86.31 11.02 13.12 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 110.299 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 65.5 m -40.86 -54.61 2.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.601 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -47.07 -30.07 2.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.957 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.456 ' N ' ' O ' ' A' ' 138' ' ' LEU . 4.7 t -71.38 -45.19 63.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.794 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.65 -48.79 14.8 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.588 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -63.35 -48.26 78.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.206 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.33 -46.22 44.42 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.3 -52.58 64.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.64 0.257 . . . . 0.0 111.351 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.2 mt -55.53 -56.51 19.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.819 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.592 ' CE2' HD12 ' A' ' 159' ' ' ILE . 23.7 m-85 -51.33 -47.55 62.65 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.644 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.33 -52.23 54.46 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.52 -60.21 1.84 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.0 110.784 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -51.34 -51.63 52.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.563 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -51.24 -46.37 62.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.636 0.255 . . . . 0.0 110.961 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -50.23 -50.35 50.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.515 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 71.3 t80 -86.2 37.15 0.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.998 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 40.69 53.0 3.15 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.92 0.39 . . . . 0.0 111.062 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.525 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 46.0 tp60 -127.72 139.52 52.63 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.525 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 2.3 mptp? -112.95 128.06 56.38 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.439 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 10.7 pt -139.18 175.72 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.663 0.744 . . . . 0.0 111.638 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -137.78 127.09 24.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.195 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.592 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.3 mt -112.31 116.69 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.462 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.3 m -97.0 101.94 13.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.497 ' NE2' ' O ' ' A' ' 163' ' ' THR . 10.8 t-160 -104.62 74.97 1.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.91 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -81.27 -40.68 23.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.82 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.497 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 1.9 m -78.97 117.72 20.31 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.146 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 166' ' ' HIS . 14.7 t -142.16 117.35 10.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.693 0.282 . . . . 0.0 111.08 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.475 ' C ' ' N ' ' A' ' 167' ' ' THR . 24.5 ttt -33.88 -25.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.225 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.568 ' N ' ' O ' ' A' ' 164' ' ' CYS . 84.6 t60 -49.42 -19.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.568 0.699 . . . . 0.0 109.147 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.475 ' N ' ' C ' ' A' ' 165' ' ' MET . 5.9 t -94.73 -34.2 12.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.958 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 112.54 16.05 9.07 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.34 166.48 8.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.064 0.459 . . . . 0.0 110.782 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -55.56 -33.91 64.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.456 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -171.89 -169.63 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.7 m -94.7 141.94 28.04 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.562 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.5 tpt -118.02 123.6 46.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.104 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.2 100.35 5.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.162 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.544 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -88.26 126.6 41.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.702 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.84 149.74 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.183 0.516 . . . . 0.0 110.588 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -144.57 139.28 28.04 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.421 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 10.9 mt -92.65 136.55 33.13 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.116 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -46.37 143.42 2.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.439 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -155.26 21.4 0.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.522 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 61.2 t0 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.589 179.984 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.609 HMC3 ' NE2' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.915 ' H3 ' ' ND2' ' A' ' 7' ' ' ASN . 49.2 ttp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' GLY . 59.8 mttp 55.11 90.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.5 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 37' ' ' VAL . . . 58.5 117.71 0.01 OUTLIER Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 tp -53.55 -41.33 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.4 -48.4 80.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.423 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 3.2 m-85 -67.42 -24.11 65.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.753 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.915 ' ND2' ' H3 ' ' A' ' 1' ' ' MET . 52.9 t30 -71.18 -57.31 4.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.49 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.15 -35.84 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.012 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.473 HD13 ' CD2' ' A' ' 69' ' ' PHE . 26.7 tp -72.03 -41.94 66.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.413 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -53.87 -46.61 71.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.935 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.16 -45.29 93.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.927 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.599 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 3.3 tpp -58.05 -47.31 83.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.4 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.55 -36.71 76.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.828 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -63.17 -22.94 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.278 0.561 . . . . 0.0 109.661 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.77 -34.76 18.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.85 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -86.78 -76.93 0.34 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.483 ' SG ' HD21 ' A' ' 58' ' ' LEU . 88.8 m -89.84 -17.08 28.77 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.408 0.623 . . . . 0.0 110.723 -177.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.2 -179.97 31.15 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.565 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 ttt -72.85 -31.68 64.93 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.053 -1.074 . . . . 0.0 111.098 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -60.22 -39.53 86.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.165 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.83 -37.76 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -55.13 -47.38 75.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.07 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.33 -24.89 54.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.898 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -76.01 -46.42 29.53 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.819 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.991 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.37 -28.22 41.93 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.742 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.991 ' N ' HD13 ' A' ' 25' ' ' LEU . 6.8 tt -71.23 -45.86 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.232 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.4 -23.89 63.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.639 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -82.14 -40.59 21.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.423 ' CD2' ' OD2' ' A' ' 53' ' ' ASP . 59.6 m-70 -91.58 -87.37 0.21 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.177 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 31' ' ' PRO . . . -53.99 160.65 2.15 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.087 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 59.9 Cg_endo -70.45 153.99 65.34 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.702 2.268 . . . . 0.0 112.035 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' NZ ' ' OD1' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -80.26 -2.66 46.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.262 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.406 ' OD1' ' NZ ' ' A' ' 32' ' ' LYS . 86.9 m-20 -59.4 -38.49 80.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.567 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 49.76 40.39 20.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.624 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.7 m -95.78 31.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.577 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.448 ' OH ' ' CG ' ' A' ' 31' ' ' PRO . 73.1 m-85 -94.16 151.6 19.36 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.521 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.59 HG23 ' H ' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -131.98 155.04 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.862 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 1' ' ' MET . 1.5 m -81.5 39.75 0.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.715 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.59 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -153.72 3.04 0.27 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.824 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.537 ' CG ' HG22 ' A' ' 37' ' ' VAL . 14.5 mmtt -93.93 149.54 21.14 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.08 0.467 . . . . 0.0 110.343 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 65.8 m -88.9 39.62 0.94 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.27 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.404 ' CE2' ' CB ' ' A' ' 40' ' ' LYS . 49.6 m-85 -56.42 158.11 4.56 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.375 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.3 129.59 36.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.663 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -81.95 -3.31 54.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.66 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.2 m -51.79 -36.79 48.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.694 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.54 -28.89 70.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.644 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.9 OUTLIER -47.82 -57.95 4.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.203 0.525 . . . . 0.0 110.354 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -37.14 -44.82 0.58 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.98 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.5 m -71.91 -32.26 67.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.123 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 47' ' ' LEU . 14.1 mt -71.6 -52.3 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.31 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -59.63 -21.89 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.445 178.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.692 ' HG3' HD12 ' A' ' 62' ' ' ILE . 1.9 tt0 -80.34 -41.03 25.53 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.111 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.6 ' OD2' HD23 ' A' ' 25' ' ' LEU . 37.2 m-20 -58.53 -57.32 13.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.71 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.41 -37.61 64.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.555 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.55 87.98 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.236 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -63.4 -31.4 72.55 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.498 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -73.21 -46.24 51.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.541 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.483 HD21 ' SG ' ' A' ' 17' ' ' CYS . 30.6 mt -76.31 -7.48 55.03 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.879 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.59 48.59 16.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.439 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 18.3 mmt -127.7 149.81 71.43 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.131 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.08 137.48 66.99 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.475 1.45 . . . . 0.0 111.233 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.692 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.7 tt -52.82 -29.72 14.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.023 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -73.45 -29.54 62.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.497 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -79.4 -34.65 41.64 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.06 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.535 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 55.7 t -66.14 -58.79 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.5 p -48.53 -38.8 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.662 178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -54.55 -44.31 72.77 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.739 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.31 -59.32 5.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.305 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.535 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 5.5 m-30 -45.98 -29.98 1.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.289 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.88 -52.64 51.09 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -57.02 -51.74 68.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.962 0.411 . . . . 0.0 110.143 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.599 ' CD1' ' SD ' ' A' ' 12' ' ' MET . 55.5 m-85 -56.73 -43.02 80.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.798 0.808 . . . . 0.0 110.595 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.0 tp -55.45 -38.38 68.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.614 -1.176 . . . . 0.0 112.057 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 74' ' ' PHE . 43.6 t80 -68.91 -40.26 79.23 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.965 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -57.22 -70.2 0.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.038 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.87 -41.68 36.69 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.789 -178.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.2 mt -57.4 -44.83 84.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.274 0.537 . . . . 0.0 111.615 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -49.17 -20.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.903 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 t -81.77 -41.62 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.119 0.485 . . . . 0.0 109.834 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.414 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 1.5 mmp_? -65.41 -74.52 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.696 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.68 ' CE1' HMC3 ' A' ' 182' ' ' HEM . 0.2 OUTLIER -84.39 37.28 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.596 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.8 m -48.11 -46.43 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.111 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -54.22 -34.02 59.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.049 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.54 -21.93 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.685 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 87' ' ' LYS . 73.7 t -70.96 -41.49 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.765 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -54.75 -0.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.467 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.539 ' H ' ' C ' ' A' ' 85' ' ' VAL . 77.6 mttt -84.25 -28.01 27.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.52 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.12 119.47 36.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.587 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 58.2 t0 -84.02 -13.66 52.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.118 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.454 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 60.8 m-20 -162.02 167.63 24.1 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.431 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -53.83 -52.65 59.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.685 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.9 m -53.04 -37.68 61.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.259 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.4 m -60.88 -40.65 93.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.337 0.589 . . . . 0.0 110.14 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 ' CAB' ' A' ' 182' ' ' HEM . 8.4 tt -60.76 -59.3 5.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.318 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.9 t -52.72 -37.4 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.229 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 91.8 mmm -86.23 -5.68 59.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.731 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -114.93 -15.14 8.08 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.377 -0.68 . . . . 0.0 113.112 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 97' ' ' GLY . 10.3 mt -28.03 -104.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 117.763 0.782 . . . . 0.0 112.763 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 118' ' ' ILE . 8.1 p80 -39.39 -49.88 2.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.075 0.464 . . . . 0.0 111.229 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -44.47 -87.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -71.52 -51.89 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mp -63.92 -45.48 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.756 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.38 -52.73 51.03 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.7 tp -51.67 -52.36 48.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.791 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.537 ' CD ' ' HZ1' ' A' ' 87' ' ' LYS . 58.3 mm-40 -53.85 -46.0 71.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.329 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.4 t -55.29 -51.39 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 110' ' ' TYR . 20.2 t-20 -48.69 -42.74 35.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.684 0.278 . . . . 0.0 110.883 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -63.39 -36.69 84.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.746 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.7 tp -56.56 -32.55 65.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.66 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 107' ' ' ASN . 14.0 t80 -150.81 -133.94 0.06 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.335 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -152.67 161.33 42.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.528 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 46.66 59.93 15.37 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.534 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.11 -29.01 8.51 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.679 2.253 . . . . 0.0 111.998 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.5 t 43.26 59.6 2.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.759 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.6 mt -76.08 152.58 84.35 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.205 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.19 -172.86 0.37 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.285 1.99 . . . . 0.0 111.842 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -100.32 116.11 31.53 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.815 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 1.5 mp -130.43 128.61 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.657 0.265 . . . . 0.0 110.308 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -135.22 127.08 29.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.714 0.293 . . . . 0.0 110.859 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -117.56 135.01 11.49 Favored Glycine 0 N--CA 1.466 0.692 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -131.96 126.19 33.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 tp -72.47 136.32 45.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.97 0.414 . . . . 0.0 110.885 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.405 HD13 ' HB2' ' A' ' 129' ' ' ALA . 5.2 mp -110.56 160.58 28.04 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 59.6 Cg_endo -72.15 165.7 31.86 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.284 1.99 . . . . 0.0 111.898 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' PRO . 15.4 t-20 86.46 -62.66 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.103 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.692 ' ND2' HD21 ' A' ' 180' ' ' ASN . 5.7 p30 154.84 52.59 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.162 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -128.46 159.34 35.71 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.675 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.9 mt -134.38 117.16 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.405 ' HB2' HD13 ' A' ' 123' ' ' LEU . . . -86.95 123.03 31.62 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.63 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.6 tp -116.94 137.24 52.35 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.111 0.481 . . . . 0.0 111.011 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.486 ' NE ' ' NE2' ' A' ' 171' ' ' HIS . 42.1 ttm180 -127.14 126.12 42.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.832 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.603 ' HH ' ' CGA' ' A' ' 182' ' ' HEM . 33.2 t80 -128.62 129.87 46.49 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.521 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.33 133.6 24.56 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.066 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.57 ' H ' ' NH1' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -176.01 171.4 1.11 Allowed Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -39.39 -70.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.978 1.786 . . . . 0.0 110.103 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 79.8 mtm-85 -89.09 170.26 10.79 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.57 ' NH1' ' H ' ' A' ' 134' ' ' SER . 22.5 mmt180 -114.48 -32.82 5.78 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.799 0.727 . . . . 0.0 110.867 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.577 ' N ' HD22 ' A' ' 138' ' ' LEU . 2.8 mm? 48.18 15.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.498 ' N ' ' C ' ' A' ' 137' ' ' ARG . 21.7 p -40.76 -52.75 2.94 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.12 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.463 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 62.4 m-85 -47.78 -35.82 10.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 138' ' ' LEU . 6.7 t -76.46 -51.78 11.11 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -43.31 -45.74 6.08 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.941 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -62.72 -46.46 87.98 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.167 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.24 -52.95 40.66 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.8 mt -54.38 -55.85 24.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.706 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.3 mt -54.3 -55.43 28.42 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.097 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.536 ' CE2' HD12 ' A' ' 159' ' ' ILE . 5.9 m-85 -50.43 -48.49 56.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.678 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.18 -51.1 60.47 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.58 -59.61 2.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.887 0.375 . . . . 0.0 110.625 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -48.16 -50.23 29.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.87 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -52.81 -47.4 67.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.155 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -49.79 -50.32 45.27 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.668 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 153' ' ' PHE . 70.6 t80 -86.01 37.19 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.025 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 39.73 54.11 2.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.993 0.425 . . . . 0.0 111.109 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.483 HE21 ' H ' ' A' ' 156' ' ' LYS . 50.1 tp60 -129.52 141.86 50.9 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.746 ' H ' HE21 ' A' ' 179' ' ' GLN . 67.9 mttm -118.71 107.54 13.8 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.998 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 38.7 pt -114.56 -178.19 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.507 0.67 . . . . 0.0 111.559 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -145.18 126.38 14.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.252 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.536 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.2 mt -110.76 119.08 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 120.69 0.281 . . . . 0.0 110.828 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.2 t -101.07 103.71 14.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.834 0.35 . . . . 0.0 110.276 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 163' ' ' THR . 21.0 t-160 -100.15 73.62 1.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.454 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -79.26 -48.68 13.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.478 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 1.0 OUTLIER -73.63 124.53 26.13 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.914 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.581 ' O ' HG22 ' A' ' 167' ' ' THR . 70.8 m -126.55 174.11 8.92 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.801 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 168' ' ' GLY . 1.1 tmt? -90.18 -27.35 19.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.092 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -52.57 -23.16 5.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.489 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.1 t -88.91 -25.28 22.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.454 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 97.74 23.27 14.03 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.012 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.09 168.71 11.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 110.768 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -54.22 -34.16 59.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.52 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.486 ' NE2' ' NE ' ' A' ' 131' ' ' ARG . 5.5 p-80 -174.52 -169.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 92.5 m -93.28 138.7 31.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.7 tpt -117.98 124.25 47.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.169 0.509 . . . . 0.0 110.074 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.4 mt -126.26 102.87 7.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.701 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -87.33 128.72 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.67 151.45 14.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.416 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -143.13 141.33 31.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.598 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 179' ' ' GLN . 14.0 mt -92.07 174.18 7.45 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.837 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.746 HE21 ' H ' ' A' ' 156' ' ' LYS . 83.2 mt-30 -55.82 -155.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.187 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.692 HD21 ' ND2' ' A' ' 126' ' ' ASN . 6.1 p-10 42.87 43.94 3.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.726 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 51.9 p30 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.59 -179.998 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.68 HMC3 ' CE1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' O ' ' A' ' 36' ' ' TYR . 20.6 tpp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -60.44 -31.1 70.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.423 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 6' ' ' PHE . . . -163.96 -172.61 31.65 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' SER . 2.2 tp -55.92 -42.49 71.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.677 0.275 . . . . 0.0 110.849 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.1 mm -59.88 -50.18 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.88 0.372 . . . . 0.0 110.147 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.401 ' HB2' ' H ' ' A' ' 3' ' ' GLY . 88.5 m-85 -67.52 -24.28 65.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.424 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.486 ' C ' HD22 ' A' ' 7' ' ' ASN . 0.4 OUTLIER -67.77 -53.17 29.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.974 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.6 t -65.68 -35.99 76.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.364 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.487 HD13 ' CE2' ' A' ' 69' ' ' PHE . 21.1 tp -69.6 -45.4 68.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.562 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -50.39 -43.9 54.76 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.661 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -62.78 -51.31 67.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.928 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 12' ' ' MET . 1.6 tmt? -51.18 -39.98 57.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.84 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.7 t -71.38 -34.78 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.557 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.98 -22.53 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.227 0.537 . . . . 0.0 109.957 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.64 -34.65 19.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.237 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -84.52 -76.99 0.28 Allowed 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' HD21 ' A' ' 58' ' ' LEU . 96.3 m -91.33 -19.19 23.21 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.211 0.529 . . . . 0.0 110.708 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.18 173.72 27.52 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.772 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 ttt -69.32 -27.65 65.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.888 -1.156 . . . . 0.0 110.516 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 t -63.21 -42.57 99.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.0 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.73 -36.57 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -50.68 -45.48 58.17 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -71.88 -30.64 65.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.238 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -66.5 -51.14 59.88 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.959 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.44 -24.77 39.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.275 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.959 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.1 tt -71.92 -46.03 59.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.131 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -71.69 -25.25 62.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.841 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -81.32 -40.67 23.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.524 ' CE1' ' OD2' ' A' ' 53' ' ' ASP . 80.2 m80 -95.09 -84.79 0.33 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.267 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 31' ' ' PRO . . . -54.42 164.53 1.05 Allowed Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.194 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 89.2 Cg_exo -35.45 160.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 123.124 2.55 . . . . 0.0 112.648 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 22.7 pttm -58.83 -44.87 91.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.124 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 32' ' ' LYS . 64.0 m-20 -160.09 12.43 0.12 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.009 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.468 ' NE ' ' OH ' ' A' ' 36' ' ' TYR . 50.3 ttt85 -79.57 117.05 20.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.776 0.322 . . . . 0.0 110.365 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.6 166.59 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.515 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.468 ' OH ' ' NE ' ' A' ' 34' ' ' ARG . 25.3 m-85 -136.68 -171.07 2.83 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.489 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.708 HG22 ' CG ' ' A' ' 40' ' ' LYS . 1.8 m -82.42 -169.69 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 4' ' ' ILE . 44.0 m -71.64 -41.12 69.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.095 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.611 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -97.32 46.04 1.03 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.715 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.708 ' CG ' HG22 ' A' ' 37' ' ' VAL . 20.5 mmtt -135.44 156.25 49.22 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.123 0.487 . . . . 0.0 110.691 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 40' ' ' LYS . 42.1 m 44.81 -173.49 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.729 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.526 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 10.6 p90 -171.72 61.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.34 0.591 . . . . 0.0 110.574 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 45' ' ' SER . . . -82.21 24.05 0.69 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.468 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.538 ' CD ' HH22 ' A' ' 136' ' ' ARG . 78.4 tt0 -44.83 -18.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.435 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' ALA . 21.7 m -69.08 -42.96 75.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.314 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -70.37 -27.45 64.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.594 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -38.52 -55.83 1.36 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.808 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.66 -40.98 1.0 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.029 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -72.61 -34.3 67.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.972 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.566 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.9 mp -68.63 -55.27 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.293 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -53.86 -26.39 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.967 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.672 ' HG3' HD12 ' A' ' 62' ' ' ILE . 6.9 tt0 -75.41 -41.06 57.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.646 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.551 ' OD2' HD23 ' A' ' 25' ' ' LEU . 40.4 m-20 -59.34 -56.79 17.65 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.968 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.4 p -56.77 -38.27 57.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.073 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.533 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -60.88 -38.88 87.15 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.256 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -62.76 -32.07 73.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -74.08 -43.0 59.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.569 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 17' ' ' CYS . 39.0 mt -79.6 -8.04 58.92 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.669 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.5 t30 57.23 49.87 12.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.607 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.4 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 23.9 mmt -129.06 149.53 72.84 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.182 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.39 138.93 74.1 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.539 1.493 . . . . 0.0 110.996 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.672 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.4 tt -53.05 -29.38 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.281 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -72.13 -31.14 65.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 111.206 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.92 -32.36 51.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 55' ' ' ALA . 82.6 t -70.82 -56.94 9.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 67' ' ' LYS . 8.0 p -52.06 -41.81 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.267 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.507 ' N ' HG13 ' A' ' 66' ' ' VAL . 33.7 mtpt -53.59 -50.86 64.72 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.47 82.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.684 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.487 ' CE2' HD13 ' A' ' 9' ' ' LEU . 7.7 m-30 -52.91 -29.62 29.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.382 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.15 -49.57 56.87 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -55.26 -52.14 64.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 110.054 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -57.83 -42.74 84.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.773 0.796 . . . . 0.0 110.649 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.9 tp -56.47 -39.9 73.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.537 -1.21 . . . . 0.0 112.223 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 21.7 t80 -66.52 -44.29 82.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.31 0.576 . . . . 0.0 109.863 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -53.58 -68.73 0.15 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.241 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -48.05 -48.57 25.32 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.967 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.1 mt -52.38 -41.52 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.24 0.52 . . . . 0.0 112.063 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -56.34 -27.48 55.99 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.507 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -73.52 -55.38 6.4 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.048 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -43.31 55.75 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.034 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.443 ' CE1' ' CBC' ' A' ' 182' ' ' HEM . 94.7 m-70 -89.18 28.1 1.28 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.779 0.323 . . . . 0.0 110.577 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 87.2 m -54.11 -37.26 64.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.079 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.523 ' O ' ' NZ ' ' A' ' 87' ' ' LYS . 88.3 m-20 -57.58 -30.54 65.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -85.88 -18.42 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.569 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.426 ' C ' ' N ' ' A' ' 87' ' ' LYS . 49.7 t -70.53 -45.28 75.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.418 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -51.2 -15.49 0.37 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.014 0.435 . . . . 0.0 110.354 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 83' ' ' ASP . 42.8 mmtm -69.08 -28.63 66.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.975 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 8.8 p90 -121.94 115.61 22.88 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.072 0.463 . . . . 0.0 110.732 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 55.2 t0 -84.48 -6.08 59.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.448 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.525 ' OD1' ' CZ ' ' A' ' 153' ' ' PHE . 38.0 m-20 -158.13 158.69 35.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.141 0.496 . . . . 0.0 111.681 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -50.38 -50.29 51.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.653 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.9 m -57.88 -42.99 85.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.534 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 90.2 p -62.89 -35.59 80.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.077 0.465 . . . . 0.0 110.3 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.407 HD21 ' CBB' ' A' ' 182' ' ' HEM . 4.6 tt -67.28 -50.13 61.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.345 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 88.1 t -59.87 -36.58 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.223 0.535 . . . . 0.0 110.648 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 81.3 mmm -86.34 -8.67 57.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.34 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -111.57 -12.26 15.33 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 119.704 -0.498 . . . . 0.0 113.073 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.601 ' HA ' HD13 ' A' ' 102' ' ' ILE . 9.4 mt -33.59 -92.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 117.777 0.789 . . . . 0.0 111.937 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -41.08 -51.67 3.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.512 . . . . 0.0 111.267 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -46.63 -91.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.061 0.764 . . . . 0.0 113.061 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.546 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.8 m -68.42 -50.71 54.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.6 mp -63.78 -42.06 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.423 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.74 -56.8 19.11 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -49.55 -53.66 22.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.012 0.434 . . . . 0.0 110.494 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -54.05 -46.36 71.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.094 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 109' ' ' LEU . 39.4 t -55.1 -51.72 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -44.52 -44.63 8.79 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.351 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 110' ' ' TYR . 30.3 mmtp -58.11 -36.47 72.94 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 106' ' ' VAL . 48.0 mt -80.91 23.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.87 178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 110' ' ' TYR . 36.8 p90 -28.81 143.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.34 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -159.92 -62.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.297 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.67 ' H ' ' CD ' ' A' ' 113' ' ' PRO . 31.3 tt0 -173.88 -38.67 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.857 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.67 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 23.2 Cg_exo -64.22 151.76 84.04 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 122.291 1.994 . . . . 0.0 112.504 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.9 m -119.88 148.08 43.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.007 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.28 144.48 29.87 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.92 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -81.44 -160.04 0.12 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.45 2.1 . . . . 0.0 112.189 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -98.12 111.86 24.03 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.016 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.9 mt -125.18 127.76 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.703 0.287 . . . . 0.0 110.723 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -135.39 127.89 30.57 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.701 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -132.18 151.95 20.03 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -144.06 157.65 44.19 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.1 tp -95.27 148.96 21.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 0.0 110.791 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.66 160.24 43.05 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.85 -39.07 2.58 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.544 2.163 . . . . 0.0 113.532 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -79.8 45.52 0.71 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.334 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.419 ' N ' HD22 ' A' ' 126' ' ' ASN . 2.8 m120 44.3 59.33 3.31 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.541 0.686 . . . . 0.0 110.716 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -136.04 159.42 41.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.958 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.6 mt -138.86 113.63 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.53 121.84 28.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 46.4 tp -114.88 135.13 54.53 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.859 0.361 . . . . 0.0 110.579 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.633 ' HE ' ' CD2' ' A' ' 171' ' ' HIS . 62.0 ttt180 -119.46 123.44 44.06 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.994 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -124.13 116.48 22.81 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.765 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.01 123.94 38.24 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.584 0.23 . . . . 0.0 110.828 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 136' ' ' ARG . 5.0 p -170.97 147.54 2.33 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.668 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.7 12.54 1.37 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.175 1.917 . . . . 0.0 110.776 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.648 ' HE ' ' CGA' ' A' ' 182' ' ' HEM . 48.8 mtp85 -94.19 113.27 25.17 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.866 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.409 ' C ' HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -69.3 37.03 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.19 -179.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 136' ' ' ARG . 3.3 mm? -99.75 7.06 45.37 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.963 0.411 . . . . 0.0 110.531 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 98.6 m -42.94 -51.02 5.75 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.587 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -46.76 -36.1 6.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.047 0.451 . . . . 0.0 110.229 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 10.2 t -66.81 -43.35 84.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.1 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.56 -50.83 16.72 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.864 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -61.36 -51.9 66.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.019 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.44 -43.28 20.18 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.51 -51.16 68.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.579 0.228 . . . . 0.0 111.551 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.3 mt -57.06 -56.37 22.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.739 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.445 ' CE2' HD12 ' A' ' 159' ' ' ILE . 33.9 m-85 -49.92 -47.99 51.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.673 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.02 -51.79 56.33 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.67 -60.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.057 0.456 . . . . 0.0 110.708 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.61 -51.09 39.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.919 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -50.92 -46.27 60.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.073 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -50.11 -49.95 50.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.735 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.525 ' CZ ' ' OD1' ' A' ' 90' ' ' ASP . 65.8 t80 -86.22 37.46 0.73 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.247 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 42.35 49.26 4.53 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 110.739 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.519 HE21 ' H ' ' A' ' 156' ' ' LYS . 49.8 tp60 -128.61 143.77 51.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.519 ' H ' HE21 ' A' ' 155' ' ' GLN . 56.0 tttp -127.51 107.22 9.75 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.787 ' O ' HD13 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -119.72 164.14 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.392 0.615 . . . . 0.0 110.892 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -119.51 132.42 55.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.445 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.1 mt -110.44 118.27 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.6 t -103.41 116.01 31.61 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.555 0.217 . . . . 0.0 111.238 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 56.7 p-80 -98.16 79.11 2.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.385 0.612 . . . . 0.0 111.714 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -82.43 -1.02 48.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.158 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.09 109.82 5.77 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.511 ' O ' HG22 ' A' ' 167' ' ' THR . 14.2 m -112.71 -179.9 3.79 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.901 0.381 . . . . 0.0 110.26 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 168' ' ' GLY . 0.5 OUTLIER -92.18 -27.96 17.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -54.42 -23.82 17.44 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.791 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 164' ' ' CYS . 3.5 t -87.11 -25.37 24.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.173 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 165' ' ' MET . . . 95.34 21.92 23.47 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.026 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.05 164.93 16.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.973 0.415 . . . . 0.0 110.773 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -50.41 -32.93 18.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.237 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.633 ' CD2' ' HE ' ' A' ' 131' ' ' ARG . 34.1 p80 -173.19 -172.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 2.8 m -94.1 141.23 28.77 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.4 124.04 46.71 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.36 101.11 6.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.631 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -89.27 126.43 42.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.603 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.61 149.32 11.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.967 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -139.8 136.53 34.16 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.44 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.6 mt -86.48 135.4 33.48 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.234 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.34 149.65 9.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.499 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 181' ' ' ASP . 36.4 t30 -156.98 92.89 1.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.459 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 180' ' ' ASN . 69.0 m-20 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.514 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.648 ' CGA' ' HE ' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.425 ' H3 ' ' ND2' ' A' ' 7' ' ' ASN . 74.2 mtp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 3' ' ' GLY . 30.9 mmtm -81.99 107.23 14.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.471 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 7' ' ' ASN . . . 57.76 122.03 0.01 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 5' ' ' ILE . 3.1 tp -55.16 -46.03 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.459 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.425 ' N ' HG23 ' A' ' 4' ' ' ILE . 36.7 mm -62.29 -50.1 81.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -69.57 -21.91 63.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.846 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 3' ' ' GLY . 25.5 t-20 -70.57 -51.52 27.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.827 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.77 -33.79 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.029 0.442 . . . . 0.0 109.944 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.501 HD13 ' CE2' ' A' ' 69' ' ' PHE . 22.6 tp -74.64 -42.74 57.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.367 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -51.85 -45.71 64.14 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.605 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.58 -49.95 74.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.793 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.495 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 10.9 tpt -52.49 -41.35 63.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.682 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.72 -35.52 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.565 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.0 t -61.19 -23.37 29.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.343 0.592 . . . . 0.0 110.109 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.68 -34.31 19.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.078 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -84.78 -75.82 0.34 Allowed 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.517 ' SG ' HD21 ' A' ' 58' ' ' LEU . 98.4 m -92.34 -20.26 21.27 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.708 -178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.48 172.36 25.87 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.724 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.6 ttt -68.01 -28.4 67.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.867 -1.166 . . . . 0.0 110.424 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.0 m -63.21 -41.69 99.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.139 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.86 -36.32 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -53.26 -45.19 68.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.773 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -74.24 -26.97 60.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.41 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -69.38 -49.5 54.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.996 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.87 -23.06 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 110.243 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.996 ' N ' HD13 ' A' ' 25' ' ' LEU . 7.1 tt -75.3 -59.01 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.519 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' N ' HD23 ' A' ' 26' ' ' LEU . 94.5 mt-10 -60.12 -21.66 61.84 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.391 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 tttp -80.92 -38.13 28.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.467 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 13.7 m80 -90.6 -87.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.522 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.34 152.96 71.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.476 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.82 146.87 89.08 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.533 2.155 . . . . 0.0 112.016 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' CD ' ' H ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -90.72 -21.42 21.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.233 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -80.27 -57.17 3.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.708 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.423 ' CD ' ' N ' ' A' ' 34' ' ' ARG . 10.7 mpt_? -69.5 136.99 52.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.243 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.39 150.32 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.274 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -120.16 173.58 7.02 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.563 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.604 HG22 ' CG ' ' A' ' 40' ' ' LYS . 1.7 m -121.89 166.67 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.923 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' A' ' 1' ' ' MET . 1.9 m -77.43 36.06 0.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.908 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.534 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -157.9 2.26 0.11 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.063 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.604 ' CG ' HG22 ' A' ' 37' ' ' VAL . 14.7 mmtt -98.02 167.64 10.77 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 110.518 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.5 t -72.86 145.13 47.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.437 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -146.18 155.84 42.99 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.675 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.95 124.95 36.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.422 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -72.34 -23.72 61.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.757 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.7 p -59.13 -32.21 69.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.702 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -66.94 -54.29 23.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.701 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -40.69 -55.1 2.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.022 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -41.0 -41.8 1.74 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.255 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 m -74.82 -28.82 60.86 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' A' ' 47' ' ' LEU . 25.3 mm -70.21 -53.17 24.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.916 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.43 ' H ' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -61.31 -22.42 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.189 178.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.67 ' HG3' HD12 ' A' ' 62' ' ' ILE . 5.0 tt0 -80.87 -42.12 22.03 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.064 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.623 ' OD2' HD23 ' A' ' 25' ' ' LEU . 45.2 m-20 -58.69 -56.69 18.88 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.665 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 55' ' ' ALA . 12.4 p -59.13 -38.43 74.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.471 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.401 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -59.88 -38.74 83.09 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.128 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -63.91 -32.09 73.5 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.645 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -73.12 -42.43 62.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.563 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.517 HD21 ' SG ' ' A' ' 17' ' ' CYS . 29.0 mt -80.74 -7.18 59.29 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.831 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.6 t30 55.9 47.76 19.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.578 0.704 . . . . 0.0 109.406 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.8 mmt -125.38 149.49 64.58 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.031 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.56 135.58 53.84 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.353 1.368 . . . . 0.0 111.054 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.67 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.8 tt -50.54 -30.73 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.271 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -71.37 -30.46 66.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.871 0.367 . . . . 0.0 111.227 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.19 -32.37 50.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.131 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 78.1 t -71.37 -56.2 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.523 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -51.38 -43.43 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.263 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.523 ' N ' HG13 ' A' ' 66' ' ' VAL . 34.6 mtpt -52.73 -51.25 61.24 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.224 0.535 . . . . 0.0 109.569 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.75 -51.35 67.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.963 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.549 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 7.7 m-30 -51.57 -30.73 21.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.565 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.66 -53.91 35.03 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -53.71 -49.8 67.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.153 0.501 . . . . 0.0 109.781 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.495 ' CE2' ' SD ' ' A' ' 12' ' ' MET . 8.3 m-85 -58.44 -41.04 84.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.709 0.766 . . . . 0.0 110.307 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.04 -38.45 82.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.484 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.58 -35.99 73.35 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.168 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.546 ' CG ' ' HE2' ' A' ' 152' ' ' HIS . 4.3 m120 -58.94 -69.52 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.059 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -52.63 -41.65 57.3 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.501 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 19.9 mt -57.2 -46.48 82.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.056 0.428 . . . . 0.0 111.269 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.3 -12.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.119 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.479 ' N ' ' C ' ' A' ' 77' ' ' LEU . 8.5 p -89.2 -43.92 10.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.202 0.525 . . . . 0.0 110.173 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.463 ' N ' ' HE ' ' A' ' 80' ' ' ARG . 2.0 mmp_? -65.07 -55.26 19.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.505 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.4 p80 -101.77 31.19 3.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.296 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 m -46.31 -43.32 15.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.302 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.443 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 83.8 m-20 -55.82 -30.73 61.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.208 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.0 t -78.5 -23.53 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.847 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.473 ' C ' ' H ' ' A' ' 87' ' ' LYS . 72.0 t -76.06 -42.42 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.34 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 83' ' ' ASP . 1.4 p30 -54.9 -8.67 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 85' ' ' VAL . 63.4 mmtt -67.35 -28.13 67.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.204 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.417 ' CD1' ' OG ' ' A' ' 93' ' ' SER . 8.1 m-85 -129.39 128.71 43.58 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.056 0.455 . . . . 0.0 111.161 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -87.52 16.01 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -167.75 165.45 14.14 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 119.219 -0.993 . . . . 0.0 113.075 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CZ ' HD13 ' A' ' 157' ' ' ILE . 80.6 t80 -64.2 -63.18 1.21 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.789 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.6 m -45.91 -43.84 14.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.307 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.417 ' OG ' ' CD1' ' A' ' 88' ' ' PHE . 16.1 p -64.37 -38.03 89.61 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.491 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.51 -55.29 28.88 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.781 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.9 t -50.05 -38.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.087 0.47 . . . . 0.0 110.438 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 85.0 mmm -84.84 -7.45 59.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.362 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -109.17 -12.86 19.12 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.873 -0.404 . . . . 0.0 112.694 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.683 ' HA ' HD13 ' A' ' 102' ' ' ILE . 43.0 mt -32.46 -103.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 99' ' ' HIS . 2.1 p80 -38.17 -43.8 0.79 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -48.65 -88.87 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.606 ' CG2' HD12 ' A' ' 102' ' ' ILE . 3.0 m -69.05 -51.15 46.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.683 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.7 mp -59.79 -45.77 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.047 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.33 -55.49 25.51 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.7 tp -50.4 -53.91 25.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.023 0.439 . . . . 0.0 110.75 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -53.1 -45.4 68.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.463 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 102' ' ' ILE . 37.9 t -53.11 -52.35 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 110' ' ' TYR . 20.1 t-20 -46.87 -42.66 17.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.835 0.35 . . . . 0.0 110.657 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -62.23 -37.32 84.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.505 ' O ' ' CG ' ' A' ' 110' ' ' TYR . 7.4 mp -70.05 -40.53 75.06 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.302 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.505 ' CG ' ' O ' ' A' ' 109' ' ' LEU . 91.4 m-85 -157.35 172.85 17.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.548 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -62.82 -143.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.662 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 61.01 59.8 3.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.725 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.08 -25.22 11.94 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.775 2.317 . . . . 0.0 111.917 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.1 m -72.58 54.26 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.671 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 116' ' ' PRO . 10.9 mt -72.55 153.47 91.73 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.279 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 115' ' ' LEU . 75.0 Cg_exo -35.83 161.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.811 2.34 . . . . 0.0 113.074 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -98.28 118.6 35.3 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.144 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 mm -120.39 126.29 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.712 0.291 . . . . 0.0 110.675 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -124.97 105.43 9.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.119 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.62 159.66 13.63 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -151.28 158.5 43.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.755 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.59 146.06 30.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp -118.69 160.73 39.09 Favored Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.23 -37.08 3.59 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.592 2.195 . . . . 0.0 113.083 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -81.52 45.74 0.9 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.151 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.8 m120 43.76 58.62 3.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.339 0.59 . . . . 0.0 110.742 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -135.09 159.99 39.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.017 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.2 mt -136.96 116.41 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.07 121.46 30.5 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 21.9 tp -118.62 130.99 56.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.251 0.548 . . . . 0.0 110.632 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -126.54 131.22 51.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.517 ' CD1' ' O1A' ' A' ' 182' ' ' HEM . 0.0 OUTLIER -131.46 137.41 48.59 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.252 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 134' ' ' SER . 10.4 p -140.44 133.75 29.77 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.18 0.514 . . . . 0.0 111.92 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 136' ' ' ARG . 0.7 OUTLIER 167.09 155.2 0.11 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.955 179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -67.91 31.93 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.268 1.978 . . . . 0.0 111.673 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.538 ' C ' ' H ' ' A' ' 138' ' ' LEU . 5.5 mpt_? -101.23 95.67 6.69 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 139' ' ' CYS . 83.8 mtm180 -64.86 11.07 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.257 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 136' ' ' ARG . 0.7 OUTLIER -74.67 23.93 0.09 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.818 0.342 . . . . 0.0 110.13 -179.531 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.562 ' HG ' ' HG ' ' A' ' 172' ' ' CYS . 62.5 m -48.88 -64.26 0.86 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.121 0.486 . . . . 0.0 111.38 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -46.73 -37.12 7.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.335 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 5.1 t -65.51 -43.18 90.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -44.54 -51.99 8.42 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.669 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.474 ' OE2' ' CB ' ' A' ' 161' ' ' HIS . 40.0 mt-10 -60.34 -49.34 78.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.281 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.5 -48.75 41.42 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.7 mt -57.89 -54.89 41.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.515 0.198 . . . . 0.0 111.495 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 28.0 mt -54.61 -54.86 35.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.713 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.654 ' CE2' HD12 ' A' ' 159' ' ' ILE . 13.2 m-85 -49.79 -50.79 43.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.943 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -56.92 -51.72 55.46 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.794 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -43.52 -54.59 4.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.441 . . . . 0.0 110.613 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -53.06 -48.86 67.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.053 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -50.59 -53.66 28.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.901 0.381 . . . . 0.0 111.04 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.546 ' HE2' ' CG ' ' A' ' 75' ' ' ASN . 85.6 m-70 -45.73 -49.89 14.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.161 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.61 33.75 0.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 40.75 51.72 3.1 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.148 0.499 . . . . 0.0 110.657 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.497 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 48.7 tp60 -126.86 140.71 52.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.275 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.497 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 29.8 mmtp -115.74 124.77 51.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.472 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 10.8 pt -136.16 170.84 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.665 0.745 . . . . 0.0 112.143 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -132.7 125.74 30.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.852 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.654 HD12 ' CE2' ' A' ' 147' ' ' PHE . 5.3 mt -110.94 117.47 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.676 0.274 . . . . 0.0 110.5 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.3 t -97.65 101.02 12.43 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.959 0.409 . . . . 0.0 109.979 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.52 ' NE2' ' O ' ' A' ' 163' ' ' THR . 11.7 t-160 -104.52 75.4 1.23 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.869 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -80.61 -42.76 21.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.895 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.52 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.4 m -76.05 117.98 18.33 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.913 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 166' ' ' HIS . 1.6 p -144.13 113.79 7.14 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.048 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.8 ttt -37.3 -21.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.853 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.572 ' N ' ' O ' ' A' ' 164' ' ' CYS . 83.3 t60 -52.49 -26.81 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.454 ' CG2' ' N ' ' A' ' 168' ' ' GLY . 4.5 t -88.17 -42.88 12.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.141 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.454 ' N ' ' CG2' ' A' ' 167' ' ' THR . . . 133.72 10.26 1.86 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.5 162.33 10.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.041 0.448 . . . . 0.0 110.939 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -58.88 -33.18 70.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.616 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -170.05 -170.45 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.562 ' HG ' ' HG ' ' A' ' 139' ' ' CYS . 85.0 m -94.61 137.04 34.21 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.971 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.6 tpt -115.68 123.89 49.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.05 103.37 6.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.422 0.629 . . . . 0.0 111.577 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.5 mp -92.89 126.19 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.329 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 177' ' ' GLU . 4.6 mp -112.64 153.17 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.549 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.403 ' N ' HG22 ' A' ' 176' ' ' ILE . 88.1 tt0 -139.5 138.84 36.69 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.571 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 17.0 mt -90.83 144.1 26.05 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.8 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -154.78 -179.49 8.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.559 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.41 HD22 ' CG ' ' A' ' 156' ' ' LYS . 59.2 t30 57.57 43.64 22.28 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.52 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 48.9 p30 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.563 179.922 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.517 ' O1A' ' CD1' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.52 ' O ' ' N ' ' A' ' 3' ' ' GLY . 44.4 mmm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.628 ' HZ2' HG22 ' A' ' 37' ' ' VAL . 17.9 mtpp -55.32 83.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.129 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -179.9 151.51 10.06 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.423 ' H ' HG22 ' A' ' 4' ' ' ILE . 2.0 tp -70.28 -36.28 66.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.968 0.413 . . . . 0.0 110.705 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.4 mm -62.46 -44.57 99.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.096 0.474 . . . . 0.0 109.912 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.503 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 64.7 m-85 -71.34 -25.41 62.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.54 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.539 ' ND2' ' OG ' ' A' ' 38' ' ' SER . 95.4 m-20 -69.4 -52.51 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.071 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.26 -35.0 70.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.423 HD13 ' CD2' ' A' ' 69' ' ' PHE . 31.6 tp -67.44 -40.82 85.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.773 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -55.54 -45.47 77.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.039 0.447 . . . . 0.0 109.839 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.81 -53.75 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.569 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.608 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 49.1 mtm -52.3 -44.28 64.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.118 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.17 -36.61 77.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.75 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.29 -25.83 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.151 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.36 -33.79 21.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.173 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -84.2 -76.16 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.8 m -93.22 -21.84 19.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.26 0.552 . . . . 0.0 110.805 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.7 173.96 22.97 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 122.129 0.85 . . . . 0.0 112.962 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.1 ttt -68.14 -28.38 67.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.65 -1.275 . . . . 0.0 110.408 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -61.83 -39.27 91.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.841 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -77.53 -38.52 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -56.13 -47.84 77.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.128 0.489 . . . . 0.0 110.31 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -75.63 -22.97 56.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.584 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -76.29 -47.11 24.84 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.604 -0.439 . . . . 0.0 112.04 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.981 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.61 -25.53 38.38 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.981 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.3 tt -73.65 -44.15 57.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.492 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -73.05 -21.1 60.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.964 0.411 . . . . 0.0 110.555 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 tttt -87.15 -42.0 13.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.866 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -105.49 1.04 27.26 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.569 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 31' ' ' PRO . . . -152.22 164.62 19.69 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 120.667 0.27 . . . . 0.0 110.792 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 97.4 Cg_exo -34.61 169.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 124.061 3.174 . . . . 0.0 114.267 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 42.0 pttt -73.58 37.72 0.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.794 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 32' ' ' LYS . 6.9 t0 83.64 46.71 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -77.29 19.14 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.094 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.536 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 24.2 m -60.65 132.72 26.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.724 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.536 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 41.6 m-85 -163.71 -106.08 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.965 0.412 . . . . 0.0 111.585 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.628 HG22 ' HZ2' ' A' ' 2' ' ' LYS . 33.5 m -45.94 -178.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.47 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.539 ' OG ' ' ND2' ' A' ' 7' ' ' ASN . 3.1 m -151.8 47.03 0.79 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.329 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.506 ' O ' ' CD2' ' A' ' 111' ' ' HIS . . . -159.03 -6.23 0.07 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.81 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HG2' HG21 ' A' ' 37' ' ' VAL . 5.4 mmpt? -77.28 -168.29 1.09 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.526 0.679 . . . . 0.0 110.834 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.7 t -59.38 137.0 58.15 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.47 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.513 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 54.4 p90 -109.83 127.63 54.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.585 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.39 75.17 4.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.343 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' A' ' 44' ' ' GLU . 0.4 OUTLIER -51.39 -37.85 50.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.721 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.475 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 80.1 p -56.17 -32.51 64.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.708 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -75.96 -36.46 59.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -49.95 -58.42 5.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.198 0.523 . . . . 0.0 110.805 -179.605 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -38.64 -43.09 0.85 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.055 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.6 p -74.14 -30.03 62.09 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.035 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 47' ' ' LEU . 18.6 mt -72.98 -50.66 30.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.123 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 47' ' ' LEU . 1.1 m -60.66 -22.42 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.0 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.694 ' HG3' HD12 ' A' ' 62' ' ' ILE . 2.0 tt0 -80.49 -40.68 25.68 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.898 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.621 ' OD2' HD23 ' A' ' 25' ' ' LEU . 55.9 m-20 -58.83 -57.4 13.21 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.837 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.21 -39.41 78.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.582 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.428 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -58.63 -39.1 79.54 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.857 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -64.64 -32.94 74.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -72.6 -41.78 65.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.196 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.508 ' O ' ' SD ' ' A' ' 60' ' ' MET . 30.1 mt -79.27 -3.96 48.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.503 ' O ' ' SD ' ' A' ' 60' ' ' MET . 10.6 t-20 52.72 46.62 26.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.475 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -125.56 153.05 72.66 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.863 179.308 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.48 136.68 47.63 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.717 1.612 . . . . 0.0 110.816 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.694 HD12 ' HG3' ' A' ' 52' ' ' GLN . 4.9 tt -51.19 -28.76 7.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.819 -178.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.629 ' NE2' ' CZ ' ' A' ' 140' ' ' PHE . 3.0 tp-100 -76.04 -32.22 59.24 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.973 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -80.15 -31.61 38.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.86 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.499 ' CG1' ' CZ ' ' A' ' 69' ' ' PHE . 63.5 t -67.84 -58.17 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -49.86 -40.86 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.495 ' N ' HG13 ' A' ' 66' ' ' VAL . 2.2 ttpp -51.65 -47.18 63.84 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.896 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.36 -59.76 4.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.171 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CZ ' ' CG1' ' A' ' 65' ' ' VAL . 5.1 m-30 -45.15 -29.0 0.83 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.763 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.94 -52.15 50.21 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -55.51 -51.4 67.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.075 0.464 . . . . 0.0 110.302 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.608 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 45.5 m-85 -59.19 -43.38 92.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.757 0.789 . . . . 0.0 110.909 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 tp -52.06 -38.32 56.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.296 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 22.6 t80 -70.87 -41.48 71.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.106 0.479 . . . . 0.0 110.014 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -54.22 -74.52 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.14 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -50.64 -37.18 33.41 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.767 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' A' ' 81' ' ' HIS . 19.2 mt -58.56 -47.25 84.86 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.337 0.569 . . . . 0.0 112.139 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.43 -20.94 0.26 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.231 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' ' 82' ' ' THR . 19.7 t -77.8 -50.17 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 111.003 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -64.28 -64.74 0.8 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.571 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 26.4 p80 -83.64 31.21 0.47 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.737 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 79' ' ' SER . 94.3 m -48.29 -45.85 35.32 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.452 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -53.16 -29.78 33.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.052 0.453 . . . . 0.0 109.863 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 3.3 t -83.21 -23.98 8.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 t -63.31 -39.68 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -53.48 -13.59 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.434 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 84' ' ' VAL . 37.8 mmtm -66.6 -31.08 71.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.51 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 20.5 p90 -120.39 117.13 26.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.059 0.457 . . . . 0.0 110.931 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.36 0.78 48.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.317 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 48.6 t0 -163.86 157.74 19.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.626 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.507 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 82.5 t80 -48.13 -51.44 24.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.712 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 83.9 m -56.32 -41.86 76.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.522 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.3 m -62.74 -36.54 83.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.411 0.624 . . . . 0.0 110.563 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.493 HD12 ' CD2' ' A' ' 88' ' ' PHE . 2.2 tt -65.91 -62.52 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.289 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.5 t -47.43 -41.44 7.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 O-C-N 123.337 0.398 . . . . 0.0 111.879 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.6 ppp? -85.67 -8.11 58.4 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.278 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 98' ' ' ILE . . . -107.77 -14.21 18.11 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.461 -0.4 . . . . 0.0 112.334 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.606 ' HA ' HD13 ' A' ' 102' ' ' ILE . 33.4 mt -31.87 -97.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 117.398 0.599 . . . . 0.0 111.997 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -39.95 -49.99 2.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.173 0.511 . . . . 0.0 111.377 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -46.89 -90.02 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.568 ' CG2' HD12 ' A' ' 102' ' ' ILE . 2.6 m -68.97 -50.75 51.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.606 HD13 ' HA ' ' A' ' 98' ' ' ILE . 4.1 mp -64.19 -42.52 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.493 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.56 -57.98 10.22 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.595 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 56.7 tp -46.73 -55.11 8.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.143 0.496 . . . . 0.0 110.438 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -52.41 -44.52 65.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.8 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 102' ' ' ILE . 30.4 t -55.44 -52.32 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -47.04 -44.75 20.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.64 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.595 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 27.0 mmtm -58.9 -34.79 72.07 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.932 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -57.9 -35.24 70.76 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.435 ' CB ' ' O ' ' A' ' 109' ' ' LEU . 9.5 t80 82.04 102.42 0.06 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.694 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 36.0 t-80 -173.6 -0.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.458 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 111' ' ' HIS . 7.1 pt-20 32.81 61.46 1.48 Allowed Pre-proline 0 N--CA 1.468 0.456 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.68 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.53 -15.51 13.82 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.827 2.352 . . . . 0.0 112.159 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.7 t 57.54 84.51 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.505 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.4 mt -74.36 147.98 85.62 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.502 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.89 -177.14 2.7 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.246 1.964 . . . . 0.0 111.95 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -84.55 113.5 21.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.557 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.8 mt -128.48 129.1 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.674 0.273 . . . . 0.0 110.886 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -134.08 123.34 24.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.718 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.91 127.01 7.04 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.458 ' C ' HD12 ' A' ' 122' ' ' LEU . 86.9 mt-30 -117.33 166.34 12.41 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.458 HD12 ' C ' ' A' ' 121' ' ' GLN . 11.2 mp -109.31 133.96 52.39 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.93 160.71 28.84 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 125' ' ' ASN . 58.5 Cg_endo -71.78 159.02 51.83 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.188 1.925 . . . . 0.0 111.883 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.605 HD22 HD21 ' A' ' 126' ' ' ASN . 11.0 t30 90.91 -59.17 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.296 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.629 ' N ' HD22 ' A' ' 126' ' ' ASN . 0.0 OUTLIER 151.83 53.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.894 0.747 . . . . 0.0 109.499 179.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -127.74 164.06 22.96 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.976 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.4 mt -141.24 119.2 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.67 123.33 33.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.083 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 47.4 tp -118.24 132.34 56.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.074 0.464 . . . . 0.0 110.965 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -115.7 122.81 46.65 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.234 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.519 ' CE2' HMA1 ' A' ' 182' ' ' HEM . 22.8 t80 -125.63 124.58 41.5 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.585 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.05 122.15 23.73 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.765 0.316 . . . . 0.0 110.199 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.8 t -153.76 143.01 14.87 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.047 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.95 -6.93 18.71 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.962 1.775 . . . . 0.0 112.012 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -78.42 -20.3 51.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.124 0.488 . . . . 0.0 110.339 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 60.39 29.63 19.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.984 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp -83.46 15.2 3.17 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.332 0.587 . . . . 0.0 109.94 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 32.9 m -41.73 -48.29 4.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.702 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.629 ' CZ ' ' NE2' ' A' ' 63' ' ' GLN . 98.2 m-85 -48.13 -39.88 21.93 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.708 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.3 t -64.44 -43.23 94.95 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 139' ' ' CYS . . . -45.97 -52.97 10.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.436 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -55.14 -50.07 70.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.08 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.97 -48.22 46.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.09 -54.23 49.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.743 0.306 . . . . 0.0 111.369 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.8 mt -54.88 -55.66 27.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.849 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.563 ' CE2' HD12 ' A' ' 159' ' ' ILE . 14.1 m-85 -49.75 -48.53 50.14 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.817 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.95 -51.31 59.94 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.35 -60.13 2.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.736 0.303 . . . . 0.0 110.832 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' ' 155' ' ' GLN . . . -51.34 -51.09 57.56 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.317 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -52.98 -48.75 67.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.053 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -47.97 -49.15 31.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.504 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 73.3 t80 -83.42 36.28 0.52 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.71 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 40.78 58.25 2.48 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.939 0.399 . . . . 0.0 111.228 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.629 HE21 HG23 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -132.63 152.59 51.61 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.52 ' N ' ' NE2' ' A' ' 155' ' ' GLN . 62.6 mttp -120.8 117.94 28.71 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.629 HG23 HE21 ' A' ' 155' ' ' GLN . 36.5 pt -130.68 169.7 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.624 0.726 . . . . 0.0 112.63 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -134.73 127.12 30.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.898 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.563 HD12 ' CE2' ' A' ' 147' ' ' PHE . 3.8 mt -110.42 118.65 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.8 m -103.01 111.55 23.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.398 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 161' ' ' HIS . 16.7 p80 -96.61 77.22 2.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.513 0.673 . . . . 0.0 111.558 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 54.7 t0 -82.1 -3.3 54.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.415 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.56 114.6 8.64 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.438 ' O ' HG22 ' A' ' 167' ' ' THR . 92.3 m -118.62 -175.93 2.99 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.628 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 72.7 mtp -94.73 -26.47 16.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -55.61 -23.66 28.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.798 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 164' ' ' CYS . 4.0 t -87.16 -29.69 21.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.5 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.41 18.0 22.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.63 167.03 9.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.847 0.356 . . . . 0.0 110.423 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.544 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 94.4 m-20 -45.55 -49.6 13.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.69 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.544 ' ND1' ' O ' ' A' ' 170' ' ' ASP . 73.6 m-70 -160.76 -168.14 2.03 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.5 t -93.85 144.27 25.59 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.149 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.2 120.93 36.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.061 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.53 103.62 7.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.469 0.652 . . . . 0.0 110.502 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 175' ' ' ILE . 1.4 mp -89.95 127.12 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.379 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mp -110.93 150.51 13.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.32 0.581 . . . . 0.0 110.869 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -136.17 136.08 39.71 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.897 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.2 mt -96.83 159.72 14.76 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.62 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -138.93 167.66 21.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.845 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -71.59 -40.03 70.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.731 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.561 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.519 HMA1 ' CE2' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' H2 ' ' HA ' ' A' ' 39' ' ' ALA . 86.9 mtp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HZ1' ' CD ' ' A' ' 112' ' ' GLU . 55.2 mttp -148.09 -155.85 0.67 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.538 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.16 -16.3 61.37 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.654 HD13 ' NH1' ' A' ' 80' ' ' ARG . 2.5 tp -53.9 -38.46 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.029 0.443 . . . . 0.0 109.881 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.3 -54.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -60.99 -31.22 70.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.267 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -59.94 -60.33 4.0 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.075 0.464 . . . . 0.0 111.428 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.18 -24.26 29.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.474 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.8 tp -74.29 -41.75 60.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.516 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.533 ' OE2' ' CG ' ' A' ' 36' ' ' TYR . 3.4 mt-10 -58.16 -39.25 78.35 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.316 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -60.9 -56.04 25.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.532 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 18.1 tpt -50.73 -41.66 56.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.203 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.31 -34.45 62.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.692 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 10' ' ' GLU . 40.8 t -63.36 -23.96 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.22 0.533 . . . . 0.0 110.055 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.65 -33.99 18.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.96 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -85.63 -76.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.7 m -91.37 -19.2 23.17 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.52 171.85 28.12 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.847 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.7 ttt -67.37 -29.51 69.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.776 -1.212 . . . . 0.0 110.327 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 t -61.92 -41.5 98.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.947 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.78 -38.64 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -51.64 -45.89 63.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.0 109.732 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -71.76 -29.8 64.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.011 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.525 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 75.5 mt-10 -68.12 -51.64 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.966 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.91 -23.2 48.76 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.436 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.966 ' N ' HD13 ' A' ' 25' ' ' LEU . 8.7 tt -74.26 -41.88 60.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.528 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -66.97 -19.08 65.66 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 24' ' ' GLU . 1.1 ptpp? -91.66 -29.0 17.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.505 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 3.4 m-70 -94.2 -88.4 0.24 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.82 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 26' ' ' LEU . . . -74.85 151.9 86.71 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.57 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -67.46 147.85 78.02 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.626 2.218 . . . . 0.0 111.95 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -83.06 -22.63 33.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.726 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -67.43 -46.15 73.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.929 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.431 ' O ' ' OH ' ' A' ' 42' ' ' TYR . 30.9 mmm-85 -71.82 94.52 1.42 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.134 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -61.06 138.63 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.483 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.533 ' CG ' ' OE2' ' A' ' 10' ' ' GLU . 49.6 p90 -78.95 125.79 29.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.966 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.554 HG23 ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -143.9 148.67 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.614 179.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.7 m -77.09 39.31 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.854 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.554 ' H ' HG23 ' A' ' 37' ' ' VAL . . . -151.63 -2.15 0.31 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.008 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.531 ' CG ' HG22 ' A' ' 37' ' ' VAL . 14.2 mmtt -87.37 167.97 13.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.049 0.452 . . . . 0.0 110.423 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.5 t -91.49 44.32 1.18 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.01 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' A' ' 34' ' ' ARG . 3.2 m-85 -57.28 137.32 56.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.21 123.07 27.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.588 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.501 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 36.8 mp0 -65.68 -28.97 69.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 95.3 p -56.93 -33.76 67.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.821 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -68.32 -33.79 74.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.027 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 50' ' ' ILE . 0.6 OUTLIER -43.17 -57.5 2.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.165 0.507 . . . . 0.0 110.641 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -38.8 -43.43 0.92 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.724 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.1 m -71.84 -32.44 67.54 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.42 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' LEU . 2.6 mp -71.71 -53.81 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.667 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.446 HG13 ' H ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -55.9 -23.37 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.374 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.674 ' HG3' HD12 ' A' ' 62' ' ' ILE . 4.7 tt0 -79.79 -40.1 29.39 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.14 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 4.4 m-20 -59.69 -57.01 14.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.586 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 55' ' ' ALA . 6.8 p -56.17 -41.09 68.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.522 -0.763 . . . . 0.0 108.998 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.412 ' N ' HG13 ' A' ' 54' ' ' VAL . . . -57.05 -39.1 74.22 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.944 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -64.93 -34.6 78.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.4 mmt-85 -70.52 -38.26 74.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.178 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.518 ' O ' ' SD ' ' A' ' 60' ' ' MET . 49.0 mt -82.7 -4.9 58.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.519 ' O ' ' SD ' ' A' ' 60' ' ' MET . 41.1 t-20 51.76 44.52 29.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.244 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -125.82 155.81 72.24 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.854 179.188 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.19 140.53 71.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.015 1.81 . . . . 0.0 111.036 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.674 HD12 ' HG3' ' A' ' 52' ' ' GLN . 5.9 tt -55.44 -27.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.859 -178.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' CD ' ' CZ ' ' A' ' 140' ' ' PHE . 88.6 mt-30 -76.36 -33.46 58.93 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.45 -30.07 42.06 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.088 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG12 ' CZ ' ' A' ' 69' ' ' PHE . 96.8 t -72.06 -56.07 11.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.499 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -50.98 -40.12 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.499 ' N ' HG13 ' A' ' 66' ' ' VAL . 1.9 ttpt -52.66 -50.98 62.15 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.895 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.28 -53.98 42.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.721 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.485 ' CZ ' HG12 ' A' ' 65' ' ' VAL . 2.9 m-30 -54.25 -27.98 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.92 -52.78 45.57 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -56.44 -47.93 78.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 0.8 OUTLIER -59.33 -43.97 92.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.866 0.841 . . . . 0.0 110.337 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -53.35 -38.68 63.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.809 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.455 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 26.2 t80 -69.84 -41.25 75.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.934 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -55.15 -71.87 0.08 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.781 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.61 -44.48 22.91 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.405 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.8 mt -56.36 -40.63 74.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.0 0.4 . . . . 0.0 111.431 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -59.31 -29.29 67.51 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.879 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.9 t -72.83 -54.17 9.52 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.828 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.654 ' NH1' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -72.59 -49.48 31.95 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.222 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -83.97 25.44 0.82 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.442 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 52.6 m -50.44 -38.92 46.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.045 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -57.14 -32.41 66.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.18 -22.07 9.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.547 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 87' ' ' LYS . 40.9 t -69.25 -42.63 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.649 -0.421 . . . . 0.0 109.952 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -52.51 -15.02 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.034 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' N ' ' C ' ' A' ' 85' ' ' VAL . 38.4 mmtm -67.58 -29.92 69.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.648 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.565 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 13.1 p90 -120.85 119.84 33.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.063 0.459 . . . . 0.0 110.967 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -86.28 1.88 49.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.447 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.48 ' OD1' ' CE2' ' A' ' 153' ' ' PHE . 45.4 t0 -166.75 160.15 14.48 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.22 0.533 . . . . 0.0 111.627 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 95' ' ' VAL . 84.2 t80 -51.54 -51.05 58.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.941 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.8 m -55.67 -45.38 77.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.734 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 90' ' ' ASP . 54.9 p -61.66 -36.45 80.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.408 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.483 HD12 ' CD2' ' A' ' 88' ' ' PHE . 5.2 tt -65.89 -52.16 52.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.23 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.416 HG21 ' CE2' ' A' ' 91' ' ' PHE . 69.8 t -56.31 -36.69 47.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.208 0.527 . . . . 0.0 110.43 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 95.5 mmm -86.61 -6.89 58.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.33 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 98' ' ' ILE . . . -112.9 -14.82 9.75 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.982 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.581 ' HA ' HD13 ' A' ' 102' ' ' ILE . 10.3 mt -30.05 -100.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 117.648 0.724 . . . . 0.0 112.348 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -40.35 -49.05 2.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.023 0.44 . . . . 0.0 111.182 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -46.22 -88.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.577 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.6 m -70.67 -52.88 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.581 HD13 ' HA ' ' A' ' 98' ' ' ILE . 3.3 mp -60.62 -46.12 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.302 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.92 -55.25 30.8 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.7 tp -51.74 -53.45 39.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -53.5 -47.36 69.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.159 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 102' ' ' ILE . 33.6 t -52.44 -49.22 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -50.13 -41.44 48.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.778 0.323 . . . . 0.0 110.637 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -62.32 -38.61 90.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.722 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.14 -40.94 77.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -158.64 144.64 16.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.419 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -63.6 -154.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.426 ' CD ' ' HZ1' ' A' ' 2' ' ' LYS . 36.0 tt0 61.09 60.67 3.15 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.752 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.471 ' C ' ' H ' ' A' ' 115' ' ' LEU . 73.7 Cg_endo -75.23 35.84 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.69 2.26 . . . . 0.0 111.701 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.7 m -70.8 38.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.853 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.471 ' H ' ' C ' ' A' ' 113' ' ' PRO . 11.2 mt -71.59 152.32 93.7 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.97 168.63 22.6 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.384 2.056 . . . . 0.0 112.08 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -81.53 116.29 21.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.323 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.5 mt -127.5 128.25 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.728 0.299 . . . . 0.0 110.879 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -132.61 119.66 20.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.744 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -113.72 137.88 14.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -135.04 128.31 32.08 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.565 0.221 . . . . 0.0 110.532 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 tp -76.89 149.52 36.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.756 0.312 . . . . 0.0 111.07 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.18 160.47 43.16 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.12 -36.43 4.28 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.578 2.185 . . . . 0.0 113.059 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -80.65 46.41 0.87 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.046 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 43.49 55.87 4.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.52 0.676 . . . . 0.0 110.739 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -133.48 159.22 41.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.876 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.0 mt -136.65 114.65 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.5 121.58 29.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.084 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.7 tp -116.16 134.7 54.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.094 0.473 . . . . 0.0 110.619 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -120.58 124.55 45.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -122.34 105.99 10.69 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.68 121.19 41.78 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 121.198 -0.201 . . . . 0.0 110.539 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 136' ' ' ARG . 4.8 p -174.64 149.25 1.29 Allowed Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.374 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.9 18.09 0.37 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.086 1.858 . . . . 0.0 110.817 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.553 ' NE ' ' CGA' ' A' ' 182' ' ' HEM . 25.1 mtp180 -95.83 104.65 16.59 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.64 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -71.15 40.37 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.634 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.479 ' H ' ' C ' ' A' ' 136' ' ' ARG . 1.6 tp -102.09 9.67 40.1 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.112 0.482 . . . . 0.0 110.268 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.9 t -40.05 -48.21 2.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.638 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.417 ' CZ ' ' CD ' ' A' ' 63' ' ' GLN . 90.7 m-85 -48.2 -36.87 14.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.613 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 53.8 t -68.53 -44.4 74.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.023 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.78 -45.71 14.83 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.507 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -63.97 -48.96 74.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.217 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.08 -48.12 39.73 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.4 mt -59.96 -53.55 56.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.734 0.302 . . . . 0.0 111.535 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.9 mt -54.81 -55.88 25.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.078 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.594 ' CE2' HD12 ' A' ' 159' ' ' ILE . 21.7 m-85 -51.68 -48.14 63.59 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.978 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.69 -51.66 56.63 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -44.21 -60.27 1.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.754 0.311 . . . . 0.0 111.008 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -49.38 -50.87 38.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.005 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -52.44 -47.14 66.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.249 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -50.01 -50.69 46.47 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.704 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.51 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 69.5 t80 -86.11 37.03 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.933 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 39.17 55.71 2.14 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.937 0.398 . . . . 0.0 111.061 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.566 ' NE2' ' H ' ' A' ' 156' ' ' LYS . 49.0 tp60 -129.87 141.65 50.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.566 ' H ' ' NE2' ' A' ' 155' ' ' GLN . 62.4 tttm -112.34 125.61 54.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.259 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 26.1 pt -137.07 170.15 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.61 0.719 . . . . 0.0 111.993 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -134.96 126.62 28.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.116 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.594 HD12 ' CE2' ' A' ' 147' ' ' PHE . 4.5 mt -110.52 116.8 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.669 0.271 . . . . 0.0 110.328 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.3 t -101.46 107.94 19.38 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.383 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.559 ' CD2' ' O ' ' A' ' 161' ' ' HIS . 55.8 p-80 -93.97 65.79 3.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.605 0.717 . . . . 0.0 111.065 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -68.25 -25.35 65.14 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.823 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.502 ' HB ' ' H ' ' A' ' 173' ' ' MET . 1.8 m -112.52 112.0 23.24 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.588 ' O ' ' N ' ' A' ' 166' ' ' HIS . 49.9 t -137.3 115.26 11.5 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.602 0.239 . . . . 0.0 110.839 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.412 ' C ' ' N ' ' A' ' 167' ' ' THR . 24.0 ttt -35.18 -22.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.261 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 164' ' ' CYS . 57.7 t-80 -51.11 -21.45 1.92 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.464 HG23 ' N ' ' A' ' 168' ' ' GLY . 6.7 t -90.08 -41.35 11.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.913 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.464 ' N ' HG23 ' A' ' 167' ' ' THR . . . 124.81 15.0 3.3 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.08 155.86 30.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.976 0.417 . . . . 0.0 110.821 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.92 -27.93 21.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.379 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -172.49 178.87 2.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 6.3 m -94.46 139.72 30.77 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.66 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.502 ' H ' ' HB ' ' A' ' 163' ' ' THR . 16.2 ttm -127.62 94.99 4.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.525 0.679 . . . . 0.0 109.68 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.1 mt -93.12 113.07 25.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.523 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.9 mm -89.14 126.16 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.585 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.38 148.72 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.25 0.548 . . . . 0.0 110.268 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -137.8 136.8 37.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.339 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.3 mt -93.9 146.05 24.19 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.863 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -141.56 178.2 7.62 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.858 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 15.1 m120 54.35 43.62 30.19 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.59 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 51.0 p30 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.591 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.553 ' CGA' ' NE ' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' IMD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_